Citrus Sinensis ID: 021774
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 307 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.846 | 0.250 | 0.536 | 7e-77 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.986 | 0.293 | 0.443 | 1e-76 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.908 | 0.273 | 0.507 | 3e-76 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.846 | 0.251 | 0.528 | 4e-76 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.980 | 0.291 | 0.453 | 9e-76 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.824 | 0.265 | 0.542 | 5e-74 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.853 | 0.258 | 0.530 | 1e-73 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.934 | 0.281 | 0.486 | 1e-71 | |
| Q8GWJ7 | 645 | Cysteine-rich receptor-li | no | no | 0.977 | 0.465 | 0.443 | 8e-68 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.973 | 0.440 | 0.456 | 6e-67 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 287 bits (734), Expect = 7e-77, Method: Compositional matrix adjust.
Identities = 140/261 (53%), Positives = 184/261 (70%), Gaps = 1/261 (0%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G IAVK LS++SKQG REF+TEI +S ++HPNLV+L GCC++G +LVYEY+
Sbjct: 686 GVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYL 745
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL R L G K + L+W R+ IC+GIAKGLA+LHEE IVHRDIKA+N+LLD
Sbjct: 746 ENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDL 805
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
N KI DFGLAKL D THI+TRIAGT GY+APEY + G LT KADVYSFGV+ LEI+
Sbjct: 806 SLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIV 865
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQA 240
SG+++ + +LL+WA+ L ++ LELVDP+LG + E +R + +A CT
Sbjct: 866 SGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNP 925
Query: 241 AASRRPQMNQVIKMLTKNIRL 261
+ + RP M+ V+ ML I++
Sbjct: 926 SPTLRPPMSSVVSMLEGKIKV 946
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 138/311 (44%), Positives = 207/311 (66%), Gaps = 8/311 (2%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +GR +AVK LS S+QG +F+ EI+ +S V+H NLV+L GCC +G R+LVYEY+
Sbjct: 710 GKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYL 769
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N SLD+ L G + + L+W R +IC+G+A+GL +LHEE IVHRD+KASNILLD
Sbjct: 770 PNGSLDQALFG--EKTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDS 827
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ PK+ DFGLAKL+ D THI+TR+AGT GYLAPEY + G LT K DVY+FGV+ LE++
Sbjct: 828 KLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELV 887
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SGR + ++LLEWAW LH++ + +EL+D +L E+ E R + +A CTQ +
Sbjct: 888 SGRPNSDENLEDEKRYLLEWAWNLHEKGREVELIDHQLTEFNMEEGKRMIGIALLCTQTS 947
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGL-----FQDSESSSVGTSDKKSSDSTLQMSS 296
+ RP M++V+ ML+ ++ +++ + PG F D+ +SS+ +++ ++ +S
Sbjct: 948 HALRPPMSRVVAMLSGDVEVSDVT-SKPGYLTDWRFDDTTASSISGFPLRNTQASESFTS 1006
Query: 297 VPVTITQVTPR 307
++++PR
Sbjct: 1007 FVAPRSEISPR 1017
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 142/280 (50%), Positives = 190/280 (67%), Gaps = 1/280 (0%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G +T+G IAVK LSA+SKQG REF+ EI +S ++HP+LV+L GCCV+G + +LVYEY+
Sbjct: 689 GIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYL 748
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL R L G + I LNW R ICVGIA+GLA+LHEE IVHRDIKA+N+LLD+
Sbjct: 749 ENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 808
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
E NPKI DFGLAKL + THI+TR+AGT GY+APEY + G LT KADVYSFGV+ LEI+
Sbjct: 809 ELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIV 868
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQA 240
G+++ + +LL+W L ++ LE+VDP LG +Y E + +++ CT
Sbjct: 869 HGKSNTSSRSKADTFYLLDWVHVLREQNTLLEVVDPRLGTDYNKQEALMMIQIGMLCTSP 928
Query: 241 AASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSV 280
A RP M+ V+ ML + +N E+L + + + SV
Sbjct: 929 APGDRPSMSTVVSMLEGHSTVNVEKLLEASVNNEKDEESV 968
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 138/261 (52%), Positives = 184/261 (70%), Gaps = 1/261 (0%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G IAVK LS++SKQG REF+TEI +S ++HPNLV+L GCC++G +LVYEY+
Sbjct: 684 GVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYL 743
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL R L G K + L+W R+ +C+GIAKGLA+LHEE IVHRDIKA+N+LLD
Sbjct: 744 ENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDL 803
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
N KI DFGLAKL + THI+TRIAGT GY+APEY + G LT KADVYSFGV+ LEI+
Sbjct: 804 SLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIV 863
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQA 240
SG+++ + +LL+WA+ L ++ LELVDP+LG + E +R + +A CT
Sbjct: 864 SGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNP 923
Query: 241 AASRRPQMNQVIKMLTKNIRL 261
+ + RP M+ V+ ML I++
Sbjct: 924 SPTLRPPMSSVVSMLQGKIKV 944
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 283 bits (725), Expect = 9e-76, Method: Compositional matrix adjust.
Identities = 141/311 (45%), Positives = 204/311 (65%), Gaps = 10/311 (3%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +GR +AVK LS S+QG +F+ EI+ +S+V H NLV+L GCC +G R+LVYEY+
Sbjct: 711 GNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYL 770
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N SLD+ L G + L+W R +IC+G+A+GL +LHEE IVHRD+KASNILLD
Sbjct: 771 PNGSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDS 828
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
P+I DFGLAKL+ D THI+TR+AGT GYLAPEY + G LT K DVY+FGV+ LE++
Sbjct: 829 RLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELV 888
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SGR + + K+LLEWAW LH++ + +EL+D +L ++ E R + +A CTQ +
Sbjct: 889 SGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTS 948
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGL-----FQDSESSSVGTSDKKSSDSTLQMSS 296
+ RP M++V+ ML+ ++ + + + PG F D+ SS+ S + D+T S
Sbjct: 949 HALRPPMSRVVAMLSGDVEIGDVT-SKPGYVSDWRFDDTTGSSL--SGFQIKDTTGYSMS 1005
Query: 297 VPVTITQVTPR 307
+ ++++PR
Sbjct: 1006 LVAPGSEISPR 1016
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 5e-74, Method: Compositional matrix adjust.
Identities = 139/256 (54%), Positives = 181/256 (70%), Gaps = 3/256 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G IAVK LS SKQG REF+ EI +S + HPNLV+L GCCV+G + +LVYE+V
Sbjct: 641 GKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFV 700
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL R L G + ++L+W R IC+G+A+GLA+LHEE IVHRDIKA+N+LLD+
Sbjct: 701 ENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDK 760
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ NPKI DFGLAKL ++ THI+TRIAGT GY+APEY + G LT KADVYSFG++ LEI+
Sbjct: 761 QLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV 820
Query: 182 SGRNSGKAMWGQMNKF-LLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQ 239
GR S K + N F L++W L ++ LELVDP LG EY E + +++A CT
Sbjct: 821 HGR-SNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTS 879
Query: 240 AAASRRPQMNQVIKML 255
+ RP M++V+KML
Sbjct: 880 SEPCERPSMSEVVKML 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 140/264 (53%), Positives = 184/264 (69%), Gaps = 2/264 (0%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L+ G+ IAVK LSA+S+QG REF+ EI +S ++HPNLV+L GCCV+G + ILVYEY+
Sbjct: 695 GELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLILVYEYL 754
Query: 62 ENNSLDRVLLGATKAN-IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
ENN L R L G +++ +KL+W R I +GIAKGL FLHEE IVHRDIKASN+LLD
Sbjct: 755 ENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLD 814
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
++ N KI DFGLAKL D THI+TRIAGT GY+APEY + G LT KADVYSFGV+ LEI
Sbjct: 815 KDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEI 874
Query: 181 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQ 239
+SG+++ + +LL+WA+ L + LELVDP L +Y E + + VA CT
Sbjct: 875 VSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELVDPTLASDYSEEEAMLMLNVALMCTN 934
Query: 240 AAASRRPQMNQVIKMLTKNIRLNE 263
A+ + RP M+QV+ ++ + E
Sbjct: 935 ASPTLRPTMSQVVSLIEGKTAMQE 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 142/292 (48%), Positives = 194/292 (66%), Gaps = 5/292 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L++G IAVK LS++S QG REF+ EI +S + HPNLV+L GCCV+ + +LVYEY+
Sbjct: 690 GELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLVYEYM 749
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL L G + ++KL+W R ICVGIA+GL FLH+ +VHRDIK +N+LLD
Sbjct: 750 ENNSLALALFG--QNSLKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDT 807
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ N KI DFGLA+L THI+T++AGT GY+APEY L GQLT KADVYSFGV+ +EI+
Sbjct: 808 DLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFGVVAMEIV 867
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQA 240
SG+++ K + L+ WA L Q LE+VD L GE+ +E +R +KVA CT +
Sbjct: 868 SGKSNTKQQGNADSVSLINWALTLQQTGDILEIVDRMLEGEFNRSEAVRMIKVALVCTNS 927
Query: 241 AASRRPQMNQVIKMLTKNIRLNEEELTAPGLF-QDSESSSVGTSDKKSSDST 291
+ S RP M++ +KML I + + ++ PG++ D S + D SS ST
Sbjct: 928 SPSLRPTMSEAVKMLEGEIEIT-QVMSDPGIYGHDWSISKLRDIDTHSSSST 978
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 257 bits (656), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 137/309 (44%), Positives = 196/309 (63%), Gaps = 9/309 (2%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL++G ++AVK LS S QG +EF E++ ++ ++H NLV+L+G C++G +ILVYE+V
Sbjct: 343 GTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFV 402
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N SLD L +T +KL+W +R I GIA+G+ +LH++ I+HRD+KA NILLD
Sbjct: 403 PNKSLDHFLFDST-MKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDD 461
Query: 122 EFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ NPKI DFG+A++F D +T R+ GT GY++PEY + GQ +MK+DVYSFGVLVLEI
Sbjct: 462 DMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEI 521
Query: 181 ISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE-YPPNEIIRYMKVAFFCT 238
ISG +NS + L+ + W+L P ELVDP G+ Y +EI R + +A C
Sbjct: 522 ISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCV 581
Query: 239 QAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVP 298
Q A RP M+ +++MLT ++ + E PG F S+ G S DS+ S
Sbjct: 582 QEDAEDRPTMSSIVQMLTTSL-IALAEPRPPGFFFRSKQEQAG----PSIDSSTHCSVDE 636
Query: 299 VTITQVTPR 307
+IT+VTPR
Sbjct: 637 ASITRVTPR 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 6e-67, Method: Compositional matrix adjust.
Identities = 143/313 (45%), Positives = 194/313 (61%), Gaps = 14/313 (4%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G G+ IAVK LS S QG EF EI+ L+ ++H NLV LIG C+QG R+LVYE++
Sbjct: 374 GVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFI 433
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+N SLD+ + K + L+W R + GIA+GL +LHE+ I+HRD+KASNILLDQ
Sbjct: 434 KNASLDQFIFDTEKRQL-LDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQ 492
Query: 122 EFNPKIGDFGLAKLFPDN--ITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
E NPKI DFGLAKLF +TH T+RIAGT GY+APEY + GQ ++K DV+SFGVLV+
Sbjct: 493 EMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVI 552
Query: 179 EIISGR--NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236
EII+G+ N+G + + + LL W W+ +E+ L ++DP L NEI+R + +
Sbjct: 553 EIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLL 612
Query: 237 CTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSE--SSSVGTSDKKSSDSTLQM 294
C Q +A+ RP M V M LN T P + + S V S+ SS LQM
Sbjct: 613 CVQESAATRPTMATVSLM------LNSYSFTLPTPLRPAFVLESVVIPSNVSSSTEGLQM 666
Query: 295 SSVPVTITQVTPR 307
SS VT+++ +PR
Sbjct: 667 SSNDVTVSEFSPR 679
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 307 | ||||||
| 356521337 | 367 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.825 | 0.742 | 1e-133 | |
| 356548747 | 367 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.822 | 0.733 | 1e-130 | |
| 297742896 | 441 | unnamed protein product [Vitis vinifera] | 0.980 | 0.682 | 0.741 | 1e-129 | |
| 359496587 | 364 | PREDICTED: probable LRR receptor-like se | 0.980 | 0.826 | 0.741 | 1e-129 | |
| 224078940 | 306 | predicted protein [Populus trichocarpa] | 0.889 | 0.892 | 0.772 | 1e-126 | |
| 255555999 | 367 | Serine/threonine-protein kinase PBS1, pu | 0.996 | 0.833 | 0.715 | 1e-126 | |
| 358346657 | 392 | hypothetical protein MTR_084s0004 [Medic | 0.990 | 0.775 | 0.714 | 1e-125 | |
| 224125454 | 310 | predicted protein [Populus trichocarpa] | 0.885 | 0.877 | 0.746 | 1e-123 | |
| 449457713 | 383 | PREDICTED: probable leucine-rich repeat | 0.996 | 0.798 | 0.649 | 1e-116 | |
| 357446519 | 370 | Cysteine-rich receptor-like protein kina | 0.986 | 0.818 | 0.662 | 1e-116 |
| >gi|356521337|ref|XP_003529313.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1234), Expect = e-133, Method: Compositional matrix adjust.
Identities = 228/307 (74%), Positives = 266/307 (86%), Gaps = 4/307 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL NGR++AVK LSA SKQGVREF+TEI T+SNV+HPNLVEL+GCCVQ RILVYE+V
Sbjct: 64 GTLKNGRQVAVKTLSAGSKQGVREFLTEIKTISNVKHPNLVELVGCCVQEPNRILVYEFV 123
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSLDR LLG+ +NI+L+W KRS IC+G A+GLAFLHEE VPHIVHRDIKASNILLD+
Sbjct: 124 ENNSLDRALLGSRGSNIRLDWRKRSAICMGTARGLAFLHEEHVPHIVHRDIKASNILLDR 183
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+FNPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GGQLTMKADVYSFGVL+LEII
Sbjct: 184 DFNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGQLTMKADVYSFGVLILEII 243
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SG++S + WG NKFLLEWAWQL++E K LELVDP++ E+P E+IRYMKVAFFCTQAA
Sbjct: 244 SGKSSARTNWGGSNKFLLEWAWQLYEEGKLLELVDPDMVEFPEKEVIRYMKVAFFCTQAA 303
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDST-LQMSSVPVT 300
ASRRP M+QV+ ML+KN+RLNE++LTAPGLFQDS +SS K S +ST Q SS P +
Sbjct: 304 ASRRPMMSQVVDMLSKNMRLNEKQLTAPGLFQDSGASS---QKKSSFESTGYQFSSNPSS 360
Query: 301 ITQVTPR 307
ITQ+ PR
Sbjct: 361 ITQLAPR 367
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548747|ref|XP_003542761.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1213), Expect = e-130, Method: Compositional matrix adjust.
Identities = 226/308 (73%), Positives = 265/308 (86%), Gaps = 6/308 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL NG+++AVK LSA SKQGVREF+TEI T+SNV+HPNLVEL+GCCVQ RILVYEYV
Sbjct: 64 GTLKNGQQVAVKTLSAGSKQGVREFLTEIKTISNVKHPNLVELVGCCVQEPNRILVYEYV 123
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSLDR LLG +NI+L+W KRS IC+G A+GLAFLHEELVPHIVHRDIKASNILLD+
Sbjct: 124 ENNSLDRALLGPRSSNIRLDWRKRSAICMGTARGLAFLHEELVPHIVHRDIKASNILLDR 183
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+F PKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GGQLTMKADVYSFGVL+LEII
Sbjct: 184 DFKPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGQLTMKADVYSFGVLILEII 243
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SG++S + WG NKFLLEWAW L++E K LELVDP++ E+P E+IRYMKVAFFCTQAA
Sbjct: 244 SGKSSARTNWGGSNKFLLEWAWNLYEEGKLLELVDPDMVEFPEEEVIRYMKVAFFCTQAA 303
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSS--DSTLQMSSVPV 299
ASRRP M+QV+ ML+KN+RLNE++LTAPGLFQDS +S S KKSS ++ Q SS
Sbjct: 304 ASRRPMMSQVVDMLSKNMRLNEKQLTAPGLFQDSGAS----SQKKSSFESTSYQFSSNSS 359
Query: 300 TITQVTPR 307
+ITQ++PR
Sbjct: 360 SITQLSPR 367
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742896|emb|CBI35687.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1203), Expect = e-129, Method: Compositional matrix adjust.
Identities = 227/306 (74%), Positives = 259/306 (84%), Gaps = 5/306 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL NGR +AVK LS SKQG+REF+TEI T+SNVRHPNLVELIGCCV G +ILVYEYV
Sbjct: 141 GTLKNGREVAVKMLSTSSKQGLREFLTEINTISNVRHPNLVELIGCCVHGNNKILVYEYV 200
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNS+D+VLLG I L+W KRS IC+G A+GLAFLHEELVPHIVHRDIKASNILL++
Sbjct: 201 ENNSIDQVLLGH---KIILDWGKRSAICMGTARGLAFLHEELVPHIVHRDIKASNILLEK 257
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+F+PKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLTMKADVYSFGVLVLEII
Sbjct: 258 DFSPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTMKADVYSFGVLVLEII 317
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SG+ S +A +G KFLLEWAWQLH E + LELVDPEL E+P E++RY KVAFFCTQAA
Sbjct: 318 SGKTSSQANFGGSQKFLLEWAWQLHIEGRFLELVDPELVEFPEEEVMRYAKVAFFCTQAA 377
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTI 301
ASRRP M+QV+ ML++NIRLNE+ELTAPG FQ S+ S S S ++ QMSSVPVTI
Sbjct: 378 ASRRPLMSQVVDMLSRNIRLNEKELTAPGYFQTSDDCSRKPSSTDS--ASYQMSSVPVTI 435
Query: 302 TQVTPR 307
T+VTPR
Sbjct: 436 TEVTPR 441
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496587|ref|XP_003635271.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 467 bits (1202), Expect = e-129, Method: Compositional matrix adjust.
Identities = 227/306 (74%), Positives = 259/306 (84%), Gaps = 5/306 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL NGR +AVK LS SKQG+REF+TEI T+SNVRHPNLVELIGCCV G +ILVYEYV
Sbjct: 64 GTLKNGREVAVKMLSTSSKQGLREFLTEINTISNVRHPNLVELIGCCVHGNNKILVYEYV 123
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNS+D+VLLG I L+W KRS IC+G A+GLAFLHEELVPHIVHRDIKASNILL++
Sbjct: 124 ENNSIDQVLLGH---KIILDWGKRSAICMGTARGLAFLHEELVPHIVHRDIKASNILLEK 180
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+F+PKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLTMKADVYSFGVLVLEII
Sbjct: 181 DFSPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTMKADVYSFGVLVLEII 240
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SG+ S +A +G KFLLEWAWQLH E + LELVDPEL E+P E++RY KVAFFCTQAA
Sbjct: 241 SGKTSSQANFGGSQKFLLEWAWQLHIEGRFLELVDPELVEFPEEEVMRYAKVAFFCTQAA 300
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSVPVTI 301
ASRRP M+QV+ ML++NIRLNE+ELTAPG FQ S+ S S S ++ QMSSVPVTI
Sbjct: 301 ASRRPLMSQVVDMLSRNIRLNEKELTAPGYFQTSDDCSRKPSSTDS--ASYQMSSVPVTI 358
Query: 302 TQVTPR 307
T+VTPR
Sbjct: 359 TEVTPR 364
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078940|ref|XP_002305688.1| predicted protein [Populus trichocarpa] gi|222848652|gb|EEE86199.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1175), Expect = e-126, Method: Compositional matrix adjust.
Identities = 211/273 (77%), Positives = 243/273 (89%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL +G ++AVK LSA+SKQGVREF+ EI T+SNVRHPNLVELIGCCVQG RILVYEY+
Sbjct: 34 GTLRSGIQVAVKTLSAQSKQGVREFLNEIKTISNVRHPNLVELIGCCVQGANRILVYEYL 93
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSLDR LLG+ NI+L+W +RS IC+GIA+GLAFLHEELVPHIVHRDIKASNILLD+
Sbjct: 94 ENNSLDRALLGSRSTNIRLDWGRRSAICLGIARGLAFLHEELVPHIVHRDIKASNILLDK 153
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ NPKIGDFGLAKLFP+NITHI+TRIAGTTGYLAPEY LGGQLTMKADVYSFGVL+LEII
Sbjct: 154 DLNPKIGDFGLAKLFPENITHISTRIAGTTGYLAPEYALGGQLTMKADVYSFGVLILEII 213
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SGRNS K WG M K LLEWAWQLH+E +PLELVDPE+GE+P E+IRY+KVAFFCTQ+A
Sbjct: 214 SGRNSTKPSWGGMEKLLLEWAWQLHEEGRPLELVDPEMGEFPEEEVIRYIKVAFFCTQSA 273
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQD 274
A+RRP +QV+ ML+K IRLN++ LTAPG F+D
Sbjct: 274 ANRRPLTSQVVDMLSKQIRLNDKLLTAPGFFRD 306
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555999|ref|XP_002519034.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223541697|gb|EEF43245.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1174), Expect = e-126, Method: Compositional matrix adjust.
Identities = 221/309 (71%), Positives = 256/309 (82%), Gaps = 3/309 (0%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL +GR+IAVK LSA+SKQG+REF+ EI TLS VRHPNLVELIGCCV G RILVYEYV
Sbjct: 59 GTLKDGRQIAVKTLSAQSKQGMREFLNEINTLSRVRHPNLVELIGCCVLGANRILVYEYV 118
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL+R LLG+ N L+W KRS IC GIAKGLAFLHEELVPHIVHRDIKASN+LLD+
Sbjct: 119 ENNSLERALLGSQNTNTTLDWGKRSAICFGIAKGLAFLHEELVPHIVHRDIKASNVLLDK 178
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
E+NPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GG LTMKADVYSFG+L+LEII
Sbjct: 179 EYNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGPLTMKADVYSFGILILEII 238
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SGR+S K G M K LLEWAW+L++ K LELVDP+LGE+P E+IR+MKVA FCTQ
Sbjct: 239 SGRSSSKPSCGGMEKLLLEWAWELYEGGKLLELVDPQLGEFPEEEVIRHMKVALFCTQEV 298
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTS--DKKSSDST-LQMSSVP 298
SRRP M+QV++ML+KNIRLNE+ L+APG F+D S G S K S+DST L SS+P
Sbjct: 299 GSRRPLMSQVVEMLSKNIRLNEKLLSAPGFFRDLSGLSGGPSVTKKSSTDSTGLHTSSIP 358
Query: 299 VTITQVTPR 307
TIT++ PR
Sbjct: 359 GTITELAPR 367
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346657|ref|XP_003637382.1| hypothetical protein MTR_084s0004 [Medicago truncatula] gi|355503317|gb|AES84520.1| hypothetical protein MTR_084s0004 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1167), Expect = e-125, Method: Compositional matrix adjust.
Identities = 223/312 (71%), Positives = 260/312 (83%), Gaps = 8/312 (2%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL NGR++A+K LSA SKQGVREF+TEI T+S+V+HPNLVEL+GCC Q R LVYEYV
Sbjct: 83 GTLKNGRQVAIKSLSAASKQGVREFLTEIKTISHVKHPNLVELVGCCAQEPNRTLVYEYV 142
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSLDR LLG NIKL+W KRS+IC G A+GLAFLHEE VPHIVHRDIKASNILLD+
Sbjct: 143 ENNSLDRALLGNRSTNIKLDWGKRSNICTGTARGLAFLHEEAVPHIVHRDIKASNILLDR 202
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
FNPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY +GGQLTMKADVYSFGVL+LE+I
Sbjct: 203 HFNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYAMGGQLTMKADVYSFGVLILEVI 262
Query: 182 SGRNSGKAMWGQMNKFLLEW------AWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
SG++S + WG NKFLLEW AWQLH+EE+ LELVDP++ E+P E+IRYMKVAF
Sbjct: 263 SGQSSARTNWGGSNKFLLEWVRFQLPAWQLHEEERLLELVDPDMVEFPKEEVIRYMKVAF 322
Query: 236 FCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMS 295
FCTQAAASRRP M+QV+ ML+K IRLNE+++TAPG FQ S SS+ S +S ++ Q S
Sbjct: 323 FCTQAAASRRPSMSQVVDMLSKKIRLNEKQITAPGFFQTSGESSLKKSSFES--TSHQFS 380
Query: 296 SVPVTITQVTPR 307
S PV+ TQVTPR
Sbjct: 381 SAPVSFTQVTPR 392
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125454|ref|XP_002329809.1| predicted protein [Populus trichocarpa] gi|222870871|gb|EEF08002.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-123, Method: Compositional matrix adjust.
Identities = 203/272 (74%), Positives = 239/272 (87%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL +G ++AVK LSA+S QGV+EF+ EI T+S V+HPNLVELIGCC QG+ RILVYEYV
Sbjct: 39 GTLKSGTQVAVKTLSAQSNQGVQEFLNEIKTISKVKHPNLVELIGCCAQGSNRILVYEYV 98
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSLDR LLG+ +IKL+W +RS IC+GIA+GL FLH+E+VPHIVHRDIKASNILLD+
Sbjct: 99 ENNSLDRALLGSRSTDIKLDWGRRSAICLGIARGLDFLHKEVVPHIVHRDIKASNILLDK 158
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+FNPKIGDFGLAKLFPDNITHI+TRIAGTTGYLAPEY LGGQLTMKADVYSFGVL+LEI+
Sbjct: 159 DFNPKIGDFGLAKLFPDNITHISTRIAGTTGYLAPEYALGGQLTMKADVYSFGVLILEIV 218
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SGR+S K WG K LLEWAWQLH+E K LELVDPE+GE+P E+IRY+KVAFFCTQ+A
Sbjct: 219 SGRSSAKPSWGGTQKLLLEWAWQLHEEGKHLELVDPEMGEFPEEEVIRYIKVAFFCTQSA 278
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ 273
A+RRP M QV+ ML++ I+LN++ELTAPG FQ
Sbjct: 279 ANRRPIMTQVVDMLSRQIQLNDKELTAPGFFQ 310
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457713|ref|XP_004146592.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] gi|449488434|ref|XP_004158036.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1093), Expect = e-116, Method: Compositional matrix adjust.
Identities = 200/308 (64%), Positives = 248/308 (80%), Gaps = 2/308 (0%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL NG ++A+K LS ESKQG REF+TEI T+SN+RHPNLVELIGCC Q RILVYEY+
Sbjct: 76 GTLRNGVQVAIKKLSIESKQGAREFLTEIKTISNIRHPNLVELIGCCSQKASRILVYEYL 135
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSLD LL K ++ L+W KRS IC+G A+GL FLHEE VPHIVHRDIKASNILLD+
Sbjct: 136 ENNSLDHALLDPKKISVHLDWRKRSSICIGTARGLQFLHEEAVPHIVHRDIKASNILLDK 195
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+FNPKIGDFGLAKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLT+KADVYSFGVL+LE++
Sbjct: 196 DFNPKIGDFGLAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTLKADVYSFGVLILELV 255
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SG+ S +++ LL W+L++E K L++VDP LG+YP E++RYMKVA FCTQAA
Sbjct: 256 SGKRSSTVFGVEISILLLGRVWELYEEGKLLDIVDPRLGDYPQEEVLRYMKVALFCTQAA 315
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSD--STLQMSSVPV 299
A+RRP M+QVI MLTKN +LNE+ LTAPG + +S + + KK+S+ S+ +MS +
Sbjct: 316 ANRRPVMSQVIDMLTKNNKLNEKLLTAPGFYGGLGTSDIPSVSKKTSNASSSNEMSFAGI 375
Query: 300 TITQVTPR 307
+IT++TPR
Sbjct: 376 SITKITPR 383
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357446519|ref|XP_003593537.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355482585|gb|AES63788.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/308 (66%), Positives = 245/308 (79%), Gaps = 5/308 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL +GR+IAVKPLS SKQGVREF+TEI TLSNV+H NLVEL+G C+QG R +VYEYV
Sbjct: 66 GTLKDGRKIAVKPLSVGSKQGVREFLTEIKTLSNVKHSNLVELVGFCIQGPNRTVVYEYV 125
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
EN +L LLG ++K+ W +RS IC+G AKGLA+LHEEL HIVHRDIKASN+LLD+
Sbjct: 126 ENGNLHTALLGKKSLSVKMKWRERSTICIGTAKGLAYLHEELTQHIVHRDIKASNVLLDK 185
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+FNPKIGDFG+AKLFPD+ITHI+TRIAGTTGYLAPEY LGGQLT KADVYSFGVL+LEII
Sbjct: 186 DFNPKIGDFGMAKLFPDDITHISTRIAGTTGYLAPEYALGGQLTKKADVYSFGVLILEII 245
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SG++S + W +K LLEWAWQLH+EEK L LVDPE+ E+P E+I+Y+KVA FCTQAA
Sbjct: 246 SGKSSSRTNWDGSHKSLLEWAWQLHEEEKWLALVDPEMEEFPEKEVIKYIKVALFCTQAA 305
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTL--QMSSVPV 299
A RRP M QV+ ML+K I+LN+++LTAPGLF TS KKS+ +L SS
Sbjct: 306 ARRRPLMTQVVDMLSKEIQLNDKQLTAPGLFNYDAGE---TSQKKSNPESLVYHTSSTQP 362
Query: 300 TITQVTPR 307
+IT+VT R
Sbjct: 363 SITEVTAR 370
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 307 | ||||||
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.885 | 0.692 | 0.641 | 2e-95 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.879 | 0.692 | 0.534 | 3.8e-78 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.866 | 0.254 | 0.501 | 9.5e-72 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.846 | 0.251 | 0.528 | 2.6e-69 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.859 | 0.277 | 0.528 | 8e-69 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.866 | 0.257 | 0.486 | 4.4e-68 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.876 | 0.277 | 0.479 | 1.5e-63 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.872 | 0.248 | 0.490 | 1.6e-63 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.973 | 0.440 | 0.437 | 1.9e-60 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.977 | 0.465 | 0.427 | 3.1e-60 |
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 2.0e-95, P = 2.0e-95
Identities = 175/273 (64%), Positives = 219/273 (80%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G ++AVK LSAESKQG REF+TEI +SN+ HPNLV+LIGCC++G RILVYEY+
Sbjct: 63 GVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIHHPNLVKLIGCCIEGNNRILVYEYL 122
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL VLLG+ + L+W KR+ ICVG A GLAFLHEE+ PH+VHRDIKASNILLD
Sbjct: 123 ENNSLASVLLGSRSRYVPLDWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNILLDS 182
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
F+PKIGDFGLAKLFPDN+TH++TR+AGT GYLAPEY L GQLT KADVYSFG+LVLE+I
Sbjct: 183 NFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVLEVI 242
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SG +S +A +G L+EW W+L +E + LE VDPEL ++P +E+ R++KVA FCTQAA
Sbjct: 243 SGNSSTRAAFGDEYMVLVEWVWKLREERRLLECVDPELTKFPADEVTRFIKVALFCTQAA 302
Query: 242 ASRRPQMNQVIKMLT-KNIRLNEEELTAPGLFQ 273
A +RP M QV++ML K + LNE+ LT PG+++
Sbjct: 303 AQKRPNMKQVMEMLRRKELNLNEDALTEPGVYR 335
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 786 (281.7 bits), Expect = 3.8e-78, P = 3.8e-78
Identities = 146/273 (53%), Positives = 205/273 (75%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G+ A+K LSAES+QGV+EF+TEI +S ++H NLV+L GCCV+G RILVY ++
Sbjct: 58 GCLKDGKLAAIKVLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFL 117
Query: 62 ENNSLDRVLL--GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
ENNSLD+ LL G T++ I+ +W R++ICVG+AKGLAFLHEE+ PHI+HRDIKASNILL
Sbjct: 118 ENNSLDKTLLAGGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILL 177
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
D+ +PKI DFGLA+L P N+TH++TR+AGT GYLAPEY + GQLT KAD+YSFGVL++E
Sbjct: 178 DKYLSPKISDFGLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLME 237
Query: 180 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCT 238
I+SGR++ ++LLE AW+L++ + ++LVD L G + E RY+K+ CT
Sbjct: 238 IVSGRSNKNTRLPTEYQYLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCT 297
Query: 239 QAAASRRPQMNQVIKMLTKNIRLNEEELTAPGL 271
Q + RP M+ V+++LT ++ ++++ PGL
Sbjct: 298 QDSPKLRPSMSTVVRLLTGEKDIDYKKISRPGL 330
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 9.5e-72, P = 9.5e-72
Identities = 135/269 (50%), Positives = 189/269 (70%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +GR +AVK LS S+QG +F+ EI+ +S+V H NLV+L GCC +G R+LVYEY+
Sbjct: 727 GNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYL 786
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N SLD+ L G ++ L+W R +IC+G+A+GL +LHEE I+HRD+KASNILLD
Sbjct: 787 PNGSLDQALFG--DKSLHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDS 844
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
E PK+ DFGLAKL+ D THI+TR+AGT GYLAPEY + G LT K DVY+FGV+ LE++
Sbjct: 845 ELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELV 904
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SGR + + K+LLEWAW LH++ + +EL+D EL EY E+ R + +A CTQ++
Sbjct: 905 SGRKNSDENLEEGKKYLLEWAWNLHEKNRDVELIDDELSEYNMEEVKRMIGIALLCTQSS 964
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPG 270
+ RP M++V+ ML+ + +N+ + PG
Sbjct: 965 YALRPPMSRVVAMLSGDAEVNDAT-SKPG 992
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 706 (253.6 bits), Expect = 2.6e-69, P = 2.6e-69
Identities = 138/261 (52%), Positives = 184/261 (70%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G IAVK LS++SKQG REF+TEI +S ++HPNLV+L GCC++G +LVYEY+
Sbjct: 684 GVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYL 743
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL R L G K + L+W R+ +C+GIAKGLA+LHEE IVHRDIKA+N+LLD
Sbjct: 744 ENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDL 803
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
N KI DFGLAKL + THI+TRIAGT GY+APEY + G LT KADVYSFGV+ LEI+
Sbjct: 804 SLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIV 863
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQA 240
SG+++ + +LL+WA+ L ++ LELVDP+LG + E +R + +A CT
Sbjct: 864 SGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNP 923
Query: 241 AASRRPQMNQVIKMLTKNIRL 261
+ + RP M+ V+ ML I++
Sbjct: 924 SPTLRPPMSSVVSMLQGKIKV 944
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 698 (250.8 bits), Expect = 8.0e-69, P = 8.0e-69
Identities = 141/267 (52%), Positives = 185/267 (69%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G IAVK LS SKQG REF+ EI +S + HPNLV+L GCCV+G + +LVYE+V
Sbjct: 641 GKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFV 700
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENNSL R L G + ++L+W R IC+G+A+GLA+LHEE IVHRDIKA+N+LLD+
Sbjct: 701 ENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDK 760
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ NPKI DFGLAKL ++ THI+TRIAGT GY+APEY + G LT KADVYSFG++ LEI+
Sbjct: 761 QLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIV 820
Query: 182 SGRNSGKAMWGQMNKF-LLEWAWQLHQEEKPLELVDPELG-EYPPNEIIRYMKVAFFCTQ 239
GR S K + N F L++W L ++ LELVDP LG EY E + +++A CT
Sbjct: 821 HGR-SNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTS 879
Query: 240 AAASRRPQMNQVIKMLTKNIRLNEEEL 266
+ RP M++V+KML + E+L
Sbjct: 880 SEPCERPSMSEVVKMLEGKKMVEVEKL 906
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 695 (249.7 bits), Expect = 4.4e-68, P = 4.4e-68
Identities = 131/269 (48%), Positives = 185/269 (68%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +GR +AVK LS S+QG +F+ EI+ +S+V H NLV+L GCC +G R+LVYEY+
Sbjct: 711 GNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYL 770
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N SLD+ L G + L+W R +IC+G+A+GL +LHEE IVHRD+KASNILLD
Sbjct: 771 PNGSLDQALFG--DKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDS 828
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
P+I DFGLAKL+ D THI+TR+AGT GYLAPEY + G LT K DVY+FGV+ LE++
Sbjct: 829 RLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELV 888
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
SGR + + K+LLEWAW LH++ + +EL+D +L ++ E R + +A CTQ +
Sbjct: 889 SGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTS 948
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEELTAPG 270
+ RP M++V+ ML+ ++ + + + PG
Sbjct: 949 HALRPPMSRVVAMLSGDVEIGDVT-SKPG 976
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 652 (234.6 bits), Expect = 1.5e-63, P = 1.5e-63
Identities = 131/273 (47%), Positives = 188/273 (68%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G IAVK LS++S QG +EF+ EI ++ ++HPNLV+L GCCV+ + +LVYEY+
Sbjct: 657 GRLPDGTLIAVKKLSSKSHQGNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYL 716
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENN L L A ++ +KL W R IC+GIA+GLAFLHE+ I+HRDIK +N+LLD+
Sbjct: 717 ENNCLSDALF-AGRSCLKLEWGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDK 775
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ N KI DFGLA+L DN +HITTR+AGT GY+APEY + G LT KADVYSFGV+ +EI+
Sbjct: 776 DLNSKISDFGLARLHEDNQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIV 835
Query: 182 SGRNSGK-AMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQ 239
SG+++ K + LL+WA+ L ++ E++DP L G + E R +KV+ C
Sbjct: 836 SGKSNAKYTPDDECCVGLLDWAFVLQKKGDIAEILDPRLEGMFDVMEAERMIKVSLLCAN 895
Query: 240 AAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF 272
+++ RP M+QV+KML + E+ ++ PG++
Sbjct: 896 KSSTLRPNMSQVVKMLEGETEI-EQIISDPGVY 927
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 1.6e-63, P = 1.6e-63
Identities = 134/273 (49%), Positives = 189/273 (69%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L NG IAVK LS++S QG +EFI EI ++ ++HPNLV+L GCCV+ T+ +LVYEY+
Sbjct: 694 GRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVEKTQLLLVYEYL 753
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
ENN L L G ++ +KL+W R IC+GIA+GLAFLHE+ I+HRDIK +NILLD+
Sbjct: 754 ENNCLADALFG--RSGLKLDWRTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNILLDK 811
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ N KI DFGLA+L D+ +HITTR+AGT GY+APEY + G LT KADVYSFGV+ +EI+
Sbjct: 812 DLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIV 871
Query: 182 SGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQ 239
SG+ N+ + LL+WA+ L ++ E++DP+L G + E R +KV+ C+
Sbjct: 872 SGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEILDPKLEGVFDVMEAERMIKVSLLCSS 931
Query: 240 AAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF 272
+ + RP M++V+KML + EE ++ PG +
Sbjct: 932 KSPTLRPTMSEVVKMLEGETEI-EEIISDPGAY 963
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 137/313 (43%), Positives = 188/313 (60%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G G+ IAVK LS S QG EF EI+ L+ ++H NLV LIG C+QG R+LVYE++
Sbjct: 374 GVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFI 433
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+N SLD+ + K + L+W R + GIA+GL +LHE+ I+HRD+KASNILLDQ
Sbjct: 434 KNASLDQFIFDTEKRQL-LDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQ 492
Query: 122 EFNPKIGDFGLAKLFPDN--ITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
E NPKI DFGLAKLF +TH T+RIAGT GY+APEY + GQ ++K DV+SFGVLV+
Sbjct: 493 EMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVI 552
Query: 179 EIISGR--NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236
EII+G+ N+G + + + LL W W+ +E+ L ++DP L NEI+R + +
Sbjct: 553 EIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLL 612
Query: 237 CTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQXXXXXXXXX--XXXXXXXXXLQM 294
C Q +A+ RP M T ++ LN T P + LQM
Sbjct: 613 CVQESAATRPTM------ATVSLMLNSYSFTLPTPLRPAFVLESVVIPSNVSSSTEGLQM 666
Query: 295 SSVPVTITQVTPR 307
SS VT+++ +PR
Sbjct: 667 SSNDVTVSEFSPR 679
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
Identities = 132/309 (42%), Positives = 190/309 (61%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GTL++G ++AVK LS S QG +EF E++ ++ ++H NLV+L+G C++G +ILVYE+V
Sbjct: 343 GTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFV 402
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N SLD L +T +KL+W +R I GIA+G+ +LH++ I+HRD+KA NILLD
Sbjct: 403 PNKSLDHFLFDSTM-KMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDD 461
Query: 122 EFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ NPKI DFG+A++F D +T R+ GT GY++PEY + GQ +MK+DVYSFGVLVLEI
Sbjct: 462 DMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEI 521
Query: 181 ISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE-YPPNEIIRYMKVAFFCT 238
ISG +NS + L+ + W+L P ELVDP G+ Y +EI R + +A C
Sbjct: 522 ISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCV 581
Query: 239 QAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQXXXXXXXXXXXXXXXXXXLQMSSVP 298
Q A RP M+ +++MLT ++ + E PG F + +S
Sbjct: 582 QEDAEDRPTMSSIVQMLTTSL-IALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEAS-- 638
Query: 299 VTITQVTPR 307
IT+VTPR
Sbjct: 639 --ITRVTPR 645
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 307 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-45
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 6 NGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G+++A+K + E + E + EI L + HPN+V+L G LV EY E
Sbjct: 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EF 123
SL +L + KL+ ++ I + I +GL +LH I+HRD+K NILLD
Sbjct: 77 SLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNG 130
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIIS 182
K+ DFGL+KL + + I GT Y+APE +LG G + K+D++S GV++ E+
Sbjct: 131 KVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPE 189
Query: 183 GRNSGKAMWGQMNKFLLEWAWQLHQEEKP 211
++ L+ Q E++P
Sbjct: 190 LKD------------LIRKMLQKDPEKRP 206
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-44
Identities = 60/180 (33%), Positives = 96/180 (53%), Gaps = 10/180 (5%)
Query: 6 NGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G+ +A+K + + + RE + EI L ++HPN+V L + LV EY E
Sbjct: 23 TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L +L K +L+ ++ I L +LH + IVHRD+K NILLD++ +
Sbjct: 83 DLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGH 135
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
K+ DFGLA+ D +TT + GT Y+APE +LG D++S GV++ E+++G+
Sbjct: 136 VKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 29/256 (11%)
Query: 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+AVK L + S+Q + EF+ E + + HPN+V+L+G C + +V EY+E
Sbjct: 26 KKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEG 85
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L L KL+ + IA+G+ +L + + +HRD+ A N L+ +
Sbjct: 86 GDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENL 139
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPEYVLGGQLTMKADVYSFGVLVLEI 180
KI DFGL++ D R G ++APE + G+ T K+DV+SFGVL+ EI
Sbjct: 140 VVKISDFGLSRDLYD---DDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 196
Query: 181 ISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
+ G+ + M N+ +LE+ ++ +P P E+ M C
Sbjct: 197 FTL---GEQPYPGMSNEEVLEYLKNGYRLPQP---------PNCPPELYDLMLQ---CWA 241
Query: 240 AAASRRPQMNQVIKML 255
RP ++++++L
Sbjct: 242 EDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-42
Identities = 70/251 (27%), Positives = 123/251 (49%), Gaps = 30/251 (11%)
Query: 11 AVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
AVK L + S+Q + EF+ E + + HPN+V+L+G C + ++V EY+ L
Sbjct: 32 AVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDY 91
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
L +L+ + IA+G+ +L + + +HRD+ A N L+ + KI D
Sbjct: 92 LR--KNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISD 146
Query: 130 FGLAK-LFPDNITHITTR---IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
FGL++ L+ D+ + I ++APE + G+ T K+DV+SFGVL+ EI +
Sbjct: 147 FGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-- 200
Query: 186 SGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244
G+ + M N +LE+ + ++ KP P E+ + M C
Sbjct: 201 -GEEPYPGMSNAEVLEYLKKGYRLPKP---------PNCPPELYKLMLQ---CWAEDPED 247
Query: 245 RPQMNQVIKML 255
RP ++++++L
Sbjct: 248 RPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-42
Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 34/258 (13%)
Query: 11 AVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
AVK L S++ ++F+ E + + HPN+V L+G C + LV EY+E L
Sbjct: 27 AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86
Query: 70 LLGATKANIK-----LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L + L+ + + IAKG+ +L + VHRD+ A N L+ ++
Sbjct: 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLV 143
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVLVLE 179
KI DFGL++ D+ + T G ++APE + G T K+DV+SFGVL+ E
Sbjct: 144 VKISDFGLSRDVYDDDYYRKK----TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199
Query: 180 IISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238
I + G + + N+ +LE+ + ++ KP EY P+E+ M C
Sbjct: 200 IFTL---GATPYPGLSNEEVLEYLRKGYRLPKP---------EYCPDELYELML---SCW 244
Query: 239 QAAASRRPQMNQVIKMLT 256
Q RP +++++ L
Sbjct: 245 QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-42
Identities = 65/182 (35%), Positives = 93/182 (51%), Gaps = 11/182 (6%)
Query: 6 NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
G+ +AVK +E + + EI L + HPN+V LI LV EY E
Sbjct: 23 TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEG 82
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L L L+ ++ I + I +GL +LH I+HRD+K NILLD+
Sbjct: 83 GDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENG 135
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIIS 182
KI DFGLAK + + +TT GT Y+APE +LGG K DV+S GV++ E+++
Sbjct: 136 VVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT 194
Query: 183 GR 184
G+
Sbjct: 195 GK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 74/257 (28%), Positives = 117/257 (45%), Gaps = 32/257 (12%)
Query: 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
++AVK L S++ EF+ E + + HPN+V L+G C QG +V EY+
Sbjct: 27 TETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGG 86
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L L K KL + + + IAKG+ +L + + VHRD+ A N L+ +
Sbjct: 87 DLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLV 140
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLE 179
KI DFGL++ I G L APE + G+ T K+DV+SFGVL+ E
Sbjct: 141 VKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWE 196
Query: 180 IISGRNSGKAMWGQMNKF-LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238
I + G+ + M+ +LE ++ +P E P+E+ M C
Sbjct: 197 IFTL---GEQPYPGMSNEEVLELLEDGYRLPRP---------ENCPDELYELMLQ---CW 241
Query: 239 QAAASRRPQMNQVIKML 255
RP +++++ L
Sbjct: 242 AYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-38
Identities = 66/189 (34%), Positives = 96/189 (50%), Gaps = 18/189 (9%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVY-E 59
G +AVK LS +S++ + EI LS+++HPN+V G + ++ E
Sbjct: 22 KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICV---GIAKGLAFLHEELVPHIVHRDIKASN 116
YV SL +L K KL E I I +GLA+LH IVHRDIK +N
Sbjct: 82 YVSGGSLSSLL----KKFGKLP-E--PVIRKYTRQILEGLAYLHSN---GIVHRDIKGAN 131
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
IL+D + K+ DFG AK D T T + GT ++APE + G + AD++S G
Sbjct: 132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC 191
Query: 176 LVLEIISGR 184
V+E+ +G+
Sbjct: 192 TVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 58/180 (32%), Positives = 93/180 (51%), Gaps = 8/180 (4%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
G+ +A+K + ESK+ + I EI L +HPN+V+ G ++ +V E+ S
Sbjct: 24 TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L +L N L + + +C + KGL +LH I+HRDIKA+NILL +
Sbjct: 84 LKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEV 137
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
K+ DFGL+ + T + GT ++APE + G KAD++S G+ +E+ G+
Sbjct: 138 KLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 6/181 (3%)
Query: 6 NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+G+ +K LS S++ + + E+ L + HPN+++ + + +V EY +
Sbjct: 24 DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L + + K E+ D V + L +LH I+HRDIK NI L
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNG 140
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+GDFG++K+ + T + GT YL+PE K+D++S G ++ E+ +
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
Query: 184 R 184
+
Sbjct: 200 K 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 55/183 (30%), Positives = 97/183 (53%), Gaps = 10/183 (5%)
Query: 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
L G +A+K +S E ++ ++ + EI L N++HPN+V+ IG ++ EY
Sbjct: 22 LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
EN SL +++ K + + +GLA+LHE+ ++HRDIKA+NIL +
Sbjct: 82 ENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTK 134
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ K+ DFG+A D + + GT ++APE + + +D++S G V+E++
Sbjct: 135 DGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELL 193
Query: 182 SGR 184
+G
Sbjct: 194 TGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 62/190 (32%), Positives = 95/190 (50%), Gaps = 17/190 (8%)
Query: 1 MGTLTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 57
MGT ++AVK L K G F+ E + +RH LV+L C + +V
Sbjct: 24 MGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
EY+ SL L ++L + D+ IA+G+A+L + +HRD+ A NI
Sbjct: 80 TEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLESR---NYIHRDLAARNI 134
Query: 118 LLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
L+ + KI DFGLA+L D+ + + APE G+ T+K+DV+SFG+
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKSDVWSFGI 192
Query: 176 LVLEIIS-GR 184
L+ EI++ GR
Sbjct: 193 LLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 70/236 (29%), Positives = 121/236 (51%), Gaps = 17/236 (7%)
Query: 28 TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87
+EI + ++HPN+V+LIG C L++EY+E +L VL L+WE+R
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRK 784
Query: 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 147
I +GIAK L FLH P +V ++ I++D + P + +L + T+
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKC 838
Query: 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ 207
++ Y+APE +T K+D+Y FG++++E+++G++ A +G ++ ++EWA +
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS 897
Query: 208 EEKPLELVDPELGEYPP---NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260
+ +DP + NEI+ M +A CT + RP N V+K L R
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (274), Expect = 1e-27
Identities = 74/310 (23%), Positives = 127/310 (40%), Gaps = 22/310 (7%)
Query: 8 RRIAVKPLSAE---SKQGVREFITEIMTLSNVRHP-NLVELIGCCVQGTRRILVYEYVEN 63
+ +A+K L+ + + V F+ EI L+++ HP N+V+L LV EYV+
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE- 122
SL+ LL L+ + I I L +LH + I+HRDIK NILLD++
Sbjct: 83 GSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDG 138
Query: 123 FNPKIGDFGLAKLFPDNITH-----ITTRIAGTTGYLAPEYVLGGQL---TMKADVYSFG 174
K+ DFGLAKL PD + + + GT GY+APE +LG L + +D++S G
Sbjct: 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLG 198
Query: 175 VLVLEIISGRNSGKAMWGQMNKF-LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233
+ + E+++G + L+ +L + P E +K
Sbjct: 199 ITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP-LSPSNPELISKAASDLLKK 257
Query: 234 AFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQ 293
R + + +E + L D + +
Sbjct: 258 ---LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISS 314
Query: 294 MSSVPVTITQ 303
++S+ ++ +
Sbjct: 315 LNSLAISGSD 324
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 15/183 (8%)
Query: 7 GRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVE 62
G+ A+K L + ++ V +TE LS + HP +V+L Q ++ LV EY
Sbjct: 18 GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAP 76
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L L + + E+R+ I L +LH I++RD+K NILLD
Sbjct: 77 GGELFSHL----SKEGRFS-EERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDA 128
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ + K+ DFGLAK + T GT YLAPE +LG D +S GVL+ E++
Sbjct: 129 DGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML 187
Query: 182 SGR 184
+G+
Sbjct: 188 TGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 52/181 (28%), Positives = 96/181 (53%), Gaps = 6/181 (3%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G N R+A+K L ++ ++F E+ L +RH +L+ L C G ++ E +
Sbjct: 25 GLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
E SL L + + D+ +A+G+A+L E+ + +HRD+ A NIL+ +
Sbjct: 85 EKGSLLAFLRSPEGQVLPV--ASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGE 139
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ K+ DFGLA+L +++ ++++ + APE G + K+DV+SFG+L+ E+
Sbjct: 140 DLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198
Query: 182 S 182
+
Sbjct: 199 T 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 56/180 (31%), Positives = 100/180 (55%), Gaps = 11/180 (6%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
G+++AVK L +S + F+ E ++ +RHPNLV+L+G +QG +V EY+ SL
Sbjct: 29 GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
L ++ + ++ + + +G+ +L E+ + VHRD+ A N+L+ ++ K
Sbjct: 88 VDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAK 142
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRN 185
+ DFGLAK + + ++ + APE + + + K+DV+SFG+L+ EI S GR
Sbjct: 143 VSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 51/185 (27%), Positives = 100/185 (54%), Gaps = 24/185 (12%)
Query: 7 GRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G+ +A+K L ++K+ + I EI+ + + +HPN+V+ + G +V EY++
Sbjct: 44 GKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
SL ++ T+ +++N + + +C + +GL +LH + +++HRDIK+ NILL ++ +
Sbjct: 101 SLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGS 154
Query: 125 PKIGDFGLAKLFPDNITHITTR------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
K+ DFG A +T + GT ++APE + K D++S G++ +
Sbjct: 155 VKLADFGFA-------AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCI 207
Query: 179 EIISG 183
E+ G
Sbjct: 208 EMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 57/180 (31%), Positives = 96/180 (53%), Gaps = 10/180 (5%)
Query: 7 GRRIAVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIGC-CVQGTRRILVYEYVENN 64
G+ A+K + + + R+ + E+ TL + P +V+ G +G I V EY++
Sbjct: 26 GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGG 84
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
SL +L K K+ + I I KGL +LH + HI+HRDIK SN+L++ +
Sbjct: 85 SLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGE 138
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
KI DFG++K+ + + T + GT Y++PE + G + AD++S G+ +LE G+
Sbjct: 139 VKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 57/181 (31%), Positives = 94/181 (51%), Gaps = 11/181 (6%)
Query: 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVEN 63
G ++AVK L+ +Q +F EI L + H N+V+ G C + R L+ EY+ +
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL R L + I N ++ I KG+ +L + +HRD+ A NIL++ E
Sbjct: 93 GSL-RDYLQRHRDQI--NLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESED 146
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEII 181
KI DFGLAK+ P++ + + G + + APE + + + +DV+SFGV + E+
Sbjct: 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
Query: 182 S 182
+
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 53/176 (30%), Positives = 93/176 (52%), Gaps = 7/176 (3%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
+AVK L + ++F+ E + +RHP L++L C +V E ++ SL
Sbjct: 33 VAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
L G +KL + D+ +A G+A+L + + +HRD+ A N+L+ + K+ D
Sbjct: 92 LQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD 146
Query: 130 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 184
FGLA++ ++I + APE L + ++K+DV+SFG+L+ EI++ GR
Sbjct: 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 70/190 (36%), Positives = 101/190 (53%), Gaps = 18/190 (9%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVRE---FITEIMTLSNVRHPNLVELIGCCVQGTRRILV 57
MG ++A+K L KQG F+ E + ++HP LV L Q I +
Sbjct: 24 MGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYI-I 78
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
EY+EN SL L T IKL K D+ IA+G+AF+ + + +HRD++A+NI
Sbjct: 79 TEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANI 133
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGV 175
L+ + KI DFGLA+L DN T R + APE + G T+K+DV+SFG+
Sbjct: 134 LVSETLCCKIADFGLARLIEDN--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 191
Query: 176 LVLEIIS-GR 184
L+ EI++ GR
Sbjct: 192 LLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 67/260 (25%), Positives = 112/260 (43%), Gaps = 45/260 (17%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
L G +AVK + + ++E E+ L ++HPNLV+ G V + + EY
Sbjct: 22 LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHRDIKASN 116
+L+ +L + + + + +GLA+LH IVHRDIK +N
Sbjct: 82 SGGTLEELLEHGRILD---------EHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPAN 129
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPEYVLGGQLTMK---ADV 170
I LD K+GDFG A +N T + + G Y+APE + GG+ AD+
Sbjct: 130 IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189
Query: 171 YSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--WQLHQEEKPLELVDPELGEYPPNEII 228
+S G +VLE+ +G+ W +++ E+ + + KP P + +
Sbjct: 190 WSLGCVVLEMATGKRP----WSELDN---EFQIMFHVGAGHKP---------PIPDSLQL 233
Query: 229 RYMKVAFF--CTQAAASRRP 246
F C ++ +RP
Sbjct: 234 SPEGKDFLDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 12/177 (6%)
Query: 8 RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+ I ++ A KQ +RE +I L P +V G + EY++ SLD
Sbjct: 32 KTIRLEINEAIQKQILREL--DI--LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI 127
++L + I V + KGL +LHE+ I+HRD+K SNIL++ K+
Sbjct: 88 KILKEVQGR---IPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKL 142
Query: 128 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
DFG++ ++ + GT+ Y+APE + G ++K+D++S G+ ++E+ +GR
Sbjct: 143 CDFGVSGQLVNS---LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-23
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 10 IAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L + R+ F E L+N +H N+V+ G C +G I+V+EY+E+ L++
Sbjct: 38 VAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK 97
Query: 69 VL----------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
L +L + I V IA G+ +L + H VHRD+ N L
Sbjct: 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCL 154
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFG 174
+ + KIGDFG+++ D T R+ G T ++ PE ++ + T ++DV+SFG
Sbjct: 155 VGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 211
Query: 175 VLVLEIISGRNSGKAMWGQMN 195
V++ EI + GK W ++
Sbjct: 212 VVLWEIFT---YGKQPWYGLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 21/181 (11%)
Query: 10 IAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K L S + +E + E +++V HP++V L+G C+ ++ L+ + + L
Sbjct: 39 VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLD 97
Query: 69 VL---LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
+ + LNW CV IAKG+++L E+ +VHRD+ A N+L+ +
Sbjct: 98 YVRNHKDNIGSQYLLNW------CVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHV 148
Query: 126 KIGDFGLAKLFP--DNITHITTRIAGTT--GYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
KI DFGLAKL + H G ++A E +L T K+DV+S+GV V E++
Sbjct: 149 KITDFGLAKLLDVDEKEYHAE---GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205
Query: 182 S 182
+
Sbjct: 206 T 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-23
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 4 LTNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY 58
L +G AVK ++ V++ EI LS ++HPN+V+ +G + +
Sbjct: 22 LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81
Query: 59 EYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
E V SL ++L G+ + + ++ I GL +LH+ + VHRDIK +N
Sbjct: 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHDR---NTVHRDIKGAN 132
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGV 175
IL+D K+ DFG+AK + G+ ++APE + G + AD++S G
Sbjct: 133 ILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190
Query: 176 LVLEIISGRNSGKAMWGQ 193
VLE+ +GK W Q
Sbjct: 191 TVLEMA----TGKPPWSQ 204
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 3e-23
Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 4 LTNGRRIAVKPLSAES-KQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYE 59
G +A+K + E+ K+G I EI L +RHPN+V L + +V+E
Sbjct: 21 KKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80
Query: 60 YVEN--NSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
Y+++ L D + T++ IK + +GL +LH I+HRDIK SN
Sbjct: 81 YMDHDLTGLLDSPEVKFTESQIKC-------YMKQLLEGLQYLHSN---GILHRDIKGSN 130
Query: 117 ILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFG 174
IL++ + K+ DFGLA+ + N T R+ T Y PE +LG + + D++S G
Sbjct: 131 ILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVG 189
Query: 175 VLVLEIISGRN 185
++ E+ G+
Sbjct: 190 CILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 7e-23
Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
G+ +A+K + ++ ++E I EI L P +V+ G + T +V EY S
Sbjct: 27 TGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
+ ++ T N L E+ + I KGL +LH +HRDIKA NILL++E
Sbjct: 85 V-SDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQA 138
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
K+ DFG++ D + T I GT ++APE + KAD++S G+ +E+ G+
Sbjct: 139 KLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 8e-23
Identities = 61/184 (33%), Positives = 99/184 (53%), Gaps = 13/184 (7%)
Query: 9 RIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
R+AVK L + Q +EF+ E +SN HPN+V+L+G C+ + ++ E +E L
Sbjct: 28 RVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87
Query: 68 RVLLGATKANIK---LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L A L ++ DIC+ +AKG +L + H +HRD+ A N L+ ++
Sbjct: 88 SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGY 144
Query: 125 P-----KIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
KIGDFGLA+ ++ + ++APE +L G+ T ++DV+SFGVL+
Sbjct: 145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMW 204
Query: 179 EIIS 182
EI++
Sbjct: 205 EILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-22
Identities = 78/268 (29%), Positives = 122/268 (45%), Gaps = 41/268 (15%)
Query: 7 GRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRI--LVYEYVEN 63
G +AVK L E Q + EI L + H N+V+ GCC + + L+ EYV
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICV---GIAKGLAFLHEELVPHIVHRDIKASNILLD 120
SL L K + L + + + I +G+A+LH + H +HRD+ A N+LLD
Sbjct: 93 GSLRDYL---PKHKLNL-----AQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLD 141
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVL 178
+ KIGDFGLAK P+ + R G + + A E + + + +DV+SFGV +
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 179 EIISGRNSGKA-----------MWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227
E+++ +S ++ GQM L + E+ + L P + P E+
Sbjct: 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL-----IELLERGMRLPCP---KNCPQEV 253
Query: 228 IRYMKVAFFCTQAAASRRPQMNQVIKML 255
MK C + A RP +I +L
Sbjct: 254 YILMKN---CWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-22
Identities = 56/185 (30%), Positives = 90/185 (48%), Gaps = 19/185 (10%)
Query: 6 NGRRI--AVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+G+ + AVK L E G +EF+ E ++ + HP +V LIG C +G +LV E
Sbjct: 20 SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAP 78
Query: 63 NNSLDRVLLG---ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
L + L +++K + +A G+A+L + H VHRD+ A N+LL
Sbjct: 79 LGPLLKYLKKRREIPVSDLKE-LAHQ------VAMGMAYLESK---HFVHRDLAARNVLL 128
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLV 177
KI DFG+++ + AG + APE + G+ + K+DV+S+GV +
Sbjct: 129 VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
Query: 178 LEIIS 182
E S
Sbjct: 189 WEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-22
Identities = 60/185 (32%), Positives = 91/185 (49%), Gaps = 18/185 (9%)
Query: 7 GRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GR +AVK P S E+K+ V EI L N++H +V+ GC + EY+
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 62 ENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
S+ L GA + + ++ I +G+ +LH IVHRDIK +NIL
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN---MIVHRDIKGANILR 137
Query: 120 DQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
D N K+GDFG +K + T + GT +++PE + G KADV+S G V
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTV 197
Query: 178 LEIIS 182
+E+++
Sbjct: 198 VEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-22
Identities = 62/184 (33%), Positives = 96/184 (52%), Gaps = 18/184 (9%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENN 64
G +AVK L + + +R+F EI L +++H N+V+ G C RR LV EY+
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 65 SLDRVLLGATKANIKLNWEK----RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
SL L K +L+ K S IC KG+ +L + VHRD+ NIL++
Sbjct: 93 SLRDYL---QKHRERLDHRKLLLYASQIC----KGMEYLGSK---RYVHRDLATRNILVE 142
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVL 178
E KIGDFGL K+ P + + R G + + APE + + ++ +DV+SFGV++
Sbjct: 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
Query: 179 EIIS 182
E+ +
Sbjct: 203 ELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 9e-22
Identities = 58/179 (32%), Positives = 95/179 (53%), Gaps = 16/179 (8%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K L A S R +F+TE + HPN++ L G + +++ EY+EN SLD+
Sbjct: 35 VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L + + K + + GIA G+ +L E + VHRD+ A NIL++ K+
Sbjct: 95 FL---RENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVS 148
Query: 129 DFGLAKLFPDNITHITTR-----IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
DFGL++ D+ TT+ I T APE + + T +DV+SFG+++ E++S
Sbjct: 149 DFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-22
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV---QGTRRILVYEYVENNSL 66
I P KQ +RE EI + + P +V+ G + + I + EY E SL
Sbjct: 34 ITTDPNPDLQKQILREL--EIN--KSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSL 88
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
D + K ++ + I + KGL++LH I+HRDIK SNILL ++ K
Sbjct: 89 DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVK 145
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
+ DFG++ + + GT+ Y+APE + G ++ +DV+S G+ +LE+ R
Sbjct: 146 LCDFGVSGEL---VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-21
Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88
EI L ++HPN+V+L+ + LV+EY + + L + L + N K I
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMD-L-KKYLDKRPGPLSPNLIKS--I 103
Query: 89 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 148
+ +GLA+ H I+HRD+K NIL++++ K+ DFGLA+ F + T +
Sbjct: 104 MYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160
Query: 149 GTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 184
T Y APE +LG + + D++S G + E+I+G+
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 55/164 (33%), Positives = 87/164 (53%), Gaps = 16/164 (9%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--LGATKANIKLNWEKRS 86
EI L ++H N+V+ +G + + EYV S+ +L GA + + N+ ++
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ- 114
Query: 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 146
I KGL +LH I+HRDIK +NIL+D + KI DFG++K N T
Sbjct: 115 -----ILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
Query: 147 IA-----GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
A G+ ++APE V T KAD++S G LV+E+++G++
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-21
Identities = 74/258 (28%), Positives = 120/258 (46%), Gaps = 39/258 (15%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL--- 66
+AVK L S ++F E L+N++H ++V+ G CV+G I+V+EY+++ L
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 67 ------DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
D VL+ +L + I IA G+ +L + H VHRD+ N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 154
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVL 176
+ KIGDFG+++ D + R+ G T ++ PE ++ + T ++DV+S GV+
Sbjct: 155 ENLLVKIGDFGMSR---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211
Query: 177 VLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
+ EI + GK W Q+ N ++E Q ++P P E+ M
Sbjct: 212 LWEIFT---YGKQPWYQLSNNEVIECITQGRVLQRPRTC---------PKEVYDLM---L 256
Query: 236 FCTQAAASRRPQMNQVIK 253
C Q R P M IK
Sbjct: 257 GCWQ----REPHMRLNIK 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-21
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 22/187 (11%)
Query: 7 GRRIAVKP-LSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G +A+K +E + V++ E+ L +RH N+V L + R LV+EYVE
Sbjct: 26 GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85
Query: 65 SLDRVLLGATKANI------KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
L+ LL A+ + W+ + + +A+ H +I+HRDIK NIL
Sbjct: 86 LLE--LLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHSH---NIIHRDIKPENIL 132
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLV 177
+ + K+ DFG A+ T T Y APE ++G K DV++ G ++
Sbjct: 133 VSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM 192
Query: 178 LEIISGR 184
E++ G
Sbjct: 193 AELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-21
Identities = 58/185 (31%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 7 GRRIAVKPLSAESKQG-VREFITEIMTLSNVRH---PNLVELIGCCVQGTRRILVYEYVE 62
GR +A+K ++ ++ V + E+ LS +R PN+ + G ++G R ++ EY E
Sbjct: 26 GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAK---GLAFLHEELVPHIVHRDIKASNILL 119
S+ R L+ A K I V I + L ++H+ ++HRDIKA+NIL+
Sbjct: 86 GGSV-RTLMKAGPIAEKY-------ISVIIREVLVALKYIHKV---GVIHRDIKAANILV 134
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVL 178
N K+ DFG+A L N + +T GT ++APE + G+ KAD++S G+ +
Sbjct: 135 TNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKYYDTKADIWSLGITIY 193
Query: 179 EIISG 183
E+ +G
Sbjct: 194 EMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 38/263 (14%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
+AVK L + ++F E L+N++H ++V+ G C G I+V+EY+++ L++
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 70 LLG------------ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
L +A +L + I IA G+ +L + H VHRD+ N
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNC 154
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYSF 173
L+ KIGDFG+++ D + R+ G T ++ PE ++ + T ++DV+SF
Sbjct: 155 LVGANLLVKIGDFGMSR---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 174 GVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232
GV++ EI + GK W Q+ N ++E Q E+P P E+ M
Sbjct: 212 GVILWEIFT---YGKQPWFQLSNTEVIECITQGRVLERP---------RVCPKEVYDIM- 258
Query: 233 VAFFCTQAAASRRPQMNQVIKML 255
C Q +R + ++ K+L
Sbjct: 259 --LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 61/232 (26%), Positives = 110/232 (47%), Gaps = 28/232 (12%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+G R++A+K + E +FI E + + HP LV+L G C + + LV+E+
Sbjct: 22 LGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+E+ L L A + K + E +C+ + +G+A+L V +HRD+ A N L+
Sbjct: 81 MEHGCLSD-YLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNV---IHRDLAARNCLVG 134
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ K+ DFG+ + D+ +T + +PE + + K+DV+SFGVL+ E+
Sbjct: 135 ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
Query: 181 IS-GR---------------NSGKAMW-----GQMNKFLLEWAWQLHQEEKP 211
S G+ N+G ++ Q L++ W+ E++P
Sbjct: 195 FSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 10/176 (5%)
Query: 10 IAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A K + +K VR+ I E+ + R P +V G + + E+++ SLDR
Sbjct: 33 MAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR 92
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
+ K + E I V + +GL +L+ I+HRDIK SNIL++ K+
Sbjct: 93 IY----KKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLC 146
Query: 129 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
DFG++ + I I GT+ Y++PE + GG+ T+K+DV+S G+ ++E+ G+
Sbjct: 147 DFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 57/184 (30%), Positives = 95/184 (51%), Gaps = 10/184 (5%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
MG N ++AVK L + V+ F+ E + ++H LV L + ++ EY
Sbjct: 24 MGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ SL L + K+ K D IA+G+A++ + + +HRD++A+N+L+
Sbjct: 83 MAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVS 137
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVL 178
+ KI DFGLA++ DN T R + APE + G T+K+DV+SFG+L+
Sbjct: 138 ESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLY 195
Query: 179 EIIS 182
EI++
Sbjct: 196 EIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 72/257 (28%), Positives = 117/257 (45%), Gaps = 35/257 (13%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
+AVK L S+ ++F E L+ ++H ++V G C +G ++V+EY+ + L+R
Sbjct: 38 VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97
Query: 70 LL-----------GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
L G A +L + I IA G+ +L H VHRD+ N L
Sbjct: 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCL 154
Query: 119 LDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
+ Q KIGDFG+++ ++ + + R ++ PE +L + T ++D++SFGV++
Sbjct: 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214
Query: 178 LEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236
EI + GK W Q+ N +E Q + E+P P E+ M
Sbjct: 215 WEIFT---YGKQPWYQLSNTEAIECITQGRELERPRTC---------PPEVYAIM----- 257
Query: 237 CTQAAASRRPQMNQVIK 253
Q R PQ VIK
Sbjct: 258 --QGCWQREPQQRMVIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 63/182 (34%), Positives = 90/182 (49%), Gaps = 20/182 (10%)
Query: 6 NGRRIAVKPLSAESKQGV---REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+A+K +S KQ ++ I E+ L +RHPN +E GC ++ LV EY
Sbjct: 39 TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
++ D +L K L + + IC G +GLA+LH +HRDIKA NILL +
Sbjct: 99 GSASD--ILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEP 151
Query: 123 FNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVL 178
K+ DFG A L P N GT ++APE +L GQ K DV+S G+ +
Sbjct: 152 GTVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 179 EI 180
E+
Sbjct: 206 EL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 60/189 (31%), Positives = 89/189 (47%), Gaps = 15/189 (7%)
Query: 4 LTNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
L N ++A+K + E Q V E E+ +S HPN+V+ V G LV Y+
Sbjct: 23 LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICV---GIAKGLAFLHEELVPHIVHRDIKASNILL 119
SL ++ K++ + I + KGL +LH I HRDIKA NILL
Sbjct: 83 GGSLLDIM----KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--GQI-HRDIKAGNILL 135
Query: 120 DQEFNPKIGDFGL-AKLFPDNITHITTR--IAGTTGYLAPEYVLGGQ-LTMKADVYSFGV 175
++ + KI DFG+ A L R GT ++APE + KAD++SFG+
Sbjct: 136 GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGI 195
Query: 176 LVLEIISGR 184
+E+ +G
Sbjct: 196 TAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-20
Identities = 54/186 (29%), Positives = 98/186 (52%), Gaps = 19/186 (10%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L A+ + R +F+ EI +S +++PN++ L+G CV ++ EY+EN L++
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 69 VLLGATKANIKLNWEKRSDI-CVG----------IAKGLAFLHEELVPHIVHRDIKASNI 117
L ++ I+ + ++I V IA G+ +L + VHRD+ N
Sbjct: 107 FL---SQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160
Query: 118 LLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
L+ + KI DFG+++ L+ + I R ++A E +L G+ T +DV++FGV
Sbjct: 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220
Query: 177 VLEIIS 182
+ E+ +
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-20
Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 8/185 (4%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
MGT R+A+K L + F+ E + +RH LV+L V +V EY
Sbjct: 24 MGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEY 81
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ SL L G ++L + D+ IA G+A++ + VHRD++A+NIL+
Sbjct: 82 MSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG 136
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ K+ DFGLA+L DN + APE L G+ T+K+DV+SFG+L+ E+
Sbjct: 137 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 181 IS-GR 184
+ GR
Sbjct: 197 TTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-20
Identities = 71/269 (26%), Positives = 121/269 (44%), Gaps = 48/269 (17%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+AVK L + +++ + + ++E+ + + +H N++ L+G C Q +V EY + +L
Sbjct: 45 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL- 103
Query: 68 RVLLGA-----TKANIKLNWEKRSDI--------CVGIAKGLAFLHEELVPHIVHRDIKA 114
R L A A+ + +A+G+ FL + +HRD+ A
Sbjct: 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKAD 169
N+L+ ++ KI DFGLA+ +I HI T G L APE + T ++D
Sbjct: 161 RNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216
Query: 170 VYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226
V+SFGVL+ EI + S G + ++ K L E ++ EKP E
Sbjct: 217 VWSFGVLLWEIFTLGGSPYPGIPVE-ELFKLLKEG----YRMEKPQ---------NCTQE 262
Query: 227 IIRYMKVAFFCTQAAASRRPQMNQVIKML 255
+ M+ C S+RP Q+++ L
Sbjct: 263 LYHLMRD---CWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 55/189 (29%), Positives = 92/189 (48%), Gaps = 20/189 (10%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G A K + ES++ + +F+ EI LS +HPN+V L + ++ E+ +
Sbjct: 28 ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGG 87
Query: 65 SLDRVLL----GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+LD ++L G T+ I+ +C + + L FLH V +HRD+KA NILL
Sbjct: 88 ALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHSHKV---IHRDLKAGNILLT 137
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGV 175
+ + K+ DFG++ + T I GT ++APE V KAD++S G+
Sbjct: 138 LDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDYKADIWSLGI 196
Query: 176 LVLEIISGR 184
++E+
Sbjct: 197 TLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 7/183 (3%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+G +A+K + E +FI E + + HPNLV+L G C + +V EY
Sbjct: 22 LGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ N L L K KL E D+C + + + +L +HRD+ A N L+
Sbjct: 81 MANGCL-LNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVG 134
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
++ K+ DFGLA+ D+ + + PE + + K+DV+SFGVL+ E+
Sbjct: 135 EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
Query: 181 ISG 183
S
Sbjct: 195 FSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 23/190 (12%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K L ++ V+ EF E +S+++HPN+V L+G C + +++EY+ + L
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 69 VLL------------GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
L+ G L+ I + IA G+ +L H VHRD+ A N
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARN 154
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYS 172
L+ + KI DFGL++ D + R+ + ++ PE +L G+ T ++D++S
Sbjct: 155 CLVGEGLTVKISDFGLSR---DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWS 211
Query: 173 FGVLVLEIIS 182
FGV++ EI S
Sbjct: 212 FGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 8/184 (4%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
G L +AVK + ++ F+ E L HPN+V+LIG CVQ +V E
Sbjct: 14 GVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL 73
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V SL L K + + K + + A G+ +L + + +HRD+ A N L+
Sbjct: 74 VPGGSLLTFLRK-KKNRLTVK--KLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVG 127
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
+ KI DFG+++ I ++ + + APE + G+ T ++DV+S+G+L+ E
Sbjct: 128 ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187
Query: 180 IISG 183
S
Sbjct: 188 TFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 54/163 (33%), Positives = 86/163 (52%), Gaps = 19/163 (11%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRR---ILVYEYVEN---NSLDRVLLGATKANIKLNW 82
EI L N+RHPN+VEL V G LV EY E + LD + +++ +K
Sbjct: 56 EITLLLNLRHPNIVELKEV-VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-- 112
Query: 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 142
+ + + +GL +LHE I+HRD+K SN+LL + KI DFGLA+ +
Sbjct: 113 -----LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164
Query: 143 ITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 184
+T ++ T Y APE +LG A D+++ G ++ E+++ +
Sbjct: 165 MTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 54/181 (29%), Positives = 101/181 (55%), Gaps = 17/181 (9%)
Query: 7 GRRIAVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
GR++AVK + KQ RE + E++ + + +HPN+VE+ + G +V E++E +
Sbjct: 44 GRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L ++ + ++N E+ + +C+ + K L+FLH + V +HRDIK+ +ILL +
Sbjct: 103 LTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILLTSDGRV 154
Query: 126 KIGDFGLAKLFPDNITHITTR---IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
K+ DFG F ++ R + GT ++APE + + D++S G++V+E++
Sbjct: 155 KLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD 210
Query: 183 G 183
G
Sbjct: 211 G 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-19
Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 30/193 (15%)
Query: 6 NGRRIAVKPLS----AESKQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
GR +A+K + E+K G+ + EI L ++HPN++ L+ + LV+E+
Sbjct: 24 TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83
Query: 61 --------VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI 112
+++ S+ VL T A+IK ++ +GL +LH I+HRD+
Sbjct: 84 METDLEKVIKDKSI--VL---TPADIK-SYMLM------TLRGLEYLHSN---WILHRDL 128
Query: 113 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVY 171
K +N+L+ + K+ DFGLA+ F +T ++ T Y APE + G + D++
Sbjct: 129 KPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHYGVGVDMW 187
Query: 172 SFGVLVLEIISGR 184
S G + E++
Sbjct: 188 SVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-19
Identities = 60/185 (32%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 10 IAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L + S+Q +F+ E + +S H N+V LIG + R ++ E + L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 69 VL-LGATKAN--IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L + L + +AKG +L E H +HRDI A N LL + P
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GP 154
Query: 126 ----KIGDFGLAKLFPDNITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYSFGVLV 177
KI DFG+A+ D R G ++ PE L G T K DV+SFGVL+
Sbjct: 155 GRVAKIADFGMAR---DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 178 LEIIS 182
EI S
Sbjct: 212 WEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 7e-19
Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 38/193 (19%)
Query: 6 NGRRIAVKPLS----AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEY 60
+G+ A+K LS + KQ V + E L ++RHP LV L G Q + LV EY
Sbjct: 25 SGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLYGS-FQDDSNLYLVMEY 82
Query: 61 VENNSL-------DRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 110
V L R + A + L L +LH IV+R
Sbjct: 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVL--------------ALEYLHSL---DIVYR 125
Query: 111 DIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADV 170
D+K N+LLD + KI DFG AK T + GT YLAPE +L D
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDW 181
Query: 171 YSFGVLVLEIISG 183
++ G+L+ E+++G
Sbjct: 182 WALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-19
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 25/189 (13%)
Query: 6 NGRRIAVKPLSAESKQGVREFIT--EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
G +A+K + + EI L + HPN+++L+ LV+E+++
Sbjct: 23 TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82
Query: 64 N---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ + G ++ IK + +GLAF H I+HRD+K N+L++
Sbjct: 83 DLYKLIKDRQRGLPESLIK-------SYLYQLLQGLAFCHSH---GILHRDLKPENLLIN 132
Query: 121 QEFNPKIGDFGLAKLF---PDNITH-ITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGV 175
E K+ DFGLA+ F TH + TR Y APE +LG + D++S G
Sbjct: 133 TEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLGDKGYSTPVDIWSVGC 187
Query: 176 LVLEIISGR 184
+ E++S R
Sbjct: 188 IFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-19
Identities = 45/178 (25%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
+GR++AVK + +Q E++ + + +H N+VE+ + G ++ E+++ +
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L ++ + +LN E+ + +C + + L +LH + V +HRDIK+ +ILL +
Sbjct: 105 LTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQGV---IHRDIKSDSILLTLDGRV 156
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+ DFG ++ + GT ++APE + + D++S G++V+E++ G
Sbjct: 157 KLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 12/182 (6%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L ++ R +F+ E+ LS + PN+ L+G C ++ EY+EN L++
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 69 VLLGATKANIKLNWEKRS-------DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L L +S + IA G+ +L E L + VHRD+ N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESL--NFVHRDLATRNCLVGK 165
Query: 122 EFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ KI DFG+++ L+ + + R ++A E VL G+ T K+DV++FGV + EI
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 181 IS 182
++
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-19
Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 10/177 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
G +A+K + E EI L RHPN+V G ++ + +V EY S
Sbjct: 27 TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L + L+ + + +C KGLA+LHE +HRDIK +NILL ++ +
Sbjct: 87 LQDIYQ---VTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDV 140
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLE 179
K+ DFG++ I + I GT ++APE G K D+++ G+ +E
Sbjct: 141 KLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 69/266 (25%), Positives = 109/266 (40%), Gaps = 42/266 (15%)
Query: 6 NGRRI--AVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
G+ I AVK L ++ + +F+ E + ++ H NL+ L G V ++V E
Sbjct: 20 GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV-VLTHPLMMVTELAP 78
Query: 63 NNSLDRVL----LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
SL L LG + ++ V IA G+ +L + +HRD+ A NIL
Sbjct: 79 LGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYLESK---RFIHRDLAARNIL 129
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTR------IAGTTGYLAPEYVLGGQLTMKADVYS 172
L + KIGDFGL + P N H A + APE + + +DV+
Sbjct: 130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAPESLRTRTFSHASDVWM 185
Query: 173 FGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE-LVDPELGEYPPNEIIRYM 231
FGV + E+ + +G+ L + L + +K E L P E P +I M
Sbjct: 186 FGVTLWEMFT--------YGEEPWAGLSGSQILKKIDKEGERLERP---EACPQDIYNVM 234
Query: 232 KVAFFCTQAAASRRPQMNQVIKMLTK 257
C + RP + + L +
Sbjct: 235 LQ---CWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYE 59
MGT ++AVK L + F+ E + +RH LV+L V I +V E
Sbjct: 24 MGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA--VVSEEPIYIVTE 80
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
Y+ SL L +KL D+ +A G+A++ + +HRD++++NIL+
Sbjct: 81 YMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILV 135
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLV 177
KI DFGLA+L DN T R + APE L G+ T+K+DV+SFG+L+
Sbjct: 136 GDGLVCKIADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193
Query: 178 LEIISGRNSGKAMWGQMN 195
E+++ G+ + MN
Sbjct: 194 TELVT---KGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 12/180 (6%)
Query: 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
+ +A+K + E ++ + + EI LS R P + + G ++G++ ++ EY
Sbjct: 25 TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84
Query: 65 S-LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
S LD + G KL+ + I + GL +LHEE +HRDIKA+NILL +E
Sbjct: 85 SCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEG 135
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ K+ DFG++ ++ T GT ++APE + KAD++S G+ +E+ G
Sbjct: 136 DVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 18/188 (9%)
Query: 4 LTNGRRIAVKPLSAESKQG--VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G +A+K ++ +G + + EI L +HP +V+L+ G+ +LV EY+
Sbjct: 22 RETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81
Query: 62 ENNSLDRVLLGA----TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
+ L VL +A +K + KG+A++H I+HRD+K +N+
Sbjct: 82 PS-DLSEVLRDEERPLPEAQVKS-------YMRMLLKGVAYMHAN---GIMHRDLKPANL 130
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVL 176
L+ + KI DFGLA+LF + + + T Y APE + G + D+++ G +
Sbjct: 131 LISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI 190
Query: 177 VLEIISGR 184
E+++G
Sbjct: 191 FAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 5 TNGRRIAVK-----PLSAES-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR 54
T G +AVK A K V+ +EI TL ++ H N+V+ +G
Sbjct: 24 TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83
Query: 55 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
+ EYV S+ L + + + + +GLA+LH + I+HRD+KA
Sbjct: 84 SIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKA 136
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYLAPEYVLGGQ--LTMKADV 170
N+L+D + KI DFG++K D+I + G+ ++APE + + K D+
Sbjct: 137 DNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDI 195
Query: 171 YSFGVLVLEIISGRNSGKAMWGQMNKF 197
+S G +VLE+ +GR W
Sbjct: 196 WSLGCVVLEMFAGRRP----WSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 66/253 (26%), Positives = 124/253 (49%), Gaps = 23/253 (9%)
Query: 10 IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K L A +++ R+F++E + HPN++ L G + ++V EY+EN SLD
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L K + + + + GIA G+ +L + VHRD+ A NIL++ K+
Sbjct: 95 FL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVS 148
Query: 129 DFGLAKLFPDNITHITTRIAGTTG--YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 186
DFGL+++ D+ T G + APE + + T +DV+S+G+++ E++S
Sbjct: 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--YG 206
Query: 187 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246
+ W N+ +++ + ++ P++ P + + M C Q + RP
Sbjct: 207 ERPYWEMSNQDVIKAIEEGYRLPAPMDC---------PAALHQLM---LDCWQKDRNERP 254
Query: 247 QMNQVIKMLTKNI 259
+ Q++ +L K I
Sbjct: 255 KFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 29/176 (16%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87
E++T N HP +++L Q + V EY N L L + L+ +
Sbjct: 53 EVLTRLN-GHPGIIKLY-YTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLDEKCTRF 106
Query: 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 147
I L +LH + I+HRD+K NILLD++ + KI DFG AK+ N + + +
Sbjct: 107 YAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 148 A-------------------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GT Y++PE + +D+++ G ++ ++++G+
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 12/183 (6%)
Query: 6 NGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+ R A+K LS +++ E I E L+ + ++ + + +V EY EN
Sbjct: 24 DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83
Query: 64 NSLDRVLLGATKANIKLN--WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L ++L + + W + I GLA LH + I+HRDIK+ N+ LD
Sbjct: 84 GDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAHLHSK---KILHRDIKSLNLFLDA 136
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
N KIGD G+AKL DN T+ I GT YL+PE K+DV++ GV++ E
Sbjct: 137 YDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC 195
Query: 182 SGR 184
+G+
Sbjct: 196 TGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 61/182 (33%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 6 NGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
N +A+K +S KQ ++ I E+ L +RHPN ++ GC ++ LV EY
Sbjct: 39 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
++ D LL K L + + + G +GLA+LH +++HRD+KA NILL +
Sbjct: 99 GSASD--LLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 151
Query: 123 FNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVL 178
K+GDFG A + P N GT ++APE +L GQ K DV+S G+ +
Sbjct: 152 GLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 179 EI 180
E+
Sbjct: 206 EL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 56/185 (30%), Positives = 90/185 (48%), Gaps = 20/185 (10%)
Query: 7 GRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
GR A+K + + VR I EI L +V HPN+V+ ++ E+++ S
Sbjct: 99 GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158
Query: 66 LDRVLLGATKANIKLNWEKR-SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L+ + E+ +D+ I G+A+LH HIVHRDIK SN+L++ N
Sbjct: 159 LE---------GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKN 206
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV-----LGGQLTMKADVYSFGVLVLE 179
KI DFG++++ + + + GT Y++PE + G D++S GV +LE
Sbjct: 207 VKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 180 IISGR 184
GR
Sbjct: 266 FYLGR 270
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 56/178 (31%), Positives = 92/178 (51%), Gaps = 15/178 (8%)
Query: 10 IAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-- 66
+A+K + S +Q +E ++ + ++ H +V L+G C G LV + SL
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLD 97
Query: 67 -DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
R + LNW CV IAKG+ +L E +VHR++ A NILL +
Sbjct: 98 HVRQHRDSLDPQRLLNW------CVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV 148
Query: 126 KIGDFGLAKL-FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
+I DFG+A L +PD+ + + ++A E +L G+ T ++DV+S+GV V E++S
Sbjct: 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 52/170 (30%), Positives = 90/170 (52%), Gaps = 6/170 (3%)
Query: 15 LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74
L + S++ + + EI L++V HPN++ + G + +V EY L + +
Sbjct: 35 LGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRK 94
Query: 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134
K + ++ I + + +GL LHE+ I+HRD+K++NILL KIGD G++K
Sbjct: 95 KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISK 151
Query: 135 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
+ N+ T+I GT Y+APE G + K+D++S G L+ E+ +
Sbjct: 152 VLKKNMAK--TQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 65/270 (24%), Positives = 111/270 (41%), Gaps = 51/270 (18%)
Query: 7 GRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
R+A+K ++ S + EF+ E + ++V L+G G ++V E +
Sbjct: 36 ETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGD 95
Query: 66 LDRVL------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
L L LG + IA G+A+L + VHRD+
Sbjct: 96 LKSYLRSRRPEAENNPGLGPPTLQKFIQM------AAEIADGMAYLAAK---KFVHRDLA 146
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT----TGYLAPEYVLGGQLTMKAD 169
A N ++ ++ KIGDFG+ + D R G ++APE + G T K+D
Sbjct: 147 ARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSD 203
Query: 170 VYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP----ELGEYPPN 225
V+SFGV++ E+ + L E +Q E+ L+ V +L E P+
Sbjct: 204 VWSFGVVLWEMAT---------------LAEQPYQGLSNEEVLKFVIDGGHLDLPENCPD 248
Query: 226 EIIRYMKVAFFCTQAAASRRPQMNQVIKML 255
+++ M++ C Q RP +++ L
Sbjct: 249 KLLELMRM---CWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 45/179 (25%), Positives = 94/179 (52%), Gaps = 9/179 (5%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
++G+ +AVK + +Q E++ + + +H N+VE+ + G +V E++E
Sbjct: 43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
+L ++ + ++N E+ + +C+ + K L+ LH + ++HRDIK+ +ILL +
Sbjct: 103 ALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGR 154
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+ DFG + + GT ++APE + + D++S G++V+E++ G
Sbjct: 155 VKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
MGT ++A+K L + F+ E + +RH LV L V +V E+
Sbjct: 24 MGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAV-VSEEPIYIVTEF 81
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ SL L +KL + D+ IA G+A++ + +HRD++A+NIL+
Sbjct: 82 MGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVG 136
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
KI DFGLA+L DN + APE L G+ T+K+DV+SFG+L+ E+
Sbjct: 137 DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 181 ISGRNSGKAMW-GQMNKFLLE 200
++ G+ + G +N+ +LE
Sbjct: 197 VT---KGRVPYPGMVNREVLE 214
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 51/190 (26%), Positives = 97/190 (51%), Gaps = 16/190 (8%)
Query: 2 GTLTNGRRIA-VKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
GTL +++ V+ S+E ++ V EI ++ + HP+++ ++G + + L E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 61 VENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
+ S+ +L GA K + +N+ + +GL++LHE I+HRD+K +N+L
Sbjct: 85 MAGGSVSHLLSKYGAFKEAVIINY------TEQLLRGLSYLHEN---QIIHRDVKGANLL 135
Query: 119 LDQEFNP-KIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFG 174
+D +I DFG A T ++ GT ++APE + G Q DV+S G
Sbjct: 136 IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG 195
Query: 175 VLVLEIISGR 184
+++E+ + +
Sbjct: 196 CVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L ++ + R +F+ EI +S ++ PN++ L+ C+ ++ EY+EN L++
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 69 VLLGATKANIKLNWEKR----SDIC---VGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L + S + IA G+ +L + VHRD+ N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165
Query: 122 EFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ KI DFG+++ L+ + I R +++ E +L G+ T +DV++FGV + EI
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 181 IS 182
++
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 63/188 (33%), Positives = 93/188 (49%), Gaps = 22/188 (11%)
Query: 7 GRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--VYE 59
GR +AVK P S E+ + V EI L N+RH +V+ GC + L E
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 60 YVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
Y+ S+ L GA N+ + ++ I +G+++LH + IVHRDIK +NI
Sbjct: 87 YMPGGSIKDQLKAYGALTENVTRRYTRQ------ILQGVSYLHSNM---IVHRDIKGANI 137
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPEYVLGGQLTMKADVYSFG 174
L D N K+GDFG +K I T I TG +++PE + G KADV+S
Sbjct: 138 LRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVA 196
Query: 175 VLVLEIIS 182
V+E+++
Sbjct: 197 CTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 61/190 (32%), Positives = 94/190 (49%), Gaps = 22/190 (11%)
Query: 7 GRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV--YE 59
GR +A K P S E+ + V EI L N++H +V+ GC + L E
Sbjct: 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86
Query: 60 YVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
Y+ S+ L GA ++ + ++ I +G+++LH + IVHRDIK +NI
Sbjct: 87 YMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLHSNM---IVHRDIKGANI 137
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG---YLAPEYVLGGQLTMKADVYSFG 174
L D N K+GDFG +K I T I TG +++PE + G KADV+S G
Sbjct: 138 LRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLG 196
Query: 175 VLVLEIISGR 184
V+E+++ +
Sbjct: 197 CTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-18
Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 20/190 (10%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L ++ + R +F+ E+ LS ++ PN++ L+G CV ++ EY+EN L++
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 69 VL---------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
L + +++ + + IA G+ +L + VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165
Query: 114 ASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYS 172
N L+ + KI DFG+++ L+ + I R ++A E +L G+ T +DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 173 FGVLVLEIIS 182
FGV + EI+
Sbjct: 226 FGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-18
Identities = 50/174 (28%), Positives = 90/174 (51%), Gaps = 12/174 (6%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
+AVK L E V EF+ E + ++HPNLV+L+G C + ++ E++ +L
Sbjct: 34 VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
L + ++N + I+ + +L ++ + +HRD+ A N L+ + K+ D
Sbjct: 93 LRECNRQ--EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 147
Query: 130 FGLAKLFPDNITHITTRIAGTT---GYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
FGL++L + T AG + APE + + ++K+DV++FGVL+ EI
Sbjct: 148 FGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-18
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 9/218 (4%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
M T ++AVK + S V F+ E + ++H LV+L + I+ E+
Sbjct: 24 MATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT-EF 81
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ SL L + + + K K D IA+G+AF+ + + +HRD++A+NIL+
Sbjct: 82 MAKGSLLD-FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 136
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
KI DFGLA++ DN + APE + G T+K+DV+SFG+L++EI
Sbjct: 137 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 196
Query: 181 IS-GRNSGKAMWGQMNKFLLEWAWQLHQEEK-PLELVD 216
++ GR M LE +++ + E P EL +
Sbjct: 197 VTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-18
Identities = 58/185 (31%), Positives = 97/185 (52%), Gaps = 11/185 (5%)
Query: 7 GRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRI-LVYEYVEN 63
G ++AVK L ES + + EI L N+ H N+V+ G C + G I L+ E++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL L + K+N +++ V I KG+ +L VHRD+ A N+L++ E
Sbjct: 93 GSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146
Query: 124 NPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
KIGDFGL K + + T + + + APE ++ + + +DV+SFGV + E++
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 182 SGRNS 186
+ +S
Sbjct: 207 TYCDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-18
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 7 GRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVE 62
G A+K + V + +TE LS + P +V+L QG + + LV EY+
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLP 76
Query: 63 NNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
L +L +G+ L+ + I L +LH I+HRD+K NIL+D
Sbjct: 77 GGDLASLLENVGS------LDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILID 127
Query: 121 QEFNPKIGDFGLAK-------LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
+ K+ DFGL+K + ++ RI GT Y+APE +LG + D +S
Sbjct: 128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSL 187
Query: 174 GVLVLEIISG 183
G ++ E + G
Sbjct: 188 GCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-18
Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 8/184 (4%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
L+ RIA+K + + V+ EI S ++H N+V+ +G + + E V
Sbjct: 30 LSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL LL + +K N + I +GL +LH+ IVHRDIK N+L++
Sbjct: 90 GSLS-ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYS 145
Query: 124 NP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEI 180
KI DFG +K I T GT Y+APE + G AD++S G ++E+
Sbjct: 146 GVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204
Query: 181 ISGR 184
+G+
Sbjct: 205 ATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 44/178 (24%), Positives = 93/178 (52%), Gaps = 9/178 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
G+++AVK + +Q E++ + + H N+V++ + G +V E++E +
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L ++ + ++N E+ + +C+ + + L++LH + ++HRDIK+ +ILL +
Sbjct: 106 LTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRI 157
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+ DFG + + GT ++APE + + D++S G++V+E+I G
Sbjct: 158 KLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 58/180 (32%), Positives = 92/180 (51%), Gaps = 11/180 (6%)
Query: 7 GRRIAVKP-LSAESKQGVREF-ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G+ +A+K L +E + V++ + EI L +RH NLV LI + R LV+E+V++
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
LD + K L+ + I +G+ F H +I+HRDIK NIL+ Q
Sbjct: 86 VLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGV 138
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 183
K+ DFG A+ + T T Y APE ++G +A D+++ G LV E+++G
Sbjct: 139 VKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 60/177 (33%), Positives = 90/177 (50%), Gaps = 18/177 (10%)
Query: 10 IAVKPLSAESKQGV---REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
+A+K +S KQ ++ I E+ L ++HPN +E GC ++ LV EY ++
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
D LL K L + + I G +GLA+LH +++HRDIKA NILL + K
Sbjct: 113 D--LLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 165
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEI 180
+ DFG A +I GT ++APE +L GQ K DV+S G+ +E+
Sbjct: 166 LADFGSA-----SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 20/189 (10%)
Query: 7 GRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--VYE 59
GR +AVK P S E+ + V EI L N+ H +V+ GC R L E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 60 YVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
++ S+ L GA N+ + ++ I +G+++LH + IVHRDIK +NI
Sbjct: 87 HMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGVSYLHSNM---IVHRDIKGANI 137
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
L D N K+GDFG +K T + GT +++PE + G KAD++S G
Sbjct: 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGC 197
Query: 176 LVLEIISGR 184
V+E+++ +
Sbjct: 198 TVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 11/178 (6%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
G+ +A+K ++ + + I EI+ + +HPN+V + + G +V EY+ SL
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
V+ ++ + + +C + L FLH ++HRDIK+ NILL + + K
Sbjct: 104 TDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK 155
Query: 127 IGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ DFG A++ P+ T + GT ++APE V K D++S G++ +E++ G
Sbjct: 156 LTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 60/177 (33%), Positives = 90/177 (50%), Gaps = 18/177 (10%)
Query: 10 IAVKPLSAESKQ---GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
+AVK +S KQ ++ I E+ L ++HPN +E GC ++ LV EY ++
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
D LL K L + + I G +GLA+LH +++HRDIKA NILL + K
Sbjct: 109 D--LLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 161
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLVLEI 180
+ DFG A + + GT ++APE +L GQ K DV+S G+ +E+
Sbjct: 162 LADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 31/259 (11%)
Query: 9 RIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
++AVK L + RE ++E+ +S++ H N+V L+G C G +++ EY L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
L K L E +AKG+AFL + + +HRD+ A N+LL K
Sbjct: 127 LNFL--RRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181
Query: 127 IGDFGLAKLFPDNITHITTRIA-GTT----GYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
I DFGLA+ +I + + + G ++APE + T ++DV+S+G+L+ EI
Sbjct: 182 ICDFGLAR----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 182 S-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240
S G N M ++ + + ++ +P E+ P EI MK C A
Sbjct: 238 SLGSNPYPGM--PVDSKFYKLIKEGYRMAQP---------EHAPAEIYDIMKT---CWDA 283
Query: 241 AASRRPQMNQVIKMLTKNI 259
+RP Q+++++ K +
Sbjct: 284 DPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 4e-17
Identities = 48/178 (26%), Positives = 91/178 (51%), Gaps = 11/178 (6%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
G+ +A+K ++ + + I EI+ + +++PN+V + + G +V EY+ SL
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
V+ ++ + +C + L FLH ++HRDIK+ N+LL + + K
Sbjct: 104 TDVVTETCMDEAQI-----AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVK 155
Query: 127 IGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ DFG A++ P+ T + GT ++APE V K D++S G++ +E++ G
Sbjct: 156 LTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 12/176 (6%)
Query: 10 IAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK + VRE F+ E + HP++V+LIG + I V E L R
Sbjct: 37 VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWI-VMELAPLGEL-R 94
Query: 69 VLLGATKANIKLNWEKRSDI--CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
L K ++ L S I ++ LA+L + VHRDI A N+L+ K
Sbjct: 95 SYLQVNKYSLDL----ASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK 147
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
+GDFGL++ D + ++ ++APE + + T +DV+ FGV + EI+
Sbjct: 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 60/251 (23%), Positives = 122/251 (48%), Gaps = 26/251 (10%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
G+++AVK + + + F+ E ++ + H NLV L+G + I V E + +L
Sbjct: 29 GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNL 85
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
L T+ ++ + + +A+G+ +L + +VHRD+ A NIL+ ++ K
Sbjct: 86 VNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 186
+ DFGLA++ + +++ + APE + + + K+DV+S+GVL+ E+ S
Sbjct: 141 VSDFGLARVGSMGVD--NSKLP--VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS---Y 193
Query: 187 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246
G+A + +M+ L E + + + ++P G ++ M C + +RP
Sbjct: 194 GRAPYPKMS--LKEVKECVEKGYR----MEPPEGCPADVYVL--MTS---CWETEPKKRP 242
Query: 247 QMNQVIKMLTK 257
+++ + L K
Sbjct: 243 SFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-17
Identities = 67/266 (25%), Positives = 129/266 (48%), Gaps = 38/266 (14%)
Query: 7 GRR---IAVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
G+R +A+K L + +++ R+F++E + HPN++ L G + +++ E++E
Sbjct: 29 GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICV-----GIAKGLAFLHEELVPHIVHRDIKASNI 117
N +LD L + N + + I + GIA G+ +L E + VHRD+ A NI
Sbjct: 89 NGALDSFL--------RQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNI 137
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG--YLAPEYVLGGQLTMKADVYSF 173
L++ K+ DFGL++ D+ + T+ + G + APE + + T +DV+S+
Sbjct: 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSY 197
Query: 174 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233
G+++ E++S + W N+ ++ Q ++ P++ P + + M
Sbjct: 198 GIVMWEVMS--YGERPYWDMSNQDVINAIEQDYRLPPPMDC---------PTALHQLM-- 244
Query: 234 AFFCTQAAASRRPQMNQVIKMLTKNI 259
C Q + RP+ Q++ L K I
Sbjct: 245 -LDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-17
Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 10/184 (5%)
Query: 4 LTNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G +A+K + E+ +GV I EI L + HPN+V L+ + LV+E++
Sbjct: 21 KLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+ LD + L+ + +G+A+ H ++HRD+K N+L+D+
Sbjct: 81 D---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDR 134
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEI 180
E K+ DFGLA+ F + T + T Y APE +LG Q + D++S G + E+
Sbjct: 135 EGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEM 193
Query: 181 ISGR 184
++ R
Sbjct: 194 VNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 7 GRRIAVKPLSAESKQGVRE---FITEIMTLSNVRHPNLVELIGCCVQGTRRIL-VYEYVE 62
G +A+K L ++ + + F E + + HPN+V L+ + V+EYV
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--- 119
+L R +L A A L + + + + LA H + IVHRD+K NI++
Sbjct: 63 GRTL-REVLAADGA---LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 120 DQEFNPKIGDFGLAKLFPD----NITHIT--TRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
+ K+ DFG+ L P ++ +T T + GT Y APE + G +T +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 174 GVLVLEIISGR 184
G++ LE ++G+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-17
Identities = 52/158 (32%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 30 IMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88
++ L+ +HP L +L C Q R+ V EYV N D L+ + + + + +
Sbjct: 48 VLALAG-KHPFLTQLH-SCFQTKDRLFFVMEYV--NGGD--LMFHIQRSGRFDEPRARFY 101
Query: 89 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTR- 146
I GL FLHE I++RD+K N+LLD E + KI DFG+ K + I +TT
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155
Query: 147 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GT Y+APE + D ++ GVL+ E+++G+
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 38/94 (40%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I L +LH + I+HRDIK NILLD++ + I DF +A + +TT +GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTP 163
Query: 152 GYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 184
GY+APE VL Q A D +S GV E + G+
Sbjct: 164 GYMAPE-VLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 5/162 (3%)
Query: 27 ITEIMTLSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84
++E+ L ++HPN+V + +V EY E L +++ K + E
Sbjct: 47 VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF 106
Query: 85 RSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH 142
I + L H P ++HRD+K +NI LD N K+GDFGLAK+ + +
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 143 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T GT Y++PE + K+D++S G L+ E+ +
Sbjct: 167 AKT-YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I GL LH+ IV+RD+K N+LLD N +I D GLA AGT
Sbjct: 104 IICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTP 158
Query: 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GY+APE + G D ++ G + E+I+GR
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 23/193 (11%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L E S +F E ++ HPN+V+L+G C G L++EY+ L+
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 69 VL----------LGATKANIKLNWEKRSDIC--------VGIAKGLAFLHEELVPHIVHR 110
L L + ++ + + +A G+A+L E VHR
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR 154
Query: 111 DIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKAD 169
D+ N L+ + KI DFGL+ ++ + + A ++ PE + + T ++D
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESD 214
Query: 170 VYSFGVLVLEIIS 182
V+++GV++ EI S
Sbjct: 215 VWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 25/183 (13%)
Query: 10 IAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--------VYEY 60
+A+K L A S + +E + E +++V +P++ L+G C+ T +++ + +Y
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY 98
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V + D + + LNW CV IAKG+ +L E +VHRD+ A N+L+
Sbjct: 99 VREHK-DNI-----GSQYLLNW------CVQIAKGMNYLEER---RLVHRDLAARNVLVK 143
Query: 121 QEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
+ KI DFGLAKL D + ++A E +L T ++DV+S+GV V E
Sbjct: 144 TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 203
Query: 180 IIS 182
+++
Sbjct: 204 LMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 25/195 (12%)
Query: 10 IAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L + +R+ ++E L V HP++++L G C Q +L+ EY + SL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 69 VL------------LGATKANIKLNWEKRSDICVG--------IAKGLAFLHEELVPHIV 108
L + + L+ + +G I++G+ +L E +V
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLV 149
Query: 109 HRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 167
HRD+ A N+L+ + KI DFGL++ ++ ++ ++ ++A E + T +
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ 209
Query: 168 ADVYSFGVLVLEIIS 182
+DV+SFGVL+ EI++
Sbjct: 210 SDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 6 NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI------LV 57
G+ +A+K + + ++ ++E + SN HPN+ G ++ LV
Sbjct: 30 TGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN--HPNIATFYGAFIKKNPPGNDDQLWLV 87
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
E S+ ++ G K +L E + I +GLA+LHE ++HRDIK NI
Sbjct: 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNI 144
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-----LTMKADVYS 172
LL + K+ DFG++ + T I GT ++APE + + ++DV+S
Sbjct: 145 LLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWS 203
Query: 173 FGVLVLEIISG 183
G+ +E+ G
Sbjct: 204 LGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+ VK L + ++ EF E+ + H N+V L+G C + ++ EY + L +
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97
Query: 69 VLLGATKANIK------LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
L ATK+ + L+ +++ +C IA G+ L VHRD+ A N L+ +
Sbjct: 98 FLR-ATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQ 153
Query: 123 FNPKIGDFGLAK------LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
K+ L+K + I R +LAPE V + K+DV+SFGVL
Sbjct: 154 REVKVSLLSLSKDVYNSEYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWSFGVL 207
Query: 177 VLEIIS 182
+ E+ +
Sbjct: 208 MWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 52/157 (33%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 32 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI--- 88
T ++ RHP LV L C V EY L + + E R+
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL------MMHIHTDVFSEPRAVFYAA 108
Query: 89 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTR 146
CV + GL +LHE IV+RD+K N+LLD E KI DFGL K + + T+
Sbjct: 109 CVVL--GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST 160
Query: 147 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
GT +LAPE + T D + GVL+ E++ G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-16
Identities = 52/187 (27%), Positives = 98/187 (52%), Gaps = 18/187 (9%)
Query: 5 TNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
T G +A+K + ++++G I EI + ++H N+V L + +LV+EY++
Sbjct: 23 TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82
Query: 64 NSLDRVL-----LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
+ L + + GA N ++ + + KG+AF HE ++HRD+K N+L
Sbjct: 83 D-LKKYMDTHGVRGALDPNTVKSFTYQ------LLKGIAFCHEN---RVLHRDLKPQNLL 132
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLV 177
+++ K+ DFGLA+ F + + + T Y AP+ +LG + + D++S G ++
Sbjct: 133 INKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIM 191
Query: 178 LEIISGR 184
E+I+GR
Sbjct: 192 AEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-16
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 25 EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84
EFI E + + H LV+L G C + +V EY+ N L L K + +
Sbjct: 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK---RFQPSQ 101
Query: 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 144
++C + +G+A+L + +HRD+ A N L+D + K+ DFGL++ D+ +
Sbjct: 102 LLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 145 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
+ PE +L + + K+DV++FGVL+ E+ S
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-16
Identities = 49/181 (27%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+ G+ +A+K ++ + + I EI+ + ++PN+V + + G +V EY+
Sbjct: 41 IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL V+ ++ + + +C + L FLH ++HRDIK+ NILL +
Sbjct: 101 GSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDG 152
Query: 124 NPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
+ K+ DFG A++ P+ T + GT ++APE V K D++S G++ +E++
Sbjct: 153 SVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210
Query: 183 G 183
G
Sbjct: 211 G 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 10/176 (5%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A K + E K +R + I E+ L P +V G + E+++ SLD+
Sbjct: 33 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 92
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
VL K ++ E + + + +GLA+L E+ I+HRD+K SNIL++ K+
Sbjct: 93 VL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLC 146
Query: 129 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
DFG++ D++ + GT Y++PE + G ++++D++S G+ ++E+ GR
Sbjct: 147 DFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-16
Identities = 61/251 (24%), Positives = 121/251 (48%), Gaps = 23/251 (9%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K L + R +F++E + H N++ L G + +++ EY+EN +LD+
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L + + + + + GIA G+ +L + + VHRD+ A NIL++ K+
Sbjct: 96 YL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVS 149
Query: 129 DFGLAKLFPDN--ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 186
DFGL+++ D+ T+ T+ + APE + + T +DV+SFG+++ E++S
Sbjct: 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS--FG 207
Query: 187 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246
+ W N +++ + P++ P+ + + M C Q +RRP
Sbjct: 208 ERPYWDMSNHEVMKAINDGFRLPAPMDC---------PSAVYQLM---LQCWQQDRARRP 255
Query: 247 QMNQVIKMLTK 257
+ ++ +L K
Sbjct: 256 RFVDIVNLLDK 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 67/257 (26%), Positives = 116/257 (45%), Gaps = 23/257 (8%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
GTL + +AVK + Q ++ +F++E L HPN+V+LIG C Q +V E
Sbjct: 14 GTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL 73
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V L K +L ++ + A G+A+L + + +HRD+ A N L+
Sbjct: 74 VPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVG 127
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ KI DFG+++ D I + + APE + G+ + ++DV+S+G+L+ E
Sbjct: 128 ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWET 187
Query: 181 IS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
S G M Q + Q EK + P + P+++ + M+ C
Sbjct: 188 FSLGVCPYPGMTNQQAR---------EQVEKGYRMSCP---QKCPDDVYKVMQR---CWD 232
Query: 240 AAASRRPQMNQVIKMLT 256
RP+ +++ K L
Sbjct: 233 YKPENRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 10/183 (5%)
Query: 5 TNGRRIAVKP--LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
G +A+K L E++ I EI L + HPN+V+L+ + LV+E++
Sbjct: 23 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL- 81
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
+ L + + + + I L K + +GLAF H V +HRD+K N+L++ E
Sbjct: 82 HQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTE 136
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEII 181
K+ DFGLA+ F + T + T Y APE +LG + A D++S G + E++
Sbjct: 137 GAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
Query: 182 SGR 184
+ R
Sbjct: 196 TRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 53/187 (28%), Positives = 95/187 (50%), Gaps = 11/187 (5%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K L E+++ VR E + E + + +P +V +IG C + +LV E L++
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNK 83
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L K I + ++ ++ G+ +L + + VHRD+ A N+LL + KI
Sbjct: 84 -FLSGKKDEITV--SNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKIS 137
Query: 129 DFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRN 185
DFGL+K + ++ R AG + APE + + + ++DV+S+G+ + E S G+
Sbjct: 138 DFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
Query: 186 SGKAMWG 192
K M G
Sbjct: 198 PYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 54/184 (29%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 5 TNGRRIAVKPLSAESK-QGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
G+ +A+K + ES+ +GV I EI L ++HPN+V L +Q +R L++E++
Sbjct: 23 KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL- 81
Query: 63 NNSLD-RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
S+D + L + ++ E I +G+ F H ++HRD+K N+L+D
Sbjct: 82 --SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDN 136
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEI 180
+ K+ DFGLA+ F + T + T Y APE +LG + D++S G + E+
Sbjct: 137 KGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
Query: 181 ISGR 184
+ +
Sbjct: 196 ATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 11/181 (6%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+ G+ +A++ ++ + + I EI+ + ++PN+V + + G +V EY+
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL V+ ++ + + +C + L FLH ++HRDIK+ NILL +
Sbjct: 102 GSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG 153
Query: 124 NPKIGDFGL-AKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
+ K+ DFG A++ P+ + + GT ++APE V K D++S G++ +E+I
Sbjct: 154 SVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 183 G 183
G
Sbjct: 212 G 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 21/166 (12%)
Query: 29 EIMTLSNVR-HPNLVELIGCCV---QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWE 83
EIM L + HPN+V+L+ V + + I LV+EY+E + L V+ +ANI +
Sbjct: 56 EIMFLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYMETD-LHAVI----RANILEDVH 108
Query: 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF----PDN 139
KR I + K L ++H +++HRD+K SNILL+ + K+ DFGLA+ +
Sbjct: 109 KRY-IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164
Query: 140 ITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 184
+ T T Y APE +LG K D++S G ++ E++ G+
Sbjct: 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 68/276 (24%), Positives = 128/276 (46%), Gaps = 40/276 (14%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
++AVK L ++ +++ + + I+E+ + + +H N++ L+G C Q ++ EY +L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 67 DRVLLGATKANIK------------LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
L ++ L+++ +A+G+ +L + +HRD+ A
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKAD 169
N+L+ ++ KI DFGLA+ +I HI T G ++APE + T ++D
Sbjct: 169 RNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 170 VYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229
V+SFGVL+ EI + G G + L + + H+ +KP NE+
Sbjct: 225 VWSFGVLLWEIFT--LGGSPYPGVPVEELFKLLKEGHRMDKPSNCT---------NELYM 273
Query: 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
M+ C A S+RP Q+++ L + + L +
Sbjct: 274 MMRD---CWHAVPSQRPTFKQLVEDLDRILALTSNQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 53/176 (30%), Positives = 91/176 (51%), Gaps = 10/176 (5%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A K + E K +R + I E+ L P +V G + E+++ SLD+
Sbjct: 29 MARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 88
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
VL A + I N + I V +GL +L E+ I+HRD+K SNIL++ K+
Sbjct: 89 VLKKAGR--IPENILGKISIAV--LRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 142
Query: 129 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
DFG++ D++ + GT Y++PE + G T+++D++S G+ ++E+ GR
Sbjct: 143 DFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 54/241 (22%), Positives = 108/241 (44%), Gaps = 21/241 (8%)
Query: 15 LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74
L+ S++ R+ + EI+ LS ++HPN++ + ++ EY +L ++
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV-RQ 93
Query: 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134
K + E I ++++H+ I+HRDIK NI L + K+GDFG++K
Sbjct: 94 KGQL-FEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISK 149
Query: 135 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 194
+ + T + GT Y++PE G + K+D+++ G ++ E+++ + + A
Sbjct: 150 ILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA----- 203
Query: 195 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254
L ++ Q P + Y +E+I + Q +RP ++V+
Sbjct: 204 -TNPLNLVVKIVQGNY-----TPVVSVY-SSELISLVHS---LLQQDPEKRPTADEVLDQ 253
Query: 255 L 255
Sbjct: 254 P 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 30/240 (12%)
Query: 18 ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKA 76
E++ + + EI LS P + G ++GT+ ++ EY+ S LD + G
Sbjct: 41 EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--- 97
Query: 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136
L + I I KGL +LH E +HRDIKA+N+LL ++ + K+ DFG+A
Sbjct: 98 ---LEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151
Query: 137 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG------------- 183
D T + GT ++APE + KAD++S G+ +E+ G
Sbjct: 152 TDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 210
Query: 184 ----RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
+NS + GQ +K E+ ++ EL ++ I RY K F T+
Sbjct: 211 FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH--KFITRYTKKTSFLTE 268
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
L R +AVK PL + + ++ ++E+ L P ++ G R + E++
Sbjct: 23 LLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+ SLD K+ I V + KGL +L I+HRD+K SN+L++
Sbjct: 82 DGGSLD--------VYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNT 130
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
K+ DFG++ + I GT Y+APE + G Q + +DV+S G+ +E+
Sbjct: 131 RGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELA 187
Query: 182 SGR 184
GR
Sbjct: 188 LGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 49/181 (27%), Positives = 95/181 (52%), Gaps = 24/181 (13%)
Query: 11 AVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL 70
A K + +S++ + +++ EI L+ HP +V+L+G + ++ E+ ++D ++
Sbjct: 41 AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100
Query: 71 L----GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
L G T+ I++ IC + + L +LH I+HRD+KA N+LL + + K
Sbjct: 101 LELDRGLTEPQIQV-------ICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIK 150
Query: 127 IGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLGGQLT-----MKADVYSFGVLVLE 179
+ DFG++ N+ + R GT ++APE V+ + KAD++S G+ ++E
Sbjct: 151 LADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 207
Query: 180 I 180
+
Sbjct: 208 M 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 52/180 (28%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNS 65
G ++AVK + ++ + F+ E ++ +RH NLV+L+G V+ + +V EY+ S
Sbjct: 29 GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L L ++ L + + + + + +L + VHRD+ A N+L+ ++
Sbjct: 87 LVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVA 141
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 184
K+ DFGL K + T T ++ + APE + + + K+DV+SFG+L+ EI S GR
Sbjct: 142 KVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 11/163 (6%)
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V + SLD+ + + + I V I K L +LH +L ++HRD+K SN+L++
Sbjct: 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLIN 138
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG----GQLTMKADVYSFGVL 176
+ K+ DFG++ D++ T AG Y+APE + +K+DV+S G+
Sbjct: 139 RNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGIT 196
Query: 177 VLEIISGR---NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 216
++E+ +GR +S K + Q+ + + E + QL E+ E D
Sbjct: 197 MIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWEKR 85
EI L ++HPNLV LI + + LV+EY ++ N L++ G + IK
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK------ 103
Query: 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 145
I + + F H+ + +HRD+K NIL+ ++ K+ DFG A++ T
Sbjct: 104 -KIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 146 RIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMW 191
+A T Y APE ++G Q DV++ G + E++ +G+ +W
Sbjct: 160 YVA-TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL----TGQPLW 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 25/179 (13%)
Query: 29 EIMTLSNVRHPNLVEL--IGCCVQGTR--RI-LVYEYVENN---SLDRVLLGATKANIKL 80
EI L ++HPN+V + + V G+ +I +V EYVE++ ++ + ++ +K
Sbjct: 54 EINILLKLQHPNIVTVKEV---VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC 110
Query: 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 140
+ + + G+A LH+ I+HRD+K SN+LL+ KI DFGLA+ + +
Sbjct: 111 -------LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 141 THITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNK 196
T++ T Y APE +LG + + D++S G + E+++ + GK+ Q+NK
Sbjct: 161 KPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 6e-15
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 56/208 (26%)
Query: 6 NGRRIAVK--------PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL- 56
GR++A+K + A K+ +RE I L ++RH N++ L IL
Sbjct: 24 TGRKVAIKKISNVFDDLIDA--KRILRE----IKLLRHLRHENIIGL--------LDILR 69
Query: 57 ------------VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 104
V E +E + L +V+ K+ L + I +GL +LH
Sbjct: 70 PPSPEDFNDVYIVTELMETD-LHKVI----KSPQPLTDDHIQYFLYQILRGLKYLHSA-- 122
Query: 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLF------PDNIT-HITTRIAGTTGYLAPE 157
+++HRD+K SNIL++ + KI DFGLA+ +T ++ TR Y APE
Sbjct: 123 -NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW-----YRAPE 176
Query: 158 YVLGGQLTMKA-DVYSFGVLVLEIISGR 184
+L KA D++S G + E+++ +
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-15
Identities = 50/167 (29%), Positives = 89/167 (53%), Gaps = 24/167 (14%)
Query: 25 EFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--------VYEYVENNSLDRVLLGATKA 76
EF+ E + ++++ HP+LV L+G C+ T +++ + +YV + D + +
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHK-DNI-----GS 108
Query: 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136
+ LNW CV IAKG+ +L E +VHRD+ A N+L+ + KI DFGLA+L
Sbjct: 109 QLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
Query: 137 P-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
D + ++A E + + T ++DV+S+GV + E+++
Sbjct: 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 49/176 (27%), Positives = 91/176 (51%), Gaps = 10/176 (5%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A K + E K +R + I E+ L P +V G + E+++ SLD+
Sbjct: 33 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 92
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
VL A + ++ + + + KGL +L E+ I+HRD+K SNIL++ K+
Sbjct: 93 VLKKAGRIPEQI----LGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 146
Query: 129 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
DFG++ D++ + GT Y++PE + G ++++D++S G+ ++E+ GR
Sbjct: 147 DFGVSGQLIDSMAN---SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-15
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 50/280 (17%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+AVK L + +++ + + ++E+ + + +H N++ L+G C Q ++ EY +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 68 RVLLGATKANIKLNWEKRSDI---------------CV-GIAKGLAFLHEELVPHIVHRD 111
L +A E DI C +A+G+ +L + +HRD
Sbjct: 110 EYL----RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRD 162
Query: 112 IKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTM 166
+ A N+L+ + KI DFGLA+ ++ +I T G ++APE + T
Sbjct: 163 LAARNVLVTENNVMKIADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218
Query: 167 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226
++DV+SFGVL+ EI + G G + L + + H+ +KP NE
Sbjct: 219 QSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------NE 267
Query: 227 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL--NEE 264
+ M+ C A S RP Q+++ L + + L NEE
Sbjct: 268 LYMMMRD---CWHAIPSHRPTFKQLVEDLDRILTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 40/100 (40%), Positives = 59/100 (59%), Gaps = 7/100 (7%)
Query: 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 147
I V K L +L EEL I+HRD+K SNILLD+ N K+ DFG++ D+I TR
Sbjct: 112 IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRD 167
Query: 148 AGTTGYLAPEYVLGGQLT---MKADVYSFGVLVLEIISGR 184
AG Y+APE + +++DV+S G+ + E+ +G+
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTR 146
+ +LH I++RD+K N+LLD K+ DFG AK L T
Sbjct: 98 YIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--- 151
Query: 147 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GT Y+APE +L D +S G+L+ E+++GR
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 10/182 (5%)
Query: 10 IAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K + E++ + + EI LS P + + G ++GT+ ++ EY+ S
Sbjct: 32 VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD 91
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
+L ++ + + I KGL +LH E +HRDIKA+N+LL ++ + K+
Sbjct: 92 LLRAGPFDEFQI-----ATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLA 143
Query: 129 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK 188
DFG+A D T + GT ++APE + KAD++S G+ +E+ G
Sbjct: 144 DFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202
Query: 189 AM 190
M
Sbjct: 203 DM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 11/176 (6%)
Query: 8 RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
++I V+ ++ + + + E L + HPN++E ++ ++V EY +L
Sbjct: 31 KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-K 126
+ + N L+ + V I L +H +L I+HRD+K NILLD+ K
Sbjct: 88 EYI--QKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVK 142
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
IGDFG++K+ T + GT Y++PE G K+D+++ G ++ E+ S
Sbjct: 143 IGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 14/183 (7%)
Query: 9 RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR------ILVYEY 60
++AVK + ++ + +F++E + + HPN++ LIG C+Q +++ +
Sbjct: 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87
Query: 61 VENNSLDRVLLGATKAN--IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
+++ L LL + + L + IA G+ +L + +HRD+ A N +
Sbjct: 88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCM 144
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLV 177
L++ N + DFGL+K + + RIA ++A E + T K+DV+SFGV +
Sbjct: 145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTM 204
Query: 178 LEI 180
EI
Sbjct: 205 WEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 58/188 (30%), Positives = 92/188 (48%), Gaps = 20/188 (10%)
Query: 4 LTNGRRIAVKPLS-AESKQGV-----REFITEIMTLSNVRHPNLVELIGCC--VQGTRRI 55
L GR +A+K + S++G+ RE I + L + HPN+V L+ C + R +
Sbjct: 21 LNTGRFVALKKVRVPLSEEGIPLSTLRE-IALLKQLESFEHPNIVRLLDVCHGPRTDREL 79
Query: 56 ---LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI 112
LV+E+V+ + L L K + E D+ + +G+ FLH IVHRD+
Sbjct: 80 KLTLVFEHVDQD-LATYLSKCPKPGLPP--ETIKDLMRQLLRGVDFLHSHR---IVHRDL 133
Query: 113 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYS 172
K NIL+ + KI DFGLA+++ + T + T Y APE +L D++S
Sbjct: 134 KPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWS 191
Query: 173 FGVLVLEI 180
G + E+
Sbjct: 192 VGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAG 149
I GL FLH++ I++RD+K N+LLD++ + KI DFG+ K N+ + G
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCG 158
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
T Y+APE + G + D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-14
Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 7/174 (4%)
Query: 9 RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
++A+K ++ E +FI E + + HP LV+L G C Q +V E++EN L
Sbjct: 30 KVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L + KL+ + +C + +G+ +L +HRD+ A N L+ K+
Sbjct: 89 YL---RQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVS 142
Query: 129 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
DFG+ + D+ ++ + PE + + K+DV+SFGVL+ E+ +
Sbjct: 143 DFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 41/262 (15%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--------VYEY 60
+A+K L S + +E + E ++ V P + L+G C+ T +++ + +Y
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDY 98
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V N DR+ + LNW CV IAKG+++L E +VHRD+ A N+L+
Sbjct: 99 VRENK-DRI-----GSQDLLNW------CVQIAKGMSYLEE---VRLVHRDLAARNVLVK 143
Query: 121 QEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
+ KI DFGLA+L D + ++A E +L + T ++DV+S+GV V E
Sbjct: 144 SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWE 203
Query: 180 IIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238
+++ G + + LLE +L Q PP I + C
Sbjct: 204 LMTFGAKPYDGIPAREIPDLLEKGERLPQ---------------PPICTIDVYMIMVKCW 248
Query: 239 QAAASRRPQMNQVIKMLTKNIR 260
+ RP+ +++ ++ R
Sbjct: 249 MIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 51/190 (26%), Positives = 97/190 (51%), Gaps = 23/190 (12%)
Query: 10 IAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+K L +++ +RE F E M S ++HPN+V L+G + +++ Y ++ L
Sbjct: 38 VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97
Query: 69 VLL--------GATKAN--IKLNWEKRS--DICVGIAKGLAFLHEELVPHIVHRDIKASN 116
L+ G+T + +K E I IA G+ FL H+VH+D+ N
Sbjct: 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRN 154
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT----GYLAPEYVLGGQLTMKADVYS 172
+L+ + N KI D G LF + ++ G + +++PE ++ G+ ++ +D++S
Sbjct: 155 VLVFDKLNVKISDLG---LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS 211
Query: 173 FGVLVLEIIS 182
+GV++ E+ S
Sbjct: 212 YGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 38/102 (37%), Positives = 60/102 (58%), Gaps = 10/102 (9%)
Query: 88 ICVGIAKGLAFLHEELVPH-IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 146
+ V I K L +L E+ H ++HRD+K SNILLD N K+ DFG++ D+ TR
Sbjct: 119 MTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 147 IAGTTGYLAPEYV----LGGQLTMKADVYSFGVLVLEIISGR 184
AG Y+APE + + ++ADV+S G+ ++E+ +G+
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 38 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 97
HP LV L C +R V EYV L + + KL E I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 98 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 155
+LHE I++RD+K N+LLD E + K+ D+G+ K L P + T + GT Y+A
Sbjct: 111 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIA 164
Query: 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
PE + G D ++ GVL+ E+++GR+
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 38/96 (39%), Positives = 59/96 (61%), Gaps = 8/96 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 149
I GL FLH + I++RD+K N++LD++ + KI DFG+ K +F DN + G
Sbjct: 105 IVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCG 158
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
T Y+APE + G + T D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-14
Identities = 66/253 (26%), Positives = 115/253 (45%), Gaps = 25/253 (9%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+A+ L A S + R F+ E +TL H N+V L G +G ++V EY+ N +LD
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L K +L + + G+A G+ +L E VH+ + A +L++ + KI
Sbjct: 96 FL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKIS 149
Query: 129 DFGLAKLFPDNITHITTRIAGTTGYL--APEYVLGGQLTMKADVYSFGVLVLEIISGRNS 186
F +L D I T ++G + L APE + + +DV+SFG+++ E++S
Sbjct: 150 GFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS--YG 205
Query: 187 GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246
+ W + +++ E L P PN + + M C Q RP
Sbjct: 206 ERPYWDMSGQDVIKAV------EDGFRLPAP---RNCPNLLHQLM---LDCWQKERGERP 253
Query: 247 QMNQVIKMLTKNI 259
+ +Q+ +L+K +
Sbjct: 254 RFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 18 ESKQGVREFITEIMTL-SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA 76
E + + + ++E+ + +RHPN+V ++ R +V + +E L +
Sbjct: 47 ERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK 106
Query: 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136
+ E+ +I V + L +LH+E IVHRD+ +NI+L ++ I DFGLAK
Sbjct: 107 KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164
Query: 137 PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
T + GT Y PE V KADV++FG ++ ++
Sbjct: 165 QPESK--LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-14
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 29/196 (14%)
Query: 3 TLTNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
+ R+ VK L A + F+ E+ + HPN+++ +G C++ +LV E+
Sbjct: 18 RGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSD---------ICVGIAKGLAFLHEELVPHIVHRDI 112
LG K ++ N + + +A GL +LH+ +H D+
Sbjct: 78 P--------LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDL 126
Query: 113 KASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYV-------LGGQL 164
N L + + KIGD+GLA + +P++ A +LAPE V L
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186
Query: 165 TMKADVYSFGVLVLEI 180
T K++++S GV + E+
Sbjct: 187 TKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 49/196 (25%), Positives = 95/196 (48%), Gaps = 22/196 (11%)
Query: 4 LTNGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+ + + +A+K L + Q EF E ++ + HPN+V L+G Q +++EY+
Sbjct: 31 MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 63 NNSLDRVLL---------------GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 107
L L+ G K++ L+ I + IA G+ +L
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSS--LDHGDFLHIAIQIAAGMEYLSSHF---F 145
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166
VH+D+ A NIL+ ++ + KI D GL++ ++ + + + ++ PE ++ G+ +
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 167 KADVYSFGVLVLEIIS 182
+D++SFGV++ EI S
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 38 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 97
+P LV L C +R LV EYV L + + KL E I L
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALN 110
Query: 98 FLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAGTTGYLA 155
FLHE I++RD+K N+LLD + + K+ D+G+ K L P + T + GT Y+A
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIA 164
Query: 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
PE + G + D ++ GVL+ E+++GR+
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 14/185 (7%)
Query: 9 RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR------ILVYEY 60
++AVK + + + + EF++E + + HPN+++LIG C + + +++ +
Sbjct: 29 KVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPF 88
Query: 61 VENNSLDRVLLGATKAN--IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
+++ L LL + KL + V IA G+ +L + +HRD+ A N +
Sbjct: 89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCM 145
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLV 177
L ++ + DFGL+K + RIA ++A E + T K+DV++FGV +
Sbjct: 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 205
Query: 178 LEIIS 182
EI +
Sbjct: 206 WEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 10/96 (10%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTR-IA 148
IA GL FLH + I++RD+K N++LD E + KI DFG+ K +F TTR
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GT Y+APE + D ++FGVL+ E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 16/177 (9%)
Query: 11 AVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL 70
A K + +S++ + +++ EI L++ HPN+V+L+ ++ E+ ++D V+
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93
Query: 71 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF 130
L + L + +C + L +LHE I+HRD+KA NIL + + K+ DF
Sbjct: 94 LELERP---LTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADF 147
Query: 131 GLAKLFPDNITHITTR--IAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEI 180
G++ N I R GT ++APE V+ KADV+S G+ ++E+
Sbjct: 148 GVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 26/199 (13%)
Query: 1 MGTLTNGRRIAVKP--------LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT 52
G G+ IAVK L+AE + + E+ L +++H N+V+ +G C+
Sbjct: 18 CGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSLKHVNIVQYLGTCLDDN 75
Query: 53 RRILVYEYVENNSLDRVL--LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 110
+ E+V S+ +L G + + K+ I G+A+LH V VHR
Sbjct: 76 TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ------ILDGVAYLHNNCV---VHR 126
Query: 111 DIKASNILLDQEFNPKIGDFGLAK---LFPDNITH--ITTRIAGTTGYLAPEYVLGGQLT 165
DIK +N++L K+ DFG A+ + TH + + GT ++APE +
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG 186
Query: 166 MKADVYSFGVLVLEIISGR 184
K+D++S G V E+ +G+
Sbjct: 187 RKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 59/192 (30%), Positives = 100/192 (52%), Gaps = 19/192 (9%)
Query: 2 GTL--TNGRRI--AVKPLSA-ESKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRI 55
GTL ++G++I AVK L+ + V +F+ E + + + HPN++ L+G C+ +
Sbjct: 14 GTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL 73
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG--IAKGLAFLHEELVPHIVHRDIK 113
+V Y+++ L + T N + I G +AKG+ +L + VHRD+
Sbjct: 74 VVLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLA 125
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYLAPEYVLGGQLTMKADV 170
A N +LD+ F K+ DFGLA+ D H T ++A E + + T K+DV
Sbjct: 126 ARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDV 185
Query: 171 YSFGVLVLEIIS 182
+SFGVL+ E+++
Sbjct: 186 WSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAG 149
I GL FLH + IV+RD+K NILLD + + KI DFG+ K +N+ T G
Sbjct: 105 IICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCG 158
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
T Y+APE +LG + D +SFGVL+ E++ G++
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 18 ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS-LDRVLLGATKA 76
E++ + + EI LS P + + G ++ T+ ++ EY+ S LD + G
Sbjct: 41 EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--- 97
Query: 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136
L+ + + I I KGL +LH E +HRDIKA+N+LL + K+ DFG+A
Sbjct: 98 ---LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151
Query: 137 PDNITHIT-TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
D T I GT ++APE + KAD++S G+ +E+ G
Sbjct: 152 TD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 15/188 (7%)
Query: 7 GRRIAVKPLSAESKQGV---REFITEIMTLSNVRHPNLVELIGCCVQ-GTRRI-LVYEYV 61
G+ A+K + +Q + EI L ++H N+V L+ ++ + + L+++Y
Sbjct: 27 GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
E++ + + + + I G+ +LH ++HRD+K +NIL+
Sbjct: 87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMG 143
Query: 122 EFNP----KIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEYVLGGQLTMKA-DVYSFG 174
E KIGD GLA+LF + + + T Y APE +LG + KA D+++ G
Sbjct: 144 EGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
Query: 175 VLVLEIIS 182
+ E+++
Sbjct: 204 CIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 5 TNGRRIAVKPL--SAESKQGVREFITEIMTLSNVRHPNLV------ELIGCCVQGTRRIL 56
+G++ +K + S S + E E+ LSN++HPN+V E G +
Sbjct: 23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLY------I 76
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
V +Y E L + + + + ++ D V I L +H+ I+HRDIK+ N
Sbjct: 77 VMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQN 131
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
I L ++ K+GDFG+A++ + T I GT YL+PE K+D+++ G +
Sbjct: 132 IFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCV 190
Query: 177 VLEIISGRNSGKAMWGQMNKFLLE 200
+ E+ + +++ +A G M +L+
Sbjct: 191 LYEMCTLKHAFEA--GNMKNLVLK 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 48/212 (22%)
Query: 4 LTNGRRIAVKPLSAES-KQGVREFIT---EIMTLSNVRHPNLVELIGCCV------QGTR 53
+ GR +A+K + + K G IT EI L ++HPN+V LI V + R
Sbjct: 30 IKTGRVVALKKILMHNEKDGFP--ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87
Query: 54 RI--LVYEY--------VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 103
+V Y +EN V L T++ IK + + +G+ +LHE
Sbjct: 88 GSVYMVTPYMDHDLSGLLENP---SVKL--TESQIKC-------YMLQLLEGINYLHEN- 134
Query: 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG----------Y 153
HI+HRDIKA+NIL+D + KI DFGLA+ + + G T Y
Sbjct: 135 --HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWY 192
Query: 154 LAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 184
PE +LG + T D++ G + E+ + R
Sbjct: 193 RPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 20/189 (10%)
Query: 7 GRRIAVKPLSAESKQ------GVREFITEIMTLSNVRHPNLVELIGCCV-----QGTRRI 55
GR +A+K + ++ + +RE + + L HPN+V L C + T+
Sbjct: 27 GRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
LV+E+V+ + L L + + E D+ + +GL FLH +VHRD+K
Sbjct: 86 LVFEHVDQD-LTTYLDKVPEPGVPT--ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQ 139
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
NIL+ K+ DFGLA+++ + T + T Y APE +L D++S G
Sbjct: 140 NILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197
Query: 176 LVLEIISGR 184
+ E+ +
Sbjct: 198 IFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 23/233 (9%)
Query: 25 EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84
+F+ E L HPN+V LIG C Q +V E V+ L +L ++
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKE 95
Query: 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 144
+ A G+ +L + H +HRD+ A N L+ ++ KI DFG+++ D + T
Sbjct: 96 LIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152
Query: 145 TRIAGT-TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWA 202
+ + APE + G+ + ++DV+SFG+L+ E S G + Q + +
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--- 209
Query: 203 WQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 255
E+ + L PEL P+ + R M+ C + +RP + V + L
Sbjct: 210 ------EQGVRLPCPELC---PDAVYRLMER---CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 4 LTNGRRIAVKPLSAESKQG------VREFITEIMTLSNVRHPNLVELIGCCV-----QGT 52
+G +A+K + ++ + VRE + + L HPN+V L+ C + T
Sbjct: 22 PHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVRLMDVCATSRTDRET 80
Query: 53 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDI 112
+ LV+E+V+ + L L + E D+ +GL FLH IVHRD+
Sbjct: 81 KVTLVFEHVDQD-LRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFLHANC---IVHRDL 134
Query: 113 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYS 172
K NIL+ K+ DFGLA+++ + T + T Y APE +L D++S
Sbjct: 135 KPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWS 192
Query: 173 FGVLVLEI 180
G + E+
Sbjct: 193 VGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 41/100 (41%), Positives = 59/100 (59%), Gaps = 9/100 (9%)
Query: 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 145
++IC G L LH+E IV+RD+K NILLD + +I D GLA P+ T I
Sbjct: 109 AEICCG----LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG 160
Query: 146 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
R+ GT GY+APE V + T D ++ G L+ E+I+G++
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-13
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 4/93 (4%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I GL LH+ I++RD+K N+LLD + N +I D GLA D + T AGT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTP 161
Query: 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
G++APE + G + D ++ GV + E+I+ R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 14/156 (8%)
Query: 32 TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG 91
T SN HP LV L C +R V E+V L + + KL E
Sbjct: 51 TASN--HPFLVGLHSCFQTESRLFFVIEFVSGGDL----MFHMQRQRKLPEEHARFYSAE 104
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 149
I+ L FLHE I++RD+K N+LLD E + K+ D+G+ K + P + T + G
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCG 158
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
T Y+APE + G D ++ GVL+ E+++GR+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-13
Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 24/178 (13%)
Query: 18 ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 77
ESK + I E+ L P +V+ G + EY++ SLD++ G
Sbjct: 40 ESK--FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATE 97
Query: 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL----- 132
R I + KGL FL EE +I+HRD+K +N+L++ K+ DFG+
Sbjct: 98 GIPEDVLRR-ITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154
Query: 133 AKLFPDNITHITTRIAGTTGYLAPEYVLGGQL------TMKADVYSFGVLVLEIISGR 184
A L NI G Y+APE + G T+++DV+S G+ +LE+ GR
Sbjct: 155 ASLAKTNI--------GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-13
Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 30 IMTLSNVRHPNLVELIGCCVQGTRRIL-VYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88
I+ L+ +HP L L CC Q R+ V EYV L + + K + E RS
Sbjct: 48 ILALA-AKHPFLTALH-CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRF 100
Query: 89 CVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITT 145
+ L FLH V ++RD+K NILLD E + K+ DFG+ K + I + TT
Sbjct: 101 YAAEVTLALMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTT 154
Query: 146 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GT Y+APE + + D ++ GVL+ E+++G+
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGT 150
I +GL +LH I+HRDIK N+L++ KI DFGLA++ PD H+T + T
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 151 TGYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGR 184
Y APE ++G + T D++S G + E++ R
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 71/262 (27%), Positives = 113/262 (43%), Gaps = 35/262 (13%)
Query: 19 SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLL 71
SK R+F E+ L + HPN++ L+G C L EY + +L RVL
Sbjct: 47 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 106
Query: 72 G------ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
A L+ ++ +A+G+ +L ++ +HRD+ A NIL+ + +
Sbjct: 107 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
KI DFGL++ + R+ ++A E + T +DV+S+GVL+ EI+S
Sbjct: 164 KIADFGLSRGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--L 219
Query: 186 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245
G G L E Q ++ EKPL D E+ M+ C + R
Sbjct: 220 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDD---------EVYDLMRQ---CWREKPYER 267
Query: 246 PQMNQVIKMLTKNIRLNEEELT 267
P Q++ L R+ EE T
Sbjct: 268 PSFAQILVSLN---RMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 74/306 (24%), Positives = 137/306 (44%), Gaps = 51/306 (16%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+AVK L + + + + + ++E+ + + +H N++ L+G C Q ++ EY +L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL- 105
Query: 68 RVLLGATKA-------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
R L A + +L ++ +A+G+ +L + +HRD+ A
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKAD 169
N+L+ ++ KI DFGLA+ ++ +I T G ++APE + T ++D
Sbjct: 163 RNVLVTEDNVMKIADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218
Query: 170 VYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229
V+SFGVL+ EI + G G + L + + H+ +KP +E+
Sbjct: 219 VWSFGVLLWEIFT--LGGSPYPGIPVEELFKLLKEGHRMDKPANCT---------HELYM 267
Query: 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEE----ELTAPGLFQDSESSSVGTSDK 285
M+ C A S+RP Q+++ L + + + +L+ P E S G D
Sbjct: 268 IMRE---CWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVP-----FEQYSPGCPDS 319
Query: 286 KSSDST 291
SS S+
Sbjct: 320 PSSCSS 325
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 40/93 (43%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I GL LH E IV+RD+K NILLD + +I D GLA P+ T I R+ GT
Sbjct: 111 ITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTV 165
Query: 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GY+APE V + T D + G L+ E+I G+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 48/184 (26%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 4 LTNGRRIAVKP------LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 57
L +GR +A+K + A+++Q + + EI L + HPN+++ + ++ +V
Sbjct: 24 LLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRS-DICVGIAKGLAFLHEELVPHIVHRDIKASN 116
E + L R ++ K +L E+ V + L +H + I+HRDIK +N
Sbjct: 81 LELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPAN 136
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
+ + K+GD GL + F T + + GT Y++PE + K+D++S G L
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 177 VLEI 180
+ E+
Sbjct: 196 LYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 57/192 (29%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G+ A+K L E +K V +TE L N RHP L L R V EY
Sbjct: 18 ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77
Query: 62 ENNSL------DRVLLGATKANIKLNWEKRSDIC-VGIAKGLAFLHEELVPHIVHRDIKA 114
L +RV E R+ I L +LH +V+RD+K
Sbjct: 78 NGGELFFHLSRERVFS-----------EDRARFYGAEIVSALGYLHSC---DVVYRDLKL 123
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYS 172
N++LD++ + KI DFGL K + I+ GT YLAPE + D +
Sbjct: 124 ENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 173 FGVLVLEIISGR 184
GV++ E++ GR
Sbjct: 181 LGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 37/273 (13%)
Query: 9 RIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
R+AVK ++ + R EF+ E + ++V L+G +G ++V E + + L
Sbjct: 38 RVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL- 96
Query: 68 RVLLGATKANIKLN-------WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ L + + + N ++ + IA G+A+L+ + VHRD+ A N ++
Sbjct: 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVA 153
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGV 175
+F KIGDFG+ + +I G G ++APE + G T +D++SFGV
Sbjct: 154 HDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 209
Query: 176 LVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVA 234
++ EI S L E +Q E+ L+ V D + P N R +
Sbjct: 210 VLWEITS---------------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLM 254
Query: 235 FFCTQAAASRRPQMNQVIKMLTKNIRLNEEELT 267
C Q RP +++ +L ++ + E++
Sbjct: 255 RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 37/198 (18%)
Query: 3 TLTNGRR----IAVKPLSAES---KQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRR 54
TLT G +A KP + K G + + E M L NV HP+++ + V G
Sbjct: 73 TLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132
Query: 55 ILV--------YEYVENNSLDRVLLGATKANIKLNWEKRSDICV--GIAKGLAFLHEELV 104
+V Y Y+ S I + + I +GL +LH +
Sbjct: 133 CMVLPHYSSDLYTYLTKRS--------RPLPI------DQALIIEKQILEGLRYLHAQ-- 176
Query: 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164
I+HRD+K NI ++ IGD G A+ FP +AGT APE + +
Sbjct: 177 -RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG-LAGTVETNAPEVLARDKY 233
Query: 165 TMKADVYSFGVLVLEIIS 182
KAD++S G+++ E+++
Sbjct: 234 NSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 54/188 (28%), Positives = 93/188 (49%), Gaps = 13/188 (6%)
Query: 10 IAVKPLSAESKQGV--REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+AVK L ++ E + E + + +P +V +IG C + +LV E E L+
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLN 83
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI 127
+ L + N + + +++ ++ G+ +L E + VHRD+ A N+LL + KI
Sbjct: 84 KFL----QKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKI 136
Query: 128 GDFGLAKLFPDNITHITTRIAGT--TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GR 184
DFGL+K + + + G + APE + + + K+DV+SFGVL+ E S G+
Sbjct: 137 SDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQ 196
Query: 185 NSGKAMWG 192
K M G
Sbjct: 197 KPYKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 16/184 (8%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRIL-VYEY 60
+GR AVK L + V +TE LS R HP L +L CC Q R+ V E+
Sbjct: 19 SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY-CCFQTPDRLFFVMEF 77
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V N D L+ + + + + + I L FLH++ I++RD+K N+LLD
Sbjct: 78 V--NGGD--LMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLD 130
Query: 121 QEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
E + K+ DFG+ K + T T+ GT Y+APE + D ++ GVL+ E
Sbjct: 131 HEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYE 188
Query: 180 IISG 183
++ G
Sbjct: 189 MLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 60/190 (31%), Positives = 82/190 (43%), Gaps = 29/190 (15%)
Query: 7 GRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
GR A+K L E +K V +TE L N RHP L L R V EY
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79
Query: 64 NSL------DRVLLGATKANIKLNWEKRSDIC-VGIAKGLAFLHEELVPHIVHRDIKASN 116
L +RV E+R+ I L +LH +V+RDIK N
Sbjct: 80 GELFFHLSRERVFT-----------EERARFYGAEIVSALEYLHSR---DVVYRDIKLEN 125
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEYVLGGQLTMKADVYSFG 174
++LD++ + KI DFGL K + I+ T GT YLAPE + D + G
Sbjct: 126 LMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 175 VLVLEIISGR 184
V++ E++ GR
Sbjct: 183 VVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-12
Identities = 57/184 (30%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+G+ A+K L E +K V +TE L N RHP L L R V EYV
Sbjct: 19 SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
L ++ + + ++ I L +LH IV+RD+K N++LD++
Sbjct: 79 GGEL---FFHLSRERV-FSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKD 131
Query: 123 FNPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ KI DFGL K + IT T GT YLAPE + D + GV++ E+
Sbjct: 132 GHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 181 ISGR 184
+ GR
Sbjct: 189 MCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 45/175 (25%), Positives = 89/175 (50%), Gaps = 27/175 (15%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-T 150
+A+G+ FL + + +HRD+ A N+LL KI DFGLA+ ++ ++ A
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM---NKF--LLEWAWQL 205
++APE + T+++DV+S+G+L+ EI S GK+ + + +KF +++ +Q+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---LGKSPYPGILVNSKFYKMVKRGYQM 334
Query: 206 HQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260
+ ++ P EI MK+ C + RP +Q+ +++ + +
Sbjct: 335 SRP------------DFAPPEIYSIMKM---CWNLEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 8/89 (8%)
Query: 95 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154
G+ LH+ I+HRDIK N+L+DQ + K+ DFGL++ + GT YL
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYL 160
Query: 155 APEYVLGGQLTMKADVYSFGVLVLEIISG 183
APE +LG +D +S G ++ E + G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR-------VLLGATKANIKLN 81
E++ L+ ++HPN+V + R +V EY + L + VL + L+
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LS 105
Query: 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNI 140
W V I+ GL +H+ I+HRDIK+ NI L + K+GDFG+A+ D+
Sbjct: 106 W------FVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS- 155
Query: 141 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ GT YL+PE K D++S G ++ E+
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 34/77 (44%), Positives = 48/77 (62%), Gaps = 1/77 (1%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166
I++RD+K NILLD+E + K+ DFGL+K D+ GT Y+APE V T
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 167 KADVYSFGVLVLEIISG 183
AD +SFGVL+ E+++G
Sbjct: 178 SADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 11/179 (6%)
Query: 10 IAVKPLSAESK-QGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
IA+K + E + +GV I EI L ++H N+V L R LV+EY++ LD
Sbjct: 30 IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD---LD 86
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-K 126
+ + N I +G+A+ H ++HRD+K N+L+D+ N K
Sbjct: 87 LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALK 143
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGR 184
+ DFGLA+ F + T + T Y APE +LG + D++S G + E+++ +
Sbjct: 144 LADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 65/257 (25%), Positives = 111/257 (43%), Gaps = 35/257 (13%)
Query: 9 RIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
R+A+K ++ + R EF+ E + ++V L+G QG +++ E + L
Sbjct: 38 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 97
Query: 68 ---RVLLGATKANIKL---NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
R L + N + +K + IA G+A+L+ VHRD+ A N ++ +
Sbjct: 98 SYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 154
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKADVYSFGVL 176
+F KIGDFG+ + +I G G +++PE + G T +DV+SFGV+
Sbjct: 155 DFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210
Query: 177 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYMKVAF 235
+ EI + L E +Q E+ L V + L + P N ++
Sbjct: 211 LWEIAT---------------LAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMR 255
Query: 236 FCTQAAASRRPQMNQVI 252
C Q RP ++I
Sbjct: 256 MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 66/273 (24%), Positives = 125/273 (45%), Gaps = 42/273 (15%)
Query: 3 TLTNGRRIAVKPL--SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
T T R+ VK L +A SK+ EF+ + ++HPN+++ +G CV+ +LV+EY
Sbjct: 18 TDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSD--------ICVGIAKGLAFLHEELVPHIVHRDI 112
E LG K+ + R + + IA G+ +H+ + +H D+
Sbjct: 77 CE--------LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDL 125
Query: 113 KASNILLDQEFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYV-------LGGQ 163
N L + K+GD+G+ ++ D I + +LAPE V + +
Sbjct: 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR-WLAPELVGEFHGGLITAE 184
Query: 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 223
T ++V++ GV + E+ N+ + ++ +L + ++ ++L P+L E P
Sbjct: 185 QTKPSNVWALGVTLWELFE--NAAQPYSHLSDREVLNHVIK----DQQVKLFKPQL-ELP 237
Query: 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 256
+E R+ +V FC + +R +V ++LT
Sbjct: 238 YSE--RWYEVLQFC-WLSPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 59/188 (31%), Positives = 82/188 (43%), Gaps = 24/188 (12%)
Query: 7 GRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
GR A+K L E +K V +TE L N RHP L L R V EY
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79
Query: 64 NSL------DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
L +RV + ++ I L +LH E ++V+RD+K N+
Sbjct: 80 GELFFHLSRERVF----------SEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENL 127
Query: 118 LLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
+LD++ + KI DFGL K D T T GT YLAPE + D + GV+
Sbjct: 128 MLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 185
Query: 177 VLEIISGR 184
+ E++ GR
Sbjct: 186 MYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 68/277 (24%), Positives = 123/277 (44%), Gaps = 44/277 (15%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNV--RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
+AVK L + + + + I+E M L + +H N++ L+G C Q ++ EY +L
Sbjct: 47 VAVKMLKDNATDKDLADLISE-MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 67 DRVLLGATK-------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
R L A + +L+++ +A+G+ +L +HRD+
Sbjct: 106 -REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLA 161
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG-----YLAPEYVLGGQLTMKA 168
A N+L+ ++ KI DFGLA+ + I + G ++APE + T ++
Sbjct: 162 ARNVLVTEDNVMKIADFGLAR----GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 169 DVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228
DV+SFG+L+ EI + G G + L + + H+ +KP +E+
Sbjct: 218 DVWSFGILMWEIFT--LGGSPYPGIPVEELFKLLREGHRMDKPSNC---------THELY 266
Query: 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
M+ C A ++RP Q+++ L K + EE
Sbjct: 267 MLMRE---CWHAVPTQRPTFKQLVEALDKVLAAVSEE 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGT 150
I+ GL FLH I++RD+K N++LD E + KI DFG+ K + +TTR GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164
Query: 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
Y+APE + D +++GVL+ E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 54/188 (28%), Positives = 82/188 (43%), Gaps = 26/188 (13%)
Query: 5 TNGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYE 59
G A+K L KQ V+ E L + HP +V ++ C Q R+ + E
Sbjct: 41 GTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVNMM-CSFQDENRVYFLLE 98
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDI----CVGIAKGLAFLHEELVPHIVHRDIKAS 115
+V L L A + +D+ + +LH + I++RD+K
Sbjct: 99 FVVGGELFTHLRKAGRFP--------NDVAKFYHAELVLAFEYLHSK---DIIYRDLKPE 147
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
N+LLD + + K+ DFG AK PD T + GT YLAPE + D ++ GV
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 176 LVLEIISG 183
L+ E I+G
Sbjct: 204 LLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 30/191 (15%)
Query: 7 GRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
GR++A+K LS +S + E+ L ++ H N++ L+ +
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS---------SLE 90
Query: 65 SLDRV-----LLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
V L+GA NI KL+ + + I +GL ++H I+HRD+K S
Sbjct: 91 DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPS 147
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLG-GQLTMKADVYSF 173
NI ++++ KI DFGLA+ D +T ++ TR Y APE +L D++S
Sbjct: 148 NIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSV 202
Query: 174 GVLVLEIISGR 184
G ++ E+++G+
Sbjct: 203 GCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 6 NGRRIAVKPLSAES-KQGVREFIT---EIMTLSNVRHPNLVELIGCC---VQGTRR---- 54
+ +A+K + E+ K+G IT EI L ++H N+V LI C R
Sbjct: 36 TKQIVALKKVLMENEKEGFP--ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93
Query: 55 -ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
LV+E+ E++ L +L + N+K + + + GL ++H I+HRD+K
Sbjct: 94 FYLVFEFCEHD-LAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMK 146
Query: 114 ASNILLDQEFNPKIGDFGLAKLFP----DNITHITTRIAGTTGYLAPEYVLG 161
A+NIL+ ++ K+ DFGLA+ F T R+ T Y PE +LG
Sbjct: 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPELLLG 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 3/96 (3%)
Query: 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLGGQL 164
H++HRDIK++NILL K+GDFG +K++ ++ R GT Y+APE
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 165 TMKADVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 198
+ KAD++S GVL+ E+++ + G+ M M+K L
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258
|
Length = 496 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I GL LH E + V+RD+K NILLD + +I D GLA P+ I R+ GT
Sbjct: 111 ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRV-GTV 165
Query: 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 189
GY+APE + + T+ D + G L+ E+I G++ +
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I G+ LH IV+RD+K N+LLD + N ++ D GLA D T T+ AGT
Sbjct: 104 ITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTN 158
Query: 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GY+APE + + D ++ G + E+++GR
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 37/95 (38%), Positives = 58/95 (61%), Gaps = 8/95 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTR-IAG 149
IA GL FLH + I++RD+K N++LD E + KI DFG+ K +N+ +TT+ G
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T Y+APE + D ++FGVL+ E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 13/190 (6%)
Query: 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--VYEY 60
T+G++ +K L+ S++ + E LS ++HPN+V +G +L V +
Sbjct: 23 TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGF 81
Query: 61 VENNSLDRVLLGATKANIKLNWEKR-SDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
E L L + KL E + + V IA L +LHE+ HI+HRD+K N+ L
Sbjct: 82 CEGGDLYHKL---KEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFL 135
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
+ K+GD G+A++ +N + + + GT Y++PE K+DV++ G V E
Sbjct: 136 TRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
Query: 180 IISGRNSGKA 189
+ + +++ A
Sbjct: 195 MATLKHAFNA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 95 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154
GL L E IV+RD+K NILLD + +I D GLA P+ T + R+ GT GY+
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYM 168
Query: 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
APE + + T D + G L+ E+I G++
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 58/247 (23%), Positives = 105/247 (42%), Gaps = 43/247 (17%)
Query: 26 FITEIMTLSNVRHPNLVELIGCCVQGTRRILV-YEYVENNSLDRVL----LGATKANIKL 80
+ E L + H N++ ++ C++ V Y Y+ +L L LG L
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDN 139
+ ++ + + IA G+++LH+ ++H+DI A N ++D+E KI D L++ LFP +
Sbjct: 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 140 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 199
+ ++A E ++ + + +DV+SFGVL+ E+++ GQ
Sbjct: 172 YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT--------LGQT----- 218
Query: 200 EWAWQLHQEEKPLELVDP-ELGEY---------PPNEIIRYMKVAFFCTQAAASRRPQMN 249
P +DP E+ Y P N V C RP +
Sbjct: 219 -----------PYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFS 267
Query: 250 QVIKMLT 256
Q+++ LT
Sbjct: 268 QLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 14 PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DRVLLG 72
P S+ + + R+ E + L+ ++HPN+V +V EY + L ++ L
Sbjct: 36 PKSSSAVEDSRK---EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ 92
Query: 73 ATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
K + L W +C+G+ +HE+ V +HRDIK+ NI L Q K+GD
Sbjct: 93 RGKLFPEDTILQW--FVQMCLGVQH----IHEKRV---LHRDIKSKNIFLTQNGKVKLGD 143
Query: 130 FGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 189
FG A+L + T + GT Y+ PE K+D++S G ++ E+ + ++ +A
Sbjct: 144 FGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 20/186 (10%)
Query: 7 GRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G R+AVK LS +S + E+ L +++H N++ L+ E +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----LEEFNDV 97
Query: 65 SLDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
L L+GA NI KL + + I +GL ++H I+HRD+K SN+ ++
Sbjct: 98 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 154
Query: 121 QEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVL 178
++ KI DFGLA+ D +T ++ TR Y APE +L D++S G ++
Sbjct: 155 EDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 179 EIISGR 184
E+++GR
Sbjct: 210 ELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 25 EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84
F +S + H +LV+L G CV+ I+V EYV+ LD V L K N+ L+W
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLD-VFLHREKNNVSLHW-- 102
Query: 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-----DQEFNP--KIGDFGLAKLFP 137
+ D+ +A L +L ++ +VH ++ NIL+ ++ + P K+ D G+ +
Sbjct: 103 KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-ITV 158
Query: 138 DNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVLEIISG 183
+ RI ++APE + GQ LT+ AD +SFG +LEI S
Sbjct: 159 LSREERVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 27 ITEIMTLSNVRHPNLVELIGCCVQGTRRI----------LVYEYVENNSLDRVLLGATKA 76
I EI L + H N+V L + LV+EY+ D L+G ++
Sbjct: 54 IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLES 108
Query: 77 N-IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135
+ + + + +GL + H++ + +HRDIK SNILL+ + K+ DFGLA+L
Sbjct: 109 GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 136 FPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 184
+ + T T Y PE +LG + A DV+S G ++ E+ + +
Sbjct: 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 32/79 (40%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-- 164
I++RDIK NILLD E + + DFGL+K F GT Y+APE + GG
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 165 TMKADVYSFGVLVLEIISG 183
D +S GVL E+++G
Sbjct: 186 DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 17/154 (11%)
Query: 33 LSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRVLLGATKANIKLNWEKRSDICV 90
L V HP ++ L + +R L + EYV L L + + + S+I
Sbjct: 55 LKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC 112
Query: 91 GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT 150
+ +LH + IV+RD+K NILLD+E + K+ DFG AK D T + GT
Sbjct: 113 ALE----YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGT 161
Query: 151 TGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISG 183
YLAPE V+ + KA D ++ G+L+ E++ G
Sbjct: 162 PEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 31/198 (15%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI----------- 55
+R+AVK + Q V+ + EI + + H N+V++ +
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 56 ---LVYEYVENNSLDRVLLGATKAN--IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 110
+V EY+E + L VL + +L + +GL ++H +++HR
Sbjct: 90 SVYIVQEYMETD-LANVLEQGPLSEEHARL-------FMYQLLRGLKYIHS---ANVLHR 138
Query: 111 DIKASNILLDQE-FNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLG-GQLTM 166
D+K +N+ ++ E KIGDFGLA++ + +H + T Y +P +L T
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198
Query: 167 KADVYSFGVLVLEIISGR 184
D+++ G + E+++G+
Sbjct: 199 AIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 23 VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82
+RE + + L+ HPN+V+L + V+EY+E N L + +
Sbjct: 45 LRE-VKSLRKLNE--HPNIVKLKEVFRENDELYFVFEYMEGNLYQ---LMKDRKGKPFSE 98
Query: 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDN 139
I I +GLA +H+ HRD+K N+L+ KI DFGLA+ P
Sbjct: 99 SVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155
Query: 140 ITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 184
+++TR Y APE +L + D+++ G ++ E+ + R
Sbjct: 156 TDYVSTR-----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 19/189 (10%)
Query: 7 GRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR-----ILVYE 59
G ++A+K ++ E + EI L +RHP++VE+ + +RR +V+E
Sbjct: 25 GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
+E++ L +V+ KAN L E + + L ++H ++ HRD+K NIL
Sbjct: 85 LMESD-LHQVI----KANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILA 136
Query: 120 DQEFNPKIGDFGLAKL-FPDNITHIT-TRIAGTTGYLAPEYV--LGGQLTMKADVYSFGV 175
+ + KI DFGLA++ F D T I T T Y APE + T D++S G
Sbjct: 137 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 196
Query: 176 LVLEIISGR 184
+ E+++G+
Sbjct: 197 IFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 23/172 (13%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG-T 150
+AKG++FL + + +HRD+ A NILL KI DFGLA+ ++ ++ A
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQMNKFLLEWAWQLHQ 207
++APE + T ++DV+S+G+L+ EI S +S G + + K + E L
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339
Query: 208 EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259
E P E+ D I++ C A +RP Q+++++ + +
Sbjct: 340 ECAPSEMYD----------IMKS------CWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 5/152 (3%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88
E LS + HP +V+ ++ ++ EY E LD L L+ + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 89 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 148
+ + G+ ++H+ I+HRD+KA NI L KIGDFG+++L + TT
Sbjct: 112 FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FT 166
Query: 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
GT Y++PE + K+D++S G ++ E+
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 31/77 (40%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166
+++RD+K NILLD + + + DFGL KL + T GT YLAPE +LG T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 167 KADVYSFGVLVLEIISG 183
D ++ GVL+ E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 7 GRRIAVKPL------SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
G+ +A+K + +K+ RE + L ++RH N++ L + I
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRE----LKLLKHLRHENIISLSDIFISPLEDIYFVTE 90
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ L R+L L + I +GL ++H V VHRD+K SNIL++
Sbjct: 91 LLGTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAGV---VHRDLKPSNILIN 142
Query: 121 QEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVL 178
+ + KI DFGLA++ +T +++TR Y APE +L Q ++ D++S G +
Sbjct: 143 ENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFA 197
Query: 179 EIISGR 184
E++ G+
Sbjct: 198 EMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 32/252 (12%)
Query: 19 SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVE-NNSLDRV----LLG 72
S+ R+F E+ L + HPN++ L+G C + EY N LD + +L
Sbjct: 42 SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLE 101
Query: 73 ATKANIK-------LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
A K L ++ +A G+ +L E+ +HRD+ A N+L+ +
Sbjct: 102 TDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
KI DFGL++ + R+ ++A E + T K+DV+SFGVL+ EI+S
Sbjct: 159 KIADFGLSRGEEVYVKKTMGRLP--VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS--L 214
Query: 186 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245
G G L E Q ++ EKP D E+ M+ C + R
Sbjct: 215 GGTPYCGMTCAELYEKLPQGYRMEKPRNCDD---------EVYELMRQ---CWRDRPYER 262
Query: 246 PQMNQVIKMLTK 257
P Q+ L++
Sbjct: 263 PPFAQISVQLSR 274
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 4/154 (2%)
Query: 27 ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86
I EI L + HPN+++ ++ +V E + L R++ K + +
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 146
V + L +H ++HRDIK +N+ + K+GD GL + F T +
Sbjct: 110 KYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 165
Query: 147 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ GT Y++PE + K+D++S G L+ E+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 34/193 (17%)
Query: 7 GRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRR----- 54
G+ +A+K LS +K+ RE + +M L N H N++ L+ Q +
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELV--LMKLVN--HKNIIGLLNVFTPQKSLEEFQDV 96
Query: 55 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
LV E ++ N L +V+ + L+ E+ S + + G+ LH I+HRD+K
Sbjct: 97 YLVMELMDAN-LCQVI------QMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKP 146
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTMKADVY 171
SNI++ + KI DFGLA+ + ++ TR Y APE +LG D++
Sbjct: 147 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIW 201
Query: 172 SFGVLVLEIISGR 184
S G ++ E+I G
Sbjct: 202 SVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 46/214 (21%)
Query: 7 GRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
RR+A+K + +E+ + F+ E +++ HP +V + C G Y+E
Sbjct: 27 SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86
Query: 64 NSLDRVLLGATKANIKLNWEKRS---------------DICVGIAKGLAFLHEELVPHIV 108
+L +L K W+K S I I + ++H + ++
Sbjct: 87 YTLKSLL--------KSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVL 135
Query: 109 HRDIKASNILLDQEFNPKIGDFGLAK---------LFPD----NITH----ITTRIAGTT 151
HRD+K NILL I D+G A L D NI + I +I GT
Sbjct: 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTP 195
Query: 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
Y+APE +LG + D+Y+ GV++ ++++
Sbjct: 196 DYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 28 TEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86
TE L ++R P LV L T+ L+ +Y+ L L + E+
Sbjct: 53 TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEV 107
Query: 87 DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 145
I G I L LH+ I++RDIK NILLD + + DFGL+K F ++
Sbjct: 108 QIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164
Query: 146 RIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISG 183
GT Y+AP+ V GG D +S GVL+ E+++G
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 43/171 (25%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88
E+ ++ ++H N++ L+ V+G LV + + ++ L +V+ I+L + I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCI 124
Query: 89 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF------------ 136
+ I GL LH+ + +HRD+ +NI ++ + KI DFGLA+ +
Sbjct: 125 LLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 137 --PDNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 184
+T+++ T Y APE ++G + A D++S G + E+++G+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 51/185 (27%), Positives = 89/185 (48%), Gaps = 20/185 (10%)
Query: 6 NGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
NG+ +A+K + + ++G I E L ++H N+V L LV+EYV +
Sbjct: 29 NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTD 88
Query: 65 ---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+D+ G N+KL + +GL+++H+ +I+HRD+K N+L+
Sbjct: 89 LCQYMDKHPGGLHPENVKL-------FLFQLLRGLSYIHQR---YILHRDLKPQNLLISD 138
Query: 122 EFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVL 178
K+ DFGL AK P +H + T Y P+ +LG + + D++ G + +
Sbjct: 139 TGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFV 195
Query: 179 EIISG 183
E+I G
Sbjct: 196 EMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 20/185 (10%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
+ +K L + F +S + H +LV G CV G I+V EYV+ SLD
Sbjct: 30 VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLD-T 88
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAF-LHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L K I ++W+ + +AK LA+ LH + H ++ A N+LL +E + K G
Sbjct: 89 YLKKNKNLINISWK------LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTG 142
Query: 129 DFGLAKLFPDNIT-------HITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEI 180
+ KL I+ + RI ++ PE + Q L++ AD +SFG + EI
Sbjct: 143 NPPFIKLSDPGISITVLPKEILLERIP----WVPPECIENPQNLSLAADKWSFGTTLWEI 198
Query: 181 ISGRN 185
SG +
Sbjct: 199 FSGGD 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 148
+AKG+ FL +HRD+ A NILL + KI DFGLA+ PD + R+
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
++APE + T+++DV+SFGVL+ EI S
Sbjct: 245 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 148
+A+G+ FL +HRD+ A NILL + KI DFGLA+ PD + R+
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
++APE + T ++DV+SFGVL+ EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 33/183 (18%)
Query: 15 LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74
+ A + G TE L + HP++++L G + Y N ++L
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKG----------TFTY---NKFTCLILPRY 165
Query: 75 KANIK--LNWEKRSDICVGIA------KGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
K ++ L ++ IC +A + + +LHE I+HRDIKA NI ++ +
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222
Query: 127 IGDFGLAKLFPDNITHITTRI---AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+GDFG A FP +I + AGT APE + D++S G+++ E+ +
Sbjct: 223 LGDFG-AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 184 RNS 186
+S
Sbjct: 280 HDS 282
|
Length = 391 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 34/78 (43%), Positives = 46/78 (58%), Gaps = 1/78 (1%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166
IV+RDIK NILLD E + + DFGL+K F T GT Y+APE + G
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 167 KA-DVYSFGVLVLEIISG 183
KA D +S G+L+ E+++G
Sbjct: 186 KAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 44/188 (23%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR------ILV 57
+ +++AVK L A+ S + EF+ E + HPN+++LIG ++ + +++
Sbjct: 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDI--CVGIAKGLAFLHEELVPHIVHRDIKAS 115
++++ L LL + ++ + + IA G+ +L + + +HRD+ A
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAAR 142
Query: 116 NILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFG 174
N +L++ + DFGL+ K++ + +LA E + T +DV++FG
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202
Query: 175 VLVLEIIS 182
V + EI++
Sbjct: 203 VTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 40/90 (44%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 96 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL-FPDNITHITTRIAGTTGYL 154
L LH+ IV+RD+K NILLD + + DFGL+K DN T T GTT YL
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 155 APEYVLGGQ-LTMKADVYSFGVLVLEIISG 183
APE +L + T D +S GVLV E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIA 148
+A+G+ FL +HRD+ A NILL + KI DFGLA+ PD + + R+
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
++APE + T ++DV+SFGVL+ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 11/177 (6%)
Query: 10 IAVKPLSAESK-QGVREF-ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+A+K + + +GV + EI L ++H N+V L + LV+EY + + L
Sbjct: 28 VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQD-LK 86
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI 127
+ N ++ E + KGLAF H +++HRD+K N+L+++ K+
Sbjct: 87 KYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKL 140
Query: 128 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISG 183
DFGLA+ F + + + T Y P+ + G +L + D++S G + E+ +
Sbjct: 141 ADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 9/177 (5%)
Query: 10 IAVKPLS-AESKQGVREF-ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+A+K +E + V+E + E+ L ++ N+VEL + + LV+EYVE N L+
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI 127
L N + RS I + K + + H+ IVHRDIK N+L+ K+
Sbjct: 89 ---LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKL 141
Query: 128 GDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
DFG A+ + T T Y +PE +LG D++S G ++ E+ G+
Sbjct: 142 CDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 41/183 (22%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 4 LTNGRRIAVKP------LSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 57
L + + +A+K + A+++Q + + EI L + HPN+++ + ++ +V
Sbjct: 24 LLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
E + L +++ K + V + + +H ++HRDIK +N+
Sbjct: 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANV 137
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
+ K+GD GL + F T + + GT Y++PE + K+D++S G L+
Sbjct: 138 FITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
Query: 178 LEI 180
E+
Sbjct: 197 YEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 20/185 (10%)
Query: 7 GRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRR-----ILVY 58
G +AVK LS +++ + E++ L V H N++ L+ Q + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 59 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
E ++ N L +V+ +++L+ E+ S + + G+ LH I+HRD+K SNI+
Sbjct: 106 ELMDAN-LCQVI------HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 155
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
+ + KI DFGLA+ N + T T Y APE +LG D++S G ++
Sbjct: 156 VKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 179 EIISG 183
E++ G
Sbjct: 214 ELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 48/191 (25%), Positives = 92/191 (48%), Gaps = 26/191 (13%)
Query: 6 NGRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-----LVY 58
++A+K ++ +++ + + EI L ++ H N++ + R +VY
Sbjct: 29 TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88
Query: 59 EYVENNSLDRVLLGATKANIKLNWEKRSDIC----VGIAKGLAFLHEELVPHIVHRDIKA 114
E ++ + L ++ I+ + D C + +GL ++H +++HRD+K
Sbjct: 89 ELMDTD-LHQI--------IRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKP 136
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSF 173
SN+LL+ + KI DFGLA+ + +T + T Y APE +L + T DV+S
Sbjct: 137 SNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSV 195
Query: 174 GVLVLEIISGR 184
G + E++ GR
Sbjct: 196 GCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 36/97 (37%), Positives = 58/97 (59%), Gaps = 8/97 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIA 148
I +GL ++H +++HRD+K SN+LL+ + KI DFGLA++ H +T +A
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 149 GTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGR 184
T Y APE +L + KA D++S G ++ E++S R
Sbjct: 172 -TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 31/190 (16%)
Query: 6 NGR--RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
NGR R+ +K L + F +S V H +L + G CV+G+ I+V E+VE+
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---- 119
LD V L K + + W + + +A L++L ++ ++VH ++ A NILL
Sbjct: 101 GPLD-VCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154
Query: 120 ----DQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADV 170
F +P + L++ RI ++APE V GG L+ AD
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIP----WIAPECVPGGNSLSTAADK 204
Query: 171 YSFGVLVLEI 180
+SFG +LEI
Sbjct: 205 WSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 19 SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVE-NNSLD-----RVLL 71
SK R+F E+ L + HPN++ L+G C L EY N LD RVL
Sbjct: 35 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 94
Query: 72 G----ATKANIKLNWEKRS--DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
A + + +A+G+ +L ++ +HRD+ A NIL+ + +
Sbjct: 95 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 151
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
KI DFGL++ + R+ ++A E + T +DV+S+GVL+ EI+S
Sbjct: 152 KIADFGLSRGQEVYVKKTMGRLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 12/96 (12%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GT 150
+A+G+ FL + + VHRD+ A N+LL Q KI DFGLA+ +I H + ++ G+
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298
Query: 151 T----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
T ++APE + T +DV+S+G+L+ EI S
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 30 IMTLSNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84
+ +L N HPN+V+ G + G + LV E S+ ++ G +L+
Sbjct: 72 LQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL-AKLFPDNITHI 143
S I G GL LH I+HRD+K +NILL E K+ DFG+ A+L +
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 144 TTRIAGTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLEIISG 183
T+ GT ++APE + Q + DV+S G+ +E+ G
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 6 NGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G+ +A+K + E ++G I E L +++H N+V L LV+EY++ +
Sbjct: 29 TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD 88
Query: 65 ---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+D G + N++L + +GLA+ H+ ++HRD+K N+L+ +
Sbjct: 89 LKQYMDDCGGGLSMHNVRL-------FLFQLLRGLAYCHQR---RVLHRDLKPQNLLISE 138
Query: 122 EFNPKIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVL 178
K+ DFGL AK P + + T Y P+ +LG + + D++ G +
Sbjct: 139 RGELKLADFGLARAKSVP---SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFY 195
Query: 179 EIISGR 184
E+ +GR
Sbjct: 196 EMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 20/182 (10%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN---S 65
+A+K + E ++G I E+ L N++H N+V L LV+EY++++
Sbjct: 33 VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQY 92
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
LD + N+K+ + +GL++ H+ I+HRD+K N+L++++
Sbjct: 93 LDNCGNLMSMHNVKI-------FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGEL 142
Query: 126 KIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIIS 182
K+ DFGL AK P T + T Y P+ +LG + + D++ G ++ E+ +
Sbjct: 143 KLADFGLARAKSVP---TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
Query: 183 GR 184
GR
Sbjct: 200 GR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 55/181 (30%), Positives = 79/181 (43%), Gaps = 32/181 (17%)
Query: 33 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 86
L NV+HP LV L + V +Y+ L +R L E R+
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-----------EPRA 98
Query: 87 DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--I 143
IA L +LH +IV+RD+K NILLD + + + DFGL K +NI H
Sbjct: 99 RFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGT 152
Query: 144 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG------RNSGKAMWGQMNKF 197
T+ GT YLAPE + D + G ++ E++ G RN+ + +NK
Sbjct: 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212
Query: 198 L 198
L
Sbjct: 213 L 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 13/134 (9%)
Query: 56 LVYEYVENNSLDRVLLGATKAN-IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
LV E+ S+ L+ TK N +K +W + IC I +GLA LH ++HRDIK
Sbjct: 96 LVMEFCGAGSVTD-LVKNTKGNALKEDW--IAYICREILRGLAHLH---AHKVIHRDIKG 149
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKAD 169
N+LL + K+ DFG++ + T I GT ++APE + ++D
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDYRSD 208
Query: 170 VYSFGVLVLEIISG 183
++S G+ +E+ G
Sbjct: 209 IWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 4/77 (5%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166
+HRD+K N L+D + K+ DFGL+K I + G+ Y+APE + G
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 167 KADVYSFGVLVLEIISG 183
D +S G ++ E + G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 11 AVKPLSAESKQGVREFITEIMT-----LSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
AVK L ++ +E IM L NV+HP LV L + V +YV
Sbjct: 24 AVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGE 82
Query: 66 L------DRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNIL 118
L +R E R+ IA L +LH +I++RD+K NIL
Sbjct: 83 LFFHLQRERSFP-----------EPRARFYAAEIASALGYLHSL---NIIYRDLKPENIL 128
Query: 119 LDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
LD + + + DFGL K + I H T+ GT YLAPE + D + G +
Sbjct: 129 LDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAV 185
Query: 177 VLEIISG 183
+ E++ G
Sbjct: 186 LYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 20 KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79
++ V +E L+ + HP V L G + LV E+V + G ++
Sbjct: 72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV--------IGGEFFTFLR 123
Query: 80 LNWEKRSDICVGIAKGLAFLHEELVP-HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 138
N +D+ A + + E L +IV+RD+K N+LLD++ K+ DFG AK+
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--- 180
Query: 139 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ T + GT Y+APE +L AD ++ G+ + EI+ G
Sbjct: 181 -VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN---S 65
+A+K + E ++G I E+ L +++H N+V L LV+EY++ +
Sbjct: 34 VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQY 93
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
+D + N+K+ I +GLA+ H ++HRD+K N+L+++
Sbjct: 94 MDDCGNIMSMHNVKI-------FLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGEL 143
Query: 126 KIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIIS 182
K+ DFGL AK P T + T Y P+ +LG + + + D++ G + E+ S
Sbjct: 144 KLADFGLARAKSVP---TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
Query: 183 GR 184
GR
Sbjct: 201 GR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 28/77 (36%), Positives = 50/77 (64%), Gaps = 1/77 (1%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLT 165
++HRD+K++NI L K+GDFG +K + D+++ + + GT YLAPE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 166 MKADVYSFGVLVLEIIS 182
KAD++S GV++ E+++
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 34/110 (30%), Positives = 59/110 (53%), Gaps = 11/110 (10%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL---FPDNITHITTRIA 148
+ +GL ++H +++HRD+K SN+L++++ +IGDFG+A+ P + T
Sbjct: 116 LLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 149 GTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNS---GKAMWGQM 194
T Y APE +L + T D++S G + E++ GR GK Q+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQL 221
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I GL +H V V+RD+K +NILLD+ + +I D GLA F H + GT
Sbjct: 106 IILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTH 159
Query: 152 GYLAPEYVLGGQ-LTMKADVYSFGVLVLEIISGRN 185
GY+APE + G AD +S G ++ +++ G +
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 7/90 (7%)
Query: 95 GLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154
GL +H V V+RD+K +NILLD+ + +I D GLA F H + GT GY+
Sbjct: 109 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 155 APEYVLGG-QLTMKADVYSFGVLVLEIISG 183
APE + G AD +S G ++ +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 32/104 (30%), Positives = 47/104 (45%), Gaps = 28/104 (26%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAK------------------LFPDNITHITTR--- 146
+HRDIK NIL+D + + K+ DFGL K LF DN+
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 147 -------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
GT Y+APE + G ++ D +S GV++ E++ G
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 20/185 (10%)
Query: 8 RRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
+++AVK LS +S R E+ L +++H N++ L+ T E
Sbjct: 41 QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS----IENFNEVY 96
Query: 66 LDRVLLGATKANI----KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L L+GA NI KL+ E + + +GL ++H I+HRD+K SN+ +++
Sbjct: 97 LVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNE 153
Query: 122 EFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLE 179
+ +I DFGLA+ D +T ++ TR Y APE +L D++S G ++ E
Sbjct: 154 DCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 180 IISGR 184
++ G+
Sbjct: 209 LLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-09
Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 6 NGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
++ VK L + S Q +F+ E +++H NL++ +G C + T +LV E+
Sbjct: 21 TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80
Query: 65 SLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L L KA + + + IA GL LH+ + +H D+ N LL +
Sbjct: 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADL 137
Query: 124 NPKIGDFGLAKLFPDNITHITT-RIAGTTGYLAPEYV--LGGQL-----TMKADVYSFGV 175
KIGD+GL+ ++T ++ ++APE V + G L T +++V+S GV
Sbjct: 138 TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197
Query: 176 LVLEI 180
+ E+
Sbjct: 198 TIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 8e-09
Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 18/168 (10%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSLDRVLLG-ATKANIKLNWEKR 85
EI L ++HPN++ L + + R L+++Y E++ + A+KAN K R
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 86 S---DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFP 137
S + I G+ +LH V +HRD+K +NIL+ E P KI D G A+LF
Sbjct: 108 SMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFN 163
Query: 138 DNITHIT--TRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIIS 182
+ + + T Y APE +LG + KA D+++ G + E+++
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-09
Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 11/133 (8%)
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
LV E+ S+ L+ TK N L E + IC I +GL+ LH+ ++HRDIK
Sbjct: 86 LVMEFCGAGSVTD-LIKNTKGN-TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ 140
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADV 170
N+LL + K+ DFG++ + T I GT ++APE + K+D+
Sbjct: 141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDL 199
Query: 171 YSFGVLVLEIISG 183
+S G+ +E+ G
Sbjct: 200 WSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 8 RRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENN 64
R +A+K LS +++ + E++ + V H N++ L+ Q + Y+
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
+D L + ++L+ E+ S + + G+ LH I+HRD+K SNI++ +
Sbjct: 103 LMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 157
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
KI DFGLA+ + + T T Y APE +LG D++S G ++ E++
Sbjct: 158 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 51/187 (27%), Positives = 93/187 (49%), Gaps = 22/187 (11%)
Query: 6 NGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
NG+ +A+K +S ++++GV I E L ++H N+V L V+EY+ +
Sbjct: 29 NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88
Query: 65 SLDRVLL----GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
L + ++ G N++L + +GLA++H + HI+HRD+K N+L+
Sbjct: 89 -LAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQ---HILHRDLKPQNLLIS 137
Query: 121 QEFNPKIGDFGLA--KLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLV 177
K+ DFGLA K P T+ + + T Y P+ +LG + D++ G +
Sbjct: 138 YLGELKLADFGLARAKSIPSQ-TYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIF 194
Query: 178 LEIISGR 184
+E++ G+
Sbjct: 195 IEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 24/195 (12%)
Query: 4 LTNGRRIAVKPLSAES-KQGV-----REFITEIMTLSNVRHPNLVELIGCCVQGTRR--- 54
G+ +A+K E ++G+ RE I+ + LS + +V L+ V+
Sbjct: 23 KNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLSESIY--IVRLL--DVEHVEEKNG 77
Query: 55 ----ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 110
LV+EY++++ + L + + KG+A H+ ++HR
Sbjct: 78 KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHR 134
Query: 111 DIKASNILLDQEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKA 168
D+K N+L+D++ KI D GL + F + T I T Y APE +LG +
Sbjct: 135 DLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPV 193
Query: 169 DVYSFGVLVLEIISG 183
D++S G + E+
Sbjct: 194 DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 33 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG- 91
L V+HP +V+LI G + L+ EY+ L + + I + E + +
Sbjct: 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFM--EDTACFYLSE 108
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 149
I+ L LH++ I++RD+K NILLD + + K+ DFGL K + +TH G
Sbjct: 109 ISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCG 162
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
T Y+APE ++ D +S G L+ ++++G
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 44/198 (22%)
Query: 7 GRRIAVK----PLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
G ++A+K P +E +K+ RE + L +++H N++ L+ +
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMKHENVIGLLDV------------F 83
Query: 61 VENNSLDRVL------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 108
+ SLDR LG + KL+ ++ + + KGL ++H I+
Sbjct: 84 TPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGII 140
Query: 109 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTM 166
HRD+K N+ ++++ KI DFGLA+ +T ++ TR Y APE +L T
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQ 195
Query: 167 KADVYSFGVLVLEIISGR 184
D++S G ++ E+++G+
Sbjct: 196 TVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 41/114 (35%), Positives = 62/114 (54%), Gaps = 11/114 (9%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT----HITTRI 147
I GL ++H V +HRD+K N+L++ + KI DFGLA+ F +N +T +
Sbjct: 114 ILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 148 AGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIISGRN--SGKAMWGQMNKFL 198
A T Y APE +L Q KA DV+S G ++ E++ + GK Q+N+ L
Sbjct: 171 A-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL 223
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 12/96 (12%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-GT 150
+A G+ FL + + VHRD+ A N+L+ + KI DFGLA+ +I + I+ G+
Sbjct: 248 VANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLAR----DIMRDSNYISKGS 300
Query: 151 T----GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
T ++APE + T +DV+SFG+L+ EI +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 29 EIMTLSNVRHPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLG-ATKAN---IKLNW 82
EI L ++HPN++ L + R++ L+++Y E++ + A+KAN ++L
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-----KIGDFGLAKLFP 137
+ I G+ +LH V +HRD+K +NIL+ E P KI D G A+LF
Sbjct: 108 GMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGE-GPERGRVKIADMGFARLFN 163
Query: 138 DNITHIT--TRIAGTTGYLAPEYVLGGQLTMKA-DVYSFGVLVLEIIS 182
+ + + T Y APE +LG + KA D+++ G + E+++
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 10 IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN---S 65
+A+K + E ++G I E+ L +++H N+V L LV+EY++ +
Sbjct: 34 VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQY 93
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
LD N+KL + +GL + H ++HRD+K N+L+++
Sbjct: 94 LDDCGNSINMHNVKL-------FLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGEL 143
Query: 126 KIGDFGL--AKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIIS 182
K+ DFGL AK P T + T Y P+ +LG + + D++ G + E+ +
Sbjct: 144 KLADFGLARAKSIP---TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
Query: 183 GR 184
GR
Sbjct: 201 GR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 11/180 (6%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+ G A+K + E + EI+ + + +H N+V G ++ + + E+
Sbjct: 31 VNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL + L+ + + + +GL +LH + +HRDIK +NILL
Sbjct: 91 GSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNG 143
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLEI 180
+ K+ DFG++ I + I GT ++APE G D+++ G+ +E+
Sbjct: 144 HVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 49/180 (27%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 8 RRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENN 64
R +A+K LS +++ + E++ + V H N++ L+ Q + Y+
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
+D L + ++L+ E+ S + + G+ LH I+HRD+K SNI++ +
Sbjct: 110 LMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
KI DFGLA+ + + T T Y APE +LG D++S G ++ E+I G
Sbjct: 165 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 13/181 (7%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
L G AVK + E EI + +H N+V G + + + EY
Sbjct: 31 LHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90
Query: 64 NSLDRVL-LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
SL + + + +++ + +C +GLA+LH + +HRDIK +NILL
Sbjct: 91 GSLQDIYHVTGPLSELQIAY-----VCRETLQGLAYLHSK---GKMHRDIKGANILLTDN 142
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---GGQLTMKADVYSFGVLVLE 179
+ K+ DFG+A I + I GT ++APE G D+++ G+ +E
Sbjct: 143 GDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201
Query: 180 I 180
+
Sbjct: 202 L 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-08
Identities = 32/134 (23%), Positives = 55/134 (41%), Gaps = 13/134 (9%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLV-ELIGCCVQGTRRILVYEYVEN 63
T +K + K RE I+ L R V +++ L+ E++E
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASGESDGWSYLLMEWIEG 77
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
+LD +++ E++ DI +A+ LA LH+ + + H D+ NIL+D
Sbjct: 78 ETLD-----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126
Query: 124 NPKIGDFGLAKLFP 137
I D+ A P
Sbjct: 127 ILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 7 GRRIAVKPLSA--ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR------ILVY 58
G ++A+K LS +S+ + E+ L +++H N++ L+ LV
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 59 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
Y++ + L +++ L+ +K + + GL ++H I+HRD+K N+
Sbjct: 100 PYMQTD-LQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLA 149
Query: 119 LDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVL 176
++++ KI DFGLA+ +T ++ TR Y APE +L D++S G +
Sbjct: 150 VNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCI 204
Query: 177 VLEIISGRN--SGKAMWGQMNKFL 198
+ E+++G+ GK Q+ + L
Sbjct: 205 MAEMLTGKTLFKGKDYLDQLTQIL 228
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 24/193 (12%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RHPNLVELIGC-----CVQGTRRI 55
NG + AVK L + + EI N+ HPN+V+ G G +
Sbjct: 42 NGSKAAVKILDP-----IHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
LV E S+ ++ G K ++ + I GL LH +HRD+K +
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGN 153
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV-----LGGQLTMKADV 170
NILL E K+ DFG++ T + GT ++APE + L + DV
Sbjct: 154 NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDV 212
Query: 171 YSFGVLVLEIISG 183
+S G+ +E+ G
Sbjct: 213 WSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 26/160 (16%)
Query: 33 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL------DRVLLGATKANIKLNWEKRS 86
L N++HP LV L + V +YV L +R L E R+
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL-----------EPRA 98
Query: 87 DICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHI 143
+A + +LH +I++RD+K NILLD + + + DFGL K + P+
Sbjct: 99 RFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152
Query: 144 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
T+ GT YLAPE + D + G ++ E++ G
Sbjct: 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 6/83 (7%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL------G 161
VHRDIK N+L+D+ + K+ DFG A N + GT Y+APE +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 162 GQLTMKADVYSFGVLVLEIISGR 184
G ++ D +S GV+ E+I GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
IA L +LH +IV+RD+K NILLD + + + DFGL K + TT GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTP 160
Query: 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
YLAPE + D + G ++ E++ G
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 22/162 (13%)
Query: 29 EIMTLSNVR-HPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85
EI L + HPN++ LI R LV+E ++ N L K + EKR
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMN-----LYELIKGRKRPLPEKR 101
Query: 86 S-DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---PDNIT 141
+ K L +H I HRDIK NIL+ + K+ DFG + P
Sbjct: 102 VKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE 157
Query: 142 HITTRIAGTTGYLAPEYVL-GGQLTMKADVYSFGVLVLEIIS 182
+I+TR Y APE +L G K D+++ G + EI+S
Sbjct: 158 YISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG----G 162
+HRD+K N+LLD+ + K+ DFG K+ + + T + GT Y++PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 163 QLTMKADVYSFGVLVLEIISG 183
+ D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---- 161
H VHRDIK N+LLD + ++ DFG + T ++ GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 162 -GQLTMKADVYSFGVLVLEIISG 183
G+ + D +S GV + E++ G
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87
+IM +N P +V+L C Q + + +V EY+ L ++ + ++ W K
Sbjct: 95 DIMAFAN--SPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYT 148
Query: 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTR 146
V +A L +H ++HRD+K N+LLD+ + K+ DFG K+ + T
Sbjct: 149 AEVVLA--LDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 147 IAGTTGYLAPEYVLG----GQLTMKADVYSFGVLVLEIISG 183
+ GT Y++PE + G + D +S GV + E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 7/84 (8%)
Query: 106 HIVHRDIKASNILLDQEFNPKIGDFG-LAKLFPDNITHITTRIAGTTGYLAPEYVLG--- 161
H VHRDIK NIL+D + ++ DFG KL D + + GT Y++PE +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 162 --GQLTMKADVYSFGVLVLEIISG 183
G+ + D +S GV + E++ G
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 14/91 (15%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT------HIT--TR------IAGTTG 152
IVHRD+K N+L+ + K+ DFGL+K+ ++T HI TR + GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
Y+APE +L D ++ G+++ E + G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 38/189 (20%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 6 NGRRIAVKPL---SAESKQGVREFITEIMTLSNVRHPNLVELIG----CCVQGTRRILVY 58
N + + ++ K + EI L + N++++ G R L+
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 59 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL-VPHIVHRDIKASNI 117
EY L VL L+++ + D+ + KGL L++ P+ +++ + +
Sbjct: 102 EYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSF 154
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGV 175
L+ + + KI GL K+ + Y + + + + T+K D+YS GV
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 176 LVLEIISGR 184
++ EI +G+
Sbjct: 211 VLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRI 147
+ + LA++H + I HRD+K N+L+D + K+ DFG AK ++++I +R
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 148 AGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISG 183
Y APE +LG T D++S G ++ E+I G
Sbjct: 236 -----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 9/85 (10%)
Query: 106 HIVHRDIKASNILLDQEFNPKIGDFG-LAKLFPDNITHITTRIA-GTTGYLAPEYVLG-- 161
VHRDIK N+LLD+ + ++ DFG +L D + + +A GT Y++PE +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAME 179
Query: 162 ---GQLTMKADVYSFGVLVLEIISG 183
G+ + D +S GV + E++ G
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 27/74 (36%), Positives = 40/74 (54%), Gaps = 1/74 (1%)
Query: 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLT 165
I+HRDIK N+L++ + +GDFG A + T IAGT APE + G T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 166 MKADVYSFGVLVLE 179
D++S G+++ E
Sbjct: 341 PSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 49/245 (20%)
Query: 57 VYEYVENNSL---DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
+Y ++ + + DR LL T+A +K + + ++H++ ++HRDIK
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTRAIMK-----------QLLCAVEYIHDKK---LIHRDIK 294
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
NI L+ + +GDFG A F GT +PE + G D++S
Sbjct: 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354
Query: 174 GVLVLEIIS------GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227
G+++L+++S G GK G+ QL + L + D E + PP ++
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKP--GK----------QLLKIIDSLSVCDEEFPD-PPCKL 401
Query: 228 IRYMKVAFFCTQAAASRRPQMNQ----------VIKMLTKNIRL--NEEELTAPGLFQDS 275
Y+ A A S P + ++KMLT + L EL A LF
Sbjct: 402 FDYIDSAEI-DHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460
Query: 276 ESSSV 280
E +
Sbjct: 461 EEEEI 465
|
Length = 501 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 25/162 (15%)
Query: 28 TEIMTLSNVRHPNLVELIG--------CCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79
EI L + H ++ LI C V + ++ YV+ +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG-------------P 181
Query: 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA-KLFPD 138
L E+ I + + LA+LH I+HRD+K NI LD+ N +GDFG A KL
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 139 NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
T +GT +PE + K D++S G+++ E+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 17 AESKQGVRE-----FITEIMTLSNVRHPNLVELIGCCVQGTRRIL--VYEYVENNSLDRV 69
A S +G++E + E+ + ++H N+V I + + L + E+ + L R
Sbjct: 45 AISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRN 104
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPH---IVHRDIKASNILLD----- 120
+ K K+ DI + LA+ H + P+ ++HRD+K NI L
Sbjct: 105 IQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164
Query: 121 ------QEFN------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM-- 166
Q N KIGDFGL+K I + GT Y +PE +L +
Sbjct: 165 IGKITAQANNLNGRPIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDD 222
Query: 167 KADVYSFGVLVLEIISGR 184
K+D+++ G ++ E+ SG+
Sbjct: 223 KSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLG----G 162
+HRD+K N+LLD+ + K+ DFG K+ + + T + GT Y++PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 163 QLTMKADVYSFGVLVLEIISG 183
+ D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 29/161 (18%)
Query: 33 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGI 92
+ V H ++V L G CV+ I+V E+VE LD L K+++ L + + +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDV-LTTPWKFKVAKQL 114
Query: 93 AKGLAFLHEELVPHIVHRDIKASNILL-----DQEFNP--KIGDFGLAKLFPDNITHIT- 144
A L++L ++ +VH ++ NILL D E P K+ D G+ IT ++
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSR 165
Query: 145 ----TRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEI 180
RI ++APE V + L++ AD +SFG + EI
Sbjct: 166 QECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 56/220 (25%)
Query: 7 GRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
G+ A+K L + + V+ +TE L+ + HP L L T LV +Y
Sbjct: 26 GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85
Query: 64 NSLDRVLLGATKANIKLNWEKRSD--ICVGIAK--------GLAFLHEELVPHIVHRDIK 113
L R+L +++ + +A+ L +LH IV+RD+K
Sbjct: 86 GELFRLL------------QRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLK 130
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPD----------------NITHITTRIA--------- 148
NILL + + + DF L+K ++ I +
Sbjct: 131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSN 190
Query: 149 ---GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
GT Y+APE + G D ++ G+L+ E++ G
Sbjct: 191 SFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 42/199 (21%), Positives = 78/199 (39%), Gaps = 35/199 (17%)
Query: 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+AVK ++ + SK+ ++ EI+T ++HPN++ + + + +V +
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 63 NNSLDRVLL------GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
S LL G + I I + L ++H + +HR +KAS+
Sbjct: 83 YGSC-EDLLKTHFPEGLPELAIAF-------ILKDVLNALDYIHSK---GFIHRSVKASH 131
Query: 117 ILLDQEFNPKIGDF---------GLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--- 164
ILL + + G + + +L+PE VL L
Sbjct: 132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD---FPKSSVKNLPWLSPE-VLQQNLQGY 187
Query: 165 TMKADVYSFGVLVLEIISG 183
K+D+YS G+ E+ +G
Sbjct: 188 NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 37/113 (32%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLF----------------PDNITHITT------ 145
+HRDIK N+LLD + + K+ DFGL P N +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 146 ---------RIA------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
R A GT Y+APE L + D +S GV++ E++ G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 42/119 (35%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLF----------------------PDNITHITT 145
+HRDIK NIL+D++ + K+ DFGL F + + I
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 146 R--------------------IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
+ GT Y+APE +L T D +S GV++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 13/147 (8%)
Query: 38 HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 97
+PN ++L +L+ +Y+++ L +L K KL+ + I + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALN 123
Query: 98 FLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156
LH+ +I+H DIK N+L D+ + + D+GL K I + GT Y +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSP 175
Query: 157 EYVLGGQLTMKADVYSFGVLVLEIISG 183
E + G + D ++ GVL E+++G
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 34/110 (30%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLA--------KLFPDNITH----------------- 142
+HRDIK N+LLD + + K+ DFGL F N+TH
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 143 ---------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ GT Y+APE + D +S GV++ E++ G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 43/165 (26%), Positives = 67/165 (40%), Gaps = 22/165 (13%)
Query: 27 ITEIMTLSNVRHPNLVELIGC-----CVQGTRRILVYEYVEN-NSLDRVLLGATKANIKL 80
I + N+ H + + GC C R IL+ + VEN + + + K IK
Sbjct: 71 IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK- 129
Query: 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI 140
+I + L ++HE I H DIK NI++D I D+G+A F +
Sbjct: 130 ------NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180
Query: 141 THITTRIA------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
HI GT Y + G +T + D+ S G +L+
Sbjct: 181 KHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 32/123 (26%), Positives = 48/123 (39%), Gaps = 46/123 (37%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLFP------------------------------ 137
+HRDIK NIL+D++ + K+ DFGL F
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 138 ----DNITHITTRIA------------GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
D + + R A GT Y+APE +L T D +S GV++ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 182 SGR 184
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 24/111 (21%)
Query: 90 VGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNP-------------KIGDFGLA 133
G+A L + H EL H++H D+K NIL+ D +P +I D G
Sbjct: 240 TGVA--LDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295
Query: 134 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
+ H T I T Y +PE VLG D++S G ++ E+ +G+
Sbjct: 296 C----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 28/110 (25%), Positives = 43/110 (39%), Gaps = 34/110 (30%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGL----------------------------------A 133
+HRDIK N+LLD + + K+ DFGL A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 134 KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ + N + GT Y+APE + D +S GV++ E++ G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 3/44 (6%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135
+A L +LH I+HRD+K N+L+ E + K+ DFGL+K+
Sbjct: 113 VALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 30/123 (24%), Positives = 49/123 (39%), Gaps = 46/123 (37%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLFP-------------------------DNITH 142
+HRDIK NIL+D + + K+ DFGL F D++++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 143 ---------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ + GT Y+APE +L T D +S GV++ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 182 SGR 184
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 15/29 (51%), Positives = 21/29 (72%)
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLF 136
+HRDIK NIL+D+ + K+ DFGL+ F
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 307 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.44 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.78 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.41 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.37 | |
| PLN02236 | 344 | choline kinase | 97.31 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.2 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.19 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.11 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.99 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.91 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.77 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.69 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.62 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.6 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.52 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.15 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.03 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.98 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.66 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.51 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.46 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.33 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.7 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=362.00 Aligned_cols=256 Identities=50% Similarity=0.818 Sum_probs=221.5
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
|.+.+|..||||++.........+|..|+.++.+++|||+++++|||.+.+ ..++|+||+++|+|.+.++..... .+
T Consensus 94 G~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L 171 (361)
T KOG1187|consen 94 GVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PL 171 (361)
T ss_pred EEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CC
Confidence 788999999999888765431456999999999999999999999999999 599999999999999999653332 88
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCC-CcccccccccCCCCcCCcccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+|..+++|+.++|.||+|||....+.|+|||||++|||||+++++||+|||+++..+. ........ .||.+|+|||++
T Consensus 172 ~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 172 DWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYA 250 (361)
T ss_pred CHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeec-CCCCccCChhhh
Confidence 9999999999999999999998777899999999999999999999999999976654 22111111 799999999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCC--CCCH-HHHHHHHHHHHh
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG--EYPP-NEIIRYMKVAFF 236 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~l~~~ 236 (307)
..+..+.|+||||||++++||+||+.+.....+.....+..|.+....+....+++|+.+. .+.. .++.++..++.+
T Consensus 251 ~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~ 330 (361)
T KOG1187|consen 251 STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALR 330 (361)
T ss_pred ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHH
Confidence 9999999999999999999999999887655544445588999888888899999999984 4444 688999999999
Q ss_pred ccccccCCCCCHHHHHHHHHhccc
Q 021774 237 CTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
|++.+|.+||+|.+|++.|+.+..
T Consensus 331 C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 331 CLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999999999999966554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=329.41 Aligned_cols=229 Identities=25% Similarity=0.432 Sum_probs=189.0
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+-+|+|.+... ++...+++.+|++++++.+||+||++||.|.++. ..+++||||++|||+.++ ...+++++
T Consensus 102 ~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~----k~~g~i~E 177 (364)
T KOG0581|consen 102 PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDIL----KRVGRIPE 177 (364)
T ss_pred CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHH----hhcCCCCH
Confidence 46788999999654 4566788999999999999999999999999999 599999999999999998 33467999
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 83 EKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
..+.+++.+|++||.|||. . +|+||||||+|||++++|+|||||||.+..+.+. ....+.||..|||||.+.+
T Consensus 178 ~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 178 PVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISG 251 (364)
T ss_pred HHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcC
Confidence 9999999999999999995 7 9999999999999999999999999999876554 4567899999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHH-HHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN-EIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~c~~~ 240 (307)
..|+.++||||||++++||.+|+.|+....+.. ....+.......+. -+..+.+ +..++..++..|++.
T Consensus 252 ~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~Ll~~Iv~~p---------pP~lP~~~fS~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 252 ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFELLCAIVDEP---------PPRLPEGEFSPEFRSFVSCCLRK 321 (364)
T ss_pred CcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHHHHHHhcCC---------CCCCCcccCCHHHHHHHHHHhcC
Confidence 999999999999999999999999987641111 11111111111111 1122222 455688888889999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
||.+||++.+++.
T Consensus 322 dp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 322 DPSERPSAKQLLQ 334 (364)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=339.80 Aligned_cols=236 Identities=31% Similarity=0.456 Sum_probs=193.6
Q ss_pred CCE-EEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 7 GRR-IAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 7 g~~-vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
|+. ||+|++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++|+|.++++.. ....+++
T Consensus 64 g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~ 141 (362)
T KOG0192|consen 64 GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPL 141 (362)
T ss_pred CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCH
Confidence 444 9999998753 233668999999999999999999999999988 789999999999999999543 4678999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCC-eeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPH-IVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
..+++++.|||.||.|||++ + ||||||||+|||++.++ ++||+|||+++...... ...+...||+.|||||++.
T Consensus 142 ~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 142 KVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred HHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhc
Confidence 99999999999999999999 8 99999999999999997 99999999998765432 2234478999999999999
Q ss_pred --CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 --GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 --~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
...|+.|+||||||+++|||+||+.||..... .+.+......... +.+ +..+...+..++.+||
T Consensus 218 ~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R-----p~~---p~~~~~~l~~l~~~CW 283 (362)
T KOG0192|consen 218 GEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR-----PPI---PKECPPHLSSLMERCW 283 (362)
T ss_pred CCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC-----CCC---CccCCHHHHHHHHHhC
Confidence 56999999999999999999999999877654 1112222222211 111 2224445777888899
Q ss_pred ccccCCCCCHHHHHHHHHhccccC
Q 021774 239 QAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+.||..||++.+++..|+.+....
T Consensus 284 ~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 284 LVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCCCcCCCHHHHHHHHHHHHHhh
Confidence 999999999999999999877533
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=340.09 Aligned_cols=239 Identities=28% Similarity=0.416 Sum_probs=196.5
Q ss_pred CcccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 1 ~g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+|.+++..+||+|.++..+- ...+|.+|+++|++|+|+|||+++++|..++..+|||||++.|+|.++|.. ..+..+
T Consensus 224 ~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l 300 (468)
T KOG0197|consen 224 LGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLL 300 (468)
T ss_pred EEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCcc
Confidence 46777777999999987532 236799999999999999999999999999999999999999999999954 356678
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+++...++.........-...|.|||++.
T Consensus 301 ~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~ 377 (468)
T KOG0197|consen 301 NLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALN 377 (468)
T ss_pred chHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHh
Confidence 8999999999999999999999 9999999999999999999999999999976665554444455567899999999
Q ss_pred CCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+.++.|||||||||+||||+| |+.|+..... ..++..+.+..+. ..|..++..+.+++..||+
T Consensus 378 ~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev~~~le~GyRl------------p~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 378 YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEVLELLERGYRL------------PRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred hCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHHHHHHhccCcC------------CCCCCCCHHHHHHHHHHhh
Confidence 9999999999999999999998 6666554432 2222222222221 1233445557778888999
Q ss_pred cccCCCCCHHHHHHHHHhccc
Q 021774 240 AAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~~~~~ 260 (307)
.+|++||||+.+...|+++..
T Consensus 443 ~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 443 EDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCcccCCCHHHHHHHHHHhhh
Confidence 999999999999999988764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=313.76 Aligned_cols=230 Identities=24% Similarity=0.345 Sum_probs=184.4
Q ss_pred cCCCCEEEEEEccccC-----h--HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC
Q 021774 4 LTNGRRIAVKPLSAES-----K--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-----~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
-++|+.||||+++... . .......+|+++|++|+|||||+++++|...+..|+||||++||.|-+.+ -.
T Consensus 194 ~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v----v~ 269 (475)
T KOG0615|consen 194 KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV----VA 269 (475)
T ss_pred cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH----Hh
Confidence 3679999999998641 1 12234579999999999999999999999999999999999999999988 45
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CceEEeeccCcccCCCCcccccccccCCCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGY 153 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 153 (307)
++.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+++..+. ...+..++||+.|
T Consensus 270 nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~--~sfm~TlCGTpsY 344 (475)
T KOG0615|consen 270 NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE--GSFMKTLCGTPSY 344 (475)
T ss_pred ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhcccc--ceehhhhcCCccc
Confidence 56677777788999999999999999 99999999999999776 6699999999998763 3456779999999
Q ss_pred CCcccccCCc---ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 154 LAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 154 ~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
.|||++.+.. +..++|+||+||+||-+|+|.+||...+.... + .+....++.. +- +........+.
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQI~~G~y~--f~---p~~w~~Iseea 413 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQILKGRYA--FG---PLQWDRISEEA 413 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHHHhcCccc--cc---ChhhhhhhHHH
Confidence 9999998753 34588999999999999999999987765431 1 1111111110 00 11123455668
Q ss_pred HHHHHhccccccCCCCCHHHHHH
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+++.++|..||++|||+.|++.
T Consensus 414 ~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 414 LDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHHhhEeCcccCcCHHHHhc
Confidence 88999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=323.69 Aligned_cols=226 Identities=25% Similarity=0.399 Sum_probs=190.1
Q ss_pred cCCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+.+|+.||+|++... .....+...+|+++.++|+|||||+++++|++.++.|+|.|+|..++|..++ +..+.+
T Consensus 40 ~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~----Krrk~l 115 (592)
T KOG0575|consen 40 LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELL----KRRKPL 115 (592)
T ss_pred cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHH----HhcCCC
Confidence 377999999999864 3455677899999999999999999999999999999999999999999998 355679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||.|||++ +|+|||||..|+||+++.+|||+|||+|.....+.. .....+||+.|.|||++.
T Consensus 116 tEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-rk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 116 TEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-RKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred CcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc-ccceecCCCcccChhHhc
Confidence 9999999999999999999999 999999999999999999999999999998765432 345689999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
....+..+||||+||++|-||+|++||+... +-+ .......... ..|........+||..+|+.
T Consensus 192 k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vke-ty~~Ik~~~Y---------~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 192 KSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKE-TYNKIKLNEY---------SMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred cCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHH-HHHHHHhcCc---------ccccccCHHHHHHHHHHhcC
Confidence 9999999999999999999999999987532 111 1122211111 11223334577888889999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
+|.+|||+++|+.
T Consensus 256 ~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 256 NPSERPSLDEVLD 268 (592)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=300.70 Aligned_cols=234 Identities=21% Similarity=0.368 Sum_probs=191.0
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceee-EEEeCCe-eEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIG-CCVQGTR-RILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
+.+|..||.|.++.. +.+..++...|+.+|++|+|||||++++ .+..++. .++|||+|++|+|.+.+...+..+..
T Consensus 41 ~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ 120 (375)
T KOG0591|consen 41 LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRL 120 (375)
T ss_pred ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhcccc
Confidence 678889999988754 5666778999999999999999999999 4444444 78999999999999999888888889
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVP-HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
++++.+++++.|++.||..+|.+.++ -|+||||||.||+|+.+|.|||+|||+++.+.... ......+||+.||+||.
T Consensus 121 ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~ 199 (375)
T KOG0591|consen 121 IPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPER 199 (375)
T ss_pred CchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh-HHHHhhcCCCcccCHHH
Confidence 99999999999999999999995432 38899999999999999999999999999876543 34567899999999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCC-HHHHHHHHHHHHhc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP-PNEIIRYMKVAFFC 237 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~c 237 (307)
+...+|+.+|||||+||++|||+.-+.||... .+.....+ ..... .+..+ ......+.+|+..|
T Consensus 200 i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd--------~~~~p~~~YS~~l~~li~~c 264 (375)
T KOG0591|consen 200 IHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGD--------YPPLPDEHYSTDLRELINMC 264 (375)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCC--------CCCCcHHHhhhHHHHHHHHH
Confidence 99999999999999999999999999998764 12222211 11111 11222 34556688888889
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
+..||+.||+...++.
T Consensus 265 i~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 265 IAVDPEQRPDTVPYVQ 280 (375)
T ss_pred ccCCcccCCCcchHHH
Confidence 9999999998443333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=307.07 Aligned_cols=179 Identities=30% Similarity=0.519 Sum_probs=161.6
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
++|..||||.+... .+...+.+..|+.+|+.++|||||.+++++..++..|+|||||.||+|.++++ ..+.+++
T Consensus 33 ~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~----~~~~l~e 108 (429)
T KOG0595|consen 33 KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR----RRGRLPE 108 (429)
T ss_pred cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH----HcCCCCH
Confidence 45789999999877 56777788999999999999999999999999999999999999999999993 4457999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC------CceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE------FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+..++.|||.||++||++ +||||||||+||||+.+ -.+||+|||+++.+... ......+|++.||||
T Consensus 109 ~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~--~~a~tlcGSplYMAP 183 (429)
T KOG0595|consen 109 ATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG--SMAETLCGSPLYMAP 183 (429)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch--hHHHHhhCCccccCH
Confidence 99999999999999999999 99999999999999765 45899999999988643 335568899999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCcccc
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG 192 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 192 (307)
|+++.++|+.|+|+||+|+++|+|++|+.||.....
T Consensus 184 EV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 184 EVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred HHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 999999999999999999999999999999875543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=303.93 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=189.4
Q ss_pred cCCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 4 LTNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+.++.||||++..+. ....+.+.+|+..++.++||||++++..|..+...|+||+||.+||+.+++......+ +++
T Consensus 48 ~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G--l~E 125 (516)
T KOG0582|consen 48 IPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG--LEE 125 (516)
T ss_pred cccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc--ccH
Confidence 4567999999998763 3446889999999999999999999999999999999999999999999996655444 999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc---cccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~ 159 (307)
..+..|+.++++||.|||++ |.||||||+.||||+++|.|||+|||.+-.+.+..... ...+.|++.|||||++
T Consensus 126 ~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 126 ASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred HHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHh
Confidence 99999999999999999999 99999999999999999999999999987665543221 1557899999999996
Q ss_pred cC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC-CCCCHHHHHHHHHHHHh
Q 021774 160 LG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 160 ~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~ 236 (307)
.+ ..|+.|+||||||++..||.+|..||....+- ........+..+... -..+ .+........+.+++..
T Consensus 203 ~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~ 275 (516)
T KOG0582|consen 203 MQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPTLL-TSGLDKDEDKKFSKSFREMIAL 275 (516)
T ss_pred hhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCCcc-cccCChHHhhhhcHHHHHHHHH
Confidence 54 47999999999999999999999998766541 111122222221110 0000 01111223357777888
Q ss_pred ccccccCCCCCHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~ 253 (307)
|++.||.+|||+.++++
T Consensus 276 CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 276 CLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhhcCcccCCCHHHHhc
Confidence 99999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.29 Aligned_cols=240 Identities=26% Similarity=0.448 Sum_probs=196.5
Q ss_pred CCCCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC------CC
Q 021774 5 TNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------AN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~ 77 (307)
.+..-||||.++..+.. ...+|.+|++++..|+|||||+++|+|..++..++|+||++.|+|.++|..... .+
T Consensus 514 ~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g 593 (774)
T KOG1026|consen 514 QDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASG 593 (774)
T ss_pred ccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCC
Confidence 34457999999987544 778999999999999999999999999999999999999999999999954432 12
Q ss_pred CC----CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCC
Q 021774 78 IK----LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTG 152 (307)
Q Consensus 78 ~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~ 152 (307)
.. ++..+.+.|+.|||.|+.||-++ .+|||||..+|+||.++..|||+|||+++..-..... ......-.++
T Consensus 594 ~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIR 670 (774)
T KOG1026|consen 594 QDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIR 670 (774)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeee
Confidence 22 88999999999999999999999 9999999999999999999999999999854332222 2223334579
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
|||||.+..++++++||||||||+|||+++ |+-|+.+...++ +++ ..+.+.. -..+.+++.++.
T Consensus 671 WMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---VIe----~i~~g~l--------L~~Pe~CP~~vY 735 (774)
T KOG1026|consen 671 WMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---VIE----CIRAGQL--------LSCPENCPTEVY 735 (774)
T ss_pred cCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---HHH----HHHcCCc--------ccCCCCCCHHHH
Confidence 999999999999999999999999999998 777776554432 222 2222222 244566677789
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+|+..||+.+|.+||++.||-..|+......
T Consensus 736 ~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 736 SLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 9999999999999999999999998876533
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=309.52 Aligned_cols=228 Identities=24% Similarity=0.439 Sum_probs=190.3
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
..+++.||||++........+..++|+.+|+.++|+|||.+++.|...+..|+||||++||+|.+.+ ....+++.
T Consensus 295 ~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV-----t~~~~~E~ 369 (550)
T KOG0578|consen 295 ISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV-----TKTRMTEG 369 (550)
T ss_pred ccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh-----hcccccHH
Confidence 4567889999998765444567889999999999999999999999999999999999999999998 34459999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
++..|..+++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+..... .....+||+.|||||+.....
T Consensus 370 qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 370 QIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred HHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhhhcc
Confidence 9999999999999999999 999999999999999999999999999987765433 456688999999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
|+.+.||||||++++||+-|.+||-...+-- ..+.....+.+. + ..+......+.+++.+||+.|++
T Consensus 446 YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng~P~------l-k~~~klS~~~kdFL~~cL~~dv~ 512 (550)
T KOG0578|consen 446 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTPK------L-KNPEKLSPELKDFLDRCLVVDVE 512 (550)
T ss_pred cCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcCCCC------c-CCccccCHHHHHHHHHHhhcchh
Confidence 9999999999999999999999986533311 122222222221 1 11233344577888889999999
Q ss_pred CCCCHHHHHH
Q 021774 244 RRPQMNQVIK 253 (307)
Q Consensus 244 ~RPs~~~v~~ 253 (307)
+||++.|+|+
T Consensus 513 ~RasA~eLL~ 522 (550)
T KOG0578|consen 513 QRASAKELLE 522 (550)
T ss_pred cCCCHHHHhc
Confidence 9999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=299.70 Aligned_cols=232 Identities=28% Similarity=0.417 Sum_probs=181.8
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
++|+..|||.+...+....+.+.+|+.+|.+++|||||+++|...... ..+++|||+++|+|.+++.. .+..+++
T Consensus 40 ~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~---~g~~l~E 116 (313)
T KOG0198|consen 40 KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR---YGGKLPE 116 (313)
T ss_pred CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH---cCCCCCH
Confidence 348899999888764333677899999999999999999999855444 68999999999999999943 2227999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCC--CcccccccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPD--NITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~--~~~~~~~~~~g~~~y~aPE~~ 159 (307)
..+..++.|+++||+|||++ ||+|+||||+||||+. ++.+||+|||++..... ..........||+.|||||++
T Consensus 117 ~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi 193 (313)
T KOG0198|consen 117 PLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVI 193 (313)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhh
Confidence 99999999999999999999 9999999999999999 79999999999987663 222334568899999999999
Q ss_pred cCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 LGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.++ ....++|||||||++.||+||+.||...... ..+........ ..|. .+........+++.+|+
T Consensus 194 ~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~-----~~~~~~ig~~~-----~~P~---ip~~ls~~a~~Fl~~C~ 260 (313)
T KOG0198|consen 194 RNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE-----AEALLLIGRED-----SLPE---IPDSLSDEAKDFLRKCF 260 (313)
T ss_pred cCCCcCCccchhhhcCCEEEeccCCCCcchhhcch-----HHHHHHHhccC-----CCCC---CCcccCHHHHHHHHHHh
Confidence 864 3345999999999999999999998764111 11111111111 1112 22233344666777799
Q ss_pred ccccCCCCCHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKML 255 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L 255 (307)
+.+|++|||+.+++...
T Consensus 261 ~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 261 KRDPEKRPTAEELLEHP 277 (313)
T ss_pred hcCcccCcCHHHHhhCh
Confidence 99999999999998754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=297.77 Aligned_cols=229 Identities=19% Similarity=0.315 Sum_probs=183.3
Q ss_pred CCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 6 NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
+|+.||||.++... ....+.|.+|+.+|++++||||+++++++.+ ....++||||+++|+|.+++. ...
T Consensus 42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~ 117 (283)
T PHA02988 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEK 117 (283)
T ss_pred CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh----hCC
Confidence 68899999998653 2335778899999999999999999999877 346789999999999999984 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
.+++...+.++.+++.||.|||+ . +++||||||+||++++++.+||+|||++....... ....|+..|+|||
T Consensus 118 ~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE 190 (283)
T PHA02988 118 DLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYK 190 (283)
T ss_pred CCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHH
Confidence 68899999999999999999997 5 78899999999999999999999999998654321 2345788999999
Q ss_pred cccC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 158 YVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 158 ~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
++.+ ..++.++|||||||++|||++|..||..... ..+.. ........ .. .+......+.+++.
T Consensus 191 ~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~---~i~~~~~~-----~~---~~~~~~~~l~~li~ 256 (283)
T PHA02988 191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYD---LIINKNNS-----LK---LPLDCPLEIKCIVE 256 (283)
T ss_pred HhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHhcCCC-----CC---CCCcCcHHHHHHHH
Confidence 9876 6899999999999999999999999875432 11111 11111111 01 11123445888899
Q ss_pred hccccccCCCCCHHHHHHHHHhcc
Q 021774 236 FCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
+||+.||++|||+.++++.|+...
T Consensus 257 ~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 257 ACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHhcCCcccCcCHHHHHHHHHHHH
Confidence 999999999999999999998654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=308.91 Aligned_cols=224 Identities=29% Similarity=0.470 Sum_probs=182.4
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|.+++ +.||||+++.- -..++.-|++|+|+||+.+.|+|....-+|||||||..|-|..+| +.+..+.
T Consensus 143 Grl~n-etVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL----ka~~~it 210 (904)
T KOG4721|consen 143 GRLHN-ETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL----KAGRPIT 210 (904)
T ss_pred eeccC-ceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH----hccCccC
Confidence 44444 78999988732 234688899999999999999999999999999999999999999 5677888
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
...+..|..+||.|+.|||.+ .|||||||.-||||..+..|||+|||.++...+.. ..-.+.||..|||||++++
T Consensus 211 p~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIrn 285 (904)
T KOG4721|consen 211 PSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIRN 285 (904)
T ss_pred HHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhhhhhhHhhhCHHHhhc
Confidence 999999999999999999999 99999999999999999999999999998765542 2345789999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.+.++|+|||||||+|||||||..|+..-.. ...+|.+..+ .+.-.+ +..++.-+.-|++.||+..
T Consensus 286 ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIwGVGsN-----sL~Lpv---PstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 286 EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIWGVGSN-----SLHLPV---PSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred CCcccccceehhHHHHHHHHhcCCCccccch------heeEEeccCC-----cccccC---cccCchHHHHHHHHHHhcC
Confidence 9999999999999999999999999764322 1122222211 111111 2223334666777799999
Q ss_pred cCCCCCHHHHHHHHH
Q 021774 242 ASRRPQMNQVIKMLT 256 (307)
Q Consensus 242 p~~RPs~~~v~~~L~ 256 (307)
|..||+|.+++..|+
T Consensus 352 pRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 352 PRNRPSFRQILLHLD 366 (904)
T ss_pred CCCCccHHHHHHHHh
Confidence 999999999998874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=284.97 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=186.2
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++... ++...+-.++|+++|++++|+|+|.++.+|......++|+|||+..-|+++- .....++.
T Consensus 25 ~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe----~~p~G~~~ 100 (396)
T KOG0593|consen 25 DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELE----RYPNGVPS 100 (396)
T ss_pred CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHH----hccCCCCH
Confidence 45999999999764 3455566889999999999999999999999999999999999885555543 33445888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 161 (307)
..+.++++|++.|+.|+|++ +++||||||+||||+.+|.+||||||.++...... ...+..+.|.+|.|||.+.+
T Consensus 101 ~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-d~YTDYVATRWYRaPELLvGD 176 (396)
T KOG0593|consen 101 ELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-DNYTDYVATRWYRAPELLVGD 176 (396)
T ss_pred HHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc-chhhhhhhhhhccChhhhccc
Confidence 99999999999999999999 99999999999999999999999999999876532 23344567899999999887
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHH--------HHHhhcCCcc------cccCCC-CCCCCHHH
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--------WQLHQEEKPL------ELVDPE-LGEYPPNE 226 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~------~~~~~~-~~~~~~~~ 226 (307)
-+|...+||||+||++.||++|.+.|.+..+-++.+..... .+.+.....+ +.-+++ +..-.+..
T Consensus 177 tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~ 256 (396)
T KOG0593|consen 177 TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKI 256 (396)
T ss_pred CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccc
Confidence 68999999999999999999999877665544333322211 1111111111 111111 11222334
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..-+++++..|++.||.+|++.++++.
T Consensus 257 s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 257 SNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hHHHHHHHHHHhcCCccccccHHHHhc
Confidence 446789999999999999999999873
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=291.58 Aligned_cols=219 Identities=27% Similarity=0.320 Sum_probs=179.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
++|+.+|+|++++. .....+....|..+|.+++||.||+++..|++.+..|+|+||+.||.|...+ ...+.++
T Consensus 48 dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL----~~eg~F~ 123 (357)
T KOG0598|consen 48 DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL----QREGRFS 123 (357)
T ss_pred ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH----HhcCCcc
Confidence 56888999999865 2445678899999999999999999999999999999999999999999998 4567899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+.-++++|+.||.|||++ ||+||||||+|||||.+|+++|+|||+++...... ..+..++||+.|||||++.+
T Consensus 124 E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 124 EDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred hhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-CccccccCCccccChHHHhc
Confidence 999999999999999999999 99999999999999999999999999998654332 23455899999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..|+.++|.||||+++|||++|.+||..... ..+....... + +...+.-......+++.+.+..|
T Consensus 200 ~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~-k--------~~~~p~~ls~~ardll~~LL~rd 264 (357)
T KOG0598|consen 200 KGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKG-K--------LPLPPGYLSEEARDLLKKLLKRD 264 (357)
T ss_pred CCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcC-c--------CCCCCccCCHHHHHHHHHHhccC
Confidence 9999999999999999999999999865432 1111111111 1 11111112234667777789999
Q ss_pred cCCCC
Q 021774 242 ASRRP 246 (307)
Q Consensus 242 p~~RP 246 (307)
|++|-
T Consensus 265 p~~RL 269 (357)
T KOG0598|consen 265 PRQRL 269 (357)
T ss_pred HHHhc
Confidence 99995
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.57 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=184.8
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCC-----
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKA----- 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~----- 76 (307)
.+++.||||+++... ......+.+|+.+++++ +||||+++++++...+ ..++||||+++|+|.+++......
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~ 114 (338)
T cd05102 35 SSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYR 114 (338)
T ss_pred ccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhccccc
Confidence 346789999997543 34456789999999999 8999999999887654 578999999999999998543210
Q ss_pred -----------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 021774 77 -----------------------------------------------------NIKLNWEKRSDICVGIAKGLAFLHEEL 103 (307)
Q Consensus 77 -----------------------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~ 103 (307)
...+++..+..++.||+.||+|||++
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~- 193 (338)
T cd05102 115 EKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR- 193 (338)
T ss_pred ccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 13478889999999999999999999
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt 182 (307)
||+||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++
T Consensus 194 --~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 194 --KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred --CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999865432211 1223345678999999998899999999999999999997
Q ss_pred -CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 183 -GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 183 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
|..||....... .+. ......... ..+......+.+++.+||+.||.+|||+.+|++.|++++.
T Consensus 272 ~g~~pf~~~~~~~--~~~----~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 272 LGASPYPGVQINE--EFC----QRLKDGTRM--------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCCCCccH--HHH----HHHhcCCCC--------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 888876533211 111 111111110 1112233458889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=303.37 Aligned_cols=234 Identities=25% Similarity=0.445 Sum_probs=187.5
Q ss_pred EEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 9 RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 9 ~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
.||||+++.. +.+..+.|++|+..|++-+|.||+-++|+|..... .||+.+|+|.+|+.+++. ...+|...+.+
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~i 491 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTI 491 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHH
Confidence 6999999977 45678899999999999999999999999999888 899999999999999964 34679999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCC-cccccccccCCCCcCCcccccC---C
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLG---G 162 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~---~ 162 (307)
.|+.|+++|+.|||++ +|||||||..||||++++.|||+|||++.....- .........|...|||||+++. .
T Consensus 492 dIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~n 568 (678)
T KOG0193|consen 492 DIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDN 568 (678)
T ss_pred HHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccC
Confidence 9999999999999999 9999999999999999999999999999754321 1112233456778999999864 5
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
+|+.++||||||+++|||+||..|+.....+ +.++.+-+. .+.+.+.....++..++.+|+..||.+++
T Consensus 569 PfS~qSDVYaFGiV~YELltg~lPysi~~~d------qIifmVGrG-----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~ 637 (678)
T KOG0193|consen 569 PFSFQSDVYAFGIVWYELLTGELPYSIQNRD------QIIFMVGRG-----YLMPDLSKIRSNCPKAMKRLLSDCWKFDR 637 (678)
T ss_pred CCCcccchhhhhHHHHHHHhCcCCcCCCChh------heEEEeccc-----ccCccchhhhccCHHHHHHHHHHHHhcCc
Confidence 7999999999999999999999998732111 111111111 11122222223444567777778999999
Q ss_pred CCCCCHHHHHHHHHhccc
Q 021774 243 SRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 243 ~~RPs~~~v~~~L~~~~~ 260 (307)
++||.+.+|+..|+++++
T Consensus 638 ~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 638 EERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccCccHHHHHHHHHHhhh
Confidence 999999999999988876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.21 Aligned_cols=235 Identities=29% Similarity=0.431 Sum_probs=189.6
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC---CCCCCHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA---NIKLNWEK 84 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---~~~~~~~~ 84 (307)
.||+|.++.. +.+...+|++|+.+|+.++||||++++|++.+....++++|||.||+|..++.+.+.. ...++...
T Consensus 724 ~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~d 803 (1025)
T KOG1095|consen 724 QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRD 803 (1025)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHH
Confidence 5999999876 4667789999999999999999999999999999999999999999999999655322 45689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCC-CCcccccccccCCCCcCCcccccCCc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
++.++.|||.|+.||+++ ++|||||..+|+||+....|||+|||+++.+- .+.........-...|||||.+..+.
T Consensus 804 Ll~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i 880 (1025)
T KOG1095|consen 804 LLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI 880 (1025)
T ss_pred HHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcc
Confidence 999999999999999999 99999999999999999999999999999433 22222222223346899999999999
Q ss_pred ccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
++.|+|||||||++||++| |..|+..... ..+... ....++. +.+..+..++.+++..||+.+|
T Consensus 881 FtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~~---~~~ggRL---------~~P~~CP~~ly~lM~~CW~~~p 945 (1025)
T KOG1095|consen 881 FTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLLD---VLEGGRL---------DPPSYCPEKLYQLMLQCWKHDP 945 (1025)
T ss_pred cccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHHH---HHhCCcc---------CCCCCCChHHHHHHHHHccCCh
Confidence 9999999999999999999 5566544332 222221 1122211 2234455567788889999999
Q ss_pred CCCCCHHHHHHHHHhcccc
Q 021774 243 SRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 243 ~~RPs~~~v~~~L~~~~~~ 261 (307)
++||++..|++.+..+...
T Consensus 946 e~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 946 EDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred hhCccHHHHHhhhhhhhhh
Confidence 9999999999988877653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.70 Aligned_cols=225 Identities=24% Similarity=0.349 Sum_probs=183.9
Q ss_pred cCCCCEEEEEEcccc----Ch-HhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 4 LTNGRRIAVKPLSAE----SK-QGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 4 ~~~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
..+|+.||+|++... .. ...+...+|+.++++++ ||||++++.++......++||||+.||.|.+++. ..
T Consensus 39 ~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~----~~ 114 (370)
T KOG0583|consen 39 RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV----NK 114 (370)
T ss_pred ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH----Hc
Confidence 456799999977764 12 23456678999999998 9999999999999999999999999999999993 35
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
+++.+..+..++.|++.|++|||++ ||+||||||+||+++.+ +++||+|||++.... .........+|++.|+||
T Consensus 115 g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aP 190 (370)
T KOG0583|consen 115 GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAP 190 (370)
T ss_pred CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCH
Confidence 6788999999999999999999999 99999999999999999 999999999999874 222345668899999999
Q ss_pred ccccCCc-cc-ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHH-HHHHHHH
Q 021774 157 EYVLGGQ-LT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE-IIRYMKV 233 (307)
Q Consensus 157 E~~~~~~-~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l 233 (307)
|++.+.. |+ .++||||+|++||-|++|..||.... ....... ...... .++... ...+..+
T Consensus 191 Evl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~k-i~~~~~---------~~p~~~~S~~~~~L 254 (370)
T KOG0583|consen 191 EVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRK-IRKGEF---------KIPSYLLSPEARSL 254 (370)
T ss_pred HHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcCCc---------cCCCCcCCHHHHHH
Confidence 9999877 86 88999999999999999999987622 1111112 111111 111111 4568889
Q ss_pred HHhccccccCCCCCHHHHH
Q 021774 234 AFFCTQAAASRRPQMNQVI 252 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~ 252 (307)
+.+|+..||..|+++.+|+
T Consensus 255 i~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 255 IEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHcCCCcccCCCHHHHh
Confidence 9999999999999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=290.51 Aligned_cols=240 Identities=24% Similarity=0.330 Sum_probs=187.7
Q ss_pred cCCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
..+|+.||+|++..+. .....-..+|+.+|++|+||||+++.+...+. ..+|+|+|||+. +|.-++. ..+..
T Consensus 139 ~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~---~p~vk 214 (560)
T KOG0600|consen 139 LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS---SPGVK 214 (560)
T ss_pred cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc---CCCcc
Confidence 5678999999998764 44445567999999999999999999998876 688999999977 8988883 45678
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
|++.++..++.||+.||.|+|.+ ||+|||||.+|||||.+|.+||+|||+++++........+..+-|.+|.|||.+
T Consensus 215 ft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 215 FTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELL 291 (560)
T ss_pred cChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHh
Confidence 99999999999999999999999 999999999999999999999999999998877766666778889999999999
Q ss_pred cCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC----------CcccccCCC------CCCC
Q 021774 160 LGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE----------KPLELVDPE------LGEY 222 (307)
Q Consensus 160 ~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~------~~~~ 222 (307)
.|. .|+.+.|+||.||+|.||++|++.+.....-++ +..+....... .....+.+. +.+.
T Consensus 292 LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~ 368 (560)
T KOG0600|consen 292 LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET 368 (560)
T ss_pred cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH
Confidence 884 799999999999999999999987765543222 22222211110 000111111 1111
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
........++|+..+|..||.+|.|+.+++.
T Consensus 369 ~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 369 FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1112233567777889999999999998874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=288.65 Aligned_cols=239 Identities=25% Similarity=0.406 Sum_probs=182.6
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC----------
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------- 75 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 75 (307)
+..||+|.+... ......+|.+|++++.+++||||+++++++.+.+..++||||+++++|.+++.....
T Consensus 46 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (304)
T cd05096 46 PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125 (304)
T ss_pred ceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccc
Confidence 447999998865 344556899999999999999999999999999999999999999999998844321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccC
Q 021774 76 -----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAG 149 (307)
Q Consensus 76 -----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g 149 (307)
....+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||++........ .......+
T Consensus 126 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05096 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL 202 (304)
T ss_pred cccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCC
Confidence 123478899999999999999999999 999999999999999999999999999986543222 12233445
Q ss_pred CCCcCCcccccCCcccccCceeehHHHHHHHHhC--CCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHH
Q 021774 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG--RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227 (307)
Q Consensus 150 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (307)
+..|+|||++.++.++.++||||||+++|||+++ ..|+..... ................... ...++...
T Consensus 203 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 274 (304)
T cd05096 203 PIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD---EQVIENAGEFFRDQGRQVY-----LFRPPPCP 274 (304)
T ss_pred CccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH---HHHHHHHHHHhhhcccccc-----ccCCCCCC
Confidence 7789999999888999999999999999999874 455544322 1122222222111110000 01112233
Q ss_pred HHHHHHHHhccccccCCCCCHHHHHHHHH
Q 021774 228 IRYMKVAFFCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 228 ~~~~~l~~~c~~~~p~~RPs~~~v~~~L~ 256 (307)
..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus 275 ~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 275 QGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 46888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=295.09 Aligned_cols=228 Identities=25% Similarity=0.347 Sum_probs=184.8
Q ss_pred cCCCCEEEEEEccccC---hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.++++.+|||++.+.- ..-.+-...|-+.|.+| .||.|+++|..|.++..+|+|+||+++|.|.+++ ...+.
T Consensus 95 ~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i----~K~Gs 170 (604)
T KOG0592|consen 95 KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLI----KKYGS 170 (604)
T ss_pred cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHH----HHhCc
Confidence 3568899999987541 12223456788999999 8999999999999999999999999999999999 45577
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc----------c--cccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH----------I--TTRI 147 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~----------~--~~~~ 147 (307)
|++.....++.+|+.||.|||++ |||||||||+||||+++++++|+|||.++.++..... . ...+
T Consensus 171 fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SF 247 (604)
T KOG0592|consen 171 FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSF 247 (604)
T ss_pred chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccce
Confidence 99999999999999999999999 9999999999999999999999999999987543211 1 1458
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHH
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (307)
+||..|.+||++..+..+..+|+|+|||++|+|+.|.+||...-. ++. .+.... ++ -.+++...
T Consensus 248 VGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yli---FqkI~~------l~---y~fp~~fp 311 (604)
T KOG0592|consen 248 VGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YLI---FQKIQA------LD---YEFPEGFP 311 (604)
T ss_pred eeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HHH---HHHHHH------hc---ccCCCCCC
Confidence 999999999999999999999999999999999999999875422 110 111110 01 12333344
Q ss_pred HHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 228 IRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 228 ~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
....+|+.+.|..||.+|++.++|-+.
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhC
Confidence 567788888999999999999888753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=293.51 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=184.7
Q ss_pred cCCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|..||||+++..- ....--=++|+..|++|+ ||||+++.+++.+.+ .+++|||||+. +|.+++++ .+..|
T Consensus 32 ~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~---R~r~f 107 (538)
T KOG0661|consen 32 KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKD---RNRLF 107 (538)
T ss_pred cCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhh---cCCcC
Confidence 4568889999998763 222233468999999998 999999999999988 99999999955 99999954 36789
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+++........ +..+.|.+|+|||++.
T Consensus 108 se~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY--TeYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 108 SESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY--TEYVSTRWYRAPEVLL 182 (538)
T ss_pred CHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCCc--chhhhcccccchHHhh
Confidence 9999999999999999999999 9999999999999999999999999999977554332 3346788999999875
Q ss_pred -CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHH--------------HHhhcCCcccccCCCCCCCCHH
Q 021774 161 -GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW--------------QLHQEEKPLELVDPELGEYPPN 225 (307)
Q Consensus 161 -~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~ 225 (307)
.+.|+.+.|+|++||+++|+.+-++-|.+....++-+-+-.+. .....-+........+....+.
T Consensus 183 rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~ 262 (538)
T KOG0661|consen 183 RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN 262 (538)
T ss_pred hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc
Confidence 5789999999999999999999887655433222111110000 0000000001111112333345
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
...+.++++.+|+++||.+|||+.+.++.
T Consensus 263 ~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 263 ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 67778999999999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=292.21 Aligned_cols=225 Identities=26% Similarity=0.306 Sum_probs=181.3
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++.. .......+.+|++++++++||||+++++++...+..++||||+++++|.+++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~ 93 (323)
T cd05571 18 ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS----RERVFS 93 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCC
Confidence 57899999998754 23445678899999999999999999999999999999999999999999883 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..... ........|+..|+|||++.+
T Consensus 94 ~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05571 94 EDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceecCccccChhhhcC
Confidence 999999999999999999999 9999999999999999999999999998753221 112334568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|..||..... ....... .. ... .++......+.+++.+||+.|
T Consensus 170 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~---~~-~~~---------~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI---LM-EEI---------RFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHH---Hc-CCC---------CCCCCCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999864321 1111111 11 110 112223345778899999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 234 PKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHcCCCCCCCHHHHHc
Confidence 99999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=297.27 Aligned_cols=233 Identities=29% Similarity=0.405 Sum_probs=185.4
Q ss_pred EEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 10 IAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 10 vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
||+|..+.. ......+|++|++++++++||||+++||++......++|||+|.||+|.++|.. ....++..+.+
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~ 265 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKL 265 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHH
Confidence 899998853 467788999999999999999999999999999999999999999999999943 33369999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
.++.+.|.||+|||++ +++||||..+|+|++.++.+||+|||+++.-..-. .......-...|+|||.+....|+.
T Consensus 266 ~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~-~~~~~~klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 266 RFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV-MKKFLKKLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred HHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee-eccccccCcceecChhhhccCcccc
Confidence 9999999999999999 99999999999999999999999999987543111 1111223467899999999999999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++|||||||++||+++ |..|+.+.... .+..++ ...+... ......+ ..+..++..||..+|++|
T Consensus 342 kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~~~r~-----~~~~~~p---~~~~~~~~~c~~~~p~~R 407 (474)
T KOG0194|consen 342 KTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKNGYRM-----PIPSKTP---KELAKVMKQCWKKDPEDR 407 (474)
T ss_pred ccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---HhcCccC-----CCCCCCH---HHHHHHHHHhccCChhhc
Confidence 9999999999999998 67676554332 111111 1211111 1112233 345556668999999999
Q ss_pred CCHHHHHHHHHhccccCc
Q 021774 246 PQMNQVIKMLTKNIRLNE 263 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~~~~ 263 (307)
|+|.++.+.|+.+.....
T Consensus 408 ~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 408 PTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCHHHHHHHHHHHHhccc
Confidence 999999999998886543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=284.62 Aligned_cols=232 Identities=25% Similarity=0.361 Sum_probs=183.4
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+..||+|.++... ......|.+|+..+++++||||+++++++...+..++||||+++|+|.+++.. ....+++..
T Consensus 32 ~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~ 108 (266)
T cd05064 32 RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQ 108 (266)
T ss_pred ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHH
Confidence 46689999988653 34456789999999999999999999999999999999999999999999843 234689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
++.++.|++.||+|||++ +++||||||+||+++.++.++++|||.+...............++..|+|||.+.+..+
T Consensus 109 ~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (266)
T cd05064 109 LMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185 (266)
T ss_pred HHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCc
Confidence 999999999999999999 99999999999999999999999999876543221111222334568999999999999
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++|||||||++||+++ |..||...... ..... ....... ..+......+.+++.+||+.+|.
T Consensus 186 ~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~--------~~~~~~~~~~~~li~~c~~~~p~ 250 (266)
T cd05064 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGFRL--------PAPRNCPNLLHQLMLDCWQKERG 250 (266)
T ss_pred cchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCCCC--------CCCCCCCHHHHHHHHHHcCCCch
Confidence 999999999999999775 98888654321 11111 1111110 11222334578888999999999
Q ss_pred CCCCHHHHHHHHHhc
Q 021774 244 RRPQMNQVIKMLTKN 258 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~ 258 (307)
+||++.+|.+.|.+.
T Consensus 251 ~RP~~~~i~~~l~~~ 265 (266)
T cd05064 251 ERPRFSQIHSILSKM 265 (266)
T ss_pred hCCCHHHHHHHHHhh
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=298.09 Aligned_cols=226 Identities=26% Similarity=0.347 Sum_probs=186.5
Q ss_pred cCCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+..|||++.... ........+|+-+|+-++||||+.+|+++....+.|+|.||++||-|.+++ ...+.+
T Consensus 34 ~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdyl----v~kG~l 109 (786)
T KOG0588|consen 34 AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYL----VRKGPL 109 (786)
T ss_pred ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHH----HhhCCC
Confidence 5689999999998652 233345678999999999999999999999999999999999999999998 566789
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++...++++.||+.|+.|+|.. +|+||||||+|+||+..+++||+|||+|.+-..+ ......+|.++|.+||++.
T Consensus 110 ~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--klLeTSCGSPHYA~PEIV~ 184 (786)
T KOG0588|consen 110 PEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KLLETSCGSPHYAAPEIVS 184 (786)
T ss_pred CCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--ccccccCCCcccCCchhhc
Confidence 9999999999999999999999 9999999999999999999999999999864433 2345568999999999999
Q ss_pred CCccc-ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
|.+|+ .++||||.||+||.||||+.||... --+.++. ++.... . +.+.....+..+|+.+|+.
T Consensus 185 G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLl---KV~~G~-f---------~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 185 GRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLL---KVQRGV-F---------EMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred CCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHH---HHHcCc-c---------cCCCcCCHHHHHHHHHHhc
Confidence 99986 8899999999999999999998732 1122222 222211 1 1122333457788899999
Q ss_pred cccCCCCCHHHHHHH
Q 021774 240 AAASRRPQMNQVIKM 254 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~ 254 (307)
.||++|.|++||++.
T Consensus 249 VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 249 VDPSTRITTEEILKH 263 (786)
T ss_pred cCccccccHHHHhhC
Confidence 999999999999873
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=289.95 Aligned_cols=227 Identities=24% Similarity=0.278 Sum_probs=179.5
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.++.. .......+.+|+.++++++||||+++++++...+..++||||+++|+|.+++. ....++
T Consensus 16 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~ 91 (312)
T cd05585 16 DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ----REGRFD 91 (312)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH----hcCCCC
Confidence 46889999998753 33445678899999999999999999999999999999999999999999883 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++....... .......|+..|+|||++.+
T Consensus 92 ~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 167 (312)
T cd05585 92 LSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLG 167 (312)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcC
Confidence 999999999999999999999 99999999999999999999999999997543221 22334568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|+.||..... ... ....... .. ..+......+.+++.+||+.|
T Consensus 168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~---~~~~~~~-~~---------~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEM---YRKILQE-PL---------RFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCCCCccceechhHHHHHHHhCCCCcCCCCH---HHH---HHHHHcC-CC---------CCCCcCCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999864321 111 1111111 10 111222345778889999999
Q ss_pred cCCCCCHHHHHHHH
Q 021774 242 ASRRPQMNQVIKML 255 (307)
Q Consensus 242 p~~RPs~~~v~~~L 255 (307)
|.+||++..+.+.|
T Consensus 232 p~~R~~~~~~~e~l 245 (312)
T cd05585 232 PTRRLGYNGAQEIK 245 (312)
T ss_pred HHHcCCCCCHHHHH
Confidence 99998654333333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=306.38 Aligned_cols=229 Identities=21% Similarity=0.306 Sum_probs=184.5
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||++||+|.+++.........+++..+.
T Consensus 93 ~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~ 172 (478)
T PTZ00267 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172 (478)
T ss_pred CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence 67899998766665555678899999999999999999999999999999999999999998875443445568999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcccccCCccc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..+..... .......||..|+|||++.+..++
T Consensus 173 ~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 173 LLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred HHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence 9999999999999999 999999999999999999999999999987654322 123445689999999999998999
Q ss_pred ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 166 MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 166 ~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
.++|||||||++|||++|+.||..... ..+.. ...... . . ..+......+.+++.+||+.+|++|
T Consensus 250 ~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~---~~~~~~-~----~----~~~~~~s~~~~~li~~~L~~dP~~R 314 (478)
T PTZ00267 250 KKADMWSLGVILYELLTLHRPFKGPSQ---REIMQ---QVLYGK-Y----D----PFPCPVSSGMKALLDPLLSKNPALR 314 (478)
T ss_pred cHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHhCC-C----C----CCCccCCHHHHHHHHHHhccChhhC
Confidence 999999999999999999999864322 11111 111111 1 0 1111223457888999999999999
Q ss_pred CCHHHHHH
Q 021774 246 PQMNQVIK 253 (307)
Q Consensus 246 Ps~~~v~~ 253 (307)
|++.+++.
T Consensus 315 ps~~~~l~ 322 (478)
T PTZ00267 315 PTTQQLLH 322 (478)
T ss_pred cCHHHHHh
Confidence 99999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=288.94 Aligned_cols=222 Identities=24% Similarity=0.283 Sum_probs=179.1
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++. ....++
T Consensus 41 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~ 116 (329)
T PTZ00263 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR----KAGRFP 116 (329)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH----HcCCCC
Confidence 35889999998753 22345678899999999999999999999999999999999999999999883 345688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||++...... .....|++.|+|||++.+
T Consensus 117 ~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 117 NDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQS 189 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999999866432 223568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|..||...... ... ........ .+ +......+.+++.+||+.|
T Consensus 190 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~----~~i~~~~~------~~---p~~~~~~~~~li~~~L~~d 253 (329)
T PTZ00263 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIY----EKILAGRL------KF---PNWFDGRARDLVKGLLQTD 253 (329)
T ss_pred CCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHH----HHHhcCCc------CC---CCCCCHHHHHHHHHHhhcC
Confidence 88999999999999999999999998643221 111 11111111 01 1112235778999999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|.+||+ +.+++.
T Consensus 254 P~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 254 HTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHcCCCCCCCHHHHhc
Confidence 999997 576663
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.33 Aligned_cols=239 Identities=24% Similarity=0.408 Sum_probs=185.1
Q ss_pred cCCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC------
Q 021774 4 LTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------ 75 (307)
Q Consensus 4 ~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------ 75 (307)
..++..||+|+++.. .......+.+|+++++.+ +|+||+++++++......++||||+++|+|.+++.....
T Consensus 65 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~ 144 (374)
T cd05106 65 EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFV 144 (374)
T ss_pred ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccc
Confidence 345568999999754 334456788999999999 899999999999999999999999999999998843210
Q ss_pred ------------------------------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 021774 76 ------------------------------------------------------------ANIKLNWEKRSDICVGIAKG 95 (307)
Q Consensus 76 ------------------------------------------------------------~~~~~~~~~~~~i~~~i~~~ 95 (307)
....+++..+++++.|++.|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 224 (374)
T cd05106 145 MALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQG 224 (374)
T ss_pred ccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHH
Confidence 11347888999999999999
Q ss_pred HHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccccCceeehH
Q 021774 96 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFG 174 (307)
Q Consensus 96 l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG 174 (307)
|+|||++ |++||||||+|||+++++.++|+|||++......... ......++..|+|||++.+..++.++||||||
T Consensus 225 L~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 301 (374)
T cd05106 225 MDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 301 (374)
T ss_pred HHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHH
Confidence 9999999 9999999999999999999999999999765433221 11223345679999999888999999999999
Q ss_pred HHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 175 VLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 175 ~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
|++|||++ |+.||....... ... ....... ...... .....+.+++.+||+.||.+||++.+|++
T Consensus 302 vil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~-----~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 302 ILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGY-----QMSRPD---FAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHhCCCCCCccccccH--HHH----HHHHccc-----CccCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999997 998876543211 111 1111110 000111 11245788889999999999999999999
Q ss_pred HHHhcc
Q 021774 254 MLTKNI 259 (307)
Q Consensus 254 ~L~~~~ 259 (307)
.|++++
T Consensus 368 ~l~~~~ 373 (374)
T cd05106 368 LIQRQL 373 (374)
T ss_pred HHHHHh
Confidence 998865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=265.71 Aligned_cols=240 Identities=26% Similarity=0.362 Sum_probs=186.7
Q ss_pred cCCCCEEEEEEccccCh-Hh-HHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAESK-QG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.++|+.||||+++.... +. ....++|+..|+.++|+||+.++++|...+...+|+||++. +|+..++ .....++
T Consensus 24 ~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIk---d~~i~l~ 99 (318)
T KOG0659|consen 24 TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIK---DKNIILS 99 (318)
T ss_pred cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhc---ccccccC
Confidence 46799999999986532 22 24578999999999999999999999999999999999965 9999993 4566799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
...+..++.+++.||+|||++ .|+||||||.|+||+++|.+||+|||+++.+......... .+-|.+|.|||.+.|
T Consensus 100 pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~-~V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 100 PADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH-QVVTRWYRAPELLFG 175 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc-ceeeeeccChHHhcc
Confidence 999999999999999999999 9999999999999999999999999999998765544333 367889999998887
Q ss_pred -CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccc--------------c-CCCCCCCCHH
Q 021774 162 -GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL--------------V-DPELGEYPPN 225 (307)
Q Consensus 162 -~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~-~~~~~~~~~~ 225 (307)
..|+...|+||.||++.||+-|.+-+.+..+-+ .+..+............ . .+.+....+.
T Consensus 176 sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid---QL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~a 252 (318)
T KOG0659|consen 176 SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID---QLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPA 252 (318)
T ss_pred chhcCCcchhhhHHHHHHHHHccCCCCCCCchHH---HHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccccc
Confidence 579999999999999999999876544333222 12222222211111000 0 0111223344
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
+....++++..++.+||.+|.++.|.++.
T Consensus 253 as~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 253 ASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 45557889999999999999999998763
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.16 Aligned_cols=246 Identities=28% Similarity=0.407 Sum_probs=184.6
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|..||+|.++... ......+.+|++++++++||||+++++++... ...++||||+++++|.+++.. ..++
T Consensus 31 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~ 105 (283)
T cd05080 31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLN 105 (283)
T ss_pred CCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCC
Confidence 467889999987653 34456788999999999999999999988754 467899999999999999832 3589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~ 159 (307)
+..++.++.|++.||.|||++ +++||||||+||++++++.++|+|||++......... ......++..|+|||++
T Consensus 106 ~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 106 LAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHh
Confidence 999999999999999999999 9999999999999999999999999999876543221 11223355679999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC-CCCCHHHHHHHHHHHHhcc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~ 238 (307)
.+..++.++||||||+++|||+||..|+........... ................+... ...+......+.+++.+||
T Consensus 183 ~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 261 (283)
T cd05080 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCW 261 (283)
T ss_pred cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 888899999999999999999999988765432211100 00000000000000011000 1112233456888999999
Q ss_pred ccccCCCCCHHHHHHHHHhcc
Q 021774 239 QAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~~~~ 259 (307)
+.+|.+|||+.+|+..|+++.
T Consensus 262 ~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 262 ETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccChhhCCCHHHHHHHHHHhh
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=287.49 Aligned_cols=225 Identities=28% Similarity=0.320 Sum_probs=180.0
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|..||+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++|+|..++. ....++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~~~ 93 (323)
T cd05595 18 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT 93 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH----HcCCCC
Confidence 46899999998754 23445677889999999999999999999999999999999999999998873 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ |++||||||+|||++.++.+||+|||++....... .......|+..|+|||++.+
T Consensus 94 ~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05595 94 EERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccC
Confidence 999999999999999999999 99999999999999999999999999987532221 11233568999999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|+.||...... .... ...... . ..+......+.+++.+||+.|
T Consensus 170 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~---~~~~~~-~---------~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEE-I---------RFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred CCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHhcCC-C---------CCCCCCCHHHHHHHHHHccCC
Confidence 89999999999999999999999998643221 1111 111111 0 111222345778888999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 234 PKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHhCCCCCCCHHHHHc
Confidence 99998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.70 Aligned_cols=231 Identities=21% Similarity=0.243 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++... ......+.+|++++.+++||||+++++++...+..++||||++|++|.+++. ....++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~ 99 (333)
T cd05600 24 DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN----NLGVLS 99 (333)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH----HcCCCC
Confidence 358899999987542 2345678899999999999999999999999999999999999999999983 345688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ +++||||||+||++++++.+||+|||++..... ......|+..|+|||++.+
T Consensus 100 ~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 100 EDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcC
Confidence 999999999999999999999 999999999999999999999999999986543 2334568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|..||....... ......... .. ...+............+.+++.+||..+
T Consensus 173 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~---~~--~~~~~~~~~~~~~s~~~~~li~~~l~~~ 244 (333)
T cd05600 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLKYWK---ET--LQRPVYDDPRFNLSDEAWDLITKLINDP 244 (333)
T ss_pred CCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHHhcc---cc--ccCCCCCccccccCHHHHHHHHHHhhCh
Confidence 899999999999999999999999986543211 111111100 00 0001111001123345788889999999
Q ss_pred cCCCCCHHHHHHH
Q 021774 242 ASRRPQMNQVIKM 254 (307)
Q Consensus 242 p~~RPs~~~v~~~ 254 (307)
|.+||++.++++.
T Consensus 245 ~~rr~s~~~ll~h 257 (333)
T cd05600 245 SRRFGSLEDIKNH 257 (333)
T ss_pred hhhcCCHHHHHhC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=281.86 Aligned_cols=238 Identities=25% Similarity=0.418 Sum_probs=190.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---------
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 75 (307)
.++..+++|.+........+.+.+|++++++++|+||+++++++...+..++||||+++++|.+++..+..
T Consensus 33 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (291)
T cd05094 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112 (291)
T ss_pred CcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccc
Confidence 34566899998876666667899999999999999999999999999999999999999999999854321
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCC
Q 021774 76 ---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTT 151 (307)
Q Consensus 76 ---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~ 151 (307)
....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||++........ .......++.
T Consensus 113 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~ 189 (291)
T cd05094 113 PRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189 (291)
T ss_pred cccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcce
Confidence 234589999999999999999999999 999999999999999999999999999976543321 1123344677
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
.|+|||++.+..++.++||||||+++|||+| |..|+...... ... .......... .+......+
T Consensus 190 ~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~--------~~~~~~~~~ 254 (291)
T cd05094 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI----ECITQGRVLE--------RPRVCPKEV 254 (291)
T ss_pred eecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhCCCCCC--------CCccCCHHH
Confidence 8999999998899999999999999999999 88887543321 111 1111111111 111233457
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
.+++.+||+.+|.+||++.+|++.|+++..
T Consensus 255 ~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 255 YDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=279.77 Aligned_cols=231 Identities=23% Similarity=0.393 Sum_probs=182.2
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..+++..+|+|.+.... ....++.+|++++++++||||+++++++...+..++||||+++|+|.+++... ...+++
T Consensus 24 ~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~ 99 (256)
T cd05114 24 KWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSK 99 (256)
T ss_pred EeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCH
Confidence 45667789999887443 22357889999999999999999999999999999999999999999988432 235889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+...............++..|+|||++.+.
T Consensus 100 ~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd05114 100 DMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccC
Confidence 99999999999999999999 999999999999999999999999999986543322222233455689999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |+.||..... ....... ...... ..+ ......+.+++.+||+.+
T Consensus 177 ~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i---~~~~~~---~~~------~~~~~~~~~li~~c~~~~ 241 (256)
T cd05114 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMI---SRGFRL---YRP------KLASMTVYEVMYSCWHEK 241 (256)
T ss_pred ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---HCCCCC---CCC------CCCCHHHHHHHHHHccCC
Confidence 89999999999999999999 8888754322 1111111 111111 011 112245788999999999
Q ss_pred cCCCCCHHHHHHHH
Q 021774 242 ASRRPQMNQVIKML 255 (307)
Q Consensus 242 p~~RPs~~~v~~~L 255 (307)
|.+||++.+++..|
T Consensus 242 p~~Rps~~~l~~~l 255 (256)
T cd05114 242 PEGRPTFAELLRAI 255 (256)
T ss_pred cccCcCHHHHHHhh
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=278.24 Aligned_cols=233 Identities=24% Similarity=0.382 Sum_probs=185.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
++++.||+|.+.... .....+.+|++++++++|+||+++++++..++..++||||+++++|.+++... ....+++..
T Consensus 29 ~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~ 105 (263)
T cd05052 29 KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVV 105 (263)
T ss_pred cCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHH
Confidence 357889999987543 33567899999999999999999999999999999999999999999998432 234589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
++.++.|++.||+|||++ +++||||||+||++++++.++|+|||++...............++..|+|||.+.+..+
T Consensus 106 ~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (263)
T cd05052 106 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182 (263)
T ss_pred HHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCC
Confidence 999999999999999999 99999999999999999999999999998765433222222334567999999998899
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++||||||+++|||++ |..|+...... ... ........ . ..+......+.+++.+||+.+|+
T Consensus 183 ~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~-----~---~~~~~~~~~~~~li~~cl~~~p~ 247 (263)
T cd05052 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY----ELLEKGYR-----M---ERPEGCPPKVYELMRACWQWNPS 247 (263)
T ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCC-----C---CCCCCCCHHHHHHHHHHccCCcc
Confidence 999999999999999998 88886543211 111 11111110 1 11122334588899999999999
Q ss_pred CCCCHHHHHHHHHhc
Q 021774 244 RRPQMNQVIKMLTKN 258 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~ 258 (307)
+||++.++++.|+.+
T Consensus 248 ~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 248 DRPSFAEIHQAFETM 262 (263)
T ss_pred cCCCHHHHHHHHHhh
Confidence 999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=281.53 Aligned_cols=230 Identities=23% Similarity=0.283 Sum_probs=181.2
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||+++|+|..++.. .....++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~ 100 (285)
T cd05631 23 ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFD 100 (285)
T ss_pred cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHh--hCCCCCC
Confidence 578999999887542 23334678999999999999999999999999999999999999999887742 2234689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++....... ......|+..|+|||++.+
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 101 EQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcC
Confidence 999999999999999999999 99999999999999999999999999998754322 1234568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|+.||.......... .......... ..++......+.+++.+||+.|
T Consensus 176 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~s~~~~~li~~~l~~~ 243 (285)
T cd05631 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQ---------EEYSEKFSEDAKSICRMLLTKN 243 (285)
T ss_pred CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhccc---------ccCCccCCHHHHHHHHHHhhcC
Confidence 999999999999999999999999987543321111 1111111100 0112223345788899999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|.+||+ ++++++
T Consensus 244 P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 244 PKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHhcCCCCCCHHHHhc
Confidence 999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=283.13 Aligned_cols=230 Identities=32% Similarity=0.512 Sum_probs=176.8
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++||||+++|+|.+++... ....+++..
T Consensus 27 ~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~ 104 (259)
T PF07714_consen 27 KNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQ 104 (259)
T ss_dssp SEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHH
T ss_pred CCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 3668999999764 3455788999999999999999999999999888899999999999999999543 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCcccccCCc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
++.|+.|++.||+|||++ +++|++|+++||++++++.+||+|||++....... ........+...|+|||.+.+..
T Consensus 105 ~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 105 RLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred cccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999 99999999999999999999999999998763221 22233344667899999999989
Q ss_pred ccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
++.++||||||+++||+++ |+.|+..... ..+.... ...... ..+......+.+++.+||+.+|
T Consensus 182 ~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~----~~~~~~--------~~~~~~~~~~~~li~~C~~~~p 246 (259)
T PF07714_consen 182 YTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKL----KQGQRL--------PIPDNCPKDIYSLIQQCWSHDP 246 (259)
T ss_dssp ESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHH----HTTEET--------TSBTTSBHHHHHHHHHHT-SSG
T ss_pred cccccccccccccccccccccccccccccc---ccccccc----cccccc--------eeccchhHHHHHHHHHHcCCCh
Confidence 9999999999999999999 6677654422 1111111 111111 1112234457889999999999
Q ss_pred CCCCCHHHHHHHH
Q 021774 243 SRRPQMNQVIKML 255 (307)
Q Consensus 243 ~~RPs~~~v~~~L 255 (307)
++||++.++++.|
T Consensus 247 ~~RPs~~~i~~~L 259 (259)
T PF07714_consen 247 EKRPSFQEILQEL 259 (259)
T ss_dssp GGS--HHHHHHHH
T ss_pred hhCcCHHHHHhcC
Confidence 9999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.63 Aligned_cols=225 Identities=27% Similarity=0.325 Sum_probs=180.9
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|+|..++. ....++
T Consensus 18 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~~l~ 93 (328)
T cd05593 18 ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS----RERVFS 93 (328)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH----hcCCCC
Confidence 46899999999754 23445678899999999999999999999999999999999999999998883 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++....... .......|+..|+|||++.+
T Consensus 94 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 169 (328)
T cd05593 94 EDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLED 169 (328)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcC
Confidence 999999999999999999999 99999999999999999999999999987533221 12234568999999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|+|++|+.||...... .... ...... . ..+......+.+++.+||+.|
T Consensus 170 ~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~---~~~~~~-------~---~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LILMED-------I---KFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred CCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHH---HhccCC-------c---cCCCCCCHHHHHHHHHHcCCC
Confidence 89999999999999999999999998643221 1111 111110 0 111222345778889999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|.+|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~il~ 250 (328)
T cd05593 234 PNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHcCCCCCCCHHHHhc
Confidence 99997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=292.83 Aligned_cols=237 Identities=26% Similarity=0.407 Sum_probs=183.3
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-------
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 75 (307)
.++..||||+++... ......+.+|+++++.+ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 63 ~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~ 142 (375)
T cd05104 63 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKH 142 (375)
T ss_pred ccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccc
Confidence 346689999997542 34456788999999999 899999999999999999999999999999998854221
Q ss_pred ----------------------------------------------------------------CCCCCCHHHHHHHHHH
Q 021774 76 ----------------------------------------------------------------ANIKLNWEKRSDICVG 91 (307)
Q Consensus 76 ----------------------------------------------------------------~~~~~~~~~~~~i~~~ 91 (307)
....+++..+..++.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 222 (375)
T cd05104 143 EDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQ 222 (375)
T ss_pred cchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHH
Confidence 1124788999999999
Q ss_pred HHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccccCce
Q 021774 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADV 170 (307)
Q Consensus 92 i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv 170 (307)
|+.||+|||++ +++||||||+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++||
T Consensus 223 i~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi 299 (375)
T cd05104 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 299 (375)
T ss_pred HHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH
Confidence 99999999999 9999999999999999999999999999866443221 1122334567999999999999999999
Q ss_pred eehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHH
Q 021774 171 YSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMN 249 (307)
Q Consensus 171 ~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~ 249 (307)
|||||++|||++ |..||...... ..... ........ .... ....++.+++.+||+.||++||++.
T Consensus 300 ~slG~~l~ellt~g~~p~~~~~~~--~~~~~----~~~~~~~~-----~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ 365 (375)
T cd05104 300 WSYGILLWEIFSLGSSPYPGMPVD--SKFYK----MIKEGYRM-----LSPE---CAPSEMYDIMKSCWDADPLKRPTFK 365 (375)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCch--HHHHH----HHHhCccC-----CCCC---CCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999999998 77777543221 11111 11111110 0111 1223577888999999999999999
Q ss_pred HHHHHHHhc
Q 021774 250 QVIKMLTKN 258 (307)
Q Consensus 250 ~v~~~L~~~ 258 (307)
+|++.|++.
T Consensus 366 eil~~l~~~ 374 (375)
T cd05104 366 QIVQLIEQQ 374 (375)
T ss_pred HHHHHHHhh
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=289.52 Aligned_cols=225 Identities=26% Similarity=0.425 Sum_probs=188.6
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+.++.||+|++.-+ ....+.+..+|+.+|.+++++||.++|+.+..+...+++||||.||++.+++ ..+..+.+.
T Consensus 36 ~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL----~~~~~~~E~ 111 (467)
T KOG0201|consen 36 KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL----KSGNILDEF 111 (467)
T ss_pred cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhh----ccCCCCccc
Confidence 45788999999876 4566788999999999999999999999999999999999999999999999 344455888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+.-++.+++.||.|||.+ +.+|||||+.||++..+|.+||+|||.+-.+...... ...++||+.|||||++.+..
T Consensus 112 ~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r~tfvGTPfwMAPEVI~~~~ 187 (467)
T KOG0201|consen 112 EIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-RKTFVGTPFWMAPEVIKQSG 187 (467)
T ss_pred eeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc-cccccccccccchhhhcccc
Confidence 8888999999999999999 9999999999999999999999999999877665433 37789999999999999989
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCC-CCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE-LGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
|+.|+||||||++.+||.+|.+|+....+- ++...+... -+.........+.+++..|++.||
T Consensus 188 Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 188 YDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred ccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 999999999999999999999998765441 111111111 111122344457788888999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
+.||++.++++
T Consensus 252 ~~RpsA~~LLK 262 (467)
T KOG0201|consen 252 EFRPSAKELLK 262 (467)
T ss_pred ccCcCHHHHhh
Confidence 99999999985
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=281.43 Aligned_cols=233 Identities=26% Similarity=0.467 Sum_probs=185.4
Q ss_pred CCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC----------
Q 021774 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------- 75 (307)
Q Consensus 7 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 75 (307)
+..||+|.++... ......|.+|++++++++||||+++++++......+++|||+++++|.+++.....
T Consensus 35 ~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 114 (283)
T cd05048 35 ATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114 (283)
T ss_pred eeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCccccccccc
Confidence 3679999987543 44456789999999999999999999999999999999999999999999854321
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCC
Q 021774 76 --ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTG 152 (307)
Q Consensus 76 --~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 152 (307)
....+++..++.++.|++.||+|||++ +++|+||||+||++++++.++|+|||++........ .......++..
T Consensus 115 ~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~ 191 (283)
T cd05048 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191 (283)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCccccc
Confidence 114588999999999999999999999 999999999999999999999999999976533221 12233456788
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
|+|||.+.+..++.++|||||||++|||++ |..||...... .+.. ....... ...+......+.
T Consensus 192 y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~----~i~~~~~--------~~~~~~~~~~~~ 256 (283)
T cd05048 192 WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE----MIRSRQL--------LPCPEDCPARVY 256 (283)
T ss_pred ccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcCCc--------CCCcccCCHHHH
Confidence 999999988899999999999999999998 88887654321 1111 1111111 111233445688
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHh
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
+++.+||+.+|.+||++.+|++.|+.
T Consensus 257 ~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 257 ALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHhc
Confidence 89999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=287.54 Aligned_cols=177 Identities=27% Similarity=0.462 Sum_probs=154.5
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|..||+|.+... .......+.+|++++++++||||+++++++..++..++||||+++++|.+++. ....+++.
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~ 103 (331)
T cd06649 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----EAKRIPEE 103 (331)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHH----HcCCCCHH
Confidence 35788999988765 34455679999999999999999999999999999999999999999999983 33468899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||++. +++||||||+||++++++.++|+|||++....... .....|+..|+|||++.+..
T Consensus 104 ~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~ 178 (331)
T cd06649 104 ILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTH 178 (331)
T ss_pred HHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cccCCCCcCcCCHhHhcCCC
Confidence 99999999999999999851 59999999999999999999999999987654321 23356899999999999989
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 179 YSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=283.29 Aligned_cols=242 Identities=22% Similarity=0.271 Sum_probs=181.5
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|+++.. .......+.+|+.++++++||||+++++++..++..++||||++++++..+. .....+++
T Consensus 24 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~ 99 (287)
T cd07848 24 ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE----EMPNGVPP 99 (287)
T ss_pred CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH----hcCCCCCH
Confidence 35789999998754 2334567889999999999999999999999999999999999988777654 22346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...............|+..|+|||++.+.
T Consensus 100 ~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 176 (287)
T cd07848 100 EKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCC
Confidence 99999999999999999999 999999999999999999999999999987654332223345688999999999988
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHH--------HHHh-hcCCcccccCCCC-------CCCCHHH
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--------WQLH-QEEKPLELVDPEL-------GEYPPNE 226 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~-------~~~~~~~ 226 (307)
.++.++|||||||++|||++|+.||............... .... ..........+.. .......
T Consensus 177 ~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07848 177 PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGIL 256 (287)
T ss_pred CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhccc
Confidence 8999999999999999999999998654321111000000 0000 0000000000000 0001112
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.+++.+||+.||++|||++++++
T Consensus 257 s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 257 SGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=284.21 Aligned_cols=225 Identities=25% Similarity=0.290 Sum_probs=179.1
Q ss_pred CCCCEEEEEEcccc----ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .......+..|++++++++||||+++++++..++..++||||+++++|.+++. ....+
T Consensus 22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~ 97 (323)
T cd05584 22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE----REGIF 97 (323)
T ss_pred CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH----HcCCC
Confidence 46889999998753 22334567889999999999999999999999999999999999999999883 34567
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
.+..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++...... .......|+..|+|||++.
T Consensus 98 ~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 98 MEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhcc
Confidence 8888999999999999999999 99999999999999999999999999987543221 1233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|+.||...... .. ...... ... ..++.....+.+++.+||+.
T Consensus 174 ~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~---~~~~~~-~~~---------~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KT---IDKILK-GKL---------NLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred CCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HH---HHHHHc-CCC---------CCCCCCCHHHHHHHHHHccc
Confidence 888999999999999999999999998653221 11 111111 110 11122234577889999999
Q ss_pred ccCCCC-----CHHHHHH
Q 021774 241 AASRRP-----QMNQVIK 253 (307)
Q Consensus 241 ~p~~RP-----s~~~v~~ 253 (307)
+|++|| ++.+++.
T Consensus 238 ~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHhHcCCCCCCCHHHHhc
Confidence 999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=302.33 Aligned_cols=236 Identities=27% Similarity=0.418 Sum_probs=197.5
Q ss_pred CEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 8 RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 8 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
..||||.++.. ......+|+.|+.||-+++||||+++-|+....+...||+|||++|+|+.+|.. ..+.|++.++.
T Consensus 658 ~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLV 734 (996)
T KOG0196|consen 658 ITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLV 734 (996)
T ss_pred eeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHH
Confidence 47999999976 456678999999999999999999999999999999999999999999999954 34569999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccccc--ccCCCCcCCcccccCCcc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~--~~g~~~y~aPE~~~~~~~ 164 (307)
-++.+||.|+.||-+. ++|||||..+|||+++|..+|++|||+++.+.++.....+. .....+|.|||.+..+++
T Consensus 735 gMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 735 GMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred HHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhccc
Confidence 9999999999999999 99999999999999999999999999999886654332222 233468999999999999
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.+|||||||+++||.++ |..|+-.+.. ++++..+.+..+. ..+.+++..|.+|+..||+.|-.
T Consensus 812 TsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIkaIe~gyRL------------PpPmDCP~aL~qLMldCWqkdR~ 876 (996)
T KOG0196|consen 812 TSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKAIEQGYRL------------PPPMDCPAALYQLMLDCWQKDRN 876 (996)
T ss_pred CchhhccccceEEEEecccCCCcccccch---HHHHHHHHhccCC------------CCCCCCcHHHHHHHHHHHHHHhh
Confidence 999999999999999765 8888655443 3333322222211 12345667799999999999999
Q ss_pred CCCCHHHHHHHHHhccccCcc
Q 021774 244 RRPQMNQVIKMLTKNIRLNEE 264 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~~~~~~~ 264 (307)
.||.|.+|+..|.++++.+..
T Consensus 877 ~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 877 RRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred cCCCHHHHHHHHHHHhcCchh
Confidence 999999999999999987643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=268.34 Aligned_cols=214 Identities=28% Similarity=0.348 Sum_probs=179.6
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|..+|+|+++... -...++..+|.++|+.+.||.++++++.+.+.+..++||||++||.|.+++ +..++|+
T Consensus 67 ~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~L----rk~~rF~ 142 (355)
T KOG0616|consen 67 HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYL----RKSGRFS 142 (355)
T ss_pred cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHH----HhcCCCC
Confidence 468889999998763 455678889999999999999999999999999999999999999999999 5667899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+.-++.||+.||+|||++ +|++|||||+|||||.+|.+||+|||.++..... +...+||+.|+|||.+..
T Consensus 143 e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 143 EPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred chhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHhhc
Confidence 999999999999999999999 9999999999999999999999999999976543 567899999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..+..++|.||||+++|||+.|.+||....+ .. ..++.-.... .+|.-....+.+|+...++.|
T Consensus 216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~-iY~KI~~~~v---------~fP~~fs~~~kdLl~~LL~vD 279 (355)
T KOG0616|consen 216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQ-IYEKILEGKV---------KFPSYFSSDAKDLLKKLLQVD 279 (355)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HH-HHHHHHhCcc---------cCCcccCHHHHHHHHHHHhhh
Confidence 9999999999999999999999999876543 11 1122211111 222333334666777778888
Q ss_pred cCCC
Q 021774 242 ASRR 245 (307)
Q Consensus 242 p~~R 245 (307)
-.+|
T Consensus 280 ~t~R 283 (355)
T KOG0616|consen 280 LTKR 283 (355)
T ss_pred hHhh
Confidence 7777
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=276.87 Aligned_cols=235 Identities=27% Similarity=0.425 Sum_probs=186.8
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||+++++|.+++... ....++
T Consensus 25 ~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~ 101 (261)
T cd05072 25 GYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVL 101 (261)
T ss_pred EEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCC
Confidence 3456778899998875433 3467899999999999999999999999999999999999999999998432 345688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||+. +++||||+|+||++++++.++|+|||++...............++..|+|||++.+
T Consensus 102 ~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05072 102 LPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc
Confidence 999999999999999999999 99999999999999999999999999998765433222233345678999999988
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|+|+| |..||...... ...... ...... +... .....+.+++.+|++.
T Consensus 179 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~~~~----~~~~~~~~li~~~l~~ 243 (261)
T cd05072 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----QRGYRM----PRME----NCPDELYDIMKTCWKE 243 (261)
T ss_pred CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCC----CCCC----CCCHHHHHHHHHHccC
Confidence 889999999999999999998 88887543221 111111 111110 1111 2234578899999999
Q ss_pred ccCCCCCHHHHHHHHHh
Q 021774 241 AASRRPQMNQVIKMLTK 257 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~ 257 (307)
+|++||+++++.+.|++
T Consensus 244 ~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 244 KAEERPTFDYLQSVLDD 260 (261)
T ss_pred CcccCcCHHHHHHHHhc
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=282.58 Aligned_cols=238 Identities=24% Similarity=0.423 Sum_probs=188.7
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC---------CC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---------KA 76 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~ 76 (307)
++..+|+|.+..........+.+|++++++++||||+++++++...+..++||||+++++|.+++.... ..
T Consensus 34 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (288)
T cd05093 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113 (288)
T ss_pred cceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCC
Confidence 345689999887666666789999999999999999999999999999999999999999999985432 12
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCC
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLA 155 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~a 155 (307)
...+++..++.++.|++.||+|||++ |++||||||+||++++++.++|+|||++........ .......++..|+|
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence 23589999999999999999999999 999999999999999999999999999986543221 11223345678999
Q ss_pred cccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
||++.+..++.++||||||+++|+|++ |..||...... .... ......... . +......+.+++
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~----~i~~~~~~~-----~---~~~~~~~l~~li 255 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE----CITQGRVLQ-----R---PRTCPKEVYDLM 255 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCcCC-----C---CCCCCHHHHHHH
Confidence 999998889999999999999999998 88887543321 1111 111111110 1 111224588999
Q ss_pred HhccccccCCCCCHHHHHHHHHhcccc
Q 021774 235 FFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
.+||+.+|.+|||+.++.+.|+++.+.
T Consensus 256 ~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 256 LGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=284.76 Aligned_cols=222 Identities=25% Similarity=0.281 Sum_probs=179.2
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ....++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~ 99 (291)
T cd05612 24 ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR----NSGRFS 99 (291)
T ss_pred CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH----HcCCCC
Confidence 368899999987532 2345678899999999999999999999999999999999999999999983 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ |++||||||+||++++++.++|+|||++...... .....|+..|+|||++.+
T Consensus 100 ~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 100 NSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999999865432 223568999999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|+|++|..||...... .... .... ... .++......+.+++.+||+.|
T Consensus 173 ~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~---~i~~-~~~---------~~~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYE---KILA-GKL---------EFPRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-CCc---------CCCccCCHHHHHHHHHHcCCC
Confidence 88999999999999999999999998654321 1111 1111 110 111122345788999999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|.+||+ +.++++
T Consensus 237 p~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 237 RTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHccCCccCCHHHHhc
Confidence 999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=288.52 Aligned_cols=228 Identities=24% Similarity=0.364 Sum_probs=190.8
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe-eEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR-RILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
++..+|+|.+... +....+...+|+.+++++.|||||.+.+.|..++. .+|||+||+||++.+.+... ++..+++
T Consensus 28 ~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E 105 (426)
T KOG0589|consen 28 DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPE 105 (426)
T ss_pred CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH--hhccccH
Confidence 4568999988765 23334567899999999999999999999999888 89999999999999999543 3577999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+.++.|+.|++.|+.|||++ .|+|||||+.|||++.++.|+|+|||+++.+.... .......||+.|+.||.+.+.
T Consensus 106 ~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~ 181 (426)
T KOG0589|consen 106 ERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDI 181 (426)
T ss_pred HHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCCC
Confidence 99999999999999999999 99999999999999999999999999999887654 234557899999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
+|..|+|||||||++|||++-+++|..... ...+.+..... ....+......+..++..|++.+|
T Consensus 182 pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki~~~~---------~~Plp~~ys~el~~lv~~~l~~~P 246 (426)
T KOG0589|consen 182 PYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKINRGL---------YSPLPSMYSSELRSLVKSMLRKNP 246 (426)
T ss_pred CCCccCcchhhcchHHHHHhcccccCccch------HHHHHHHhhcc---------CCCCCccccHHHHHHHHHHhhcCC
Confidence 999999999999999999999988875432 22222222111 122344556668888889999999
Q ss_pred CCCCCHHHHHHH
Q 021774 243 SRRPQMNQVIKM 254 (307)
Q Consensus 243 ~~RPs~~~v~~~ 254 (307)
..||++.+++..
T Consensus 247 ~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 247 EHRPSALELLRR 258 (426)
T ss_pred ccCCCHHHHhhC
Confidence 999999999975
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=277.91 Aligned_cols=233 Identities=25% Similarity=0.450 Sum_probs=185.0
Q ss_pred CCCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC----------
Q 021774 6 NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---------- 74 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 74 (307)
+++.||+|.++..... ....+.+|++++++++|+||+++++++......++||||+++++|.+++....
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (280)
T cd05049 34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113 (280)
T ss_pred CcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccc
Confidence 4578999998865433 55789999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCc
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGY 153 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y 153 (307)
.....+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++........ .......++..|
T Consensus 114 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05049 114 SPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190 (280)
T ss_pred cccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCccccee
Confidence 1234578999999999999999999999 999999999999999999999999999975433221 112233456789
Q ss_pred CCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 154 LAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 154 ~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
+|||++.+..++.++||||||+++|||++ |..||...... ...... ...... ..+......+.+
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~----~~~~~~--------~~~~~~~~~~~~ 255 (280)
T cd05049 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI----TQGRLL--------QRPRTCPSEVYD 255 (280)
T ss_pred cChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCCcC--------CCCCCCCHHHHH
Confidence 99999999999999999999999999998 98887543321 111111 111111 111223345888
Q ss_pred HHHhccccccCCCCCHHHHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~~L~ 256 (307)
++.+||+.||++||++.||++.|+
T Consensus 256 li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 256 IMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHcCCCcccCCCHHHHHHHhh
Confidence 999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.65 Aligned_cols=230 Identities=25% Similarity=0.275 Sum_probs=179.4
Q ss_pred CCCCEEEEEEcccc----ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE----SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||+|++... .......+..|+.+++++ +|+||+++++++...+..++||||+++|+|.+++. ....
T Consensus 26 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~ 101 (332)
T cd05614 26 DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDN 101 (332)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH----HcCC
Confidence 46889999998743 223345688899999999 69999999999999999999999999999999883 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+............||..|+|||++
T Consensus 102 ~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 102 FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHh
Confidence 89999999999999999999999 999999999999999999999999999986544333333446789999999998
Q ss_pred cCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 LGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.+. .++.++|||||||++|||+||..||........... ....... .++.+ +......+.+++.+||
T Consensus 179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---~~~~~~~------~~~~~---~~~~~~~~~~li~~~l 246 (332)
T cd05614 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE---VSRRILK------CDPPF---PSFIGPEAQDLLHKLL 246 (332)
T ss_pred cCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH---HHHHHhc------CCCCC---CCCCCHHHHHHHHHHc
Confidence 765 478899999999999999999999864322211111 1111111 11111 1122334778889999
Q ss_pred ccccCCCC-----CHHHHHH
Q 021774 239 QAAASRRP-----QMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RP-----s~~~v~~ 253 (307)
+.||++|| +++++++
T Consensus 247 ~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 247 RKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCHHHcCCCCCCCHHHHHc
Confidence 99999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.38 Aligned_cols=234 Identities=26% Similarity=0.441 Sum_probs=185.3
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
...+++.||+|.++... ...+.+.+|++++++++|+||+++++++...+..++|||++++++|.+++... .+..+++
T Consensus 26 ~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 102 (261)
T cd05068 26 LWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKL 102 (261)
T ss_pred EecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCH
Confidence 34567789999987543 23467889999999999999999999999999999999999999999998432 2346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||++ |++||||||+||++++++.++|+|||++................+..|+|||++.+.
T Consensus 103 ~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05068 103 PQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccC
Confidence 99999999999999999999 999999999999999999999999999987653322222222234579999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||+| |+.|+...... .+.. ........ ..+......+.+++.+|++.+
T Consensus 180 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~ 244 (261)
T cd05068 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQGYRM--------PCPPGCPKELYDIMLDCWKED 244 (261)
T ss_pred CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCC--------CCCCcCCHHHHHHHHHHhhcC
Confidence 99999999999999999999 88887543221 1111 11111100 011223346888999999999
Q ss_pred cCCCCCHHHHHHHHHh
Q 021774 242 ASRRPQMNQVIKMLTK 257 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~ 257 (307)
|.+||++.++++.|++
T Consensus 245 P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 245 PDDRPTFETLQWKLED 260 (261)
T ss_pred cccCCCHHHHHHHHhc
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=277.74 Aligned_cols=232 Identities=25% Similarity=0.396 Sum_probs=182.1
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
...++..+|+|.+..... ....|.+|+.++++++||||+++++++......++||||+.+++|.+++... ...+++
T Consensus 24 ~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~ 99 (256)
T cd05113 24 KWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH---GKRFQP 99 (256)
T ss_pred EecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc---CCCCCH
Confidence 344556799998875432 2367899999999999999999999999998999999999999999998432 236899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.++..............++..|+|||++.+.
T Consensus 100 ~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 176 (256)
T cd05113 100 SQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC
Confidence 99999999999999999999 999999999999999999999999999986644322222223456789999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|+|++ |..|+...... ...... ...... . .+......+.+++.+||+.+
T Consensus 177 ~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~~~~~~-~--------~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV---SQGLRL-Y--------RPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH---hcCCCC-C--------CCCCCCHHHHHHHHHHcCCC
Confidence 89999999999999999998 88887543321 111111 111111 0 01112346788999999999
Q ss_pred cCCCCCHHHHHHHHH
Q 021774 242 ASRRPQMNQVIKMLT 256 (307)
Q Consensus 242 p~~RPs~~~v~~~L~ 256 (307)
|.+||++.++++.|+
T Consensus 242 p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 242 AEERPTFQQLLSSIE 256 (256)
T ss_pred cccCCCHHHHHHhhC
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.55 Aligned_cols=231 Identities=26% Similarity=0.334 Sum_probs=179.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .......+..|..++.++ +||||+++++++...+..++||||+++|+|..++. ....+
T Consensus 18 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~----~~~~l 93 (329)
T cd05588 18 KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ----RQRKL 93 (329)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH----HcCCC
Confidence 46889999999854 234456688999999998 79999999999999999999999999999998873 34579
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||.|||++ |++||||||+||++++++.+||+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05588 94 PEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-CccccccCCccccCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999987432211 1223456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccch--hHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM--NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+..++.++|+|||||++|||++|+.||....... ......+..+....... ..+......+.+++.+|+
T Consensus 170 ~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~p~~~~~~~~~li~~~L 240 (329)
T cd05588 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------RIPRSLSVKASSVLKGFL 240 (329)
T ss_pred CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------CCCCCCCHHHHHHHHHHh
Confidence 9999999999999999999999999985321111 11111112222221111 111222345788899999
Q ss_pred ccccCCCCC------HHHHH
Q 021774 239 QAAASRRPQ------MNQVI 252 (307)
Q Consensus 239 ~~~p~~RPs------~~~v~ 252 (307)
+.||.+||+ +.+++
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHh
Confidence 999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=277.30 Aligned_cols=234 Identities=26% Similarity=0.420 Sum_probs=188.7
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..+++..+|+|.+..........+..|+++++.++|+||+++++++...+..++||||+++++|.+++... .+..+++
T Consensus 26 ~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 103 (261)
T cd05148 26 LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPV 103 (261)
T ss_pred EecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC--CCCCCCH
Confidence 44568899999998776655678999999999999999999999999999999999999999999998542 3456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ |++|+||+|+||++++++.++|+|||.+......... .....++..|+|||.+.+.
T Consensus 104 ~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~ 179 (261)
T cd05148 104 ASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHG 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccCCCCceEecCHHHHccC
Confidence 99999999999999999999 9999999999999999999999999999876443221 2233456789999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|+|++ |+.|+...... ....... ..... ..+......+.+++.+||+.+
T Consensus 180 ~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---~~~~~---------~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05148 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT---AGYRM---------PCPAKCPQEIYKIMLECWAAE 244 (261)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH---hCCcC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 89999999999999999998 78887543321 1111111 11000 111233345788999999999
Q ss_pred cCCCCCHHHHHHHHHh
Q 021774 242 ASRRPQMNQVIKMLTK 257 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~ 257 (307)
|.+|||+.++++.|+.
T Consensus 245 p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 245 PEDRPSFKALREELDN 260 (261)
T ss_pred chhCcCHHHHHHHHhc
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.36 Aligned_cols=233 Identities=24% Similarity=0.304 Sum_probs=182.3
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+..|++++++++|+||+++.+++......++||||+++|+|...+......+..++
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~ 95 (280)
T cd05608 16 ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP 95 (280)
T ss_pred cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCC
Confidence 468899999987542 22345678899999999999999999999999999999999999999988754444556799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++........ ......|+..|+|||++.+
T Consensus 96 ~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 171 (280)
T cd05608 96 EPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQG 171 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcC
Confidence 999999999999999999999 999999999999999999999999999976544322 1233568899999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|||++|+.||......... ........... ...+......+.+++.+||+.|
T Consensus 172 ~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS---------VTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC---------CCCcccCCHHHHHHHHHHhcCC
Confidence 99999999999999999999999998653321110 00001010000 0112233445788889999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|++|| +++++++
T Consensus 240 P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 240 PEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHhcCCCCCCHHHHhc
Confidence 99999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=278.28 Aligned_cols=224 Identities=24% Similarity=0.389 Sum_probs=189.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+.|+.||||.++.. +.++.-+..+|+++|..|+||||+.+|.+|.+.+...+||||..+|.|++++ ...+.++
T Consensus 76 ~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYi----Ser~~Ls 151 (668)
T KOG0611|consen 76 KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYI----SERGSLS 151 (668)
T ss_pred cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHH----HHhcccc
Confidence 56999999988764 5677778899999999999999999999999999999999999999999999 4556799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+.....++.||..|+.|+|.+ +++|||||.+|||||.|+++||+|||++.++.... ....++|++-|.+||++.+
T Consensus 152 ErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 152 EREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred HHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc--HHHHhcCCcccCCccccCC
Confidence 999999999999999999999 99999999999999999999999999999887653 3456899999999999999
Q ss_pred Cccc-ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
.+|. +..|.||||++||-|+.|..||.+.. .+.++..+. .+.. .. +..+....-||+||+-.
T Consensus 227 ~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs----~GaY---rE-------P~~PSdA~gLIRwmLmV 289 (668)
T KOG0611|consen 227 TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQIS----RGAY---RE-------PETPSDASGLIRWMLMV 289 (668)
T ss_pred CCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhh----cccc---cC-------CCCCchHHHHHHHHHhc
Confidence 8885 88999999999999999999986543 222222111 1111 11 11222366788999999
Q ss_pred ccCCCCCHHHHHHH
Q 021774 241 AASRRPQMNQVIKM 254 (307)
Q Consensus 241 ~p~~RPs~~~v~~~ 254 (307)
+|++|.|+.+|...
T Consensus 290 NP~RRATieDiAsH 303 (668)
T KOG0611|consen 290 NPERRATIEDIASH 303 (668)
T ss_pred CcccchhHHHHhhh
Confidence 99999999999853
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.86 Aligned_cols=234 Identities=21% Similarity=0.225 Sum_probs=175.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.... ..+.+|++++++++||||+++++++......++|+|++. ++|..++. ....+++..
T Consensus 115 ~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~ 183 (391)
T PHA03212 115 KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA----AKRNIAICD 183 (391)
T ss_pred CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHH----hcCCCCHHH
Confidence 4678899996542 346789999999999999999999999999999999995 68888873 334688999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++...............||..|+|||++.+..+
T Consensus 184 ~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 260 (391)
T PHA03212 184 ILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY 260 (391)
T ss_pred HHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCC
Confidence 999999999999999999 99999999999999999999999999997543332223344679999999999998899
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccch-----hHHHHHHHHHHhhcC---Cc----------------ccccCCCCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQM-----NKFLLEWAWQLHQEE---KP----------------LELVDPELG 220 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~---~~----------------~~~~~~~~~ 220 (307)
+.++|||||||++|||++|..|+....... ...+.. ........ .. .....+...
T Consensus 261 ~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (391)
T PHA03212 261 GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSR 339 (391)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCC
Confidence 999999999999999999998764322110 011111 10000000 00 000000000
Q ss_pred ---CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 ---EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ---~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.........+.+++.+||+.||.+|||+.|+++
T Consensus 340 ~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 340 PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000123346788999999999999999999975
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=288.26 Aligned_cols=225 Identities=26% Similarity=0.308 Sum_probs=179.8
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.++.. .......+..|+++++.++||||+++++++...+..++||||+++|+|..++. ....++
T Consensus 18 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~l~ 93 (325)
T cd05594 18 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS----RERVFS 93 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCC
Confidence 46889999998754 23445677889999999999999999999999999999999999999998883 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
+..+..++.||+.||+|||+ + ||+||||||+|||+++++.+||+|||++........ ......|+..|+|||++.
T Consensus 94 ~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05594 94 EDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLE 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccccCCcccCCHHHHc
Confidence 99999999999999999997 7 999999999999999999999999999875432211 123456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||...... ...... ..... ..+......+.+++.+||+.
T Consensus 170 ~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i----~~~~~---------~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI----LMEEI---------RFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred cCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHH----hcCCC---------CCCCCCCHHHHHHHHHHhhc
Confidence 989999999999999999999999998643221 111111 11100 11112233577888999999
Q ss_pred ccCCCC-----CHHHHHH
Q 021774 241 AASRRP-----QMNQVIK 253 (307)
Q Consensus 241 ~p~~RP-----s~~~v~~ 253 (307)
||++|+ ++.++++
T Consensus 234 dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CHHHhCCCCCCCHHHHhc
Confidence 999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=275.35 Aligned_cols=238 Identities=18% Similarity=0.328 Sum_probs=188.9
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||.+... .......+.+|++++++++||||+++++++...+..++|+||+++++|.+++.........++
T Consensus 25 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 104 (267)
T cd08228 25 LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP 104 (267)
T ss_pred CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCC
Confidence 36889999987642 344456789999999999999999999999999999999999999999998854444455689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~ 180 (267)
T cd08228 105 ERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhcc
Confidence 999999999999999999999 999999999999999999999999999987654322 1223457889999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+||||+++|||++|+.|+........ ..... ...... +.. ........+.+++.+||+.+
T Consensus 181 ~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----~~~~~-~~~~~~-----~~~--~~~~~~~~~~~li~~cl~~~ 248 (267)
T cd08228 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----SLCQK-IEQCDY-----PPL--PTEHYSEKLRELVSMCIYPD 248 (267)
T ss_pred CCCCchhhHHHHHHHHHHHhcCCCCCccccccHH----HHHHH-HhcCCC-----CCC--ChhhcCHHHHHHHHHHCCCC
Confidence 8899999999999999999999999754322111 11111 111110 110 11223356888999999999
Q ss_pred cCCCCCHHHHHHHHHhc
Q 021774 242 ASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~ 258 (307)
|.+||++.+|++.++.+
T Consensus 249 p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 249 PDQRPDIGYVHQIAKQM 265 (267)
T ss_pred cccCcCHHHHHHHHHHh
Confidence 99999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=273.14 Aligned_cols=231 Identities=25% Similarity=0.348 Sum_probs=181.0
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|..... .......+.+|++++++++||||+++++++...+..++||||+++++|.+++.. ....+++.
T Consensus 18 ~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~ 94 (252)
T cd05084 18 ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVK 94 (252)
T ss_pred cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHH
Confidence 36889999987654 344556799999999999999999999999999999999999999999999842 33468899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc-ccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~ 162 (307)
.++.++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........... ....++..|+|||.+.+.
T Consensus 95 ~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 171 (252)
T cd05084 95 ELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171 (252)
T ss_pred HHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCC
Confidence 9999999999999999999 999999999999999999999999999876543211111 111234569999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..|+....... .. ......... ..+......+.+++.+|++.+
T Consensus 172 ~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~----~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TR----EAIEQGVRL--------PCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCCCC--------CCcccCCHHHHHHHHHHcCCC
Confidence 89999999999999999998 777765432211 11 111111000 111222346888999999999
Q ss_pred cCCCCCHHHHHHHHH
Q 021774 242 ASRRPQMNQVIKMLT 256 (307)
Q Consensus 242 p~~RPs~~~v~~~L~ 256 (307)
|++||++.+|++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=282.39 Aligned_cols=224 Identities=24% Similarity=0.337 Sum_probs=174.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .......+..|..++... +||||+++++++...+..++||||++||+|..++. ....+
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~----~~~~~ 93 (316)
T cd05592 18 GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ----SSGRF 93 (316)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCC
Confidence 45788999998754 123344556677777654 89999999999999999999999999999999883 34468
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05592 94 DEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILK 169 (316)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999997543222 2233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||..... ..+.. . ..... +. .+......+.+++.+||+.
T Consensus 170 ~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~---~-i~~~~------~~---~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFD---S-ILNDR------PH---FPRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCC------CC---CCCCCCHHHHHHHHHHccC
Confidence 98999999999999999999999999865322 11111 1 11111 11 1112233467888899999
Q ss_pred ccCCCCCHH-HHH
Q 021774 241 AASRRPQMN-QVI 252 (307)
Q Consensus 241 ~p~~RPs~~-~v~ 252 (307)
+|.+||++. +++
T Consensus 234 ~P~~R~~~~~~l~ 246 (316)
T cd05592 234 DPTKRLGVDGDIR 246 (316)
T ss_pred CHHHcCCChHHHH
Confidence 999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=276.99 Aligned_cols=236 Identities=26% Similarity=0.414 Sum_probs=186.1
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC---------
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT--------- 74 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 74 (307)
++..+|+|.+... ......++.+|+++++++ +|+||+++++++......+++|||+++|+|..++....
T Consensus 41 ~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~ 120 (293)
T cd05053 41 ETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120 (293)
T ss_pred CceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccc
Confidence 3467999988754 344456789999999999 89999999999999999999999999999999985422
Q ss_pred ---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCC
Q 021774 75 ---KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGT 150 (307)
Q Consensus 75 ---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~ 150 (307)
.....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||+++.+...... ......++
T Consensus 121 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 197 (293)
T cd05053 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197 (293)
T ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCC
Confidence 2345689999999999999999999999 9999999999999999999999999999866543211 12223345
Q ss_pred CCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 151 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
..|+|||++.+..++.++|||||||++|||++ |..|+...... ... ........ ...+......
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~~~--------~~~~~~~~~~ 262 (293)
T cd05053 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---ELF----KLLKEGYR--------MEKPQNCTQE 262 (293)
T ss_pred ccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HHH----HHHHcCCc--------CCCCCCCCHH
Confidence 67999999988889999999999999999998 87776543221 111 11111110 0112233446
Q ss_pred HHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
+.+++.+||+.+|.+|||+.++++.|++++
T Consensus 263 ~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 263 LYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 888999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=287.28 Aligned_cols=241 Identities=28% Similarity=0.477 Sum_probs=191.3
Q ss_pred CCCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.++.+||||.++..+. ...++|.+|+.+|.+++||||+.++|+|..++.+++|+||+++|+|.+++..+.... +.-.
T Consensus 560 eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt--~~t~ 637 (807)
T KOG1094|consen 560 EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT--AETA 637 (807)
T ss_pred cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc--cccc
Confidence 3468999999998754 445899999999999999999999999999999999999999999999996654433 4445
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccC-CCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
...+|+.||+.|++||.+. +++||||.++|+|++.++++||+|||.++.+ ..+......+.+-..+|||+|.+..+
T Consensus 638 ~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg 714 (807)
T KOG1094|consen 638 PGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG 714 (807)
T ss_pred hhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc
Confidence 6677999999999999999 9999999999999999999999999999844 33444445556667899999999999
Q ss_pred cccccCceeehHHHHHHHHh--CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS--GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+++.++|||+||+++||+++ ...|+..... ....+........+... . ....++-+...+.+++.+||..
T Consensus 715 kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~-~----~l~~P~~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 715 KFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQ-V----VLSRPPACPQGLYELMLRCWRR 786 (807)
T ss_pred cccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcc-e----eccCCCcCcHHHHHHHHHHhch
Confidence 99999999999999999764 5566554332 12222222222221111 1 1222444556688999999999
Q ss_pred ccCCCCCHHHHHHHHHhc
Q 021774 241 AASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~ 258 (307)
+-++||+++++...|.+.
T Consensus 787 es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 787 ESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhcCCCHHHHHHHHHHh
Confidence 999999999999988754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.12 Aligned_cols=220 Identities=24% Similarity=0.275 Sum_probs=177.8
Q ss_pred CCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 7 GRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 7 g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+..||+|.+... .......+.+|+++++.++||||+++++++.+.+..++||||+.+|+|.+++. ....+++.
T Consensus 56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~ 131 (340)
T PTZ00426 56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPND 131 (340)
T ss_pred CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCCCHH
Confidence 368999988643 23345678899999999999999999999999999999999999999999983 34568999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||++ |++||||||+|||++.++.++|+|||++...... .....||+.|+|||++.+..
T Consensus 132 ~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~ 204 (340)
T PTZ00426 132 VGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVG 204 (340)
T ss_pred HHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCC
Confidence 9999999999999999999 9999999999999999999999999999865432 23456899999999999888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++|||||||++|||++|..||...... .. ......... ..+......+.+++.+|++.||+
T Consensus 205 ~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~----~~~i~~~~~---------~~p~~~~~~~~~li~~~l~~dp~ 268 (340)
T PTZ00426 205 HGKAADWWTLGIFIYEILVGCPPFYANEPL---LI----YQKILEGII---------YFPKFLDNNCKHLMKKLLSHDLT 268 (340)
T ss_pred CCccccccchhhHHHHHhcCCCCCCCCCHH---HH----HHHHhcCCC---------CCCCCCCHHHHHHHHHHcccCHH
Confidence 999999999999999999999998654321 11 111111110 01111223467888999999999
Q ss_pred CCC-----CHHHHHH
Q 021774 244 RRP-----QMNQVIK 253 (307)
Q Consensus 244 ~RP-----s~~~v~~ 253 (307)
+|+ +++++++
T Consensus 269 ~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 269 KRYGNLKKGAQNVKE 283 (340)
T ss_pred HcCCCCCCCHHHHHc
Confidence 995 7888865
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=280.59 Aligned_cols=224 Identities=26% Similarity=0.343 Sum_probs=174.3
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHH---hcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTL---SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||+++... ....+.+.+|++++ ++++||||+++++++...+..++||||+++++|...+. ..
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~ 96 (324)
T cd05589 22 KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TD 96 (324)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-----cC
Confidence 468899999997542 23345566676655 56689999999999999999999999999999998873 24
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.+++..+..++.|++.||+|||++ |++||||||+||++++++.+||+|||++....... .......|+..|+|||+
T Consensus 97 ~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~ 172 (324)
T cd05589 97 VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEV 172 (324)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhH
Confidence 689999999999999999999999 99999999999999999999999999987532221 12334568999999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+.+..++.++|||||||++|||++|+.||...... .... .... ... ..+......+.+++.+||
T Consensus 173 ~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~---~i~~-~~~---------~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFD---SIVN-DEV---------RYPRFLSREAISIMRRLL 236 (324)
T ss_pred hcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHh-CCC---------CCCCCCCHHHHHHHHHHh
Confidence 99989999999999999999999999998654321 1111 1111 111 111122345778899999
Q ss_pred ccccCCCC-----CHHHHHH
Q 021774 239 QAAASRRP-----QMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RP-----s~~~v~~ 253 (307)
+.||.+|| ++.++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhh
Confidence 99999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=275.03 Aligned_cols=231 Identities=29% Similarity=0.445 Sum_probs=183.9
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
...||+|.++.. .......|.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ....+++..+
T Consensus 32 ~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~ 108 (266)
T cd05033 32 EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQL 108 (266)
T ss_pred cceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHH
Confidence 457999988755 344456789999999999999999999999999999999999999999999843 2347899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcccccCCcc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+.++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++........ .......++..|+|||.+.+..+
T Consensus 109 ~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 185 (266)
T cd05033 109 VGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185 (266)
T ss_pred HHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCC
Confidence 99999999999999999 999999999999999999999999999987752211 11222334568999999998899
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++||||||+++|+|++ |..||..... ..+.... ...... +. +......+.+++.+||+.+|+
T Consensus 186 ~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~----~~----~~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 186 TSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRL----PP----PMDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred ccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCC----CC----CCCCCHHHHHHHHHHcCCCcc
Confidence 999999999999999998 8888754322 1111111 111110 00 112234578899999999999
Q ss_pred CCCCHHHHHHHHHhc
Q 021774 244 RRPQMNQVIKMLTKN 258 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~ 258 (307)
+||++.+|++.|+++
T Consensus 251 ~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 251 ERPTFSQIVSTLDKM 265 (266)
T ss_pred cCcCHHHHHHHHHhh
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=279.63 Aligned_cols=240 Identities=28% Similarity=0.439 Sum_probs=184.2
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.++..||+|.++... ......+.+|++++++++||||+++++++... ...++||||++|++|.+++.. ....++
T Consensus 31 ~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~ 107 (284)
T cd05079 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKIN 107 (284)
T ss_pred CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCC
Confidence 457889999987653 44556899999999999999999999998875 567899999999999999832 233589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~ 159 (307)
+..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++..+...... ......++..|+|||++
T Consensus 108 ~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 184 (284)
T cd05079 108 LKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHh
Confidence 999999999999999999999 9999999999999999999999999999866433221 12234566789999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhH--------HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
.+..++.++||||||+++|||+|+..|+......... ................ .........+.
T Consensus 185 ~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 256 (284)
T cd05079 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL--------PRPPNCPEEVY 256 (284)
T ss_pred ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC--------CCCCCCCHHHH
Confidence 8888999999999999999999987664332211000 0000011111111110 11122345688
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
+++.+||+.+|++||++.++++.|+++
T Consensus 257 ~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 257 QLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=271.08 Aligned_cols=234 Identities=26% Similarity=0.368 Sum_probs=184.8
Q ss_pred cccCCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
|+..++..+|+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.+++.. ....+
T Consensus 14 ~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~ 90 (250)
T cd05085 14 GTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK---KKDEL 90 (250)
T ss_pred EEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh---cCCCC
Confidence 445678899999987653 33445788999999999999999999999999999999999999999998842 23457
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..++.++.|++.||.|||++ |++||||+|+||++++++.++|+|||++...............++..|+|||++.
T Consensus 91 ~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 167 (250)
T cd05085 91 KTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167 (250)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhc
Confidence 8999999999999999999999 9999999999999999999999999999754433222222233456799999998
Q ss_pred CCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..++.++||||||+++|++++ |..||....... .. ......... ..+......+.+++.+|++
T Consensus 168 ~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~----~~~~~~~~~--------~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR----EQVEKGYRM--------SCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----HHHHcCCCC--------CCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999998 888875432211 11 111111110 1112234568889999999
Q ss_pred cccCCCCCHHHHHHHHH
Q 021774 240 AAASRRPQMNQVIKMLT 256 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~ 256 (307)
.+|++||++.++++.|.
T Consensus 233 ~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 233 YKPENRPKFSELQKELA 249 (250)
T ss_pred cCcccCCCHHHHHHHhc
Confidence 99999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=272.15 Aligned_cols=231 Identities=23% Similarity=0.368 Sum_probs=181.1
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+..||+|.+.... ......+.+|+.++++++||||+++++++.. ...++||||+++++|.+++.. ....+++..
T Consensus 21 ~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 96 (257)
T cd05115 21 KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG---KKDEITVSN 96 (257)
T ss_pred CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHH
Confidence 45579999987653 3445679999999999999999999998754 567999999999999999842 234689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc--cccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~ 162 (307)
++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++.......... .....++..|+|||++.+.
T Consensus 97 ~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05115 97 VVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173 (257)
T ss_pred HHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC
Confidence 999999999999999999 99999999999999999999999999998654332211 1112235689999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..||....... .. ........ ...+......+.+++.+||..+
T Consensus 174 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~--------~~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM----SFIEQGKR--------LDCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHCCCC--------CCCCCCCCHHHHHHHHHHcCCC
Confidence 89999999999999999996 888886543211 11 11111111 1112233456778999999999
Q ss_pred cCCCCCHHHHHHHHHhc
Q 021774 242 ASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~ 258 (307)
|++||++.+|.+.|+..
T Consensus 239 ~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 239 WEDRPNFAKVEERMRTY 255 (257)
T ss_pred hhhCcCHHHHHHHHhhh
Confidence 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=282.13 Aligned_cols=227 Identities=26% Similarity=0.346 Sum_probs=176.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .......+..|+.++.++ +||||+++++++...+..++||||+++++|..++. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~----~~~~l 93 (329)
T cd05618 18 KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKL 93 (329)
T ss_pred CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH----HcCCC
Confidence 46789999998854 234455678899998877 89999999999999999999999999999988873 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05618 94 PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999987532211 1223456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccch--hHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM--NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+..++.++|||||||++|||++|+.||....... ......+.......... ..+......+.+++.+||
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~~p~~~~~~~~~ll~~~L 240 (329)
T cd05618 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------RIPRSLSVKAASVLKSFL 240 (329)
T ss_pred CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------CCCCCCCHHHHHHHHHHh
Confidence 9999999999999999999999999985321111 11111112222111111 112223345778899999
Q ss_pred ccccCCCCCH
Q 021774 239 QAAASRRPQM 248 (307)
Q Consensus 239 ~~~p~~RPs~ 248 (307)
+.||++||++
T Consensus 241 ~~dP~~R~~~ 250 (329)
T cd05618 241 NKDPKERLGC 250 (329)
T ss_pred cCCHHHcCCC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=260.39 Aligned_cols=241 Identities=23% Similarity=0.291 Sum_probs=194.0
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
+.+++.+|+|++...+.+..+..++|++..++++||||++++++...+. ..|++++|+..|||.+.+.....++.
T Consensus 43 ~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~ 122 (302)
T KOG2345|consen 43 LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN 122 (302)
T ss_pred cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCC
Confidence 5678899999999888788889999999999999999999999886544 48999999999999999877777777
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--------ccccccCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------ITTRIAGT 150 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~g~ 150 (307)
.+++.+++.|+.+|.+||.+||+..+ .+.||||||.||++++++.++|.|||.+....-.... .-....-|
T Consensus 123 ~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct 201 (302)
T KOG2345|consen 123 FVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCT 201 (302)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCC
Confidence 89999999999999999999999822 4999999999999999999999999999866432111 11223467
Q ss_pred CCcCCccccc---CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC--CCCCHH
Q 021774 151 TGYLAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL--GEYPPN 225 (307)
Q Consensus 151 ~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 225 (307)
..|.|||.+. +...++++|||||||++|+|+.|..||...+.+-. ........+.+ ++ ...
T Consensus 202 ~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-------------SlaLAv~n~q~s~P~-~~~ 267 (302)
T KOG2345|consen 202 IPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-------------SLALAVQNAQISIPN-SSR 267 (302)
T ss_pred CcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-------------eEEEeeeccccccCC-CCC
Confidence 8999999885 35678999999999999999999999875443211 11111112121 11 112
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
....+.+++++|++.||.+||++.+++..+..++
T Consensus 268 yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 268 YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 5567999999999999999999999999987654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=286.21 Aligned_cols=241 Identities=23% Similarity=0.309 Sum_probs=175.5
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||.++.. .......+.+|++++++++||||+++++++...+ ..++||||+. ++|.+++. ..
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~----~~ 97 (338)
T cd07859 23 HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK----AN 97 (338)
T ss_pred CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH----hc
Confidence 46899999988743 2334457889999999999999999999886432 4799999994 68988883 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLA 155 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~a 155 (307)
..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++....... .......|+..|+|
T Consensus 98 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~a 174 (338)
T cd07859 98 DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174 (338)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCC
Confidence 5689999999999999999999999 999999999999999999999999999986533211 11234568999999
Q ss_pred cccccC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHH--------HHHHhhcCCcc---cccC----CC
Q 021774 156 PEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW--------AWQLHQEEKPL---ELVD----PE 218 (307)
Q Consensus 156 PE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~---~~~~----~~ 218 (307)
||++.+ ..++.++|||||||++|||+||+.||.............. ........... ..+. ..
T Consensus 175 PE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 254 (338)
T cd07859 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254 (338)
T ss_pred HHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCc
Confidence 998876 6789999999999999999999999865332111000000 00000000000 0000 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 219 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 219 ~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.....+.+++.+||+.||++||++.++++
T Consensus 255 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 255 FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00001112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.18 Aligned_cols=234 Identities=24% Similarity=0.386 Sum_probs=181.2
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC------CC
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------NI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~ 78 (307)
++..||+|.++.. ......++.+|+.+++.++||||+++++++......++||||+++++|.+++...... ..
T Consensus 35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 114 (277)
T cd05062 35 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114 (277)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 3567999988654 3344567899999999999999999999999999999999999999999998543221 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
.+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......... ......++..|+|||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 467889999999999999999999 9999999999999999999999999998755432221 112234567899999
Q ss_pred cccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
.+.+..++.++||||||+++|||++ |..||...... .... ........ ..+......+.+++.+
T Consensus 192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~~~~~~~~--------~~~~~~~~~~~~li~~ 256 (277)
T cd05062 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----FVMEGGLL--------DKPDNCPDMLFELMRM 256 (277)
T ss_pred HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcCCcC--------CCCCCCCHHHHHHHHH
Confidence 9998889999999999999999999 67777543221 1111 11111110 1111223457889999
Q ss_pred ccccccCCCCCHHHHHHHHHh
Q 021774 237 CTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~~ 257 (307)
||+.+|++|||+.++++.|++
T Consensus 257 ~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 257 CWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCChhhCcCHHHHHHHhhC
Confidence 999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.29 Aligned_cols=222 Identities=25% Similarity=0.262 Sum_probs=177.6
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|++.... ......+..|++++++++||||+++++++...+..++||||+++++|.+++. ....+++
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~ 97 (318)
T cd05582 22 DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTE 97 (318)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCCH
Confidence 468899999987542 2234567789999999999999999999999999999999999999999883 3456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.||+.||+|||++ +++||||||+||++++++.++|+|||++....... .......|+..|+|||++.+.
T Consensus 98 ~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~ 173 (318)
T cd05582 98 EDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRR 173 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCC
Confidence 99999999999999999999 99999999999999999999999999987654321 123345789999999999988
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|||||||++|||++|+.||...... .... .... ... ..+......+.+++.+||+.||
T Consensus 174 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~i~~-~~~---------~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---MILK-AKL---------GMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred CCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---HHHc-CCC---------CCCCCCCHHHHHHHHHHhhcCH
Confidence 8999999999999999999999998653221 1111 1111 110 1111223357788899999999
Q ss_pred CCCCCHHH
Q 021774 243 SRRPQMNQ 250 (307)
Q Consensus 243 ~~RPs~~~ 250 (307)
++||++.+
T Consensus 238 ~~R~~a~~ 245 (318)
T cd05582 238 ANRLGAGP 245 (318)
T ss_pred hHcCCCCC
Confidence 99999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=281.66 Aligned_cols=239 Identities=25% Similarity=0.392 Sum_probs=185.2
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCCC-----
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKA----- 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~----- 76 (307)
.+++.||+|+++... ......+..|+.+++++ +|+||+++++++... ...+++|||+++++|.+++......
T Consensus 35 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~ 114 (337)
T cd05054 35 ASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYR 114 (337)
T ss_pred cccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccc
Confidence 346789999987543 33446788999999999 899999999988754 5678999999999999988532211
Q ss_pred ----------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 021774 77 ----------------------------------------------------NIKLNWEKRSDICVGIAKGLAFLHEELV 104 (307)
Q Consensus 77 ----------------------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 104 (307)
...+++..+..++.|++.||+|||++
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-- 192 (337)
T cd05054 115 NKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192 (337)
T ss_pred cccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 13688999999999999999999999
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh-
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS- 182 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt- 182 (307)
||+||||||+||++++++.++|+|||++..+...... ......++..|+|||++.+..++.++|||||||++|||++
T Consensus 193 -~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~ 271 (337)
T cd05054 193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271 (337)
T ss_pred -CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHc
Confidence 9999999999999999999999999999866432221 1223445678999999999999999999999999999998
Q ss_pred CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 183 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
|..||....... .+. ......... ..+......+.+++.+||+.+|++||++.+|++.|+++++
T Consensus 272 g~~p~~~~~~~~--~~~----~~~~~~~~~--------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 272 GASPYPGVQIDE--EFC----RRLKEGTRM--------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCCCCCCCccH--HHH----HHHhccCCC--------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 888876533221 111 111111110 0112233458889999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=287.70 Aligned_cols=237 Identities=23% Similarity=0.343 Sum_probs=184.7
Q ss_pred CCEEEEEEccccC-hHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---------
Q 021774 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------- 75 (307)
Q Consensus 7 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 75 (307)
+..||||+++... ......+.+|+++++++. ||||+++++++......++||||+++|+|.+++.....
T Consensus 67 ~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~ 146 (400)
T cd05105 67 VMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146 (400)
T ss_pred ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccc
Confidence 4579999997543 344567999999999995 99999999999999999999999999999998754211
Q ss_pred --------------------------------------------------------------------------------
Q 021774 76 -------------------------------------------------------------------------------- 75 (307)
Q Consensus 76 -------------------------------------------------------------------------------- 75 (307)
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 226 (400)
T cd05105 147 PKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLL 226 (400)
T ss_pred ccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHH
Confidence
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCC
Q 021774 76 ---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTT 151 (307)
Q Consensus 76 ---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~ 151 (307)
....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......... ......++.
T Consensus 227 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 303 (400)
T cd05105 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303 (400)
T ss_pred HhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCc
Confidence 113478889999999999999999999 9999999999999999999999999999865432211 122334667
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
.|+|||++.+..++.++|||||||++|||++ |..||....... ... ......... ..+......+
T Consensus 304 ~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~----~~~~~~~~~--------~~~~~~~~~l 369 (400)
T cd05105 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY----NKIKSGYRM--------AKPDHATQEV 369 (400)
T ss_pred ceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH----HHHhcCCCC--------CCCccCCHHH
Confidence 8999999988899999999999999999997 888875432211 111 111111110 0112233468
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
.+++.+||+.+|++||++.+|.+.|+++++
T Consensus 370 ~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 370 YDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 889999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.21 Aligned_cols=225 Identities=26% Similarity=0.383 Sum_probs=174.2
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||.+.... ......+.+|+++++.++|+||+++++++...+..++||||+++++|.... ...+.
T Consensus 97 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~ 168 (353)
T PLN00034 97 PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQ 168 (353)
T ss_pred CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHH
Confidence 468999999986543 344567899999999999999999999999999999999999999986532 34567
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC--
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-- 161 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 161 (307)
.+..++.||+.||+|||++ +++||||||+|||+++++.+||+|||++..+..... ......|+..|+|||++..
T Consensus 169 ~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 244 (353)
T PLN00034 169 FLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDL 244 (353)
T ss_pred HHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccccCccccCcccccccc
Confidence 7889999999999999999 999999999999999999999999999986543221 1234568999999998743
Q ss_pred ---CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 162 ---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 162 ---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
...+.++|||||||++|||++|+.||..........+.. ....... ..........+.+++.+||
T Consensus 245 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~~l~~li~~~l 312 (353)
T PLN00034 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICMSQP---------PEAPATASREFRHFISCCL 312 (353)
T ss_pred ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhccCC---------CCCCCccCHHHHHHHHHHc
Confidence 234568999999999999999999987332221111111 1111000 1112223345888999999
Q ss_pred ccccCCCCCHHHHHH
Q 021774 239 QAAASRRPQMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~ 253 (307)
+.||++||++.|+++
T Consensus 313 ~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 313 QREPAKRWSAMQLLQ 327 (353)
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999976
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=285.13 Aligned_cols=223 Identities=25% Similarity=0.380 Sum_probs=188.5
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+++.||+|.+.+. .+...+.+.+|+++++.++||||+.++++|+...+.++|+||+.| +|..++ .....++++
T Consensus 26 t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il----~~d~~lpEe 100 (808)
T KOG0597|consen 26 TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTIL----EQDGKLPEE 100 (808)
T ss_pred ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHH----HhccCCCHH
Confidence 4668999988764 345667899999999999999999999999999999999999977 999999 567789999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.+++.||.|||++ +|+|||+||.||++..++.+|+||||+++.+... ........||+.|||||...++.
T Consensus 101 ~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e~p 176 (808)
T KOG0597|consen 101 QVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEEQP 176 (808)
T ss_pred HHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcCCC
Confidence 9999999999999999999 9999999999999999999999999999987653 23355678999999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
|+..+|+||+||++|||++|++||... .+.+.+.....+.. ..+......+..++...+..||.
T Consensus 177 yd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v----------~~p~~~S~~f~nfl~gLL~kdP~ 240 (808)
T KOG0597|consen 177 YDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPV----------KPPSTASSSFVNFLQGLLIKDPA 240 (808)
T ss_pred ccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCC----------CCcccccHHHHHHHHHHhhcChh
Confidence 999999999999999999999998542 22333333222211 12334555677788888999999
Q ss_pred CCCCHHHHHH
Q 021774 244 RRPQMNQVIK 253 (307)
Q Consensus 244 ~RPs~~~v~~ 253 (307)
+|-+..+++.
T Consensus 241 ~RltW~~Ll~ 250 (808)
T KOG0597|consen 241 QRLTWTDLLG 250 (808)
T ss_pred hcccHHHHhc
Confidence 9999999874
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=271.85 Aligned_cols=230 Identities=27% Similarity=0.398 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+++..+|+|+++... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++++|.+++. ....+++
T Consensus 20 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~----~~~~~~~ 94 (257)
T cd05116 20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQ----KNKHVTE 94 (257)
T ss_pred CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHH----hcCCCCH
Confidence 467889999987543 4456789999999999999999999998754 46689999999999999983 3346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc--cccccCCCCcCCccccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~ 160 (307)
..+..++.|++.||+|||++ |++||||||+||++++++.++|+|||++.......... .....++..|+|||++.
T Consensus 95 ~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 95 KNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence 99999999999999999999 99999999999999999999999999998765432211 12223456899999998
Q ss_pred CCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
...++.++|+||||+++|||++ |..||...... .+... ....... ..+......+.+++.+||+
T Consensus 172 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----i~~~~~~--------~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM----IESGERM--------ECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCCCC--------CCCCCCCHHHHHHHHHHhc
Confidence 8889999999999999999998 88888654321 11111 1111110 1112233457889999999
Q ss_pred cccCCCCCHHHHHHHHHh
Q 021774 240 AAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~~ 257 (307)
.||++||++.+|.+.|++
T Consensus 237 ~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 237 YGVDERPGFAVVELRLRN 254 (257)
T ss_pred cCchhCcCHHHHHHHHhc
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=272.33 Aligned_cols=231 Identities=24% Similarity=0.382 Sum_probs=180.7
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..+++..+|+|.+..... ....+.+|++++++++|+||+++++++...+..++||||+++++|.+++.. ....+++
T Consensus 24 ~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 99 (256)
T cd05059 24 KWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGT 99 (256)
T ss_pred EecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCH
Confidence 345567899998874332 235688999999999999999999999999999999999999999999843 2236899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||+++..............++..|+|||.+.+.
T Consensus 100 ~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 176 (256)
T cd05059 100 EWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccC
Confidence 99999999999999999999 999999999999999999999999999986543322212222334579999999988
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..||....... .. .. ...... .. .+......+.+++.+||+.+
T Consensus 177 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~-~~~~~~-----~~---~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV---ES-VSAGYR-----LY---RPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH---HH-HHcCCc-----CC---CCCCCCHHHHHHHHHHhcCC
Confidence 99999999999999999999 788875432211 11 11 111110 01 11123446888999999999
Q ss_pred cCCCCCHHHHHHHH
Q 021774 242 ASRRPQMNQVIKML 255 (307)
Q Consensus 242 p~~RPs~~~v~~~L 255 (307)
|++|||+.++++.|
T Consensus 242 p~~Rpt~~~~l~~l 255 (256)
T cd05059 242 PEDRPAFKKLLSQL 255 (256)
T ss_pred hhhCcCHHHHHHHh
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=273.15 Aligned_cols=238 Identities=20% Similarity=0.338 Sum_probs=188.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.+|||.+... ......++.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++.........++
T Consensus 25 ~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 104 (267)
T cd08229 25 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 104 (267)
T ss_pred CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCC
Confidence 57899999987643 234456789999999999999999999999999999999999999999998854444456789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||++ |++|+||+|+||+++.++.++|+|||++......... .....++..|+|||++.+
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~ape~~~~ 180 (267)
T cd08229 105 EKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHE 180 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc-cccccCCcCccCHHHhcC
Confidence 999999999999999999999 9999999999999999999999999998766443221 223457889999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+||||+++|+|++|..||........ ..... .... ..+.. ........+.+++.+||+.+
T Consensus 181 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~ 248 (267)
T cd08229 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKK-IEQC-----DYPPL--PSDHYSEELRQLVNMCINPD 248 (267)
T ss_pred CCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHhhh-hhcC-----CCCCC--CcccccHHHHHHHHHhcCCC
Confidence 8899999999999999999999999754322111 11111 1100 00111 01123446888899999999
Q ss_pred cCCCCCHHHHHHHHHhc
Q 021774 242 ASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~ 258 (307)
|.+|||+.+|++.+++.
T Consensus 249 p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 249 PEKRPDITYVYDVAKRM 265 (267)
T ss_pred cccCCCHHHHHHHHhhh
Confidence 99999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=281.25 Aligned_cols=177 Identities=27% Similarity=0.450 Sum_probs=153.3
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|..+|+|.+... .......+.+|++++++++||||+++++++..++..++||||+++++|.+++. ....+++.
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~ 103 (333)
T cd06650 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQ 103 (333)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH----HcCCCCHH
Confidence 35788999988765 33445678999999999999999999999999999999999999999999983 33468899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||+.. +++|+||||+||++++++.+||+|||++....... .....|+..|+|||++.+..
T Consensus 104 ~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 178 (333)
T cd06650 104 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTH 178 (333)
T ss_pred HHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---cccCCCCccccCHHHhcCCC
Confidence 99999999999999999741 79999999999999999999999999987553321 22346889999999999888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 179 YSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=281.30 Aligned_cols=227 Identities=26% Similarity=0.330 Sum_probs=177.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++++|..++. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l 93 (327)
T cd05617 18 KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ----RQRKL 93 (327)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCC
Confidence 46789999999864 234456688999999988 79999999999999999999999999999998873 34569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ |++||||||+||++++++.+||+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (327)
T cd05617 94 PEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILR 169 (327)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHC
Confidence 9999999999999999999999 99999999999999999999999999987532211 1233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||........................ ..+......+.+++.+||+.
T Consensus 170 ~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p~~~~~~~~~li~~~L~~ 240 (327)
T cd05617 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIPRFLSVKASHVLKGFLNK 240 (327)
T ss_pred CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCCCCCCHHHHHHHHHHhcc
Confidence 999999999999999999999999998643222111111122222211111 11112234577889999999
Q ss_pred ccCCCCCH
Q 021774 241 AASRRPQM 248 (307)
Q Consensus 241 ~p~~RPs~ 248 (307)
||.+|+++
T Consensus 241 dP~~R~~~ 248 (327)
T cd05617 241 DPKERLGC 248 (327)
T ss_pred CHHHcCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=281.82 Aligned_cols=230 Identities=23% Similarity=0.249 Sum_probs=180.5
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++... ......+.+|+.+++.++|+||+++++++.+.+..++||||+++|+|.+++.. ....++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~ 100 (330)
T cd05601 24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFD 100 (330)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH---hcCCCC
Confidence 468899999988542 33456788999999999999999999999999999999999999999999843 234689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...............|+..|+|||++.
T Consensus 101 ~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 101 EDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhcc
Confidence 999999999999999999999 9999999999999999999999999999876544333334456899999999886
Q ss_pred -----CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 161 -----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 161 -----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
+..++.++|||||||++|||++|..||....... .............. +. .+.....+.+++.
T Consensus 178 ~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~--~~----~~~~~~~~~~li~ 245 (330)
T cd05601 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKF--PE----DPKVSSDFLDLIQ 245 (330)
T ss_pred ccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCC--CC----CCCCCHHHHHHHH
Confidence 4567899999999999999999999986543211 11111111111000 11 1122344777888
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
.|++ +|.+||++.+++.
T Consensus 246 ~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 246 SLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHcc-ChhhCCCHHHHhC
Confidence 8998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=284.88 Aligned_cols=230 Identities=22% Similarity=0.245 Sum_probs=182.1
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||||+++++|.+++.. ...++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~ 99 (350)
T cd05573 24 DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFP 99 (350)
T ss_pred CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCC
Confidence 368999999987542 23456788999999999999999999999999999999999999999999843 35789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc---------------------
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--------------------- 140 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--------------------- 140 (307)
+..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (350)
T cd05573 100 EETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176 (350)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccc
Confidence 999999999999999999999 99999999999999999999999999998665432
Q ss_pred -------ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc
Q 021774 141 -------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE 213 (307)
Q Consensus 141 -------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (307)
........||..|+|||++.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~~~-- 248 (350)
T cd05573 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET------YNKIINWKES-- 248 (350)
T ss_pred ccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH------HHHHhccCCc--
Confidence 1122345689999999999999999999999999999999999999865432111 1111110000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccccCCCCC-HHHHHHH
Q 021774 214 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ-MNQVIKM 254 (307)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs-~~~v~~~ 254 (307)
...+.... ....+.+++.+|+. +|.+||+ +.++++.
T Consensus 249 ~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 249 LRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 00011111 23457788888997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.12 Aligned_cols=236 Identities=20% Similarity=0.357 Sum_probs=188.8
Q ss_pred CCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+|+.||+|.++.. .......+.+|++++++++|+|++++++++...+..++||||+++++|.+++.........+++
T Consensus 26 ~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 105 (267)
T cd08224 26 DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE 105 (267)
T ss_pred CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCH
Confidence 7899999988642 3344567899999999999999999999999999999999999999999998654445566899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.+++.||+|||+. |++||||+|+||+++.++.++|+|||++......... .....++..|+|||.+.+.
T Consensus 106 ~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~ 181 (267)
T cd08224 106 RTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc-cceecCCccccCHHHhccC
Confidence 99999999999999999999 9999999999999999999999999998765433211 2334578889999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCH-HHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP-NEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|+||||+++|+|++|+.|+....... ...... ...... ...+. .....+.+++.+||..+
T Consensus 182 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~i~~cl~~~ 248 (267)
T cd08224 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-IEKCDY--------PPLPADHYSEELRDLVSRCINPD 248 (267)
T ss_pred CCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HHHHhh-hhcCCC--------CCCChhhcCHHHHHHHHHHcCCC
Confidence 89999999999999999999999875433211 111111 111100 11111 33445788899999999
Q ss_pred cCCCCCHHHHHHHHHhc
Q 021774 242 ASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~ 258 (307)
|.+||++.+|++.|+++
T Consensus 249 p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 249 PEKRPDISYVLQVAKEM 265 (267)
T ss_pred cccCCCHHHHHHHHHHh
Confidence 99999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=277.50 Aligned_cols=240 Identities=26% Similarity=0.397 Sum_probs=182.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+........+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++.. ....+++
T Consensus 31 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~ 107 (284)
T cd05081 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDH 107 (284)
T ss_pred CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCH
Confidence 4688999999987766667789999999999999999999998754 3467899999999999999842 2345899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc--cccccCCCCcCCccccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~ 160 (307)
..++.++.|++.||+|||++ |++||||||+||++++++.++|+|||++.......... .....++..|+|||++.
T Consensus 108 ~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (284)
T cd05081 108 RKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc
Confidence 99999999999999999999 99999999999999999999999999998765432211 11122344699999998
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhH---------HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK---------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
+..++.++||||||+++|||++|..++......... .............. ...........+.
T Consensus 185 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 256 (284)
T cd05081 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG--------RLPAPPGCPAEIY 256 (284)
T ss_pred cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC--------cCCCCCCCCHHHH
Confidence 888999999999999999999987664332111000 00000000010000 0011122334588
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
+++.+||+.+|++|||+.+|++.|+.+
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 257 AIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=273.83 Aligned_cols=231 Identities=24% Similarity=0.298 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+..|++++++++||||+++++++......++||||++|++|..++... ....++
T Consensus 16 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~ 93 (277)
T cd05607 16 NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLE 93 (277)
T ss_pred cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc--cccCCC
Confidence 458999999886432 122345567999999999999999999999999999999999999999887432 334588
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||+. |++||||||+||++++++.++|+|||++....... ......|+..|+|||++.+
T Consensus 94 ~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 168 (277)
T cd05607 94 MERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKE 168 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHcc
Confidence 999999999999999999999 99999999999999999999999999998664432 1233568899999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|+.||......... ......... ... .. ........+.+++.+||+.|
T Consensus 169 ~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~-~~~----~~----~~~~~~~~~~~li~~~L~~~ 237 (277)
T cd05607 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLE-DEV----KF----EHQNFTEESKDICRLFLAKK 237 (277)
T ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhc-ccc----cc----ccccCCHHHHHHHHHHhccC
Confidence 88999999999999999999999998654322111 111111111 100 00 01122335788899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++||++.|+++
T Consensus 238 P~~R~~~~~~~~ 249 (277)
T cd05607 238 PEDRLGSREKND 249 (277)
T ss_pred HhhCCCCccchh
Confidence 999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.84 Aligned_cols=221 Identities=25% Similarity=0.289 Sum_probs=172.8
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+.+|+|..++. ....+
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~ 93 (323)
T cd05575 18 ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ----RERSF 93 (323)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH----hcCCC
Confidence 468999999987532 222344555544 5678899999999999999999999999999999999883 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...... ........|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~ 169 (323)
T cd05575 94 PEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPEVLR 169 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccccCChhhcChhhhc
Confidence 9999999999999999999999 9999999999999999999999999998753221 12233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||..... ... ...... ... ...+.....+.+++.+|++.
T Consensus 170 ~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~---~~~i~~-~~~---------~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEM---YDNILN-KPL---------RLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred CCCCCccccccccchhhhhhhcCCCCCCCCCH---HHH---HHHHHc-CCC---------CCCCCCCHHHHHHHHHHhhc
Confidence 99999999999999999999999999865321 111 111111 110 11112234578899999999
Q ss_pred ccCCCCCHH
Q 021774 241 AASRRPQMN 249 (307)
Q Consensus 241 ~p~~RPs~~ 249 (307)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (323)
T cd05575 234 DRTKRLGAK 242 (323)
T ss_pred CHHhCCCCC
Confidence 999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.81 Aligned_cols=240 Identities=23% Similarity=0.411 Sum_probs=182.4
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC-------CC
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-------NI 78 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------~~ 78 (307)
+..||+|.+... ......+|.+|++++++++|+||+++++++...+..++||||+++++|.+++...... ..
T Consensus 46 ~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (296)
T cd05095 46 PVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125 (296)
T ss_pred eeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccc
Confidence 446899999865 3445578999999999999999999999999999999999999999999998553322 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.|++.||+|||++ |++|+||||+||++++++.++|+|||++..+...... ......++..|++||
T Consensus 126 ~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 202 (296)
T cd05095 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE 202 (296)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence 478889999999999999999999 9999999999999999999999999999865432211 122233456899999
Q ss_pred cccCCcccccCceeehHHHHHHHHh--CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS--GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
+..++.++.++|||||||++|||++ |..|+...... ................ ...+. +..+...+.+++.
T Consensus 203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~li~ 274 (296)
T cd05095 203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE---QVIENTGEFFRDQGRQ-VYLPK----PALCPDSLYKLML 274 (296)
T ss_pred HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH---HHHHHHHHHHhhcccc-ccCCC----CCCCCHHHHHHHH
Confidence 9888889999999999999999998 56676543221 1111111111111100 00111 1123356888999
Q ss_pred hccccccCCCCCHHHHHHHHHh
Q 021774 236 FCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
+||+.||.+||++.+|++.|++
T Consensus 275 ~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 275 SCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHcCCCcccCCCHHHHHHHHhC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=282.78 Aligned_cols=220 Identities=27% Similarity=0.327 Sum_probs=175.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||+++.. .......+..|..++..+ +||||+++++++...+..++||||+++|+|..++. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~----~~~~l 93 (320)
T cd05590 18 ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRF 93 (320)
T ss_pred CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH----HcCCC
Confidence 45889999998753 223445677888888877 79999999999999999999999999999998883 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (320)
T cd05590 94 DEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQ 169 (320)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999987532221 1233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|+.||...... .+. ........ ..+......+.+++.+|++.
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~----~~i~~~~~---------~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF----EAILNDEV---------VYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCCC---------CCCCCCCHHHHHHHHHHccc
Confidence 889999999999999999999999998654321 111 11111111 01112234577888999999
Q ss_pred ccCCCCCH
Q 021774 241 AASRRPQM 248 (307)
Q Consensus 241 ~p~~RPs~ 248 (307)
||.+||++
T Consensus 234 dP~~R~~~ 241 (320)
T cd05590 234 NPTMRLGS 241 (320)
T ss_pred CHHHCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=275.21 Aligned_cols=233 Identities=26% Similarity=0.417 Sum_probs=183.8
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC----------
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------- 75 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 75 (307)
++..+|+|.+..........+.+|++++++++|+||+++++++......+++|||+++++|.+++.....
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (280)
T cd05092 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113 (280)
T ss_pred CceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccccc
Confidence 4568899998877666677899999999999999999999999999999999999999999999854321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCc
Q 021774 76 -ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGY 153 (307)
Q Consensus 76 -~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y 153 (307)
....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||++........ .......++..|
T Consensus 114 ~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05092 114 VAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190 (280)
T ss_pred CCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccc
Confidence 113588999999999999999999999 999999999999999999999999999975543221 112223346789
Q ss_pred CCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 154 LAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 154 ~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
+|||++.+..++.++|||||||++|||++ |..||....... ... . ....... ..+......+.+
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~-~~~~~~~--------~~~~~~~~~~~~ 255 (280)
T cd05092 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIE---C-ITQGREL--------ERPRTCPPEVYA 255 (280)
T ss_pred cCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHH---H-HHcCccC--------CCCCCCCHHHHH
Confidence 99999998899999999999999999998 888875432211 111 1 1111110 001122335778
Q ss_pred HHHhccccccCCCCCHHHHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~~L~ 256 (307)
++.+||+.||.+||++.+|++.|+
T Consensus 256 li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 256 IMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHccCChhhCCCHHHHHHHHh
Confidence 999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=272.01 Aligned_cols=239 Identities=22% Similarity=0.332 Sum_probs=182.4
Q ss_pred CCCCEEEEEEcc--ccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe-----CCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLS--AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||+|++. ..+.-..++..+|+.+|+.++|+||+.+++.+.. -+..|+|+|++ +.+|.+.+ ..+
T Consensus 45 ~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~ii----k~~ 119 (359)
T KOG0660|consen 45 RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQII----KSQ 119 (359)
T ss_pred CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHH----HcC
Confidence 568999999998 3466777889999999999999999999999875 34679999999 66999998 455
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAP 156 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aP 156 (307)
..++..++.-+++|++.||.|+|+. +++||||||+|++++.+..+||+|||+++...... ....+..+.|.+|.||
T Consensus 120 ~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAP 196 (359)
T KOG0660|consen 120 QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAP 196 (359)
T ss_pred ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCH
Confidence 5699999999999999999999999 99999999999999999999999999999875431 1223556778999999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHH-----------------HHHHHhhcCCcccccCCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE-----------------WAWQLHQEEKPLELVDPE 218 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~ 218 (307)
|.+.. ..|+.+.||||.||++.||++|++-|.+...-.+-.+.. .+............ ..
T Consensus 197 Elll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~--~~ 274 (359)
T KOG0660|consen 197 ELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPK--QP 274 (359)
T ss_pred HHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCC--CC
Confidence 97754 689999999999999999999998665543221111110 01111110000000 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 219 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 219 ~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+....++.....++|+.+|+..||.+|+|++|.+.
T Consensus 275 f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 275 FSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 01111233445788899999999999999998875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=292.98 Aligned_cols=234 Identities=22% Similarity=0.282 Sum_probs=188.4
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeE-EEe------CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGC-CVQ------GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
|.+||+|++-..+....+...+|+++|++|+ |+|||.+++. ... ....+|.||||.||+|-+++.. +-..
T Consensus 62 ~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~--Rlq~ 139 (738)
T KOG1989|consen 62 GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNT--RLQT 139 (738)
T ss_pred CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHH--HHhc
Confidence 4899999998888888899999999999995 9999999993 321 1356899999999999999843 2334
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--------ccccccCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------ITTRIAGT 150 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~g~ 150 (307)
.|++..+++|++++++|+++||.. .+.|||||||-+||||+.+++.||||||.+.-....... ..-...-|
T Consensus 140 ~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TT 218 (738)
T KOG1989|consen 140 RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTT 218 (738)
T ss_pred cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCC
Confidence 499999999999999999999998 346999999999999999999999999999743221100 11224568
Q ss_pred CCcCCcccc---cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCC-CHHH
Q 021774 151 TGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY-PPNE 226 (307)
Q Consensus 151 ~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (307)
+-|+|||++ .+..+++|+|||+|||+||-|+....||+..- ...+++....-- .+..
T Consensus 219 p~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------------~laIlng~Y~~P~~p~y 279 (738)
T KOG1989|consen 219 PQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------------KLAILNGNYSFPPFPNY 279 (738)
T ss_pred ccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------------ceeEEeccccCCCCccH
Confidence 899999987 56789999999999999999999999986431 122333322111 2567
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
...+..||+.||+.||.+||++.+|+..+.++....
T Consensus 280 s~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 280 SDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred HHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 788999999999999999999999999998887544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=277.04 Aligned_cols=238 Identities=20% Similarity=0.279 Sum_probs=177.5
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++ +|.+++.. .+..+++.
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~ 103 (288)
T cd07871 28 LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMH 103 (288)
T ss_pred CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHH
Confidence 468899999887543 22335678999999999999999999999999999999999975 89888732 33457899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-C
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-G 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 162 (307)
.+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||++........ ......++..|+|||++.+ .
T Consensus 104 ~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 179 (288)
T cd07871 104 NVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGST 179 (288)
T ss_pred HHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cccCceecccccChHHhcCCc
Confidence 9999999999999999999 999999999999999999999999999975433211 1233457889999998865 5
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC------------cccccCCCC-----CCCCHH
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK------------PLELVDPEL-----GEYPPN 225 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~-----~~~~~~ 225 (307)
.++.++|||||||++|||+||+.||........ ............ ......+.. ....+.
T Consensus 180 ~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (288)
T cd07871 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPR 256 (288)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCC
Confidence 689999999999999999999999865432211 111111110000 000000110 000112
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++.+|++.||.+|||++++++
T Consensus 257 ~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 257 LDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 2345778999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.03 Aligned_cols=230 Identities=20% Similarity=0.252 Sum_probs=176.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .......+.+|++++++++||||+++++++.+.+..++||||++||+|.+++. ....++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~ 99 (381)
T cd05626 24 DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFP 99 (381)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH----hcCCCC
Confidence 56889999999754 23445678999999999999999999999999999999999999999999983 345688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--------------------
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------------------- 141 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------------------- 141 (307)
+..+..++.||+.||.|||++ ||+||||||+||||+.++.++|+|||++..+.....
T Consensus 100 e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (381)
T cd05626 100 EVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176 (381)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccc
Confidence 999999999999999999999 999999999999999999999999999754311000
Q ss_pred --------------------------cccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchh
Q 021774 142 --------------------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN 195 (307)
Q Consensus 142 --------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 195 (307)
.......||..|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 256 (381)
T cd05626 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET 256 (381)
T ss_pred cccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH
Confidence 001234689999999999988899999999999999999999999875433211
Q ss_pred HHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh--ccccccCCCCCHHHHHH
Q 021774 196 KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF--CTQAAASRRPQMNQVIK 253 (307)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--c~~~~p~~RPs~~~v~~ 253 (307)
. ........... -+...... ..+.+++.+ |+..++..||++.+++.
T Consensus 257 ~------~~i~~~~~~~~--~~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 257 Q------LKVINWENTLH--IPPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred H------HHHHccccccC--CCCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 0 01111000000 01111122 235556655 66677777999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=273.76 Aligned_cols=234 Identities=24% Similarity=0.386 Sum_probs=182.7
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC----------
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---------- 74 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------- 74 (307)
++..||+|+++... ......+.+|+.++.+++||||+++++++......++++||+.+++|.+++....
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05091 34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113 (283)
T ss_pred ceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccc
Confidence 45789999998653 3344678899999999999999999999999999999999999999999984221
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCC
Q 021774 75 --KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTT 151 (307)
Q Consensus 75 --~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~ 151 (307)
.....+++..+..++.|++.||+|||++ |++||||||+||++++++.+||+|||+++....... .......++.
T Consensus 114 ~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 190 (283)
T cd05091 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190 (283)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCc
Confidence 1123578899999999999999999999 999999999999999999999999999886543221 1223344567
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
.|+|||.+.+..++.++|||||||++|||++ |..|+...... ..... ...... ...+......+
T Consensus 191 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~----i~~~~~--------~~~~~~~~~~~ 255 (283)
T cd05091 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEM----IRNRQV--------LPCPDDCPAWV 255 (283)
T ss_pred cccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHcCCc--------CCCCCCCCHHH
Confidence 8999999988889999999999999999998 77776543221 11111 111111 11122334457
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHh
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
.+++..||+.+|.+||++.+|+..|+.
T Consensus 256 ~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 256 YTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=275.66 Aligned_cols=239 Identities=25% Similarity=0.421 Sum_probs=187.3
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--------
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------- 75 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 75 (307)
++..||+|.+... .......+.+|+.+++.+ +||||+++++++......++||||+.+++|.+++.....
T Consensus 46 ~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 125 (304)
T cd05101 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125 (304)
T ss_pred cceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 3557999998754 234557789999999999 899999999999999999999999999999999865322
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCC
Q 021774 76 ----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGT 150 (307)
Q Consensus 76 ----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~ 150 (307)
....+++..++.++.|++.||+|||++ |++||||||+||++++++.++|+|||++......... ......++
T Consensus 126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05101 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202 (304)
T ss_pred cccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCC
Confidence 123578899999999999999999999 9999999999999999999999999999876543222 12223456
Q ss_pred CCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 151 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
..|+|||++.+..++.++||||||+++|+|++ |..|+..... ..+. ......... ..+......
T Consensus 203 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~--------~~~~~~~~~ 267 (304)
T cd05101 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELF----KLLKEGHRM--------DKPANCTNE 267 (304)
T ss_pred ceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHHcCCcC--------CCCCCCCHH
Confidence 78999999988889999999999999999998 6666643221 1111 111111110 111223445
Q ss_pred HHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+.+++.+||+.+|.+||++.++++.|.+++...
T Consensus 268 ~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 268 LYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 888999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=279.01 Aligned_cols=225 Identities=26% Similarity=0.318 Sum_probs=178.0
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .......+..|.+++..+ +||||+++++++...+..++||||+++++|...+. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~----~~~~~ 93 (321)
T cd05591 18 GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ----RSRKF 93 (321)
T ss_pred CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH----HcCCC
Confidence 35789999998754 233445677899999876 89999999999999999999999999999998883 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||.|||++ ||+||||||+||++++++.++|+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05591 94 DEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQ 169 (321)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999987543221 1233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|+.||...... .... ........ .+......+.+++.+||+.
T Consensus 170 ~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~~~~~~----------~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SILHDDVL----------YPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred CCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHHcCCCC----------CCCCCCHHHHHHHHHHhcc
Confidence 889999999999999999999999998654321 1111 11111100 1111223577888999999
Q ss_pred ccCCCC-------CHHHHHH
Q 021774 241 AASRRP-------QMNQVIK 253 (307)
Q Consensus 241 ~p~~RP-------s~~~v~~ 253 (307)
||++|| ++.++++
T Consensus 234 dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhc
Confidence 999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.00 Aligned_cols=232 Identities=26% Similarity=0.410 Sum_probs=181.7
Q ss_pred EEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.||+|.++... .....++.+|+.+++.++||||+++++++... ..++|+||+++|+|.+++.. ....+++..++.
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~ 113 (316)
T cd05108 38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLN 113 (316)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHH
Confidence 48999987543 45557899999999999999999999999875 46799999999999999843 234588999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc-cccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.+....... .....++..|+|||++.+..++.
T Consensus 114 ~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 190 (316)
T cd05108 114 WCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190 (316)
T ss_pred HHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCc
Confidence 999999999999999 99999999999999999999999999998765432221 12233456799999999999999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++||||||+++|||++ |..|+...... .+. ......... + .++.....+.+++.+||+.+|.+|
T Consensus 191 ~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~----~----~~~~~~~~~~~li~~cl~~~p~~R 255 (316)
T cd05108 191 QSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS----SILEKGERL----P----QPPICTIDVYMIMVKCWMIDADSR 255 (316)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhCCCCC----C----CCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999999998 88887643221 111 111111110 0 011223457889999999999999
Q ss_pred CCHHHHHHHHHhccccC
Q 021774 246 PQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~~~ 262 (307)
|++.+++..|..+.+..
T Consensus 256 ps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 256 PKFRELIIEFSKMARDP 272 (316)
T ss_pred cCHHHHHHHHHHHHcCC
Confidence 99999999998876533
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=271.53 Aligned_cols=235 Identities=28% Similarity=0.435 Sum_probs=183.1
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+..++..||+|.++.... ....|.+|++++++++|+||+++++++. ....++||||+++++|.+++... ....+++
T Consensus 26 ~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 101 (262)
T cd05071 26 TWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE--MGKYLRL 101 (262)
T ss_pred EecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc--cccCCCH
Confidence 345556799999885432 2357899999999999999999999874 45679999999999999998432 2345789
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+..+............++..|+|||+..+.
T Consensus 102 ~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 178 (262)
T cd05071 102 PQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccC
Confidence 99999999999999999999 999999999999999999999999999986654332222234456789999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||+| |..||...... .... ........ .........+.+++.+|++.+
T Consensus 179 ~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~----~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~ 243 (262)
T cd05071 179 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYRM--------PCPPECPESLHDLMCQCWRKE 243 (262)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH----HHhcCCCC--------CCccccCHHHHHHHHHHccCC
Confidence 89999999999999999999 77777544321 1111 11111100 111233456889999999999
Q ss_pred cCCCCCHHHHHHHHHhcc
Q 021774 242 ASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~ 259 (307)
|++||++.++++.|++.+
T Consensus 244 p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 244 PEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCCCHHHHHHHHHHhc
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=270.12 Aligned_cols=221 Identities=22% Similarity=0.330 Sum_probs=173.8
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
+.+|++|.+..........|.+|+.++++++||||+++++++......++||||+++++|..++. .....+++..++
T Consensus 32 ~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~ 108 (262)
T cd05077 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKF 108 (262)
T ss_pred ceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHH---hcCCCCCHHHHH
Confidence 34689998876655556688999999999999999999999999999999999999999999873 234568999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-------eEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
.++.|++.||+|||++ +++||||||+||+++.++. ++++|||++...... ....++..|+|||++
T Consensus 109 ~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~ 180 (262)
T cd05077 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECV 180 (262)
T ss_pred HHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhh
Confidence 9999999999999999 9999999999999987664 899999998754322 234567889999988
Q ss_pred c-CCcccccCceeehHHHHHHHH-hCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 160 L-GGQLTMKADVYSFGVLVLEII-SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 160 ~-~~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
. +..++.++|||||||++|||+ +|..|+......... .... ... .. .......+.+++.+|
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~~-~~~-~~--------~~~~~~~~~~li~~c 243 (262)
T cd05077 181 EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFYE-GQC-ML--------VTPSCKELADLMTHC 243 (262)
T ss_pred cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHHh-cCc-cC--------CCCChHHHHHHHHHH
Confidence 6 467899999999999999998 477776543211110 0011 100 00 111234577899999
Q ss_pred cccccCCCCCHHHHHHHH
Q 021774 238 TQAAASRRPQMNQVIKML 255 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~L 255 (307)
|+.||.+||++.+|+..+
T Consensus 244 l~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 244 MNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCCChhhCcCHHHHHHhc
Confidence 999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.66 Aligned_cols=229 Identities=22% Similarity=0.275 Sum_probs=184.3
Q ss_pred cCCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
-.+|..+|+|++++. ......+.+.|-.+|...++|.||++|..|.+.+.+||||||++||++-.+| .....|
T Consensus 163 k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL----~~~~~L 238 (550)
T KOG0605|consen 163 KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL----MRKDTL 238 (550)
T ss_pred ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHH----HhcCcC
Confidence 356999999999875 3566778899999999999999999999999999999999999999999999 456779
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCC----------------------
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD---------------------- 138 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~---------------------- 138 (307)
++..+...+.+++.|+.-||+. |||||||||+|+|||..|++||+||||+..+..
T Consensus 239 ~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~ 315 (550)
T KOG0605|consen 239 TEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKP 315 (550)
T ss_pred chHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCC
Confidence 9999999999999999999999 999999999999999999999999999953211
Q ss_pred -Ccc-----c------------------ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccch
Q 021774 139 -NIT-----H------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 194 (307)
Q Consensus 139 -~~~-----~------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 194 (307)
+.. . .....+||+.|+|||++.+..|+..+|.|||||++||||.|.+||....+.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~ 395 (550)
T KOG0605|consen 316 SDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQE 395 (550)
T ss_pred ccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 000 0 0123579999999999999999999999999999999999999998876654
Q ss_pred h-HHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCC---CHHHHHH
Q 021774 195 N-KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP---QMNQVIK 253 (307)
Q Consensus 195 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP---s~~~v~~ 253 (307)
. ..+..|...... +.+ .....+..+||.+|+. ||++|- .++||-+
T Consensus 396 T~rkI~nwr~~l~f---P~~----------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 396 TYRKIVNWRETLKF---PEE----------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHHhhhccC---CCc----------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 3 223332211111 100 0111457788888888 999995 4666653
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.98 Aligned_cols=230 Identities=19% Similarity=0.199 Sum_probs=178.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||++||+|.+++. ...++
T Consensus 66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-----~~~l~ 140 (370)
T cd05596 66 SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS-----NYDIP 140 (370)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH-----hcCCC
Confidence 46889999998643 22334567899999999999999999999999999999999999999999983 23578
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||++...............|++.|+|||++.+
T Consensus 141 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 217 (370)
T cd05596 141 EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhcc
Confidence 888999999999999999999 99999999999999999999999999998664433222344678999999998865
Q ss_pred C----cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 162 G----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 162 ~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
. .++.++|||||||++|||++|..||...... .. ............ .+. .......+.+++.+|
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~---~~~i~~~~~~~~--~~~----~~~~s~~~~~li~~~ 285 (370)
T cd05596 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GT---YSKIMDHKNSLT--FPD----DIEISKQAKDLICAF 285 (370)
T ss_pred CCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HH---HHHHHcCCCcCC--CCC----cCCCCHHHHHHHHHH
Confidence 3 4789999999999999999999998653221 11 111111110000 011 011234577888999
Q ss_pred cccccCC--CCCHHHHHHH
Q 021774 238 TQAAASR--RPQMNQVIKM 254 (307)
Q Consensus 238 ~~~~p~~--RPs~~~v~~~ 254 (307)
++.+|.+ ||++.+++..
T Consensus 286 L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 286 LTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ccChhhccCCCCHHHHhcC
Confidence 9989987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=270.01 Aligned_cols=228 Identities=27% Similarity=0.362 Sum_probs=184.3
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.|++|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|.+++... .+..+++
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~ 100 (256)
T cd08529 23 ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPE 100 (256)
T ss_pred CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCH
Confidence 46889999988643 3455678999999999999999999999999999999999999999999998542 2456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++........ ......|+..|+|||++.+.
T Consensus 101 ~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08529 101 DQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDK 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hhhccccCccccCHHHhcCC
Confidence 99999999999999999999 999999999999999999999999999886654322 12334578899999999988
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|+||||+++|+|++|+.|+..... ..... . ...... ..........+.+++.+||+.+|
T Consensus 177 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~-~~~~~~--------~~~~~~~~~~~~~~i~~~l~~~p 241 (256)
T cd08529 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALIL---K-IIRGVF--------PPVSQMYSQQLAQLIDQCLTKDY 241 (256)
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCCC--------CCCccccCHHHHHHHHHHccCCc
Confidence 899999999999999999999999864431 11111 1 111111 11111233458889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
++||++.++++
T Consensus 242 ~~Rp~~~~ll~ 252 (256)
T cd08529 242 RQRPDTFQLLR 252 (256)
T ss_pred ccCcCHHHHhh
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.86 Aligned_cols=236 Identities=27% Similarity=0.414 Sum_probs=185.1
Q ss_pred CCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC----------
Q 021774 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------- 75 (307)
Q Consensus 7 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 75 (307)
+..+++|.+.... .....++.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++.....
T Consensus 30 ~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 109 (290)
T cd05045 30 YTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDG 109 (290)
T ss_pred ceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCcccccccccc
Confidence 4578999887553 34456799999999999999999999999999999999999999999998854321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-cc
Q 021774 76 ----------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-IT 144 (307)
Q Consensus 76 ----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~ 144 (307)
....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||+++........ ..
T Consensus 110 ~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 186 (290)
T cd05045 110 NRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186 (290)
T ss_pred ccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcc
Confidence 123578999999999999999999999 9999999999999999999999999999765332211 12
Q ss_pred ccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCC
Q 021774 145 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 223 (307)
Q Consensus 145 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (307)
....++..|+|||++.+..++.++||||||+++|||++ |..||....+. .+. ........ . ..+
T Consensus 187 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~-----~---~~~ 251 (290)
T cd05045 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLF----NLLKTGYR-----M---ERP 251 (290)
T ss_pred cCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhCCCC-----C---CCC
Confidence 22345678999999988889999999999999999998 88887543321 111 11111110 0 011
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
......+.+++.+||+.+|++||++.++++.|++++.
T Consensus 252 ~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 252 ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1223457888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=288.60 Aligned_cols=232 Identities=22% Similarity=0.376 Sum_probs=189.3
Q ss_pred CEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 8 RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 8 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
-.||||.++.+.- ...+|++|+.+|+.++|||+|+++|+|..+..+|||+|||.+|+|.++|..+.+ ..++...++.
T Consensus 293 lTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLly 369 (1157)
T KOG4278|consen 293 LTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLY 369 (1157)
T ss_pred eeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch--hhcchhHHHH
Confidence 3689999986543 357899999999999999999999999999999999999999999999965433 3467788899
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 167 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 167 (307)
++.||+.|+.||..+ ++|||||..+|+|+.++..||++|||+++++..+.........-.+-|.|||-+..+.++.|
T Consensus 370 MAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiK 446 (1157)
T KOG4278|consen 370 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 446 (1157)
T ss_pred HHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccc
Confidence 999999999999999 99999999999999999999999999999998876655544445678999999999999999
Q ss_pred CceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCC
Q 021774 168 ADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246 (307)
Q Consensus 168 ~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP 246 (307)
+|||+||++|||+.| |-.|+ ++.+.. .++.....+-. -+.+..+..++.+|++.||++.|.+||
T Consensus 447 SDVWAFGVLLWEIATYGMsPY----PGidlS---qVY~LLEkgyR--------M~~PeGCPpkVYeLMraCW~WsPsDRP 511 (1157)
T KOG4278|consen 447 SDVWAFGVLLWEIATYGMSPY----PGIDLS---QVYGLLEKGYR--------MDGPEGCPPKVYELMRACWNWSPSDRP 511 (1157)
T ss_pred hhhHHHHHHHHHHHhcCCCCC----CCccHH---HHHHHHhcccc--------ccCCCCCCHHHHHHHHHHhcCCcccCc
Confidence 999999999999988 43343 222211 11122221111 123445556788999999999999999
Q ss_pred CHHHHHHHHHhccc
Q 021774 247 QMNQVIKMLTKNIR 260 (307)
Q Consensus 247 s~~~v~~~L~~~~~ 260 (307)
++.|+-+.++..+.
T Consensus 512 sFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 512 SFAEIHQAFETMFS 525 (1157)
T ss_pred cHHHHHHHHHHHhc
Confidence 99999998887764
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=271.32 Aligned_cols=232 Identities=22% Similarity=0.344 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|++..........+.+|+.++++++||||+++++++...+..++||||+++++|.+++. ....+++..
T Consensus 32 ~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~ 107 (267)
T cd06646 32 HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQ 107 (267)
T ss_pred CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCCHHH
Confidence 5688999999976554455678899999999999999999999999999999999999999999883 334688999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc---C
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---G 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~ 161 (307)
+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........ ......|+..|+|||.+. .
T Consensus 108 ~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~ 183 (267)
T cd06646 108 IAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKN 183 (267)
T ss_pred HHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCccccCccccCHhHcccccC
Confidence 999999999999999999 999999999999999999999999999986543221 122345788999999874 3
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|||++|+.|+....+.... ....... ...+.. .........+.+++.+||+.+
T Consensus 184 ~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~---~~~~~~-~~~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06646 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSN---FQPPKL-KDKTKWSSTFHNFVKISLTKN 252 (267)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCC---CCCCCC-ccccccCHHHHHHHHHHhhCC
Confidence 45788999999999999999999987543221100 0000000 000111 111123346888999999999
Q ss_pred cCCCCCHHHHHHHH
Q 021774 242 ASRRPQMNQVIKML 255 (307)
Q Consensus 242 p~~RPs~~~v~~~L 255 (307)
|++||+++++++.|
T Consensus 253 P~~Rp~~~~il~~l 266 (267)
T cd06646 253 PKKRPTAERLLTHL 266 (267)
T ss_pred hhhCcCHHHHhcCC
Confidence 99999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=271.48 Aligned_cols=234 Identities=23% Similarity=0.412 Sum_probs=182.5
Q ss_pred CCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe------eEEEEeccCCCCHHHHhccCCC--C
Q 021774 7 GRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR------RILVYEYVENNSLDRVLLGATK--A 76 (307)
Q Consensus 7 g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~--~ 76 (307)
+..||+|.++.. .......+.+|++.++.++||||+++++++...+. .+++|||+++++|..++..... .
T Consensus 27 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~ 106 (273)
T cd05035 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106 (273)
T ss_pred cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC
Confidence 467999998854 34445689999999999999999999998876554 7899999999999988844332 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCC
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLA 155 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~a 155 (307)
...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++........ ......++..|+|
T Consensus 107 ~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (273)
T cd05035 107 PEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183 (273)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccC
Confidence 34689999999999999999999999 9999999999999999999999999999865433221 1122334568999
Q ss_pred cccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
||.+.+..++.++|||||||++|||++ |..|+..... ..+.... ...... ..+......+.+++
T Consensus 184 pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~--------~~~~~~~~~~~~li 248 (273)
T cd05035 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL----RHGNRL--------KQPEDCLDELYDLM 248 (273)
T ss_pred HhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC--------CCCcCCCHHHHHHH
Confidence 999988889999999999999999999 7777754322 1111111 111111 11223345688899
Q ss_pred HhccccccCCCCCHHHHHHHHHhc
Q 021774 235 FFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
.+||+.||.+||++.+|++.|+++
T Consensus 249 ~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 249 YSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=276.07 Aligned_cols=221 Identities=23% Similarity=0.273 Sum_probs=172.4
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHH-HHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEI-MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++++|...+. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~ 93 (321)
T cd05603 18 SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ----RERCF 93 (321)
T ss_pred CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH----HcCCC
Confidence 468899999987532 22234455554 46788899999999999999999999999999999988873 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05603 94 LEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLR 169 (321)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhc
Confidence 8899999999999999999999 99999999999999999999999999987532221 1233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||..... ..+ ...... .. ...++.....+.+++.+|++.
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~---~~~i~~-~~---------~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQM---YDNILH-KP---------LQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred CCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHH---HHHHhc-CC---------CCCCCCCCHHHHHHHHHHccC
Confidence 88999999999999999999999999865321 111 111111 11 011223344578899999999
Q ss_pred ccCCCCCHH
Q 021774 241 AASRRPQMN 249 (307)
Q Consensus 241 ~p~~RPs~~ 249 (307)
+|.+||++.
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=271.81 Aligned_cols=233 Identities=23% Similarity=0.391 Sum_probs=183.4
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC------CCC
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------ANI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~ 78 (307)
.+..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|.+++..... ...
T Consensus 35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (277)
T cd05032 35 PETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114 (277)
T ss_pred cceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCC
Confidence 35789999987543 34456788999999999999999999999999999999999999999999854322 123
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE 157 (307)
.+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+++....... .......++..|+|||
T Consensus 115 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05032 115 PPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHH
Confidence 478899999999999999999999 999999999999999999999999999876543321 1223344677899999
Q ss_pred cccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
.+.+..++.++|||||||++|||+| |..|+...... ...... ...... ..+......+.+++.+
T Consensus 192 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~--------~~~~~~~~~~~~li~~ 256 (277)
T cd05032 192 SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFV----IDGGHL--------DLPENCPDKLLELMRM 256 (277)
T ss_pred HHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHH----hcCCCC--------CCCCCCCHHHHHHHHH
Confidence 9988889999999999999999998 88887543221 111111 111111 1112224568889999
Q ss_pred ccccccCCCCCHHHHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~ 256 (307)
||+.+|++|||+.+++..|+
T Consensus 257 ~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 257 CWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HcCCChhhCCCHHHHHHHhc
Confidence 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=274.73 Aligned_cols=237 Identities=25% Similarity=0.415 Sum_probs=185.0
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---------
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------- 75 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 75 (307)
+..+|+|.++.. .......+..|+++++++ +||||+++++++......++||||+++|+|.+++.....
T Consensus 44 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~ 123 (314)
T cd05099 44 TVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123 (314)
T ss_pred ceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccc
Confidence 457899988854 344566789999999999 699999999999999999999999999999999855321
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCC
Q 021774 76 ---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTT 151 (307)
Q Consensus 76 ---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~ 151 (307)
....+++..+..++.|++.||.|||++ |++||||||+||++++++.+||+|||+++........ ......++.
T Consensus 124 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 200 (314)
T cd05099 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200 (314)
T ss_pred cCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCc
Confidence 234589999999999999999999999 9999999999999999999999999999866432211 112223445
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
.|+|||++.+..++.++||||||+++|||++ |..||...... .+.... ...... ..+......+
T Consensus 201 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~~--------~~~~~~~~~l 265 (314)
T cd05099 201 KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---ELFKLL----REGHRM--------DKPSNCTHEL 265 (314)
T ss_pred cccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC--------CCCCCCCHHH
Confidence 7999999988889999999999999999999 77777543221 111111 111110 1122233457
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
.+++.+||+.+|++||++.++++.|.++...
T Consensus 266 ~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 7899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=271.25 Aligned_cols=235 Identities=25% Similarity=0.427 Sum_probs=183.1
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 75 (307)
.++..||+|.+... .......+.+|++++++++||||+++++++......++||||+++++|.+++.....
T Consensus 32 ~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 111 (283)
T cd05090 32 DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS 111 (283)
T ss_pred CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccc
Confidence 35678999999754 344456789999999999999999999999999999999999999999999843211
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccC
Q 021774 76 -----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAG 149 (307)
Q Consensus 76 -----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g 149 (307)
....+++..++.++.|++.||.|||++ +++||||||+||++++++.++|+|||++........ .......+
T Consensus 112 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 188 (283)
T cd05090 112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188 (283)
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCc
Confidence 123478999999999999999999999 999999999999999999999999999986543221 12233345
Q ss_pred CCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 150 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
+..|+|||++.+..++.++||||||+++|||++ |..||..... ..... ........ ..+.....
T Consensus 189 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~~~~--------~~~~~~~~ 253 (283)
T cd05090 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE----MVRKRQLL--------PCSEDCPP 253 (283)
T ss_pred cceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcCCcC--------CCCCCCCH
Confidence 667999999988889999999999999999998 8877754321 11111 11111111 01112234
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHh
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
.+.+++.+||+.+|.+||++.+|++.|..
T Consensus 254 ~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 254 RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 57888899999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=268.97 Aligned_cols=229 Identities=27% Similarity=0.391 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccccC-----hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|++||+|.+.... ......+.+|++++++++||||+++++++..++..++|+||+++++|.+++. ....
T Consensus 25 ~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~ 100 (263)
T cd06625 25 DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK----AYGA 100 (263)
T ss_pred CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH----HhCC
Confidence 468899999876432 2234578899999999999999999999999999999999999999999883 3345
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc--ccccCCCCcCCcc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPE 157 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE 157 (307)
+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........... ....++..|+|||
T Consensus 101 ~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (263)
T cd06625 101 LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcc
Confidence 88999999999999999999999 999999999999999999999999999976543211111 2345778899999
Q ss_pred cccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
++.+..++.++||||||+++|||++|+.||........ .......... ...+......+.+++.+|
T Consensus 178 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~--------~~~~~~~~~~~~~li~~~ 243 (263)
T cd06625 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPTN--------PQLPSHVSPDARNFLRRT 243 (263)
T ss_pred eeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccCCC--------CCCCccCCHHHHHHHHHH
Confidence 99998899999999999999999999999865422110 1111111110 111222334577888999
Q ss_pred cccccCCCCCHHHHHHH
Q 021774 238 TQAAASRRPQMNQVIKM 254 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~ 254 (307)
|..+|.+||++.++++.
T Consensus 244 l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 244 FVENAKKRPSAEELLRH 260 (263)
T ss_pred hhcCcccCCCHHHHhhC
Confidence 99999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.27 Aligned_cols=239 Identities=25% Similarity=0.416 Sum_probs=184.0
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-------CCC
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------ANI 78 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~ 78 (307)
+..||+|.+... .......+.+|++++++++||||+++++++..+...+++||++++++|.+++..... ...
T Consensus 46 ~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (296)
T cd05051 46 PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125 (296)
T ss_pred ceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCC
Confidence 457899998865 345567899999999999999999999999999999999999999999999854331 123
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE 157 (307)
.+++..++.++.|++.||+|||++ +++|+||||+||++++++.++|+|||++........ .......++..|+|||
T Consensus 126 ~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (296)
T cd05051 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE 202 (296)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence 689999999999999999999999 999999999999999999999999999876543221 1223344567899999
Q ss_pred cccCCcccccCceeehHHHHHHHHh--CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS--GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
++.+..++.++|||||||++|||++ |..|+..... ................... ...+......+.+++.
T Consensus 203 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~ 274 (296)
T cd05051 203 SVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD---QQVIENAGHFFRDDGRQIY-----LPRPPNCPKDIYELML 274 (296)
T ss_pred HhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---HHHHHHHHhcccccccccc-----CCCccCCCHHHHHHHH
Confidence 9988889999999999999999998 5556543321 1122222221111111000 0112223356889999
Q ss_pred hccccccCCCCCHHHHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~ 256 (307)
+||+.||.+|||+.+|++.|+
T Consensus 275 ~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 275 ECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHhccChhcCCCHHHHHHHhc
Confidence 999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.95 Aligned_cols=230 Identities=26% Similarity=0.302 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|..++.. .....++
T Consensus 23 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~ 100 (285)
T cd05605 23 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFD 100 (285)
T ss_pred CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCC
Confidence 468899999987532 22334578899999999999999999999999999999999999999988742 2234689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ +++||||+|+||++++++.++|+|||++........ .....|+..|+|||++.+
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 101 EERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcC
Confidence 999999999999999999999 999999999999999999999999999986543221 223468899999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||+|+++|||++|..||......... ........... ...+......+.+++.+||+.|
T Consensus 176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05605 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ---------EEYSEKFSEAARSICRQLLTKD 243 (285)
T ss_pred CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc---------cccCcccCHHHHHHHHHHccCC
Confidence 88999999999999999999999998754322111 11111111110 1112223345788899999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|.+|| ++.+++.
T Consensus 244 P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 244 PGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHhcCCCCCCHHHHhc
Confidence 99999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.37 Aligned_cols=230 Identities=27% Similarity=0.401 Sum_probs=194.1
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.||||.-+.. +++..+.|+.|+-++++++||||++++|+|.+. ..++|||+++.|.|..++. .....++...+..
T Consensus 420 aVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~l 495 (974)
T KOG4257|consen 420 AVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQ---QNKDSLPLRTLTL 495 (974)
T ss_pred eeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHH---hccccchHHHHHH
Confidence 4888988875 456678899999999999999999999999876 5699999999999999994 4556789999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 167 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 167 (307)
++.||..||+|||++ .+|||||..+|||+.+..-|||+|||+++.+.++.........-.+-|||||-+.-.+++.+
T Consensus 496 y~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtA 572 (974)
T KOG4257|consen 496 YCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTA 572 (974)
T ss_pred HHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccch
Confidence 999999999999999 99999999999999999999999999999998876665555555678999999999999999
Q ss_pred CceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCC
Q 021774 168 ADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246 (307)
Q Consensus 168 ~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP 246 (307)
+|||-||+++||++. |..||..-...+ .+..+-.......++.++..+..|+.+||+++|.+||
T Consensus 573 SDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRP 637 (974)
T KOG4257|consen 573 SDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRP 637 (974)
T ss_pred hhHHHHHHHHHHHHHhcCCccccccccc---------------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCC
Confidence 999999999999865 888886533211 1122222233345667777899999999999999999
Q ss_pred CHHHHHHHHHhccc
Q 021774 247 QMNQVIKMLTKNIR 260 (307)
Q Consensus 247 s~~~v~~~L~~~~~ 260 (307)
.+.++...|.+++.
T Consensus 638 rftei~~~lsdv~q 651 (974)
T KOG4257|consen 638 RFTEIKAILSDVLQ 651 (974)
T ss_pred cHHHHHHHHHHHHH
Confidence 99999998887764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.23 Aligned_cols=233 Identities=27% Similarity=0.428 Sum_probs=182.3
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+.+++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||+++++|.+++... ....+++
T Consensus 26 ~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 101 (260)
T cd05070 26 TWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG--EGRALKL 101 (260)
T ss_pred EecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc--CCCCCCH
Confidence 446678899999875432 2356899999999999999999999875 45678999999999999998532 2345899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++...............++..|+|||++.+.
T Consensus 102 ~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 178 (260)
T cd05070 102 PNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcC
Confidence 99999999999999999999 999999999999999999999999999987654332222223355679999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|+|++ |..||...... ..... ...... . ..+......+.+++.+|++.+
T Consensus 179 ~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~-----~---~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05070 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQ----VERGYR-----M---PCPQDCPISLHELMLQCWKKD 243 (260)
T ss_pred CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCC-----C---CCCCcCCHHHHHHHHHHcccC
Confidence 89999999999999999999 78887543221 11111 111100 0 111223345888999999999
Q ss_pred cCCCCCHHHHHHHHHh
Q 021774 242 ASRRPQMNQVIKMLTK 257 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~ 257 (307)
|++|||+.++.+.|++
T Consensus 244 p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 244 PEERPTFEYLQSFLED 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=266.36 Aligned_cols=232 Identities=28% Similarity=0.438 Sum_probs=186.9
Q ss_pred CCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC-----CCCC
Q 021774 7 GRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-----NIKL 80 (307)
Q Consensus 7 g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~ 80 (307)
+..|++|.++..... ....+.+|++.++.++|+||+++++++......++||||+++++|.+++...... ...+
T Consensus 23 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 102 (262)
T cd00192 23 TTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102 (262)
T ss_pred CceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccC
Confidence 788999999876432 3678999999999999999999999999999999999999999999998543221 4679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~ 159 (307)
++..++.++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+........ .......++..|+|||.+
T Consensus 103 ~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 103 SLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHh
Confidence 9999999999999999999999 999999999999999999999999999987654321 223345567889999999
Q ss_pred cCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.+..++.++||||||+++|||++ |..||..... ..+.. ....... ...+......+.+++.+||
T Consensus 180 ~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~--------~~~~~~~~~~~~~li~~~l 244 (262)
T cd00192 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLE----YLRKGYR--------LPKPEYCPDELYELMLSCW 244 (262)
T ss_pred ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCC--------CCCCccCChHHHHHHHHHc
Confidence 88889999999999999999999 5888765522 11111 1111111 0112222456888999999
Q ss_pred ccccCCCCCHHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~ 256 (307)
+.+|.+||++.++++.|+
T Consensus 245 ~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 245 QLDPEDRPTFSELVERLE 262 (262)
T ss_pred cCCcccCcCHHHHHHhhC
Confidence 999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=271.09 Aligned_cols=220 Identities=25% Similarity=0.378 Sum_probs=173.6
Q ss_pred CEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 8 RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 8 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
..||+|.+..........|.+|+.++++++||||+++++++......++||||+++++|..++.. ....+++..++.
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~ 121 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKIT 121 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHH
Confidence 46899999866555567889999999999999999999999999999999999999999998842 345688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-------ceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++.|++.||+|||++ +++||||||+||+++..+ .++++|||++...... ....++..|+|||.+.
T Consensus 122 i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 122 VAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhc
Confidence 999999999999999 999999999999997643 3899999988643221 2234678899999886
Q ss_pred C-CcccccCceeehHHHHHHHH-hCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 G-GQLTMKADVYSFGVLVLEII-SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 ~-~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+ ..++.++||||||+++|||+ +|..|+......... ... .... .. +......+.+++.+||
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~~-------~~---~~~~~~~~~~li~~cl 256 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE---RFY----EKKH-------RL---PEPSCKELATLISQCL 256 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH---HHH----Hhcc-------CC---CCCCChHHHHHHHHHc
Confidence 5 56899999999999999985 688887654332111 111 1000 00 0111235788999999
Q ss_pred ccccCCCCCHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKML 255 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L 255 (307)
+.+|++||++.+|++.|
T Consensus 257 ~~~p~~Rps~~~il~~L 273 (274)
T cd05076 257 TYEPTQRPSFRTILRDL 273 (274)
T ss_pred ccChhhCcCHHHHHHhh
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=277.87 Aligned_cols=225 Identities=26% Similarity=0.310 Sum_probs=178.5
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||.++.. .......+..|.++++.+ +||||+++++++...+..++||||+++++|...+. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l 93 (318)
T cd05570 18 GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ----RSGRF 93 (318)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH----HcCCC
Confidence 35789999998854 233456678899999888 79999999999999999999999999999998873 34569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~ 169 (318)
T cd05570 94 DEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILS 169 (318)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhc
Confidence 9999999999999999999999 99999999999999999999999999987532211 1223356899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|+|++|+.||..... ..... ....... ..+......+.+++.+||+.
T Consensus 170 ~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~----~i~~~~~---------~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQ----SILEDEV---------RYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHH----HHHcCCC---------CCCCcCCHHHHHHHHHHccC
Confidence 99999999999999999999999999864321 11111 1111111 01112234578889999999
Q ss_pred ccCCCCCH-----HHHHH
Q 021774 241 AASRRPQM-----NQVIK 253 (307)
Q Consensus 241 ~p~~RPs~-----~~v~~ 253 (307)
||.+||++ .+++.
T Consensus 234 dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 99999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=270.05 Aligned_cols=233 Identities=27% Similarity=0.409 Sum_probs=181.6
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+.+++..+|+|.+.... .....+.+|++++++++|+|++++++++. .+..++||||+.+++|.+++... ....+++
T Consensus 26 ~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~ 101 (260)
T cd05069 26 TWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKL 101 (260)
T ss_pred EEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCH
Confidence 34556689999887543 23357889999999999999999998875 45678999999999999998532 2345889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||+. |++|+||+|+||++++++.++|+|||++...............++..|+|||...+.
T Consensus 102 ~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 178 (260)
T cd05069 102 PQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccC
Confidence 99999999999999999999 999999999999999999999999999986644332222233456789999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||+| |..|+...... .... ....... . ..+......+.+++.+||+.+
T Consensus 179 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~-----~---~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05069 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLE----QVERGYR-----M---PCPQGCPESLHELMKLCWKKD 243 (260)
T ss_pred CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC-----C---CCCcccCHHHHHHHHHHccCC
Confidence 89999999999999999999 88887653321 1111 1111110 0 111223345888899999999
Q ss_pred cCCCCCHHHHHHHHHh
Q 021774 242 ASRRPQMNQVIKMLTK 257 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~ 257 (307)
|.+||++++|++.|++
T Consensus 244 p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 244 PDERPTFEYIQSFLED 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=294.49 Aligned_cols=232 Identities=23% Similarity=0.350 Sum_probs=183.8
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC--------eeEEEEeccCCCCHHHHhccC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--------RRILVYEYVENNSLDRVLLGA 73 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~ 73 (307)
..+|+.||||.+... +......+.+|+.++..++|+||+++...+.... ..++||||+++|+|.+++...
T Consensus 54 ~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~ 133 (496)
T PTZ00283 54 VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSR 133 (496)
T ss_pred cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHh
Confidence 357899999998654 3455667889999999999999999988765432 357999999999999998655
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCC
Q 021774 74 TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTG 152 (307)
Q Consensus 74 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 152 (307)
......+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+..... .......||..
T Consensus 134 ~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~ 210 (496)
T PTZ00283 134 AKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210 (496)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcc
Confidence 55556799999999999999999999999 999999999999999999999999999986643221 22334578999
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...... ... + ..++.....+.+
T Consensus 211 Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~---~~~~~~-~~~----~----~~~~~~~~~l~~ 275 (496)
T PTZ00283 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EV---MHKTLA-GRY----D----PLPPSISPEMQE 275 (496)
T ss_pred eeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHhc-CCC----C----CCCCCCCHHHHH
Confidence 99999999999999999999999999999999998643211 11 111111 111 1 112223345888
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||+.+|.+||++.+++.
T Consensus 276 li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 276 IVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHHHHcccChhhCcCHHHHHh
Confidence 899999999999999999875
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=269.90 Aligned_cols=234 Identities=29% Similarity=0.456 Sum_probs=184.0
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+..++|+.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++||++.+++|.+++... .+..++
T Consensus 25 ~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~ 100 (260)
T cd05067 25 GYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--EGIKLT 100 (260)
T ss_pred eecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc--CCCCCC
Confidence 3456789999998875433 2357899999999999999999999874 45689999999999999988432 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||++...............++..|+|||++.+
T Consensus 101 ~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~ 177 (260)
T cd05067 101 INKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177 (260)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc
Confidence 999999999999999999999 99999999999999999999999999998765332222233445678999999988
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|||++ |+.||...... ..... ....... .. +......+.+++.+||+.
T Consensus 178 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~-----~~---~~~~~~~~~~li~~~l~~ 242 (260)
T cd05067 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN----LERGYRM-----PR---PDNCPEELYELMRLCWKE 242 (260)
T ss_pred CCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH----HHcCCCC-----CC---CCCCCHHHHHHHHHHccC
Confidence 889999999999999999999 89888643321 11111 1111110 01 112234588899999999
Q ss_pred ccCCCCCHHHHHHHHHh
Q 021774 241 AASRRPQMNQVIKMLTK 257 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~ 257 (307)
+|++||++++++..|+.
T Consensus 243 ~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 243 KPEERPTFEYLRSVLED 259 (260)
T ss_pred ChhhCCCHHHHHHHhhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.70 Aligned_cols=238 Identities=24% Similarity=0.307 Sum_probs=175.2
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++. .....+++..
T Consensus 29 ~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~ 104 (303)
T cd07869 29 NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMD---KHPGGLHPEN 104 (303)
T ss_pred CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHH---hCCCCCCHHH
Confidence 68899999987543 2233467889999999999999999999999999999999995 57777763 2335688999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-Cc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 163 (307)
+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++....... .......++..|+|||++.+ ..
T Consensus 105 ~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 180 (303)
T cd07869 105 VKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTE 180 (303)
T ss_pred HHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCC
Confidence 999999999999999999 99999999999999999999999999987543221 12233567889999998875 45
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC--------cccccCCC-CCCCCH----------
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--------PLELVDPE-LGEYPP---------- 224 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~---------- 224 (307)
++.++|||||||++|||++|..||...... ...+.... ....... ......+. .....+
T Consensus 181 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (303)
T cd07869 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLERIF-LVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKL 258 (303)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHH-HHhCCCChhhccchhhccccccccccccCCccHHHHhhcc
Confidence 788999999999999999999998754321 11111111 1000000 00000000 000000
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+|++.||++|||+.++++
T Consensus 259 ~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 259 SYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 01234678899999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=280.92 Aligned_cols=230 Identities=20% Similarity=0.234 Sum_probs=174.4
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||.+.... ......+.+|++++++++|+||+++++.+.+++..++||||+++|+|.+++. ....++
T Consensus 24 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~----~~~~~~ 99 (376)
T cd05598 24 DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RLGIFE 99 (376)
T ss_pred CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCC
Confidence 468899999987432 2334668899999999999999999999999999999999999999999983 345688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc---------------------
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--------------------- 140 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--------------------- 140 (307)
+..+..++.||+.||+|||++ ||+||||||+|||++.++.++|+|||++..+....
T Consensus 100 ~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (376)
T cd05598 100 EDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176 (376)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccc
Confidence 899999999999999999999 99999999999999999999999999975321000
Q ss_pred ---------------------ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHH
Q 021774 141 ---------------------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLL 199 (307)
Q Consensus 141 ---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 199 (307)
........||..|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~ 253 (376)
T cd05598 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET---Q 253 (376)
T ss_pred ccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHH---H
Confidence 0001134689999999999999999999999999999999999999865433211 0
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCC---CHHHHHHH
Q 021774 200 EWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP---QMNQVIKM 254 (307)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP---s~~~v~~~ 254 (307)
......... ...+..... ...+.+++.+|+ .+|.+|+ ++.+++..
T Consensus 254 ---~~i~~~~~~--~~~~~~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 254 ---LKVINWETT--LHIPSQAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ---HHHhccCcc--ccCCCCCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 011110000 000111112 223555666655 4999999 88888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=277.28 Aligned_cols=224 Identities=25% Similarity=0.323 Sum_probs=175.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.++... ......+..|.+++... +||||+++++++...+..++||||+.+++|..++. ....+
T Consensus 18 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~----~~~~~ 93 (316)
T cd05620 18 GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ----DKGRF 93 (316)
T ss_pred CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH----HcCCC
Confidence 368899999987542 23345567788888765 89999999999999999999999999999998883 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ ||+||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05620 94 DLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEILQ 169 (316)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccCCCcCccCHHHHc
Confidence 8999999999999999999999 9999999999999999999999999998743221 11233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||..... ..+.. ...... +.. +......+.+++.+||+.
T Consensus 170 ~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~----~~~~~~------~~~---~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFE----SIRVDT------PHY---PRWITKESKDILEKLFER 233 (316)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhCC------CCC---CCCCCHHHHHHHHHHccC
Confidence 99999999999999999999999999864322 11111 111111 111 111233577888999999
Q ss_pred ccCCCCCHH-HHH
Q 021774 241 AASRRPQMN-QVI 252 (307)
Q Consensus 241 ~p~~RPs~~-~v~ 252 (307)
||.+||++. +++
T Consensus 234 dP~~R~~~~~~~~ 246 (316)
T cd05620 234 DPTRRLGVVGNIR 246 (316)
T ss_pred CHHHcCCChHHHH
Confidence 999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=282.98 Aligned_cols=241 Identities=21% Similarity=0.265 Sum_probs=179.1
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||.+... .......+.+|+++++.++|+||+++++++...+ ..++||||+. ++|.+.+ ...
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~ 97 (372)
T cd07853 23 RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKII----VSP 97 (372)
T ss_pred CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHH----hcC
Confidence 57899999998753 3344567889999999999999999999998776 7899999996 5788777 344
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++...............++..|+|||
T Consensus 98 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE 174 (372)
T cd07853 98 QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174 (372)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHH
Confidence 5789999999999999999999999 9999999999999999999999999999865433322333446788999999
Q ss_pred cccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHH----------------HHHHHhhcCCcccccCCCCC
Q 021774 158 YVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE----------------WAWQLHQEEKPLELVDPELG 220 (307)
Q Consensus 158 ~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 220 (307)
++.+. .++.++|||||||++|||++|+.||............. ..................+.
T Consensus 175 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (372)
T cd07853 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY 254 (372)
T ss_pred HHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc
Confidence 98774 57899999999999999999999986543221110000 00000000000000000000
Q ss_pred CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.........+.+++.+|++.||++|||+.+++.
T Consensus 255 ~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 255 TLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 111222445788999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=281.60 Aligned_cols=229 Identities=22% Similarity=0.261 Sum_probs=177.1
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .......+.+|+++++.++||||+++++++.+.+..++||||+++|+|.+++. ....++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~----~~~~l~ 99 (364)
T cd05599 24 DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM----KKDTFT 99 (364)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH----HcCCCC
Confidence 46889999999753 23445668899999999999999999999999999999999999999999983 344689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-------------------
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH------------------- 142 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~------------------- 142 (307)
+..+..++.|++.||+|||++ +++||||||+|||++.++.++|+|||++..+......
T Consensus 100 ~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (364)
T cd05599 100 EEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176 (364)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccc
Confidence 999999999999999999999 9999999999999999999999999998754321100
Q ss_pred ------------------ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHH
Q 021774 143 ------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ 204 (307)
Q Consensus 143 ------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 204 (307)
......||+.|+|||++.+..++.++|||||||++|||++|..||....... . ...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~---~---~~~ 250 (364)
T cd05599 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE---T---YRK 250 (364)
T ss_pred ccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH---H---HHH
Confidence 0112458999999999998899999999999999999999999986543211 1 111
Q ss_pred HhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCC---HHHHHH
Q 021774 205 LHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ---MNQVIK 253 (307)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs---~~~v~~ 253 (307)
.......... +... .....+.+++.+|+. +|.+|++ +.+++.
T Consensus 251 i~~~~~~~~~--~~~~----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 251 IINWKETLQF--PDEV----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHcCCCccCC--CCCC----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 1110000000 1101 112346677778886 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=270.54 Aligned_cols=237 Identities=25% Similarity=0.393 Sum_probs=179.6
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--------CCCC
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------ANIK 79 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~ 79 (307)
.||+|.++.. .......|.+|++++++++|+|++++++++...+..++||||+++++|.+++..... ....
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 125 (295)
T cd05097 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125 (295)
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCc
Confidence 5899998765 344556799999999999999999999999999999999999999999999843221 1124
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEY 158 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~ 158 (307)
+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||++........ .......++..|+|||+
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 202 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES 202 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence 78899999999999999999999 999999999999999999999999999976533221 11223345678999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhC--CCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISG--RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
+.+..++.++||||||+++|+|+++ ..||..... ................... ...++.....+.+++.+
T Consensus 203 ~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~ 274 (295)
T cd05097 203 ILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---EQVIENTGEFFRNQGRQIY-----LSQTPLCPSPVFKLMMR 274 (295)
T ss_pred hccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---HHHHHHHHHhhhhcccccc-----CCCCCCCCHHHHHHHHH
Confidence 9888899999999999999999984 445543222 1111111111111100000 01111223468899999
Q ss_pred ccccccCCCCCHHHHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~ 256 (307)
||+.+|++||++.+|++.|.
T Consensus 275 ~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 275 CWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HcCCCchhCcCHHHHHHHHh
Confidence 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.36 Aligned_cols=231 Identities=24% Similarity=0.368 Sum_probs=184.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++.. ....+++..
T Consensus 26 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~ 102 (262)
T cd06613 26 ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQ 102 (262)
T ss_pred CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHH
Confidence 45778999999876655667899999999999999999999999999999999999999999998842 225689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC--
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-- 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-- 162 (307)
+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+........ ......++..|+|||.+.+.
T Consensus 103 ~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~ 178 (262)
T cd06613 103 IAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERK 178 (262)
T ss_pred HHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccccccCCccccCchhhccccc
Confidence 999999999999999999 999999999999999999999999999876543221 12334678889999998776
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|+||||+++|+|+||..|+........ .. ....... .+............+.+++.+||+.+
T Consensus 179 ~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~----~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (262)
T cd06613 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LF----LISKSNF-----PPPKLKDKEKWSPVFHDFIKKCLTKD 247 (262)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhccC-----CCccccchhhhhHHHHHHHHHHcCCC
Confidence 788999999999999999999999865432111 10 1111100 01111122334556889999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+||++.+|+.
T Consensus 248 p~~Rpt~~~il~ 259 (262)
T cd06613 248 PKKRPTATKLLQ 259 (262)
T ss_pred hhhCCCHHHHhc
Confidence 999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=274.46 Aligned_cols=238 Identities=26% Similarity=0.429 Sum_probs=185.8
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---------
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------- 75 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 75 (307)
+..+|+|.++.. .......+.+|+++++++ +||||+++++++...+..++||||+++++|.+++.....
T Consensus 50 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 129 (307)
T cd05098 50 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP 129 (307)
T ss_pred cceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence 457999999864 234456788999999999 799999999999999999999999999999999854332
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCC
Q 021774 76 ---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTT 151 (307)
Q Consensus 76 ---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~ 151 (307)
....+++..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||.+......... ......++.
T Consensus 130 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~ 206 (307)
T cd05098 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206 (307)
T ss_pred ccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCcc
Confidence 123588999999999999999999999 9999999999999999999999999998765432111 112223446
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
.|+|||++.+..++.++|||||||++|||++ |..|+..... ..+.. ........ ..+......+
T Consensus 207 ~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~~~~~--------~~~~~~~~~~ 271 (307)
T cd05098 207 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFK----LLKEGHRM--------DKPSNCTNEL 271 (307)
T ss_pred ceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH----HHHcCCCC--------CCCCcCCHHH
Confidence 7999999988889999999999999999998 7777643221 11111 11111110 1122233467
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+++.+||+.+|.+||++.+|++.|.++++..
T Consensus 272 ~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 272 YMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 88999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=269.25 Aligned_cols=230 Identities=27% Similarity=0.401 Sum_probs=179.0
Q ss_pred EEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
++++|.+.... .....++..|+..+++++||||+++++++.. ...++++||+++|+|.+++.. ....+++..+..
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~ 113 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLN 113 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHH
Confidence 47888876443 3344678888999999999999999998764 456789999999999999842 334689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.|++.||+|||++ +++||||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.
T Consensus 114 i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 190 (279)
T cd05111 114 WCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190 (279)
T ss_pred HHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCc
Confidence 999999999999999 9999999999999999999999999999865433221 122344667899999998889999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++||||||+++|||++ |..|+........ ... ........ .+. .....+.+++.+||..+|.+|
T Consensus 191 ~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~~--~~~------~~~~~~~~li~~c~~~~p~~R 255 (279)
T cd05111 191 QSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDL----LEKGERLA--QPQ------ICTIDVYMVMVKCWMIDENVR 255 (279)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCCCcCC--CCC------CCCHHHHHHHHHHcCCCcccC
Confidence 9999999999999998 8888765433211 111 11111100 111 122346778889999999999
Q ss_pred CCHHHHHHHHHhccc
Q 021774 246 PQMNQVIKMLTKNIR 260 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~ 260 (307)
||+.++++.|..+.+
T Consensus 256 ps~~el~~~l~~~~~ 270 (279)
T cd05111 256 PTFKELANEFTRMAR 270 (279)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.41 Aligned_cols=232 Identities=23% Similarity=0.394 Sum_probs=179.3
Q ss_pred EEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCC--CCC
Q 021774 9 RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATK--ANI 78 (307)
Q Consensus 9 ~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~--~~~ 78 (307)
.||+|.++.. +......+.+|++++++++|+||+++++++... ...+++|||+++|+|.+++..... ...
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 6899988754 345567899999999999999999999987542 246899999999999988743221 234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc-cccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE 157 (307)
.+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+|||++..+....... .....++..|++||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence 589999999999999999999999 99999999999999999999999999998764432211 12233566899999
Q ss_pred cccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
+..+..++.++||||||+++|||++ |..||..... .... ......... ..++.....+.+++.+
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~--------~~~~~~~~~~~~li~~ 249 (272)
T cd05075 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIY----DYLRQGNRL--------KQPPDCLDGLYSLMSS 249 (272)
T ss_pred HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHcCCCC--------CCCCCCCHHHHHHHHH
Confidence 9998899999999999999999999 7777754322 1111 111111111 0112233457889999
Q ss_pred ccccccCCCCCHHHHHHHHHhc
Q 021774 237 CTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
||+.+|++|||+.++++.|+++
T Consensus 250 ~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 250 CWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.67 Aligned_cols=231 Identities=20% Similarity=0.238 Sum_probs=176.1
Q ss_pred cCCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+.||||++... .......+.+|++++++++||||+++++++.+.+..|+||||++||+|.+++. ....+
T Consensus 23 ~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~ 98 (377)
T cd05629 23 KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTF 98 (377)
T ss_pred CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH----hcCCC
Confidence 357889999988643 23345678899999999999999999999999999999999999999999983 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc------------------
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH------------------ 142 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~------------------ 142 (307)
++..+..++.|++.||+|||++ ||+||||||+|||++.++.++|+|||+++.+......
T Consensus 99 ~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (377)
T cd05629 99 SEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175 (377)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccc
Confidence 8999999999999999999999 9999999999999999999999999998643211000
Q ss_pred ----------------------------ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccch
Q 021774 143 ----------------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 194 (307)
Q Consensus 143 ----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 194 (307)
......||..|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 255 (377)
T cd05629 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE 255 (377)
T ss_pred ccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH
Confidence 0012468999999999998899999999999999999999999986543211
Q ss_pred hHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC---CCHHHHHHH
Q 021774 195 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR---PQMNQVIKM 254 (307)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R---Ps~~~v~~~ 254 (307)
... ........... +... .....+.+++.+|+. +|.+| +++.+++..
T Consensus 256 ---~~~---~i~~~~~~~~~--p~~~----~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 256 ---TYR---KIINWRETLYF--PDDI----HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ---HHH---HHHccCCccCC--CCCC----CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 111 11110000000 1100 122347778888997 66665 589888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=265.88 Aligned_cols=228 Identities=27% Similarity=0.405 Sum_probs=182.3
Q ss_pred EEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++++|.+++..... ..+++..++.
T Consensus 25 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~ 101 (257)
T cd05040 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCD 101 (257)
T ss_pred EEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHH
Confidence 699999987655 667789999999999999999999999988 888999999999999999854322 4689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCCccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
++.|++.||+|||++ +++|+||+|+||+++.++.+||+|||++......... ......++..|+|||++.+..++
T Consensus 102 ~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 178 (257)
T cd05040 102 YAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178 (257)
T ss_pred HHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcC
Confidence 999999999999999 9999999999999999999999999999876543221 11234567789999999888999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++|||||||++|||++ |..||...... ........ ..... ..+......+.+++.+||+.+|++
T Consensus 179 ~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~---~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd05040 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDK---EGERL--------ERPEACPQDIYNVMLQCWAHNPAD 244 (257)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh---cCCcC--------CCCccCCHHHHHHHHHHCCCCccc
Confidence 99999999999999999 99887543221 11111111 11000 011122345788899999999999
Q ss_pred CCCHHHHHHHHH
Q 021774 245 RPQMNQVIKMLT 256 (307)
Q Consensus 245 RPs~~~v~~~L~ 256 (307)
||++.+++..|.
T Consensus 245 Rps~~~~~~~l~ 256 (257)
T cd05040 245 RPTFAALREFLP 256 (257)
T ss_pred CCCHHHHHHHhc
Confidence 999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.46 Aligned_cols=237 Identities=24% Similarity=0.339 Sum_probs=173.6
Q ss_pred CCCEEEEEEccccC--hHhHHHHHHHHHHHhcC---CCCCccceeeEEEe-----CCeeEEEEeccCCCCHHHHhccCCC
Q 021774 6 NGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 6 ~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
+|+.||+|.++... ......+.+|+.+++++ +||||+++++++.. ....++||||+. ++|.+++...
T Consensus 26 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-- 102 (290)
T cd07862 26 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV-- 102 (290)
T ss_pred CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC--
Confidence 46789999887542 22234566777777665 69999999999862 446799999996 5898888432
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
....+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++...... .......|+..|+|
T Consensus 103 ~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~a 177 (290)
T cd07862 103 PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRA 177 (290)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccC
Confidence 234589999999999999999999999 9999999999999999999999999999865433 22334568899999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC----Ccc------cccCCC----CCC
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE----KPL------ELVDPE----LGE 221 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~------~~~~~~----~~~ 221 (307)
||++.+..++.++|||||||++|||++|.+||....... ....+....... ... ..+.+. +..
T Consensus 178 PE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T cd07862 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 254 (290)
T ss_pred hHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHH
Confidence 999988899999999999999999999999987543321 111111111000 000 000000 001
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..+.....+.+++.+|++.||++|||+.++++
T Consensus 255 ~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 255 FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11223345678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=273.59 Aligned_cols=237 Identities=25% Similarity=0.419 Sum_probs=185.2
Q ss_pred CEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC----------
Q 021774 8 RRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------- 75 (307)
Q Consensus 8 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 75 (307)
..||+|.++... ......+.+|+++++++ +||||+++++++...+..+++|||+++|+|.+++.....
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (334)
T cd05100 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124 (334)
T ss_pred eeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 468999887542 34557899999999999 899999999999999999999999999999999854321
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCC
Q 021774 76 --ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTG 152 (307)
Q Consensus 76 --~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~ 152 (307)
....+++..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||+++........ ......++..
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 201 (334)
T cd05100 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201 (334)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCce
Confidence 234588999999999999999999999 9999999999999999999999999999865432211 1222334467
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
|+|||++.+..++.++||||||+++|||++ |..||..... ..+.. . ....... ..+......+.
T Consensus 202 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~---~-~~~~~~~--------~~~~~~~~~l~ 266 (334)
T cd05100 202 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EELFK---L-LKEGHRM--------DKPANCTHELY 266 (334)
T ss_pred EcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHH---H-HHcCCCC--------CCCCCCCHHHH
Confidence 999999999899999999999999999998 7777654321 11111 1 1111110 11122334588
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+++.+||+.+|.+||++.++++.|+++....
T Consensus 267 ~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 267 MIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 8999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=275.35 Aligned_cols=222 Identities=24% Similarity=0.270 Sum_probs=173.4
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++++|...+. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~ 93 (325)
T cd05604 18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ----RERSF 93 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH----HcCCC
Confidence 46899999998754 2233344555554 5677899999999999999999999999999999988873 44568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ |++||||||+|||+++++.++|+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05604 94 PEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIR 169 (325)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999987532211 1233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||...... .+ ......... ...+.....+.+++.+|++.
T Consensus 170 ~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~---~~~~~~~~~----------~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EM---YDNILHKPL----------VLRPGASLTAWSILEELLEK 233 (325)
T ss_pred CCCCCCcCccccccceehhhhcCCCCCCCCCHH---HH---HHHHHcCCc----------cCCCCCCHHHHHHHHHHhcc
Confidence 999999999999999999999999998643211 11 111111110 01112334577889999999
Q ss_pred ccCCCCCHHH
Q 021774 241 AASRRPQMNQ 250 (307)
Q Consensus 241 ~p~~RPs~~~ 250 (307)
+|.+||++.+
T Consensus 234 ~p~~R~~~~~ 243 (325)
T cd05604 234 DRQRRLGAKE 243 (325)
T ss_pred CHHhcCCCCC
Confidence 9999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.06 Aligned_cols=230 Identities=28% Similarity=0.445 Sum_probs=182.0
Q ss_pred CEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 8 RRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 8 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
..+|+|.++... ......+.+|+.++++++||||+++++++..++..++||||+++++|.+++.. ....+++..++
T Consensus 33 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~ 109 (267)
T cd05066 33 IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLV 109 (267)
T ss_pred eEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHH
Confidence 379999887543 34456899999999999999999999999999999999999999999999842 23468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc--ccccCCCCcCCcccccCCcc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~ 164 (307)
.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++..+........ ....++..|+|||++.+..+
T Consensus 110 ~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 186 (267)
T cd05066 110 GMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186 (267)
T ss_pred HHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCcc
Confidence 9999999999999999 999999999999999999999999999987654322111 12223457999999998899
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++|+||||+++||+++ |..||....... ..... ...... +. +......+.+++.+|++.+|.
T Consensus 187 ~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~~~----~~----~~~~~~~~~~li~~~l~~~p~ 251 (267)
T cd05066 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGYRL----PA----PMDCPAALHQLMLDCWQKDRN 251 (267)
T ss_pred CchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCCcC----CC----CCCCCHHHHHHHHHHcccCch
Confidence 999999999999999886 998876543211 11111 111100 11 112234578899999999999
Q ss_pred CCCCHHHHHHHHHhc
Q 021774 244 RRPQMNQVIKMLTKN 258 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~ 258 (307)
+||++.++++.|.++
T Consensus 252 ~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 252 ERPKFEQIVSILDKL 266 (267)
T ss_pred hCCCHHHHHHHHHhh
Confidence 999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=278.63 Aligned_cols=179 Identities=23% Similarity=0.308 Sum_probs=154.6
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++.... ......+..|+.++.+++|+||+++++++.+....++||||++||+|.+++. ....++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~ 99 (363)
T cd05628 24 DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLT 99 (363)
T ss_pred CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH----hcCCCC
Confidence 468899999997532 3344578889999999999999999999999999999999999999999983 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--------------------
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------------------- 141 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------------------- 141 (307)
+..+..++.|++.||+|||++ ||+||||||+|||++.++.++|+|||++........
T Consensus 100 ~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (363)
T cd05628 100 EEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176 (363)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccc
Confidence 999999999999999999999 999999999999999999999999999875432110
Q ss_pred --------------cccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 142 --------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 142 --------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
.......||..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012356899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=268.00 Aligned_cols=230 Identities=20% Similarity=0.340 Sum_probs=180.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++++|.+++. ....+++..
T Consensus 32 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 107 (267)
T cd06645 32 NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQ 107 (267)
T ss_pred CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH----hcCCCCHHH
Confidence 4688999999887655555678899999999999999999999999999999999999999999983 344689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc---C
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---G 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~ 161 (307)
++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++. .
T Consensus 108 ~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 183 (267)
T cd06645 108 IAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERK 183 (267)
T ss_pred HHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccccccCcccccChhhhccccC
Confidence 999999999999999999 99999999999999999999999999987654321 1223456889999999874 4
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+|||||++|+|++|..|+....+... + ......... .+.... .......+.+++.+|++.+
T Consensus 184 ~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~~~~~~~----~~~~~~-~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06645 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMTKSNFQ----PPKLKD-KMKWSNSFHHFVKMALTKN 252 (267)
T ss_pred CCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----HhhhccCCC----CCcccc-cCCCCHHHHHHHHHHccCC
Confidence 5688999999999999999999998754332111 1 010000000 011100 0112234778899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++||++.+|++
T Consensus 253 P~~R~~~~~ll~ 264 (267)
T cd06645 253 PKKRPTAEKLLQ 264 (267)
T ss_pred chhCcCHHHHhc
Confidence 999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=271.75 Aligned_cols=234 Identities=27% Similarity=0.429 Sum_probs=183.7
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
++..||||.++... ......+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++... ....+++.
T Consensus 64 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~ 141 (302)
T cd05055 64 AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLE 141 (302)
T ss_pred ceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHH
Confidence 35579999887553 34456789999999999 8999999999999999999999999999999998432 22348999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+.
T Consensus 142 ~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 218 (302)
T cd05055 142 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218 (302)
T ss_pred HHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC
Confidence 9999999999999999999 9999999999999999999999999999865443221 12223456789999999988
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..|+........ +. ......... ..+......+.+++.+|++.+
T Consensus 219 ~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~ 284 (302)
T cd05055 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY----KLIKEGYRM--------AQPEHAPAEIYDIMKTCWDAD 284 (302)
T ss_pred CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH----HHHHcCCcC--------CCCCCCCHHHHHHHHHHcCCC
Confidence 89999999999999999998 8888754332111 11 111111110 001112345888999999999
Q ss_pred cCCCCCHHHHHHHHHhc
Q 021774 242 ASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~ 258 (307)
|++||++.++++.|+++
T Consensus 285 p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 285 PLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred chhCcCHHHHHHHHHhh
Confidence 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=264.50 Aligned_cols=230 Identities=27% Similarity=0.417 Sum_probs=181.0
Q ss_pred CCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+..+|+|.+..... .....+.+|+.++++++|+||+++++++. .+..++||||+.+++|.+++. ....+++..+
T Consensus 23 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~ 97 (257)
T cd05060 23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK----KRREIPVSDL 97 (257)
T ss_pred cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH----hCCCCCHHHH
Confidence 36899999886543 34567899999999999999999999876 446799999999999999984 2336899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc--ccccCCCCcCCcccccCCc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~ 163 (307)
+.++.|++.||+|||.. +++|+||||+||+++.++.++|+|||+++.......... ....++..|+|||++.+..
T Consensus 98 ~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05060 98 KELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174 (257)
T ss_pred HHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC
Confidence 99999999999999999 999999999999999999999999999986644322211 1122346799999998889
Q ss_pred ccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
++.++||||||+++|+|++ |..||..... ..+..... ..... ..+......+.+++.+||+.+|
T Consensus 175 ~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~--------~~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERL--------PRPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred CCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcC--------CCCCCCCHHHHHHHHHHhcCCh
Confidence 9999999999999999998 8888765432 11211111 11110 1112223457889999999999
Q ss_pred CCCCCHHHHHHHHHhcc
Q 021774 243 SRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 243 ~~RPs~~~v~~~L~~~~ 259 (307)
.+||++.+|++.|+++.
T Consensus 240 ~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 240 EDRPTFSELESTFRRDP 256 (257)
T ss_pred hhCcCHHHHHHHHHhcc
Confidence 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=266.12 Aligned_cols=230 Identities=25% Similarity=0.427 Sum_probs=182.0
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.+|+|.+... .......+..|++++++++|+||+++++++...+..++||||+++++|.+++.. ....+++..+..
T Consensus 35 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~ 111 (268)
T cd05063 35 AVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVG 111 (268)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHH
Confidence 7999998765 344456799999999999999999999999999999999999999999999843 335689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc--ccccCCCCcCCcccccCCccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~ 165 (307)
++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........... .....+..|+|||++.+..++
T Consensus 112 ~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (268)
T cd05063 112 MLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188 (268)
T ss_pred HHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC
Confidence 999999999999999 999999999999999999999999999986643222111 112234579999999888899
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++|||||||++|||++ |..|+..... ....... ..... .+. .......+.+++.+||+.+|.+
T Consensus 189 ~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i----~~~~~----~~~----~~~~~~~~~~li~~c~~~~p~~ 253 (268)
T cd05063 189 SASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI----NDGFR----LPA----PMDCPSAVYQLMLQCWQQDRAR 253 (268)
T ss_pred hHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH----hcCCC----CCC----CCCCCHHHHHHHHHHcCCCccc
Confidence 99999999999999997 9988754322 1111111 11110 011 1122345788999999999999
Q ss_pred CCCHHHHHHHHHhcc
Q 021774 245 RPQMNQVIKMLTKNI 259 (307)
Q Consensus 245 RPs~~~v~~~L~~~~ 259 (307)
||++.+|++.|++++
T Consensus 254 Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 254 RPRFVDIVNLLDKLL 268 (268)
T ss_pred CcCHHHHHHHHHhhC
Confidence 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=277.79 Aligned_cols=230 Identities=20% Similarity=0.232 Sum_probs=174.9
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .......+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++. ...++
T Consensus 66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~-----~~~~~ 140 (370)
T cd05621 66 SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-----NYDVP 140 (370)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-----hcCCC
Confidence 45789999998642 22334568899999999999999999999999999999999999999999983 23578
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++...............||..|+|||++.+
T Consensus 141 ~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 141 EKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhc
Confidence 899999999999999999999 99999999999999999999999999998764433222345679999999999865
Q ss_pred C----cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 162 G----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 162 ~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
. .++.++|||||||++|||++|..||....... . ............. +. .......+.+++..|
T Consensus 218 ~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---~---~~~i~~~~~~~~~--p~----~~~~s~~~~~li~~~ 285 (370)
T cd05621 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---T---YSKIMDHKNSLNF--PE----DVEISKHAKNLICAF 285 (370)
T ss_pred cCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCcccCC--CC----cccCCHHHHHHHHHH
Confidence 4 37889999999999999999999986543211 1 1111111110000 00 011223466677778
Q ss_pred cccccCC--CCCHHHHHHH
Q 021774 238 TQAAASR--RPQMNQVIKM 254 (307)
Q Consensus 238 ~~~~p~~--RPs~~~v~~~ 254 (307)
+..++.+ |+++.++++.
T Consensus 286 L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 286 LTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCchhccCCCCHHHHhcC
Confidence 8755443 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=266.18 Aligned_cols=230 Identities=27% Similarity=0.463 Sum_probs=180.9
Q ss_pred CEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 8 RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 8 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
..||||.++.. .......|..|+.++++++||||+++++++..+...++||||+++++|.+++.. ....+++..++
T Consensus 33 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~ 109 (269)
T cd05065 33 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLV 109 (269)
T ss_pred eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHH
Confidence 36999998865 455567899999999999999999999999999999999999999999999843 23468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc--ccc--cCCCCcCCcccccCC
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT--TRI--AGTTGYLAPEYVLGG 162 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~--~g~~~y~aPE~~~~~ 162 (307)
.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++........... ... ..+..|+|||++.+.
T Consensus 110 ~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (269)
T cd05065 110 GMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186 (269)
T ss_pred HHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccC
Confidence 9999999999999999 999999999999999999999999999876544322111 111 123479999999988
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..||...... .....+ ...... +. +......+.+++.+||+.+
T Consensus 187 ~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~~~----~~----~~~~~~~~~~li~~~l~~~ 251 (269)
T cd05065 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDYRL----PP----PMDCPTALHQLMLDCWQKD 251 (269)
T ss_pred cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCcC----CC----cccCCHHHHHHHHHHcCCC
Confidence 99999999999999999886 88887543221 111111 111100 01 1122344778899999999
Q ss_pred cCCCCCHHHHHHHHHhc
Q 021774 242 ASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~ 258 (307)
|.+||++.+|+..|+++
T Consensus 252 p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 252 RNARPKFGQIVSTLDKM 268 (269)
T ss_pred hhhCcCHHHHHHHHHhh
Confidence 99999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.52 Aligned_cols=224 Identities=27% Similarity=0.327 Sum_probs=175.6
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.++... ......+..|..++... +||||+++++++...+..++||||+++|+|..++. ....+
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~----~~~~~ 93 (316)
T cd05619 18 GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKF 93 (316)
T ss_pred CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCC
Confidence 457899999987541 23345567788888765 99999999999999999999999999999999983 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05619 94 DLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILL 169 (316)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHc
Confidence 8999999999999999999999 99999999999999999999999999987532211 1223456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||..... ..+... ..... +.. +......+.+++.+||+.
T Consensus 170 ~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~----i~~~~------~~~---~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQS----IRMDN------PCY---PRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCC------CCC---CccCCHHHHHHHHHHhcc
Confidence 98999999999999999999999999865322 111111 11111 111 111223477888999999
Q ss_pred ccCCCCCHH-HHH
Q 021774 241 AASRRPQMN-QVI 252 (307)
Q Consensus 241 ~p~~RPs~~-~v~ 252 (307)
||.+||++. ++.
T Consensus 234 ~P~~R~~~~~~l~ 246 (316)
T cd05619 234 EPERRLGVKGDIR 246 (316)
T ss_pred CHhhcCCChHHHH
Confidence 999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=267.25 Aligned_cols=229 Identities=24% Similarity=0.405 Sum_probs=179.5
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|..+. .+++.
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~ 95 (279)
T cd06619 24 LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEH 95 (279)
T ss_pred CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHH
Confidence 56889999988654 3445567999999999999999999999999999999999999999997653 36788
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++...... ......|+..|+|||++.+..
T Consensus 96 ~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 169 (279)
T cd06619 96 VLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQ 169 (279)
T ss_pred HHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChhhcCceeecCCC
Confidence 8999999999999999999 9999999999999999999999999999765432 123356888999999999888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++||||||+++|+|++|..||........................ +.+. .......+.+++.+||+.+|+
T Consensus 170 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~li~~~l~~~P~ 242 (279)
T cd06619 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----PVLP--VGQFSEKFVHFITQCMRKQPK 242 (279)
T ss_pred CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----CCCC--CCcCCHHHHHHHHHHhhCChh
Confidence 999999999999999999999998654332211111111111111111 1110 111223578889999999999
Q ss_pred CCCCHHHHHHH
Q 021774 244 RRPQMNQVIKM 254 (307)
Q Consensus 244 ~RPs~~~v~~~ 254 (307)
+||+++++++.
T Consensus 243 ~Rp~~~eil~~ 253 (279)
T cd06619 243 ERPAPENLMDH 253 (279)
T ss_pred hCCCHHHHhcC
Confidence 99999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.89 Aligned_cols=231 Identities=26% Similarity=0.375 Sum_probs=179.4
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-----------
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------- 75 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------- 75 (307)
.+++|.++.. .......+.+|+++++++ +||||+++++++...+..++||||+++++|.+++.....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 103 (270)
T cd05047 24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103 (270)
T ss_pred EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 4688888754 345556889999999999 899999999999999999999999999999999854321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 76 -ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 76 -~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++...... ........+..|+
T Consensus 104 ~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~ 178 (270)
T cd05047 104 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWM 178 (270)
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchh--hhccCCCCccccC
Confidence 123578999999999999999999999 9999999999999999999999999998632211 1111122355799
Q ss_pred CcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
|||++.+..++.++||||||+++|||++ |..||...... ... ......... ..+......+.++
T Consensus 179 apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~----~~~~~~~~~--------~~~~~~~~~~~~l 243 (270)
T cd05047 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY----EKLPQGYRL--------EKPLNCDDEVYDL 243 (270)
T ss_pred ChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHH----HHHhCCCCC--------CCCCcCCHHHHHH
Confidence 9999988889999999999999999997 88887543211 111 111111000 0111223457889
Q ss_pred HHhccccccCCCCCHHHHHHHHHhcc
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
+.+||+.+|.+|||+.+++..|.+++
T Consensus 244 i~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 244 MRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHcccChhhCCCHHHHHHHHHHhh
Confidence 99999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.29 Aligned_cols=234 Identities=26% Similarity=0.427 Sum_probs=182.2
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---------
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------- 75 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 75 (307)
++..||+|.+... .......+.+|+.++++++||||+++++++.++...++||||+++++|.+++.....
T Consensus 34 ~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (288)
T cd05050 34 PFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113 (288)
T ss_pred cceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 5678999998765 344556799999999999999999999999999999999999999999999853221
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccc
Q 021774 76 ---------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITT 145 (307)
Q Consensus 76 ---------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~ 145 (307)
....+++..++.++.|++.||+|||++ +++||||+|+||++++++.++|+|||++........ ....
T Consensus 114 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 190 (288)
T cd05050 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190 (288)
T ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccC
Confidence 123478899999999999999999999 999999999999999999999999999875433221 1112
Q ss_pred cccCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCH
Q 021774 146 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 224 (307)
Q Consensus 146 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (307)
....+..|+|||.+.+..++.++|||||||++|||++ |..|+...... ... ......... ..+.
T Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---~~~----~~~~~~~~~--------~~~~ 255 (288)
T cd05050 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---EVI----YYVRDGNVL--------SCPD 255 (288)
T ss_pred CCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhcCCCC--------CCCC
Confidence 2234567999999988899999999999999999998 77776433211 111 111111111 1122
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHHHHHh
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
.....+.+++.+||+.+|.+||++.|+++.|++
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 256 NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 234568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=279.44 Aligned_cols=179 Identities=23% Similarity=0.310 Sum_probs=152.9
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++. ....++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~ 99 (382)
T cd05625 24 DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFP 99 (382)
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCC
Confidence 468899999987542 3345678899999999999999999999999999999999999999999983 334688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc---------------------
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--------------------- 140 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--------------------- 140 (307)
+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 100 e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (382)
T cd05625 100 EDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccc
Confidence 999999999999999999999 99999999999999999999999999975321000
Q ss_pred -------------------------ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 141 -------------------------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 141 -------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred ccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 00012346899999999999989999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=270.57 Aligned_cols=227 Identities=23% Similarity=0.430 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+..........+.+|+.+++.++|+||+++++.+......++||||+++++|.+++. ...+++..
T Consensus 43 ~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~ 117 (296)
T cd06654 43 ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQ 117 (296)
T ss_pred CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH-----hcCCCHHH
Confidence 4688999998886654555778999999999999999999999999999999999999999999983 23578999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||+|||++ |++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 118 ~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred HHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCC
Confidence 999999999999999999 999999999999999999999999999876533211 1223467889999999988888
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|||||||++|+|++|+.||........ +. ........ . + ..+......+.+++.+||..+|++
T Consensus 194 ~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~----~~~~~~~~-~-----~-~~~~~~~~~l~~li~~~l~~~p~~ 260 (296)
T cd06654 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATNGTP-E-----L-QNPEKLSAIFRDFLNRCLDMDVEK 260 (296)
T ss_pred CccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HH----HHhcCCCC-C-----C-CCccccCHHHHHHHHHHCcCCccc
Confidence 9999999999999999999999865432111 10 11111110 0 0 111223345788999999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
||++.+++.
T Consensus 261 Rpt~~eil~ 269 (296)
T cd06654 261 RGSAKELLQ 269 (296)
T ss_pred CcCHHHHhh
Confidence 999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=273.05 Aligned_cols=239 Identities=26% Similarity=0.435 Sum_probs=184.9
Q ss_pred CCCCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|..||||.++..... ....|.+|++++++++|+||+++++++.. ....++||||+++++|.+++.. ....++
T Consensus 31 ~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~ 107 (284)
T cd05038 31 NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQIN 107 (284)
T ss_pred CCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccC
Confidence 35789999999866442 56789999999999999999999999887 5578999999999999999843 223589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~ 159 (307)
+..++.++.|++.||+|||++ |++|+||+|+||+++.++.++|+|||.+......... ......++..|++||.+
T Consensus 108 ~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 184 (284)
T cd05038 108 LKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHH
Confidence 999999999999999999999 9999999999999999999999999999876532221 11123345579999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhH---------HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK---------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
.+..++.++||||||+++|||+||..|+......... ...... ......... ..+......+
T Consensus 185 ~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~ 255 (284)
T cd05038 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELLKEGERL--------PRPPSCPDEV 255 (284)
T ss_pred ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHHHcCCcC--------CCCccCCHHH
Confidence 8888999999999999999999999887543322100 000111 111111100 0112223568
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHhc
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
.+++.+||+.+|++||++.+|++.|+++
T Consensus 256 ~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 256 YDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 8899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=275.35 Aligned_cols=181 Identities=20% Similarity=0.261 Sum_probs=150.2
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||+++++|.+++..+. ...+++
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~l~~ 100 (327)
T cd08227 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMSE 100 (327)
T ss_pred ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc--cCCCCH
Confidence 568899999997642 3444567789999999999999999999999999999999999999999984322 235899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc------ccccccCCCCcCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAP 156 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aP 156 (307)
..+..++.|++.||+|||++ +++||||||+||+++.++.++++||+........... ......++..|+||
T Consensus 101 ~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (327)
T cd08227 101 LAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177 (327)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccCh
Confidence 99999999999999999999 9999999999999999999999999865433221110 11223456779999
Q ss_pred ccccC--CcccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 157 EYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 157 E~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
|++.+ ..++.++|||||||++|||++|+.||...
T Consensus 178 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99876 46889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.61 Aligned_cols=236 Identities=25% Similarity=0.386 Sum_probs=176.6
Q ss_pred CCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-CCCCCCHHH
Q 021774 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-ANIKLNWEK 84 (307)
Q Consensus 7 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~ 84 (307)
+..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+|.+++..... .....++..
T Consensus 22 ~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 101 (269)
T cd05087 22 PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101 (269)
T ss_pred ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHH
Confidence 4579999887653 33445789999999999999999999999999999999999999999999854332 223567788
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCC-
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGG- 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~- 162 (307)
+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......... ......++..|+|||++.+.
T Consensus 102 ~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (269)
T cd05087 102 LQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178 (269)
T ss_pred HHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccc
Confidence 889999999999999999 9999999999999999999999999999754332221 12234567789999988542
Q ss_pred ------cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 163 ------QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 163 ------~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
.++.++||||||+++|||++ |..||....... ...... ........++.+.... ...+.+++.
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~---~~~~~~l~~ 248 (269)
T cd05087 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV----REQQLKLPKPRLKLPL---SDRWYEVMQ 248 (269)
T ss_pred ccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh----hcccCCCCCCccCCCC---ChHHHHHHH
Confidence 35789999999999999996 998886543221 111111 1111112222222112 223566777
Q ss_pred hccccccCCCCCHHHHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~ 256 (307)
+|| .+|++|||+.+|.+.|+
T Consensus 249 ~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 249 FCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHh-cCcccCCCHHHHHHHhc
Confidence 899 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=267.70 Aligned_cols=236 Identities=22% Similarity=0.352 Sum_probs=185.0
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeccCCCCHHHHhccCCCC----CCCC
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKA----NIKL 80 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~ 80 (307)
+..|++|.+... .......+.+|+.++++++|+||+++++++.. ....+++++|+++++|.+++...... ...+
T Consensus 35 ~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l 114 (280)
T cd05043 35 EEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114 (280)
T ss_pred eeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCC
Confidence 678999988754 34556778999999999999999999998876 46789999999999999998544322 1568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~ 159 (307)
++..++.++.|++.||+|||++ +++|+||+|+||++++++.+||+|||+++.+...... ......++..|+|||++
T Consensus 115 ~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 9999999999999999999999 9999999999999999999999999999865432221 12223456789999999
Q ss_pred cCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.+..++.++||||||+++||+++ |+.|+..... ..+. .......... ........+.+++.+||
T Consensus 192 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~~--------~~~~~~~~~~~li~~~l 256 (280)
T cd05043 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMA----AYLKDGYRLA--------QPINCPDELFAVMACCW 256 (280)
T ss_pred hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHH----HHHHcCCCCC--------CCCcCCHHHHHHHHHHc
Confidence 88889999999999999999999 8888754322 1111 1111111100 01112345788999999
Q ss_pred ccccCCCCCHHHHHHHHHhccc
Q 021774 239 QAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
..+|++|||+.+++..|+++.+
T Consensus 257 ~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 257 ALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCChhhCCCHHHHHHHHHHHHh
Confidence 9999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=267.90 Aligned_cols=233 Identities=27% Similarity=0.377 Sum_probs=180.5
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---CCCCCC
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~ 81 (307)
.+..||+|...... ......|.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++..... ....++
T Consensus 35 ~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~ 114 (277)
T cd05036 35 VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114 (277)
T ss_pred CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCC
Confidence 46789999887543 44456799999999999999999999999999999999999999999999854432 123589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
+..++.++.||+.||+|||++ +++||||+|+||+++.++ .++|+|||+++........ .......+..|+|||
T Consensus 115 ~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05036 115 MKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHH
Confidence 999999999999999999999 999999999999998765 5999999999866332111 111223346799999
Q ss_pred cccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
++.+..++.++|||||||++|||++ |..||...... .+.... ...... ..+......+.+++.+
T Consensus 192 ~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~---~~~~~~---------~~~~~~~~~~~~~i~~ 256 (277)
T cd05036 192 AFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV---TGGGRL---------DPPKGCPGPVYRIMTD 256 (277)
T ss_pred HHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---HcCCcC---------CCCCCCCHHHHHHHHH
Confidence 9998899999999999999999997 88887643321 111111 111110 1112223467889999
Q ss_pred ccccccCCCCCHHHHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~ 256 (307)
|++.+|++||++.+|++.|+
T Consensus 257 cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 257 CWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCCcccCcCHHHHHHHhh
Confidence 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=266.04 Aligned_cols=229 Identities=21% Similarity=0.345 Sum_probs=184.3
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.+++|.+... +.....++.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++... ....+++
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~ 100 (256)
T cd08221 23 EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEE 100 (256)
T ss_pred CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCH
Confidence 56889999987754 3455677899999999999999999999999999999999999999999998532 2456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ ......++..|+|||++.+.
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~ 176 (256)
T cd08221 101 EMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGV 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCC
Confidence 99999999999999999999 999999999999999999999999999986644332 22345678899999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++||||||+++|||++|..|+...... .......... . ..........+.+++.+||+.+|
T Consensus 177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~-~--------~~~~~~~~~~~~~~i~~~l~~~p 241 (256)
T cd08221 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQGN-Y--------TPVVSVYSSELISLVHSLLQQDP 241 (256)
T ss_pred CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC-C--------CCCccccCHHHHHHHHHHcccCc
Confidence 8899999999999999999999987543221 1111111111 1 01112233457788899999999
Q ss_pred CCCCCHHHHHHH
Q 021774 243 SRRPQMNQVIKM 254 (307)
Q Consensus 243 ~~RPs~~~v~~~ 254 (307)
.+||++.++++.
T Consensus 242 ~~R~s~~~ll~~ 253 (256)
T cd08221 242 EKRPTADEVLDQ 253 (256)
T ss_pred ccCCCHHHHhhC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=266.96 Aligned_cols=232 Identities=25% Similarity=0.393 Sum_probs=181.2
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
+||+|.++.. .......+.+|+.+++.++|+||+++++++... ..++++|++++|+|.+++.. ....+++..++.
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~ 113 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLN 113 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHH
Confidence 4899998764 344556789999999999999999999998754 46789999999999999843 234689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.|++.||+|||++ +++||||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.
T Consensus 114 ~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05109 114 WCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190 (279)
T ss_pred HHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCc
Confidence 999999999999999 9999999999999999999999999999876533221 112223456799999998888999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++|||||||++|||++ |..|+...... .+..... ..... ..+......+.+++.+||+.||++|
T Consensus 191 ~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R 255 (279)
T cd05109 191 QSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KGERL--------PQPPICTIDVYMIMVKCWMIDSECR 255 (279)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCCcC--------CCCccCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999998 88887543321 1111111 11110 0111233457889999999999999
Q ss_pred CCHHHHHHHHHhccccC
Q 021774 246 PQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~~~ 262 (307)
|++.++++.|++..+..
T Consensus 256 p~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 256 PRFRELVDEFSRMARDP 272 (279)
T ss_pred cCHHHHHHHHHHhhcCC
Confidence 99999999998776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=273.41 Aligned_cols=232 Identities=21% Similarity=0.190 Sum_probs=175.8
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .......+.+|..++..++|+||+++++++.+.+..++||||++||+|.+++.. ....++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~ 100 (331)
T cd05624 24 HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLP 100 (331)
T ss_pred CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCC
Confidence 46788999998742 223345688899999999999999999999999999999999999999999843 234688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...............|+..|+|||++.+
T Consensus 101 ~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 101 EDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhc
Confidence 999999999999999999999 99999999999999999999999999998765443333334568999999998875
Q ss_pred -----CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 162 -----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 162 -----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
+.++.++||||||+++|||++|+.||...... ............. .+..........+.+++.+
T Consensus 178 ~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~-----~~p~~~~~~~~~~~~li~~ 246 (331)
T cd05624 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF-----QFPSHITDVSEEAKDLIQR 246 (331)
T ss_pred cccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc-----cCCCccccCCHHHHHHHHH
Confidence 46788999999999999999999998643221 1111111111100 0111111223457778888
Q ss_pred ccccccCC--CCCHHHHHH
Q 021774 237 CTQAAASR--RPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~--RPs~~~v~~ 253 (307)
|+..++.+ |++++++++
T Consensus 247 ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 247 LICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HccCchhhcCCCCHHHHhc
Confidence 88765543 467877765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=255.21 Aligned_cols=228 Identities=25% Similarity=0.358 Sum_probs=182.7
Q ss_pred CCCCEEEEEEcccc----C----hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC
Q 021774 5 TNGRRIAVKPLSAE----S----KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~----~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
++|...|+|++... + ....+.-.+|+.+|+++ .||||+++.+++..+...++|+|.++.|.|.+++ .
T Consensus 40 ~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL----t 115 (411)
T KOG0599|consen 40 ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL----T 115 (411)
T ss_pred ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh----h
Confidence 56888999987532 1 22334567899999998 7999999999999999999999999999999999 4
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
....++++...+|+.|+.+|+.|||.+ +|+||||||+|||+++|.+++|+|||.++.+... ......+||++|+|
T Consensus 116 s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G--ekLrelCGTPgYLA 190 (411)
T KOG0599|consen 116 SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPG--EKLRELCGTPGYLA 190 (411)
T ss_pred hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCc--hhHHHhcCCCcccC
Confidence 566799999999999999999999999 9999999999999999999999999999977553 33456889999999
Q ss_pred cccccC------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 156 PEYVLG------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 156 PE~~~~------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
||.+.- ..|+...|+|++|+++|-|+.|.+||.... +-..+..+.+... ++-.++ -.+....
T Consensus 191 PEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~ImeGky-----qF~spe----Wadis~~ 258 (411)
T KOG0599|consen 191 PETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRMIMEGKY-----QFRSPE----WADISAT 258 (411)
T ss_pred hhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHHHHhccc-----ccCCcc----hhhcccc
Confidence 998753 357888999999999999999999974321 1112222222111 111111 2234445
Q ss_pred HHHHHHhccccccCCCCCHHHHHH
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..+|+.+|++.||.+|.|++|.+.
T Consensus 259 ~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 259 VKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHHeeCchhcccHHHHhc
Confidence 788999999999999999999985
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=265.03 Aligned_cols=232 Identities=27% Similarity=0.376 Sum_probs=181.8
Q ss_pred cCCCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 4 LTNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..+|+.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++++|.+++.. ....+++
T Consensus 16 ~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~ 92 (251)
T cd05041 16 LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTV 92 (251)
T ss_pred EeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCH
Confidence 34589999998876543 3556899999999999999999999999999999999999999999999843 2345789
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc-ccccCCCCcCCcccccC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~ 161 (307)
..++.++.+++.||+|||++ +++||||+|+||+++.++.++|+|||++........... ....++..|+|||.+.+
T Consensus 93 ~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 169 (251)
T cd05041 93 KKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169 (251)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc
Confidence 99999999999999999999 999999999999999999999999999986543221111 11233557999999988
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+.++.++|+||||+++|||+| |..|+....... .... ....... ..+......+.+++.+||+.
T Consensus 170 ~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~----~~~~~~~--------~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 170 GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER----IESGYRM--------PAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH----HhcCCCC--------CCCccCCHHHHHHHHHHhcc
Confidence 889999999999999999999 777764432211 1111 1111000 01112234688899999999
Q ss_pred ccCCCCCHHHHHHHHH
Q 021774 241 AASRRPQMNQVIKMLT 256 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~ 256 (307)
+|.+||++.+|++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.95 Aligned_cols=220 Identities=25% Similarity=0.382 Sum_probs=173.5
Q ss_pred CEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 8 RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 8 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.+||+|.+........+.+.+|+.++++++||||+++++++......++||||+++|+|.+++.. ....+++..++.
T Consensus 28 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~ 104 (258)
T cd05078 28 TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLE 104 (258)
T ss_pred chhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHH
Confidence 35888888765555567889999999999999999999999999999999999999999999843 234689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--------eEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
++.|++.||+|||++ +++||||||+||+++.++. ++++|||++..... .....++..|+|||++
T Consensus 105 ~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~ 176 (258)
T cd05078 105 VAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECI 176 (258)
T ss_pred HHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccccCC-----chhccccCCccCchhc
Confidence 999999999999999 9999999999999987765 69999998875432 1234577889999999
Q ss_pred cC-CcccccCceeehHHHHHHHHhCC-CCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 160 LG-GQLTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 160 ~~-~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
.+ ..++.++||||||+++|||++|. .|+........ . ...... . ..+......+.+++.+|
T Consensus 177 ~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~----~~~~~~-------~---~~~~~~~~~~~~li~~~ 239 (258)
T cd05078 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L----QFYEDR-------H---QLPAPKWTELANLINQC 239 (258)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H----HHHHcc-------c---cCCCCCcHHHHHHHHHH
Confidence 86 45789999999999999999995 44332221110 0 011100 0 11122234588899999
Q ss_pred cccccCCCCCHHHHHHHH
Q 021774 238 TQAAASRRPQMNQVIKML 255 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~L 255 (307)
|+.+|++|||+.++++.|
T Consensus 240 l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 240 MDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred hccChhhCCCHHHHHHhc
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=275.49 Aligned_cols=224 Identities=24% Similarity=0.276 Sum_probs=172.8
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHH-HHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEI-MTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++++|.+++. ....+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~ 93 (325)
T cd05602 18 AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ----RERCF 93 (325)
T ss_pred CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH----hcCCC
Confidence 467889999987532 22223444444 45678899999999999999999999999999999999883 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||.|||++ ||+||||||+||+++.++.++|+|||++....... .......|+..|+|||++.
T Consensus 94 ~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05602 94 LEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLH 169 (325)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHc
Confidence 8888999999999999999999 99999999999999999999999999987543221 1233456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||...... .... ...... . ...+.....+.+++.+|++.
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~~~-~---------~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NILNKP-L---------QLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred CCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH---HHHhCC-c---------CCCCCCCHHHHHHHHHHccc
Confidence 999999999999999999999999998643221 1111 111110 0 01112233577888899999
Q ss_pred ccCCCCCHHHHH
Q 021774 241 AASRRPQMNQVI 252 (307)
Q Consensus 241 ~p~~RPs~~~v~ 252 (307)
+|.+||++.+.+
T Consensus 234 ~p~~R~~~~~~~ 245 (325)
T cd05602 234 DRTKRLGAKDDF 245 (325)
T ss_pred CHHHCCCCCCCH
Confidence 999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=264.67 Aligned_cols=227 Identities=29% Similarity=0.465 Sum_probs=182.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
.|+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++... ....+++..+
T Consensus 28 ~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~ 104 (256)
T cd05039 28 RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQ 104 (256)
T ss_pred cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHH
Confidence 478999999986644 5678999999999999999999999999999999999999999999998432 2236899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+........ ...++..|+|||++.+..++
T Consensus 105 ~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~ 177 (256)
T cd05039 105 LGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFS 177 (256)
T ss_pred HHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcCCcCC
Confidence 99999999999999999 999999999999999999999999999986633211 23345679999999888899
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++||||||+++|||++ |..|+..... ..+.... ...... ..+......+.+++.+||..+|++
T Consensus 178 ~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~ 242 (256)
T cd05039 178 TKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHV----EKGYRM--------EAPEGCPPEVYKVMKDCWELDPAK 242 (256)
T ss_pred cHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hcCCCC--------CCccCCCHHHHHHHHHHhccChhh
Confidence 99999999999999997 8888754322 1111111 111110 011122345788999999999999
Q ss_pred CCCHHHHHHHHHh
Q 021774 245 RPQMNQVIKMLTK 257 (307)
Q Consensus 245 RPs~~~v~~~L~~ 257 (307)
||++.++++.|+.
T Consensus 243 Rp~~~~l~~~l~~ 255 (256)
T cd05039 243 RPTFKQLREQLAL 255 (256)
T ss_pred CcCHHHHHHHHhc
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=264.83 Aligned_cols=226 Identities=27% Similarity=0.410 Sum_probs=181.8
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+|+.+++|.+..... ...+.+|++++++++|+||+++++++......++++||+.+++|.+++.. ....+++..+
T Consensus 27 ~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~ 101 (256)
T cd06612 27 TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEI 101 (256)
T ss_pred CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHH
Confidence 478999999875433 57899999999999999999999999999999999999999999999832 3456899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........ ......++..|+|||++.+..++
T Consensus 102 ~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~ 177 (256)
T cd06612 102 AAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYN 177 (256)
T ss_pred HHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCC
Confidence 99999999999999999 999999999999999999999999999987654321 22334578899999999888899
Q ss_pred ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 166 MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 166 ~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
.++||||||+++|+|++|+.|+......... ....... ......+......+.+++.+||+.+|.+|
T Consensus 178 ~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 244 (256)
T cd06612 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKP------PPTLSDPEKWSPEFNDFVKKCLVKDPEER 244 (256)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCC------CCCCCchhhcCHHHHHHHHHHHhcChhhC
Confidence 9999999999999999999998654321110 0000000 00011122233457888999999999999
Q ss_pred CCHHHHHH
Q 021774 246 PQMNQVIK 253 (307)
Q Consensus 246 Ps~~~v~~ 253 (307)
|++.+|++
T Consensus 245 ps~~~il~ 252 (256)
T cd06612 245 PSAIQLLQ 252 (256)
T ss_pred cCHHHHhc
Confidence 99999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=270.30 Aligned_cols=234 Identities=26% Similarity=0.370 Sum_probs=180.3
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-----------
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------- 75 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------- 75 (307)
.+|+|.++.. .......+.+|++++.++ +|+||+++++++..++..++||||+++++|.+++.....
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (303)
T cd05088 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115 (303)
T ss_pred eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 4577777653 344556788999999999 899999999999999999999999999999999854321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 76 -ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 76 -~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..++.++.|++.||+|||++ |++||||||+||++++++.++|+|||++...... .......++..|+
T Consensus 116 ~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~ 190 (303)
T cd05088 116 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWM 190 (303)
T ss_pred cccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchh--hhcccCCCccccc
Confidence 123588999999999999999999999 9999999999999999999999999998642211 1111223356799
Q ss_pred CcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
|||.+.+..++.++|||||||++|||+| |..||...... .... ........ ..+......+.++
T Consensus 191 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~~~--------~~~~~~~~~~~~l 255 (303)
T cd05088 191 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE----KLPQGYRL--------EKPLNCDDEVYDL 255 (303)
T ss_pred CHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH----HHhcCCcC--------CCCCCCCHHHHHH
Confidence 9999988889999999999999999998 88887543221 1111 11111000 0111123357889
Q ss_pred HHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+.+||+.+|++||++.+++..|.+++...
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999998876533
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=264.50 Aligned_cols=234 Identities=29% Similarity=0.454 Sum_probs=184.3
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..++++.||||.+.... ....++.+|+.++++++|+||+++++++......++|||++++++|.+++... .+..+++
T Consensus 26 ~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~~~~ 102 (261)
T cd05034 26 TWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRL 102 (261)
T ss_pred EEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc--ccCCCCH
Confidence 34567789999888543 23467899999999999999999999999989999999999999999998432 2346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++...............++..|+|||.+.+.
T Consensus 103 ~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 179 (261)
T cd05034 103 PQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccC
Confidence 99999999999999999999 999999999999999999999999999987654322222223345689999999988
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|+||||+++|+|++ |+.|+..... ....... ..... ... +......+.+++.+|++.+
T Consensus 180 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~-----~~~---~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05034 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQV----ERGYR-----MPR---PPNCPEELYDLMLQCWDKD 244 (261)
T ss_pred CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCC-----CCC---CCCCCHHHHHHHHHHcccC
Confidence 89999999999999999999 8888754322 1111111 11100 000 1112345788899999999
Q ss_pred cCCCCCHHHHHHHHHh
Q 021774 242 ASRRPQMNQVIKMLTK 257 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~ 257 (307)
|++||++.++.+.|+.
T Consensus 245 p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 245 PEERPTFEYLQSFLED 260 (261)
T ss_pred cccCCCHHHHHHHHhc
Confidence 9999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=267.90 Aligned_cols=227 Identities=27% Similarity=0.419 Sum_probs=179.8
Q ss_pred CCCCEEEEEEccccCh---------HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC
Q 021774 5 TNGRRIAVKPLSAESK---------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
.+++.+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|.+++.
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---- 98 (267)
T cd06628 23 SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN---- 98 (267)
T ss_pred CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHH----
Confidence 4578999998865321 233568899999999999999999999999999999999999999999983
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-----ccccccCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-----ITTRIAGT 150 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~g~ 150 (307)
....+++..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||.+......... ......|+
T Consensus 99 ~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 175 (267)
T cd06628 99 NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175 (267)
T ss_pred hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCC
Confidence 335688999999999999999999999 9999999999999999999999999999876532111 11224577
Q ss_pred CCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 151 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . ....... . ..+ ..+......+
T Consensus 176 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~----~~~~~~~-~-----~~~---~~~~~~~~~~ 240 (267)
T cd06628 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--Q----AIFKIGE-N-----ASP---EIPSNISSEA 240 (267)
T ss_pred cCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--H----HHHHHhc-c-----CCC---cCCcccCHHH
Confidence 8899999998888999999999999999999999998653221 0 0111111 0 111 1122333457
Q ss_pred HHHHHhccccccCCCCCHHHHHH
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+++.+||+.+|.+||++.++++
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhh
Confidence 78889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.23 Aligned_cols=233 Identities=30% Similarity=0.474 Sum_probs=181.5
Q ss_pred CCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---CCCCCCH
Q 021774 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKLNW 82 (307)
Q Consensus 7 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~ 82 (307)
+..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|.+++..... ....+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred ceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 3578999876543 34456789999999999999999999999999999999999999999999854322 2245789
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-----ceEEeeccCcccCCCCcc-cccccccCCCCcCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-----NPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAP 156 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-----~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aP 156 (307)
..++.++.|++.||+|||++ +++|+||+|+||+++.++ .++|+|||++........ .......++..|+||
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence 99999999999999999999 999999999999999887 899999999976533211 112233456789999
Q ss_pred ccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
|++.+..++.++||||||+++|||+| |..||..... ....... ..... ...+......+.+++.
T Consensus 183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~~--------~~~~~~~~~~~~~li~ 247 (269)
T cd05044 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TAGGR--------LQKPENCPDKIYQLMT 247 (269)
T ss_pred HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hcCCc--------cCCcccchHHHHHHHH
Confidence 99999899999999999999999998 8888754322 1111111 11110 0111223456788999
Q ss_pred hccccccCCCCCHHHHHHHHHh
Q 021774 236 FCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
+||+.+|.+||++.+|++.|++
T Consensus 248 ~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 248 NCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHcCCCcccCCCHHHHHHHHhC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=265.25 Aligned_cols=232 Identities=25% Similarity=0.378 Sum_probs=177.2
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEE-eCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+..||+|.+... .......+.+|+.+++.++||||+++++++. .+...++||||+.+++|.+++.. ....+++..
T Consensus 23 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~ 99 (262)
T cd05058 23 KIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKD 99 (262)
T ss_pred eEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHH
Confidence 457999988643 3455678899999999999999999999876 45567899999999999999842 233467888
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc---cccccccCCCCcCCcccccC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~ 161 (307)
++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....... .......++..|+|||++.+
T Consensus 100 ~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 100 LIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred HHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence 899999999999999999 999999999999999999999999999976543211 11122345678999999988
Q ss_pred CcccccCceeehHHHHHHHHhCC-CCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|||++|. +|+..... ..... ........ .. +......+.+++.+||+.
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~---~~~~~~~~------~~---~~~~~~~~~~li~~cl~~ 241 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITV---YLLQGRRL------LQ---PEYCPDPLYEVMLSCWHP 241 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---HHhcCCCC------CC---CCcCCHHHHHHHHHHcCC
Confidence 88999999999999999999964 44432211 11111 11111111 00 111223577899999999
Q ss_pred ccCCCCCHHHHHHHHHhcc
Q 021774 241 AASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~ 259 (307)
+|++||++.+|++.|+++.
T Consensus 242 ~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 242 KPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ChhhCCCHHHHHHHHHHHh
Confidence 9999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=277.98 Aligned_cols=238 Identities=23% Similarity=0.357 Sum_probs=184.4
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-------
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 75 (307)
.++..||||+++... ......+.+|+.+|.++. ||||+++++++...+..++||||+++|+|.++++....
T Consensus 65 ~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~ 144 (401)
T cd05107 65 QSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYL 144 (401)
T ss_pred CCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhc
Confidence 345689999998653 333457889999999997 99999999999999999999999999999999854321
Q ss_pred --------------------------------------------------------------------------------
Q 021774 76 -------------------------------------------------------------------------------- 75 (307)
Q Consensus 76 -------------------------------------------------------------------------------- 75 (307)
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (401)
T cd05107 145 DKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERT 224 (401)
T ss_pred ccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCc
Confidence
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccc
Q 021774 76 -------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 147 (307)
Q Consensus 76 -------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 147 (307)
....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||+++....... ......
T Consensus 225 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 301 (401)
T cd05107 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301 (401)
T ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCc
Confidence 112467888999999999999999999 999999999999999999999999999986533221 112233
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHH
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
.++..|+|||++.+..++.++||||||+++|||++ |..|+....... .. ......... + ..+...
T Consensus 302 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--~~----~~~~~~~~~-----~---~~p~~~ 367 (401)
T cd05107 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--QF----YNAIKRGYR-----M---AKPAHA 367 (401)
T ss_pred CCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--HH----HHHHHcCCC-----C---CCCCCC
Confidence 56778999999988889999999999999999998 777875432211 11 111111110 0 111223
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
...+.+++.+||+.+|.+||++.+|+..|++++
T Consensus 368 ~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 368 SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 346888899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=273.53 Aligned_cols=220 Identities=26% Similarity=0.295 Sum_probs=173.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||++... .......+..|.+++..++| ++|+++++++...+..++||||+++|+|..++. ....+
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~ 98 (324)
T cd05587 23 GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGKF 98 (324)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCC
Confidence 35778999998753 23445678889999999965 468889999999999999999999999999883 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ ||+||||||+|||+++++.++|+|||++....... .......|+..|+|||++.
T Consensus 99 ~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 99 KEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhc
Confidence 8999999999999999999999 99999999999999999999999999987432211 1223456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||+||+.||..... ......+ ..... ..+......+.+++.+||..
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i----~~~~~---------~~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSI----MEHNV---------SYPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH----HcCCC---------CCCCCCCHHHHHHHHHHhhc
Confidence 98999999999999999999999999864432 1111111 11110 11112234577888999999
Q ss_pred ccCCCCCH
Q 021774 241 AASRRPQM 248 (307)
Q Consensus 241 ~p~~RPs~ 248 (307)
||.+|++.
T Consensus 239 ~P~~R~~~ 246 (324)
T cd05587 239 HPAKRLGC 246 (324)
T ss_pred CHHHcCCC
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.18 Aligned_cols=229 Identities=22% Similarity=0.306 Sum_probs=181.9
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.+|+|.++.. .....+.+..|+.++++++|+||+++++++...+..++||||+++++|.+++.. ..+..+++.
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~ 100 (255)
T cd08219 23 NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPED 100 (255)
T ss_pred CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHH
Confidence 46889999988643 344556788999999999999999999999999999999999999999998742 234458899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+........ ......|+..|+|||++.+..
T Consensus 101 ~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~ 176 (255)
T cd08219 101 TILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMP 176 (255)
T ss_pred HHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCC
Confidence 9999999999999999999 999999999999999999999999999976543221 122345788999999998888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++|+||||+++|+|++|..||...... .. ...... .... ..+......+.+++.+||+.||+
T Consensus 177 ~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~---~~~~~~-~~~~--------~~~~~~~~~~~~li~~~l~~~P~ 241 (255)
T cd08219 177 YNNKSDIWSLGCILYELCTLKHPFQANSWK---NL---ILKVCQ-GSYK--------PLPSHYSYELRSLIKQMFKRNPR 241 (255)
T ss_pred cCchhhhhhhchhheehhhccCCCCCCCHH---HH---HHHHhc-CCCC--------CCCcccCHHHHHHHHHHHhCCcc
Confidence 999999999999999999999998643211 11 111111 1110 11112234577889999999999
Q ss_pred CCCCHHHHHHH
Q 021774 244 RRPQMNQVIKM 254 (307)
Q Consensus 244 ~RPs~~~v~~~ 254 (307)
+||++.+++..
T Consensus 242 ~Rp~~~~il~~ 252 (255)
T cd08219 242 SRPSATTILSR 252 (255)
T ss_pred cCCCHHHHhhc
Confidence 99999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=270.40 Aligned_cols=238 Identities=22% Similarity=0.354 Sum_probs=179.9
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|..+|+|.++.. ......++.+|++++++++||||+++++++..++..++||||+++++|.+++. ....+++.
T Consensus 24 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~----~~~~~~~~ 99 (308)
T cd06615 24 PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEN 99 (308)
T ss_pred CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHH----hcCCCCHH
Confidence 46788999988755 33445678899999999999999999999999999999999999999999984 33568899
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||.|||+ . +++|+||+|+||++++++.++|+|||++....... .....|+..|+|||++.+.
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~ 173 (308)
T cd06615 100 ILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGT 173 (308)
T ss_pred HHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc---cccCCCCcCccChhHhcCC
Confidence 999999999999999997 6 89999999999999999999999999987553321 2335678899999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc------------------------ccccCCC
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP------------------------LELVDPE 218 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~ 218 (307)
.++.++|+||||+++|+|++|..|+........................ .....+.
T Consensus 174 ~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T cd06615 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK 253 (308)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCcc
Confidence 8999999999999999999999987543211110000000000000000 0000000
Q ss_pred CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 219 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 219 ~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
+.. ......+.+++.+||+.+|++||++.+|+..
T Consensus 254 ~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 254 LPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0123357889999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=252.12 Aligned_cols=225 Identities=24% Similarity=0.310 Sum_probs=185.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+++.-||+|++-.. ......++.+|+++-+.|+||||+++|++|.+....|+++||...|++...|.. .....++
T Consensus 45 ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~ 122 (281)
T KOG0580|consen 45 KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFD 122 (281)
T ss_pred cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh--ccccccc
Confidence 45667999988754 233446788999999999999999999999999999999999999999999843 2455688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+.....++.|+|.||.|+|.+ +++||||||+|+|++.++.+||+|||.+...+. ......+||..|++||+..+
T Consensus 123 e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 123 EQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---NKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred ccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC---CCceeeecccccCCHhhcCC
Confidence 999999999999999999999 999999999999999999999999999986552 33566889999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++...|+|++|++.||++.|.+||.....++ .. +.....+. .++........+++.+|+..+
T Consensus 197 ~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tY----krI~k~~~---------~~p~~is~~a~dlI~~ll~~~ 260 (281)
T KOG0580|consen 197 RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TY----KRIRKVDL---------KFPSTISGGAADLISRLLVKN 260 (281)
T ss_pred CCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HH----HHHHHccc---------cCCcccChhHHHHHHHHhccC
Confidence 999999999999999999999999997654221 11 11111111 112223334778888999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|.+..++.+
T Consensus 261 p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 261 PIERLALTEVMD 272 (281)
T ss_pred ccccccHHHHhh
Confidence 999999999875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=267.91 Aligned_cols=235 Identities=23% Similarity=0.396 Sum_probs=181.7
Q ss_pred CCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC------CCCC
Q 021774 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------ANIK 79 (307)
Q Consensus 7 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~ 79 (307)
+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++..... ....
T Consensus 36 ~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 115 (288)
T cd05061 36 ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115 (288)
T ss_pred ceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCC
Confidence 5589999887543 33445688999999999999999999999999999999999999999999854221 1234
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEY 158 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~ 158 (307)
+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||+++........ ......++..|+|||+
T Consensus 116 ~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~ 192 (288)
T cd05061 116 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHH
Confidence 56788899999999999999999 9999999999999999999999999998865432211 1222345678999999
Q ss_pred ccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
+.+..++.++|||||||++|||++ |..||...... ...... ...... ..+......+.+++.+|
T Consensus 193 ~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~~~~---------~~~~~~~~~~~~li~~~ 257 (288)
T cd05061 193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKFV---MDGGYL---------DQPDNCPERVTDLMRMC 257 (288)
T ss_pred hccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcCCCC---------CCCCCCCHHHHHHHHHH
Confidence 998889999999999999999998 67777543221 111111 111110 11112234688899999
Q ss_pred cccccCCCCCHHHHHHHHHhcc
Q 021774 238 TQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
++.+|++|||+.++++.|.+.+
T Consensus 258 l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 258 WQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred cCCChhHCcCHHHHHHHHHhhc
Confidence 9999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=264.34 Aligned_cols=228 Identities=25% Similarity=0.427 Sum_probs=179.6
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+|..+++|.+..........+.+|+++++.++||||+++++++...+..++||||+++++|..++.. ....+++..+
T Consensus 29 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~ 105 (282)
T cd06643 29 TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQI 105 (282)
T ss_pred CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHH
Confidence 4678899998776666677899999999999999999999999999999999999999999988742 2346899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-----
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL----- 160 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----- 160 (307)
..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++........ ......++..|+|||++.
T Consensus 106 ~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 181 (282)
T cd06643 106 RVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSK 181 (282)
T ss_pred HHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccccccccccccCHhhccccCCC
Confidence 99999999999999999 999999999999999999999999999876543221 123346788999999874
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..|+...... .... ........ ... .+......+.+++.+||+.
T Consensus 182 ~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~----~~~~~~~~-~~~------~~~~~~~~~~~li~~~l~~ 248 (282)
T cd06643 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLL----KIAKSEPP-TLA------QPSRWSSEFKDFLKKCLEK 248 (282)
T ss_pred CCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHH----HHhhcCCC-CCC------CccccCHHHHHHHHHHccC
Confidence 345778999999999999999999987643221 1111 11111110 000 1112234578889999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
+|.+||++.++++
T Consensus 249 ~p~~Rp~~~~il~ 261 (282)
T cd06643 249 NVDARWTTTQLLQ 261 (282)
T ss_pred ChhhCcCHHHHhc
Confidence 9999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.02 Aligned_cols=233 Identities=27% Similarity=0.433 Sum_probs=182.9
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
...++..+|+|.+.... .....+.+|++++++++|+||+++++++.. ...+++|||+++++|.+++... .+..+++
T Consensus 26 ~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~ 101 (260)
T cd05073 26 TYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD--EGSKQPL 101 (260)
T ss_pred EecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC--CccccCH
Confidence 44567789999887543 234678999999999999999999999887 7789999999999999998432 3456889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||.+...............++..|+|||++.+.
T Consensus 102 ~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 178 (260)
T cd05073 102 PKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178 (260)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccC
Confidence 99999999999999999999 999999999999999999999999999986654332222233456779999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|+||||+++|+++| |..||..... ..+... ....... + ........+.+++.+||+.+
T Consensus 179 ~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~----~~~~~~~----~----~~~~~~~~~~~~i~~~l~~~ 243 (260)
T cd05073 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRA----LERGYRM----P----RPENCPEELYNIMMRCWKNR 243 (260)
T ss_pred CcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HhCCCCC----C----CcccCCHHHHHHHHHHcccC
Confidence 89999999999999999999 8888754322 111111 1111110 0 11223345888899999999
Q ss_pred cCCCCCHHHHHHHHHh
Q 021774 242 ASRRPQMNQVIKMLTK 257 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~ 257 (307)
|++||++.++.+.|+.
T Consensus 244 p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 244 PEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=263.32 Aligned_cols=235 Identities=25% Similarity=0.381 Sum_probs=173.1
Q ss_pred CCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC-CCCCCHHH
Q 021774 7 GRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-NIKLNWEK 84 (307)
Q Consensus 7 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~ 84 (307)
...+|+|.+.... ......|.+|++.++.++|+||+++++++......++||||+++|+|.+++...... ....++..
T Consensus 22 ~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 101 (269)
T cd05042 22 KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101 (269)
T ss_pred CeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHH
Confidence 3468888776543 344567889999999999999999999999999999999999999999998554322 23356788
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccC--
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLG-- 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-- 161 (307)
+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......... ......++..|+|||++..
T Consensus 102 ~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (269)
T cd05042 102 LQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178 (269)
T ss_pred HHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcc
Confidence 899999999999999999 9999999999999999999999999998754332111 1222345667999998743
Q ss_pred -----CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 162 -----GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 162 -----~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
..++.++|||||||++|||++ |..||...... ... ...... .......+... ......+.+++.
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~ 248 (269)
T cd05042 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVL---KQVVRE-QDIKLPKPQLD---LKYSDRWYEVMQ 248 (269)
T ss_pred ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhhc-cCccCCCCccc---ccCCHHHHHHHH
Confidence 356889999999999999999 66776543221 111 111111 11111122221 122234556677
Q ss_pred hccccccCCCCCHHHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIKML 255 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L 255 (307)
.|| .||++||++.+|++.|
T Consensus 249 ~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 249 FCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHh-cCcccccCHHHHHHHh
Confidence 788 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=264.64 Aligned_cols=231 Identities=25% Similarity=0.435 Sum_probs=181.1
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
...++..+|+|.+..... ....|..|++++++++|||++++++++......++||||+++++|.+++.. ....+++
T Consensus 24 ~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~ 99 (256)
T cd05112 24 YWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQ 99 (256)
T ss_pred EEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCH
Confidence 345578899998875432 235688999999999999999999999999999999999999999999842 2345889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...............++..|+|||.+.+.
T Consensus 100 ~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~ 176 (256)
T cd05112 100 ETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccC
Confidence 99999999999999999999 999999999999999999999999999886543322222223345689999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..|+..... ...... ..... ....+. .....+.+++.+||+.+
T Consensus 177 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~--~~~~~~------~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVET----INAGF--RLYKPR------LASQSVYELMQHCWKER 241 (256)
T ss_pred CcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH----HhCCC--CCCCCC------CCCHHHHHHHHHHcccC
Confidence 89999999999999999998 8888754322 111111 11110 111111 12345888999999999
Q ss_pred cCCCCCHHHHHHHH
Q 021774 242 ASRRPQMNQVIKML 255 (307)
Q Consensus 242 p~~RPs~~~v~~~L 255 (307)
|++||++.++++.|
T Consensus 242 p~~Rp~~~~~l~~l 255 (256)
T cd05112 242 PEDRPSFSLLLHQL 255 (256)
T ss_pred hhhCCCHHHHHHhh
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=270.41 Aligned_cols=227 Identities=23% Similarity=0.436 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||+++++|..++. ...+++..
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~ 116 (296)
T cd06655 42 ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-----ETCMDEAQ 116 (296)
T ss_pred CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH-----hcCCCHHH
Confidence 5788999998876554455678999999999999999999999999999999999999999999883 23589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||+|||++ |++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 117 ~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred HHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCC
Confidence 999999999999999999 999999999999999999999999999876543221 1223467889999999988889
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|||||||++|+|++|+.||........ . . ........ .. ..+......+.+++.+||..+|.+
T Consensus 193 ~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~-~---~~~~~~~~-~~------~~~~~~~~~~~~li~~~l~~dp~~ 259 (296)
T cd06655 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L-Y---LIATNGTP-EL------QNPEKLSPIFRDFLNRCLEMDVEK 259 (296)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H---HHHhcCCc-cc------CCcccCCHHHHHHHHHHhhcChhh
Confidence 9999999999999999999999865432111 1 0 11111100 00 011122335778899999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
||++.+++.
T Consensus 260 Rpt~~~il~ 268 (296)
T cd06655 260 RGSAKELLQ 268 (296)
T ss_pred CCCHHHHhh
Confidence 999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=267.29 Aligned_cols=225 Identities=25% Similarity=0.406 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.+++. ...+++.
T Consensus 27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~ 101 (277)
T cd06642 27 RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEET 101 (277)
T ss_pred CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh-----cCCCCHH
Confidence 357889999887543 4455678999999999999999999999999999999999999999999883 2458899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........ ......++..|+|||++.+..
T Consensus 102 ~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06642 102 YIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccCcccccCHHHhCcCC
Confidence 9999999999999999999 999999999999999999999999999976543221 122345788899999999888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++||||||+++|||++|..|+....+... . .. ..... .+ .........+.+++.+||+.+|.
T Consensus 178 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---~~-~~~~~-----~~---~~~~~~~~~~~~li~~~l~~~p~ 242 (277)
T cd06642 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L---FL-IPKNS-----PP---TLEGQYSKPFKEFVEACLNKDPR 242 (277)
T ss_pred CchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H---hh-hhcCC-----CC---CCCcccCHHHHHHHHHHccCCcc
Confidence 99999999999999999999998764332111 0 00 00000 11 11223344578889999999999
Q ss_pred CCCCHHHHHH
Q 021774 244 RRPQMNQVIK 253 (307)
Q Consensus 244 ~RPs~~~v~~ 253 (307)
+||++.+++.
T Consensus 243 ~Rp~~~~il~ 252 (277)
T cd06642 243 FRPTAKELLK 252 (277)
T ss_pred cCcCHHHHHH
Confidence 9999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=266.11 Aligned_cols=231 Identities=24% Similarity=0.339 Sum_probs=181.6
Q ss_pred CEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 8 RRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 8 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
..||+|...... ....+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++.. ....+++..++
T Consensus 35 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~ 110 (270)
T cd05056 35 IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLI 110 (270)
T ss_pred cceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHH
Confidence 468999887654 5556789999999999999999999998875 456899999999999999843 23458999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...............++..|+|||.+....++.
T Consensus 111 ~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 187 (270)
T cd05056 111 LYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187 (270)
T ss_pred HHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCc
Confidence 9999999999999999 9999999999999999999999999999866543222222233456799999988888999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++||||||+++|||++ |..||...... ..... ....... ..+......+.+++.+|+..+|.+|
T Consensus 188 ~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~R 252 (270)
T cd05056 188 ASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----IENGERL--------PMPPNCPPTLYSLMTKCWAYDPSKR 252 (270)
T ss_pred hhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCcC--------CCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999986 99887644321 11111 1111110 0112223458888999999999999
Q ss_pred CCHHHHHHHHHhccc
Q 021774 246 PQMNQVIKMLTKNIR 260 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~ 260 (307)
||+.++++.|.++..
T Consensus 253 pt~~~~~~~l~~~~~ 267 (270)
T cd05056 253 PRFTELKAQLSDILQ 267 (270)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=272.38 Aligned_cols=220 Identities=25% Similarity=0.298 Sum_probs=174.0
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.++... ......+..|.+++..+ +|++|+++++++...+..++||||+++|+|.+++. ....+
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~----~~~~~ 98 (323)
T cd05616 23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRF 98 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH----HcCCC
Confidence 357899999987542 23345567788888877 68999999999999999999999999999998883 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||++....... .......|++.|+|||++.
T Consensus 99 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 99 KEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhc
Confidence 8999999999999999999999 99999999999999999999999999987543221 1223456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||+||+.||..... ..+...+. .... .++......+.+++.+|++.
T Consensus 175 ~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~----~~~~---------~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM----EHNV---------AYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCCC---------CCCCcCCHHHHHHHHHHccc
Confidence 99999999999999999999999999865432 11111111 1110 11122334578899999999
Q ss_pred ccCCCCCH
Q 021774 241 AASRRPQM 248 (307)
Q Consensus 241 ~p~~RPs~ 248 (307)
+|.+|++.
T Consensus 239 ~p~~R~~~ 246 (323)
T cd05616 239 HPGKRLGC 246 (323)
T ss_pred CHHhcCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=274.61 Aligned_cols=226 Identities=26% Similarity=0.232 Sum_probs=172.2
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||++.... ......+..|..++... +||||+++++++...+..++||||+++|+|..++. ...
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~ 91 (330)
T cd05586 16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ----KEG 91 (330)
T ss_pred CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH----hcC
Confidence 468899999986432 22334556677777665 79999999999999999999999999999998883 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++....... .......|+..|+|||+
T Consensus 92 ~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~ 167 (330)
T cd05586 92 RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEV 167 (330)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHH
Confidence 689999999999999999999999 99999999999999999999999999987543221 12334568999999999
Q ss_pred ccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 159 VLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 159 ~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
+.+. .++.++|||||||++|+|++|..||...... .. . ........ .+.. ......+.+++.+|
T Consensus 168 ~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~---~-~~i~~~~~------~~~~--~~~~~~~~~li~~~ 232 (330)
T cd05586 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QM---Y-RNIAFGKV------RFPK--NVLSDEGRQFVKGL 232 (330)
T ss_pred HcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HH---H-HHHHcCCC------CCCC--ccCCHHHHHHHHHH
Confidence 8764 4789999999999999999999998653221 11 1 11111110 0100 01223467888999
Q ss_pred cccccCCCC----CHHHHHH
Q 021774 238 TQAAASRRP----QMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RP----s~~~v~~ 253 (307)
|+.||.+|| ++.++++
T Consensus 233 L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhc
Confidence 999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=264.42 Aligned_cols=226 Identities=25% Similarity=0.388 Sum_probs=183.3
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.+... .......+.+|+.++++++|+||+++++++.++...++||||+++++|.+++. ...+++.
T Consensus 27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~-----~~~l~~~ 101 (277)
T cd06640 27 RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEF 101 (277)
T ss_pred cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh-----cCCCCHH
Confidence 35789999988754 34556789999999999999999999999999999999999999999999883 2358889
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......++..|+|||++.+..
T Consensus 102 ~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~ 177 (277)
T cd06640 102 QIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccccCcccccCHhHhccCC
Confidence 9999999999999999999 999999999999999999999999999976543221 122345778899999998888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++|+||||+++|||+||..|+....+... . .. ..... ...........+.+++.+||+.+|+
T Consensus 178 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---~~-~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~ 242 (277)
T cd06640 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRV---L---FL-IPKNN--------PPTLTGEFSKPFKEFIDACLNKDPS 242 (277)
T ss_pred CccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---h---hh-hhcCC--------CCCCchhhhHHHHHHHHHHcccCcc
Confidence 99999999999999999999999865432111 0 00 00000 1122334556688999999999999
Q ss_pred CCCCHHHHHHH
Q 021774 244 RRPQMNQVIKM 254 (307)
Q Consensus 244 ~RPs~~~v~~~ 254 (307)
+||++.+++..
T Consensus 243 ~Rp~~~~il~~ 253 (277)
T cd06640 243 FRPTAKELLKH 253 (277)
T ss_pred cCcCHHHHHhC
Confidence 99999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=294.49 Aligned_cols=241 Identities=21% Similarity=0.314 Sum_probs=184.9
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC------
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------ 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------ 75 (307)
.+|+.||+|++... .....++|.+|++++++++||||+++++++.+.+..++||||++|++|.+++.....
T Consensus 25 ~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e 104 (932)
T PRK13184 25 VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK 104 (932)
T ss_pred CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccch
Confidence 45889999998754 234456799999999999999999999999999999999999999999998853211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc--------------
Q 021774 76 -ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-------------- 140 (307)
Q Consensus 76 -~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-------------- 140 (307)
....+++..++.++.||+.||+|||++ ||+||||||+||+++.++.++|+|||++.......
T Consensus 105 ~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~ 181 (932)
T PRK13184 105 ELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181 (932)
T ss_pred hhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccc
Confidence 123466788899999999999999999 99999999999999999999999999998652110
Q ss_pred ---ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCC
Q 021774 141 ---THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 217 (307)
Q Consensus 141 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (307)
........||+.|+|||++.+..++.++|||||||++|||+||..||....... .. .... ...+... .
T Consensus 182 ~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k---i~---~~~~-i~~P~~~--~ 252 (932)
T PRK13184 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK---IS---YRDV-ILSPIEV--A 252 (932)
T ss_pred ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh---hh---hhhh-ccChhhc--c
Confidence 001123468999999999999999999999999999999999999986532211 00 0000 0000000 0
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCC-CCHHHHHHHHHhcccc
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRR-PQMNQVIKMLTKNIRL 261 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~~ 261 (307)
. .......+.+++.+|++.||++| ++++++++.|+..+..
T Consensus 253 p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 253 P----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 01223347788999999999999 4678888888877653
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=270.30 Aligned_cols=234 Identities=26% Similarity=0.359 Sum_probs=181.7
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-----------
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK----------- 75 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------- 75 (307)
.+++|.++.. .....+.+.+|++++.++ +||||+++++++......++||||+++++|.+++.....
T Consensus 31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (297)
T cd05089 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110 (297)
T ss_pred eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence 4788888753 344556789999999999 799999999999999999999999999999999854321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 76 -ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 76 -~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||++....... .......+..|+
T Consensus 111 ~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~ 185 (297)
T cd05089 111 GTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWM 185 (297)
T ss_pred CccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCcccc
Confidence 123588999999999999999999999 99999999999999999999999999986432211 111122345799
Q ss_pred CcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
|||++.+..++.++|||||||++|||++ |..||....... +.. ....... .. .+......+.++
T Consensus 186 aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~----~~~~~~~-----~~---~~~~~~~~~~~l 250 (297)
T cd05089 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE----KLPQGYR-----ME---KPRNCDDEVYEL 250 (297)
T ss_pred CchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhcCCC-----CC---CCCCCCHHHHHH
Confidence 9999988889999999999999999997 988886543211 111 1111100 00 111233457889
Q ss_pred HHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+.+||+.+|.+||++.++++.|++++...
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.42 Aligned_cols=230 Identities=25% Similarity=0.292 Sum_probs=179.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+..|+.++++++|+||+++++.+...+..++||||+.+++|.+++... ....++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~ 100 (285)
T cd05630 23 ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFE 100 (285)
T ss_pred CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh--cccCCC
Confidence 468899999886532 233356788999999999999999999999999999999999999999988432 234589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........ .....|+..|+|||++.+
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 101 EGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--ccCCCCCccccChHHHcC
Confidence 999999999999999999999 999999999999999999999999999876543221 223468899999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..||.................... .. ........+.+++..||+.|
T Consensus 176 ~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~---~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05630 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------EE---YSEKFSPDARSLCKMLLCKD 243 (285)
T ss_pred CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------hh---cCccCCHHHHHHHHHHhhcC
Confidence 8999999999999999999999999875433221111110000000 00 11112234778888999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|++||| +.++++
T Consensus 244 p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 244 PKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHccCCCCCchHHHHc
Confidence 999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=271.34 Aligned_cols=233 Identities=20% Similarity=0.194 Sum_probs=174.3
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++... .......+.+|+.++..++|+||+++++++...+..++||||+++|+|.+++.. ....++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~ 100 (331)
T cd05597 24 NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLP 100 (331)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCC
Confidence 46889999998742 223345688999999999999999999999999999999999999999999832 245689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ +++||||||+|||++.++.++|+|||++...............|+..|+|||++..
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 101 EDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhh
Confidence 999999999999999999999 99999999999999999999999999987654433222333568999999999863
Q ss_pred -----CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 162 -----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 162 -----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
..++.++|||||||++|||++|+.||...... .............. +.+... .....+.+++.+
T Consensus 178 ~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~~~~~~----~~~~~~~~li~~ 246 (331)
T cd05597 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ-FPPDVT----DVSEEAKDLIRR 246 (331)
T ss_pred ccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc-CCCccC----CCCHHHHHHHHH
Confidence 45788999999999999999999998643221 11111111111111 111111 122345666666
Q ss_pred cccc--ccCCCCCHHHHHHH
Q 021774 237 CTQA--AASRRPQMNQVIKM 254 (307)
Q Consensus 237 c~~~--~p~~RPs~~~v~~~ 254 (307)
|+.. ++..||++.++++.
T Consensus 247 ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 247 LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HccCcccccCCCCHHHHhcC
Confidence 6644 44447899888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=274.00 Aligned_cols=231 Identities=19% Similarity=0.226 Sum_probs=175.5
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++. ...++
T Consensus 66 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~-----~~~~~ 140 (371)
T cd05622 66 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-----NYDVP 140 (371)
T ss_pred CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH-----hcCCC
Confidence 46789999998642 22334567899999999999999999999999999999999999999999983 23478
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...............||+.|+|||++.+
T Consensus 141 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 141 EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhc
Confidence 888999999999999999999 99999999999999999999999999998765433323345679999999999875
Q ss_pred C----cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 162 G----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 162 ~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
. .++.++|||||||++|||++|..||...... ............... +. .......+.+++.+|
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--~~----~~~~s~~~~~li~~~ 285 (371)
T cd05622 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTF--PD----DNDISKEAKNLICAF 285 (371)
T ss_pred cCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcccC--CC----cCCCCHHHHHHHHHH
Confidence 3 3789999999999999999999998653221 111111111111111 00 112233467788889
Q ss_pred cccccCC--CCCHHHHHHHH
Q 021774 238 TQAAASR--RPQMNQVIKML 255 (307)
Q Consensus 238 ~~~~p~~--RPs~~~v~~~L 255 (307)
+..++.+ ||++.++++..
T Consensus 286 L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 286 LTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCChhhhcCCCCHHHHhcCc
Confidence 9743332 77888887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=264.83 Aligned_cols=233 Identities=26% Similarity=0.397 Sum_probs=183.5
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++++|.+++. ....+++.
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~ 103 (284)
T cd06620 28 PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK----KGGPIPVE 103 (284)
T ss_pred CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHH----hccCCCHH
Confidence 468899999887543 3455788999999999999999999999999999999999999999999883 33468999
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.+++.||.|||+ . +++||||+|+||++++++.++|+|||++....... .....|+..|+|||++.+.
T Consensus 104 ~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 104 ILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred HHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cCccccCcccCCHHHHccC
Confidence 999999999999999996 6 89999999999999999999999999986543221 2235688999999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccch-----hHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-----NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
.++.++|+|||||++|+|+||..||....... ...+............ +.+. .......+.+++.+|
T Consensus 178 ~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~li~~~ 249 (284)
T cd06620 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRLP--SSDFPEDLRDFVDAC 249 (284)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------CCCC--chhcCHHHHHHHHHH
Confidence 89999999999999999999999987543321 1111121111111110 1110 011334578899999
Q ss_pred cccccCCCCCHHHHHHHH
Q 021774 238 TQAAASRRPQMNQVIKML 255 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~L 255 (307)
|+.||++||++.++++..
T Consensus 250 l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 250 LLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hcCCcccCcCHHHHhcCc
Confidence 999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.97 Aligned_cols=229 Identities=23% Similarity=0.421 Sum_probs=180.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|..|++|.+...+......+.+|+.++++++|+||+++++++..++..++||||+++++|..++.. ....+++..
T Consensus 35 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~ 111 (292)
T cd06644 35 ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQ 111 (292)
T ss_pred CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHH
Confidence 45889999999877777778899999999999999999999999999999999999999999888732 234589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc----
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---- 160 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 160 (307)
+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++....... .......++..|+|||++.
T Consensus 112 ~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 187 (292)
T cd06644 112 IQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETM 187 (292)
T ss_pred HHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cccceecCCccccCceeeccccc
Confidence 999999999999999999 99999999999999999999999999887543321 1123345788999999885
Q ss_pred -CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 -GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 -~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
...++.++|||||||++|||++|..|+...... .. .......... .. ..+......+.+++.+||+
T Consensus 188 ~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~----~~~~~~~~~~------~~-~~~~~~~~~~~~li~~~l~ 254 (292)
T cd06644 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RV----LLKIAKSEPP------TL-SQPSKWSMEFRDFLKTALD 254 (292)
T ss_pred cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HH----HHHHhcCCCc------cC-CCCcccCHHHHHHHHHHhc
Confidence 345678999999999999999999987543221 10 1111111110 00 0112233457888999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.+|++||++.++++
T Consensus 255 ~~p~~Rp~~~~il~ 268 (292)
T cd06644 255 KHPETRPSAAQLLE 268 (292)
T ss_pred CCcccCcCHHHHhc
Confidence 99999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=267.62 Aligned_cols=241 Identities=23% Similarity=0.288 Sum_probs=177.1
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..||+|.++... ......+.+|+.++++++||||+++++++.+++..++||||+. ++|.+++.... .+..+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~ 100 (285)
T cd07861 23 KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDA 100 (285)
T ss_pred CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCH
Confidence 468899999887542 2334678899999999999999999999999999999999997 58888874322 2356899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++....... .......++..|+|||++.+.
T Consensus 101 ~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 101 ELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCC
Confidence 99999999999999999999 99999999999999999999999999997654321 112234567889999988754
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHh-------h--------cCCcccccCCCCCCCCHHH
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH-------Q--------EEKPLELVDPELGEYPPNE 226 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~--------~~~~~~~~~~~~~~~~~~~ 226 (307)
.++.++||||||+++|+|+||+.|+........ ......... . ...................
T Consensus 177 ~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T cd07861 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNL 254 (285)
T ss_pred CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCC
Confidence 578899999999999999999998865332111 000000000 0 0000000000000011112
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..++.+++.+||+.||.+|||+.+|+.
T Consensus 255 ~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 255 DEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 345778999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=265.44 Aligned_cols=231 Identities=23% Similarity=0.349 Sum_probs=181.2
Q ss_pred ccCCCCEEEEEEccccC------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC
Q 021774 3 TLTNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
...+|+.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++. .
T Consensus 20 ~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~ 95 (265)
T cd06631 20 LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN----R 95 (265)
T ss_pred EEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH----h
Confidence 34678899999886432 2334568899999999999999999999999999999999999999999983 3
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-----ccccccccCCC
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-----THITTRIAGTT 151 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~g~~ 151 (307)
...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... ........|+.
T Consensus 96 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (265)
T cd06631 96 FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172 (265)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCc
Confidence 34688999999999999999999999 99999999999999999999999999987653211 11122345788
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
.|+|||++.+..++.++||||||+++|+|++|..||........ . . ........ .+ ..+......+.
T Consensus 173 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~---~-~~~~~~~~----~~---~~~~~~~~~~~ 239 (265)
T cd06631 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--M---F-YIGAHRGL----MP---RLPDSFSAAAI 239 (265)
T ss_pred cccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--H---H-HhhhccCC----CC---CCCCCCCHHHH
Confidence 99999999988899999999999999999999999864322111 0 0 11111001 01 11222334578
Q ss_pred HHHHhccccccCCCCCHHHHHH
Q 021774 232 KVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+++.+||+.+|.+||++.+++.
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhc
Confidence 8899999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.09 Aligned_cols=229 Identities=25% Similarity=0.340 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC--CH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL--NW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~--~~ 82 (307)
.++..||+|.+..........+.+|+.++++++|+||+++++++...+..++|+||+++++|.+++... ...+ ++
T Consensus 31 ~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 107 (268)
T cd06624 31 STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNE 107 (268)
T ss_pred CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcH
Confidence 457789999988776666778999999999999999999999999999999999999999999998432 1234 78
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
..+..++.|++.||+|||++ +++||||+|+||+++. ++.++|+|||++........ ......|+..|+|||++.+
T Consensus 108 ~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 108 QTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccCCCCccccChhhhcc
Confidence 88899999999999999999 9999999999999976 67899999999876543221 1223457889999998866
Q ss_pred C--cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 162 G--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 162 ~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
. .++.++||||||+++|+|++|..|+......... .+...... .....+......+.+++.+||+
T Consensus 184 ~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~ 250 (268)
T cd06624 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK----------IHPEIPESLSAEAKNFILRCFE 250 (268)
T ss_pred ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc----------cCCCCCcccCHHHHHHHHHHcC
Confidence 4 3788999999999999999999997543221110 00000000 0111222334457888999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.+|.+||++.+++.
T Consensus 251 ~~p~~Rpt~~~ll~ 264 (268)
T cd06624 251 PDPDKRASAHDLLQ 264 (268)
T ss_pred CCchhCCCHHHHHh
Confidence 99999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=267.53 Aligned_cols=228 Identities=20% Similarity=0.382 Sum_probs=181.6
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+++++|..++. ...+++..
T Consensus 44 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-----~~~~~~~~ 118 (297)
T cd06659 44 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QTRLNEEQ 118 (297)
T ss_pred CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-----hcCCCHHH
Confidence 4688999999876544445678899999999999999999999999999999999999999999872 24588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..+
T Consensus 119 ~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 119 IATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPY 194 (297)
T ss_pred HHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCccccCHHHHccCCC
Confidence 999999999999999999 999999999999999999999999999876543322 1233567889999999988889
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+++|||++|+.||....... ... . ........ ..........+.+++.+||+.+|.+
T Consensus 195 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~---~-~~~~~~~~------~~~~~~~~~~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK---R-LRDSPPPK------LKNAHKISPVLRDFLERMLTREPQE 261 (297)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HhccCCCC------ccccCCCCHHHHHHHHHHhcCCccc
Confidence 999999999999999999999986432211 111 1 11111000 0011122334778888999999999
Q ss_pred CCCHHHHHHH
Q 021774 245 RPQMNQVIKM 254 (307)
Q Consensus 245 RPs~~~v~~~ 254 (307)
||++.++++.
T Consensus 262 Rps~~~ll~~ 271 (297)
T cd06659 262 RATAQELLDH 271 (297)
T ss_pred CcCHHHHhhC
Confidence 9999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=260.64 Aligned_cols=226 Identities=26% Similarity=0.374 Sum_probs=177.1
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEE-eCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.|..||+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++||||+++++|.+++... ....+++..
T Consensus 28 ~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~ 103 (256)
T cd05082 28 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDC 103 (256)
T ss_pred cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc--CCCCCCHHH
Confidence 47789999887543 2457899999999999999999999765 456789999999999999998432 233588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
++.++.|++.||+|||++ |++||||||+||++++++.+||+|||++....... ....++..|+|||++.+..+
T Consensus 104 ~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 104 LLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred HHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHccCCC
Confidence 999999999999999999 99999999999999999999999999987543321 22234567999999988889
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++|||||||++|||++ |+.|+..... ..+... ...... +. .+......+.+++.+||+.+|+
T Consensus 177 ~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~-----~~---~~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05082 177 STKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYK-----MD---APDGCPPVVYDVMKQCWHLDAA 241 (256)
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCC-----CC---CCCCCCHHHHHHHHHHhcCChh
Confidence 999999999999999998 8888653221 111111 111111 11 1122334578889999999999
Q ss_pred CCCCHHHHHHHHHh
Q 021774 244 RRPQMNQVIKMLTK 257 (307)
Q Consensus 244 ~RPs~~~v~~~L~~ 257 (307)
+|||+.++++.|++
T Consensus 242 ~Rpt~~~l~~~l~~ 255 (256)
T cd05082 242 TRPSFLQLREQLEH 255 (256)
T ss_pred hCcCHHHHHHHHhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=260.00 Aligned_cols=234 Identities=23% Similarity=0.395 Sum_probs=173.2
Q ss_pred EEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.+++|.++... ......|.+|+.+++.++||||+++++++......++||||+++|+|.+++.........+++..+..
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (268)
T cd05086 24 RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103 (268)
T ss_pred eEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHH
Confidence 45677666443 34457899999999999999999999999999999999999999999999865433344567778889
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCC-cccccccccCCCCcCCcccccC-----
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLG----- 161 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~----- 161 (307)
++.|++.||+|||++ +++||||||+||+++.++.++|+|||++...... .........++..|+|||++..
T Consensus 104 ~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (268)
T cd05086 104 MACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180 (268)
T ss_pred HHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence 999999999999999 9999999999999999999999999998643221 1112234567889999998743
Q ss_pred --CcccccCceeehHHHHHHHHhC-CCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 162 --GQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 162 --~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
..++.++||||||+++|||+++ ..|+..... ..... ..... ......++.+... ....+.+++..||
T Consensus 181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~---~~~~~-~~~~~~~~~~~~~---~~~~~~~l~~~c~ 250 (268)
T cd05086 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLN---HVIKD-QQVKLFKPQLELP---YSERWYEVLQFCW 250 (268)
T ss_pred ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHHhh-cccccCCCccCCC---CcHHHHHHHHHHh
Confidence 2457899999999999999975 556543221 11111 11111 1112223332211 2234667788899
Q ss_pred ccccCCCCCHHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~ 256 (307)
.+|++||++.+|++.|.
T Consensus 251 -~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 251 -LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -hCcccCCCHHHHHHHhc
Confidence 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.76 Aligned_cols=236 Identities=19% Similarity=0.202 Sum_probs=177.1
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
.+.+||+|.+... ..+.+|++++++++||||+++++++......++|||++. ++|.+++ .....+++..+
T Consensus 118 ~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~l~~~~~ 187 (392)
T PHA03207 118 QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV----DRSGPLPLEQA 187 (392)
T ss_pred cceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHH----HhcCCCCHHHH
Confidence 4578999987643 235679999999999999999999999999999999995 5888887 33457899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcccccCCcc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++........ .......||..|+|||++.+..+
T Consensus 188 ~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 264 (392)
T PHA03207 188 ITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264 (392)
T ss_pred HHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCC
Confidence 99999999999999999 999999999999999999999999999976544322 22334678999999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc-----------------cccCCCC--CCC--C
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL-----------------ELVDPEL--GEY--P 223 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~--~~~--~ 223 (307)
+.++|||||||++|||++|+.||..............+.......... ....+.. ... .
T Consensus 265 ~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (392)
T PHA03207 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK 344 (392)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhc
Confidence 999999999999999999999986543322111111111111100000 0000000 000 0
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
......+.+++.+|+..||++||++.+++..
T Consensus 345 ~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 345 YGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0123456778899999999999999999764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=272.64 Aligned_cols=237 Identities=24% Similarity=0.304 Sum_probs=173.9
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||.+... .......+.+|+.+++.++||||+++++++...+ ..++||||+++ +|.+.+.
T Consensus 44 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 117 (359)
T cd07876 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----- 117 (359)
T ss_pred CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh-----
Confidence 45889999998753 3344567889999999999999999999987543 46899999965 5666552
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++....... ......|+..|+||
T Consensus 118 -~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aP 191 (359)
T cd07876 118 -MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAP 191 (359)
T ss_pred -ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc--cCCCCcccCCCCCc
Confidence 2478889999999999999999999 99999999999999999999999999997543321 12335678999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhH----------------HHHHHHHHHhhcCCcc------cc
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK----------------FLLEWAWQLHQEEKPL------EL 214 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~------~~ 214 (307)
|++.+..++.++|||||||++|+|++|+.||......... .+.............. +.
T Consensus 192 E~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (359)
T cd07876 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEEL 271 (359)
T ss_pred hhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhh
Confidence 9999999999999999999999999999998754321100 0000000000000000 00
Q ss_pred c----CCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 215 V----DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 215 ~----~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
. .+............+.+++.+||+.||++|||+.|++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 272 FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred ccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000011112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.59 Aligned_cols=220 Identities=25% Similarity=0.297 Sum_probs=174.0
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|++... .......+..|.+++..+. |++|+++++++...+..++||||+++|+|.+++. ....+
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~----~~~~l 98 (323)
T cd05615 23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKF 98 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH----HcCCC
Confidence 46889999998754 2234456788999998885 6788889999999999999999999999999883 34569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ |++||||||+||++++++.++|+|||++....... .......|+..|+|||++.
T Consensus 99 ~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05615 99 KEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIA 174 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999987543221 1223456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||...... ....... . ... ..+......+.+++.+|++.
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~---~-~~~---------~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIM---E-HNV---------SYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h-CCC---------CCCccCCHHHHHHHHHHccc
Confidence 888999999999999999999999998654321 1111111 1 110 11112234577889999999
Q ss_pred ccCCCCCH
Q 021774 241 AASRRPQM 248 (307)
Q Consensus 241 ~p~~RPs~ 248 (307)
+|.+|++.
T Consensus 239 ~p~~R~~~ 246 (323)
T cd05615 239 HPSKRLGC 246 (323)
T ss_pred CHhhCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=260.23 Aligned_cols=229 Identities=29% Similarity=0.484 Sum_probs=181.0
Q ss_pred CCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+..||+|.++.... .....+..|++++++++|+||+++++++...+..+++||++++++|.+++.... ...+++..+
T Consensus 28 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~ 105 (258)
T smart00219 28 EVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDL 105 (258)
T ss_pred CceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHH
Confidence 48899999986643 256789999999999999999999999999999999999999999999984321 112899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
..++.|++.||++||+. +++|+||+|+||++++++.++|+|||++...............++..|+|||.+.+..++
T Consensus 106 ~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 182 (258)
T smart00219 106 LSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFT 182 (258)
T ss_pred HHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCC
Confidence 99999999999999999 999999999999999999999999999987654322222123367889999999888899
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++||||||+++++|++ |..|+..... ....... .. .... ..+......+.+++.+|+..+|++
T Consensus 183 ~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~---~~-~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~ 247 (258)
T smart00219 183 SKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL---KK-GYRL--------PKPENCPPEIYKLMLQCWAEDPED 247 (258)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---hc-CCCC--------CCCCcCCHHHHHHHHHHCcCChhh
Confidence 99999999999999998 6777654211 1111111 11 1110 111123445888999999999999
Q ss_pred CCCHHHHHHHH
Q 021774 245 RPQMNQVIKML 255 (307)
Q Consensus 245 RPs~~~v~~~L 255 (307)
|||+.++++.|
T Consensus 248 Rpt~~~ll~~l 258 (258)
T smart00219 248 RPTFSELVEIL 258 (258)
T ss_pred CcCHHHHHhhC
Confidence 99999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=264.76 Aligned_cols=230 Identities=24% Similarity=0.287 Sum_probs=179.1
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||+++++|..++.. .....++
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~ 100 (285)
T cd05632 23 ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFE 100 (285)
T ss_pred CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHH--hcCCCCC
Confidence 468899999886542 22335578899999999999999999999999999999999999999988742 2234699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ +|+||||||+||++++++.++|+|||++....... ......|+..|+|||++.+
T Consensus 101 ~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 101 EERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cccCCCCCcCccChHHhcC
Confidence 999999999999999999999 99999999999999999999999999997654321 1233468899999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+||||+++|||++|..||......... ............ .........+.+++.+|++.|
T Consensus 176 ~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05632 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETEE---------VYSAKFSEEAKSICKMLLTKD 243 (285)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhcccc---------ccCccCCHHHHHHHHHHccCC
Confidence 88999999999999999999999998754322111 111111111100 011122334678888899999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|++||+ +.+++.
T Consensus 244 P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 244 PKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HhHcCCCcccChHHHHc
Confidence 999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.13 Aligned_cols=229 Identities=25% Similarity=0.437 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.++..||+|............|..|++++++++|+||+++++++......++||||+++++|.+++.. ....+++..
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~ 104 (280)
T cd06611 28 ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQ 104 (280)
T ss_pred CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHH
Confidence 36889999999877766677899999999999999999999999999999999999999999999842 234689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc----
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---- 160 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 160 (307)
+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.
T Consensus 105 ~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~ 180 (280)
T cd06611 105 IRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETF 180 (280)
T ss_pred HHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccceeecchhhcCHHHHhhccc
Confidence 999999999999999999 999999999999999999999999998875433221 223356788999999874
Q ss_pred -CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 -GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 -~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..++.++|+||||+++|||++|+.|+...... .. .......... .+ ..+......+.+++.+||+
T Consensus 181 ~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~~~~------~~-~~~~~~~~~~~~li~~~l~ 247 (280)
T cd06611 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RV----LLKILKSEPP------TL-DQPSKWSSSFNDFLKSCLV 247 (280)
T ss_pred CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HH----HHHHhcCCCC------Cc-CCcccCCHHHHHHHHHHhc
Confidence 345778999999999999999999998654221 11 1111111110 00 1112233457788899999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.+|.+||++.++++
T Consensus 248 ~~p~~Rps~~~il~ 261 (280)
T cd06611 248 KDPDDRPTAAELLK 261 (280)
T ss_pred cChhhCcCHHHHhc
Confidence 99999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=269.22 Aligned_cols=228 Identities=21% Similarity=0.407 Sum_probs=181.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|..||||.+..........+.+|+.++++++|+||+++++.+...+..++||||+++++|.+++. ...+++..
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~ 119 (292)
T cd06658 45 HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQ 119 (292)
T ss_pred CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-----cCCCCHHH
Confidence 4688999999876555556778999999999999999999999999999999999999999999873 23588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||++........ ......|+..|+|||.+.+..+
T Consensus 120 ~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 195 (292)
T cd06658 120 IATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPY 195 (292)
T ss_pred HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCC
Confidence 999999999999999999 999999999999999999999999999876543222 1233567889999999988889
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+++|||++|+.||....... ... . ..... .+.+.. .......+..++.+||..+|.+
T Consensus 196 ~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~---~-~~~~~-----~~~~~~-~~~~~~~~~~li~~~l~~~P~~ 262 (292)
T cd06658 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR---R-IRDNL-----PPRVKD-SHKVSSVLRGFLDLMLVREPSQ 262 (292)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhcC-----CCcccc-ccccCHHHHHHHHHHccCChhH
Confidence 999999999999999999999976432211 111 1 11110 111100 1122234677888899999999
Q ss_pred CCCHHHHHHH
Q 021774 245 RPQMNQVIKM 254 (307)
Q Consensus 245 RPs~~~v~~~ 254 (307)
|||+.++++.
T Consensus 263 Rpt~~~il~~ 272 (292)
T cd06658 263 RATAQELLQH 272 (292)
T ss_pred CcCHHHHhhC
Confidence 9999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=270.59 Aligned_cols=239 Identities=26% Similarity=0.387 Sum_probs=182.1
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCC------
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATK------ 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~------ 75 (307)
.+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ...++||||+++|+|.+++.....
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~ 114 (343)
T cd05103 35 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114 (343)
T ss_pred ccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccc
Confidence 567899999997643 34456788999999999 789999999988754 467899999999999999854221
Q ss_pred ---------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 021774 76 ---------------------------------------------------------ANIKLNWEKRSDICVGIAKGLAF 98 (307)
Q Consensus 76 ---------------------------------------------------------~~~~~~~~~~~~i~~~i~~~l~~ 98 (307)
....+++..+..++.|++.||+|
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 194 (343)
T cd05103 115 TKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194 (343)
T ss_pred ccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHH
Confidence 01246888899999999999999
Q ss_pred HhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccccCceeehHHHH
Q 021774 99 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177 (307)
Q Consensus 99 LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l 177 (307)
||++ +++||||||+||++++++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++
T Consensus 195 lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 271 (343)
T cd05103 195 LASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271 (343)
T ss_pred HHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHH
Confidence 9999 9999999999999999999999999999865332211 12223456679999999888899999999999999
Q ss_pred HHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHH
Q 021774 178 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 178 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~ 256 (307)
|+|++ |..|+....... ... ......... ..... ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 272 ~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~~-----~~~~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 272 WEIFSLGASPYPGVKIDE--EFC----RRLKEGTRM-----RAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHCCCCCCCCccccH--HHH----HHHhccCCC-----CCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99997 888875432211 111 111111110 01111 1235788889999999999999999999998
Q ss_pred hccc
Q 021774 257 KNIR 260 (307)
Q Consensus 257 ~~~~ 260 (307)
.+++
T Consensus 338 ~~~~ 341 (343)
T cd05103 338 NLLQ 341 (343)
T ss_pred HHHh
Confidence 8765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=268.01 Aligned_cols=231 Identities=24% Similarity=0.334 Sum_probs=178.1
Q ss_pred cCCCCEEEEEEccccC----------h----HhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHH
Q 021774 4 LTNGRRIAVKPLSAES----------K----QGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLD 67 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~----------~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~ 67 (307)
..+|+.||+|++.... . ...+...+|+.+|++++|||||+++.+..+ .+..|+|+|||..|.+.
T Consensus 119 ~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~ 198 (576)
T KOG0585|consen 119 EVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVK 198 (576)
T ss_pred cCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccc
Confidence 4568899999997541 1 113578899999999999999999999875 45889999999988876
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc----ccc
Q 021774 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI----THI 143 (307)
Q Consensus 68 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----~~~ 143 (307)
..- .....+++.++.+++.+++.||.|||.+ ||+||||||+|+||+++|+|||+|||.+..+.... ...
T Consensus 199 w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~ 271 (576)
T KOG0585|consen 199 WCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQ 271 (576)
T ss_pred cCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHH
Confidence 542 2333399999999999999999999999 99999999999999999999999999998773321 112
Q ss_pred cccccCCCCcCCcccccCC---c-ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC
Q 021774 144 TTRIAGTTGYLAPEYVLGG---Q-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL 219 (307)
Q Consensus 144 ~~~~~g~~~y~aPE~~~~~---~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (307)
.....||+.|+|||++.++ . .+.+.||||+|++||.|+.|+.||..... .....+... ... .
T Consensus 272 L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------~~l~~KIvn-~pL-------~ 337 (576)
T KOG0585|consen 272 LSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------LELFDKIVN-DPL-------E 337 (576)
T ss_pred HhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------HHHHHHHhc-Ccc-------c
Confidence 3447899999999988763 2 35788999999999999999999865432 111112111 111 0
Q ss_pred CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHH
Q 021774 220 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 255 (307)
Q Consensus 220 ~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L 255 (307)
....++....+.+|+.++|+.||+.|.+..+|....
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111224455688899999999999999999987644
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=265.90 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=179.2
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||+++++|..+. .....+++
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~----~~~~~~~~ 99 (286)
T cd07847 24 ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELE----KNPRGVPE 99 (286)
T ss_pred CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHH----hCCCCCCH
Confidence 368899999886432 233456889999999999999999999999999999999999999888876 23446899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 161 (307)
..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||++........ ......++..|+|||++.+
T Consensus 100 ~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~ 175 (286)
T cd07847 100 HLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCC
Confidence 99999999999999999999 999999999999999999999999999987654321 1223346788999998876
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHH--------HHhhcCCc-ccccCCCC------CCCCHHH
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW--------QLHQEEKP-LELVDPEL------GEYPPNE 226 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~------~~~~~~~ 226 (307)
..++.++||||||+++|+|++|..||................ ........ .....+.. ....+..
T Consensus 176 ~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (286)
T cd07847 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNI 255 (286)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccC
Confidence 457899999999999999999999986543322111100000 00000000 00000000 0001122
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.+++.+||+.+|++||++.+++.
T Consensus 256 ~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 256 SSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 355788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.70 Aligned_cols=218 Identities=24% Similarity=0.402 Sum_probs=171.7
Q ss_pred EEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHH
Q 021774 9 RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88 (307)
Q Consensus 9 ~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i 88 (307)
.|++|.+...... ...|.+|+.++++++||||+++++++.. ...++||||+++++|.+++.. ....+++..++.+
T Consensus 32 ~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~ 106 (259)
T cd05037 32 SVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDV 106 (259)
T ss_pred eeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHH
Confidence 5788877755433 5789999999999999999999999988 778999999999999999843 2226899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-------ceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 89 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 89 ~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+.|++.||+|||++ +++||||||+||+++.++ .++|+|||++..... .....++..|+|||++.+
T Consensus 107 ~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 107 AKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRN 178 (259)
T ss_pred HHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcC
Confidence 99999999999999 999999999999999887 799999999986543 223346678999999887
Q ss_pred C--cccccCceeehHHHHHHHHhC-CCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 162 G--QLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 162 ~--~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
. .++.++||||||+++|||++| ..|+........ .. ....... . +......+.+++.+||
T Consensus 179 ~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~----~~~~~~~-------~---~~~~~~~~~~li~~~l 241 (259)
T cd05037 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER----FYQDQHR-------L---PMPDCAELANLINQCW 241 (259)
T ss_pred CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH----HHhcCCC-------C---CCCCchHHHHHHHHHh
Confidence 6 789999999999999999995 566544322111 00 0000000 0 0001156888999999
Q ss_pred ccccCCCCCHHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~ 256 (307)
..+|.+||++.+|++.|+
T Consensus 242 ~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 242 TYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ccChhhCCCHHHHHHhcC
Confidence 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.53 Aligned_cols=227 Identities=23% Similarity=0.427 Sum_probs=181.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.+++. ...+++..
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~ 116 (297)
T cd06656 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQ 116 (297)
T ss_pred CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH-----hCCCCHHH
Confidence 5789999999876554445678899999999999999999999999999999999999999999983 23578899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 117 ~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred HHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCC
Confidence 999999999999999999 999999999999999999999999999876543321 1223457889999999988889
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|+||||+++|+|++|..||........ + ......... . ...+......+.+++.+||+.+|++
T Consensus 193 ~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~----~~~~~~~~~------~-~~~~~~~~~~~~~li~~~l~~~p~~ 259 (297)
T cd06656 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L----YLIATNGTP------E-LQNPERLSAVFRDFLNRCLEMDVDR 259 (297)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--e----eeeccCCCC------C-CCCccccCHHHHHHHHHHccCChhh
Confidence 9999999999999999999999854322110 0 000000000 0 0111223344678889999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
||++.++++
T Consensus 260 Rps~~~il~ 268 (297)
T cd06656 260 RGSAKELLQ 268 (297)
T ss_pred CcCHHHHhc
Confidence 999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=268.84 Aligned_cols=226 Identities=21% Similarity=0.350 Sum_probs=188.8
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.-+|++||||++... +.-...++++|++.|+-++|||||++|.+...+..+|+|.|+-++|+|.+++.. ....+.
T Consensus 40 VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK---He~Gl~ 116 (864)
T KOG4717|consen 40 VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK---HEEGLN 116 (864)
T ss_pred hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh---hhcccc
Confidence 357999999999765 334446788999999999999999999999999999999999999999999954 345589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-CCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
+....++++||+.|+.|+|+. .+|||||||+||.+ ..-|-|||.|||++..+... ......+|...|.|||++.
T Consensus 117 E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~kL~TsCGSLAYSAPEILL 191 (864)
T KOG4717|consen 117 EDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KKLTTSCGSLAYSAPEILL 191 (864)
T ss_pred HHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc--chhhcccchhhccCchhhh
Confidence 999999999999999999999 99999999999976 55688999999999877543 3455678999999999999
Q ss_pred CCccc-ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..|+ ++.||||||++||.|++|++||+...+.+. ..-++|-.. ..+.....++.+||..|+.
T Consensus 192 GDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY-tvPshvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 192 GDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY-TVPSHVSKECRDLIQSMLV 255 (864)
T ss_pred cCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc-cCchhhhHHHHHHHHHHHh
Confidence 99997 788999999999999999999976544322 111222221 3355666778899999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||++|.+.++|..
T Consensus 256 RdPkkRAslEeI~s 269 (864)
T KOG4717|consen 256 RDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhccHHHHhc
Confidence 99999999999874
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=262.57 Aligned_cols=234 Identities=25% Similarity=0.366 Sum_probs=181.5
Q ss_pred CCCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCC-----CC
Q 021774 6 NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN-----IK 79 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-----~~ 79 (307)
+...|++|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++....... ..
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (275)
T cd05046 34 GETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113 (275)
T ss_pred CcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccC
Confidence 4567999988765433 55789999999999999999999999999999999999999999999985433221 25
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++|||++...............++..|+|||.+
T Consensus 114 l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 190 (275)
T cd05046 114 LSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhh
Confidence 89999999999999999999999 999999999999999999999999999875433222222333456679999999
Q ss_pred cCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.+..++.++||||||+++|+|++ |..|+..... ..... . ....... . .........+.+++.+||
T Consensus 191 ~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~---~-~~~~~~~-~------~~~~~~~~~l~~~i~~~l 256 (275)
T cd05046 191 QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN---R-LQAGKLE-L------PVPEGCPSRLYKLMTRCW 256 (275)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH---H-HHcCCcC-C------CCCCCCCHHHHHHHHHHc
Confidence 88888999999999999999999 6777653321 11111 1 1111110 0 001122345888999999
Q ss_pred ccccCCCCCHHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~ 256 (307)
+.+|.+||++.+++..|.
T Consensus 257 ~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 257 AVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCcccCCCHHHHHHHhc
Confidence 999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=267.78 Aligned_cols=232 Identities=19% Similarity=0.175 Sum_probs=174.0
Q ss_pred CCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+++.+|+|++... .......+.+|+.++..++|+||+++++++.+.+..++||||+++|+|.+++.. ....+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~ 101 (332)
T cd05623 25 ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPE 101 (332)
T ss_pred CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCH
Confidence 4778999998642 223345588899999999999999999999999999999999999999999842 2346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc--
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-- 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-- 160 (307)
..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++...............||..|+|||++.
T Consensus 102 ~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 178 (332)
T cd05623 102 DMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhcc
Confidence 99999999999999999999 9999999999999999999999999998765433322333457899999999886
Q ss_pred ---CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 161 ---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 161 ---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
...++.++|||||||++|||++|+.||...... ............. ............+.+++.+|
T Consensus 179 ~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~-----~~p~~~~~~s~~~~~li~~l 247 (332)
T cd05623 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERF-----QFPAQVTDVSEDAKDLIRRL 247 (332)
T ss_pred ccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccc-----cCCCccccCCHHHHHHHHHH
Confidence 346789999999999999999999998643221 1111111111000 01111112233466777777
Q ss_pred ccccc--CCCCCHHHHHHH
Q 021774 238 TQAAA--SRRPQMNQVIKM 254 (307)
Q Consensus 238 ~~~~p--~~RPs~~~v~~~ 254 (307)
+..++ ..|+++.++++.
T Consensus 248 l~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 248 ICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccChhhhcCCCCHHHHhCC
Confidence 75544 346889888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=273.15 Aligned_cols=224 Identities=30% Similarity=0.459 Sum_probs=183.6
Q ss_pred cCCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..|.+.||||++... +.+-+.+.++|++.|++++|||++.+-|+|..+...|+||||| -||-.+++. ....++
T Consensus 48 ~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlle---VhkKpl 123 (948)
T KOG0577|consen 48 VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLE---VHKKPL 123 (948)
T ss_pred cCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHH---HHhccc
Confidence 456789999999865 3455678999999999999999999999999999999999999 558888884 334568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
.+..+..|..+.+.||+|||++ +.||||||..||||++.|.|||+|||.+..+.. ...++||+.|||||++.
T Consensus 124 qEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----AnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 124 QEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANSFVGTPYWMAPEVIL 195 (948)
T ss_pred hHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----hhcccCCccccchhHhe
Confidence 8999999999999999999999 999999999999999999999999999986654 45689999999999885
Q ss_pred C---CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 161 G---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 161 ~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
. +.|+-++||||||++--||.-.++|..++.. +...+....++. |.+. .+.....+..++..|
T Consensus 196 AMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNes------PtLq--s~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 196 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------PTLQ--SNEWSDYFRNFVDSC 261 (948)
T ss_pred eccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcCC------CCCC--CchhHHHHHHHHHHH
Confidence 3 7899999999999999999999988655422 111111111111 1221 345556677788889
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
++.-|.+|||.+++++
T Consensus 262 LqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLK 277 (948)
T ss_pred HhhCcccCCcHHHHhh
Confidence 9999999999988873
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.70 Aligned_cols=226 Identities=25% Similarity=0.406 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+++++|.+++.. ..+++.
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~ 98 (274)
T cd06609 24 RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDET 98 (274)
T ss_pred CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHH
Confidence 368899999987653 44456788999999999999999999999999999999999999999999832 278999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++....... .......++..|+|||++.+..
T Consensus 99 ~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 99 YIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred HHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccCC
Confidence 9999999999999999999 99999999999999999999999999998765432 1233456788899999999888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++||||||+++|+|+||..|+...... .. ... ..... .+.+... .....+.+++.+||..+|+
T Consensus 175 ~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~---~~~-~~~~~-----~~~~~~~--~~~~~~~~~l~~~l~~~p~ 240 (274)
T cd06609 175 YDEKADIWSLGITAIELAKGEPPLSDLHPM---RV---LFL-IPKNN-----PPSLEGN--KFSKPFKDFVSLCLNKDPK 240 (274)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCchH---HH---HHH-hhhcC-----CCCCccc--ccCHHHHHHHHHHhhCChh
Confidence 999999999999999999999998643321 11 111 11111 1111111 0233577889999999999
Q ss_pred CCCCHHHHHH
Q 021774 244 RRPQMNQVIK 253 (307)
Q Consensus 244 ~RPs~~~v~~ 253 (307)
+||+++++++
T Consensus 241 ~Rpt~~~il~ 250 (274)
T cd06609 241 ERPSAKELLK 250 (274)
T ss_pred hCcCHHHHhh
Confidence 9999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=252.47 Aligned_cols=228 Identities=22% Similarity=0.246 Sum_probs=181.2
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|+.+|+|.++.. +....+.+.+|+++-+.|+||||+++.+.+......|+|+|+++|+.|-.-+. ....++
T Consensus 33 ~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV----~R~~yS 108 (355)
T KOG0033|consen 33 KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYS 108 (355)
T ss_pred ccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH----HHHHHH
Confidence 356888899988754 33455778899999999999999999999999999999999999999955441 225678
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
+..+-..+.||++||.|+|.+ +|+|||+||+|+++-+. .-+||+|||++.... .......+.||+.|||||+
T Consensus 109 Ea~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEv 183 (355)
T KOG0033|consen 109 EADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEV 183 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--CccccccccCCCcccCHHH
Confidence 888999999999999999999 99999999999999544 349999999998776 3344566889999999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+...+|+..+|||+.|++||-|+.|.+||.... ...+.+-+.+ +.. .+++. .-+.......+|+++|+
T Consensus 184 vrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~----g~y--d~~~~---~w~~is~~Ak~LvrrML 251 (355)
T KOG0033|consen 184 LKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKA----GAY--DYPSP---EWDTVTPEAKSLIRRML 251 (355)
T ss_pred hhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhc----ccc--CCCCc---ccCcCCHHHHHHHHHHh
Confidence 999999999999999999999999999986532 2222222222 111 11111 11223334778999999
Q ss_pred ccccCCCCCHHHHH
Q 021774 239 QAAASRRPQMNQVI 252 (307)
Q Consensus 239 ~~~p~~RPs~~~v~ 252 (307)
..||.+|.|+.|.+
T Consensus 252 ~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 252 TVNPKKRITADEAL 265 (355)
T ss_pred ccChhhhccHHHHh
Confidence 99999999998876
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.66 Aligned_cols=237 Identities=22% Similarity=0.316 Sum_probs=175.8
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||+++ +|.+++.. .+..+++..
T Consensus 30 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~ 105 (309)
T cd07872 30 TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHN 105 (309)
T ss_pred CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHH
Confidence 57889999987543 22334678899999999999999999999999999999999975 88887732 334588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-Cc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 163 (307)
+..++.|++.||+|||++ ||+||||||+||+++.++.++|+|||++........ ......++..|+|||++.+ ..
T Consensus 106 ~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 181 (309)
T cd07872 106 VKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSE 181 (309)
T ss_pred HHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccccccccccccCCHHHhCCCC
Confidence 999999999999999999 999999999999999999999999999975433221 1223457889999998865 46
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc---------ccccC---CCC-----CCCCHHH
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---------LELVD---PEL-----GEYPPNE 226 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~---~~~-----~~~~~~~ 226 (307)
++.++||||||+++|+|+||+.||........ ............. ....+ +.. ....+..
T Consensus 182 ~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T cd07872 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE---LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRL 258 (309)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCC
Confidence 88999999999999999999999865432211 1111110000000 00000 000 0001122
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.+++.+|++.||.+|||+.|++.
T Consensus 259 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 259 DTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 345778999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=264.13 Aligned_cols=232 Identities=28% Similarity=0.408 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccccChHhHH--HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESKQGVR--EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+......... ...+|+.++++++||||+++++++.+....++|||++++++|.+++. ....+++
T Consensus 22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~ 97 (260)
T PF00069_consen 22 KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSE 97 (260)
T ss_dssp TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH----HHSSBBH
T ss_pred CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc----ccccccc
Confidence 45778999999877543322 34569999999999999999999999999999999999999999984 4566899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-C
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-G 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~ 161 (307)
..+..++.|+++||.+||++ +++|+||||+||++++++.++|+|||.+..... .........++..|+|||++. +
T Consensus 98 ~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~ 173 (260)
T PF00069_consen 98 EEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFNPFVGTPEYMAPEVLQQG 173 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBSSSSSSGGGSCHHHHTTT
T ss_pred cccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccc
Confidence 99999999999999999999 999999999999999999999999999986522 222344566788999999998 7
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||+|+++|+|++|..|+................. ....... .........+.+++.+||+.|
T Consensus 174 ~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~------~~~~~~~~~l~~li~~~l~~~ 244 (260)
T PF00069_consen 174 KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---RPLPSSS------QQSREKSEELRDLIKKMLSKD 244 (260)
T ss_dssp SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---THHHHHT------TSHTTSHHHHHHHHHHHSSSS
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhccc---ccccccc------cccchhHHHHHHHHHHHccCC
Confidence 8899999999999999999999999876522111111111111 0000000 000011256888999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++||++.++++
T Consensus 245 p~~R~~~~~l~~ 256 (260)
T PF00069_consen 245 PEQRPSAEELLK 256 (260)
T ss_dssp GGGSTTHHHHHT
T ss_pred hhHCcCHHHHhc
Confidence 999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=262.42 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=182.0
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+++.+|+|.+.... ......+.+|++++++++||||+++++++... +..++||||+++++|.+++.........++
T Consensus 24 ~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 103 (287)
T cd06621 24 NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG 103 (287)
T ss_pred CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCC
Confidence 457899999887543 34556789999999999999999999998654 467999999999999988754334456689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... .....++..|+|||.+.+
T Consensus 104 ~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 104 EKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQG 177 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcC
Confidence 999999999999999999999 99999999999999999999999999987543321 123456788999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccc--hhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ--MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
..++.++||||||+++|+|++|..|+...... .......+ ..........+.. .........+.+++.+||+
T Consensus 178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~ 251 (287)
T cd06621 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELKDEP--GNGIKWSEEFKDFIKQCLE 251 (287)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhccCC--CCCCchHHHHHHHHHHHcC
Confidence 89999999999999999999999998755321 11111111 1111111110000 0001234567889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.+|.+|||+.|+++
T Consensus 252 ~~p~~Rpt~~eil~ 265 (287)
T cd06621 252 KDPTRRPTPWDMLE 265 (287)
T ss_pred CCcccCCCHHHHHh
Confidence 99999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.81 Aligned_cols=231 Identities=23% Similarity=0.390 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccccC------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.+.... ......+..|+.++++++|+||+++++++.+.+..++||||+++++|.+++. ...
T Consensus 23 ~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~~ 98 (268)
T cd06630 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYG 98 (268)
T ss_pred CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH----HhC
Confidence 578899999887432 2245678999999999999999999999999999999999999999999983 334
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCccc---ccccccCCCCcC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITH---ITTRIAGTTGYL 154 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~ 154 (307)
.+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||.+..+...... ......++..|+
T Consensus 99 ~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (268)
T cd06630 99 AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175 (268)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccccee
Confidence 688999999999999999999999 999999999999998776 5999999999876543211 122345788999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||.+.+..++.++||||+|+++++|++|..|+......... .......... .....+......+.+++
T Consensus 176 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~--------~~~~~~~~~~~~~~~~i 244 (268)
T cd06630 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASAT--------TAPSIPEHLSPGLRDVT 244 (268)
T ss_pred CHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccC--------CCCCCchhhCHHHHHHH
Confidence 999998888999999999999999999999998543221111 1111111100 01122333445688899
Q ss_pred HhccccccCCCCCHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~ 253 (307)
.+|+..+|.+||++.++++
T Consensus 245 ~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 245 LRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHcCCCcccCcCHHHHhc
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=261.33 Aligned_cols=231 Identities=28% Similarity=0.433 Sum_probs=182.3
Q ss_pred EEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++||||+++|+|.+++.. ....+++..++.
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~ 113 (279)
T cd05057 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLN 113 (279)
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHH
Confidence 58999887653 4455788999999999999999999999987 788999999999999999843 234589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc-cccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.|++.||+|||+. +++||||+|+||++++++.++|+|||.++......... .....++..|+|||.+....++.
T Consensus 114 ~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05057 114 WCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190 (279)
T ss_pred HHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCc
Confidence 999999999999999 99999999999999999999999999998664322211 11122356799999998888999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++|+||||+++||+++ |..||....... +.. ........ ..+......+.+++.+||..+|.+|
T Consensus 191 ~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~p~~R 255 (279)
T cd05057 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD----LLEKGERL--------PQPPICTIDVYMVLVKCWMIDAESR 255 (279)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----HHhCCCCC--------CCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999998 998876543211 111 11111110 1111223457888999999999999
Q ss_pred CCHHHHHHHHHhcccc
Q 021774 246 PQMNQVIKMLTKNIRL 261 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~~ 261 (307)
|++.++++.|.++.+.
T Consensus 256 p~~~~l~~~l~~~~~~ 271 (279)
T cd05057 256 PTFKELINEFSKMARD 271 (279)
T ss_pred CCHHHHHHHHHHHHhC
Confidence 9999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=273.59 Aligned_cols=180 Identities=23% Similarity=0.303 Sum_probs=154.9
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++.. .......+..|+.++.+++||||+++++.+.+.+..++||||++||+|.+++. ....++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~ 99 (360)
T cd05627 24 DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLS 99 (360)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH----hcCCCC
Confidence 46889999998753 23345678889999999999999999999999999999999999999999983 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--------------------
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------------------- 141 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------------------- 141 (307)
+..+..++.|++.||+|||++ ||+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (360)
T cd05627 100 EEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176 (360)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccc
Confidence 999999999999999999999 999999999999999999999999999875432110
Q ss_pred --------------cccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccc
Q 021774 142 --------------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW 191 (307)
Q Consensus 142 --------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 191 (307)
.......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred ccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 01123468999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=261.28 Aligned_cols=228 Identities=24% Similarity=0.371 Sum_probs=179.8
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .....+.+.+|++++++++|+|++++++.+.. +...+++|||+++++|.+++... ....++
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~l~ 100 (257)
T cd08223 23 TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ--KGKLLP 100 (257)
T ss_pred CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh--cCCCCC
Confidence 45788999998754 33455678899999999999999999998764 44678999999999999988432 234589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.+++.||++||++ |++||||+|+||+++.++.++|+|||++........ ......++..|+|||++.+
T Consensus 101 ~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 101 ENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-ccccccCCcCccChhHhcC
Confidence 999999999999999999999 999999999999999999999999999986643221 2334567889999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++++|++|+.|+...... .. ...... ... ...+......+.+++.+||+.+
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~---~~~~~~-~~~--------~~~~~~~~~~~~~li~~~l~~~ 241 (257)
T cd08223 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SL---VYRIIE-GKL--------PPMPKDYSPELGELIATMLSKR 241 (257)
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HH---HHHHHh-cCC--------CCCccccCHHHHHHHHHHhccC
Confidence 88999999999999999999999887543211 11 111111 111 1112233456888999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++||++.++++
T Consensus 242 p~~Rp~~~~~l~ 253 (257)
T cd08223 242 PEKRPSVKSILR 253 (257)
T ss_pred cccCCCHHHHhc
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=260.80 Aligned_cols=228 Identities=22% Similarity=0.372 Sum_probs=182.0
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|.+++.. .....+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~ 100 (256)
T cd08218 23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPE 100 (256)
T ss_pred CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCH
Confidence 46889999988743 334456789999999999999999999999999999999999999999998843 22345789
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+.
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~ 176 (256)
T cd08218 101 DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENR 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCC
Confidence 99999999999999999999 999999999999999999999999999986544221 12234578889999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|+||||+++++|++|..|+..... . ........... ...+......+.+++.+||+.+|
T Consensus 177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~---~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p 241 (256)
T cd08218 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNM---K---NLVLKIIRGSY---------PPVSSHYSYDLRNLVSQLFKRNP 241 (256)
T ss_pred CCCCccchhHHHHHHHHHHcCCCCccCCCH---H---HHHHHHhcCCC---------CCCcccCCHHHHHHHHHHhhCCh
Confidence 899999999999999999999998754321 1 11111111111 11122234458889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
.+||++.+|++
T Consensus 242 ~~Rp~~~~vl~ 252 (256)
T cd08218 242 RDRPSVNSILE 252 (256)
T ss_pred hhCcCHHHHhh
Confidence 99999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=256.83 Aligned_cols=243 Identities=24% Similarity=0.293 Sum_probs=182.1
Q ss_pred cCCCCEEEEEEccccCh-H-hHHHHHHHHHHHhcCCCCC-ccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCC
Q 021774 4 LTNGRRIAVKPLSAESK-Q-GVREFITEIMTLSNVRHPN-LVELIGCCVQGT------RRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
..+|+.||+|++..... + .-....+|+.+|++++|+| |+.+++++...+ ..++||||++. +|..++....
T Consensus 33 ~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~ 111 (323)
T KOG0594|consen 33 KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLP 111 (323)
T ss_pred ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhcc
Confidence 35689999999986633 1 2234578999999999999 999999999887 78899999955 9999995544
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.....++...+..++.||+.||+|||++ +|+||||||.||+|+++|.+||+|||+++.+.-.... ....++|.+|.
T Consensus 112 ~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~-yt~evvTlWYR 187 (323)
T KOG0594|consen 112 KKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT-YTPEVVTLWYR 187 (323)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCccc-ccccEEEeecc
Confidence 3335677789999999999999999999 9999999999999999999999999999965533222 34466789999
Q ss_pred CcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC----Ccc----cccCCCCCCCC--
Q 021774 155 APEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE----KPL----ELVDPELGEYP-- 223 (307)
Q Consensus 155 aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~-- 223 (307)
|||++.+. .|+...||||+||++.||+++++-|...... .....+....... .+. ...+.......
T Consensus 188 aPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~ 264 (323)
T KOG0594|consen 188 APEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGP 264 (323)
T ss_pred CHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCc
Confidence 99999886 7999999999999999999998766554431 1222222222111 111 00111111110
Q ss_pred -------HHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 224 -------PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 224 -------~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
+.......+++.+|++.+|.+|.|+...+..
T Consensus 265 ~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 265 KDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111357788999999999999999988763
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=259.99 Aligned_cols=228 Identities=22% Similarity=0.269 Sum_probs=183.9
Q ss_pred CCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 7 GRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 7 g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+..+|+|++.... .....+.+.|-+||+.++||-++.+|+.|..++..|++||||+||+|..+++ +..+..|++.
T Consensus 102 ~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrq--kQp~~~fse~ 179 (459)
T KOG0610|consen 102 NCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQ--KQPGKRFSES 179 (459)
T ss_pred CceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHh--hCCCCccchh
Confidence 4789999998763 3445677889999999999999999999999999999999999999999984 3556789999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCC-------------------------
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD------------------------- 138 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~------------------------- 138 (307)
.+.-++.+|+-||+|||-. |||+|||||+||||.++|++.|+||.++.....
T Consensus 180 ~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s 256 (459)
T KOG0610|consen 180 AARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPS 256 (459)
T ss_pred hHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccccccc
Confidence 9999999999999999999 999999999999999999999999999853210
Q ss_pred --------C-c---------------------ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCC
Q 021774 139 --------N-I---------------------THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGK 188 (307)
Q Consensus 139 --------~-~---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 188 (307)
. . ......++||-.|+|||++.|...+.++|.|+|||++|||+.|..||.
T Consensus 257 ~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 257 CFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred ccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC
Confidence 0 0 011234678899999999999999999999999999999999999998
Q ss_pred ccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCC----HHHHHH
Q 021774 189 AMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ----MNQVIK 253 (307)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs----~~~v~~ 253 (307)
+...... + .+...+. ..++.. +.....+.+||++.|..||.+|-. +.||-+
T Consensus 337 G~~~~~T--l----~NIv~~~-------l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 337 GSNNKET--L----RNIVGQP-------LKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CCCchhh--H----HHHhcCC-------CcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 7654321 1 1111111 111222 244566889999999999999987 666653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=268.24 Aligned_cols=179 Identities=25% Similarity=0.412 Sum_probs=145.2
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCC-----CCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATK-----ANI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~ 78 (307)
+++.||+|.+..... ...+.+|++++++++||||+++++++.. +...+++|||+. ++|.+++..... ...
T Consensus 27 ~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07868 27 DDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPV 103 (317)
T ss_pred CCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcc
Confidence 567899998875432 2457789999999999999999999864 456789999995 588887643221 223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCceEEeeccCcccCCCCccc--ccccccCCCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG 152 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~ 152 (307)
.+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+++........ ......||..
T Consensus 104 ~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07868 104 QLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccc
Confidence 588999999999999999999999 99999999999999 45678999999999876543221 2234568899
Q ss_pred cCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 153 YLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 153 y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999999877 45889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=250.84 Aligned_cols=236 Identities=25% Similarity=0.347 Sum_probs=177.3
Q ss_pred CCCCEEEEEEccccCh-Hh-HHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK-QG-VREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
++++.||+|+++.+.. .. ---.++|+.+|.+.+|||||.+-.+.+.. +..|+|||||+. +|..++.. -..+|
T Consensus 99 ~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~---m~q~F 174 (419)
T KOG0663|consen 99 KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET---MKQPF 174 (419)
T ss_pred CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh---ccCCC
Confidence 4578899999986532 11 12357999999999999999999988754 478999999966 99999843 33679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
...++..++.|++.|++|||.+ .|+|||||++|+|++..|.+||+|||+++.+++... ..+..+-|.+|.|||.+.
T Consensus 175 ~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k-~~T~lVVTLWYRaPELLL 250 (419)
T KOG0663|consen 175 LPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK-PYTPLVVTLWYRAPELLL 250 (419)
T ss_pred chHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc-cCcceEEEeeecCHHHhc
Confidence 9999999999999999999999 999999999999999999999999999998877532 345566799999999988
Q ss_pred C-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCC-----------CC--------
Q 021774 161 G-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE-----------LG-------- 220 (307)
Q Consensus 161 ~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~-------- 220 (307)
+ ..|+++.|+||+||++.||+++++-|.+...-++ +..+.... +.+.+.+-|. +.
T Consensus 251 G~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ---l~~If~ll--GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr 325 (419)
T KOG0663|consen 251 GAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ---LDKIFKLL--GTPSEAIWPGYSELPAVKKMTFSEHPYNNLR 325 (419)
T ss_pred CCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH---HHHHHHHh--CCCccccCCCccccchhhccccCCCCchhhh
Confidence 7 4689999999999999999999876654432211 11111111 1111111000 01
Q ss_pred -CCCHH-HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 -EYPPN-EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 -~~~~~-~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+... ....-++++...+.+||.+|-|+.+-++
T Consensus 326 ~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 326 KKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11110 1234566777789999999999998764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=266.29 Aligned_cols=243 Identities=20% Similarity=0.270 Sum_probs=182.1
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||+++.. .......+.+|++++++++|+||+++++++...+..+++|||+++++|.+++... ....+++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~ 100 (314)
T cd08216 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPE 100 (314)
T ss_pred CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCH
Confidence 36899999998754 4556678999999999999999999999999999999999999999999998533 2345889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc------cccccccCCCCcCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYLAP 156 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aP 156 (307)
..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||.+........ .......++..|+||
T Consensus 101 ~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (314)
T cd08216 101 LAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177 (314)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence 99999999999999999999 999999999999999999999999998875532211 111233466789999
Q ss_pred ccccC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh-----------cCCccc----ccCCC-
Q 021774 157 EYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-----------EEKPLE----LVDPE- 218 (307)
Q Consensus 157 E~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~----~~~~~- 218 (307)
|++.+ ..++.++|+|||||++|||++|..||....... ........... ...... ..++.
T Consensus 178 E~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
T cd08216 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNN 255 (314)
T ss_pred HHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccch
Confidence 98876 358899999999999999999999987533211 11111100000 000000 00000
Q ss_pred ----CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 219 ----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 219 ----~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
...........+.+++.+||+.||++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 256 RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 011122334567889999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.48 Aligned_cols=236 Identities=20% Similarity=0.266 Sum_probs=172.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--------CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--------TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||++.... ....+|+.++++++||||+++++++... ...++||||+++ +|.+++......
T Consensus 89 ~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~ 163 (440)
T PTZ00036 89 DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN 163 (440)
T ss_pred CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhc
Confidence 468899999886432 2245799999999999999999887532 245789999965 787776544445
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.+..... .....|+..|+|
T Consensus 164 ~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~a 238 (440)
T PTZ00036 164 NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRA 238 (440)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC--cccCCCCcCccC
Confidence 66799999999999999999999999 999999999999998665 699999999986543221 233467899999
Q ss_pred cccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC----------cccccCCC-----C
Q 021774 156 PEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK----------PLELVDPE-----L 219 (307)
Q Consensus 156 PE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~-----~ 219 (307)
||++.+ ..++.++|||||||++|||++|.+||....... .+.. ......... .....-+. +
T Consensus 239 PE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l 315 (440)
T PTZ00036 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVR-IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDL 315 (440)
T ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCCCHHHHHHhchhhhcccCCccCchhH
Confidence 998876 468999999999999999999999986543221 1111 111110000 00000000 0
Q ss_pred -CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 220 -GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 220 -~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..++......+.+++.+||+.||.+|||+.+++.
T Consensus 316 ~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 316 KKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0111223346888999999999999999999984
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=280.18 Aligned_cols=224 Identities=25% Similarity=0.367 Sum_probs=183.0
Q ss_pred EEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.||||+++.... ....+|++|+.+|.+|+|+|++++||+..+ ....+|||+++.|||.+.|+. .....|....+..
T Consensus 140 ~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcd 216 (1039)
T KOG0199|consen 140 NVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCD 216 (1039)
T ss_pred eEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHH
Confidence 689999997653 367899999999999999999999999988 677899999999999999965 3445678888999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCCccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
++.|||.|++||.++ ++|||||..+|++|-....|||+|||+.+-++..... ......-.+.|+|||.++...++
T Consensus 217 ya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS 293 (1039)
T KOG0199|consen 217 YAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS 293 (1039)
T ss_pred HHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc
Confidence 999999999999999 9999999999999999999999999999987654332 12223345679999999999999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccC-CCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD-PELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
.++|||+|||++|||+| |..||..-.+.. ++ +.+| .+.-.-+..+.+++.++++.||..+|+
T Consensus 294 haSDvWmyGVTiWEMFtyGEePW~G~~g~q---IL-------------~~iD~~erLpRPk~csedIY~imk~cWah~pa 357 (1039)
T KOG0199|consen 294 HASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---IL-------------KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPA 357 (1039)
T ss_pred ccchhhhhhhhHHhhhccCCCCCCCCCHHH---HH-------------HhccccccCCCCCCChHHHHHHHHHhccCCcc
Confidence 99999999999999998 566765543211 11 1111 111223456677899999999999999
Q ss_pred CCCCHHHHHHH
Q 021774 244 RRPQMNQVIKM 254 (307)
Q Consensus 244 ~RPs~~~v~~~ 254 (307)
+||+|..|.+.
T Consensus 358 DRptFsair~~ 368 (1039)
T KOG0199|consen 358 DRPTFSAIRED 368 (1039)
T ss_pred ccccHHHHHHh
Confidence 99999999743
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.17 Aligned_cols=239 Identities=24% Similarity=0.350 Sum_probs=181.5
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..||+|.+.... ......+.+|+.++++++||||+++++++......++||||+ +++|.+++.. ....+++
T Consensus 23 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~ 98 (286)
T cd07832 23 ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPE 98 (286)
T ss_pred CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCH
Confidence 468999999987653 344567999999999999999999999999999999999999 9999999843 2356899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++...............++..|+|||++.+.
T Consensus 99 ~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 99 AQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeecc
Confidence 99999999999999999999 999999999999999999999999999987654432223345678899999988654
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc------------ccccCCC-----CCCCCH
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP------------LELVDPE-----LGEYPP 224 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~-----~~~~~~ 224 (307)
.++.++||||+|++++||++|.+++...... ............... .....+. +....+
T Consensus 176 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07832 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFP 252 (286)
T ss_pred ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCC
Confidence 4689999999999999999997766443221 111111111100000 0000000 001112
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+|++.+|.+||++++++.
T Consensus 253 ~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 253 DASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 23467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=276.63 Aligned_cols=236 Identities=21% Similarity=0.242 Sum_probs=172.4
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+++.||||.... ..+.+|+++|++++|+||+++++++......++|||++. ++|..++.. ....+++..+
T Consensus 193 ~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~ 262 (461)
T PHA03211 193 YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQV 262 (461)
T ss_pred CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHH
Confidence 467899995432 346789999999999999999999999999999999995 688888732 2346999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+.++.|++.||.|||++ ||+||||||+||||+.++.++|+|||+++........ ......||..|+|||++.+..+
T Consensus 263 ~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 339 (461)
T PHA03211 263 TAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY 339 (461)
T ss_pred HHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC
Confidence 99999999999999999 9999999999999999999999999999865432211 2234568999999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccc-----hhHHHHHHHHHHhhcC-Ccccc----------------cCCCCCCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQ-----MNKFLLEWAWQLHQEE-KPLEL----------------VDPELGEY 222 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~-~~~~~----------------~~~~~~~~ 222 (307)
+.++|||||||++|||++|..++...... ....+...+....... ..... ..+.....
T Consensus 340 ~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 419 (461)
T PHA03211 340 TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRP 419 (461)
T ss_pred CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCc
Confidence 99999999999999999987654221110 1111222211111000 00000 00000000
Q ss_pred -C---HHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 223 -P---PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 223 -~---~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
. ......+.+++.+||+.||.+|||+.|+++.
T Consensus 420 ~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 420 AWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0112247788999999999999999999763
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=261.88 Aligned_cols=236 Identities=25% Similarity=0.318 Sum_probs=178.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+++.||||+.-.+.+ --.+|+++|+.++|||||+++.+|.... ...+||||++. +|.++++.....+..
T Consensus 47 e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~ 121 (364)
T KOG0658|consen 47 ETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQR 121 (364)
T ss_pred CCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCC
Confidence 3478999998875432 1236999999999999999999887543 22589999965 999999765556777
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
++...+.-+.+||.+||+|||+. ||+||||||.|+|+|.+ |.+||||||.|+..........+ .-+..|.|||.
T Consensus 122 mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSY--icSRyYRaPEL 196 (364)
T KOG0658|consen 122 MPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISY--ICSRYYRAPEL 196 (364)
T ss_pred CceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeE--EEeccccCHHH
Confidence 88888888999999999999999 99999999999999876 89999999999988665554332 34778999998
Q ss_pred ccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC----------CcccccCCCCCC------
Q 021774 159 VLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE----------KPLELVDPELGE------ 221 (307)
Q Consensus 159 ~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~------ 221 (307)
+.+ ..|+.+.||||.||++.||+-|++-|.+..+..+ +.. +.+...-. ...+...+.+..
T Consensus 197 ifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~e-Iik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~ 273 (364)
T KOG0658|consen 197 IFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVE-IIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKV 273 (364)
T ss_pred HcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHH-HHHHhCCCCHHHHhhcCcccccccCcccccccceee
Confidence 887 4799999999999999999999987766443322 222 21221111 001111122211
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.......+.++++.++++.+|.+|.++.+++.
T Consensus 274 ~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 274 FFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 22344556888999999999999999998875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=258.22 Aligned_cols=225 Identities=27% Similarity=0.409 Sum_probs=180.4
Q ss_pred CCCEEEEEEccccC-----hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 6 NGRRIAVKPLSAES-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 6 ~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+|+.|++|.+.... .+..+.+.+|+.++++++|+||+++++++......++++||+++++|.+++. ....+
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~ 99 (258)
T cd06632 24 DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK----KYGSF 99 (258)
T ss_pred CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH----hcCCC
Confidence 78999999886532 3455778999999999999999999999999999999999999999999983 33458
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||+. |++|+||+|+||+++.++.+||+|||++....... ......|+..|++||.+.
T Consensus 100 ~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~ 174 (258)
T cd06632 100 PEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIA 174 (258)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhc
Confidence 8999999999999999999999 99999999999999999999999999987654332 223455788999999887
Q ss_pred CCc-ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
... ++.++|+||||+++|+|++|..||...... .. ......... ....+......+.+++.+||+
T Consensus 175 ~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~----~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AA----VFKIGRSKE--------LPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred CCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HH----HHHHHhccc--------CCCcCCCcCHHHHHHHHHHhh
Confidence 766 899999999999999999999998654321 11 111111010 011122233457788899999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.+|.+||++.+++.
T Consensus 241 ~~p~~Rp~~~~~l~ 254 (258)
T cd06632 241 RDPSLRPTAAELLE 254 (258)
T ss_pred cCcccCcCHHHHhc
Confidence 99999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.42 Aligned_cols=239 Identities=22% Similarity=0.317 Sum_probs=180.9
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||++++.+..+. .....+++
T Consensus 24 ~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~----~~~~~~~~ 99 (288)
T cd07833 24 ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE----ASPGGLPP 99 (288)
T ss_pred CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH----hcCCCCCH
Confidence 35789999988754 2344567899999999999999999999999999999999999987777665 23445899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++...............++..|+|||++.+.
T Consensus 100 ~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 100 DAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCC
Confidence 99999999999999999999 999999999999999999999999999987655432223345677889999999887
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh------------cCCcc--cccCCCC-----CCC
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ------------EEKPL--ELVDPEL-----GEY 222 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~--~~~~~~~-----~~~ 222 (307)
.++.++||||||+++|+|++|..||....... .+.. ...... ..... ...+... ..+
T Consensus 177 ~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T cd07833 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYL-IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRY 253 (288)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhc
Confidence 78999999999999999999998876432211 1111 000000 00000 0000000 001
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+......+.+++.+||..+|++||++.++++
T Consensus 254 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 254 PGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 1112466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=260.51 Aligned_cols=227 Identities=27% Similarity=0.419 Sum_probs=173.5
Q ss_pred CCCCEEEEEEcccc-----ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|..||+|.+... .......+.+|+.++++++||||+++++++.. ....++++||+++++|.+++. ..
T Consensus 25 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~----~~ 100 (266)
T cd06651 25 DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AY 100 (266)
T ss_pred CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHH----Hc
Confidence 46889999988643 22345678899999999999999999998875 357789999999999999983 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc--ccccccccCCCCcCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYLA 155 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~g~~~y~a 155 (307)
..+++..++.++.|++.||+|||++ +++||||+|+||++++++.++|+|||++....... ........++..|+|
T Consensus 101 ~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (266)
T cd06651 101 GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177 (266)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccC
Confidence 4588999999999999999999999 99999999999999999999999999987653211 111223457889999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+..++.++|||||||++|||++|+.||....... ......... ..+.+ +......+..++
T Consensus 178 PE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~-----~~~~~---~~~~~~~~~~li- 242 (266)
T cd06651 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQP-----TNPQL---PSHISEHARDFL- 242 (266)
T ss_pred HHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCC-----CCCCC---chhcCHHHHHHH-
Confidence 999998889999999999999999999999986432211 011111100 01111 222223344455
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
.||..+|++||++++|+.
T Consensus 243 ~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 243 GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHhcCChhhCcCHHHHhc
Confidence 688899999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=261.31 Aligned_cols=227 Identities=23% Similarity=0.413 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|.+++.. ..+++..
T Consensus 42 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~ 116 (285)
T cd06648 42 STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQ 116 (285)
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHH
Confidence 46889999988765555556789999999999999999999999999999999999999999999832 4588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..+
T Consensus 117 ~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 192 (285)
T cd06648 117 IATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPY 192 (285)
T ss_pred HHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCC
Confidence 999999999999999999 999999999999999999999999998875543322 1233457889999999988889
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+++|+|++|..|+...... ..... ....... .. .........+.+++.+||+.+|++
T Consensus 193 ~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~-~~~~~~~-----~~-~~~~~~~~~l~~li~~~l~~~p~~ 259 (285)
T cd06648 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKR-IRDNLPP-----KL-KNLHKVSPRLRSFLDRMLVRDPAQ 259 (285)
T ss_pred CCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-HHhcCCC-----CC-cccccCCHHHHHHHHHHcccChhh
Confidence 99999999999999999999987543211 11111 1111110 11 011112345888999999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
||++.++++
T Consensus 260 Rpt~~~il~ 268 (285)
T cd06648 260 RATAAELLN 268 (285)
T ss_pred CcCHHHHcc
Confidence 999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=259.19 Aligned_cols=232 Identities=25% Similarity=0.351 Sum_probs=181.8
Q ss_pred CCCEEEEEEcccc----------ChHhHHHHHHHHHHHhc-CCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC
Q 021774 6 NGRRIAVKPLSAE----------SKQGVREFITEIMTLSN-VRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 6 ~g~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
+++.+|+|.+... ......++..|+.++.+ ++||||+++++++..++..++||||+++++|.+++....
T Consensus 25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~ 104 (269)
T cd08528 25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK 104 (269)
T ss_pred CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH
Confidence 4678999987642 22334567789988875 699999999999999999999999999999999875444
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCc
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 153 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 153 (307)
.....+++..++.++.|++.||.|||+ . +++|+||+|+||++++++.++|+|||.+....... ......|+..|
T Consensus 105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~ 179 (269)
T cd08528 105 EKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILY 179 (269)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccC
Confidence 455679999999999999999999996 6 89999999999999999999999999998755432 23345678899
Q ss_pred CCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 154 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 154 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
++||++.+..++.++||||||+++|+|++|+.|+...... .. ...... .... +... ......+.++
T Consensus 180 ~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~---~~~~~~-~~~~----~~~~---~~~~~~l~~l 245 (269)
T cd08528 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SL---ATKIVE-AVYE----PLPE---GMYSEDVTDV 245 (269)
T ss_pred cChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HH---HHHHhh-ccCC----cCCc---ccCCHHHHHH
Confidence 9999999888999999999999999999999987543211 11 111111 1110 0000 0122457788
Q ss_pred HHhccccccCCCCCHHHHHHHHH
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~ 256 (307)
+.+||+.||++||++.++..++.
T Consensus 246 i~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 246 ITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHCCCCCccCCCHHHHHHHhc
Confidence 88999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=256.67 Aligned_cols=226 Identities=24% Similarity=0.400 Sum_probs=177.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.++... ....+.+|+.++++++|||++++++++..+ ..++||||+++++|.+++... ....+++..
T Consensus 27 ~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~ 101 (254)
T cd05083 27 YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQ 101 (254)
T ss_pred cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHH
Confidence 467889999987543 235789999999999999999999998765 468999999999999998532 234588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
++.++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++...... ......+..|+|||++.+..+
T Consensus 102 ~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~ 174 (254)
T cd05083 102 LLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKF 174 (254)
T ss_pred HHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----CCCCCCCceecCHHHhccCCc
Confidence 999999999999999999 9999999999999999999999999998754322 112234567999999988889
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++|+||||+++|||++ |..||....... ... ........ + .+......+.+++.+||+.+|+
T Consensus 175 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~---~-----~~~~~~~~~~~li~~~l~~~p~ 239 (254)
T cd05083 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKE----CVEKGYRM---E-----PPEGCPADVYVLMTSCWETEPK 239 (254)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhCCCCC---C-----CCCcCCHHHHHHHHHHcCCChh
Confidence 999999999999999998 888875433211 111 11111110 0 1122334577899999999999
Q ss_pred CCCCHHHHHHHHHh
Q 021774 244 RRPQMNQVIKMLTK 257 (307)
Q Consensus 244 ~RPs~~~v~~~L~~ 257 (307)
+||++.++++.|++
T Consensus 240 ~Rp~~~~l~~~l~~ 253 (254)
T cd05083 240 KRPSFHKLREKLEK 253 (254)
T ss_pred hCcCHHHHHHHHcc
Confidence 99999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=279.63 Aligned_cols=219 Identities=26% Similarity=0.325 Sum_probs=179.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+++.+|||++++. ..+..+....|.+++... +||.++.++.+|...++.|+||||+.||++..+ .....|
T Consensus 391 ~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-----~~~~~F 465 (694)
T KOG0694|consen 391 GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-----IHTDVF 465 (694)
T ss_pred CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-----Eecccc
Confidence 45789999999986 356677888899998877 699999999999999999999999999994433 345679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+.-+++.|+.||+|||++ |||+||||.+|||||.+|.+||+|||+++.--.. ...+..++||+.|+|||++.
T Consensus 466 ~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~TsTfCGTpey~aPEil~ 541 (694)
T KOG0694|consen 466 SEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDRTSTFCGTPEFLAPEVLT 541 (694)
T ss_pred cHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-CCccccccCChhhcChhhhc
Confidence 9999999999999999999999 9999999999999999999999999999854322 23567899999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..|+.++|.|||||++||||.|..||......+ +.+.+ .. .++ .++.-...+...++++.+..
T Consensus 542 e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---~FdsI---~~-------d~~---~yP~~ls~ea~~il~~ll~k 605 (694)
T KOG0694|consen 542 EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---VFDSI---VN-------DEV---RYPRFLSKEAIAIMRRLLRK 605 (694)
T ss_pred cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH---hc-------CCC---CCCCcccHHHHHHHHHHhcc
Confidence 9999999999999999999999999987543221 11111 11 112 22333444577778889999
Q ss_pred ccCCCCCH
Q 021774 241 AASRRPQM 248 (307)
Q Consensus 241 ~p~~RPs~ 248 (307)
+|++|--+
T Consensus 606 ~p~kRLG~ 613 (694)
T KOG0694|consen 606 NPEKRLGS 613 (694)
T ss_pred CcccccCC
Confidence 99999655
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=263.00 Aligned_cols=238 Identities=24% Similarity=0.327 Sum_probs=173.1
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcC---CCCCccceeeEEEe-----CCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||+|.++... ......+.+|+++++++ +||||+++++++.. ....++|||++.+ +|.+++...
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~- 100 (288)
T cd07863 23 HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV- 100 (288)
T ss_pred CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc-
Confidence 468899999887542 12223456677777665 79999999998864 2457899999975 888887432
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..+..++.|++.||.|||++ |++||||||+||++++++.+||+|||++....... ......|+..|+
T Consensus 101 -~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~ 174 (288)
T cd07863 101 -PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYR 174 (288)
T ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCcc--cCCCcccccccc
Confidence 234589999999999999999999999 99999999999999999999999999998664322 123346788999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhc----CCc------ccccCCC----CC
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE----EKP------LELVDPE----LG 220 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~------~~~~~~~----~~ 220 (307)
|||++.+..++.++|||||||++|+|++|++||....... .+ ......... ... .....+. ..
T Consensus 175 aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
T cd07863 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QL-GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQ 251 (288)
T ss_pred CchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HH-HHHHHHhCCCChhhCcccccccccccCCCCCCchH
Confidence 9999998899999999999999999999999886443211 11 111111100 000 0000000 01
Q ss_pred CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.....+.+++.+|++.||++|||+.+++.
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 252 SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223445788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=260.42 Aligned_cols=229 Identities=24% Similarity=0.400 Sum_probs=179.5
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|..||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||+++++|..++.... ....+++..
T Consensus 25 ~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~ 103 (286)
T cd06622 25 TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDV 103 (286)
T ss_pred CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHH
Confidence 6889999988754 34445688999999999999999999999999999999999999999999884321 234689999
Q ss_pred HHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC-
Q 021774 85 RSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG- 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 162 (307)
+..++.|++.||.|||+ . +++|+||+|+||++++++.++|+|||++....... .....++..|+|||.+.+.
T Consensus 104 ~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 177 (286)
T cd06622 104 LRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGG 177 (286)
T ss_pred HHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCC
Confidence 99999999999999995 6 89999999999999999999999999987653322 2234577889999988553
Q ss_pred -----cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 163 -----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 163 -----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
.++.++|+|||||++|+|++|+.||....... ......... ... ....++.....+.+++.+|
T Consensus 178 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~~~--------~~~~~~~~~~~~~~li~~~ 245 (286)
T cd06622 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIV-DGD--------PPTLPSGYSDDAQDFVAKC 245 (286)
T ss_pred CCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHh-hcC--------CCCCCcccCHHHHHHHHHH
Confidence 35789999999999999999999986432211 111111111 111 1122233445678899999
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
|+.+|++||++.+++.
T Consensus 246 l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 246 LNKIPNRRPTYAQLLE 261 (286)
T ss_pred cccCcccCCCHHHHhc
Confidence 9999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=271.15 Aligned_cols=232 Identities=22% Similarity=0.286 Sum_probs=172.8
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||.+.... ......+.+|++++++++||||+++++++... ...+++++++ +++|.+++.
T Consensus 38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~----- 111 (343)
T cd07878 38 RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK----- 111 (343)
T ss_pred CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-----
Confidence 567899999987542 23345678999999999999999999987643 3468999988 789998872
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
...+++..+..++.|++.||.|||++ ||+||||||+||++++++.+||+|||++...... .....|+..|+||
T Consensus 112 ~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aP 184 (343)
T cd07878 112 CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAP 184 (343)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCc
Confidence 34689999999999999999999999 9999999999999999999999999999865432 2334688999999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccccc-----------CCCCCCCC-
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-----------DPELGEYP- 223 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~- 223 (307)
|++.+ ..++.++|||||||++|+|++|+.||....... .+.. ........ ..... ...+...+
T Consensus 185 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (343)
T cd07878 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKR-IMEVVGTP-SPEVLKKISSEHARKYIQSLPHMPQ 260 (343)
T ss_pred hHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHhCCC-CHHHHHhcchhhHHHHhhccccccc
Confidence 99877 568899999999999999999999885432111 0100 00000000 00000 00000000
Q ss_pred -------HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 -------PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 -------~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
......+.+++.+|++.||.+|||+.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 261 QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111234678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=260.48 Aligned_cols=230 Identities=23% Similarity=0.352 Sum_probs=184.2
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|..||+|.+... .......+..|++++++++|+||+++++++.. ....+++|||+++++|.+++.........+
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l 102 (265)
T cd08217 23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102 (265)
T ss_pred CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCC
Confidence 46789999988753 34455678899999999999999999998764 456789999999999999986554456679
Q ss_pred CHHHHHHHHHHHHHHHHHHh-----cCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 81 NWEKRSDICVGIAKGLAFLH-----EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
++..++.++.|++.||.||| +. +++|+||+|+||++++++.++|+|||++......... .....++..|+|
T Consensus 103 ~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~ 178 (265)
T cd08217 103 EEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMS 178 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCCccc-ccccccCCCccC
Confidence 99999999999999999999 77 9999999999999999999999999999876543321 223467889999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||.+.+..++.++|+||||+++++|++|..|+..... ..+.. ...... ....+......+.+++.
T Consensus 179 pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~--------~~~~~~~~~~~~~~l~~ 243 (265)
T cd08217 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGK--------FRRIPYRYSSELNEVIK 243 (265)
T ss_pred hhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCC--------CCCCccccCHHHHHHHH
Confidence 9999888899999999999999999999999865431 11111 111111 11222334456888999
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
+|++.+|++||++.+|++
T Consensus 244 ~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 244 SMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHccCCcccCCCHHHHhh
Confidence 999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=259.40 Aligned_cols=230 Identities=26% Similarity=0.476 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.+|+|.+.... ......+.+|++++++++||||+++++++...+..++++||+++++|.+++... ...+++.
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~ 100 (265)
T cd06605 24 PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV---QGRIPER 100 (265)
T ss_pred CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHH
Confidence 358899999887653 445567899999999999999999999999999999999999999999998432 2568899
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||+|||+ . +++|+||+|+||++++++.++|+|||.+........ ....++..|+|||++.+.
T Consensus 101 ~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~ 174 (265)
T cd06605 101 ILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQGN 174 (265)
T ss_pred HHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hcccCChhccCHHHHcCC
Confidence 999999999999999999 8 999999999999999999999999999875533211 126678899999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHH-HHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN-EIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|+|++|..|+........ ........... ... +.+ +.. ....+.+++.+||..+
T Consensus 175 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~-----~~~---~~~~~~~~~~~li~~~l~~~ 244 (265)
T cd06605 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN-EPP-----PRL---PSGKFSPDFQDFVNLCLIKD 244 (265)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc-CCC-----CCC---ChhhcCHHHHHHHHHHcCCC
Confidence 999999999999999999999999765421111 11111111111 110 111 111 3345788889999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||+.+++.
T Consensus 245 p~~Rpt~~~ll~ 256 (265)
T cd06605 245 PRERPSYKELLE 256 (265)
T ss_pred chhCcCHHHHhh
Confidence 999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=266.72 Aligned_cols=227 Identities=23% Similarity=0.270 Sum_probs=187.3
Q ss_pred CCCCEEEEEEccccCh---HhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK---QGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.+|+|.+..... .....+.+|+.+|+++. ||||+.++++|.+....++|||++.||.|.+.+... .+
T Consensus 58 ~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~ 132 (382)
T KOG0032|consen 58 STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HY 132 (382)
T ss_pred CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cC
Confidence 4599999999986532 23467899999999997 999999999999999999999999999999988443 39
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC----CceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE----FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
++..+..++.|+++|+.|||+. |++||||||+|+|+... +.++++|||++..... .......+||+.|+||
T Consensus 133 sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 133 SERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAP 207 (382)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCc
Confidence 9999999999999999999999 99999999999999543 4799999999998776 3456778999999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
|++.+..|+..+||||+|+++|.|++|..||.......... . ...... ..-+ ..-+.....+.++++.
T Consensus 208 Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~-i~~~~~-~f~~----~~w~~is~~akd~i~~ 275 (382)
T KOG0032|consen 208 EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------A-ILRGDF-DFTS----EPWDDISESAKDFIRK 275 (382)
T ss_pred hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------H-HHcCCC-CCCC----CCccccCHHHHHHHHH
Confidence 99999999999999999999999999999987655432211 1 111111 1111 1223345567888999
Q ss_pred ccccccCCCCCHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~ 253 (307)
|+..||.+|+|+.++++
T Consensus 276 ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 276 LLEFDPRKRLTAAQALQ 292 (382)
T ss_pred hcccCcccCCCHHHHhc
Confidence 99999999999999987
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=267.29 Aligned_cols=179 Identities=25% Similarity=0.415 Sum_probs=144.6
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCC-----CCCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGAT-----KANI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~ 78 (307)
++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||+.+ +|.+++.... ....
T Consensus 27 ~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07867 27 DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPM 103 (317)
T ss_pred ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCc
Confidence 457899998875432 2457889999999999999999999864 4577999999965 7777763221 1223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCceEEeeccCcccCCCCccc--ccccccCCCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTG 152 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~ 152 (307)
.+++..+..++.|++.||.|||++ +++||||||+||++ +.++.+||+|||+++........ ......|+..
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07867 104 QLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccc
Confidence 588999999999999999999999 99999999999999 56678999999999876543221 2234567889
Q ss_pred cCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 153 YLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 153 y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
|+|||++.+ ..++.++|||||||++|||+||.+||...
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999998876 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.23 Aligned_cols=228 Identities=21% Similarity=0.257 Sum_probs=181.5
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ....++
T Consensus 16 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~ 91 (262)
T cd05572 16 SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR----DRGLFD 91 (262)
T ss_pred CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHh----hcCCCC
Confidence 358899999987542 2445679999999999999999999999999999999999999999999983 334588
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++....... ......++..|++||.+.+
T Consensus 92 ~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~ 166 (262)
T cd05572 92 EYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILN 166 (262)
T ss_pred HHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcC
Confidence 999999999999999999999 99999999999999999999999999998765432 2233467889999999888
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+||||+++|+|++|..|+......... . ......... ....+......+.+++.+||+.+
T Consensus 167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~---~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-I---YNDILKGNG--------KLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-H---HHHHhccCC--------CCCCCcccCHHHHHHHHHHccCC
Confidence 88999999999999999999999998765421111 1 111111000 01112222456888999999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|++||+ +.|+++
T Consensus 235 p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 235 PEERLGNLKGGIKDIKK 251 (262)
T ss_pred hhhCcCCcccCHHHHhc
Confidence 999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=269.63 Aligned_cols=167 Identities=27% Similarity=0.366 Sum_probs=142.1
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+++.||+|..... ....|+.++++++||||+++++++......++|||++. ++|.+++. .....+++..+
T Consensus 90 ~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~ 159 (357)
T PHA03209 90 QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLT---KRSRPLPIDQA 159 (357)
T ss_pred CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHH---hccCCCCHHHH
Confidence 4678999975432 23569999999999999999999999999999999995 58888773 23456899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
..++.||+.||.|||++ +|+||||||+|||++.++.++|+|||++...... .......|+..|+|||++.+..++
T Consensus 160 ~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 234 (357)
T PHA03209 160 LIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLARDKYN 234 (357)
T ss_pred HHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--cccccccccccccCCeecCCCCCC
Confidence 99999999999999999 9999999999999999999999999999753322 112335689999999999998999
Q ss_pred ccCceeehHHHHHHHHhCCCCC
Q 021774 166 MKADVYSFGVLVLEIISGRNSG 187 (307)
Q Consensus 166 ~~~Dv~slG~~l~elltg~~p~ 187 (307)
.++|||||||++|||+++..++
T Consensus 235 ~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 235 SKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred chhhHHHHHHHHHHHHHcCCcc
Confidence 9999999999999999865554
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=256.94 Aligned_cols=230 Identities=28% Similarity=0.479 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccccCh--HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.|++|.++.... ...+.+..|++++++++|+||+++++++...+..++|+||+++++|.+++. .+..+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~ 98 (264)
T cd06626 23 DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDE 98 (264)
T ss_pred CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHh----hcCCCCh
Confidence 4688999999876543 466789999999999999999999999999999999999999999999983 3345788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc---ccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT---TRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~g~~~y~aPE~~ 159 (307)
..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........... ....++..|+|||++
T Consensus 99 ~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 175 (264)
T cd06626 99 HVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175 (264)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhc
Confidence 99999999999999999999 999999999999999999999999999987654332211 234577899999998
Q ss_pred cCCc---ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 160 LGGQ---LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 160 ~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
.+.. ++.++||||||+++|+|++|..||........ . ........ .+.+... ......+.+++.+
T Consensus 176 ~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~~~~~------~~~~~~~-~~~~~~~~~li~~ 243 (264)
T cd06626 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHVGAGH------KPPIPDS-LQLSPEGKDFLDR 243 (264)
T ss_pred cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHHhcCC------CCCCCcc-cccCHHHHHHHHH
Confidence 8765 88999999999999999999999864321110 0 11111100 1111111 1113446788999
Q ss_pred ccccccCCCCCHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~ 253 (307)
||+.+|.+||++.+++.
T Consensus 244 ~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 244 CLESDPKKRPTASELLQ 260 (264)
T ss_pred HccCCcccCCCHHHHhc
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.70 Aligned_cols=222 Identities=27% Similarity=0.326 Sum_probs=178.9
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .......+.+|++++++++||||+++++++.+.+..++||||+++++|.+++. ....++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~~~l~ 99 (290)
T cd05580 24 GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR----KSGRFP 99 (290)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHH----HcCCCC
Confidence 36899999988753 23345678899999999999999999999999999999999999999999983 335789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ |++|+||+|+||++++++.++|+|||++...... .....++..|+|||.+.+
T Consensus 100 ~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 100 EPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILS 172 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcC
Confidence 999999999999999999999 9999999999999999999999999999876543 233467889999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
...+.++||||||+++|+|++|..||...... ... ........ .+ +......+.+++.+||..+
T Consensus 173 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~------~~---~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIY----EKILEGKV------RF---PSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhcCCc------cC---CccCCHHHHHHHHHHccCC
Confidence 88899999999999999999999997643311 111 11111111 11 1122345778899999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|.+|+ ++.+++.
T Consensus 237 p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 237 LTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHccCcccCCHHHHHc
Confidence 99998 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=258.79 Aligned_cols=228 Identities=24% Similarity=0.389 Sum_probs=175.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+++.||+|.+.... .....+..|+.+++++ +|+||+++++++... ...++||||+.+++|.+++... ..
T Consensus 29 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~ 105 (272)
T cd06637 29 KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KG 105 (272)
T ss_pred CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc--cC
Confidence 457889999987543 2345788999999998 799999999998753 4678999999999999998432 23
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..+++..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++........ ......|+..|+|||
T Consensus 106 ~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE 181 (272)
T cd06637 106 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPE 181 (272)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc-cCCcccccccccCHh
Confidence 4688999999999999999999999 999999999999999999999999999976543221 233456888999999
Q ss_pred ccc-----CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 158 YVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 158 ~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
++. +..++.++|||||||++|||++|..|+......... . .... ... ... ........+.+
T Consensus 182 ~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~-~~~~-~~~-----~~~--~~~~~~~~~~~ 247 (272)
T cd06637 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F-LIPR-NPA-----PRL--KSKKWSKKFQS 247 (272)
T ss_pred HhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H-HHhc-CCC-----CCC--CCCCcCHHHHH
Confidence 886 345788999999999999999999988543321111 0 0011 100 000 01112235778
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||..+|.+|||+.++++
T Consensus 248 li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 248 FIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHcCCChhhCCCHHHHhh
Confidence 899999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=255.63 Aligned_cols=233 Identities=27% Similarity=0.418 Sum_probs=183.3
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..++|||++++++|.+++..... ...+++.
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~ 102 (267)
T cd06610 24 PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEA 102 (267)
T ss_pred CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHH
Confidence 367899999987542 33567899999999999999999999999999999999999999999999853221 2468999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCcCCccccc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~ 160 (307)
.+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||++..+...... ......|+..|+|||++.
T Consensus 103 ~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 179 (267)
T cd06610 103 IIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHc
Confidence 9999999999999999999 9999999999999999999999999999766543222 223346788999999987
Q ss_pred CC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCC--CHHHHHHHHHHHHhc
Q 021774 161 GG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY--PPNEIIRYMKVAFFC 237 (307)
Q Consensus 161 ~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~c 237 (307)
.. .++.++|+||||+++|+|++|+.||....... . ......... +.+... .......+.+++.+|
T Consensus 180 ~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~----~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~ 247 (267)
T cd06610 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--V----LMLTLQNDP------PSLETGADYKKYSKSFRKMISLC 247 (267)
T ss_pred cccCcCcccchHhHhHHHHHHHhCCCCccccChhh--h----HHHHhcCCC------CCcCCccccccccHHHHHHHHHH
Confidence 76 78999999999999999999999986543211 0 111111111 111110 112335578899999
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
|+.||++||++.++++
T Consensus 248 l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 248 LQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCChhhCcCHHHHhh
Confidence 9999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.13 Aligned_cols=240 Identities=31% Similarity=0.569 Sum_probs=188.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|..||||.+...... ...|++.+++++||||+++++++.+.+..++||||+++|+|.+++. .++|..
T Consensus 713 ~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~ 781 (968)
T PLN00113 713 KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWER 781 (968)
T ss_pred CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHH
Confidence 57889999988754321 2346889999999999999999999999999999999999999983 388999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+.+++.|++.||+|||....++++||||||+||+++.++..++. |+........ ....++..|+|||++.+..+
T Consensus 782 ~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~ 855 (968)
T PLN00113 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDI 855 (968)
T ss_pred HHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCC
Confidence 99999999999999994434499999999999999999888775 5555432211 22357889999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC---CCCCHHHHHHHHHHHHhccccc
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL---GEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
+.++|||||||++|||+||+.|+...... ...+..|.............+++.+ ......+..++++++.+||+.+
T Consensus 856 ~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~ 934 (968)
T PLN00113 856 TEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD 934 (968)
T ss_pred CcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC
Confidence 99999999999999999999998544332 2233444433333333333444443 2234567778899999999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|++||++.+|++.|+++.+..
T Consensus 935 P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 935 PTARPCANDVLKTLESASRSS 955 (968)
T ss_pred chhCcCHHHHHHHHHHhhccc
Confidence 999999999999999877533
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=270.50 Aligned_cols=238 Identities=23% Similarity=0.284 Sum_probs=174.8
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
..|+.||||.+... .......+.+|+.+++.++||||+++++++... ...++||||+++ +|.+.+.
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 113 (355)
T cd07874 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----- 113 (355)
T ss_pred CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh-----
Confidence 35789999998754 334456788999999999999999999988644 356899999965 6666652
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++...... ......|+..|+||
T Consensus 114 -~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aP 187 (355)
T cd07874 114 -MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAP 187 (355)
T ss_pred -hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc--ccCCccccCCccCH
Confidence 2478899999999999999999999 99999999999999999999999999998654321 22345688999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhH-HHH---------------HHHHHHhhc-CCcccccCCC-
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK-FLL---------------EWAWQLHQE-EKPLELVDPE- 218 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~-~~~---------------~~~~~~~~~-~~~~~~~~~~- 218 (307)
|++.+..++.++|||||||++|+|++|+.||......... ... ......... ........+.
T Consensus 188 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (355)
T cd07874 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267 (355)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhh
Confidence 9999989999999999999999999999998643221110 000 000000000 0000000000
Q ss_pred ----C----CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 219 ----L----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 219 ----~----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
. ..........+.+++.+|++.||++|||+.++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred ccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 01111223457889999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=263.52 Aligned_cols=230 Identities=26% Similarity=0.432 Sum_probs=178.7
Q ss_pred EEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.||+|.+.... ......+.+|+.++++++||||+++++++... ..++++||+++|+|.+++.. ....+++..++.
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~ 113 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLN 113 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHH
Confidence 57999887653 33345788999999999999999999998754 46789999999999999842 234588999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.|++.||+|||++ +++|+||||+||++++++.+||+|||++......... ......++..|+|||++.+..++.
T Consensus 114 ~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (303)
T cd05110 114 WCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190 (303)
T ss_pred HHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCCh
Confidence 999999999999999 9999999999999999999999999999876433221 122234567899999999889999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++||||||+++|||++ |..|+....... ..... ...... + .++.....+.+++.+||..+|++|
T Consensus 191 ~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~----~----~~~~~~~~~~~li~~c~~~~p~~R 255 (303)
T cd05110 191 QSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGERL----P----QPPICTIDVYMVMVKCWMIDADSR 255 (303)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCCC----C----CCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999997 888875432211 11111 111100 0 011223457888999999999999
Q ss_pred CCHHHHHHHHHhccc
Q 021774 246 PQMNQVIKMLTKNIR 260 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~ 260 (307)
|++.++++.|.++..
T Consensus 256 p~~~~l~~~l~~~~~ 270 (303)
T cd05110 256 PKFKELAAEFSRMAR 270 (303)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=261.79 Aligned_cols=232 Identities=25% Similarity=0.336 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEE-----eCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCV-----QGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.+|+|.+..... ....+..|+.+++++ +||||+++++++. .++..++||||+++++|.+++........
T Consensus 41 ~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 119 (286)
T cd06638 41 KNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119 (286)
T ss_pred CCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCc
Confidence 4578999998765322 225678899999999 7999999999885 34568999999999999998754434456
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++........ ......|+..|+|||+
T Consensus 120 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~ 195 (286)
T cd06638 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEV 195 (286)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhh
Confidence 789999999999999999999999 999999999999999999999999999986543221 1233468899999998
Q ss_pred ccC-----CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 159 VLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 159 ~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
+.. ..++.++|||||||++|||++|+.|+....... .+. . ..........++ ......+.++
T Consensus 196 ~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~----~-~~~~~~~~~~~~------~~~~~~~~~l 262 (286)
T cd06638 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF----K-IPRNPPPTLHQP------ELWSNEFNDF 262 (286)
T ss_pred hchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh----h-ccccCCCcccCC------CCcCHHHHHH
Confidence 753 457889999999999999999999876432211 000 0 000111011111 1122357889
Q ss_pred HHhccccccCCCCCHHHHHHH
Q 021774 234 AFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~ 254 (307)
+.+||+.+|++||++.++++.
T Consensus 263 i~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 263 IRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHccCCcccCCCHHHHhhc
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=256.56 Aligned_cols=232 Identities=26% Similarity=0.383 Sum_probs=178.3
Q ss_pred CCCCEEEEEEccccC----------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES----------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||+|.++... ....+.+..|+.++++++|+|++++++++...+..++||||+++++|.+++.
T Consensus 24 ~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--- 100 (272)
T cd06629 24 TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--- 100 (272)
T ss_pred CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHh---
Confidence 468899999876421 1123467889999999999999999999999999999999999999999984
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCc
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGY 153 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y 153 (307)
....+++..+..++.|++.||.|||++ +++||||+|+||++++++.++|+|||++......... ......|+..|
T Consensus 101 -~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y 176 (272)
T cd06629 101 -TYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176 (272)
T ss_pred -hccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccc
Confidence 235689999999999999999999999 9999999999999999999999999999865432211 12334578899
Q ss_pred CCcccccCCc--ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 154 LAPEYVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 154 ~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
+|||.+.... ++.++|+||||+++|+|++|..|+...... ............ ..+.. .........+.
T Consensus 177 ~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~ 246 (272)
T cd06629 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKRSA-PPIPP---DVSMNLSPVAL 246 (272)
T ss_pred cCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccccC-CcCCc---cccccCCHHHH
Confidence 9999887654 789999999999999999999987532211 101111111111 11111 11122345688
Q ss_pred HHHHhccccccCCCCCHHHHHH
Q 021774 232 KVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+++.+||..+|.+||++.+|+.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 247 DFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHHhcCChhhCCCHHHHhh
Confidence 8899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=268.92 Aligned_cols=237 Identities=24% Similarity=0.303 Sum_probs=173.9
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+++.||||++... .......+.+|+.+++.++||||+++++++... ...++||||+++ +|.+.+.
T Consensus 47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 120 (364)
T cd07875 47 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----- 120 (364)
T ss_pred CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH-----
Confidence 35788999998753 334456788999999999999999999987643 356999999965 6777662
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++...... ......|+..|+||
T Consensus 121 -~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aP 194 (364)
T cd07875 121 -MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAP 194 (364)
T ss_pred -hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCH
Confidence 2478899999999999999999999 99999999999999999999999999998654322 12335688999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhH-HHH---------------HHHHHHhhcCCcc-----ccc
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK-FLL---------------EWAWQLHQEEKPL-----ELV 215 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~-~~~---------------~~~~~~~~~~~~~-----~~~ 215 (307)
|++.+..++.++|||||||++|+|++|+.||......... ... ............. ...
T Consensus 195 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T cd07875 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 274 (364)
T ss_pred HHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhh
Confidence 9999999999999999999999999999998654321110 000 0000000000000 000
Q ss_pred CCC-C----CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 216 DPE-L----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 216 ~~~-~----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+. . ..........+.+++.+|++.||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0 0011112345778999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=257.95 Aligned_cols=235 Identities=22% Similarity=0.389 Sum_probs=180.3
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCC--
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATK-- 75 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~-- 75 (307)
+|+.||||.+... +....+++.+|++++++++||||+++++++...+ ..++++||+.+|+|..++.....
T Consensus 26 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 105 (273)
T cd05074 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105 (273)
T ss_pred CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC
Confidence 4788999988764 3455677899999999999999999999887542 24789999999999988743221
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYL 154 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~ 154 (307)
....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||+++........ ......++..|+
T Consensus 106 ~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 182 (273)
T cd05074 106 EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182 (273)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhc
Confidence 223578999999999999999999999 9999999999999999999999999999865432211 112233456799
Q ss_pred CcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
+||.+.+..++.++||||||+++|||++ |..|+..... ..+..... ..... ..++.....+.++
T Consensus 183 ~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~---~~~~~---------~~~~~~~~~~~~l 247 (273)
T cd05074 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI---KGNRL---------KQPPDCLEDVYEL 247 (273)
T ss_pred CHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH---cCCcC---------CCCCCCCHHHHHH
Confidence 9999988889999999999999999999 7777654322 11111111 11110 0112233468889
Q ss_pred HHhccccccCCCCCHHHHHHHHHhc
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
+.+||+.+|++||++.++++.|+++
T Consensus 248 ~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 248 MCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=257.24 Aligned_cols=227 Identities=24% Similarity=0.367 Sum_probs=180.1
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+++.+|+|.+... .......+.+|++++++++||||+++++.+...+..++||||+++++|.+++... .+..+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 100 (256)
T cd08220 23 ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDE 100 (256)
T ss_pred CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh--cccCCCH
Confidence 46889999988754 3345678999999999999999999999999999999999999999999998432 2345899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
..+..++.+++.||+|||++ +++|+||+|+||++++++ .++|+|||.+........ .....++..|+|||.+.+
T Consensus 101 ~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 101 DTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--ccccccCCcccCchhccC
Confidence 99999999999999999999 999999999999998654 589999999987654321 223457889999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|+.|+...... .... ...... . ...+......+.+++.+||+.+
T Consensus 176 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~---~~~~~~-~--------~~~~~~~~~~l~~li~~~l~~~ 240 (256)
T cd08220 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVL---KIMSGT-F--------APISDRYSPDLRQLILSMLNLD 240 (256)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHH---HHHhcC-C--------CCCCCCcCHHHHHHHHHHccCC
Confidence 88899999999999999999999887543221 1111 111111 0 0111223345788999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.+++.
T Consensus 241 p~~Rpt~~~ll~ 252 (256)
T cd08220 241 PSKRPQLSQIMA 252 (256)
T ss_pred hhhCCCHHHHhh
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=264.27 Aligned_cols=238 Identities=20% Similarity=0.287 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||++ ++|.+++.. ....+++.
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~ 104 (301)
T cd07873 29 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMH 104 (301)
T ss_pred CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHH
Confidence 357899999887542 2333567889999999999999999999999999999999996 589888742 34468899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-C
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-G 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 162 (307)
.+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++........ ......++..|+|||++.+ .
T Consensus 105 ~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~ 180 (301)
T cd07873 105 NVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGST 180 (301)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCC
Confidence 9999999999999999999 999999999999999999999999999975433221 1223456789999998865 4
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC------------CcccccCCCC-----CCCCHH
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE------------KPLELVDPEL-----GEYPPN 225 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~-----~~~~~~ 225 (307)
.++.++||||||+++|||+||+.||....... ............ .......+.. ....+.
T Consensus 181 ~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (301)
T cd07873 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPR 257 (301)
T ss_pred CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCC
Confidence 57889999999999999999999986543211 111111110000 0000000000 001112
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++.+|++.||.+|||+.+++.
T Consensus 258 ~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 258 LDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 2335778999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.33 Aligned_cols=228 Identities=26% Similarity=0.425 Sum_probs=184.6
Q ss_pred CCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.|++|.+..... .....+.+|++.+++++|+||+++++++...+..++||||+++++|.+++.. ...+++..
T Consensus 25 ~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~ 100 (264)
T cd06623 25 TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPV 100 (264)
T ss_pred CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHH
Confidence 589999999887643 4567899999999999999999999999999999999999999999999842 35689999
Q ss_pred HHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 85 RSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
++.++.|+++||+|||+ + +++||||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..
T Consensus 101 ~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~ 176 (264)
T cd06623 101 LAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGES 176 (264)
T ss_pred HHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-ccceeecccccCHhhhCCCC
Confidence 99999999999999999 9 9999999999999999999999999999876443222 22345788999999998888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHH-HHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN-EIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~c~~~~p 242 (307)
++.++|+||||+++|+|+||..|+..........+.. .... ... ...... ....+.+++.+||..+|
T Consensus 177 ~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~~p 244 (264)
T cd06623 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AICD-GPP--------PSLPAEEFSPEFRDFISACLQKDP 244 (264)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHhc-CCC--------CCCCcccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999986554211111111 1111 111 111112 34568889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
++||++.++++
T Consensus 245 ~~R~~~~~ll~ 255 (264)
T cd06623 245 KKRPSAAELLQ 255 (264)
T ss_pred hhCCCHHHHHh
Confidence 99999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=264.15 Aligned_cols=238 Identities=26% Similarity=0.347 Sum_probs=178.1
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|..+.. ....+++
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~ 99 (286)
T cd07846 24 ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDE 99 (286)
T ss_pred CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh----ccCCCCH
Confidence 358899999886542 2334678899999999999999999999999999999999999999988762 3345899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 161 (307)
..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......++..|+|||++.+
T Consensus 100 ~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07846 100 SRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-ccCcccceeeccCcHHhccc
Confidence 99999999999999999999 999999999999999999999999999876543321 1223457788999998875
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhc-----------CC-cccccCCCC------CCCC
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE-----------EK-PLELVDPEL------GEYP 223 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~-~~~~~~~~~------~~~~ 223 (307)
..++.++||||||+++|||++|.+|+....... ........... .. ......+.. ....
T Consensus 176 ~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07846 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRF 252 (286)
T ss_pred cccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhC
Confidence 457889999999999999999998875432211 00000000000 00 000000000 0111
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+.....+.+++.+||+.+|++||++.++++
T Consensus 253 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 253 PKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 233456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=258.67 Aligned_cols=226 Identities=24% Similarity=0.323 Sum_probs=182.0
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+.+++|..++. ....++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~ 98 (258)
T cd05578 23 DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS----QKVKFS 98 (258)
T ss_pred cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHH----hcCCcC
Confidence 358899999887542 3456789999999999999999999999999999999999999999999983 235788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++....... ......|+..|+|||++.+
T Consensus 99 ~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 99 EEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcc
Confidence 999999999999999999999 99999999999999999999999999998664432 2233557888999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+||||+++|+|++|..|+..........+. ..... . ....+......+.+++.+||+.+
T Consensus 174 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--~-------~~~~~~~~~~~~~~~i~~~l~~~ 240 (258)
T cd05578 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--A-------DVLYPATWSTEAIDAINKLLERD 240 (258)
T ss_pred cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--c-------cccCcccCcHHHHHHHHHHccCC
Confidence 88999999999999999999999998765432111111 11110 0 01112223356888999999999
Q ss_pred cCCCCCH--HHHH
Q 021774 242 ASRRPQM--NQVI 252 (307)
Q Consensus 242 p~~RPs~--~~v~ 252 (307)
|.+||++ .+++
T Consensus 241 p~~R~~~~~~~l~ 253 (258)
T cd05578 241 PQKRLGDNLKDLK 253 (258)
T ss_pred hhHcCCccHHHHh
Confidence 9999999 5553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=289.99 Aligned_cols=232 Identities=21% Similarity=0.285 Sum_probs=176.8
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.++..||+|.+... .......|..|+.++++++||||++++++|... ...|+||||+++++|.+++.........+
T Consensus 36 ~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L 115 (1021)
T PTZ00266 36 RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115 (1021)
T ss_pred CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCC
Confidence 35678999988754 344456789999999999999999999988654 56899999999999999986544445679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCC----CCeeeCCCCCCcEEECCC-----------------CceEEeeccCcccCCCC
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELV----PHIVHRDIKASNILLDQE-----------------FNPKIGDFGLAKLFPDN 139 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlkp~Nill~~~-----------------~~~kl~dfg~~~~~~~~ 139 (307)
++..++.|+.||+.||+|||+... .+|+||||||+||||+.+ +.+||+|||++..+...
T Consensus 116 ~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~ 195 (1021)
T PTZ00266 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195 (1021)
T ss_pred CHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc
Confidence 999999999999999999998510 159999999999999642 34899999999865432
Q ss_pred cccccccccCCCCcCCcccccC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCC
Q 021774 140 ITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 217 (307)
Q Consensus 140 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (307)
. ......||+.|+|||++.+ ..++.++|||||||++|||+||..||...... ...... ...... .
T Consensus 196 s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~-----~qli~~-lk~~p~-----l 262 (1021)
T PTZ00266 196 S--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF-----SQLISE-LKRGPD-----L 262 (1021)
T ss_pred c--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH-----HHHHHH-HhcCCC-----C
Confidence 2 1234568999999998864 45889999999999999999999998643221 111111 111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+. .....+.+++..||+.+|.+||++.+++.
T Consensus 263 pi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 263 PIK----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 011 12345788899999999999999999984
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=263.82 Aligned_cols=239 Identities=20% Similarity=0.263 Sum_probs=176.0
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.++... ......+.+|++++++++||||+++++++.+.+..++|+||+.+ +|.+++.. ....+++
T Consensus 23 ~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~ 98 (284)
T cd07839 23 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDS---CNGDIDP 98 (284)
T ss_pred CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHh---cCCCCCH
Confidence 468899999887542 22335677899999999999999999999999999999999964 78777632 2456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.||+.||.|||++ +++||||+|+||+++.++.++|+|||++........ ......++..|+|||++.+.
T Consensus 99 ~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 174 (284)
T cd07839 99 EIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGA 174 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcCCCccccCCcChHHHhCC
Confidence 99999999999999999999 999999999999999999999999999986543221 12234567899999988764
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh-----------cCCccccc---CCCC--CCCCHH
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-----------EEKPLELV---DPEL--GEYPPN 225 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~---~~~~--~~~~~~ 225 (307)
.++.++|||||||++|+|+||..|+........ .......... ........ .... ....+.
T Consensus 175 ~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd07839 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPK 252 (284)
T ss_pred cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhccc
Confidence 468999999999999999999888643322111 1111111100 00000000 0000 011122
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 253 LNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 3456778999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.47 Aligned_cols=227 Identities=25% Similarity=0.359 Sum_probs=175.7
Q ss_pred CCCCEEEEEEcccc-----ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||+|.+... .......+.+|++++++++||||+++++++.+. ...+++|||+++++|.+++. ..
T Consensus 25 ~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~ 100 (265)
T cd06652 25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SY 100 (265)
T ss_pred CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH----Hc
Confidence 46889999987532 123456788999999999999999999988763 46789999999999999883 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLA 155 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~a 155 (307)
..+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++........ .......|+..|+|
T Consensus 101 ~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (265)
T cd06652 101 GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177 (265)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccC
Confidence 4578899999999999999999999 999999999999999999999999999976532111 11223457889999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+..++.++||||||+++|||++|+.||....... . ........ .....+......+..++.
T Consensus 178 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~--------~~~~~~~~~~~~~~~~i~ 243 (265)
T cd06652 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP--------TNPVLPPHVSDHCRDFLK 243 (265)
T ss_pred hhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC--------CCCCCchhhCHHHHHHHH
Confidence 999988889999999999999999999999986432111 1 11111110 111223344456778888
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
+|+. +|++||++++|+.
T Consensus 244 ~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 244 RIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHhc-ChhhCCCHHHHhc
Confidence 8884 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=274.98 Aligned_cols=228 Identities=27% Similarity=0.359 Sum_probs=186.5
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC--CHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL--NWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~--~~~ 83 (307)
+...+|||-+...+....+-+.+|+.+-++|+|.|||+++|.+..+..+-|+||.++||||.+++.. .=+++ .+.
T Consensus 599 tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs---kWGPlKDNEs 675 (1226)
T KOG4279|consen 599 TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS---KWGPLKDNES 675 (1226)
T ss_pred ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh---ccCCCccchh
Confidence 3457899998887777778899999999999999999999999999999999999999999999943 22344 778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+--+..||++||.|||++ .|||||||-+||||+ -.|-+||+|||.++..... +..+..+-||.-|||||++..+
T Consensus 676 tm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFTGTLQYMAPEvIDqG 751 (1226)
T KOG4279|consen 676 TMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFTGTLQYMAPEVIDQG 751 (1226)
T ss_pred HHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-CccccccccchhhhChHhhccC
Confidence 8888999999999999999 999999999999995 6789999999999876543 3345668899999999999764
Q ss_pred --cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 163 --QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 163 --~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
.|..++|||||||.+.||.||++||...-.-. . ..++-+.. ..-+..+.....+...++.+|+..
T Consensus 752 ~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----A----AMFkVGmy-----KvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 752 PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----A----AMFKVGMY-----KVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred CcCCCchhhhhhccceeEeeccCCCCeeecCChh----H----hhhhhcce-----ecCCCCcHHHHHHHHHHHHHHcCC
Confidence 68999999999999999999999986542210 0 11111111 111344666777888999999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
+|.+||++.+++.
T Consensus 819 d~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQ 831 (1226)
T ss_pred CcccCccHHHhcc
Confidence 9999999999975
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=258.13 Aligned_cols=226 Identities=25% Similarity=0.391 Sum_probs=179.1
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.++.. .......+.+|+.++++++ |||++++++++......++||||+++++|.+++.. ..+
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l 98 (277)
T cd06917 24 PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPI 98 (277)
T ss_pred CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCC
Confidence 56889999998754 3445567889999999986 99999999999999999999999999999998832 268
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..++.++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++......... .....|+..|+|||.+.
T Consensus 99 ~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 99 AEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-RSTFVGTPYWMAPEVIT 174 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-cccccCCcceeCHHHhc
Confidence 8999999999999999999999 9999999999999999999999999999876543322 23346788999999886
Q ss_pred C-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 G-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+ ..++.++|+||||+++|+|++|..||....... .... .... ..+.+.. ......+.+++.+||+
T Consensus 175 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~~~-----~~~~~~~--~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IPKS-----KPPRLED--NGYSKLLREFVAACLD 240 (277)
T ss_pred cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-cccC-----CCCCCCc--ccCCHHHHHHHHHHcC
Confidence 5 456899999999999999999999986432211 0000 0000 0111111 0133457788899999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||++||++.++++
T Consensus 241 ~~p~~R~~~~~il~ 254 (277)
T cd06917 241 EEPKERLSAEELLK 254 (277)
T ss_pred CCcccCcCHHHHhh
Confidence 99999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.52 Aligned_cols=231 Identities=26% Similarity=0.431 Sum_probs=178.8
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+++.+++|.+..... ....+.+|+++++++ +|+||+++++++.... ..++||||+++++|.+++......+
T Consensus 29 ~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 107 (275)
T cd06608 29 KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG 107 (275)
T ss_pred CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcC
Confidence 3578999998876543 336789999999999 7999999999997654 4799999999999999985443345
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... .......|+..|+|||
T Consensus 108 ~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE 183 (275)
T cd06608 108 KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPE 183 (275)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHh
Confidence 6789999999999999999999999 99999999999999999999999999987654322 2223456788999999
Q ss_pred cccC-----CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 158 YVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 158 ~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
.+.. ..++.++||||||+++++|++|..||...... ..+. .... ... +.. .........+.+
T Consensus 184 ~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~~-~~~-----~~~-~~~~~~~~~~~~ 250 (275)
T cd06608 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALF----KIPR-NPP-----PTL-KSPENWSKKFND 250 (275)
T ss_pred HhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHH----Hhhc-cCC-----CCC-CchhhcCHHHHH
Confidence 8754 34678999999999999999999998643221 1111 1111 111 011 111223446788
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||..||.+|||+.++++
T Consensus 251 li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 251 FISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHhhcChhhCcCHHHHhc
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=266.21 Aligned_cols=175 Identities=26% Similarity=0.346 Sum_probs=149.5
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-C-----CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-H-----PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.++|+.||||+++.. +...++-..|+.+|..|+ | -|+|+++++|...++.|||+|++ ..+|.++++.+...
T Consensus 208 ~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~- 284 (586)
T KOG0667|consen 208 HKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFR- 284 (586)
T ss_pred cCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCC-
Confidence 467999999999954 445567788999999996 3 47999999999999999999999 55999999765444
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC--ceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF--NPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
.++...+..++.||+.||.+||+. +|||+||||+||||.+-+ .|||+|||.++....... ....+..|.|
T Consensus 285 -Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRA 356 (586)
T KOG0667|consen 285 -GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRA 356 (586)
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcce----eeeecccccc
Confidence 488999999999999999999999 999999999999996543 699999999997654322 3344678999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCc
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 189 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~ 189 (307)
||++.|.+|+.+.|||||||++.||++|.+.|.+
T Consensus 357 PEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 357 PEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred chhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 9999999999999999999999999999765443
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=261.03 Aligned_cols=233 Identities=21% Similarity=0.253 Sum_probs=180.0
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||||++|++|.+++. ....++
T Consensus 24 ~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~ 99 (305)
T cd05609 24 ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK----NIGALP 99 (305)
T ss_pred CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH----HcCCCC
Confidence 457889999887543 2345678899999999999999999999999999999999999999999983 334689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--------------cccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--------------HITTRI 147 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~ 147 (307)
+..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||+++....... ......
T Consensus 100 ~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (305)
T cd05609 100 VDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176 (305)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCC
Confidence 999999999999999999999 999999999999999999999999998864211000 011123
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHH
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (307)
.++..|+|||.+.+..++.++|+||||+++|||++|..|+..... ..+. ......... .+.. .....
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~---~~~~~~~~~----~~~~---~~~~~ 243 (305)
T cd05609 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELF---GQVISDDIE----WPEG---DEALP 243 (305)
T ss_pred ccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhcccC----CCCc---cccCC
Confidence 567789999999888899999999999999999999999754321 1111 111111110 0110 11223
Q ss_pred HHHHHHHHhccccccCCCCCHHHHHHHHHh
Q 021774 228 IRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 228 ~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
..+.+++.+||+.+|++||+..++.+.|+.
T Consensus 244 ~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 347889999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=259.93 Aligned_cols=228 Identities=24% Similarity=0.439 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|..||+|.+..........+.+|+.++++++||||+++++++...+..++|+||+++++|.+++. ...+++..
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~l~~~~ 116 (293)
T cd06647 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQ 116 (293)
T ss_pred CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh-----hcCCCHHH
Confidence 4678899999876554455678999999999999999999999999999999999999999999983 23578899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..+
T Consensus 117 ~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~ 192 (293)
T cd06647 117 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAY 192 (293)
T ss_pred HHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCC
Confidence 999999999999999999 999999999999999999999999998876543322 1223457888999999988888
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|+||||+++|+|++|..||........ + ........ +.. .........+.+++.+||+.+|.+
T Consensus 193 ~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~----~~~~~~~~------~~~-~~~~~~~~~l~~li~~~l~~~p~~ 259 (293)
T cd06647 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L----YLIATNGT------PEL-QNPEKLSAIFRDFLNRCLEMDVEK 259 (293)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChhhh--e----eehhcCCC------CCC-CCccccCHHHHHHHHHHccCChhh
Confidence 9999999999999999999999865332111 0 00000000 000 011122345778899999999999
Q ss_pred CCCHHHHHHH
Q 021774 245 RPQMNQVIKM 254 (307)
Q Consensus 245 RPs~~~v~~~ 254 (307)
||++.+++..
T Consensus 260 Rp~~~~il~h 269 (293)
T cd06647 260 RGSAKELLQH 269 (293)
T ss_pred CcCHHHHhcC
Confidence 9999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=257.55 Aligned_cols=228 Identities=22% Similarity=0.370 Sum_probs=179.9
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..||+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||+++++|.+++.. ..+..+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~ 100 (257)
T cd08225 23 SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSE 100 (257)
T ss_pred CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCH
Confidence 357889999886542 23446788999999999999999999999999999999999999999998843 23345799
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-eEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
..+..++.|++.||+|||+. +++|+||+|+||++++++. ++|+|||.+....... .......|+..|+|||++.+
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~ 176 (257)
T cd08225 101 DQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccccccCCCccccCHHHHcC
Confidence 99999999999999999999 9999999999999998864 6999999998664332 12233457889999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+||||+++|||++|..|+..... ......... ... ....+.....+.+++.+||..+
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~--------~~~~~~~~~~~~~~i~~~l~~~ 241 (257)
T cd08225 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYF--------APISPNFSRDLRSLISQLFKVS 241 (257)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccC--------CCCCCCCCHHHHHHHHHHhccC
Confidence 8899999999999999999999998754321 111111111 111 1111223345888999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||+.++++
T Consensus 242 p~~Rpt~~~ll~ 253 (257)
T cd08225 242 PRDRPSITSILK 253 (257)
T ss_pred hhhCcCHHHHhh
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=261.45 Aligned_cols=229 Identities=23% Similarity=0.277 Sum_probs=179.4
Q ss_pred CCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+|+.||+|.+.... ......+.+|+++++.++|+||+++++++.+.+..++||||+.+++|.+++.. ..+..+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~ 102 (316)
T cd05574 25 TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSE 102 (316)
T ss_pred CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCH
Confidence 58899999887653 23456789999999999999999999999999999999999999999999842 23456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--------------------
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-------------------- 142 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-------------------- 142 (307)
..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.........
T Consensus 103 ~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (316)
T cd05574 103 EVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchh
Confidence 99999999999999999999 9999999999999999999999999998754321110
Q ss_pred --------ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccc
Q 021774 143 --------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 214 (307)
Q Consensus 143 --------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (307)
......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .+. .... ...
T Consensus 180 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~----~~~~-~~~--- 249 (316)
T cd05574 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE--TFS----NILK-KEV--- 249 (316)
T ss_pred hhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH--HHH----HHhc-CCc---
Confidence 1112457888999999998889999999999999999999999986443211 111 1111 110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhccccccCCCCC----HHHHHH
Q 021774 215 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQ----MNQVIK 253 (307)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs----~~~v~~ 253 (307)
.... .......+.+++.+||+.+|++||+ +.+++.
T Consensus 250 ---~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 250 ---TFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ---cCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 0000 0113456888999999999999999 665554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=271.32 Aligned_cols=211 Identities=24% Similarity=0.385 Sum_probs=169.2
Q ss_pred hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe--eEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 021774 20 KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR--RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA 97 (307)
Q Consensus 20 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 97 (307)
+....+|.+|+.+|+.|+||||+++|.++.+... ..+|+|++..|+|..|+ ...++++.+.+..|+.||+.||.
T Consensus 82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~ 157 (632)
T KOG0584|consen 82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLV 157 (632)
T ss_pred hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhh
Confidence 4445789999999999999999999999997765 77999999999999998 45566788899999999999999
Q ss_pred HHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHH
Q 021774 98 FLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176 (307)
Q Consensus 98 ~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~ 176 (307)
|||++.+ +|+|||||.+||||+.+ |.|||+|+|+|....... .....||+.|||||+.. ..|++..||||||++
T Consensus 158 yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMC 232 (632)
T KOG0584|consen 158 YLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMC 232 (632)
T ss_pred hhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHH
Confidence 9999854 89999999999999865 789999999999775543 34478999999999776 899999999999999
Q ss_pred HHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 177 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 177 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++||+|+..|+..=.. .++..+++.....+.. +. ... ...+.++|.+|+.. ..+|||+.|+++
T Consensus 233 mLEMvT~eYPYsEC~n-----~AQIYKKV~SGiKP~s-l~----kV~---dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 233 MLEMVTSEYPYSECTN-----PAQIYKKVTSGIKPAA-LS----KVK---DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHhccCChhhhCC-----HHHHHHHHHcCCCHHH-hh----ccC---CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 9999999988653222 2222223333222221 11 111 12377888889999 999999999975
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=258.10 Aligned_cols=227 Identities=22% Similarity=0.397 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.+++. ...+++..
T Consensus 43 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~ 117 (292)
T cd06657 43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQ 117 (292)
T ss_pred CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-----cCCCCHHH
Confidence 4688999998876555556779999999999999999999999999999999999999999999873 23578999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||+|||++ |++||||+|+||++++++.++|+|||++........ ......|+..|+|||.+.+..+
T Consensus 118 ~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~ 193 (292)
T cd06657 118 IAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPY 193 (292)
T ss_pred HHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCccccCHHHhcCCCC
Confidence 999999999999999999 999999999999999999999999998876543221 1233457889999999888888
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|+||||+++|+|++|..||....... ....... ... ..+.. .......+.+++.+||+.+|.+
T Consensus 194 ~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~~~----~~~-----~~~~~-~~~~~~~l~~li~~~l~~~P~~ 260 (292)
T cd06657 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRD----NLP-----PKLKN-LHKVSPSLKGFLDRLLVRDPAQ 260 (292)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----hCC-----cccCC-cccCCHHHHHHHHHHHhCCccc
Confidence 999999999999999999999976432211 1111111 100 00100 1112234677888999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
||++.+++.
T Consensus 261 R~~~~~ll~ 269 (292)
T cd06657 261 RATAAELLK 269 (292)
T ss_pred CcCHHHHhc
Confidence 999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=262.98 Aligned_cols=243 Identities=20% Similarity=0.295 Sum_probs=178.1
Q ss_pred CCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCC-CC
Q 021774 6 NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKAN-IK 79 (307)
Q Consensus 6 ~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~-~~ 79 (307)
+|+.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...++||||+++ +|.+++....... ..
T Consensus 26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 104 (316)
T cd07842 26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVS 104 (316)
T ss_pred CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcC
Confidence 58899999998632 33446678899999999999999999999988 789999999965 6766664333333 37
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC----CCceEEeeccCcccCCCCcc--cccccccCCCCc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ----EFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGY 153 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y 153 (307)
+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++........ .......++..|
T Consensus 105 ~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 181 (316)
T cd07842 105 IPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccc
Confidence 89999999999999999999999 9999999999999999 89999999999987644322 122334578889
Q ss_pred CCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchh-------HHHHHHHHHHhhcC------------Cccc
Q 021774 154 LAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN-------KFLLEWAWQLHQEE------------KPLE 213 (307)
Q Consensus 154 ~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~------------~~~~ 213 (307)
+|||++.+ ..++.++||||||+++++|++|+.||........ ..+.. ........ ....
T Consensus 182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~ 260 (316)
T cd07842 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER-IFEVLGTPTEKDWPDIKKMPEYDT 260 (316)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH-HHHHhCCCchhHHHHHhhcccchh
Confidence 99998876 4578999999999999999999999875443320 00100 00000000 0000
Q ss_pred ----ccCCCCC-CCCH-------HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 214 ----LVDPELG-EYPP-------NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 214 ----~~~~~~~-~~~~-------~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....... .... .....+.+++.+|++.||++|||+.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 261 LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0000 22345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=259.28 Aligned_cols=231 Identities=26% Similarity=0.362 Sum_probs=177.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.+|+|.+..... ....+.+|+.+++++ +|||++++++++... ...++||||+++++|.+++......+.
T Consensus 45 ~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~ 123 (291)
T cd06639 45 KDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123 (291)
T ss_pred CCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCC
Confidence 4688999998875422 235677899999999 899999999998754 357999999999999998854434456
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........ ......|+..|+|||.
T Consensus 124 ~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~ 199 (291)
T cd06639 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEV 199 (291)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhh
Confidence 789999999999999999999999 999999999999999999999999999886543221 1223457889999998
Q ss_pred ccCC-----cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 159 VLGG-----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 159 ~~~~-----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
+... .++.++|||||||++|||++|+.|+....... .+. ... ........+ +......+.++
T Consensus 200 ~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~----~~~-~~~~~~~~~------~~~~~~~l~~l 266 (291)
T cd06639 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF----KIP-RNPPPTLLH------PEKWCRSFNHF 266 (291)
T ss_pred hcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH----HHh-cCCCCCCCc------ccccCHHHHHH
Confidence 7543 36889999999999999999999976543211 111 111 111111111 12233458889
Q ss_pred HHhccccccCCCCCHHHHHH
Q 021774 234 AFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~ 253 (307)
+.+||+.+|++||++.+++.
T Consensus 267 i~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 267 ISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHhhcChhhCcCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.07 Aligned_cols=227 Identities=25% Similarity=0.291 Sum_probs=176.3
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|.+++... ....++
T Consensus 16 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~ 93 (277)
T cd05577 16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFP 93 (277)
T ss_pred CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHc--CcCCCC
Confidence 468899999886432 233456788999999999999999999999999999999999999999988432 224689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ +++||||+|+||++++++.++|+|||.+...... .......++..|+|||++.+
T Consensus 94 ~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~~PE~~~~ 168 (277)
T cd05577 94 EARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQG 168 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccCCCCcCCHHHhcC
Confidence 999999999999999999999 9999999999999999999999999998765432 11233456788999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++++|++|+.||............ ...... .....+......+.+++.+||+.+
T Consensus 169 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTLE---------MAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhcccc---------ccccCCccCCHHHHHHHHHHccCC
Confidence 88999999999999999999999998654331111110 000000 001112223445788999999999
Q ss_pred cCCCCCHHH
Q 021774 242 ASRRPQMNQ 250 (307)
Q Consensus 242 p~~RPs~~~ 250 (307)
|.+||++.+
T Consensus 237 p~~R~~~~~ 245 (277)
T cd05577 237 PEKRLGCRG 245 (277)
T ss_pred hhHccCCCc
Confidence 999994443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=256.36 Aligned_cols=229 Identities=26% Similarity=0.383 Sum_probs=185.7
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|+.+|+|.+... .......+.+|++++++++|+||+++++++......++||||+++++|.+++.........++
T Consensus 22 ~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 101 (256)
T cd08530 22 LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIP 101 (256)
T ss_pred CCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCC
Confidence 346889999998754 234456788999999999999999999999999999999999999999999855444456789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||+. |++|+||+|+||++++++.++|+|||++...... ......++..|++||.+.+
T Consensus 102 ~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 102 EQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCC
Confidence 999999999999999999999 9999999999999999999999999999876544 1223457889999999988
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|+||||+++|+|++|+.||...... .+.. ... .. .....+......+.+++.+|++.+
T Consensus 176 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~-~~--------~~~~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08530 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY---KVQ-RG--------KYPPIPPIYSQDLQNFIRSMLQVK 240 (256)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHh-cC--------CCCCCchhhCHHHHHHHHHHcCCC
Confidence 88999999999999999999999998654321 1111 111 11 111222344556889999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++||++.+++.
T Consensus 241 p~~Rp~~~~~l~ 252 (256)
T cd08530 241 PKLRPNCDKILA 252 (256)
T ss_pred cccCCCHHHHhc
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=260.13 Aligned_cols=238 Identities=22% Similarity=0.306 Sum_probs=177.7
Q ss_pred CCCCEEEEEEccccCh-----HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK-----QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||+|.+..... .....+..|++++++++|+||+++++++.+.+..++||||+ +++|.+++.. ....
T Consensus 23 ~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~ 98 (298)
T cd07841 23 ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD---KSIV 98 (298)
T ss_pred CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhc---cCCC
Confidence 3688999999976532 23345778999999999999999999999999999999999 8899999843 2236
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.||++||+|||++ |++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+
T Consensus 99 ~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 99 LTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELL 174 (298)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHH
Confidence 89999999999999999999999 999999999999999999999999999987654321 12223457789999988
Q ss_pred cC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC---------CcccccC------CCCCCCC
Q 021774 160 LG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE---------KPLELVD------PELGEYP 223 (307)
Q Consensus 160 ~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~------~~~~~~~ 223 (307)
.+ ..++.++|||||||+++||++|.+++....... ............ ....... .......
T Consensus 175 ~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T cd07841 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIF 251 (298)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhc
Confidence 65 467899999999999999999977665432211 111111100000 0000000 0001111
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
......+.+++.+||+.+|++|||+.+++.
T Consensus 252 ~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 252 PAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 223456788999999999999999999977
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=251.17 Aligned_cols=228 Identities=30% Similarity=0.495 Sum_probs=183.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|..+++|++..........+.+|++++++++|+|++++++++......++++||+++++|.+++... ...+++..
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~---~~~~~~~~ 99 (253)
T cd05122 23 RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQ 99 (253)
T ss_pred CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc---CCCCCHHH
Confidence 368899999998766556678999999999999999999999999999999999999999999998432 25689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||.+||.+ +++||||+|+||++++++.++|+|||.+........ .....++..|++||.+.+..+
T Consensus 100 ~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~ 174 (253)
T cd05122 100 IAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPY 174 (253)
T ss_pred HHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCC
Confidence 999999999999999999 999999999999999999999999999987654322 334567889999999988888
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|+||||+++++|++|..|+........ . . .... ........ .......+.+++.+||+.||.+
T Consensus 175 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~-~---~~~~-~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~ 241 (253)
T cd05122 175 DYKADIWSLGITAIELAEGKPPYSELPPMKA--L-F---KIAT-NGPPGLRN------PEKWSDEFKDFLKKCLQKNPEK 241 (253)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCchHHH--H-H---HHHh-cCCCCcCc------ccccCHHHHHHHHHHccCChhh
Confidence 9999999999999999999998764322111 1 0 1111 11101000 0111345788889999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
|||+.++++
T Consensus 242 R~t~~~~l~ 250 (253)
T cd05122 242 RPTAEQLLK 250 (253)
T ss_pred CCCHHHHhc
Confidence 999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=254.70 Aligned_cols=230 Identities=23% Similarity=0.394 Sum_probs=185.8
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
++|+.+|+|.+.... ......+.+|++++++++|+|++++++.+......++|+|++++++|.+++......+..+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 102 (258)
T cd08215 23 SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE 102 (258)
T ss_pred CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCH
Confidence 368899999987653 355677899999999999999999999999999999999999999999998654434577999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.+++.||.|||++ |++|+||+|+||++++++.++|+|||.+....... .......|+..|+|||.+.+.
T Consensus 103 ~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~ 178 (258)
T cd08215 103 EQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNK 178 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccC
Confidence 99999999999999999999 99999999999999999999999999998765433 123334678899999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|+||+|+++++|++|..|+..... ......... ... ...+......+.+++.+||..+|
T Consensus 179 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~--------~~~~~~~~~~~~~~i~~~l~~~p 243 (258)
T cd08215 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILK-GQY--------PPIPSQYSSELRNLVSSLLQKDP 243 (258)
T ss_pred CCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhc-CCC--------CCCCCCCCHHHHHHHHHHcCCCh
Confidence 899999999999999999999998754321 111111111 111 11122333457888899999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
++||++.++++
T Consensus 244 ~~Rp~~~~ll~ 254 (258)
T cd08215 244 EERPSIAQILQ 254 (258)
T ss_pred hhCcCHHHHhc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=261.85 Aligned_cols=242 Identities=19% Similarity=0.270 Sum_probs=178.1
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++.... ...+++
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~ 100 (328)
T cd08226 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF--PEGMSE 100 (328)
T ss_pred CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc--ccCCCH
Confidence 47899999998754 33445788999999999999999999999999999999999999999999985432 235889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc------cccccCCCCcCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI------TTRIAGTTGYLAP 156 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~g~~~y~aP 156 (307)
..+..++.|++.||+|||++ +++||||||+||+++.++.++++||+.+.......... .....++..|+||
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (328)
T cd08226 101 ALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccCh
Confidence 99999999999999999999 99999999999999999999999998654332211110 1112345679999
Q ss_pred ccccCC--cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHH----------------h------------
Q 021774 157 EYVLGG--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL----------------H------------ 206 (307)
Q Consensus 157 E~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------------~------------ 206 (307)
|++.+. .++.++|||||||++|||++|..||........ ........ .
T Consensus 178 E~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (328)
T cd08226 178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIG 255 (328)
T ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccchhhhhhccchhhhhcccc
Confidence 998763 478999999999999999999999865432111 00000000 0
Q ss_pred ----hcCCcccccCCCC-CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 207 ----QEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 207 ----~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.........+..+ ..........+.+++++||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 256 ESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000000011 1112234567889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=257.92 Aligned_cols=227 Identities=23% Similarity=0.454 Sum_probs=180.8
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
++..|++|++..... ....+.+|++++++++|+||+++++++...+..++|+||+++++|.+++.... ..+++..+
T Consensus 43 ~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~ 118 (286)
T cd06614 43 TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQI 118 (286)
T ss_pred CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHH
Confidence 578899999986554 45678899999999999999999999999999999999999999999984322 37899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++
T Consensus 119 ~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~ 194 (286)
T cd06614 119 AYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYG 194 (286)
T ss_pred HHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCC
Confidence 99999999999999999 999999999999999999999999998875543221 12334577889999999888899
Q ss_pred ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 166 MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 166 ~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
.++|+||||+++|+|++|..|+........ .. ..... ..... .........+.+++.+||+.+|.+|
T Consensus 195 ~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~----~~~~~-~~~~~------~~~~~~~~~l~~li~~~l~~~p~~R 261 (286)
T cd06614 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LF----LITTK-GIPPL------KNPEKWSPEFKDFLNKCLVKDPEKR 261 (286)
T ss_pred CccccHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhc-CCCCC------cchhhCCHHHHHHHHHHhccChhhC
Confidence 999999999999999999998764322111 10 11111 11000 0011123457788999999999999
Q ss_pred CCHHHHHH
Q 021774 246 PQMNQVIK 253 (307)
Q Consensus 246 Ps~~~v~~ 253 (307)
|++.+++.
T Consensus 262 pt~~~il~ 269 (286)
T cd06614 262 PSAEELLQ 269 (286)
T ss_pred cCHHHHhh
Confidence 99999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=256.55 Aligned_cols=226 Identities=26% Similarity=0.413 Sum_probs=180.5
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|..... .......+.+|+.++++++||||+++++++..++..++||||+++++|.+++. ...+++.
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~-----~~~~~~~ 101 (277)
T cd06641 27 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDET 101 (277)
T ss_pred CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh-----cCCCCHH
Confidence 46889999987644 23445678899999999999999999999999999999999999999999883 2358899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..
T Consensus 102 ~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~ 177 (277)
T cd06641 102 QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhccccCCccccChhhhccCC
Confidence 9999999999999999999 999999999999999999999999999876543221 122345788899999998888
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++|+||||+++|+|++|..|+....... . ...... ... + .........+.+++.+||+.+|.
T Consensus 178 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~~-~~~-----~---~~~~~~~~~~~~~i~~~l~~~p~ 242 (277)
T cd06641 178 YDSKADIWSLGITAIELAKGEPPHSELHPMK---V---LFLIPK-NNP-----P---TLEGNYSKPLKEFVEACLNKEPS 242 (277)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCccchHH---H---HHHHhc-CCC-----C---CCCcccCHHHHHHHHHHccCChh
Confidence 8999999999999999999999976432211 1 111111 100 1 11122334577888899999999
Q ss_pred CCCCHHHHHHH
Q 021774 244 RRPQMNQVIKM 254 (307)
Q Consensus 244 ~RPs~~~v~~~ 254 (307)
+||++.+++..
T Consensus 243 ~Rp~~~~~l~~ 253 (277)
T cd06641 243 FRPTAKELLKH 253 (277)
T ss_pred hCcCHHHHHhC
Confidence 99999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.48 Aligned_cols=240 Identities=22% Similarity=0.304 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||.++... ......+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++.. .....+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~ 99 (284)
T cd07860 23 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPL 99 (284)
T ss_pred CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCH
Confidence 468899999887543 2333578899999999999999999999999999999999995 588888743 23456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......++..|+|||++.+.
T Consensus 100 ~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 175 (284)
T cd07860 100 PLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGC 175 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-ccccccccccccCCeEEecC
Confidence 99999999999999999999 999999999999999999999999999876543221 12223467889999988764
Q ss_pred c-ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC---------------CcccccCCCCCCCCHHH
Q 021774 163 Q-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE---------------KPLELVDPELGEYPPNE 226 (307)
Q Consensus 163 ~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~ 226 (307)
. ++.++||||||+++|||+||+.||...... .............. .........+....+..
T Consensus 176 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07860 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPL 253 (284)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccC
Confidence 4 588999999999999999999987643221 11111110000000 00000000000011112
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.+++.+||+.||.+||++.++++
T Consensus 254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 254 DEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 234678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=255.82 Aligned_cols=230 Identities=25% Similarity=0.290 Sum_probs=181.3
Q ss_pred CCCEEEEEEccccCh---HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAESK---QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+|+.+++|.+..... .....+.+|++++++++||||+++++.+......+++|||+++++|.+++.. ...+++
T Consensus 17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~ 92 (265)
T cd05579 17 TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDE 92 (265)
T ss_pred CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH----cCCCCH
Confidence 589999999875532 4556789999999999999999999999999999999999999999999842 236899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-------cccccccCCCCcCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------HITTRIAGTTGYLA 155 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~g~~~y~a 155 (307)
..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++........ .......++..|++
T Consensus 93 ~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (265)
T cd05579 93 DVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169 (265)
T ss_pred HHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccC
Confidence 99999999999999999999 999999999999999999999999999875433211 12233457788999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||...+...+.++||||||+++|+|++|..|+...... ... ..... .... -+.... ....+.+++.
T Consensus 170 Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~---~~~~~-~~~~---~~~~~~----~~~~~~~~i~ 235 (265)
T cd05579 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIF---QNILN-GKIE---WPEDVE----VSDEAIDLIS 235 (265)
T ss_pred HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHhc-CCcC---CCcccc----CCHHHHHHHH
Confidence 99998888899999999999999999999998644321 111 11111 1100 000000 1345788899
Q ss_pred hccccccCCCCCHHHHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~ 256 (307)
+||+.+|.+|||+.++.+.|.
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhc
Confidence 999999999999977766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=257.38 Aligned_cols=224 Identities=30% Similarity=0.464 Sum_probs=175.4
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .......+.+|+++++.++||||+++++++.+.+..++||||+. |++.+++.. ....++
T Consensus 38 ~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~ 113 (307)
T cd06607 38 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQ 113 (307)
T ss_pred CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCC
Confidence 46889999988643 23445678899999999999999999999999999999999996 577776632 234589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...... ....++..|+|||++.
T Consensus 114 ~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 114 EVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILA 185 (307)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeec
Confidence 999999999999999999999 9999999999999999999999999998765332 2345778899999874
Q ss_pred --CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 --GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 --~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
...++.++||||||+++|||+||..|+........ ......... +.+ ........+.+++.+||
T Consensus 186 ~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~~------~~~--~~~~~~~~~~~li~~~l 251 (307)
T cd06607 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNDS------PTL--SSNDWSDYFRNFVDSCL 251 (307)
T ss_pred cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcCCC------CCC--CchhhCHHHHHHHHHHh
Confidence 35688999999999999999999998754322110 111111111 111 01123446888999999
Q ss_pred ccccCCCCCHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKM 254 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~ 254 (307)
+.+|++||++.+|+..
T Consensus 252 ~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 252 QKIPQDRPSSEELLKH 267 (307)
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=258.92 Aligned_cols=239 Identities=21% Similarity=0.287 Sum_probs=174.4
Q ss_pred CCCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+.+ +|.+++.. ....+++.
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~ 103 (291)
T cd07844 28 LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMH 103 (291)
T ss_pred CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHH
Confidence 3688999999875432 2234577899999999999999999999999999999999975 89988743 23468899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-C
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-G 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 162 (307)
.+..++.|++.||.|||++ +++||||+|+||++++++.++|+|||++......... .....++..|+|||++.+ .
T Consensus 104 ~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~ 179 (291)
T cd07844 104 NVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLGST 179 (291)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-ccccccccccCCcHHhhcCc
Confidence 9999999999999999999 9999999999999999999999999998754321111 122345778999998876 4
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc----------------cccC-CCCCCCCHH
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL----------------ELVD-PELGEYPPN 225 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~-~~~~~~~~~ 225 (307)
.++.++||||||+++|+|++|..||....... ................ .... ..+....+.
T Consensus 180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07844 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPR 257 (291)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcC
Confidence 57899999999999999999999886443211 1111111111100000 0000 000000001
Q ss_pred --HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 --EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 --~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++.+|++.+|++||++.+++.
T Consensus 258 ~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 258 LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1245778999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=257.91 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=177.6
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||++ ++|.+++.... ...+++
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~--~~~~~~ 98 (283)
T cd07835 22 LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSP--LTGLDP 98 (283)
T ss_pred CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCC--CCCCCH
Confidence 478999999887543 2333568889999999999999999999999999999999995 68999884322 246899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||+|||++ +++||||+|+||++++++.++|+|||++......... .....++..|+|||++.+.
T Consensus 99 ~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 99 PLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cCccccccCCCCCceeecC
Confidence 99999999999999999999 9999999999999999999999999999765432211 1223457889999987664
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC-----------C----cccccCCCCCCCCHHH
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE-----------K----PLELVDPELGEYPPNE 226 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~----~~~~~~~~~~~~~~~~ 226 (307)
.++.++||||||+++|+|++|+.||...... ..+........... . .............+..
T Consensus 175 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd07835 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNL 252 (283)
T ss_pred cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCC
Confidence 5688999999999999999999988643221 11111110000000 0 0000000111112223
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.+++.+|++.+|++||++.++++
T Consensus 253 ~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 253 DEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 346788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=255.55 Aligned_cols=227 Identities=23% Similarity=0.279 Sum_probs=171.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHh---cCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLS---NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.+|+|.+.... ......+.+|..+++ ..+||||+.+++++...+..++||||+++++|.+++. ...
T Consensus 17 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~----~~~ 92 (279)
T cd05633 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS----QHG 92 (279)
T ss_pred CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH----hcC
Confidence 468899999886532 122233445544443 3479999999999999999999999999999999883 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... .....|+..|+|||.
T Consensus 93 ~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~ 166 (279)
T cd05633 93 VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 166 (279)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcCCCcCccCHHH
Confidence 699999999999999999999999 99999999999999999999999999987553321 223458899999998
Q ss_pred ccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 159 VLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 159 ~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
+.+ ..++.++|||||||++|+|++|..||..........+. ..... ... ..+......+.+++.+|
T Consensus 167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~------~~~---~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT------VNV---ELPDSFSPELKSLLEGL 233 (279)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHhhc------CCc---CCccccCHHHHHHHHHH
Confidence 864 56889999999999999999999998654332221111 11100 011 11222334577888999
Q ss_pred cccccCCCC-----CHHHHHHH
Q 021774 238 TQAAASRRP-----QMNQVIKM 254 (307)
Q Consensus 238 ~~~~p~~RP-----s~~~v~~~ 254 (307)
|+.||.+|| ++.++++.
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhC
Confidence 999999999 58887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=256.94 Aligned_cols=240 Identities=24% Similarity=0.321 Sum_probs=176.1
Q ss_pred CCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|+.+|+|.++... ......+.+|+.++++++||||+++++++... ...++||||+++ +|.+++.. ....++
T Consensus 29 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~l~ 104 (293)
T cd07843 29 TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFL 104 (293)
T ss_pred CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHh---ccCCCC
Confidence 58899999987543 22234577899999999999999999999887 889999999975 99888843 223689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||++......... .....++..|+|||.+.+
T Consensus 105 ~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~ 180 (293)
T cd07843 105 QSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-YTQLVVTLWYRAPELLLG 180 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc-cccccccccccCchhhcC
Confidence 999999999999999999999 9999999999999999999999999999876543211 223456788999998876
Q ss_pred C-cccccCceeehHHHHHHHHhCCCCCCccccchhHH-HHHH-------HHHHhhc------CCcccccCCCC-CCCCHH
Q 021774 162 G-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLEW-------AWQLHQE------EKPLELVDPEL-GEYPPN 225 (307)
Q Consensus 162 ~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~~~-------~~~~~~~------~~~~~~~~~~~-~~~~~~ 225 (307)
. .++.++|+||||+++|+|++|..|+.......... +... .+..... ..........+ ..++..
T Consensus 181 ~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (293)
T cd07843 181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL 260 (293)
T ss_pred CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc
Confidence 4 46899999999999999999999886543321100 0000 0000000 00000000001 111111
Q ss_pred -HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 -EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 -~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++..||+.+|++|||+.|++.
T Consensus 261 ~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 261 SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 2455778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=275.48 Aligned_cols=236 Identities=19% Similarity=0.196 Sum_probs=167.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC------CCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR------HPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||+++.... ....+..|+.++++++ |.+++++++++... ...++|||++ |++|.+++. ..
T Consensus 152 ~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~----~~ 225 (467)
T PTZ00284 152 KRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM----KH 225 (467)
T ss_pred CCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH----Hc
Confidence 4578899999874322 2334556777766654 45688899888765 4788999988 778888873 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCC----------------ceEEeeccCcccCCCCc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEF----------------NPKIGDFGLAKLFPDNI 140 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~----------------~~kl~dfg~~~~~~~~~ 140 (307)
..+++..+..++.||+.||.|||+ . ||+||||||+|||++.++ .+||+|||.+.....
T Consensus 226 ~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-- 300 (467)
T PTZ00284 226 GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-- 300 (467)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--
Confidence 568999999999999999999997 7 999999999999998765 499999998764322
Q ss_pred ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHH---------HH-------
Q 021774 141 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA---------WQ------- 204 (307)
Q Consensus 141 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~---------~~------- 204 (307)
......||..|+|||++.+..++.++|||||||++|||++|+.||............... ..
T Consensus 301 --~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~ 378 (467)
T PTZ00284 301 --SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEAR 378 (467)
T ss_pred --ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHH
Confidence 233467899999999999999999999999999999999999998654322111111000 00
Q ss_pred -Hhhc-CCcccccCCC----C-CCC---CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 205 -LHQE-EKPLELVDPE----L-GEY---PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 205 -~~~~-~~~~~~~~~~----~-~~~---~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.... .......++. . ... .......+.+|+.+||+.||++|||+.|+++
T Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 379 LLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 0000000000 0 000 0011245778999999999999999999986
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=255.84 Aligned_cols=228 Identities=24% Similarity=0.396 Sum_probs=174.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEe------CCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.+|+|.+.... .....+..|+.+++++ +|+||+++++++.. ....+++|||+++++|.+++... ..
T Consensus 39 ~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~ 115 (282)
T cd06636 39 KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KG 115 (282)
T ss_pred CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cC
Confidence 467899999886543 3345688899999999 79999999999863 45789999999999999998532 23
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......|+..|+|||
T Consensus 116 ~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE 191 (282)
T cd06636 116 NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPE 191 (282)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHh
Confidence 4578888999999999999999999 999999999999999999999999999875532211 123356788999999
Q ss_pred ccc-----CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 158 YVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 158 ~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
.+. +..++.++|||||||++|||++|..||......... ..... ... +.. ........+.+
T Consensus 192 ~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~~~~-~~~-----~~~--~~~~~~~~~~~ 257 (282)
T cd06636 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR-NPP-----PKL--KSKKWSKKFID 257 (282)
T ss_pred hcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hhHhh-CCC-----CCC--cccccCHHHHH
Confidence 875 346788999999999999999999998654321110 00000 000 000 01122345888
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||+.||.+||++.++++
T Consensus 258 li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 258 FIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHhCCChhhCcCHHHHhc
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=257.11 Aligned_cols=238 Identities=25% Similarity=0.321 Sum_probs=178.8
Q ss_pred CCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|+.+|+|.+.... ......+.+|++++++++|+|++++++++... +..++||||+++ +|.+++.. ....++
T Consensus 23 ~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~ 98 (287)
T cd07840 23 TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFT 98 (287)
T ss_pred CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc---cCCCCC
Confidence 57899999998653 33446788999999999999999999999988 889999999975 88888732 225789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++...............++..|+|||.+.+
T Consensus 99 ~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 99 ESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEc
Confidence 999999999999999999999 99999999999999999999999999998765543222333456788999998765
Q ss_pred -CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc-----------------cccCCCCCCCC
Q 021774 162 -GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL-----------------ELVDPELGEYP 223 (307)
Q Consensus 162 -~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~ 223 (307)
..++.++||||||+++|||++|+.|+....... ............... ......+....
T Consensus 176 ~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T cd07840 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252 (287)
T ss_pred cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHh
Confidence 457899999999999999999999876543211 111111111000000 00000000000
Q ss_pred HH-HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 PN-EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 ~~-~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.. +...+.+++.+||+.+|.+||++.++++
T Consensus 253 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 253 KHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 2456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=255.85 Aligned_cols=228 Identities=29% Similarity=0.428 Sum_probs=177.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|..||+|.+... .......+.+|++++++++|||++++++++..++..++||||+.| +|.+++. .....++
T Consensus 48 ~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~---~~~~~l~ 123 (317)
T cd06635 48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLE---VHKKPLQ 123 (317)
T ss_pred CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHH---HhcCCCC
Confidence 46889999988743 234456788999999999999999999999999999999999965 7777763 2344589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++..... .....|+..|+|||++.
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~ 195 (317)
T cd06635 124 EVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----ANSFVGTPYWMAPEVILA 195 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-----cccccCCccccChhhhhc
Confidence 999999999999999999999 999999999999999999999999998875433 22345788999999874
Q ss_pred --CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 --GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 --~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
++.++.++||||||+++|||++|..|+....... .. .......... .........+.+++.+||
T Consensus 196 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~----~~~~~~~~~~--------~~~~~~~~~l~~li~~~l 261 (317)
T cd06635 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL----YHIAQNESPT--------LQSNEWSDYFRNFVDSCL 261 (317)
T ss_pred CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HH----HHHHhccCCC--------CCCccccHHHHHHHHHHc
Confidence 4568899999999999999999999875432111 11 1111111100 001122345788899999
Q ss_pred ccccCCCCCHHHHHHHHHhc
Q 021774 239 QAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~~~ 258 (307)
+.+|.+||++.++++.+...
T Consensus 262 ~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 262 QKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred cCCcccCcCHHHHHhChhhh
Confidence 99999999999998865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=252.63 Aligned_cols=228 Identities=22% Similarity=0.248 Sum_probs=173.6
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHH-hcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTL-SNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.+.... ......+..|..++ ...+|+|++++++++...+..++||||+++++|.+++. ....+
T Consensus 19 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~ 94 (260)
T cd05611 19 STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK----TLGGL 94 (260)
T ss_pred CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH----HcCCC
Confidence 468899999987542 22223445555544 45589999999999999999999999999999999983 33468
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++..... .....++..|+|||.+.
T Consensus 95 ~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~ 166 (260)
T cd05611 95 PEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETIL 166 (260)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhc
Confidence 8999999999999999999999 999999999999999999999999999875433 22345788899999998
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++||||||+++|+|++|..|+...... .... . ....... ..... .......+.+++.+||+.
T Consensus 167 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~~--~~~~~---~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFD---N-ILSRRIN--WPEEV---KEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH---H-HHhcccC--CCCcc---cccCCHHHHHHHHHHccC
Confidence 888899999999999999999999998643321 1111 1 1111100 00111 112234588899999999
Q ss_pred ccCCCCCHHHHHHHHH
Q 021774 241 AASRRPQMNQVIKMLT 256 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~ 256 (307)
+|++||++..+.+.|.
T Consensus 235 ~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 235 DPAKRLGANGYQEIKS 250 (260)
T ss_pred CHHHccCCCcHHHHHc
Confidence 9999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.78 Aligned_cols=234 Identities=26% Similarity=0.300 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccccC----hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES----KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.++..||||.++... ......+.+|+.++.++ +||||+++++.+......++||||+++++|.+++. ....
T Consensus 26 ~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~ 101 (288)
T cd05583 26 DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREH 101 (288)
T ss_pred cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh----hcCC
Confidence 467889999887432 23345688999999999 69999999999999999999999999999999883 3346
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++...............|+..|+|||.+
T Consensus 102 ~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 102 FTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHh
Confidence 88999999999999999999999 999999999999999999999999999876544332223335578899999988
Q ss_pred cCCc--ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 160 LGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 160 ~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
.+.. .+.++||||||+++|||++|..||....... ............. +. .+......+.+++.+|
T Consensus 179 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~-------~~---~~~~~~~~l~~li~~~ 246 (288)
T cd05583 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK-------PP---FPKTMSAEARDFIQKL 246 (288)
T ss_pred cCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC-------CC---CCcccCHHHHHHHHHH
Confidence 7654 7889999999999999999999985422111 0111111111111 11 1111223477888999
Q ss_pred cccccCCCCCHHHHHHHHHh
Q 021774 238 TQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~L~~ 257 (307)
|+.+|++|||+.++.+.|..
T Consensus 247 l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 247 LEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred hcCCHhhccCcchHHHHhcC
Confidence 99999999999988887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=248.06 Aligned_cols=228 Identities=29% Similarity=0.407 Sum_probs=184.2
Q ss_pred CCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|..|++|.+.... ....+.+.+|+.++++++|+||+++++.+... ...++|+|++++++|.+++.. ...++
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~ 99 (260)
T cd06606 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLP 99 (260)
T ss_pred CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCC
Confidence 68899999987654 35567899999999999999999999999988 889999999999999999842 33789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~ 160 (307)
+..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.
T Consensus 100 ~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 176 (260)
T cd06606 100 EPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhc
Confidence 999999999999999999999 9999999999999999999999999999876554321 123356788999999998
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+...+.++||||||+++++|++|..||...... ........... .....+......+.+++.+|++.
T Consensus 177 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--------~~~~~~~~~~~~l~~~i~~~l~~ 243 (260)
T cd06606 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSG--------EPPEIPEHLSEEAKDFLRKCLRR 243 (260)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccC--------CCcCCCcccCHHHHHHHHHhCcC
Confidence 888999999999999999999999998654411 11111111100 11112223345688889999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
+|.+||++.+++.
T Consensus 244 ~p~~Rp~~~~ll~ 256 (260)
T cd06606 244 DPKKRPTADELLQ 256 (260)
T ss_pred ChhhCCCHHHHhh
Confidence 9999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=259.07 Aligned_cols=223 Identities=22% Similarity=0.327 Sum_probs=173.9
Q ss_pred CCEEEEEEccc--cChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 7 GRRIAVKPLSA--ESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 7 g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+.+|+|++.. .+.+.+.-|..|+..|.+| .|.+|+.+|+|-..+..+|+|||+- ..+|..+|.. ....++..
T Consensus 385 ~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k---~~~~~~~~ 460 (677)
T KOG0596|consen 385 KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKK---KKSIDPDW 460 (677)
T ss_pred CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHh---ccCCCchH
Confidence 35667775543 3567788899999999999 6999999999999999999999987 4599999943 22233323
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..+..|++.|+.++|++ ||||.||||.|+|+- .|.+||+|||++..+..+... .....+||+.||+||.+...
T Consensus 461 ~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~ 536 (677)
T KOG0596|consen 461 FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM 536 (677)
T ss_pred HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence 6788999999999999999 999999999999986 468999999999988776554 34567899999999988542
Q ss_pred -----------cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCC----CCCCCCHHHH
Q 021774 163 -----------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP----ELGEYPPNEI 227 (307)
Q Consensus 163 -----------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 227 (307)
+.++++|||||||+||+|+.|++||....... .+ ...+.+| ++++.++..
T Consensus 537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~---------aK-----l~aI~~P~~~Iefp~~~~~~- 601 (677)
T KOG0596|consen 537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI---------AK-----LHAITDPNHEIEFPDIPEND- 601 (677)
T ss_pred cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH---------HH-----HHhhcCCCccccccCCCCch-
Confidence 25689999999999999999999986543211 11 1122222 122333222
Q ss_pred HHHHHHHHhccccccCCCCCHHHHHH
Q 021774 228 IRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 228 ~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.++++.||+.||++||++.+++.
T Consensus 602 -~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 602 -ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2788889999999999999999975
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=255.39 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=177.9
Q ss_pred CCCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|..||+|.++.... .....+.+|++++++++|+||+++++++.+.+..++||||+++ +|.+++.... ....+++.
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~ 100 (284)
T cd07836 23 TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPN 100 (284)
T ss_pred CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHH
Confidence 3688999999876532 2345677899999999999999999999999999999999975 8888774322 23468999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC-
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG- 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 162 (307)
.+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||++........ ......++..|++||++.+.
T Consensus 101 ~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~ 176 (284)
T cd07836 101 TVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSR 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCC
Confidence 9999999999999999999 999999999999999999999999999976543221 12234467889999988664
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC--------cccccCCCC--------CCCCHHH
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--------PLELVDPEL--------GEYPPNE 226 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--------~~~~~~~ 226 (307)
.++.++||||||+++|+|++|..||........ . ........... ......... ....+..
T Consensus 177 ~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07836 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--L-LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHA 253 (284)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--H-HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhc
Confidence 568899999999999999999999865433211 1 10101000000 000000000 1111223
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.+++.+|++.||.+||++.+++.
T Consensus 254 ~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 254 DPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 455778999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=250.19 Aligned_cols=226 Identities=27% Similarity=0.433 Sum_probs=182.5
Q ss_pred CCCCEEEEEEccccCh--HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.|++|.+..... .....+.+|++++++++|+|++++++++.+.+..+++||++++++|.+++. ....+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~~~l~~ 98 (254)
T cd06627 23 ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK----KFGPFPE 98 (254)
T ss_pred CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHH----hccCCCH
Confidence 3678999999987643 556789999999999999999999999999999999999999999999983 2357899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||++ |++||||+|+||+++.++.++|+|||.+......... .....++..|+|||...+.
T Consensus 99 ~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 99 SLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred HHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCC
Confidence 99999999999999999999 9999999999999999999999999999876543221 2334678899999998887
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++||||||+++|+|++|..|+....... ..+....... ...+......+.+++.+||..+|
T Consensus 175 ~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIVQDDH---------PPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhccCC---------CCCCCCCCHHHHHHHHHHHhCCh
Confidence 78999999999999999999999876433111 0111111110 11122223457788899999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
++||++.+++.
T Consensus 240 ~~R~~~~~~l~ 250 (254)
T cd06627 240 NLRPTAKQLLK 250 (254)
T ss_pred hhCcCHHHHhc
Confidence 99999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=256.26 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccccCh--HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.+++|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++ +|.+++.. ....+++
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~ 97 (283)
T cd05118 22 LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPE 97 (283)
T ss_pred CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh---hcccCCH
Confidence 4688999998876532 3456788999999999999999999999999999999999975 88887732 2357899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus 98 ~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 98 SLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcC
Confidence 99999999999999999999 99999999999999999999999999998765433 112234567789999998776
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc---c--------------cccCCCCCCCCH
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---L--------------ELVDPELGEYPP 224 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~--------------~~~~~~~~~~~~ 224 (307)
.++.++|+||||+++|+|+||+.||........ ............. . ...........+
T Consensus 174 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd05118 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP 250 (283)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhh
Confidence 788999999999999999999988754332111 0001010000000 0 000000111123
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+||+.||.+||++.+++.
T Consensus 251 ~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 251 NASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 34567889999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.53 Aligned_cols=234 Identities=24% Similarity=0.377 Sum_probs=176.3
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhcc-CCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG-ATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||+. +++.++... .......++
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~ 105 (288)
T cd06616 27 PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIP 105 (288)
T ss_pred CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCC
Confidence 458899999887543 344567889999999995 9999999999999999999999985 466554311 112345689
Q ss_pred HHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
+..+..++.|++.||+|||+ . +++||||||+||++++++.++|+|||++........ .....|+..|+|||++.
T Consensus 106 ~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~ 180 (288)
T cd06616 106 EEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERID 180 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc--cccccCccCccCHHHhc
Confidence 99999999999999999996 5 899999999999999999999999999976543221 22335788999999987
Q ss_pred CC---cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 161 GG---QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 161 ~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
+. .++.++||||||+++|+|++|+.||..... .............+ . +. ..........+.+++.+|
T Consensus 181 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~-~-~~---~~~~~~~~~~l~~li~~~ 250 (288)
T cd06616 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGDPP-I-LS---NSEEREFSPSFVNFINLC 250 (288)
T ss_pred cccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCCCC-c-CC---CcCCCccCHHHHHHHHHH
Confidence 65 688999999999999999999999764321 11111111111111 0 00 111123445688899999
Q ss_pred cccccCCCCCHHHHHHH
Q 021774 238 TQAAASRRPQMNQVIKM 254 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~ 254 (307)
|+.+|++|||+.+|++.
T Consensus 251 l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 251 LIKDESKRPKYKELLEH 267 (288)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=249.68 Aligned_cols=227 Identities=23% Similarity=0.368 Sum_probs=188.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.+|+|.+..++ ..+...+|+.++++.+.|+||++||.+.....+++|||||..|++.+.+ +..+..+++..
T Consensus 56 EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~---R~R~K~L~E~E 130 (502)
T KOG0574|consen 56 ESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIM---RARRKPLSEQE 130 (502)
T ss_pred ccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHH---HHhcCCccHHH
Confidence 569999999988553 4577889999999999999999999999999999999999999999998 45667899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++...+.||+|||.. .-+|||||..||||+-+|.+||+|||.+-.+.+.- .......||+.|||||++..-.|
T Consensus 131 Is~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI~EIGY 206 (502)
T KOG0574|consen 131 ISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIEEIGY 206 (502)
T ss_pred HHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccccCcccccHHHHHHhcc
Confidence 999999999999999998 88999999999999999999999999997655432 23455789999999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+...||..|++|+....+--. + -..... .|.-..-+......+.++++.|+-.+|++
T Consensus 207 ~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------I-FMIPT~------PPPTF~KPE~WS~~F~DFi~~CLiK~PE~ 273 (502)
T KOG0574|consen 207 DTKADIWSLGITAIEMAEGRPPYSDIHPMRA------I-FMIPTK------PPPTFKKPEEWSSEFNDFIRSCLIKKPEE 273 (502)
T ss_pred chhhhHhhhcchhhhhhcCCCCcccccccce------e-EeccCC------CCCCCCChHhhhhHHHHHHHHHhcCCHHH
Confidence 9999999999999999999999765433100 0 000000 01111224456667889999999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
|-|+.++++
T Consensus 274 R~TA~~L~~ 282 (502)
T KOG0574|consen 274 RKTALRLCE 282 (502)
T ss_pred HHHHHHHhh
Confidence 999988875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.82 Aligned_cols=231 Identities=24% Similarity=0.403 Sum_probs=173.9
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMT-LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.++... ......+..|+.. ++.++||||+++++++..++..+++|||++ ++|.+++.........+++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~ 102 (283)
T cd06617 24 PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPE 102 (283)
T ss_pred CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCH
Confidence 468999999987542 2233455566665 556699999999999999999999999996 5888887554444567999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 161 (307)
..++.++.|++.||+|||++. +++||||||+||++++++.+||+|||++..+.... ......++..|+|||.+.+
T Consensus 103 ~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 178 (283)
T cd06617 103 DILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPE 178 (283)
T ss_pred HHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCc
Confidence 999999999999999999742 89999999999999999999999999998654321 1223457888999998865
Q ss_pred ---CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 162 ---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 162 ---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
..++.++|+||||+++|+|++|+.|+........ . ......... +.+. .......+.+++.+||
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~----~~~~~~~~~------~~~~--~~~~~~~l~~li~~~l 245 (283)
T cd06617 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-Q----LKQVVEEPS------PQLP--AEKFSPEFQDFVNKCL 245 (283)
T ss_pred ccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-H----HHHHHhcCC------CCCC--ccccCHHHHHHHHHHc
Confidence 4568899999999999999999999854322111 1 111111111 1110 0112345788999999
Q ss_pred ccccCCCCCHHHHHH
Q 021774 239 QAAASRRPQMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~ 253 (307)
..+|.+||++.+++.
T Consensus 246 ~~~p~~Rp~~~~il~ 260 (283)
T cd06617 246 KKNYKERPNYPELLQ 260 (283)
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.31 Aligned_cols=224 Identities=23% Similarity=0.421 Sum_probs=183.7
Q ss_pred EEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 021774 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 89 (307)
Q Consensus 10 vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~ 89 (307)
-|-|++...+.+...+|+-|+++|..++||+|+++++.|..++.++++.|||.||-++.++. .-+..+.+.++.-++
T Consensus 60 AAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaiml---EL~r~LtE~QIqvvc 136 (1187)
T KOG0579|consen 60 AAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIML---ELGRVLTEDQIQVVC 136 (1187)
T ss_pred hhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHH---HhccccchHHHHHHH
Confidence 36677777778888999999999999999999999999999999999999999999999884 345679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-----CCcc
Q 021774 90 VGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQL 164 (307)
Q Consensus 90 ~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~ 164 (307)
+|+++||.|||++ +|||||||..|||++-+|.++|+|||.+..... .......+.||+.|||||+.. ..+|
T Consensus 137 ~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PY 212 (1187)
T KOG0579|consen 137 YQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPY 212 (1187)
T ss_pred HHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhhccccCCcccccchheeeccccCCCc
Confidence 9999999999999 999999999999999999999999999865332 233456789999999999764 4689
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+.|.||..+.+|..... .+......... .+..++ .+......+.+++.+|+..||..
T Consensus 213 DykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaKS-ePPTLl------qPS~Ws~~F~DfLk~cL~Knp~~ 279 (1187)
T KOG0579|consen 213 DYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKS-EPPTLL------QPSHWSRSFSDFLKRCLVKNPRN 279 (1187)
T ss_pred hhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhhc-CCCccc------CcchhhhHHHHHHHHHHhcCCcc
Confidence 999999999999999999988754322 12222222222 222222 23455667888889999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
||++.++++
T Consensus 280 Rp~aaqll~ 288 (1187)
T KOG0579|consen 280 RPPAAQLLK 288 (1187)
T ss_pred CCCHHHHhh
Confidence 999999884
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.35 Aligned_cols=239 Identities=22% Similarity=0.286 Sum_probs=173.2
Q ss_pred CCCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||+. ++|.+++.. ....+++.
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~ 103 (291)
T cd07870 28 INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPY 103 (291)
T ss_pred CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHH
Confidence 4688999999875432 223467789999999999999999999999999999999995 577766632 23457888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC-
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG- 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 162 (307)
.+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++....... ......++..|+|||++.+.
T Consensus 104 ~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 179 (291)
T cd07870 104 NVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGAT 179 (291)
T ss_pred HHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCCccccccccCCceeecCC
Confidence 8999999999999999999 999999999999999999999999999875433211 12233468899999988763
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC------------Cc-cccc---CC-CCCCC--C
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE------------KP-LELV---DP-ELGEY--P 223 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~-~~~~---~~-~~~~~--~ 223 (307)
.++.++||||||+++|+|++|..||........ .....+...... .. .... .+ .+... .
T Consensus 180 ~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07870 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257 (291)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccc
Confidence 578899999999999999999999865432111 111111110000 00 0000 00 00000 0
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
......+.+++.+|+..||.+|||+.+++.
T Consensus 258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 258 LSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 011345678889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=258.35 Aligned_cols=237 Identities=24% Similarity=0.290 Sum_probs=174.5
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||+|.+... .......+.+|+.++++++|+||+++++++... ...++||||+.+ +|.+.+..
T Consensus 39 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---- 113 (353)
T cd07850 39 VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---- 113 (353)
T ss_pred CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh----
Confidence 47889999998643 334456778899999999999999999988644 356999999954 88887721
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
.+++..+..++.|++.||+|||++ |++||||||+||++++++.++|+|||++........ .....++..|+||
T Consensus 114 --~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aP 186 (353)
T cd07850 114 --DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAP 186 (353)
T ss_pred --cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC--CCCCcccccccCH
Confidence 288899999999999999999999 999999999999999999999999999986544321 2334578889999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhH-H-----------HHHH---HHHHhhcCCc-------ccc
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK-F-----------LLEW---AWQLHQEEKP-------LEL 214 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~-~-----------~~~~---~~~~~~~~~~-------~~~ 214 (307)
|++.+..++.++|||||||++|+|++|+.||......... . +... .......... ...
T Consensus 187 E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (353)
T cd07850 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL 266 (353)
T ss_pred HHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhh
Confidence 9999999999999999999999999999988643211000 0 0000 0000000000 000
Q ss_pred cCCCC-----CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 215 VDPEL-----GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 215 ~~~~~-----~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..... ..........+.+++.+||+.||++|||+.+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 267 FPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 0001123455778999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=291.83 Aligned_cols=231 Identities=28% Similarity=0.385 Sum_probs=183.3
Q ss_pred cccCCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
+...+|+-.|+|-++... ........+|+.+|..++|||+|++||+-.+.+..+|.||||++|+|.+++ ..+..
T Consensus 1255 vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll----~~gri 1330 (1509)
T KOG4645|consen 1255 VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL----EHGRI 1330 (1509)
T ss_pred ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHH----Hhcch
Confidence 346789999999777653 344566789999999999999999999999999999999999999999998 34445
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCcCCc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAP 156 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aP 156 (307)
.++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.+..+...... ......||+-||||
T Consensus 1331 ~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1331 EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCc
Confidence 66666677889999999999999 9999999999999999999999999999987654322 23457899999999
Q ss_pred ccccCC---cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 157 EYVLGG---QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 157 E~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
|++.+. .-..++||||+||++.||.||+.||......- .++ +.+.... -+++|......-.++
T Consensus 1408 Evit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--aIM---y~V~~gh---------~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1408 EVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--AIM---YHVAAGH---------KPQIPERLSSEGRDF 1473 (1509)
T ss_pred hhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--HHH---hHHhccC---------CCCCchhhhHhHHHH
Confidence 999763 45678999999999999999999997654311 011 1111111 123344445556778
Q ss_pred HHhccccccCCCCCHHHHHH
Q 021774 234 AFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~ 253 (307)
+..|++.||++|-++.++++
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHH
Confidence 88899999999988877654
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.47 Aligned_cols=241 Identities=21% Similarity=0.252 Sum_probs=174.7
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCe-----eEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTR-----RILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||.+.... ......+.+|+.+++.+ +||||+++++++...+. .++||||+++ +|.+++......
T Consensus 24 ~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~ 102 (295)
T cd07837 24 NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG 102 (295)
T ss_pred CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc
Confidence 468899999877542 22345688899999999 57999999999987665 7999999976 888887543332
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 77 -NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 77 -~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
...+++..++.++.||+.||+|||++ +++||||+|+||+++. ++.++|+|||++..+...... .....++..|+
T Consensus 103 ~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~ 178 (295)
T cd07837 103 PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYR 178 (295)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc-cCCcccccCCC
Confidence 45689999999999999999999999 9999999999999998 889999999998765332211 12234677899
Q ss_pred CcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC--cc-cc------------cCCC
Q 021774 155 APEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--PL-EL------------VDPE 218 (307)
Q Consensus 155 aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~------------~~~~ 218 (307)
|||++.+ ..++.++||||||+++|+|++|..||....... .+.... ....... .. .. ....
T Consensus 179 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T cd07837 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTPTEQVWPGVSKLRDWHEFPQWKPQD 255 (295)
T ss_pred ChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCCChhhCcchhhccchhhcCcccchh
Confidence 9998865 457899999999999999999998876432211 111111 1000000 00 00 0000
Q ss_pred CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 219 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 219 ~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+....+.....+.+++.+||..+|.+||++.+++.
T Consensus 256 ~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 256 LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00111223455788999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=250.22 Aligned_cols=226 Identities=23% Similarity=0.274 Sum_probs=172.3
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHH---HHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIM---TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.+.... ......+..|.. .++...||||+++++++...+..++||||+.|++|..++. ...
T Consensus 17 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~----~~~ 92 (278)
T cd05606 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHG 92 (278)
T ss_pred cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH----hcC
Confidence 468899999886542 121223444443 4445689999999999999999999999999999999883 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....... .....|+..|+|||+
T Consensus 93 ~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~ 166 (278)
T cd05606 93 VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 166 (278)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcCCCcCCcCcHH
Confidence 699999999999999999999999 99999999999999999999999999987554321 223468899999999
Q ss_pred ccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 159 VLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 159 ~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
+.++ .++.++||||+|+++|||++|+.||............ ...... ... .+......+.+++.+|
T Consensus 167 ~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~------~~~---~~~~~s~~~~~li~~~ 233 (278)
T cd05606 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM------AVE---LPDSFSPELRSLLEGL 233 (278)
T ss_pred hcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhcc------CCC---CCCcCCHHHHHHHHHH
Confidence 8754 6889999999999999999999998765332211110 101000 111 1112234688888999
Q ss_pred cccccCCCC-----CHHHHHH
Q 021774 238 TQAAASRRP-----QMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RP-----s~~~v~~ 253 (307)
+..+|.+|| ++.++++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHh
Confidence 999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=275.38 Aligned_cols=236 Identities=29% Similarity=0.443 Sum_probs=186.2
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC---C------
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---K------ 75 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~------ 75 (307)
...||||.++.. +....+.+..|+.+|+.+ .|+||+.++|+|......++|+||+..|+|.+++...+ .
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 457999999865 345667899999999999 79999999999999999999999999999999996655 0
Q ss_pred -CC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccC--C
Q 021774 76 -AN--IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG--T 150 (307)
Q Consensus 76 -~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g--~ 150 (307)
.. ..++...++.++.|||.|++||++. +++||||..+|||+.++..+||+|||+++..............| .
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP 484 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP 484 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence 01 2388999999999999999999999 99999999999999999999999999999655544333222222 3
Q ss_pred CCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 151 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
..|||||.+....|+.++||||||+++||++| |..|+..... ...+..+. +.+... ..+..+..+
T Consensus 485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~l~~~l----~~G~r~--------~~P~~c~~e 550 (609)
T KOG0200|consen 485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEELLEFL----KEGNRM--------EQPEHCSDE 550 (609)
T ss_pred eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHHHHHHH----hcCCCC--------CCCCCCCHH
Confidence 46999999999999999999999999999998 5556543111 11122222 222211 112233445
Q ss_pred HHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
+.++++.||+.+|++||++.++.+.++..+
T Consensus 551 iY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 551 IYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 777888899999999999999999998854
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.84 Aligned_cols=228 Identities=20% Similarity=0.281 Sum_probs=164.4
Q ss_pred hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHh
Q 021774 22 GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA-NIKLNWEKRSDICVGIAKGLAFLH 100 (307)
Q Consensus 22 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH 100 (307)
....+.+|+++|++++||||+++++++...+..++|++++. ++|..++...... ........+..++.||+.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999995 4777766332211 223446677889999999999999
Q ss_pred cCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHHHHHH
Q 021774 101 EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180 (307)
Q Consensus 101 ~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 180 (307)
++ ||+||||||+|||++.++.+||+|||++..+............|+..|+|||++.+..++.++|||||||++|||
T Consensus 285 ~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 99 999999999999999999999999999987755433334456789999999999999999999999999999999
Q ss_pred HhCCCC-CCccccchhHHHHHHHHHHh--hcCCcc------cccCC-CC---CCCCH------HHHHHHHHHHHhccccc
Q 021774 181 ISGRNS-GKAMWGQMNKFLLEWAWQLH--QEEKPL------ELVDP-EL---GEYPP------NEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 181 ltg~~p-~~~~~~~~~~~~~~~~~~~~--~~~~~~------~~~~~-~~---~~~~~------~~~~~~~~l~~~c~~~~ 241 (307)
++|..+ +..........+........ ..+.+. ..++. .. ....+ .....+.+++.+|++.|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 998754 33222222222222111100 000000 00000 00 00000 01224567788999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.|++.
T Consensus 442 P~~Rpsa~elL~ 453 (501)
T PHA03210 442 WHLRPGAAELLA 453 (501)
T ss_pred cccCcCHHHHhh
Confidence 999999999986
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=255.29 Aligned_cols=242 Identities=24% Similarity=0.289 Sum_probs=172.7
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC--------eeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--------RRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||||.+.... ......+.+|++++++++||||+++++++.... ..++||||+. ++|.+++.
T Consensus 35 ~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~--- 110 (310)
T cd07865 35 KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLS--- 110 (310)
T ss_pred CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHH---
Confidence 468899999886542 222345678999999999999999999987654 4499999995 48888773
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTT 151 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~ 151 (307)
.....+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++..+...... ......++.
T Consensus 111 ~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 187 (310)
T cd07865 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187 (310)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCc
Confidence 2334689999999999999999999999 9999999999999999999999999999866432211 122345678
Q ss_pred CcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc-----cccCC-CCCCC--
Q 021774 152 GYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL-----ELVDP-ELGEY-- 222 (307)
Q Consensus 152 ~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~-- 222 (307)
.|+|||++.+. .++.++||||||+++|||++|..|+......................... ...+. .....
T Consensus 188 ~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (310)
T cd07865 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQK 267 (310)
T ss_pred cccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccc
Confidence 89999988664 47889999999999999999998886543321111111110000000000 00000 00000
Q ss_pred --------CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 --------PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 --------~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.......+.+++.+||..||.+|||+.++++
T Consensus 268 ~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 268 RKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0011234678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=261.36 Aligned_cols=238 Identities=22% Similarity=0.318 Sum_probs=174.2
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.++... ......+.+|+.++++++|+||+++++++.... ..++|+||+.+ +|.+++. ..
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~ 101 (336)
T cd07849 28 PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK-----TQ 101 (336)
T ss_pred CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh-----cC
Confidence 468899999987532 334567889999999999999999999876543 57999999964 8888772 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAP 156 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aP 156 (307)
.+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......... ......|+..|+||
T Consensus 102 ~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (336)
T cd07849 102 HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178 (336)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccCh
Confidence 689999999999999999999999 9999999999999999999999999999765432211 12234678899999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc---cc--------c---c--CCCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---LE--------L---V--DPEL 219 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~---~--~~~~ 219 (307)
|.+.+ ..++.++||||||+++|+|++|+.||....... .............. .. . . .+..
T Consensus 179 E~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T cd07849 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKV 255 (336)
T ss_pred HHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcc
Confidence 98755 568899999999999999999999885432110 00000000000000 00 0 0 0000
Q ss_pred --CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 220 --GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 220 --~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
....+.....+.+++.+||+.+|++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 256 PWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111234558899999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=251.27 Aligned_cols=236 Identities=23% Similarity=0.275 Sum_probs=173.4
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.++... ........+|+.++.++ +|+|++++++++.+. +..++||||+.+ +|.+.+.. ....+
T Consensus 22 ~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~ 97 (282)
T cd07831 22 KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKG---RKRPL 97 (282)
T ss_pred CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHh---ccCCC
Confidence 468899999887542 22223456789999998 599999999999987 889999999965 77777732 23468
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||+. +++||||+|+||++++ +.++|+|||++........ .....++..|+|||++.
T Consensus 98 ~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 98 PEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLL 171 (282)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--cCCCCCCcccCChhHhh
Confidence 9999999999999999999999 9999999999999999 9999999999986643322 12245788999999765
Q ss_pred C-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHH-----------HhhcCCcccccCCC-----CCCCC
Q 021774 161 G-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ-----------LHQEEKPLELVDPE-----LGEYP 223 (307)
Q Consensus 161 ~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-----~~~~~ 223 (307)
+ ..++.++|||||||++|||++|..||....... ....... ............+. +....
T Consensus 172 ~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd07831 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLL 248 (282)
T ss_pred cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHc
Confidence 4 567889999999999999999999886533211 1111111 00000000000000 01111
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+.....+.+++.+||+.+|++||++.+++.
T Consensus 249 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 249 PNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=248.79 Aligned_cols=220 Identities=23% Similarity=0.302 Sum_probs=168.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|..+|+|.+........ |+.....+ +||||+++++++...+..++||||+++++|.+++. ....+++.
T Consensus 39 ~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~----~~~~l~~~ 109 (267)
T PHA03390 39 PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK----KEGKLSEA 109 (267)
T ss_pred CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHH----hcCCCCHH
Confidence 4678899998875421111 22222222 79999999999999999999999999999999983 33378999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||.|||+. +++||||+|+||+++.++ .++|+|||++...... ....++..|+|||++.+.
T Consensus 110 ~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~ 181 (267)
T PHA03390 110 EVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGH 181 (267)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCC
Confidence 9999999999999999999 999999999999999998 9999999998765432 223578899999999988
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++||||||+++|||++|..||....... .....+.... .... .........+.+++.+||+.+|
T Consensus 182 ~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~--------~~~~~~~~~~~~li~~~l~~~p 249 (267)
T PHA03390 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---QKKL--------PFIKNVSKNANDFVQSMLKYNI 249 (267)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---cccC--------CcccccCHHHHHHHHHHhccCh
Confidence 89999999999999999999999987443221 1111111111 0000 1112334457888899999999
Q ss_pred CCCCC-HHHHHH
Q 021774 243 SRRPQ-MNQVIK 253 (307)
Q Consensus 243 ~~RPs-~~~v~~ 253 (307)
.+||+ ++++++
T Consensus 250 ~~R~~~~~~~l~ 261 (267)
T PHA03390 250 NYRLTNYNEIIK 261 (267)
T ss_pred hhCCchHHHHhc
Confidence 99996 688764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=260.98 Aligned_cols=239 Identities=20% Similarity=0.318 Sum_probs=176.6
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....++||||+. ++|.+++. ...
T Consensus 28 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~ 102 (334)
T cd07855 28 RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH----SDQ 102 (334)
T ss_pred CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc----cCC
Confidence 468899999987542 2345678889999999999999999998763 346799999995 58988883 344
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCcCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLA 155 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~a 155 (307)
.+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++......... ......|+..|+|
T Consensus 103 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~ 179 (334)
T cd07855 103 PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179 (334)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccC
Confidence 589999999999999999999999 9999999999999999999999999999765432211 1223467889999
Q ss_pred cccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh-----------cCCcccc---cC----
Q 021774 156 PEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-----------EEKPLEL---VD---- 216 (307)
Q Consensus 156 PE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~---~~---- 216 (307)
||++.+ ..++.++||||||+++|||++|+.||........ ......... ....... ..
T Consensus 180 PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (334)
T cd07855 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQP 256 (334)
T ss_pred hHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCC
Confidence 998765 4688999999999999999999999865432111 000000000 0000000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 217 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
.......+.....+.+++.+||+.+|.+||++.+++..
T Consensus 257 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 257 VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001112234568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=255.33 Aligned_cols=238 Identities=26% Similarity=0.329 Sum_probs=173.9
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.++... ......+.+|+.++++++|+||+++++++... +..++||||+.+ +|.+++.. ....+
T Consensus 30 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l 105 (309)
T cd07845 30 TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPF 105 (309)
T ss_pred CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh---cccCC
Confidence 468999999887542 22223567899999999999999999998765 467999999964 88888743 23568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||++......... .....++..|+|||.+.
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 181 (309)
T cd07845 106 SESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLL 181 (309)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC-CCcccccccccChhhhc
Confidence 9999999999999999999999 9999999999999999999999999999876543211 22234567899999886
Q ss_pred C-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC--c---------ccc--cCC-CCC---CC
Q 021774 161 G-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--P---------LEL--VDP-ELG---EY 222 (307)
Q Consensus 161 ~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---------~~~--~~~-~~~---~~ 222 (307)
+ ..++.++||||||+++|||++|..||....... ............. . ... ... ... ..
T Consensus 182 ~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T cd07845 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK 258 (309)
T ss_pred CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHh
Confidence 5 467899999999999999999999886543221 1111111110000 0 000 000 000 00
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.......+.+++.+|++.||++|||+.+++.
T Consensus 259 ~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0112345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=251.42 Aligned_cols=225 Identities=29% Similarity=0.447 Sum_probs=175.1
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... ......++.+|+++++.++|+|++++++++......++||||+. |++.+++.. ....++
T Consensus 38 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~ 113 (308)
T cd06634 38 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQ 113 (308)
T ss_pred CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCC
Confidence 46788999988642 33445678899999999999999999999999999999999996 578777632 234588
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++...... ....++..|+|||.+.
T Consensus 114 ~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~ 185 (308)
T cd06634 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILA 185 (308)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhh
Confidence 999999999999999999999 9999999999999999999999999998765332 2345788999999874
Q ss_pred --CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 --GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 --~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
...++.++|||||||++|+|++|..|+........ .......... .. ........+.+++.+||
T Consensus 186 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~------~~--~~~~~~~~~~~li~~cl 251 (308)
T cd06634 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESP------AL--QSGHWSEYFRNFVDSCL 251 (308)
T ss_pred cccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcCCC------Cc--CcccccHHHHHHHHHHh
Confidence 35678899999999999999999988754322110 1111111110 00 01123345778899999
Q ss_pred ccccCCCCCHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKML 255 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L 255 (307)
+.+|.+||++.+++...
T Consensus 252 ~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 252 QKIPQDRPTSEVLLKHR 268 (308)
T ss_pred hCCcccCCCHHHHhhCc
Confidence 99999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.79 Aligned_cols=238 Identities=21% Similarity=0.295 Sum_probs=176.4
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||.+... .......+.+|+.+++.++|+||+++++++... ...++|+||+. ++|.+++. ..
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~ 102 (337)
T cd07858 28 ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR----SS 102 (337)
T ss_pred CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh----cC
Confidence 46889999988753 233445678899999999999999999988654 34799999995 68988873 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++....... .......++..|+|||
T Consensus 103 ~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE 178 (337)
T cd07858 103 QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPE 178 (337)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChH
Confidence 5699999999999999999999999 99999999999999999999999999998654332 2223345788999999
Q ss_pred cccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC-----------C-------cccccCCC
Q 021774 158 YVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE-----------K-------PLELVDPE 218 (307)
Q Consensus 158 ~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~-------~~~~~~~~ 218 (307)
.+.+ ..++.++|||||||++|+|++|+.||........ ........... . .....++.
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (337)
T cd07858 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQS 255 (337)
T ss_pred HHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccC
Confidence 8765 4688999999999999999999999864322110 00010000000 0 00000011
Q ss_pred CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 219 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 219 ~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
.....+.....+.+++.+||+.+|++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 256 FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 111112334567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=253.43 Aligned_cols=239 Identities=23% Similarity=0.302 Sum_probs=174.0
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+.... ......+.+|++++++++||||+++++++.+....++||||++ ++|.+.+.. .....+++
T Consensus 25 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~ 101 (294)
T PLN00009 25 VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNP 101 (294)
T ss_pred CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCH
Confidence 468899999886542 2334568899999999999999999999999999999999996 478777632 22334688
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++....... .......++..|+|||++.+
T Consensus 102 ~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 102 RLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-cccccCceeecccCHHHHhC
Confidence 88999999999999999999 9999999999999985 5579999999997654321 11223456788999998866
Q ss_pred -CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc---------------ccc-cCCCCCCCCH
Q 021774 162 -GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---------------LEL-VDPELGEYPP 224 (307)
Q Consensus 162 -~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~-~~~~~~~~~~ 224 (307)
..++.++||||||+++|+|+||..||....... .+.. .......... ... .........+
T Consensus 178 ~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (294)
T PLN00009 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFK-IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVP 254 (294)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCc
Confidence 457899999999999999999999986543211 1111 1010000000 000 0000000112
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+|++.+|++||++.++++
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 255 TLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23345788999999999999999999975
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=250.80 Aligned_cols=230 Identities=25% Similarity=0.314 Sum_probs=176.6
Q ss_pred CCCCEEEEEEccccC----hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES----KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|..||+|+++... ......+.+|+++++++ +|+||+++++++..+...++||||+++++|.+++. ....
T Consensus 26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~ 101 (290)
T cd05613 26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS----QRER 101 (290)
T ss_pred CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHH----HcCC
Confidence 478999999987532 23346678899999999 69999999999999999999999999999999983 3446
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++...............|+..|+|||.+
T Consensus 102 l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 102 FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhc
Confidence 88999999999999999999999 999999999999999999999999999987644332233345678899999988
Q ss_pred cCC--cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 160 LGG--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 160 ~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
.+. .++.++||||||+++|+|++|..|+...... ............... ..+......+.+++.+|
T Consensus 179 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~----------~~~~~~~~~~~~ll~~~ 246 (290)
T cd05613 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP----------PYPQEMSALAKDIIQRL 246 (290)
T ss_pred cCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC----------CCCccCCHHHHHHHHHH
Confidence 753 4678999999999999999999997532211 111111111111111 11122234577889999
Q ss_pred cccccCCCC-----CHHHHHH
Q 021774 238 TQAAASRRP-----QMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RP-----s~~~v~~ 253 (307)
|+.+|++|| ++.+++.
T Consensus 247 l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 247 LMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hcCCHHHhcCCCCCCHHHHHc
Confidence 999999997 5666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=253.77 Aligned_cols=239 Identities=25% Similarity=0.315 Sum_probs=174.9
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC----------eeEEEEeccCCCCHHHHhcc
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----------RRILVYEYVENNSLDRVLLG 72 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~sL~~~l~~ 72 (307)
.+|+.||+|.++... ......+.+|++++++++||||+++++++.+.. ..++|+||+++ ++..++..
T Consensus 30 ~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~ 108 (302)
T cd07864 30 DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES 108 (302)
T ss_pred CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc
Confidence 358899999987542 233356788999999999999999999987654 78999999976 77776632
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCC
Q 021774 73 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 152 (307)
Q Consensus 73 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~ 152 (307)
....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++...............++..
T Consensus 109 ---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 182 (302)
T cd07864 109 ---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182 (302)
T ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccC
Confidence 234689999999999999999999999 99999999999999999999999999998765433222222345778
Q ss_pred cCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc---c--------cCC---
Q 021774 153 YLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE---L--------VDP--- 217 (307)
Q Consensus 153 y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~--- 217 (307)
|+|||.+.+ ..++.++|||||||++|||++|+.|+...... . ................ . .+.
T Consensus 183 y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T cd07864 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--A-QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259 (302)
T ss_pred ccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--H-HHHHHHHHhCCCChhhcccccccccccccccccc
Confidence 999998765 45788999999999999999999888643321 1 1111111111110000 0 000
Q ss_pred ---CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ---ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ---~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
............+.+++.+||+.+|.+||++.+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 260 YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000001112345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=246.18 Aligned_cols=227 Identities=26% Similarity=0.364 Sum_probs=175.6
Q ss_pred CCCCEEEEEEcccc-----ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|..||+|.+... .......+.+|++++++++|+||+++++++.+. ...++++||+++++|.+++. ..
T Consensus 25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~~ 100 (264)
T cd06653 25 DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AY 100 (264)
T ss_pred CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH----Hc
Confidence 46889999987532 234456788999999999999999999998764 46789999999999999883 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLA 155 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~a 155 (307)
..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++....... .......++..|+|
T Consensus 101 ~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (264)
T cd06653 101 GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177 (264)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccC
Confidence 4588999999999999999999999 999999999999999999999999999986533111 11123457889999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+..++.++|+||||+++|+|++|+.||...... .. ..+...... ....+......+.+++.
T Consensus 178 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~~~~--------~~~~p~~~~~~~~~~i~ 243 (264)
T cd06653 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AA-IFKIATQPT--------KPMLPDGVSDACRDFLK 243 (264)
T ss_pred HhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HH-HHHHHcCCC--------CCCCCcccCHHHHHHHH
Confidence 99998888899999999999999999999998653211 11 111111110 01122333455778888
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
+||. +|..||++.+++.
T Consensus 244 ~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 244 QIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHhc-CcccCccHHHHhc
Confidence 8999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=265.66 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=188.2
Q ss_pred cCCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCC
Q 021774 4 LTNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
-++|+.||||.++... ....+...+|+++|++++|+|||++++.-.... ...+|||||.||||...+... .+
T Consensus 35 ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P-EN 113 (732)
T KOG4250|consen 35 KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP-EN 113 (732)
T ss_pred cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc-cc
Confidence 4569999999998763 455677889999999999999999998866443 568999999999999999553 34
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCCc--eEEeeccCcccCCCCcccccccccCCCC
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEFN--PKIGDFGLAKLFPDNITHITTRIAGTTG 152 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~--~kl~dfg~~~~~~~~~~~~~~~~~g~~~ 152 (307)
...+++..++.++.+++.||.|||++ ||+||||||.||++- .+|+ -||+|||.++...++. .....+||..
T Consensus 114 ~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~ 188 (732)
T KOG4250|consen 114 AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEE 188 (732)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchh
Confidence 56799999999999999999999999 999999999999993 3343 6999999999887654 5678899999
Q ss_pred cCCccccc-CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccC-------------CC
Q 021774 153 YLAPEYVL-GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD-------------PE 218 (307)
Q Consensus 153 y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~ 218 (307)
|++||+.. +..|+..+|.|||||++|++.||..||....+.-...-..|............... |.
T Consensus 189 YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~ 268 (732)
T KOG4250|consen 189 YLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ 268 (732)
T ss_pred hcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC
Confidence 99999988 58899999999999999999999999987765432211222211111111000000 11
Q ss_pred CCCCCHHHHHHHHHHHHhccccccCCCC--CHHHHHHHHHhccc
Q 021774 219 LGEYPPNEIIRYMKVAFFCTQAAASRRP--QMNQVIKMLTKNIR 260 (307)
Q Consensus 219 ~~~~~~~~~~~~~~l~~~c~~~~p~~RP--s~~~v~~~L~~~~~ 260 (307)
-....+.....+-.++..++..+|++|- .+.+....+..+++
T Consensus 269 p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 269 PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1223344455566666667888888887 55555555555543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=255.75 Aligned_cols=240 Identities=24% Similarity=0.327 Sum_probs=174.2
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+|+.+|+|++... .......+.+|+.+++++ +||||+++++++... ...++||||+. ++|.+++.. + .+
T Consensus 31 ~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~-~~ 104 (337)
T cd07852 31 TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA----N-IL 104 (337)
T ss_pred CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc----C-CC
Confidence 5789999988542 233445677899999999 999999999998654 36799999996 599888732 2 67
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc----cccccccCCCCcCCc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT----HITTRIAGTTGYLAP 156 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~g~~~y~aP 156 (307)
++..+..++.|++.||+|||++ |++||||+|+||+++.++.++|+|||++........ .......|+..|+||
T Consensus 105 ~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 105 EDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence 8899999999999999999999 999999999999999999999999999986644321 122334678899999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHH--------HHHhhcCCccccc-------CCCCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--------WQLHQEEKPLELV-------DPELG 220 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~ 220 (307)
|.+.+ ..++.++||||||+++|+|+||+.||............... ............+ .....
T Consensus 182 E~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (337)
T cd07852 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD 261 (337)
T ss_pred eeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchh
Confidence 98765 46788999999999999999999988543321110000000 0000000000000 00011
Q ss_pred CCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 221 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 221 ~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
...+.....+.+++.+||+.+|.+|||+.+++..
T Consensus 262 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 262 ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 1111234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.36 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||+|.+.... ....+.+.+|+.++++++|+||+++++++.... ..++||||+. ++|.+++. ..
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~ 97 (330)
T cd07834 23 RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK----SP 97 (330)
T ss_pred CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHh----CC
Confidence 358899999887643 444567999999999999999999999988775 7899999996 58988883 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLA 155 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~a 155 (307)
..+++..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++........ .......++..|+|
T Consensus 98 ~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 174 (330)
T cd07834 98 QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174 (330)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCC
Confidence 4799999999999999999999999 999999999999999999999999999987654321 12233457888999
Q ss_pred cccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC-----------cccccC-------
Q 021774 156 PEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK-----------PLELVD------- 216 (307)
Q Consensus 156 PE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~------- 216 (307)
||++.+. .++.++|+||||+++|+|++|..||........ ............ ....+.
T Consensus 175 PE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (330)
T cd07834 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK 251 (330)
T ss_pred ceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCc
Confidence 9999887 789999999999999999999999865432111 010111000000 000000
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 217 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..+....+.....+.+++.+||+.+|.+||++.+++.
T Consensus 252 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 252 KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred chhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0001111223456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=237.61 Aligned_cols=229 Identities=26% Similarity=0.412 Sum_probs=178.7
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..+|||.+... +++..++.+..++++..- ++|.||+.+|+|..+...++.||.+ +.-++.++. +-...+++
T Consensus 115 s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlk---rik~piPE 190 (391)
T KOG0983|consen 115 STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLK---RIKGPIPE 190 (391)
T ss_pred ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHH---HhcCCchH
Confidence 45778999988766 466677888888888777 5999999999999999999999998 446677763 44566999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 161 (307)
..+-++...++.||.||.++- +|+|||+||+|||+|+.|++||||||++-.+-+.. ......|-+.|||||.+.-
T Consensus 191 ~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 191 RILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPERIDPP 266 (391)
T ss_pred HhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--ccccccCCccccCccccCCC
Confidence 999999999999999998653 99999999999999999999999999998775543 3445678899999998853
Q ss_pred --CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 162 --GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 162 --~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
..|+.++||||||+.++||.||+.|+..-..+ ...+..+ ..++. ..++...+ ....+.+++..|+.
T Consensus 267 ~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkv---ln~eP--P~L~~~~g-----FSp~F~~fv~~CL~ 334 (391)
T KOG0983|consen 267 DKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKV---LNEEP--PLLPGHMG-----FSPDFQSFVKDCLT 334 (391)
T ss_pred CCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHH---HhcCC--CCCCcccC-----cCHHHHHHHHHHhh
Confidence 47899999999999999999999997653222 1222222 22221 12222211 33347788888999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.|+.+||.+.++++
T Consensus 335 kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 335 KDHRKRPKYNKLLE 348 (391)
T ss_pred cCcccCcchHHHhc
Confidence 99999999998865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=245.14 Aligned_cols=209 Identities=22% Similarity=0.176 Sum_probs=164.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++.. ...+++..
T Consensus 16 ~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~ 86 (237)
T cd05576 16 RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK----FLNIPEEC 86 (237)
T ss_pred cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH----hcCCCHHH
Confidence 568899999987543 233455555666799999999999999999999999999999998832 34589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||.|||++ +++||||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..+
T Consensus 87 ~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 159 (237)
T cd05576 87 VKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEE 159 (237)
T ss_pred HHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCCCCC
Confidence 999999999999999999 9999999999999999999999999988655432 122345667999999988888
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|+||+|+++|||++|..|+....... .. ... ...+......+.+++.+|++.||++
T Consensus 160 ~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~-----~~~---~~~~~~~~~~~~~li~~~l~~dp~~ 219 (237)
T cd05576 160 TEACDWWSLGAILFELLTGKTLVECHPSGI------------NT-----HTT---LNIPEWVSEEARSLLQQLLQFNPTE 219 (237)
T ss_pred CchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc-----ccc---cCCcccCCHHHHHHHHHHccCCHHH
Confidence 999999999999999999987653221100 00 000 0112223345788999999999999
Q ss_pred CCCHH
Q 021774 245 RPQMN 249 (307)
Q Consensus 245 RPs~~ 249 (307)
||++.
T Consensus 220 R~~~~ 224 (237)
T cd05576 220 RLGAG 224 (237)
T ss_pred hcCCC
Confidence 99973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=248.90 Aligned_cols=223 Identities=29% Similarity=0.454 Sum_probs=173.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.|++|.+... .......+.+|++++++++|||++++++++.+.+..++||||+. +++.+++. .....++
T Consensus 44 ~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~l~ 119 (313)
T cd06633 44 HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQ 119 (313)
T ss_pred CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHH---hcCCCCC
Confidence 45789999988753 23344678899999999999999999999999999999999996 57777763 2345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..++.++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++..... .....|+..|+|||++.
T Consensus 120 ~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 120 EVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILA 191 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccc
Confidence 999999999999999999999 999999999999999999999999998864322 22356788999999874
Q ss_pred --CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 --GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 --~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
...++.++||||||+++|+|++|..|+........ .......... .. ........+.+++.+||
T Consensus 192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~~------~~--~~~~~~~~l~~li~~~l 257 (313)
T cd06633 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNDSP------TL--QSNEWTDSFRGFVDYCL 257 (313)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCC------CC--CccccCHHHHHHHHHHc
Confidence 35688899999999999999999998755422111 1111111111 00 01112234778889999
Q ss_pred ccccCCCCCHHHHHH
Q 021774 239 QAAASRRPQMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~ 253 (307)
+.+|.+||++.+++.
T Consensus 258 ~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 258 QKIPQERPASAELLR 272 (313)
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=248.49 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=175.6
Q ss_pred CCCEEEEEEccccCh-HhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAESK-QGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+|+.|++|.+..... .......+|+..+++++ |+||+++++++.+++..++||||+ +++|.+++.... +..+++.
T Consensus 23 ~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~ 99 (283)
T cd07830 23 TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK--GKPFSES 99 (283)
T ss_pred CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc--cccCCHH
Confidence 578899999875422 22334567999999998 999999999999999999999999 779988874322 3468999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-C
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-G 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 162 (307)
.++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++........ .....++..|+|||++.+ .
T Consensus 100 ~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~ 174 (283)
T cd07830 100 VIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRST 174 (283)
T ss_pred HHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCc
Confidence 9999999999999999999 999999999999999999999999999986543221 223457788999998754 5
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHH-HHH---------HHHHHhhcCCcccccC----CCCCCCCHHHHH
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKF-LLE---------WAWQLHQEEKPLELVD----PELGEYPPNEII 228 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 228 (307)
.++.++|+||||++++||++|+.||.......... ... +.............+. ..+....+....
T Consensus 175 ~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (283)
T cd07830 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASP 254 (283)
T ss_pred CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCH
Confidence 67899999999999999999998875443211100 000 0000000000000000 001111112235
Q ss_pred HHHHHHHhccccccCCCCCHHHHHH
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.+++.+||+.+|++||++.|++.
T Consensus 255 ~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 255 EAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhh
Confidence 6889999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=256.07 Aligned_cols=238 Identities=22% Similarity=0.283 Sum_probs=176.3
Q ss_pred CCCCEEEEEEccccChHh--------------HHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHh
Q 021774 5 TNGRRIAVKPLSAESKQG--------------VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL 70 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l 70 (307)
.+|+.||||.++...... ...+.+|++++++++|+||+++++++...+..++||||+. ++|.+++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l 110 (335)
T PTZ00024 32 LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV 110 (335)
T ss_pred CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHH
Confidence 468899999886542111 1247789999999999999999999999999999999996 5898888
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc----------
Q 021774 71 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI---------- 140 (307)
Q Consensus 71 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---------- 140 (307)
. ....+++..+..++.|++.||+|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 111 ~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 183 (335)
T PTZ00024 111 D----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183 (335)
T ss_pred H----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeeccccccccccccccc
Confidence 3 345689999999999999999999999 99999999999999999999999999998654111
Q ss_pred ---ccccccccCCCCcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc----
Q 021774 141 ---THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---- 212 (307)
Q Consensus 141 ---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 212 (307)
........++..|+|||.+.+. .++.++|||||||++|||++|..||....... ....+..........
T Consensus 184 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~~~~i~~~~~~~~~~~~~~ 260 (335)
T PTZ00024 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRIFELLGTPNEDNWPQ 260 (335)
T ss_pred ccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCchhhCcc
Confidence 1111223467789999988764 46899999999999999999999886543221 111111111111000
Q ss_pred -----------cccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 213 -----------ELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 213 -----------~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.................+.+++.+|++.+|++||++.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 261 AKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred hhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 00000011111223455778999999999999999999975
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=248.93 Aligned_cols=228 Identities=26% Similarity=0.421 Sum_probs=172.2
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+|+.||||.++... ......+..|+.++.+. .|+||+++++++......+++|||+. ++|.+++.. ....+++.
T Consensus 39 ~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~ 114 (296)
T cd06618 39 TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPED 114 (296)
T ss_pred CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHH
Confidence 38899999987543 33345667788777777 59999999999999999999999984 578777632 23478999
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||+|||+ . +++||||+|+||++++++.++|+|||++..+..... .....++..|+|||++.+.
T Consensus 115 ~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 115 ILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred HHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCC
Confidence 999999999999999996 6 899999999999999999999999999876543222 2233567889999998754
Q ss_pred c----ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 163 Q----LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 163 ~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
. ++.++||||||+++|+|++|+.||....... ............ .... .......+.+++.+||
T Consensus 190 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~------~~~~-~~~~~~~l~~li~~~l 257 (296)
T cd06618 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEEPP------SLPP-NEGFSPDFCSFVDLCL 257 (296)
T ss_pred CCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCCCC------CCCC-CCCCCHHHHHHHHHHc
Confidence 3 7899999999999999999999985432111 111111111110 0000 0012345788999999
Q ss_pred ccccCCCCCHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKM 254 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~ 254 (307)
+.+|.+||++.+++..
T Consensus 258 ~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 258 TKDHRKRPKYRELLQH 273 (296)
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=242.49 Aligned_cols=221 Identities=29% Similarity=0.346 Sum_probs=177.0
Q ss_pred CCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+|+.+|+|.+.... ......+..|+.++++++|+||+++++.+..++..++|||++++++|.+++. ....+++
T Consensus 17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~----~~~~l~~ 92 (250)
T cd05123 17 TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS----KEGRFSE 92 (250)
T ss_pred CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHH----hcCCCCH
Confidence 58899999887542 2345678999999999999999999999999999999999999999999983 3346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... .......++..|++||...+.
T Consensus 93 ~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~ 168 (250)
T cd05123 93 ERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGK 168 (250)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCC
Confidence 99999999999999999999 99999999999999999999999999998654432 123345578899999999888
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
..+.++|+||||+++|+|++|..|+..... ..... .... .. .. .+......+.+++.+||..||
T Consensus 169 ~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~~------~~---~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-DP------LR---FPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-CC------CC---CCCCCCHHHHHHHHHHhcCCH
Confidence 889999999999999999999999854322 11111 1111 10 01 111123457788899999999
Q ss_pred CCCCCHHH
Q 021774 243 SRRPQMNQ 250 (307)
Q Consensus 243 ~~RPs~~~ 250 (307)
++||++.+
T Consensus 233 ~~R~~~~~ 240 (250)
T cd05123 233 TKRLGSGG 240 (250)
T ss_pred hhCCCccc
Confidence 99999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=258.45 Aligned_cols=225 Identities=23% Similarity=0.339 Sum_probs=182.1
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|..||+|.+... +......+.+|+++|+.++||||++++.+.......|+||||+.+|.+.+++ ..+.++.
T Consensus 78 ~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl----~~~gr~~ 153 (596)
T KOG0586|consen 78 ILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYL----VKHGRMK 153 (596)
T ss_pred cCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHH----Hhcccch
Confidence 456889999998876 3444556899999999999999999999999999999999999999999999 3455566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+.....++.|+..|++|||++ +|+|||||+.|+||+.+.++||+|||++..+... ......+|++.|.|||++.+
T Consensus 154 e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g 228 (596)
T KOG0586|consen 154 EKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNG 228 (596)
T ss_pred hhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc--ccccccCCCCCccChHhhcC
Confidence 688888999999999999999 9999999999999999999999999999987643 34566789999999999999
Q ss_pred Cccc-ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..|. +..|+||+|+++|-|+.|..||....-..- ...+.... -..+.-...++-+++++++-.
T Consensus 229 ~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------r~rvl~gk----------~rIp~~ms~dce~lLrk~lvl 292 (596)
T KOG0586|consen 229 KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------RPRVLRGK----------YRIPFYMSCDCEDLLRKFLVL 292 (596)
T ss_pred cccCCcceehhhhhhhheeeeecccccCCcccccc------cchheeee----------ecccceeechhHHHHHHhhcc
Confidence 8774 899999999999999999999875321100 00000000 011122223466777888999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
+|.+|++++++.+
T Consensus 293 ~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 293 NPSKRGPCDQIMK 305 (596)
T ss_pred CccccCCHHHhhh
Confidence 9999999998875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=245.93 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=174.4
Q ss_pred CCCEEEEEEccccC--hHhHHHHHHHHHHHhcC---CCCCccceeeEEEeCCe-----eEEEEeccCCCCHHHHhccCCC
Q 021774 6 NGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTR-----RILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 6 ~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
+|+.||+|.++... ......+.+|+.+++++ +|+|++++++++...+. .+++||++.+ +|.+++...
T Consensus 23 ~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~-- 99 (287)
T cd07838 23 TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC-- 99 (287)
T ss_pred CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHc--
Confidence 58999999997542 22234566777777665 69999999999998776 8999999965 898887432
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..+..... .....++..|+|
T Consensus 100 ~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ 174 (287)
T cd07838 100 PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRA 174 (287)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccC
Confidence 223589999999999999999999999 999999999999999999999999999987644321 122346788999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC----c------ccccCC----CCCC
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK----P------LELVDP----ELGE 221 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~------~~~~~~----~~~~ 221 (307)
||++.+..++.++|+||||+++|||++|.+|+....... .+.. ......... . ...... ....
T Consensus 175 PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07838 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDK-IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS 251 (287)
T ss_pred hHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHH-HHHHcCCCChHhcCCCcccchhhcccccccchhh
Confidence 999998889999999999999999999988876433211 1111 111100000 0 000000 0111
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..+.....+.+++.+||+.||.+||++.+++.
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 12233456778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=247.91 Aligned_cols=226 Identities=22% Similarity=0.328 Sum_probs=180.1
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|++... .......+.+|+.++++++ |+||+++++++...+..++|||++.+++|.+++. ....+
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l 99 (280)
T cd05581 24 ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR----KYGSL 99 (280)
T ss_pred CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH----HcCCC
Confidence 36899999988753 2333467889999999998 9999999999999999999999999999999983 33479
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-------------------
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT------------------- 141 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~------------------- 141 (307)
++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (280)
T cd05581 100 DEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176 (280)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccc
Confidence 9999999999999999999999 999999999999999999999999999986654321
Q ss_pred cccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 142 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 142 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
.......++..|+|||+..+..++.++|+||||++++++++|..|+...... . ... ...... ..
T Consensus 177 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~-~~~---~~~~~~----------~~ 240 (280)
T cd05581 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--L-TFQ---KILKLE----------YS 240 (280)
T ss_pred cccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--H-HHH---HHHhcC----------CC
Confidence 1223345778899999988888999999999999999999999998754311 1 111 111100 01
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCH----HHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQM----NQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~----~~v~~ 253 (307)
.+......+.+++.+||+.+|.+||++ .+++.
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 112223457888999999999999999 76653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=246.70 Aligned_cols=244 Identities=28% Similarity=0.393 Sum_probs=182.3
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhc--CCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
++.||||++.... .+.|..|-++++- ++|+||++++++-.... .+++|++|.+.|+|.++| ....+
T Consensus 233 ~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL-----~~nti 304 (534)
T KOG3653|consen 233 NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL-----KANTI 304 (534)
T ss_pred CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH-----Hhccc
Confidence 4899999999544 4568888888876 48999999999877555 789999999999999999 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEEL------VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGY 153 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y 153 (307)
+|....+++.-+++||+|||+.. .++|+|||||+.||||.+++++.|+|||++..+...... .....+||.+|
T Consensus 305 sw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RY 384 (534)
T KOG3653|consen 305 SWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRY 384 (534)
T ss_pred cHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhh
Confidence 99999999999999999999765 468999999999999999999999999999987643222 33447899999
Q ss_pred CCcccccCCc-c-----cccCceeehHHHHHHHHhCCCCC--------Cccccch---hHHHHHHHHHHhhcCCcccccC
Q 021774 154 LAPEYVLGGQ-L-----TMKADVYSFGVLVLEIISGRNSG--------KAMWGQM---NKFLLEWAWQLHQEEKPLELVD 216 (307)
Q Consensus 154 ~aPE~~~~~~-~-----~~~~Dv~slG~~l~elltg~~p~--------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 216 (307)
||||++.+.- + -.+.||||+|.++|||++...-. +.++..+ ...+-+....+.++...
T Consensus 385 MAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R----- 459 (534)
T KOG3653|consen 385 MAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR----- 459 (534)
T ss_pred cCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccC-----
Confidence 9999997632 2 24689999999999999864321 1111110 11111111111111111
Q ss_pred CCCCCC--CHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccCc
Q 021774 217 PELGEY--PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 263 (307)
Q Consensus 217 ~~~~~~--~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 263 (307)
|.+++. ....+.-+.+.+..||..||+-|-|+.=|-+.+.++....+
T Consensus 460 P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 460 PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 222111 11345567888899999999999999999999988876553
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=252.34 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=171.7
Q ss_pred CCCCEEEEEEccccCh--HhHHHHHHHHHHHhcCCCCCccceeeEEEeCC--------eeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQGT--------RRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||+|.+..... .....+.+|++++++++||||+++++++.... ..++||||+.+ +|...+.
T Consensus 31 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~--- 106 (311)
T cd07866 31 KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE--- 106 (311)
T ss_pred CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHh---
Confidence 4688999998865422 22345778999999999999999999876543 45899999965 6776663
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc----------cc
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH----------IT 144 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~----------~~ 144 (307)
.....+++..+..++.|+++||+|||++ |++|+||+|+||++++++.++|+|||++......... ..
T Consensus 107 ~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 183 (311)
T cd07866 107 NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183 (311)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCccccccc
Confidence 2345699999999999999999999999 9999999999999999999999999999865432211 11
Q ss_pred ccccCCCCcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC-------------
Q 021774 145 TRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK------------- 210 (307)
Q Consensus 145 ~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------- 210 (307)
....++..|+|||.+.+ ..++.++||||||+++|||++|++||......... ...........
T Consensus 184 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 260 (311)
T cd07866 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---HLIFKLCGTPTEETWPGWRSLPGC 260 (311)
T ss_pred ccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChhhchhhhhcccc
Confidence 22356778999998765 45789999999999999999999988654332111 11111110000
Q ss_pred ----cccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 211 ----PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 211 ----~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
......+.+..........+.+++.+|++.+|++|||+.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 261 EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred cccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000112245788999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.45 Aligned_cols=238 Identities=25% Similarity=0.340 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|.+.... ......+..|+.++++++|+|++++++++.+....++|||++. ++|.+++... ...+++
T Consensus 22 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~ 97 (282)
T cd07829 22 KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR---PGPLSP 97 (282)
T ss_pred CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh---ccCCCH
Confidence 358999999998653 3344678889999999999999999999999999999999997 5899998432 246899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||++......... .....++..|+|||.+.+.
T Consensus 98 ~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 98 NLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-cCccccCcCcCChHHhcCC
Confidence 99999999999999999999 9999999999999999999999999999866443221 2223456789999998776
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh-----------cC----CcccccCC-CCCCCCHH
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-----------EE----KPLELVDP-ELGEYPPN 225 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~----~~~~~~~~-~~~~~~~~ 225 (307)
.++.++||||||+++|||++|..|+....... .......... .. ........ ......+.
T Consensus 174 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd07829 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR 250 (282)
T ss_pred cCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccc
Confidence 78999999999999999999988875533211 1111111000 00 00000000 00011112
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++.+||+.+|++||++.+++.
T Consensus 251 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 251 LDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 2456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=242.69 Aligned_cols=218 Identities=28% Similarity=0.300 Sum_probs=177.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.+|+|+++.+ .++...+-+.|-++|+..+||.+..+-..|...+..|+||||+.||.|.-.+ .....++
T Consensus 191 at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HL----srer~Fs 266 (516)
T KOG0690|consen 191 ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHL----SRERVFS 266 (516)
T ss_pred ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeeh----hhhhccc
Confidence 35788999999876 4666778899999999999999999888899999999999999999998777 3456788
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+....-....|+.||.|||++ +||.||||.+|+|+|.+|++||+|||+++.-- .....+..++||+.|+|||++..
T Consensus 267 E~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 267 EDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred chhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-cccceeccccCChhhcCchhhcc
Confidence 888888999999999999999 99999999999999999999999999998422 22345677999999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..|..+.|.|.+|+++|||++|+.||..... ..+...+... --.++.....+...|+...+..|
T Consensus 343 nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~e-------------d~kFPr~ls~eAktLLsGLL~kd 406 (516)
T KOG0690|consen 343 NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILME-------------DLKFPRTLSPEAKTLLSGLLKKD 406 (516)
T ss_pred ccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhh-------------hccCCccCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999865432 2222211110 01122222233555666679999
Q ss_pred cCCCC
Q 021774 242 ASRRP 246 (307)
Q Consensus 242 p~~RP 246 (307)
|.+|-
T Consensus 407 P~kRL 411 (516)
T KOG0690|consen 407 PKKRL 411 (516)
T ss_pred hHhhc
Confidence 99994
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=244.10 Aligned_cols=212 Identities=20% Similarity=0.200 Sum_probs=154.2
Q ss_pred HHHHHHhcCCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 021774 28 TEIMTLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 103 (307)
Q Consensus 28 ~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 103 (307)
.+...+..++|+|++++++++.... ..+++++++. .++.+.+. .....++..+..++.|++.||+|||++
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~- 145 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEH- 145 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 3445566779999999999776543 4478888874 46776662 223357888999999999999999999
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc------ccccccCCCCcCCcccccCCcccccCceeehHHHH
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l 177 (307)
+++||||||+|||++.++.++|+|||+++.+...... ......||..|+|||++.+..++.++|||||||++
T Consensus 146 --~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l 223 (294)
T PHA02882 146 --GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCM 223 (294)
T ss_pred --CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999999999866432111 12234689999999999999999999999999999
Q ss_pred HHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHH
Q 021774 178 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKML 255 (307)
Q Consensus 178 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L 255 (307)
|||++|..||........ .................. .... ....+.+++..||+.+|++||++.++++.+
T Consensus 224 ~el~~g~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 224 LKWAGIKLPWKGFGHNGN--LIHAAKCDFIKRLHEGKI--KIKN----ANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhCCCCCCccccchH--HHHHhHHHHHHHhhhhhh--ccCC----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 999999999976532211 111110000000000000 0111 224477778889999999999999999876
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=252.04 Aligned_cols=235 Identities=23% Similarity=0.307 Sum_probs=173.5
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
..+|..||||.+... .......+.+|++++++++||||+++++++..+. ..++|||++ +++|..++.
T Consensus 37 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~---- 111 (343)
T cd07880 37 RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK---- 111 (343)
T ss_pred CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh----
Confidence 346889999988643 2334456889999999999999999999987654 358999999 779998873
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
...+++..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||++...... .....++..|+|
T Consensus 112 -~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~a 183 (343)
T cd07880 112 -HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRA 183 (343)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccC
Confidence 24689999999999999999999999 9999999999999999999999999999865432 223456888999
Q ss_pred cccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHH----------HhhcCCc-------ccccCC
Q 021774 156 PEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ----------LHQEEKP-------LELVDP 217 (307)
Q Consensus 156 PE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~-------~~~~~~ 217 (307)
||.+.+ ..++.++|+||||+++|+|++|..||....... ........ ....... ......
T Consensus 184 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07880 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKK 261 (343)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcc
Confidence 998876 457899999999999999999999986432210 00000000 0000000 000000
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+....+.....+.+++.+|++.||.+|||+.+++.
T Consensus 262 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 262 DFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111223335778999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=249.76 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=171.1
Q ss_pred CCEEEEEEcccc--ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC----CeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 7 GRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 7 g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
|..||+|.+... .......+.+|+++++++ +||||+++++++... ...+++++++. ++|.+++. ....
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~----~~~~ 101 (332)
T cd07857 27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR----SGQP 101 (332)
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh----cCCC
Confidence 778999988753 223356788999999999 699999999876432 45688899885 68988883 4456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCcCCc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAP 156 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aP 156 (307)
+++..+..++.||+.||.|||++ |++||||||+||++++++.++|+|||++......... ......|+..|+||
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aP 178 (332)
T cd07857 102 LTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCc
Confidence 89999999999999999999999 9999999999999999999999999999865432211 12334688899999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHh-----------hcCCcc-------cccCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH-----------QEEKPL-------ELVDP 217 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-------~~~~~ 217 (307)
|.+.+ ..++.++|+||||+++|+|++|..||....... ......... ...... ..-..
T Consensus 179 E~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (332)
T cd07857 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKK 255 (332)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCc
Confidence 98765 468899999999999999999998876432110 000000000 000000 00000
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+....+.....+.+++.+|++.||.+|||+.+++.
T Consensus 256 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 256 PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred chHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001111112345788999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=251.84 Aligned_cols=237 Identities=22% Similarity=0.284 Sum_probs=172.9
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .......+..|++++++++||||+++++++.. .+..++|+||+ +++|.+++. ...++
T Consensus 33 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~ 106 (328)
T cd07856 33 LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLE 106 (328)
T ss_pred CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCC
Confidence 46889999987643 23345678899999999999999999999876 56789999998 668998873 33578
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||++...... .....++..|+|||.+.+
T Consensus 107 ~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 107 KQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC----cCCCcccccccCceeeec
Confidence 888899999999999999999 9999999999999999999999999998754332 122356778999998766
Q ss_pred -CcccccCceeehHHHHHHHHhCCCCCCccccchhHHH-HHH-------HHHHhhcCCcccccCC-CC-C-----CCCHH
Q 021774 162 -GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFL-LEW-------AWQLHQEEKPLELVDP-EL-G-----EYPPN 225 (307)
Q Consensus 162 -~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~-~~-~-----~~~~~ 225 (307)
..++.++||||||+++|+|++|+.||........... ... ................ .. . ...+.
T Consensus 180 ~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (328)
T cd07856 180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN 259 (328)
T ss_pred cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCC
Confidence 5688999999999999999999998865432111000 000 0000000000000000 00 0 00112
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
....+.+++.+|++.+|++||++.+++..
T Consensus 260 ~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 260 ADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23568889999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=244.97 Aligned_cols=241 Identities=26% Similarity=0.323 Sum_probs=185.7
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcC--CCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNV--RHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
|+.||||++...++ ..+.+|.++++.. +|+||+.+++.-..++ +.++|++|.+.|||.++|. ...+
T Consensus 234 Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~-----r~tv 305 (513)
T KOG2052|consen 234 GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN-----RNTV 305 (513)
T ss_pred CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHh-----hccC
Confidence 78999999985443 5688999999875 9999999998876544 6689999999999999993 3568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCC
Q 021774 81 NWEKRSDICVGIAKGLAFLHEEL-----VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTG 152 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~ 152 (307)
+....++++..+|.||++||..+ .|.|.|||||+.|||+.+|+.+.|+|+|++......... .....+||.+
T Consensus 306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR 385 (513)
T KOG2052|consen 306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR 385 (513)
T ss_pred CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence 88999999999999999999654 689999999999999999999999999999877654322 3456789999
Q ss_pred cCCcccccCC------cccccCceeehHHHHHHHHhC----------CCCCCccccchhHHHHHHHHHHhhcCCcccccC
Q 021774 153 YLAPEYVLGG------QLTMKADVYSFGVLVLEIISG----------RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 216 (307)
Q Consensus 153 y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (307)
|||||++... ..-..+||||||.++||+.-. +.||....+.+.. . +..++......+.
T Consensus 386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~-----eeMrkVVCv~~~R 459 (513)
T KOG2052|consen 386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-F-----EEMRKVVCVQKLR 459 (513)
T ss_pred ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-H-----HHHhcceeecccC
Confidence 9999988542 123468999999999998753 2455443332211 1 1112222222223
Q ss_pred CCCC--CCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 217 PELG--EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 217 ~~~~--~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
|.++ -.....+..+.++++.||..+|.-|-|+-.+.+.|.++...
T Consensus 460 P~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 460 PNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 3331 23346788899999999999999999999999999887754
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=251.45 Aligned_cols=237 Identities=21% Similarity=0.311 Sum_probs=172.8
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||.+... .......+.+|+.++++++||||+++++++.... ..++|+||+. .+|..+.
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------ 110 (342)
T cd07879 38 RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM------ 110 (342)
T ss_pred CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH------
Confidence 46899999988753 2233456889999999999999999999987543 4589999995 4777765
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
+..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++...... .....++..|+||
T Consensus 111 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aP 183 (342)
T cd07879 111 GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAP 183 (342)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccCh
Confidence 23588999999999999999999999 9999999999999999999999999998764332 2234567889999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC-----------Ccc-------cccCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE-----------KPL-------ELVDP 217 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-------~~~~~ 217 (307)
|++.+ ..++.++||||||+++|||++|+.||...... ..+ .......... ... .....
T Consensus 184 E~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (342)
T cd07879 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQL-TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK 260 (342)
T ss_pred hhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccc
Confidence 98876 46889999999999999999999998643211 111 1011100000 000 00000
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH--HHHhc
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK--MLTKN 258 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~--~L~~~ 258 (307)
.+....+.....+.+++.+||+.||.+||++.+++. .++..
T Consensus 261 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 261 DFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000001122345788999999999999999999984 35443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=237.16 Aligned_cols=227 Identities=26% Similarity=0.359 Sum_probs=182.0
Q ss_pred CCCEEEEEEccccChHh-HHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++|++.+++|.+++.. ...+++..
T Consensus 13 ~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~ 88 (244)
T smart00220 13 TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----RGRLSEDE 88 (244)
T ss_pred CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----ccCCCHHH
Confidence 58999999998765433 67899999999999999999999999999999999999999999999842 22388999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.+++.++.+||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++||.+.+..+
T Consensus 89 ~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~ 163 (244)
T smart00220 89 ARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGY 163 (244)
T ss_pred HHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCC
Confidence 999999999999999999 99999999999999999999999999998765432 2334567888999999988888
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+++++|++|..|+...... .... .......... ..........+.+++.+|+..+|++
T Consensus 164 ~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~----~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~ 231 (244)
T smart00220 164 GKAVDVWSLGVILYELLTGKPPFPGDDQL--LELF----KKIGKPKPPF------PPPEWKISPEAKDLIRKLLVKDPEK 231 (244)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH----HHHhccCCCC------ccccccCCHHHHHHHHHHccCCchh
Confidence 99999999999999999999887553111 1111 1111111100 0000003346888999999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
||++.++++
T Consensus 232 Rp~~~~~~~ 240 (244)
T smart00220 232 RLTAEEALQ 240 (244)
T ss_pred ccCHHHHhh
Confidence 999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=252.61 Aligned_cols=238 Identities=21% Similarity=0.300 Sum_probs=172.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--------------CeeEEEEeccCCCCHHHHh
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--------------TRRILVYEYVENNSLDRVL 70 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~l 70 (307)
.+|..||+|.+........+.+.+|++++++++||||+++++++... ...++||||++ ++|.+++
T Consensus 28 ~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 106 (342)
T cd07854 28 DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL 106 (342)
T ss_pred CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHH
Confidence 46889999998776655667789999999999999999999876643 35789999996 5898887
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCccc--ccccc
Q 021774 71 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITH--ITTRI 147 (307)
Q Consensus 71 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~--~~~~~ 147 (307)
. ...+++..+..++.|++.||.|||+. |++||||||+||+++. ++.++|+|||++......... .....
T Consensus 107 ~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 178 (342)
T cd07854 107 E-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178 (342)
T ss_pred H-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccc
Confidence 3 23588999999999999999999999 9999999999999974 557899999999765332111 11223
Q ss_pred cCCCCcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHH----------hhcCCcccc--
Q 021774 148 AGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL----------HQEEKPLEL-- 214 (307)
Q Consensus 148 ~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~-- 214 (307)
.++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ........ .........
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (342)
T cd07854 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESVPVVREEDRNELLNVIPSFVRN 256 (342)
T ss_pred cccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHHhhhhhhhhhhhhhh
Confidence 56788999997754 5678899999999999999999999864432111 00000000 000000000
Q ss_pred ----cCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 215 ----VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 215 ----~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.........+.....+.+++.+||+.||.+|||+.+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 257 DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000011122345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=236.77 Aligned_cols=234 Identities=25% Similarity=0.312 Sum_probs=181.9
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+.+|..+|||++.+...+...+.++|++++.+. .|+||+.++++|++++.+|+|||.+.||+|...+ .....|++
T Consensus 100 i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI----~~~~~F~E 175 (463)
T KOG0607|consen 100 IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHI----QKRKHFNE 175 (463)
T ss_pred eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHH----HHhhhccH
Confidence 678999999999988778888999999999999 6999999999999999999999999999998887 35567999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---eEEeeccCcccCCC--C----cccccccccCCCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPD--N----ITHITTRIAGTTGY 153 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~dfg~~~~~~~--~----~~~~~~~~~g~~~y 153 (307)
..+-++..+|+.||.+||.+ ||.||||||+|||-.+-.. ||||||.+..-+.- + ........+|+..|
T Consensus 176 ~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEf 252 (463)
T KOG0607|consen 176 REASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEF 252 (463)
T ss_pred HHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhh
Confidence 99999999999999999999 9999999999999966544 89999988764321 1 11123345688899
Q ss_pred CCccccc---C--CcccccCceeehHHHHHHHHhCCCCCCccccchh--------HHHHHHHHHHhhcCCcccccCCCCC
Q 021774 154 LAPEYVL---G--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN--------KFLLEWAWQLHQEEKPLELVDPELG 220 (307)
Q Consensus 154 ~aPE~~~---~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (307)
||||+.. + -.|+.+.|.||||+++|=||+|.+||.+.-+.+= ............++. -
T Consensus 253 MAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk---------Y 323 (463)
T KOG0607|consen 253 MAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK---------Y 323 (463)
T ss_pred cchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC---------C
Confidence 9999763 2 3688999999999999999999999987654210 111111122222221 1
Q ss_pred CCCHH----HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 EYPPN----EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ~~~~~----~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.++.. ......+++...+..|+.+|-++.+++.
T Consensus 324 eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 324 EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22322 2333456677778899999999888876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=252.21 Aligned_cols=233 Identities=23% Similarity=0.318 Sum_probs=173.9
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe------eEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR------RILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||+|.+... +......+.+|+.++++++|+||+++++++...+. .++|+||+ +++|.+++.
T Consensus 38 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----- 111 (343)
T cd07851 38 KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK----- 111 (343)
T ss_pred CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh-----
Confidence 35789999988753 23344667889999999999999999998876554 89999999 679999883
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
...+++..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||++...... .....++..|+||
T Consensus 112 ~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aP 184 (343)
T cd07851 112 CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAP 184 (343)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCH
Confidence 24689999999999999999999999 9999999999999999999999999999865432 2234567889999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhc-----------CCccccc-------CC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE-----------EKPLELV-------DP 217 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-------~~ 217 (307)
|.+.+ ..++.++||||||+++|+|++|+.||....... ........... ......+ .+
T Consensus 185 E~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07851 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKK 261 (343)
T ss_pred HHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCC
Confidence 98765 467899999999999999999999886433211 11111010000 0000000 00
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+..........+.+++.+|++.+|.+|||+.+|+.
T Consensus 262 ~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 262 DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000001112456889999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=243.83 Aligned_cols=211 Identities=22% Similarity=0.344 Sum_probs=168.2
Q ss_pred HHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 021774 23 VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 102 (307)
Q Consensus 23 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 102 (307)
..++..|+.++++++||||+++++++.+.+..++||||+++++|.+++.........+++..++.++.|++.||.|||++
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 34577899999999999999999999999999999999999999998865444566799999999999999999999999
Q ss_pred CCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh
Q 021774 103 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182 (307)
Q Consensus 103 ~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt 182 (307)
|++|+||+|+||++++ +.++|+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 126 ---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 200 (260)
T cd08222 126 ---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200 (260)
T ss_pred ---CccccCCChhheEeec-CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999975 5699999999876543221 2233457888999999888888999999999999999999
Q ss_pred CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 183 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 183 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
|..|+..... ........... ....+......+.+++.+||..+|++||++.++++
T Consensus 201 ~~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 201 LAHAFEGQNF------LSVVLRIVEGP---------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCCccH------HHHHHHHHcCC---------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 9998753221 11111111111 11122334456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=249.16 Aligned_cols=234 Identities=23% Similarity=0.284 Sum_probs=171.7
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||+|++... +......+.+|++++++++||||+++++++... ...+++++++ +++|.+++.
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~----- 113 (345)
T cd07877 40 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK----- 113 (345)
T ss_pred CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh-----
Confidence 57889999998753 233346788999999999999999999988643 3467888887 789988873
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++...... .....++..|+||
T Consensus 114 ~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aP 186 (345)
T cd07877 114 CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAP 186 (345)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc----ccccccCCCccCH
Confidence 23589999999999999999999999 9999999999999999999999999998754332 2334578889999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC--c----------------ccccCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--P----------------LELVDP 217 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~----------------~~~~~~ 217 (307)
|.+.+ ..++.++|||||||++|||++|+.||....... .+.. ......... . ......
T Consensus 187 E~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (345)
T cd07877 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKL-ILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 263 (345)
T ss_pred HHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCc
Confidence 98866 567889999999999999999999885432211 1100 000000000 0 000000
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
............+.+++.+|++.||.+||++.+++..
T Consensus 264 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 264 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred chhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000011123457789999999999999999988753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=256.63 Aligned_cols=215 Identities=24% Similarity=0.272 Sum_probs=170.1
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+++..++|++... ..+-.+|+.++... +||||+++.+.+.+..+.|+|||.+.|+-+.+.+ .....+. ..
T Consensus 346 t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri----~~~~~~~-~e 416 (612)
T KOG0603|consen 346 TDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRI----RSKPEFC-SE 416 (612)
T ss_pred cccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHH----HhcchhH-HH
Confidence 4566777777644 13345688777776 8999999999999999999999999998777666 2333333 67
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-CCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
+..|+++|+.|+.|||++ |++||||||+|||+ ++.++++|+|||.++..... ....+-|..|.|||+.....
T Consensus 417 ~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~ 489 (612)
T KOG0603|consen 417 ASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQE 489 (612)
T ss_pred HHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCC
Confidence 778999999999999999 99999999999999 68899999999999876554 22234577899999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
|++++|+||||++||+||+|+.|+.....+.+ +....... .+.........+|+.+|++.||.
T Consensus 490 yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~i~~~-----------~~s~~vS~~AKdLl~~LL~~dP~ 552 (612)
T KOG0603|consen 490 YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTRIQMP-----------KFSECVSDEAKDLLQQLLQVDPA 552 (612)
T ss_pred CCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHhhcCC-----------ccccccCHHHHHHHHHhccCChh
Confidence 99999999999999999999999877665411 11211111 11133344577888999999999
Q ss_pred CCCCHHHHHH
Q 021774 244 RRPQMNQVIK 253 (307)
Q Consensus 244 ~RPs~~~v~~ 253 (307)
+||++.++..
T Consensus 553 ~Rl~~~~i~~ 562 (612)
T KOG0603|consen 553 LRLGADEIGA 562 (612)
T ss_pred hCcChhhhcc
Confidence 9999999865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=235.74 Aligned_cols=226 Identities=20% Similarity=0.209 Sum_probs=168.3
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+++|+|++... ....+|+++--.. .|||||.+++++.+ ...+++|||.++||.|.+.+.. .....|+
T Consensus 87 ~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afT 159 (400)
T KOG0604|consen 87 QEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFT 159 (400)
T ss_pred hhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccch
Confidence 445555555421 2345677765554 69999999999874 3456799999999999988843 4456799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
++++..|+.||..|+.|||+. +|.||||||+|+|... |..+||+|||.++..... ......+-|+.|.|||+
T Consensus 160 Erea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPev 234 (400)
T KOG0604|consen 160 EREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEV 234 (400)
T ss_pred HHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHH
Confidence 999999999999999999999 9999999999999964 456999999999865432 22344567899999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCC-CHHHHHHHHHHHHhc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY-PPNEIIRYMKVAFFC 237 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~c 237 (307)
+...+|+...|+||+|+++|-|++|.+||....+..-. .-.......+.. + ++.- -........++++..
T Consensus 235 lg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~gqy-~-----FP~pEWs~VSe~aKdlIR~L 305 (400)
T KOG0604|consen 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTGQY-E-----FPEPEWSCVSEAAKDLIRKL 305 (400)
T ss_pred hCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhccCc-c-----CCChhHhHHHHHHHHHHHHH
Confidence 99999999999999999999999999998766542110 000011111110 0 1111 123345567788889
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
+..+|.+|-|++++..
T Consensus 306 Lkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 306 LKTEPTERLTIEEVMD 321 (400)
T ss_pred hcCCchhheeHHHhhc
Confidence 9999999999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=239.40 Aligned_cols=234 Identities=28% Similarity=0.344 Sum_probs=179.2
Q ss_pred cCCCCEEEEEEccccC-------hHhHHHHHHHHHHHhcCCCCCccceeeEEE-eCCeeEEEEeccCCCCHHHHhccCCC
Q 021774 4 LTNGRRIAVKPLSAES-------KQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
+...+.||||+..... ....+...+|.++-+.|+||.||++|+++. +.+.+|-|.|||+|.+|+-+| .
T Consensus 485 l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL----K 560 (775)
T KOG1151|consen 485 LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL----K 560 (775)
T ss_pred cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH----H
Confidence 3457889999776431 122355779999999999999999999986 556789999999999999999 5
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCccc------cccc
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITH------ITTR 146 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~~------~~~~ 146 (307)
.+..+++..+..|+.||+.||.||.+. .++|||.||||.||||.+ .|.+||.|||+++.+.++... .+..
T Consensus 561 QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQ 639 (775)
T KOG1151|consen 561 QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQ 639 (775)
T ss_pred hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecc
Confidence 667799999999999999999999986 458999999999999954 477999999999998765332 3456
Q ss_pred ccCCCCcCCcccccCC----cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCC
Q 021774 147 IAGTTGYLAPEYVLGG----QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 222 (307)
Q Consensus 147 ~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (307)
..||.+|++||++.-+ +++.|+||||+|+++|.++.|+.||.....+. .++... .+...-.-.+ ..
T Consensus 640 gAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILqeN-------TIlkAtEVqF-P~ 709 (775)
T KOG1151|consen 640 GAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQEN-------TILKATEVQF-PP 709 (775)
T ss_pred cCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHhhh-------chhcceeccC-CC
Confidence 7899999999998643 46889999999999999999999997654432 122111 1110000000 01
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHH
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVI 252 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~ 252 (307)
.+....+...+|++|+++.-++|....++.
T Consensus 710 KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 710 KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 123334567789999999999998777664
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=257.00 Aligned_cols=232 Identities=27% Similarity=0.382 Sum_probs=190.5
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
+||+|++... ..+.-..+++|+-+|.+++|||+++++++|.... ..||++|+++|+|.++++. ....+..+..+.
T Consensus 727 pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLn 802 (1177)
T KOG1025|consen 727 PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLN 802 (1177)
T ss_pred eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHH
Confidence 6899988765 3455678999999999999999999999999877 7799999999999999954 344578899999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc-ccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
|..|||+||.|||.+ .++||||..+|||+.+-..+|+.|||+++....+..... ....-.+.|||-|.+....|+.
T Consensus 803 w~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~th 879 (1177)
T KOG1025|consen 803 WCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTH 879 (1177)
T ss_pred HHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCc
Confidence 999999999999999 999999999999999999999999999998866544322 2233346799999999999999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++|||||||++||++| |..|+......+-..+ .+.+ ..-..++.+..++..++.+||..|+..|
T Consensus 880 qSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~g--------eRLsqPpiCtiDVy~~mvkCwmid~~~r 944 (1177)
T KOG1025|consen 880 QSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKG--------ERLSQPPICTIDVYMVMVKCWMIDADSR 944 (1177)
T ss_pred hhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhcc--------ccCCCCCCccHHHHHHHHHHhccCcccC
Confidence 9999999999999988 7777655443222222 1111 1123466777789999999999999999
Q ss_pred CCHHHHHHHHHhccccC
Q 021774 246 PQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~~~ 262 (307)
|+|+++.....+..+.+
T Consensus 945 p~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 945 PTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccHHHHHHHHHHHhcCc
Confidence 99999999888877644
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=231.21 Aligned_cols=237 Identities=26% Similarity=0.398 Sum_probs=179.3
Q ss_pred cCCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhcc-CCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLG-ATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~ 80 (307)
-+.|+..|||+++... .....+++.|.+...+- ++||||++||.+..+...|+.||+++ .||+.+... .......+
T Consensus 86 k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~i 164 (361)
T KOG1006|consen 86 KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRI 164 (361)
T ss_pred CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccC
Confidence 4678999999998663 35557888888887766 89999999999999999999999994 477765411 12345568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..|....+.||.||.... .|+|||+||+||||+..|.+||||||++-.+.+.. ..+.-.|-..|||||.+.
T Consensus 165 pE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 165 PENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERID 240 (361)
T ss_pred cHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--HhhhccCCccccChhccC
Confidence 99999999999999999998654 89999999999999999999999999997554332 234456778999999885
Q ss_pred C--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 G--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 ~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
. ..|+.+|||||||++|+|+.||+.|+..... +.+...+......+.-..+..- -.....+...+..|+
T Consensus 241 p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdpp~l~~~~~~----~~~s~~~~~fintCl 311 (361)
T KOG1006|consen 241 PSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDPPILLFDKEC----VHYSFSMVRFINTCL 311 (361)
T ss_pred CccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCCCeecCcccc----cccCHHHHHHHHHHh
Confidence 4 3599999999999999999999998654322 2222333333333322222221 122334666667799
Q ss_pred ccccCCCCCHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKM 254 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~ 254 (307)
-.|-.+||.+.++.++
T Consensus 312 ~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 312 IKDRSDRPKYDDLKKF 327 (361)
T ss_pred hcccccCcchhhhhcC
Confidence 9999999999998763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=251.10 Aligned_cols=230 Identities=23% Similarity=0.399 Sum_probs=186.8
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEe-----CCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.++|+..|+|++......+ .....|+++|+.+ +|||++.+||++.. ++.+|+|||||.|||..+++++.. +
T Consensus 41 ~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g 117 (953)
T KOG0587|consen 41 VKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--G 117 (953)
T ss_pred eecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--c
Confidence 4678899999888654332 4567799999988 89999999999873 568899999999999999997654 7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
.++.|..+..|++.++.|+++||.+ .++|||||-.|||++.++.|||+|||++........ ......||+.|||||
T Consensus 118 ~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 118 NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPE 193 (953)
T ss_pred cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccc-cccCcCCCcccccce
Confidence 7899999999999999999999999 999999999999999999999999999987655332 345678999999999
Q ss_pred cccC-----CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 158 YVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 158 ~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
++.- ..|+..+|+||||++..||--|.+|+..+.+--. ... .....+ |. ...+.....++.+
T Consensus 194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------LF~-IpRNPP-----Pk-Lkrp~kWs~~Fnd 260 (953)
T KOG0587|consen 194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFL-IPRNPP-----PK-LKRPKKWSKKFND 260 (953)
T ss_pred eeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------hcc-CCCCCC-----cc-ccchhhHHHHHHH
Confidence 9854 2477889999999999999999999877655211 000 001111 11 1224567788999
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+|..|+..|.++||++.++++
T Consensus 261 FIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 261 FISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred HHHHHHhhccccCcchhhhcc
Confidence 999999999999999988874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=242.72 Aligned_cols=222 Identities=25% Similarity=0.318 Sum_probs=173.1
Q ss_pred CCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 7 GRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 7 g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
|+-+|.|.+... .+....-.+.|-.+|++++.+.||.+-..|...+..++|+..|.||+|.-.+.+. .+..|++.
T Consensus 210 GKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ 287 (591)
T KOG0986|consen 210 GKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQ 287 (591)
T ss_pred hhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeecc--CCCCCchH
Confidence 444555555433 1333445678999999999999999988899999999999999999998777432 34579999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+.-++.+|+.||.+||.. +||+|||||.|||||+.|+|+|+|+|++..+..... ....+||.+|||||++.++.
T Consensus 288 ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~ 362 (591)
T KOG0986|consen 288 RARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEV 362 (591)
T ss_pred HHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc--cccccCcccccCHHHHcCCc
Confidence 9999999999999999999 999999999999999999999999999998876543 34458999999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
|+...|.|||||++|||+.|+.||..........- +.+.... ++ ..++.....+...+.+..++.||.
T Consensus 363 Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdrr~~~-------~~--~ey~~kFS~eakslc~~LL~Kdp~ 430 (591)
T KOG0986|consen 363 YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDRRTLE-------DP--EEYSDKFSEEAKSLCEGLLTKDPE 430 (591)
T ss_pred ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHHHHhc-------ch--hhcccccCHHHHHHHHHHHccCHH
Confidence 99999999999999999999999876543322111 0011100 11 123344444566676778999999
Q ss_pred CCCC
Q 021774 244 RRPQ 247 (307)
Q Consensus 244 ~RPs 247 (307)
+|--
T Consensus 431 ~RLG 434 (591)
T KOG0986|consen 431 KRLG 434 (591)
T ss_pred Hhcc
Confidence 9863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=256.67 Aligned_cols=122 Identities=29% Similarity=0.370 Sum_probs=109.8
Q ss_pred CCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+|+.||||+++.. .......+..|+.+++.++||||+++++++......++||||+.|++|.+++. ....+++
T Consensus 28 ~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~----~~~~l~~ 103 (669)
T cd05610 28 NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDE 103 (669)
T ss_pred CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHH----hcCCCCH
Confidence 5889999998753 23445678899999999999999999999999999999999999999999983 2345888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..+..++.||+.||.|||.+ +|+||||||+||||+.++.++|+|||+++
T Consensus 104 ~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 104 EMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999999 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=233.49 Aligned_cols=236 Identities=20% Similarity=0.253 Sum_probs=178.1
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcC-C-CCC----ccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNV-R-HPN----LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~-h~~----i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+..||||+++...+ .....+-|+++|+++ + .|+ ++.+.+||...++.|+|+|.+ |.|+.+++.. .+...+
T Consensus 114 ~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~f 189 (415)
T KOG0671|consen 114 KEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPF 189 (415)
T ss_pred CceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCcccc
Confidence 67899998886543 234567799999999 3 332 677888899999999999999 7799999943 344568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC--------------------CCceEEeeccCcccCCCCc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ--------------------EFNPKIGDFGLAKLFPDNI 140 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--------------------~~~~kl~dfg~~~~~~~~~ 140 (307)
+..++..++.|+++++++||+. +++|-||||+|||+.+ +..|+|+|||.+..-....
T Consensus 190 pi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 190 PIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred chHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc
Confidence 8999999999999999999999 9999999999999932 3458999999998654443
Q ss_pred ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHH--------------Hh
Q 021774 141 THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQ--------------LH 206 (307)
Q Consensus 141 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~--------------~~ 206 (307)
...+.|..|.|||++.+-.++..+||||+||+|+||+||...|+.....+...+++.+.. .+
T Consensus 267 ----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf 342 (415)
T KOG0671|consen 267 ----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYF 342 (415)
T ss_pred ----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhh
Confidence 456678999999999999999999999999999999999987766554333323222211 00
Q ss_pred hcCCcc-----------cccC---CC--CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 207 QEEKPL-----------ELVD---PE--LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 207 ~~~~~~-----------~~~~---~~--~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..++.. ...+ +. .-.....+...+++|+++++.+||.+|+|+.|.+.
T Consensus 343 ~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 343 RRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 000000 0000 00 01223456677999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=261.12 Aligned_cols=179 Identities=25% Similarity=0.391 Sum_probs=129.2
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 55 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 55 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
||=||||+.-+|.+++..+. ..-.....++++.+|++||+|+|++ |+|||||||.||||++++.|||+|||++.
T Consensus 672 YIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 672 YIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccch
Confidence 57788888877777763211 1113567899999999999999999 99999999999999999999999999998
Q ss_pred cCC-----------------CCcccccccccCCCCcCCcccccCC---cccccCceeehHHHHHHHHhCCCCCCccccch
Q 021774 135 LFP-----------------DNITHITTRIAGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 194 (307)
Q Consensus 135 ~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 194 (307)
... .......+...||.-|+|||.+.+. .|+.|.|+||||++++||+. ||.. .+
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T---sM 819 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT---SM 819 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc---hH
Confidence 611 0011134567899999999988764 59999999999999999984 3321 11
Q ss_pred hHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 195 NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+. .. +....+.+..... .++..+....-..+++++++.||.+|||+.|++.
T Consensus 820 ER--a~-iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 ER--AS-ILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HH--HH-HHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11 11 1122222222111 2334444555678889999999999999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=255.01 Aligned_cols=226 Identities=25% Similarity=0.319 Sum_probs=172.6
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++-.+. .....+|+..|+.- +||||+++|+.-.++...||..|.|. .+|.+++...........-.
T Consensus 531 ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i 606 (903)
T KOG1027|consen 531 YEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDI 606 (903)
T ss_pred eCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccc
Confidence 357899999887443 34567899999998 79999999999999999999999995 49999995431111111113
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---C--CceEEeeccCcccCCCCccc--ccccccCCCCcCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---E--FNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAP 156 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~--~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aP 156 (307)
..+.++.|++.||++||+. +|+||||||.||||+. + ..++|+|||+++.+..+... ......||.+|+||
T Consensus 607 ~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~AP 683 (903)
T KOG1027|consen 607 DPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAP 683 (903)
T ss_pred cHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCH
Confidence 4567899999999999999 9999999999999975 3 46999999999988654332 24556799999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhC-CCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
|++.....+.++||||+||++|+.++| ..||.......... .........+.+. .++ ...+||.
T Consensus 684 E~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--------l~~~~~L~~L~~~-----~d~--eA~dLI~ 748 (903)
T KOG1027|consen 684 EQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--------LTGNYTLVHLEPL-----PDC--EAKDLIS 748 (903)
T ss_pred HHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--------hcCccceeeeccC-----chH--HHHHHHH
Confidence 999998888899999999999999987 78887665433221 1111111111111 111 5778899
Q ss_pred hccccccCCCCCHHHHH
Q 021774 236 FCTQAAASRRPQMNQVI 252 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~ 252 (307)
+|++.+|..||++.+|+
T Consensus 749 ~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 749 RMLNPDPQLRPSATDVL 765 (903)
T ss_pred HhcCCCcccCCCHHHHh
Confidence 99999999999999998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=213.31 Aligned_cols=183 Identities=27% Similarity=0.430 Sum_probs=156.2
Q ss_pred ccCCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 3 TLTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
...+|...|+|++... ..+..++.+.|+.+..+. .+|.+|.+||........++.||.++ .||+.+-.+....+..+
T Consensus 67 h~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~i 145 (282)
T KOG0984|consen 67 HIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTI 145 (282)
T ss_pred eccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcC
Confidence 4578999999999865 345557788899988877 89999999999999999999999995 48988876666788889
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+-+|+..+.+||.|||++. .++|||+||+||||+..|+||+||||.+-.+.++... +...|-..|||||.+.
T Consensus 146 pE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk--t~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 146 PEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK--TMDAGCKPYMAPERIN 221 (282)
T ss_pred chHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHH--HHhcCCCccCChhhcC
Confidence 99999999999999999999885 8999999999999999999999999999876554322 2245677899999875
Q ss_pred C----CcccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 161 G----GQLTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 161 ~----~~~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
. ..|+.++||||||+.+.||.+++.|+...
T Consensus 222 ~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 222 PELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 3 37899999999999999999999986543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=231.44 Aligned_cols=237 Identities=19% Similarity=0.280 Sum_probs=183.1
Q ss_pred cCCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCCC----C
Q 021774 4 LTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKA----N 77 (307)
Q Consensus 4 ~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~----~ 77 (307)
..|.+.|-+|.++.. +.-....++.|.-++..+.|||++.+.+++..+ ...+.++++...|+|+.++..++.. .
T Consensus 311 ~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~a 390 (563)
T KOG1024|consen 311 YNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYA 390 (563)
T ss_pred cchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccc
Confidence 344556777777654 445567899999999999999999999988754 5778999999889999999744322 2
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAP 156 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aP 156 (307)
..++-.++..++.|++.|++|||.. +++|.||..+|++|++..+|||+|=.+++-.-..... ..........||+|
T Consensus 391 qtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl 467 (563)
T KOG1024|consen 391 QTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL 467 (563)
T ss_pred cchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCH
Confidence 3467778899999999999999999 9999999999999999999999999999854322211 12223345689999
Q ss_pred ccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
|.+.+..|+.++||||||+++|||+| |+.|+....+.+ ...+.....+ -..+.+++.+++.++.
T Consensus 468 Eal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~~ylkdGyR------------laQP~NCPDeLf~vMa 532 (563)
T KOG1024|consen 468 EALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---MEHYLKDGYR------------LAQPFNCPDELFTVMA 532 (563)
T ss_pred HHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HHHHHhccce------------ecCCCCCcHHHHHHHH
Confidence 99999999999999999999999998 666755433321 1222222111 1234456667888888
Q ss_pred hccccccCCCCCHHHHHHHHHhc
Q 021774 236 FCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
-||...|++||+++++...|.+.
T Consensus 533 cCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 533 CCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHhcCcccCCCHHHHHHHHHHH
Confidence 89999999999999999999764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=227.37 Aligned_cols=178 Identities=27% Similarity=0.415 Sum_probs=148.9
Q ss_pred EEEEEEccccCh--HhHHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeccCCCCHHHHhccCCCC-CCCCCHHH
Q 021774 9 RIAVKPLSAESK--QGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKA-NIKLNWEK 84 (307)
Q Consensus 9 ~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~ 84 (307)
.+|+|.++.+.. ..-....+|+.+++.++||||+.+..++.. +...++++||.+. +|.+.++.++.. ...++...
T Consensus 55 ~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~m 133 (438)
T KOG0666|consen 55 EYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSM 133 (438)
T ss_pred hhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHH
Confidence 678888876521 112356789999999999999999999987 7788999999977 899888666543 35688999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC----CceEEeeccCcccCCCCccc--ccccccCCCCcCCccc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE----FNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEY 158 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~ 158 (307)
+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.|||+|+|+++.+.+.... .....+-|++|.|||.
T Consensus 134 vKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPEL 210 (438)
T KOG0666|consen 134 VKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPEL 210 (438)
T ss_pred HHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHH
Confidence 999999999999999999 89999999999999877 89999999999988764332 2344567899999999
Q ss_pred ccCC-cccccCceeehHHHHHHHHhCCCCCCcc
Q 021774 159 VLGG-QLTMKADVYSFGVLVLEIISGRNSGKAM 190 (307)
Q Consensus 159 ~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~ 190 (307)
+.|. .|+.+.|||+.||++.||+|-.+-|...
T Consensus 211 LLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 211 LLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred hcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9885 6899999999999999999988766543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=254.18 Aligned_cols=177 Identities=25% Similarity=0.274 Sum_probs=156.9
Q ss_pred CCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 6 ~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+++.||+|+++.- .......|.+|-.+|..-+.+-|+.+...|.++.+.|+||||++||+|-.++. ...++++
T Consensus 99 t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlS----k~~~~pE 174 (1317)
T KOG0612|consen 99 TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLS----KFDRLPE 174 (1317)
T ss_pred cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHh----hcCCChH
Confidence 4666788877752 12334568899999998899999999999999999999999999999999993 3337999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 161 (307)
..+.-++..|+.||.-||+. |+|||||||+|||||..|++||+|||.+..+..++.-.....+||+.|.+||++..
T Consensus 175 ~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 175 DWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred HHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhh
Confidence 99999999999999999999 99999999999999999999999999999998777777788899999999998853
Q ss_pred ----CcccccCceeehHHHHHHHHhCCCCCCc
Q 021774 162 ----GQLTMKADVYSFGVLVLEIISGRNSGKA 189 (307)
Q Consensus 162 ----~~~~~~~Dv~slG~~l~elltg~~p~~~ 189 (307)
+.|+..+|.||+||++|||+.|..||..
T Consensus 252 ~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 252 GDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 5789999999999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=233.76 Aligned_cols=227 Identities=23% Similarity=0.307 Sum_probs=178.2
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
-++|+.||||++.+. .+.....+..|+.+|+++.||.||.+--.|+..+..++|||.+.|--|+-.+ ....++++
T Consensus 586 RktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMIL---SsEkgRL~ 662 (888)
T KOG4236|consen 586 RKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMIL---SSEKGRLP 662 (888)
T ss_pred cccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHH---Hhhcccch
Confidence 367999999999765 2444578999999999999999999999999999999999999665555555 24556799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
+..-.-++.||+.||.|||-+ +|+|.||||+|||+.+.. ++||||||.++.+++... ....+||+.|+|||+
T Consensus 663 er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--RrsVVGTPAYLaPEV 737 (888)
T KOG4236|consen 663 ERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--RRSVVGTPAYLAPEV 737 (888)
T ss_pred HHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--hhhhcCCccccCHHH
Confidence 998888999999999999999 999999999999997653 599999999999877543 345789999999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+++..|...-|+||.|+++|--++|..||....+..+ ...+. .++-|. ..-.+.....+++|...+
T Consensus 738 LrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------QIQNA---aFMyPp--~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 738 LRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------QIQNA---AFMYPP--NPWSEISPEAIDLINNLL 803 (888)
T ss_pred HhhccccccccceeeeEEEEEEecccccCCCccchhH---------Hhhcc---ccccCC--CchhhcCHHHHHHHHHHH
Confidence 9999999999999999999999999999876543211 11110 011111 011122233567777778
Q ss_pred ccccCCCCCHHHHH
Q 021774 239 QAAASRRPQMNQVI 252 (307)
Q Consensus 239 ~~~p~~RPs~~~v~ 252 (307)
+.+-.+|-+.+.-+
T Consensus 804 qVkm~kRysvdk~l 817 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHhcchHhhc
Confidence 88888888776544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=236.86 Aligned_cols=215 Identities=20% Similarity=0.239 Sum_probs=175.3
Q ss_pred EEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 10 IAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 10 vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
+|+|++++. +.....+...|-++|.+.+.|.||++|-.|.+++..|++||-|-||.|...+ +..+.|+.....
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiL----rdRg~Fdd~tar 523 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTIL----RDRGSFDDYTAR 523 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhh----hhcCCcccchhh
Confidence 566666543 4556678889999999999999999999999999999999999999999999 556678888888
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
-++..+++|+.|||++ |||+|||||+|++|+.+|-+||.|||.++.+... ..+-.++||+.|.|||++.+...+.
T Consensus 524 F~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~KTwTFcGTpEYVAPEIILnKGHD~ 598 (732)
T KOG0614|consen 524 FYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RKTWTFCGTPEYVAPEIILNKGHDR 598 (732)
T ss_pred hhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--CceeeecCCcccccchhhhccCcch
Confidence 8999999999999999 9999999999999999999999999999987654 3456789999999999999999999
Q ss_pred cCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCC
Q 021774 167 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246 (307)
Q Consensus 167 ~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP 246 (307)
++|.||||+++|||++|.+||....+-..-.+.-.....+ .+|........+++++....+|.+|-
T Consensus 599 avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------------~~Pr~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 599 AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------------EFPRRITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------hcccccchhHHHHHHHHHhcCcHhhh
Confidence 9999999999999999999998765522211111111111 12222333455667777788999986
Q ss_pred C
Q 021774 247 Q 247 (307)
Q Consensus 247 s 247 (307)
-
T Consensus 665 G 665 (732)
T KOG0614|consen 665 G 665 (732)
T ss_pred c
Confidence 5
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=214.80 Aligned_cols=242 Identities=22% Similarity=0.322 Sum_probs=171.5
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEe--------CCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
+.|++||+|+.-.++ ...-...++|+.+|+.++|+|++.++..|.. ...+|+||.+|+. +|.-++.
T Consensus 40 n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs--- 115 (376)
T KOG0669|consen 40 NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS--- 115 (376)
T ss_pred CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc---
Confidence 457788998665432 1222356789999999999999999988753 2357999999966 8888883
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc---cccccccCCC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTT 151 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~ 151 (307)
....+++...+.+++.++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||+++.+..... ...+..+-|.
T Consensus 116 n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTL 192 (376)
T KOG0669|consen 116 NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTL 192 (376)
T ss_pred CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeee
Confidence 3446799999999999999999999999 999999999999999999999999999976643221 1233455689
Q ss_pred CcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc--------ccC-CCCCC
Q 021774 152 GYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE--------LVD-PELGE 221 (307)
Q Consensus 152 ~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~ 221 (307)
+|.+||.+.+ ..|+++.|||+.||++.||+|+.+-+.....+..-.+....-..+..+...+ .+. +.++.
T Consensus 193 wYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~ 272 (376)
T KOG0669|consen 193 WYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPK 272 (376)
T ss_pred ecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCc
Confidence 9999998887 5799999999999999999999876554433222111111100111110000 010 00110
Q ss_pred C----CHHH------HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 Y----PPNE------IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~----~~~~------~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
. ..+. ....++|+..++..||.+|+++.+++.
T Consensus 273 ~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 273 GQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred chhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0 0111 114556777799999999999998864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=199.05 Aligned_cols=174 Identities=24% Similarity=0.405 Sum_probs=147.8
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
++++.||+|+++..+ ...-...++|+-+|+.++|+||++++++...++...+|+|||+ .+|..+. ..-++.++.
T Consensus 25 ~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyf---dslng~~d~ 100 (292)
T KOG0662|consen 25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF---DSLNGDLDP 100 (292)
T ss_pred CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHH---HhcCCcCCH
Confidence 457889999887653 2223467899999999999999999999999999999999995 4888887 345677999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+.+..++.|+++||.++|++ ++.|||+||.|++|+.||++||+|||+++-++-...- ....+-|.+|.+|.++.+.
T Consensus 101 ~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc-ysaevvtlwyrppdvlfga 176 (292)
T KOG0662|consen 101 EIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGA 176 (292)
T ss_pred HHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-eeceeeeeeccCcceeeee
Confidence 99999999999999999999 9999999999999999999999999999977654322 2223458899999999885
Q ss_pred -cccccCceeehHHHHHHHHhCCCC
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNS 186 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p 186 (307)
-|++.-|+||.||++.|+.....|
T Consensus 177 kly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 177 KLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred ehhccchHhhhcchHHHHHhhcCCC
Confidence 578899999999999999875444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=205.62 Aligned_cols=195 Identities=33% Similarity=0.565 Sum_probs=168.6
Q ss_pred CCCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.+++|++...... ....+.+|++.++.+.|++|+++++++......++++|++++++|.+++... ...+++..
T Consensus 17 ~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~ 93 (215)
T cd00180 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDE 93 (215)
T ss_pred CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc---cCCCCHHH
Confidence 4899999999866432 3567999999999999999999999999999999999999999999998422 14688999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC-
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG- 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 162 (307)
+..++.+++.++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+...
T Consensus 94 ~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~ 169 (215)
T cd00180 94 ILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKG 169 (215)
T ss_pred HHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccC
Confidence 999999999999999999 9999999999999999 89999999999986654321 12334567789999988877
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|+|++|+++++| ..+.+++..|++.+|
T Consensus 170 ~~~~~~D~~~lg~~~~~l-----------------------------------------------~~~~~~l~~~l~~~p 202 (215)
T cd00180 170 YYSEKSDIWSLGVILYEL-----------------------------------------------PELKDLIRKMLQKDP 202 (215)
T ss_pred CCCchhhhHHHHHHHHHH-----------------------------------------------HHHHHHHHHHhhCCc
Confidence 788999999999999998 247888889999999
Q ss_pred CCCCCHHHHHHH
Q 021774 243 SRRPQMNQVIKM 254 (307)
Q Consensus 243 ~~RPs~~~v~~~ 254 (307)
.+||++.++++.
T Consensus 203 ~~R~~~~~l~~~ 214 (215)
T cd00180 203 EKRPSAKEILEH 214 (215)
T ss_pred ccCcCHHHHhhC
Confidence 999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=222.84 Aligned_cols=216 Identities=26% Similarity=0.299 Sum_probs=169.4
Q ss_pred CCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 7 GRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 7 g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+.+|||+++.. .....+.-..|-++|.-. +-|.++.+..+|..-+.+|+||||+.||+|--.+ .+-+++.+
T Consensus 374 dELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhi----QQ~GkFKE 449 (683)
T KOG0696|consen 374 DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGKFKE 449 (683)
T ss_pred chhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHH----HHhcccCC
Confidence 456899999865 234445566788888777 5667888888888889999999999999997666 35567888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+.-++.+||-||-+||++ ||+.||||.+||||+.+|++||+|||+++.--- ....+..+.||+.|+|||++..+
T Consensus 450 p~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~~~TTkTFCGTPdYiAPEIi~Yq 525 (683)
T KOG0696|consen 450 PVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-DGVTTKTFCGTPDYIAPEIIAYQ 525 (683)
T ss_pred chhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc-CCcceeeecCCCcccccceEEec
Confidence 88999999999999999999 999999999999999999999999999974221 22335668999999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
+|+.++|.||||++||||+.|++||..... ..+.+.+.... ..++.....+...+....+-.+|
T Consensus 526 PYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~aI~ehn-------------vsyPKslSkEAv~ickg~ltK~P 589 (683)
T KOG0696|consen 526 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQAIMEHN-------------VSYPKSLSKEAVAICKGLLTKHP 589 (683)
T ss_pred ccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHcc-------------CcCcccccHHHHHHHHHHhhcCC
Confidence 999999999999999999999999876433 22322222211 12333444456667666788888
Q ss_pred CCCC
Q 021774 243 SRRP 246 (307)
Q Consensus 243 ~~RP 246 (307)
.+|-
T Consensus 590 ~kRL 593 (683)
T KOG0696|consen 590 GKRL 593 (683)
T ss_pred cccc
Confidence 8884
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=235.54 Aligned_cols=239 Identities=18% Similarity=0.164 Sum_probs=145.9
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeE------EEeCCeeEEEEeccCCCCHHHHhccCCCC----
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGC------CVQGTRRILVYEYVENNSLDRVLLGATKA---- 76 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---- 76 (307)
|..||+|++...... ..+..+ .+....+.++..++.. .......++||||+.+++|.+++......
T Consensus 161 ~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~ 236 (566)
T PLN03225 161 EGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236 (566)
T ss_pred CcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHH
Confidence 789999987743221 111111 1222222222222221 23556789999999999999988532210
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccc
Q 021774 77 ------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHI 143 (307)
Q Consensus 77 ------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~ 143 (307)
........+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++..+.......
T Consensus 237 ~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~ 313 (566)
T PLN03225 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI 313 (566)
T ss_pred HHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC
Confidence 01112344668999999999999999 9999999999999986 5789999999998665443334
Q ss_pred cccccCCCCcCCcccccCC----------------------cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHH-
Q 021774 144 TTRIAGTTGYLAPEYVLGG----------------------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE- 200 (307)
Q Consensus 144 ~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~- 200 (307)
.....+++.|+|||.+... .++.++|||||||++|||+++..++..........+..
T Consensus 314 ~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~ 393 (566)
T PLN03225 314 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN 393 (566)
T ss_pred CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhc
Confidence 4556788999999965322 23456799999999999999765533221111100000
Q ss_pred ----HHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 201 ----WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 201 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..|.............. .............+|+.+|++.||++|||+.++++
T Consensus 394 ~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 394 DYDLVAWRKLVEPRASPDLRR-GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred CCcHHHHHHhhccccchhhhh-hhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 00000000000000000 00000111223457899999999999999999976
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=214.59 Aligned_cols=234 Identities=26% Similarity=0.323 Sum_probs=172.8
Q ss_pred CCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 7 GRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 7 g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
+++||+|++... .....++..+|..++..++|+||++++.++.-.. ..|+|||+++. +|.+.+. .
T Consensus 41 ~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~------~ 113 (369)
T KOG0665|consen 41 GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL------M 113 (369)
T ss_pred cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH------H
Confidence 678999977643 3344567789999999999999999999997544 45899999955 8888873 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.++...+..++.|++.|+.|||+. ||+||||||+||++..+..+||.|||+++.-... ...+....+..|.|||+
T Consensus 114 elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapev 188 (369)
T KOG0665|consen 114 ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEV 188 (369)
T ss_pred hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchh
Confidence 567788999999999999999999 9999999999999999999999999999854433 23455567888999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchh----------------HHHHHHHHHHhhcCCcc-------ccc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN----------------KFLLEWAWQLHQEEKPL-------ELV 215 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~-------~~~ 215 (307)
+.+-.+.+.+||||+||++.||++|..-|.+...-++ ..+...+..... .... +.+
T Consensus 189 il~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~-~~~~y~~~~f~~~f 267 (369)
T KOG0665|consen 189 ILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE-NRPQYQAISFSELF 267 (369)
T ss_pred eeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh-cChHhhccchhhhC
Confidence 9988899999999999999999999865442211000 011111111111 0000 111
Q ss_pred CCC----CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 216 DPE----LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 216 ~~~----~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
... ..+..+-......+++.+|+..+|++|-++++++.
T Consensus 268 pD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 268 PDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred CcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 01222233444667888999999999999999876
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=228.97 Aligned_cols=179 Identities=23% Similarity=0.299 Sum_probs=148.6
Q ss_pred EEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 9 RIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 9 ~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
.+|.|.+.+.+ .....+...|-.||..-+.+-||++|..|.+.+.+|+||+|++||++-.+| -..+.|.+..+
T Consensus 656 lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLL----IrmgIFeE~LA 731 (1034)
T KOG0608|consen 656 LYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMGIFEEDLA 731 (1034)
T ss_pred HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHH----HHhccCHHHHH
Confidence 34555554432 333456778999999999999999999999999999999999999999988 34566888888
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccC---------CCC--ccc------------
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF---------PDN--ITH------------ 142 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~---------~~~--~~~------------ 142 (307)
.-++.++..|+.+.|.. |+|||||||+|||||.+|++||.||||+.-+ .+. ...
T Consensus 732 RFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~ 808 (1034)
T KOG0608|consen 732 RFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADI 808 (1034)
T ss_pred HHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccc
Confidence 88999999999999999 9999999999999999999999999999532 100 000
Q ss_pred ------------------ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccch
Q 021774 143 ------------------ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM 194 (307)
Q Consensus 143 ------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 194 (307)
.....+||..|+|||++....|+..+|.||.|++||||+.|+.||-...+..
T Consensus 809 ~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 809 SKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred cccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 0123579999999999999999999999999999999999999998766644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-29 Score=224.82 Aligned_cols=238 Identities=21% Similarity=0.241 Sum_probs=157.6
Q ss_pred CCCCEEEEEEccccChHhHHHHH--------------HHHHHHhcCCCCCc-----cceeeEEEe--------CCeeEEE
Q 021774 5 TNGRRIAVKPLSAESKQGVREFI--------------TEIMTLSNVRHPNL-----VELIGCCVQ--------GTRRILV 57 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~--------------~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv 57 (307)
.+++.||||+++.......++|. .|+.++.+++|.++ ++++++|.. ....++|
T Consensus 184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV 263 (507)
T PLN03224 184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLV 263 (507)
T ss_pred ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEE
Confidence 35678999998765433333343 46666777765543 677777753 3467999
Q ss_pred EeccCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 021774 58 YEYVENNSLDRVLLGATK--------------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117 (307)
Q Consensus 58 ~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni 117 (307)
|||+.+++|.++++.... ....+++..+..++.|++.||.|||++ +++||||||+||
T Consensus 264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NI 340 (507)
T PLN03224 264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENL 340 (507)
T ss_pred EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhE
Confidence 999999999999854211 112356778899999999999999999 999999999999
Q ss_pred EECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc--------------------c--cccCceeehHH
Q 021774 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--------------------L--TMKADVYSFGV 175 (307)
Q Consensus 118 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--------------------~--~~~~Dv~slG~ 175 (307)
+++.++.++|+|||++..+............+++.|+|||.+.... + ..+.||||+||
T Consensus 341 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGv 420 (507)
T PLN03224 341 LVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGV 420 (507)
T ss_pred EECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHH
Confidence 9999999999999999765433222222234578999999875422 1 13479999999
Q ss_pred HHHHHHhCCC-CCCccccchhHHHHH-----HHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc---CCCC
Q 021774 176 LVLEIISGRN-SGKAMWGQMNKFLLE-----WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA---SRRP 246 (307)
Q Consensus 176 ~l~elltg~~-p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p---~~RP 246 (307)
++++|++|.. |+..... ....+.. ..|........ +-. ..........+++.+++..+| .+|+
T Consensus 421 il~em~~~~l~p~~~~~~-f~~~~~~~~~~~~~~r~~~~~~~----~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~Rl 492 (507)
T PLN03224 421 LLMQMCVPELRPVANIRL-FNTELRQYDNDLNRWRMYKGQKY----DFS---LLDRNKEAGWDLACKLITKRDQANRGRL 492 (507)
T ss_pred HHHHHHhCCCCCccchhh-hhhHHhhccchHHHHHhhcccCC----Ccc---cccccChHHHHHHHHHhccCCCCcccCC
Confidence 9999999875 4432110 1111100 01111111111 000 011223446777778888655 7899
Q ss_pred CHHHHHH
Q 021774 247 QMNQVIK 253 (307)
Q Consensus 247 s~~~v~~ 253 (307)
|+.|+++
T Consensus 493 Sa~eaL~ 499 (507)
T PLN03224 493 SVGQALS 499 (507)
T ss_pred CHHHHhC
Confidence 9999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-31 Score=252.61 Aligned_cols=196 Identities=16% Similarity=0.191 Sum_probs=137.7
Q ss_pred hcCCC-CCccceeeEE-------EeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 021774 34 SNVRH-PNLVELIGCC-------VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 105 (307)
Q Consensus 34 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 105 (307)
+.++| +||+.++++| .....+++++|++ +++|.+++.. ....+++..+..++.||++||.|||++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 34556 6888888887 3334667888987 6699999942 245589999999999999999999999
Q ss_pred CeeeCCCCCCcEEECCCC-------------------ceEEeeccCcccCCCCcc---------------cccccccCCC
Q 021774 106 HIVHRDIKASNILLDQEF-------------------NPKIGDFGLAKLFPDNIT---------------HITTRIAGTT 151 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~-------------------~~kl~dfg~~~~~~~~~~---------------~~~~~~~g~~ 151 (307)
||+||||||+||||+..+ .+|++|||+++....... .......||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999996544 455666666543211000 0011135788
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
.|+|||++.+..++.++|||||||++|||++|..|+..... ........ ...+.. ........
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~----~~~~~~~~ 242 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI----LLNWPKEA 242 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh----hhcCHHHH
Confidence 89999999999999999999999999999998876432111 11110000 011110 11123356
Q ss_pred HHHHhccccccCCCCCHHHHHH
Q 021774 232 KVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.++.+||+.+|.+||++.++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7788899999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-31 Score=211.14 Aligned_cols=180 Identities=27% Similarity=0.408 Sum_probs=151.6
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||+|++... +-...+++.+|+.+|..++|.|++..++...-.. ..|+++|++.. +|...+ ..-
T Consensus 76 RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKII----VSP 150 (449)
T KOG0664|consen 76 RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKII----VSP 150 (449)
T ss_pred CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhhee----ccC
Confidence 57999999988754 3344578999999999999999999988766443 44788888844 787776 455
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..++...+.-+++||++||.|||+. +|+||||||.|+|+++|..+||||||+++....+....++..+-|..|.|||
T Consensus 151 Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPE 227 (449)
T KOG0664|consen 151 QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPE 227 (449)
T ss_pred CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHH
Confidence 6788889999999999999999999 9999999999999999999999999999987666555566666788999999
Q ss_pred cccC-CcccccCceeehHHHHHHHHhCCCCCCcccc
Q 021774 158 YVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWG 192 (307)
Q Consensus 158 ~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 192 (307)
.++| ..|+.+.||||.||++.||+..+..|....+
T Consensus 228 iLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 228 LLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred HhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 9988 5799999999999999999988776655444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=208.25 Aligned_cols=221 Identities=26% Similarity=0.349 Sum_probs=172.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
++.+.+|+|+++++ +.+.++=.+.|-.+..+- +||.+|.+..+|..+...++|.||++||+|--.+ ....++
T Consensus 273 ~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhm----qrqrkl 348 (593)
T KOG0695|consen 273 KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKL 348 (593)
T ss_pred ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeeh----hhhhcC
Confidence 45678899988865 334455566777777776 8999999999999999999999999999986655 355679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
+++.+.-+...|..||.|||+. ||+.||||.+||||+..|.+||.|||.++.--. ....+..++||+.|.|||.++
T Consensus 349 peeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~-~gd~tstfcgtpnyiapeilr 424 (593)
T KOG0695|consen 349 PEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILR 424 (593)
T ss_pred cHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC-CCcccccccCCCcccchhhhc
Confidence 9999999999999999999999 999999999999999999999999999985322 233466789999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCcc-----ccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAM-----WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
+..|....|.|+||++++||+.|+.||..- .....+++.+.+..... ..+.....+...+++
T Consensus 425 geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-------------riprslsvkas~vlk 491 (593)
T KOG0695|consen 425 GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-------------RIPRSLSVKASHVLK 491 (593)
T ss_pred ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-------------cccceeehhhHHHHH
Confidence 999999999999999999999999998532 22233344443333221 111222223444555
Q ss_pred hccccccCCCC
Q 021774 236 FCTQAAASRRP 246 (307)
Q Consensus 236 ~c~~~~p~~RP 246 (307)
.-++.||.+|-
T Consensus 492 gflnkdp~erl 502 (593)
T KOG0695|consen 492 GFLNKDPKERL 502 (593)
T ss_pred HhhcCCcHHhc
Confidence 56888998874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=197.11 Aligned_cols=168 Identities=21% Similarity=0.204 Sum_probs=125.6
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc
Q 021774 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 143 (307)
Q Consensus 64 ~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 143 (307)
|+|.+++.. .+..+++..++.++.|++.||+|||++ + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999832 245699999999999999999999999 6 999999999999999 99988654421
Q ss_pred cccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCC
Q 021774 144 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP 223 (307)
Q Consensus 144 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (307)
..|+..|+|||++.+..++.++|||||||++|||+||+.|+....... ..+...... .... ++......
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~-~~~~------~~~~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNG-MPAD------DPRDRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHH-hccC------CccccccH
Confidence 257899999999999999999999999999999999999986433211 111111111 1100 00000111
Q ss_pred HHHHH--HHHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 224 PNEII--RYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 224 ~~~~~--~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
..... .+.+++.+||+.+|.+||++.++++.+....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 12222 5889999999999999999999999886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=200.69 Aligned_cols=177 Identities=34% Similarity=0.482 Sum_probs=153.9
Q ss_pred CCCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC-CCHH
Q 021774 6 NGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK-LNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~-~~~~ 83 (307)
+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++++|.+++... .. +++.
T Consensus 23 ~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~ 98 (225)
T smart00221 23 TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK----GGKLSEE 98 (225)
T ss_pred CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc----ccCCCHH
Confidence 4789999999876544 5678999999999999999999999999999999999999999999998432 22 7899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc-cCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV-LGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~ 162 (307)
.+..++.+++.++.+||++ +++|+||+|.||+++.++.++|+|||.+...............++..|++||.+ ...
T Consensus 99 ~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 175 (225)
T smart00221 99 EARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGK 175 (225)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCC
Confidence 9999999999999999999 999999999999999999999999999987755431123345677889999988 666
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKA 189 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~ 189 (307)
.++.++|+|+||+++++|++|+.||..
T Consensus 176 ~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 176 GYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 778899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=191.06 Aligned_cols=174 Identities=23% Similarity=0.390 Sum_probs=144.2
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+.|.++|+||+++.... +...+|+.+|+.|. ||||+++++...+. ....+|+|++.+.+...+. ..+
T Consensus 60 ~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl 129 (338)
T KOG0668|consen 60 ITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTL 129 (338)
T ss_pred cCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-------hhh
Confidence 56789999999996543 56788999999995 99999999998765 4667999999988877765 236
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+...+...+.+++.||.|+|+. ||.|||+||.|+|||... .++|+|+|++.++..... -...+.+..|--||.+
T Consensus 130 ~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e--YnVRVASRyfKGPELL 204 (338)
T KOG0668|consen 130 TDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELL 204 (338)
T ss_pred chhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce--eeeeeehhhcCCchhe
Confidence 6777888999999999999999 999999999999998654 599999999998765322 2334456678899988
Q ss_pred cC-CcccccCceeehHHHHHHHHhCCCCCCcccc
Q 021774 160 LG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWG 192 (307)
Q Consensus 160 ~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 192 (307)
.. +.|+..-|+|||||++..|+..+.||....+
T Consensus 205 Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 205 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred eechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 76 5688999999999999999999999765443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=196.64 Aligned_cols=229 Identities=16% Similarity=0.269 Sum_probs=166.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeE-EEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGC-CVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+...+|+|.+...-. ..++|.+|..---.| .|.||+.-|++ |...+..++++||++.|+|.+.+. ...+.+.
T Consensus 48 s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~-----~~GigE~ 121 (378)
T KOG1345|consen 48 SKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE-----AAGIGEA 121 (378)
T ss_pred CceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC-----cccccHH
Confidence 456789998875533 346899999877777 69999998876 455667789999999999998872 2457788
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CC-CceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
...+++.|++.||.|+|++ ++||||||.+||||- .+ .+|||||||+....+.. ......+..|.+||....
T Consensus 122 ~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~ 194 (378)
T KOG1345|consen 122 NTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDT 194 (378)
T ss_pred HHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhh
Confidence 8899999999999999999 999999999999993 33 46999999999865432 222334567999997643
Q ss_pred ---C--cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 162 ---G--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 162 ---~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
+ ...+.+|+|.||+++|.++||+.||+..+..+..+..-..|.......... .+..+. .+++++.++
T Consensus 195 ~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~----~F~~fs----~~a~r~Fkk 266 (378)
T KOG1345|consen 195 VVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK----KFNPFS----EKALRLFKK 266 (378)
T ss_pred ccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch----hhcccC----HHHHHHHHH
Confidence 2 346789999999999999999999986655554444333333332222211 112233 346677777
Q ss_pred ccccccCCCCCHHHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIKML 255 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L 255 (307)
-+..++++|--..++.++.
T Consensus 267 ~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 267 SLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hcCCcccccchhHHHHHHH
Confidence 8999999995555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=215.55 Aligned_cols=235 Identities=21% Similarity=0.252 Sum_probs=176.7
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCC------CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVR------HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
|..||||++.... -..+.-+.|+++|++|+ .-|.++++-.|...+++|+|||-+ ..+|.++|... ..+..|
T Consensus 457 ~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL 533 (752)
T KOG0670|consen 457 GQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGL 533 (752)
T ss_pred CCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHh-Ccccce
Confidence 7799999998542 23345678999999994 348999999999999999999998 56899998553 345568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
....+..++.|+.-||..|-.. ||+|.||||+|||++++. .+||||||.+........ +. ..-+..|.|||++
T Consensus 534 ~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei--tP-YLVSRFYRaPEIi 607 (752)
T KOG0670|consen 534 HIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEI--TP-YLVSRFYRAPEII 607 (752)
T ss_pred eehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccc--cH-HHHHHhccCccee
Confidence 8889999999999999999998 999999999999998775 489999999987655422 11 1123469999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHh--------hcCC---------------------
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH--------QEEK--------------------- 210 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~--------------------- 210 (307)
.|.+|+..-|+||.||+||||+||+..|.+... ...+....... +.+.
T Consensus 608 LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN---N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT 684 (752)
T KOG0670|consen 608 LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN---NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVT 684 (752)
T ss_pred ecCcccCCccceeeceeeEEeeccceecCCCCc---HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccc
Confidence 999999999999999999999999976654332 11211111110 0000
Q ss_pred ------cccccC------------CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 211 ------PLELVD------------PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 211 ------~~~~~~------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+...+. +.+.+-.+..+..+.+|+..|+..||++|-|..+.++
T Consensus 685 ~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 685 EREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred cceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 000011 1233444567788899999999999999999987764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=218.72 Aligned_cols=230 Identities=24% Similarity=0.362 Sum_probs=183.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
..|+..|+|+++.+......-.++|+-+++..+||||+.+++.+...+..++.||||.||+|++.- ...+.+++.+
T Consensus 38 ~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy----~~Tgplselq 113 (829)
T KOG0576|consen 38 RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY----HVTGPLSELQ 113 (829)
T ss_pred ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccccee----eecccchhHH
Confidence 347789999999877666777889999999999999999999999999999999999999999986 3567899999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc---C
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---G 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~ 161 (307)
+..+....++||+|||++ |-+|||||-.||++++.|.+|++|||.+-.+.... .....+.||+.|||||+.. .
T Consensus 114 iayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~KrksfiGtpywmapEvaaverk 189 (829)
T KOG0576|consen 114 IAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERK 189 (829)
T ss_pred HHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhc
Confidence 999999999999999999 99999999999999999999999999997665432 2356788999999999763 4
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
+.|...+|||++|+..-|+---++|-....+.....++ ....-.+...-| .......+.++++.|+-.+
T Consensus 190 ggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-----TkS~~qpp~lkD------k~kws~~fh~fvK~altkn 258 (829)
T KOG0576|consen 190 GGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-----TKSGFQPPTLKD------KTKWSEFFHNFVKGALTKN 258 (829)
T ss_pred ccccccccccccccchhhhhhcCCcccccchHHHHHHh-----hccCCCCCcccC------CccchHHHHHHHHHHhcCC
Confidence 67899999999999999997777664433322111111 111111111112 2234445777888899999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++||+++.++.
T Consensus 259 pKkRptaeklL~ 270 (829)
T KOG0576|consen 259 PKKRPTAEKLLQ 270 (829)
T ss_pred CccCCChhhhee
Confidence 999999987763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=209.24 Aligned_cols=173 Identities=25% Similarity=0.330 Sum_probs=146.4
Q ss_pred CCCEEEEEEccccC----hHhHH----HHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEecc-CCCCHHHHhccC
Q 021774 6 NGRRIAVKPLSAES----KQGVR----EFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVYEYV-ENNSLDRVLLGA 73 (307)
Q Consensus 6 ~g~~vavK~~~~~~----~~~~~----~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~ 73 (307)
+...|+||.+.++. .+..+ -.-.|+.+|..++ |+||++++++|++++.+|++||.. +|.+|.+++
T Consensus 585 n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~I--- 661 (772)
T KOG1152|consen 585 NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFI--- 661 (772)
T ss_pred cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhh---
Confidence 45689999887642 22111 1346999999996 999999999999999999999977 456788887
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCc
Q 021774 74 TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 153 (307)
Q Consensus 74 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 153 (307)
.-...+++.....|+.||+.|+++||++ ||+|||||-+||.++.+|-+||+|||.+.+..+.. ...++||..|
T Consensus 662 -E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp---fd~f~gtv~~ 734 (772)
T KOG1152|consen 662 -EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDY 734 (772)
T ss_pred -hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhcCCC---cceeeeeccc
Confidence 4556799999999999999999999999 99999999999999999999999999998765432 4567899999
Q ss_pred CCcccccCCccc-ccCceeehHHHHHHHHhCCCCCC
Q 021774 154 LAPEYVLGGQLT-MKADVYSFGVLVLEIISGRNSGK 188 (307)
Q Consensus 154 ~aPE~~~~~~~~-~~~Dv~slG~~l~elltg~~p~~ 188 (307)
.|||++.|.+|- ..-|||++|++||-++....|+.
T Consensus 735 aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 735 AAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999998885 56799999999999988777754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=195.61 Aligned_cols=109 Identities=28% Similarity=0.442 Sum_probs=89.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC--------CCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhcc
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR--------HPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLG 72 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~ 72 (307)
.+.+.||+|+.+.. ....+..+.|+.+|++++ ..+||++++.|.. ..+.|+|+|++ |-+|..++..
T Consensus 101 q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~ 178 (590)
T KOG1290|consen 101 QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY 178 (590)
T ss_pred cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH
Confidence 34678999988843 233355678999999882 2479999999974 45889999999 7788888853
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 021774 73 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119 (307)
Q Consensus 73 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill 119 (307)
.....++...+.+|+.||+.||.|||.++ ||||-||||+|||+
T Consensus 179 --s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 179 --SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred --hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 34456888999999999999999999885 99999999999999
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=187.86 Aligned_cols=248 Identities=18% Similarity=0.202 Sum_probs=181.7
Q ss_pred CEEEEEEccccChHhHHHHHHHHHHHhcCC----CCCccceeeEE-EeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 8 RRIAVKPLSAESKQGVREFITEIMTLSNVR----HPNLVELIGCC-VQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 8 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..+|+|............+..|..++..+. .+++..+++.. ......++||+.+ |.+|.++..... ...++.
T Consensus 45 ~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~ 121 (322)
T KOG1164|consen 45 KEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSR 121 (322)
T ss_pred eeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCH
Confidence 468888777653332236778888888886 36899999999 4777889999999 889999884433 578999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-----CceEEeeccCcc--cCCCCccc----c---ccccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-----FNPKIGDFGLAK--LFPDNITH----I---TTRIA 148 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~dfg~~~--~~~~~~~~----~---~~~~~ 148 (307)
.+++.++.|++.+|.+||+. |++||||||.|+++... ..++|.|||+++ .+...... . .....
T Consensus 122 ~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r 198 (322)
T KOG1164|consen 122 KTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR 198 (322)
T ss_pred hHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence 99999999999999999999 99999999999999765 459999999998 43222211 1 23456
Q ss_pred CCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 149 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
||..|.++.++.+...+++.|+||+++++.||+.|..||............. ......... . .....+.+..
T Consensus 199 GT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---~~~~~~~~~----~-~~~~~~~~~~ 270 (322)
T KOG1164|consen 199 GTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---KDPRKLLTD----R-FGDLKPEEFA 270 (322)
T ss_pred CccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---HHhhhhccc----c-ccCCChHHHH
Confidence 9999999999999999999999999999999999999996655432211111 111111110 0 2333445555
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhccccCccccCCCCCc
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF 272 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~ 272 (307)
.+... +-..+..++|.+..+...+.............|..|
T Consensus 271 ~~~~~---~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw 311 (322)
T KOG1164|consen 271 KILEY---IDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW 311 (322)
T ss_pred HHHHH---hhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence 55544 556899999999999999987776543333333333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=184.79 Aligned_cols=228 Identities=21% Similarity=0.355 Sum_probs=171.6
Q ss_pred CCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 7 GRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 7 g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
|..+++|+++.. +...-++|.+|.-.|+.+.||||+.+++.|....+..+|..|++.|||.+++++ ..+...+..+
T Consensus 213 gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sq 290 (448)
T KOG0195|consen 213 GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQ 290 (448)
T ss_pred CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc--CccEEEecch
Confidence 446777877654 233446899999999999999999999999999999999999999999999964 4556678889
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEe--eccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG--DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+++.++++|++|||+..+ -|.--.|.+..++||++.+++|+ |--.+. ........+.|++||.++..
T Consensus 291 av~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf--------qe~gr~y~pawmspealqrk 361 (448)
T KOG0195|consen 291 AVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRK 361 (448)
T ss_pred HHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee--------eccccccCcccCCHHHHhcC
Confidence 99999999999999999742 34455789999999999887764 322111 12223446789999998775
Q ss_pred cc---cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 163 QL---TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 163 ~~---~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+- -+++|+|||++++|||.|...||....+-+- ..+..-++ .....++.....+.+++.-|+.
T Consensus 362 ped~n~raadmwsfaillwel~trevpfadlspmec------gmkialeg--------lrv~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 362 PEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKIALEG--------LRVHIPPGISRHMNKLMNICMN 427 (448)
T ss_pred chhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhhhhcc--------ccccCCCCccHHHHHHHHHHhc
Confidence 43 3679999999999999999999876544211 11111111 1123345555566677777999
Q ss_pred cccCCCCCHHHHHHHHHhcc
Q 021774 240 AAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~~~~ 259 (307)
.||.+||.+..|+-.|++..
T Consensus 428 edpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 428 EDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCcCCCcceehhhHHHhc
Confidence 99999999999999998753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=181.25 Aligned_cols=242 Identities=20% Similarity=0.262 Sum_probs=192.8
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+-+++.||||.-...+. +.++..|++.++.| ..++|..+|-|.....+-.+|+|++ |.||++++ ...+..|+.
T Consensus 50 l~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLF---D~CgR~FSv 123 (449)
T KOG1165|consen 50 LYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLF---DLCGRRFSV 123 (449)
T ss_pred cccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHH---HHhcCcccH
Confidence 56788999997775543 35678899999998 6899999998888888889999999 99999998 567888999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-----CceEEeeccCcccCCCCccc------ccccccCCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-----FNPKIGDFGLAKLFPDNITH------ITTRIAGTT 151 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~ 151 (307)
.+++.++.|++.-++|+|++ .+|.|||||+|+||..- ..+.++|||+++.+-+..+. ..+..-||.
T Consensus 124 KTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTA 200 (449)
T KOG1165|consen 124 KTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTA 200 (449)
T ss_pred HhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccce
Confidence 99999999999999999999 99999999999999543 34899999999988654333 345677999
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
+||+-..+.+...+...|+-|||-++++.|-|..||+.......+.-.+.+....+...+. .++...|.++...+
T Consensus 201 RYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~-----~Lc~g~P~efa~Yl 275 (449)
T KOG1165|consen 201 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE-----VLCEGFPEEFATYL 275 (449)
T ss_pred eeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH-----HHHhcCHHHHHHHH
Confidence 9999999999999999999999999999999999998876655444433333322222221 13444566777776
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+.++ ..+-.+-|.++-+...+..++...
T Consensus 276 ~yvR---~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 276 RYVR---RLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HHHH---hcCcccCCCHHHHHHHHHHHHHhc
Confidence 6644 457777899999988888777543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=180.24 Aligned_cols=175 Identities=28% Similarity=0.406 Sum_probs=143.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
..+.||+|.+...+. -.+...|+++|..+ -+.||+++.+++..++...+|+||++.....++.. .++...
T Consensus 63 ~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~ 133 (418)
T KOG1167|consen 63 KRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR-------SLSLAE 133 (418)
T ss_pred ccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh-------cCCHHH
Confidence 467899999886542 24588999999999 69999999999999999999999999988888872 356788
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCC------------------------
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDN------------------------ 139 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~------------------------ 139 (307)
+...++.++.||+++|.+ ||+||||||+|++.+.. +.-.|+|||++......
T Consensus 134 i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~ 210 (418)
T KOG1167|consen 134 IRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHC 210 (418)
T ss_pred HHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccc
Confidence 899999999999999999 99999999999999754 56889999999721100
Q ss_pred -------------------cccccccccCCCCcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCcccc
Q 021774 140 -------------------ITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWG 192 (307)
Q Consensus 140 -------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 192 (307)
.........||++|.|||++.. ...+++.||||.|+++.-+++++.||.....
T Consensus 211 ~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 211 QSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred cccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCcc
Confidence 0001123569999999998876 4568899999999999999999999765444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=168.29 Aligned_cols=240 Identities=18% Similarity=0.237 Sum_probs=185.7
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+.+|+.||+|+-.....+ .++..|..+...|+ ...|..+..+..+...-.+||+++ |.||++++. .....++.
T Consensus 37 i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfn---fC~R~ftm 110 (341)
T KOG1163|consen 37 ITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFN---FCSRRFTM 110 (341)
T ss_pred ccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHH---HHhhhhhH
Confidence 578999999988755433 45788999999995 467888888888888999999999 999999984 34567999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CceEEeeccCcccCCCCccc------ccccccCCCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITH------ITTRIAGTTGY 153 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y 153 (307)
.+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.|+|||+++.+-+.... ......||.+|
T Consensus 111 kTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRY 187 (341)
T KOG1163|consen 111 KTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARY 187 (341)
T ss_pred HhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeee
Confidence 99999999999999999999 99999999999999543 46999999999987654322 23456799999
Q ss_pred CCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 154 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 154 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
.+-..+.+...+...|+-|+|+++.++.-|..||+.........-.+.+.+......+. .++...|. ++...
T Consensus 188 ASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie-----~LC~G~P~---EF~my 259 (341)
T KOG1163|consen 188 ASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE-----VLCKGFPA---EFAMY 259 (341)
T ss_pred hhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH-----HHhCCCcH---HHHHH
Confidence 99998888888999999999999999999999999877655544444443333222221 12222333 34445
Q ss_pred HHhccccccCCCCCHHHHHHHHHhccc
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+.-|-..--++-|....+.+...-+++
T Consensus 260 l~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 260 LNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 555888888889998887776655544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=184.33 Aligned_cols=217 Identities=27% Similarity=0.378 Sum_probs=164.1
Q ss_pred HhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eeCC
Q 021774 33 LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI-VHRD 111 (307)
Q Consensus 33 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~d 111 (307)
|+.+.|.|+.+++|.+.++...+.|.+||.-|+|.+.+.. ....+++.-...++.+++.||+|||.. .| +|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4678999999999999999999999999999999999943 566789999999999999999999987 44 9999
Q ss_pred CCCCcEEECCCCceEEeeccCcccCCCC-cccccccccCCCCcCCcccccCCc-------ccccCceeehHHHHHHHHhC
Q 021774 112 IKASNILLDQEFNPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQ-------LTMKADVYSFGVLVLEIISG 183 (307)
Q Consensus 112 lkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~elltg 183 (307)
++++|++++....+||+|||+....... .............|.|||.+.+.. .+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999999876531 011111122345699999887631 46679999999999999999
Q ss_pred CCCCCccccchhH-HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 184 RNSGKAMWGQMNK-FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 184 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
..||......... .+...+.. .....+.|.+.... .....+..++..||..+|.+||++..|...++.+...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9998775544332 22222212 11111222221111 2222588899999999999999999999988776653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=199.22 Aligned_cols=213 Identities=23% Similarity=0.301 Sum_probs=164.0
Q ss_pred HHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 021774 26 FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 105 (307)
Q Consensus 26 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 105 (307)
+..|+.+-..++|+|++..+..+.+....+-+||||++ +|..++. ....+....+-.++.|++.|+.|+|..
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~--- 439 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM--- 439 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---
Confidence 45577777778999998888777776666666999999 9999983 335688888999999999999999999
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc---cccccccCCCCcCCcccccCCcccc-cCceeehHHHHHHHH
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLGGQLTM-KADVYSFGVLVLEII 181 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~ell 181 (307)
|+.|||+|++|++++.+|.+||+|||.+..+..... .......|+..|+|||++.+..|++ ..||||.|+++..|.
T Consensus 440 GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~ 519 (601)
T KOG0590|consen 440 GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI 519 (601)
T ss_pred CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe
Confidence 999999999999999999999999999987654332 3456788999999999999999974 589999999999999
Q ss_pred hCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 182 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+|+.||.......+... . ....... .+.............+...++.++++.+|.+|-|+++|++
T Consensus 520 ~~~~~Wk~a~~~~~~~~-----~-~~~~~~~-~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 520 LGRFPWKVAKKSDNSFK-----T-NNYSDQR-NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cCCCccccccccccchh-----h-hcccccc-ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99999987765544320 0 0000000 0001111112233444667888899999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-20 Score=164.12 Aligned_cols=239 Identities=28% Similarity=0.392 Sum_probs=176.6
Q ss_pred CEEEEEEccccCh---HhHHHHHHHHHHHhcCCCC-CccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 8 RRIAVKPLSAESK---QGVREFITEIMTLSNVRHP-NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 8 ~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
..+++|.+..... .....+.+|+.++..+.|+ +++++++++......+++++++.++++.+++...... ..+...
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~ 101 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSES 101 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHH
Confidence 4578888876532 2467899999999999888 7999999998777789999999999999776322111 368899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCccc-----ccccccCCCCcCCcc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITH-----ITTRIAGTTGYLAPE 157 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~-----~~~~~~g~~~y~aPE 157 (307)
....++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+......... ......|+..|++||
T Consensus 102 ~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe 178 (384)
T COG0515 102 EALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178 (384)
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHH
Confidence 9999999999999999999 999999999999999998 7999999999865543322 235677899999999
Q ss_pred cccC---CcccccCceeehHHHHHHHHhCCCCCCccccc-hhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 158 YVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQ-MNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 158 ~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
.+.+ ..+....|+||+|++++++++|..|+...... ............... ........ .........+.++
T Consensus 179 ~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~ 254 (384)
T COG0515 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLASPLSP---SNPELISKAASDL 254 (384)
T ss_pred HhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccccccCc---cccchhhHHHHHH
Confidence 9987 57889999999999999999999985544321 011111111111111 00000000 0002223457778
Q ss_pred HHhccccccCCCCCHHHHHHH
Q 021774 234 AFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~ 254 (307)
+..|+..+|..|.+..+....
T Consensus 255 ~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 255 LKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCchhcCCHHHHhhc
Confidence 888999999999998877664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=168.91 Aligned_cols=139 Identities=22% Similarity=0.195 Sum_probs=106.7
Q ss_pred CCCEEEEEEcccc-----ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 6 NGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 6 ~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+|+.||||++... .......|.+|+++|++++|+|+++.+.. ....++||||++|++|.... ...
T Consensus 43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~~-----~~~-- 112 (365)
T PRK09188 43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLAR-----PHG-- 112 (365)
T ss_pred CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHhC-----ccc--
Confidence 5778899986532 22345678999999999999999853322 24579999999999997321 111
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEECCCCceEEeeccCcccCCCCcccc-------cccccCCCC
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDI-KASNILLDQEFNPKIGDFGLAKLFPDNITHI-------TTRIAGTTG 152 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~g~~~ 152 (307)
...++.++++||.|||++ ||+|||| ||+|||++.+++++|+|||+++.+....... .....++..
T Consensus 113 ----~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~ 185 (365)
T PRK09188 113 ----DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKR 185 (365)
T ss_pred ----hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCc
Confidence 146788999999999999 9999999 9999999999999999999999775432111 134567888
Q ss_pred cCCcccccC
Q 021774 153 YLAPEYVLG 161 (307)
Q Consensus 153 y~aPE~~~~ 161 (307)
|+|||.+.-
T Consensus 186 ~~~pe~~~~ 194 (365)
T PRK09188 186 TYAPDALTP 194 (365)
T ss_pred cCCcccCCh
Confidence 999998854
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-23 Score=190.93 Aligned_cols=230 Identities=22% Similarity=0.254 Sum_probs=158.5
Q ss_pred ccCCCCEEEEEEccccC-hHhHHHHHHHHHHHh--cCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 3 TLTNGRRIAVKPLSAES-KQGVREFITEIMTLS--NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
+..+|. |+||++-... .-..+.|.++++-++ -+++||.+++.-+...++..|+|-+|... +|++.+ ....-
T Consensus 43 k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRl----STRPF 116 (1431)
T KOG1240|consen 43 KDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRL----STRPF 116 (1431)
T ss_pred cCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhh----ccchH
Confidence 445566 9999887654 333455555554444 44899999998888888888999999955 888887 22233
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCccc--CCCCcccccccccCC----CCc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL--FPDNITHITTRIAGT----TGY 153 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~--~~~~~~~~~~~~~g~----~~y 153 (307)
+...+...|+.|++.||..+|.. ||+|||||.+||||++-..+.|+||..-+. ++++.......+..| ..|
T Consensus 117 L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCY 193 (1431)
T KOG1240|consen 117 LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCY 193 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeee
Confidence 56667778999999999999999 999999999999999999999999987753 344333322222223 369
Q ss_pred CCcccccC----------Cc-ccccCceeehHHHHHHHHhC-CCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 154 LAPEYVLG----------GQ-LTMKADVYSFGVLVLEIISG-RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 154 ~aPE~~~~----------~~-~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
+|||.+.. .. .+++.||||+||++.||++- +++|... .+..+... . ....+..-..+.+
T Consensus 194 iAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~--~-~~~~e~~Le~Ied 264 (1431)
T KOG1240|consen 194 IAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSG--N-ADDPEQLLEKIED 264 (1431)
T ss_pred cChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhcc--C-ccCHHHHHHhCcC
Confidence 99997743 12 57789999999999999884 6665421 11111110 0 0000000000111
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~ 256 (307)
..+.+++..|++.||.+|-++++.++.-.
T Consensus 265 ------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 265 ------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 13667888899999999999999987643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=157.63 Aligned_cols=147 Identities=17% Similarity=0.234 Sum_probs=112.8
Q ss_pred CCCEEEEEEccccCh---HhHHH------HHHHHHHHhcCCCCCccceeeEEEeC--------CeeEEEEeccCCCCHHH
Q 021774 6 NGRRIAVKPLSAESK---QGVRE------FITEIMTLSNVRHPNLVELIGCCVQG--------TRRILVYEYVENNSLDR 68 (307)
Q Consensus 6 ~g~~vavK~~~~~~~---~~~~~------~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~ 68 (307)
++..+|||.+..... ..... +.+|++.+.+++|++|..+.+++... ...+++|||++|.+|.+
T Consensus 53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~ 132 (232)
T PRK10359 53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND 132 (232)
T ss_pred CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence 467899999986532 22222 57899999999999999999986643 34789999999999988
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccccccc
Q 021774 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 148 (307)
Q Consensus 69 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 148 (307)
+. .++. ....+++.+|..+|+. |++|||++|+||+++.++ ++|+|||............
T Consensus 133 ~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d----- 191 (232)
T PRK10359 133 MP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD----- 191 (232)
T ss_pred hh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH-----
Confidence 74 1222 2456999999999999 999999999999999988 9999999887553221110
Q ss_pred CCCCcCCcccccCCcccccCceeehHHHHHHHH
Q 021774 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181 (307)
Q Consensus 149 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell 181 (307)
.+.....+..++|+|+||+.+..+.
T Consensus 192 --------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 192 --------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --------HHHHHhHhcccccccceeEeehHHH
Confidence 0234445668999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=149.27 Aligned_cols=125 Identities=16% Similarity=0.166 Sum_probs=94.6
Q ss_pred ccCCCCEEEEEEccccChH--h-------HHH-----------------HHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 021774 3 TLTNGRRIAVKPLSAESKQ--G-------VRE-----------------FITEIMTLSNVRHPNLVELIGCCVQGTRRIL 56 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 56 (307)
...+|+.||||+++..... . ... ...|++.+.++.++++.....+... ..++
T Consensus 17 ~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~i 94 (190)
T cd05147 17 TTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK--SHVL 94 (190)
T ss_pred ECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec--CCEE
Confidence 3458999999999754211 0 112 2349999999988776443333222 2389
Q ss_pred EEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFL-HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 57 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
||||++|+++.... .....++...+..++.|++.+|.++ |+. ||+||||||+||+++ ++.++|+|||++..
T Consensus 95 VmE~i~g~~l~~~~----~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 95 VMEFIGDDGWAAPR----LKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred EEEEeCCCCCcchh----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 99999988776543 1234688999999999999999999 798 999999999999998 47899999999975
Q ss_pred CC
Q 021774 136 FP 137 (307)
Q Consensus 136 ~~ 137 (307)
..
T Consensus 167 ~~ 168 (190)
T cd05147 167 HD 168 (190)
T ss_pred CC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=155.86 Aligned_cols=196 Identities=22% Similarity=0.272 Sum_probs=137.0
Q ss_pred CCCCccceeeEEEe---------------------------CCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 021774 37 RHPNLVELIGCCVQ---------------------------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDIC 89 (307)
Q Consensus 37 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~ 89 (307)
.||||+.+.++|.+ ....|+||..++. +|..++ .....+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl-----~~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYL-----WTRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHH-----hcCCCchHHHHHHH
Confidence 59999999998864 2355899998855 999998 33446677788899
Q ss_pred HHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCC--ceEEeeccCcccCCCCccc-----ccccccCCCCcCCccccc
Q 021774 90 VGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEF--NPKIGDFGLAKLFPDNITH-----ITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 90 ~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~--~~kl~dfg~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~ 160 (307)
.|+++|+.|||++ |+.|||+|++||||. +++ .++|+|||.+---....-+ ......|+...||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999993 333 4789999988532221111 123355788899999886
Q ss_pred CCc------ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 161 GGQ------LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 161 ~~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
..+ .-.|+|.|+.|.+.||+++...||... +....+... ....+++..+......+.+++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~-------------Yqe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRT-------------YQESQLPALPSRVPPVARQLV 490 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhh-------------hhhhhCCCCcccCChHHHHHH
Confidence 521 246899999999999999999887641 111111100 011122222333334466777
Q ss_pred HhccccccCCCCCHHHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIKML 255 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L 255 (307)
...++.||.+|++..=....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 778999999999876444444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=155.46 Aligned_cols=213 Identities=17% Similarity=0.187 Sum_probs=134.1
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCC----------CCccceeeEEEe---------C---C-----ee
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRH----------PNLVELIGCCVQ---------G---T-----RR 54 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~~~---------~---~-----~~ 54 (307)
.+|+++|||+..... ....+.+.+|.-....+.+ -.++..++...- . + ..
T Consensus 35 ~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~ 114 (288)
T PF14531_consen 35 ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNR 114 (288)
T ss_dssp TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESE
T ss_pred cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehh
Confidence 458999999775432 3446778887766666432 223322333221 1 1 22
Q ss_pred EEEEeccCCCCHHHHhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeecc
Q 021774 55 ILVYEYVENNSLDRVLLG---ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 131 (307)
Q Consensus 55 ~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg 131 (307)
+++|+.+ -++|..++.. .......+....++.+..|+++.+++||.. |++|+||+|+|++++.+|.++|+||+
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcChH
Confidence 6788888 4588887521 112223355566778889999999999999 99999999999999999999999999
Q ss_pred CcccCCCCcccccccccCCCCcCCcccccC--------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHH
Q 021774 132 LAKLFPDNITHITTRIAGTTGYLAPEYVLG--------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW 203 (307)
Q Consensus 132 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 203 (307)
.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|++|..|+....+......
T Consensus 191 ~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----- 261 (288)
T PF14531_consen 191 SLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----- 261 (288)
T ss_dssp GEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----
T ss_pred HHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----
Confidence 88765442211 234567999996633 2578899999999999999999999876544221100
Q ss_pred HHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 204 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
.+..+. +.+..+..|+..+++.+|.+|
T Consensus 262 --------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred --------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 223333 666778888999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=142.21 Aligned_cols=164 Identities=18% Similarity=0.137 Sum_probs=122.6
Q ss_pred CCCEEEEEEccccCh----HhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 6 NGRRIAVKPLSAESK----QGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 6 ~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.|.+++.+.+..... -....+.+|+++|+++ +|+++++++++ +..+++|||+.|.+|..... .
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~----~---- 91 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP----R---- 91 (218)
T ss_pred CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh----h----
Confidence 567788777765432 1123588999999999 56889999886 44689999999999876541 1
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEECCCCceEEeeccCcccCCCCccc----c--------cccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDI-KASNILLDQEFNPKIGDFGLAKLFPDNITH----I--------TTRI 147 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~dfg~~~~~~~~~~~----~--------~~~~ 147 (307)
....++.|++.+|.++|++ ||+|||| ||.|||++.++.++|+|||++......... . ....
T Consensus 92 ---~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~ 165 (218)
T PRK12274 92 ---GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKR 165 (218)
T ss_pred ---hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHH
Confidence 1135778999999999999 9999999 799999999999999999999865433210 0 1123
Q ss_pred cCCCCcCCcccccCC-ccc-ccCceeehHHHHHHHHhCCCCC
Q 021774 148 AGTTGYLAPEYVLGG-QLT-MKADVYSFGVLVLEIISGRNSG 187 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~elltg~~p~ 187 (307)
..++.|++|+...-. ..+ ...+.++-|+.+|.++|++.+.
T Consensus 166 ~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 166 MYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 367778888755432 333 5668889999999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7e-21 Score=165.91 Aligned_cols=123 Identities=28% Similarity=0.450 Sum_probs=108.7
Q ss_pred eeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccC
Q 021774 53 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 132 (307)
Q Consensus 53 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~ 132 (307)
.+|+.|++|.-.+|.+++... ......++.....++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999543 344567888999999999999999 6 999999999999999999999999999
Q ss_pred cccCCCCc-----ccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh
Q 021774 133 AKLFPDNI-----THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182 (307)
Q Consensus 133 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt 182 (307)
........ ....+...||..||+||.+.++.|+.++||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98776554 334566789999999999999999999999999999999986
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=142.43 Aligned_cols=126 Identities=18% Similarity=0.209 Sum_probs=96.6
Q ss_pred ccCCCCEEEEEEccccChH--------------------------hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 021774 3 TLTNGRRIAVKPLSAESKQ--------------------------GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL 56 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 56 (307)
+..+|+.||||+++..... ....+..|++.+.++.|+++.....+.... .++
T Consensus 17 ~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~l 94 (190)
T cd05145 17 RTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLKK--NVL 94 (190)
T ss_pred EcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEecC--CEE
Confidence 3457999999998864210 012245789999999999875444443332 489
Q ss_pred EEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 57 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
||||++|+++..... ....++......++.|++.++.++|+ + |++||||||.||+++ ++.++|+|||++..
T Consensus 95 VmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~ 166 (190)
T cd05145 95 VMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVE 166 (190)
T ss_pred EEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEccccee
Confidence 999999886543321 22457788899999999999999999 9 999999999999998 88999999999986
Q ss_pred CCC
Q 021774 136 FPD 138 (307)
Q Consensus 136 ~~~ 138 (307)
...
T Consensus 167 ~~~ 169 (190)
T cd05145 167 LDH 169 (190)
T ss_pred cCC
Confidence 544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=161.24 Aligned_cols=171 Identities=27% Similarity=0.298 Sum_probs=144.4
Q ss_pred CCCCEEEEEEccccCh--HhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK--QGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+.|.-+|+|+++..+. ........|..++...+ ||.++++...+..+...+++.++..||.|...+ .....+.
T Consensus 20 da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l----~~~~~f~ 95 (612)
T KOG0603|consen 20 DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL----SKEVMFD 95 (612)
T ss_pred cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc----ccCCchH
Confidence 4567788888876531 11225677888888885 999999999999999999999999999988776 4555677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+.........++-|+.++|+. +++|||+|++||+++.+|.+++.|||+++..-... ..+||..|||||++.
T Consensus 96 ~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~~cgt~eymApEI~~- 166 (612)
T KOG0603|consen 96 ELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----IACGTYEYRAPEIIN- 166 (612)
T ss_pred HHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh-----hcccchhhhhhHhhh-
Confidence 788888899999999999999 99999999999999999999999999998654322 228899999999888
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKA 189 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~ 189 (307)
....++|.||||++.+||+||..||..
T Consensus 167 -gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 167 -GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 567889999999999999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.8e-18 Score=136.37 Aligned_cols=117 Identities=16% Similarity=0.207 Sum_probs=90.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcC-----CCCCccceeeEEEeCC---e-eEEEEec--cCCCCHHHHhccCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV-----RHPNLVELIGCCVQGT---R-RILVYEY--VENNSLDRVLLGAT 74 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~lv~e~--~~~~sL~~~l~~~~ 74 (307)
++.+ +||++........+.+.+|+.+++++ +||||+++++++..+. . ..+|+|| +.+++|.+++..
T Consensus 24 ~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-- 100 (210)
T PRK10345 24 DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-- 100 (210)
T ss_pred CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--
Confidence 3444 68887765444456799999999999 5799999999998874 3 3378999 557999999932
Q ss_pred CCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeeCCCCCCcEEECC----CCceEEeeccCc
Q 021774 75 KANIKLNWEKRSDICVGIAKGL-AFLHEELVPHIVHRDIKASNILLDQ----EFNPKIGDFGLA 133 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~dfg~~ 133 (307)
..+++. ..++.+++.++ +|||++ +|+||||||+||+++. +++++|+|++.+
T Consensus 101 ---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 101 ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 235555 35678888777 999999 9999999999999974 347999995444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=161.77 Aligned_cols=230 Identities=17% Similarity=0.175 Sum_probs=164.2
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+-.+|+.||||+-+..+.+...--.+-...|+-.--+.|..+..++.-.+..++|+||.+.|||.+++ .....++
T Consensus 717 a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~----N~~~~m~ 792 (974)
T KOG1166|consen 717 ATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLI----NTNKVMD 792 (974)
T ss_pred eecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhh----ccCCCCC
Confidence 455679999999999877654322222222222112455677777777788889999999999999998 3677899
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-------CCCceEEeeccCcccCCC-CcccccccccCCCCc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-------QEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGY 153 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-------~~~~~kl~dfg~~~~~~~-~~~~~~~~~~g~~~y 153 (307)
|..++.++.|++..+..||.. +||||||||+|+||. .+.-++|+|||.+--+.- .........++|-.+
T Consensus 793 e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f 869 (974)
T KOG1166|consen 793 EYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLF 869 (974)
T ss_pred chhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccc
Confidence 999999999999999999999 999999999999994 234499999999864421 112345667788899
Q ss_pred CCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCH-HHHHHHHH
Q 021774 154 LAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP-NEIIRYMK 232 (307)
Q Consensus 154 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (307)
-.+|+..|.+++...|.|+|+.+++-||.|+.- + ...+.. ...+..+..+.. +...+++.
T Consensus 870 ~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------------q-~~~g~~-~~~~~~~~Ry~~~~~W~~~F~ 930 (974)
T KOG1166|consen 870 DCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------------E-VKNGSS-WMVKTNFPRYWKRDMWNKFFD 930 (974)
T ss_pred hhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------------H-hcCCcc-eeccccchhhhhHHHHHHHHH
Confidence 999999999999999999999999999998531 1 111111 111121222222 22233443
Q ss_pred HHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 233 VAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+ .|+.|-..=|...++...|++.+.
T Consensus 931 ~---lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 931 L---LLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred H---HhCcCcccchhHHHHHHHHHHHHH
Confidence 3 566555556888888888887664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=132.08 Aligned_cols=122 Identities=20% Similarity=0.183 Sum_probs=93.1
Q ss_pred cCCCCEEEEEEccccChH------------------------hHHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEE
Q 021774 4 LTNGRRIAVKPLSAESKQ------------------------GVREFITEIMTLSNVRH--PNLVELIGCCVQGTRRILV 57 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 57 (307)
..+|+.||+|.++..... ....+..|++.+.++.+ ..+.+++++ ...++|
T Consensus 51 ~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV 126 (237)
T smart00090 51 DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLV 126 (237)
T ss_pred CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEE
Confidence 468999999988753210 11235689999999965 334455543 234899
Q ss_pred EeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeeCCCCCCcEEECCCCceEEeeccCcccC
Q 021774 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH-IVHRDIKASNILLDQEFNPKIGDFGLAKLF 136 (307)
Q Consensus 58 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 136 (307)
|||++|.+|.... .....+.......++.|++.+|++||++ | ++||||||+||+++ ++.++|+|||.+...
T Consensus 127 ~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 127 MEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999998887654 1233455666789999999999999999 9 99999999999999 889999999988754
Q ss_pred C
Q 021774 137 P 137 (307)
Q Consensus 137 ~ 137 (307)
.
T Consensus 199 ~ 199 (237)
T smart00090 199 D 199 (237)
T ss_pred C
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=128.23 Aligned_cols=118 Identities=22% Similarity=0.268 Sum_probs=98.5
Q ss_pred CCCEEEEEEccccC---h-----HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 6 NGRRIAVKPLSAES---K-----QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 6 ~g~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
+|..|++|...... . .....+.+|++++..+.|+++.....++...+..+++|||++|++|.+++...
T Consensus 18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~---- 93 (211)
T PRK14879 18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN---- 93 (211)
T ss_pred CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----
Confidence 67889999765432 1 11245778999999999999888777777888889999999999999998321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
.+ .+..++.+++.+|.++|+. +++|||++|.||+++ ++.++|+|||.+..
T Consensus 94 ---~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 94 ---GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ---cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 12 7888999999999999999 999999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.4e-16 Score=125.07 Aligned_cols=116 Identities=25% Similarity=0.318 Sum_probs=94.0
Q ss_pred CCCCEEEEEEccccC--------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|..|++|...... .....++.+|++++..+.|+++.....++...+..++||||++|++|.+++...
T Consensus 15 ~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~--- 91 (199)
T TIGR03724 15 FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEG--- 91 (199)
T ss_pred cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhc---
Confidence 467899999865321 112356778999999998887766666666777789999999999999987321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
.. .++.+++.+|.+||+. |++|||++|.||+++ ++.++++|||++..
T Consensus 92 -~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 92 -ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred -HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 10 7899999999999999 999999999999999 88999999998874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.6e-15 Score=124.41 Aligned_cols=119 Identities=23% Similarity=0.226 Sum_probs=91.8
Q ss_pred CCCEEEEEEccccC-------------hHhHHHHHHHHHHHhcCCCCCc--cceeeEEEeCC----eeEEEEeccCC-CC
Q 021774 6 NGRRIAVKPLSAES-------------KQGVREFITEIMTLSNVRHPNL--VELIGCCVQGT----RRILVYEYVEN-NS 65 (307)
Q Consensus 6 ~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~----~~~lv~e~~~~-~s 65 (307)
+|..++||.+.... ......+.+|++++.++.|++| +..+++..... ..++|||+++| .+
T Consensus 54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~ 133 (239)
T PRK01723 54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARD 133 (239)
T ss_pred CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCC
Confidence 47788999885321 1223467889999999988775 67777654332 23599999997 79
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccC
Q 021774 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136 (307)
Q Consensus 66 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 136 (307)
|.+++.. ..++.. .+.+++.+|.+||++ ||+||||||.|||++.++.++|+|||.+...
T Consensus 134 L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 134 LVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 9988732 234443 357899999999999 9999999999999999999999999988753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=121.84 Aligned_cols=120 Identities=20% Similarity=0.192 Sum_probs=91.7
Q ss_pred cccCCCCEEEEEEccccCh----------------------HhHHHHHHHHHHHhcCCCC--CccceeeEEEeCCeeEEE
Q 021774 2 GTLTNGRRIAVKPLSAESK----------------------QGVREFITEIMTLSNVRHP--NLVELIGCCVQGTRRILV 57 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv 57 (307)
+..++|+.||||++..... .....+..|+.++..+.|+ .++.+++ ....++|
T Consensus 34 ~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv 109 (198)
T cd05144 34 ALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WNRHAVV 109 (198)
T ss_pred EEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cCCceEE
Confidence 3456899999998664320 0112367789999999777 4444443 2445899
Q ss_pred EeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCC
Q 021774 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 137 (307)
Q Consensus 58 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 137 (307)
|||++|++|..+.. . .....++.+++.++.++|+. |++||||+|.||++++++.++|+|||.+....
T Consensus 110 ~e~~~g~~L~~~~~----~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 110 MEYIDGVELYRVRV----L------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEeCCcchhhccc----c------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999877641 0 23567889999999999999 99999999999999999999999999996544
Q ss_pred C
Q 021774 138 D 138 (307)
Q Consensus 138 ~ 138 (307)
.
T Consensus 177 ~ 177 (198)
T cd05144 177 H 177 (198)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.7e-17 Score=150.61 Aligned_cols=229 Identities=22% Similarity=0.261 Sum_probs=165.1
Q ss_pred CEEEEEEccccC--hHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 8 RRIAVKPLSAES--KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 8 ~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
..+|+|.+.... .....+...|..+-..+. |+|++.+++...+.+..++++++.+|+++...+.. ......+...
T Consensus 47 ~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~ 124 (601)
T KOG0590|consen 47 SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSS 124 (601)
T ss_pred ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcc
Confidence 345666555442 222334445777777776 99999999999999999999999999998877621 1111355556
Q ss_pred HHHHHHHHHHHHHHHh-cCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCC--CcccccccccC-CCCcCCcccc
Q 021774 85 RSDICVGIAKGLAFLH-EELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPD--NITHITTRIAG-TTGYLAPEYV 159 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~--~~~~~~~~~~g-~~~y~aPE~~ 159 (307)
.-..+.|+..++.|+| .. ++.|+|+||+|.+++.++ ..+++|||++..+.. ..........| +..|+|||..
T Consensus 125 ~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 125 ASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred hhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence 6778999999999999 88 999999999999999999 999999999987765 23334455667 9999999988
Q ss_pred cCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 LGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.+. ......|+||.|+++.-+++|..||........... .|.... ... -...........+.+..+++
T Consensus 202 ~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~~~~~---~~~-------~~~~~~~~~~~~~~~l~k~l 270 (601)
T KOG0590|consen 202 SGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SWKSNK---GRF-------TQLPWNSISDQAHDLLHKIL 270 (601)
T ss_pred cchhhcCCCcccccccccccccccCCCCccccccccccce-eecccc---ccc-------ccCccccCChhhhhcccccc
Confidence 874 456889999999999999999999887655432111 111010 000 00001112223566777788
Q ss_pred ccccCCCCCHHHHH
Q 021774 239 QAAASRRPQMNQVI 252 (307)
Q Consensus 239 ~~~p~~RPs~~~v~ 252 (307)
..+|..|.+.+++-
T Consensus 271 ~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 271 KENPSNRLSIEELK 284 (601)
T ss_pred cCCchhcccccccc
Confidence 89999999888774
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.9e-15 Score=137.89 Aligned_cols=97 Identities=26% Similarity=0.354 Sum_probs=87.5
Q ss_pred HHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 021774 23 VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEE 102 (307)
Q Consensus 23 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 102 (307)
..++.+|++++++++|++++....++......++||||++|++|.+++. ....++.+++.+|.+||+.
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~ 447 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA 447 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC
Confidence 3568899999999999999988888888778899999999999999882 3567899999999999999
Q ss_pred CCCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 103 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 103 ~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
+++||||||+||++ +++.++|+|||+++.
T Consensus 448 ---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 448 ---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999 678999999999975
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.6e-15 Score=125.51 Aligned_cols=202 Identities=21% Similarity=0.254 Sum_probs=141.3
Q ss_pred HHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 021774 31 MTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 105 (307)
Q Consensus 31 ~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 105 (307)
.-|.++.|-||+++..|+.+.+ ...+++||+..|++.++|+........+......+|+-||+.||.|||+. -|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3445667999999998887644 45789999999999999988777788888899999999999999999997 45
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCcccCCCC----cccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHH
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDN----ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell 181 (307)
.++|+++..+.|++..+|-+|+.-- ........ .........+.++|.+||.-..-..+.++|||+||.+..||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999998887532 11111111 111223345678899999777777888999999999999998
Q ss_pred hCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHH
Q 021774 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 252 (307)
Q Consensus 182 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~ 252 (307)
.+..-....... ...+.... ......-++. -..++..|++.+|..||++.+++
T Consensus 277 ilEiq~tnseS~---~~~ee~ia----~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 277 ILEIQSTNSESK---VEVEENIA----NVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HheeccCCCcce---eehhhhhh----hheeeccCcc-----------ccCcCcccccCCCCCCcchhhhh
Confidence 775431111110 00000000 0000000110 12355669999999999998876
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.9e-14 Score=126.94 Aligned_cols=165 Identities=19% Similarity=0.275 Sum_probs=126.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|.+|.|...+..+........+-+..|+.++||||+++++.+..+...|+|+|.+. .|..++.. +....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~ 105 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEE 105 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHH
Confidence 3588899998887766444567788999999999999999999999999999999884 46666621 22456
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..-+.||+.||.+||..+ +++|++|.-+.|+++..|..||++|.++........ ......-...|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6678899999999998543 999999999999999999999999998875443221 011111122466666443221
Q ss_pred cccCceeehHHHHHHHHhC
Q 021774 165 TMKADVYSFGVLVLEIISG 183 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg 183 (307)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=110.31 Aligned_cols=116 Identities=23% Similarity=0.261 Sum_probs=96.8
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRH--PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+..+++|....... ...+..|+..++.+++ .++++++++....+..+++|||++|+.+..+ +...
T Consensus 21 ~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~ 87 (155)
T cd05120 21 DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEE 87 (155)
T ss_pred CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHH
Confidence 46899998875433 4578899999999965 5899999988888889999999988766543 4566
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
...++.+++.+++++|.....+++|+|++|.||++++.+.++++|||.+..
T Consensus 88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777899999999999986333799999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.8e-15 Score=140.46 Aligned_cols=97 Identities=28% Similarity=0.415 Sum_probs=83.1
Q ss_pred HHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc--------------ccccccccCCCCcCCccc
Q 021774 93 AKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI--------------THITTRIAGTTGYLAPEY 158 (307)
Q Consensus 93 ~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--------------~~~~~~~~g~~~y~aPE~ 158 (307)
+.+++|||+. ||+|||+||+|.+|+.=|.+|+.|||+++...... ....+..+||+.|.|||+
T Consensus 153 vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 8899999999 99999999999999999999999999997421100 011244689999999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCcccc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWG 192 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 192 (307)
+..+.|...+|.|++|+++||.+-|..||....+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 9999999999999999999999999999876644
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-13 Score=110.22 Aligned_cols=118 Identities=22% Similarity=0.263 Sum_probs=83.8
Q ss_pred ccCCCCEEEEEEccccCh--HhHHHH----------------------HHHHHHHhcCCCC--CccceeeEEEeCCeeEE
Q 021774 3 TLTNGRRIAVKPLSAESK--QGVREF----------------------ITEIMTLSNVRHP--NLVELIGCCVQGTRRIL 56 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~--~~~~~~----------------------~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~l 56 (307)
...+|+.||||+++.... .....+ ..|.+.+.++.+. .+.+.+++ ...++
T Consensus 17 ~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~~~~l 92 (187)
T cd05119 17 LDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL----NRHVL 92 (187)
T ss_pred ECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec----CCCEE
Confidence 445799999998875421 111111 3566666666433 34555443 24589
Q ss_pred EEeccCCCCH-----HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeec
Q 021774 57 VYEYVENNSL-----DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDF 130 (307)
Q Consensus 57 v~e~~~~~sL-----~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~df 130 (307)
||||++++++ .+.. .. .....++.+++.++.++|. . +++|+||+|+||+++ ++.++|+||
T Consensus 93 v~e~~~g~~~~~~~l~~~~---------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 93 VMEFIGGDGIPAPRLKDVR---------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred EEEEeCCCCccChhhhhhh---------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEEC
Confidence 9999998543 3322 11 5577899999999999999 8 999999999999999 889999999
Q ss_pred cCcccCCC
Q 021774 131 GLAKLFPD 138 (307)
Q Consensus 131 g~~~~~~~ 138 (307)
|.+.....
T Consensus 159 g~a~~~~~ 166 (187)
T cd05119 159 PQAVEIDH 166 (187)
T ss_pred cccccccC
Confidence 99975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4e-13 Score=120.83 Aligned_cols=128 Identities=19% Similarity=0.288 Sum_probs=87.1
Q ss_pred cccCCCCEEEEEEccccChHhH----------------------------------------HHHHHHHHHHhcC----C
Q 021774 2 GTLTNGRRIAVKPLSAESKQGV----------------------------------------REFITEIMTLSNV----R 37 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~~e~~~l~~l----~ 37 (307)
|++++|+.||||+.+....... -+|.+|++.+.++ +
T Consensus 136 A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~ 215 (437)
T TIGR01982 136 ARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFK 215 (437)
T ss_pred EEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcC
Confidence 5788999999999876421110 0245566666655 2
Q ss_pred CCCccceeeEEE-eCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCCeeeCCCCCC
Q 021774 38 HPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAK-GLAFLHEELVPHIVHRDIKAS 115 (307)
Q Consensus 38 h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~~~i~H~dlkp~ 115 (307)
+.+-+.+-.++. ..+..++||||++|++|.++..... .... ...++..++. .+..+|.. |++|+|++|.
T Consensus 216 ~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~~---g~~H~D~hPg 286 (437)
T TIGR01982 216 NDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLRD---GFFHADLHPG 286 (437)
T ss_pred CCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHhC---CceeCCCCcc
Confidence 222222222222 2345689999999999988763211 1122 3346666665 47889999 9999999999
Q ss_pred cEEECCCCceEEeeccCcccCCC
Q 021774 116 NILLDQEFNPKIGDFGLAKLFPD 138 (307)
Q Consensus 116 Nill~~~~~~kl~dfg~~~~~~~ 138 (307)
||+++.+++++++|||++..+..
T Consensus 287 Nilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 287 NIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred cEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.3e-12 Score=100.89 Aligned_cols=98 Identities=18% Similarity=0.227 Sum_probs=74.8
Q ss_pred HHHHHHhcCCC--CCccceeeEEEeCCeeEEEEeccCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCC
Q 021774 28 TEIMTLSNVRH--PNLVELIGCCVQGTRRILVYEYVENNSLDR-VLLGATKANIKLNWEKRSDICVGIAKGLAFL-HEEL 103 (307)
Q Consensus 28 ~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~ 103 (307)
+|++.|+++.. -++++++++ ...++||||+.+..+.. .+ ....++......+..+++.+|..+ |..
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 79999999843 466777764 45689999997643322 22 122345556677889999999999 888
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCC
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 138 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 138 (307)
|++||||++.||+++ ++.++|+|||.+....+
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999999999997 46899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-12 Score=117.23 Aligned_cols=226 Identities=20% Similarity=0.217 Sum_probs=157.7
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.++..+|+|.-+.- .+....+=.+|+.-.+++ .|+|.++.+..+...+..++-+|++ +.+|..+.+ .....++
T Consensus 141 ~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~---~~~~~~p 216 (524)
T KOG0601|consen 141 ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCH---TPCNFLP 216 (524)
T ss_pred cCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhh---cccccCC
Confidence 56778899875433 223333445677777777 5999999888999999999999999 578888873 2334466
Q ss_pred HHHHHHHHHHHHH----HHHHHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCCccc----ccccccCCCC
Q 021774 82 WEKRSDICVGIAK----GLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITH----ITTRIAGTTG 152 (307)
Q Consensus 82 ~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~----~~~~~~g~~~ 152 (307)
...++..+.+... ||.++|.. +++|-|++|.||+...+ ..++++|||+...+...... ......|...
T Consensus 217 ~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~ 293 (524)
T KOG0601|consen 217 DNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCI 293 (524)
T ss_pred chhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCce
Confidence 6777777777777 99999999 99999999999999999 88999999999988664322 1233367788
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
|++||.. .+-++..+|+|++|.++.+-.++.......+.. .|...+. .. +..++.. .-..++..
T Consensus 294 Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~r~---~~-ip~e~~~---~~s~~l~~ 357 (524)
T KOG0601|consen 294 YAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQLRQ---GY-IPLEFCE---GGSSSLRS 357 (524)
T ss_pred EeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccccccc---cc-Cchhhhc---Ccchhhhh
Confidence 9999954 557789999999999999988875432211000 0111110 00 1111111 11222333
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+..+++.+|..|++.+.+..
T Consensus 358 ~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 358 VTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred HHHHhcCcchhhhhHHHHHhc
Confidence 666689999999998887653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.4e-12 Score=98.87 Aligned_cols=113 Identities=19% Similarity=0.119 Sum_probs=81.2
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|..|++|....... ....+..|+.+++.+.+.++ .+++.+. ....++|||+++|.++.... . .
T Consensus 20 ~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~---------~---~ 84 (170)
T cd05151 20 ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED---------F---S 84 (170)
T ss_pred CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc---------c---c
Confidence 467899998765432 12346789999998855444 4555443 33458999999998765421 0 1
Q ss_pred HHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 85 RSDICVGIAKGLAFLHEEL--VPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
...++.+++++|+.||+.. ..+++|||++|.||+++ ++.++++||+.+.
T Consensus 85 ~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 85 DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 1235679999999999982 11259999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.3e-11 Score=92.93 Aligned_cols=97 Identities=29% Similarity=0.366 Sum_probs=80.6
Q ss_pred HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 021774 24 REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 103 (307)
Q Consensus 24 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 103 (307)
.+..+|++++.++.--.|.-.+-+..+.+...++|||++|..|.+++... ...++..+-.-+.-||..
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~- 111 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA- 111 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc-
Confidence 35678999999986666665566677888888999999999999888322 256778888889999999
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
||+||||+++||++..+. +.++|||++..
T Consensus 112 --givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 112 --GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred --CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999999998765 99999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.6e-10 Score=97.00 Aligned_cols=125 Identities=13% Similarity=0.086 Sum_probs=92.4
Q ss_pred CCCEEEEEEccccCh-HhHH----------HHHHHHHHHhcCCCCC--ccceeeEEEe-----CCeeEEEEeccCCC-CH
Q 021774 6 NGRRIAVKPLSAESK-QGVR----------EFITEIMTLSNVRHPN--LVELIGCCVQ-----GTRRILVYEYVENN-SL 66 (307)
Q Consensus 6 ~g~~vavK~~~~~~~-~~~~----------~~~~e~~~l~~l~h~~--i~~~~~~~~~-----~~~~~lv~e~~~~~-sL 66 (307)
+|+.+.||......- +..+ .+.+|++.+.++...+ ++.++++... ....++|||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 577899997754431 1112 3778999998884333 3455666643 23568999999885 89
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-------CCceEEeeccCccc
Q 021774 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-------EFNPKIGDFGLAKL 135 (307)
Q Consensus 67 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------~~~~kl~dfg~~~~ 135 (307)
.+++.... ....+......++.+++..++.||.. |++|+|++++|||++. +..+.|+||+.+..
T Consensus 124 ~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99873221 23345667778999999999999999 9999999999999975 46799999998864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.3e-11 Score=109.22 Aligned_cols=102 Identities=14% Similarity=0.159 Sum_probs=64.8
Q ss_pred HHHHHHHHhcC----CCCCccceeeEEEe-CCeeEEEEeccCCCCHHHHhccCCCCCC---CCCHHHHHHHHHHHHHHHH
Q 021774 26 FITEIMTLSNV----RHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANI---KLNWEKRSDICVGIAKGLA 97 (307)
Q Consensus 26 ~~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~---~~~~~~~~~i~~~i~~~l~ 97 (307)
|.+|+..+.++ .+.+.+.+-.++.+ ....++||||++|+.+.++-.- ...+. .+....+..++.|
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Q------ 275 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQ------ 275 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHH------
Confidence 44555555554 24433443344433 4466899999999999875210 11111 2223333333333
Q ss_pred HHhcCCCCCeeeCCCCCCcEEECCCC----ceEEeeccCcccCCC
Q 021774 98 FLHEELVPHIVHRDIKASNILLDQEF----NPKIGDFGLAKLFPD 138 (307)
Q Consensus 98 ~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~dfg~~~~~~~ 138 (307)
+... |++|+|++|.||+++.++ +++++|||++..++.
T Consensus 276 -if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3456 999999999999999888 999999999987654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-10 Score=88.65 Aligned_cols=125 Identities=21% Similarity=0.302 Sum_probs=90.6
Q ss_pred CCCEEEEEEcccc---C-----hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC-CCHHHHhccCCCC
Q 021774 6 NGRRIAVKPLSAE---S-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGATKA 76 (307)
Q Consensus 6 ~g~~vavK~~~~~---~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~ 76 (307)
.|+.++||.--.. . .-...+..+|++.|.++.--.|.-..-++.+.....++|||++| .++.+++......
T Consensus 29 ~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~ 108 (229)
T KOG3087|consen 29 SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMED 108 (229)
T ss_pred CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccC
Confidence 5788888843222 1 12234678899999998655555445567777788899999987 4777777433221
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---eEEeeccCccc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKL 135 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~dfg~~~~ 135 (307)
.........++..+-+.+.-||.+ +|+||||..+||+|.+++. +.++|||++..
T Consensus 109 --~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 109 --ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred --cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 223334478899999999999999 9999999999999976553 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-10 Score=99.83 Aligned_cols=162 Identities=17% Similarity=0.303 Sum_probs=124.0
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEE----eCCeeEEEEeccCC-CCHHHHhccCCC---
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV----QGTRRILVYEYVEN-NSLDRVLLGATK--- 75 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~sL~~~l~~~~~--- 75 (307)
..||..|++|+++.........-..-+++++++.|.|||++..++. .+...++|++|+++ ++|.++-.....
T Consensus 298 ~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~ 377 (655)
T KOG3741|consen 298 NVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTK 377 (655)
T ss_pred ccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccc
Confidence 3579999999995432222223345688999999999999998886 45577999999987 788776533222
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccc
Q 021774 76 --------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI 147 (307)
Q Consensus 76 --------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 147 (307)
.+...++..+|.++.|+..||.++|+. |+..+-|.+.+|+++.+.+++|+.+|.......+.
T Consensus 378 ~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------- 447 (655)
T KOG3741|consen 378 RTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------- 447 (655)
T ss_pred ccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCC-------
Confidence 234578899999999999999999999 99999999999999999999999999876654432
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCC
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 186 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 186 (307)
.+| +.+ ..+-|.=-||.+++.|.||...
T Consensus 448 ------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 448 ------TEP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 011 111 2256788899999999999643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-10 Score=91.49 Aligned_cols=122 Identities=25% Similarity=0.253 Sum_probs=78.2
Q ss_pred cccCCCCEEEEEEccccC--------------h------------HhHHHHHHHHHHHhcCCCC--CccceeeEEEeCCe
Q 021774 2 GTLTNGRRIAVKPLSAES--------------K------------QGVREFITEIMTLSNVRHP--NLVELIGCCVQGTR 53 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~ 53 (307)
|...+|..+|||..+... . .......+|++.|.++..- ++++++++. .
T Consensus 5 ~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~ 80 (188)
T PF01163_consen 5 AIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----R 80 (188)
T ss_dssp EEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----T
T ss_pred EECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----C
Confidence 345678999999876421 0 0012346899999999655 567776552 3
Q ss_pred eEEEEeccC--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeeCCCCCCcEEECCCCceEEeec
Q 021774 54 RILVYEYVE--NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF-LHEELVPHIVHRDIKASNILLDQEFNPKIGDF 130 (307)
Q Consensus 54 ~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlkp~Nill~~~~~~kl~df 130 (307)
.++||||++ |..+..+.... ++......++.+++..+.. +|.. |++||||++.||+++++ .+.++||
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred CEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 469999998 65555543111 1123345677788885555 5788 99999999999999988 9999999
Q ss_pred cCcccCC
Q 021774 131 GLAKLFP 137 (307)
Q Consensus 131 g~~~~~~ 137 (307)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7e-11 Score=105.62 Aligned_cols=222 Identities=20% Similarity=0.175 Sum_probs=149.1
Q ss_pred CCCCEEEEEEccccChHhH--HHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGV--REFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~--~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.++..+++|.+........ ..-+.|+-+...+ .|.|++..+..+....+.|+=-|||.++++.... .....+.
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~----~~~~~~d 364 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS----VTSQMLD 364 (524)
T ss_pred CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh----HHHHhcC
Confidence 3566777776665421111 1224566666666 6888888888888888888999999999887665 3344577
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCCcccccccccCCCCcC--Cccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYL--APEY 158 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~--aPE~ 158 (307)
+..++++..|++.++.++|++ .++|+|++|+||++..+ +..++.|||....+.-. .......-++. ++..
T Consensus 365 ~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~ 437 (524)
T KOG0601|consen 365 EDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEIL 437 (524)
T ss_pred cchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee----cccccccccccccchhh
Confidence 788999999999999999999 99999999999999886 77899999988642211 11112222333 5555
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.....+..+.|++|||.-+.+..++..-...... ...+....... .+.....+..+...++
T Consensus 438 ~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------~~~i~~~~~p~-~~~~~~~~q~~~kv~~ 498 (524)
T KOG0601|consen 438 LEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------SLTIRSGDTPN-LPGLKLQLQVLLKVMI 498 (524)
T ss_pred ccccccccccccccccccccccccCcccCccccc------------------ceeeecccccC-CCchHHhhhhhhhhhc
Confidence 5566788999999999999999998643211100 00111111111 1122234555555688
Q ss_pred ccccCCCCCHHHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~ 256 (307)
..++..||.+.++....+
T Consensus 499 ~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 499 NPDRKRRPSAVELSLHSE 516 (524)
T ss_pred CCccccchhhhhhcccch
Confidence 999999999988766544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.3e-10 Score=90.33 Aligned_cols=126 Identities=24% Similarity=0.329 Sum_probs=94.4
Q ss_pred CCCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCC--CCccceeeEEEeCC---eeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRH--PNLVELIGCCVQGT---RRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|..++||....... .....+..|+++++.+.+ .++.+++.+..... ..++|||+++|.++...+. ..
T Consensus 20 ~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~-----~~ 94 (223)
T cd05154 20 GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL-----RP 94 (223)
T ss_pred cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC-----CC
Confidence 4468999998765432 134578899999999965 34677777766542 5689999999988776541 13
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------------CC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEEL-----------------------------------------------------VP 105 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------------------~~ 105 (307)
.++......++.+++.+|+.||+.. ..
T Consensus 95 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (223)
T cd05154 95 ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRP 174 (223)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCc
Confidence 4677777788888888888888531 23
Q ss_pred CeeeCCCCCCcEEECC--CCceEEeeccCccc
Q 021774 106 HIVHRDIKASNILLDQ--EFNPKIGDFGLAKL 135 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~--~~~~kl~dfg~~~~ 135 (307)
.++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 5799999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-10 Score=108.23 Aligned_cols=147 Identities=25% Similarity=0.293 Sum_probs=112.5
Q ss_pred CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 021774 39 PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118 (307)
Q Consensus 39 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil 118 (307)
|-++.....+......+++++|+.+++|...++... ..+.......+..+..++.+||.. .+.|+|++|.|.+
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLL 936 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchh
Confidence 444444333445667789999999999999884322 344444555667788999999998 7999999999999
Q ss_pred ECCCCceEEeeccCcccCCC---------------------C---------cccccccccCCCCcCCcccccCCcccccC
Q 021774 119 LDQEFNPKIGDFGLAKLFPD---------------------N---------ITHITTRIAGTTGYLAPEYVLGGQLTMKA 168 (307)
Q Consensus 119 l~~~~~~kl~dfg~~~~~~~---------------------~---------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 168 (307)
+..++..+++||+.....+- . .........||..|.+||...+......+
T Consensus 937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen 937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence 99999999999984432110 0 00112345688999999999999999999
Q ss_pred ceeehHHHHHHHHhCCCCCCcccc
Q 021774 169 DVYSFGVLVLEIISGRNSGKAMWG 192 (307)
Q Consensus 169 Dv~slG~~l~elltg~~p~~~~~~ 192 (307)
|.|++|++++|.++|.+|+....+
T Consensus 1017 d~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1017 DWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred hhhhhhhhhhhhhcCCCCCCCcch
Confidence 999999999999999999887665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.7e-09 Score=90.64 Aligned_cols=200 Identities=15% Similarity=0.129 Sum_probs=125.1
Q ss_pred eeEEEEeccCCC-CHHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEee
Q 021774 53 RRILVYEYVENN-SLDRVLLG--ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129 (307)
Q Consensus 53 ~~~lv~e~~~~~-sL~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~d 129 (307)
...+.|+.+.|. .+..++.- .+.......|.-.++++..++.+.+-||.. |.+-||++++|+|+.+++.|.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 367889988774 23333311 112334578999999999999999999999 999999999999999999999998
Q ss_pred ccCcccCCCCcccccccccCCCCcCCccccc-----CCcccccCceeehHHHHHHHHhC-CCCCCccccchh-HHHHH-H
Q 021774 130 FGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----GGQLTMKADVYSFGVLVLEIISG-RNSGKAMWGQMN-KFLLE-W 201 (307)
Q Consensus 130 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~-~~~~~-~ 201 (307)
-........ ....-..+|...|++||.-. +-.-+...|.|.||+++++++.| +.|+........ ....+ .
T Consensus 161 sDsfqi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 161 SDSFQINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred ccceeeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 654443322 12233456788999999544 23456789999999999999887 778765432211 11111 0
Q ss_pred HHH-H---hhcCCcccccCCCCCCCCH-HHHHHHHHHHHhcccc--ccCCCCCHHHHHHHHHhcc
Q 021774 202 AWQ-L---HQEEKPLELVDPELGEYPP-NEIIRYMKVAFFCTQA--AASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 202 ~~~-~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~c~~~--~p~~RPs~~~v~~~L~~~~ 259 (307)
+.. . ..+......-.|. ..+- --...+..+..+|+.. ++.-|||++.++..|..+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~--~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPR--SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hhcceeeechhccCCCCCCCC--CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 000 0 0001111000011 1111 1112244555567753 4678999999988776554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.6e-09 Score=85.26 Aligned_cols=106 Identities=23% Similarity=0.238 Sum_probs=83.7
Q ss_pred HHHHHHHHHHhcCC--CCCccceeeEEEeCC----eeEEEEeccCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 021774 24 REFITEIMTLSNVR--HPNLVELIGCCVQGT----RRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGL 96 (307)
Q Consensus 24 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~----~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 96 (307)
....+|.+.+.++. .=.+++.+++..... ..++|+|++++ .+|.+++... ...+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 45678888888774 334567777766533 45899999988 4899988321 2255667788999999999
Q ss_pred HHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccC
Q 021774 97 AFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLF 136 (307)
Q Consensus 97 ~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~ 136 (307)
+-||.. |++|+|+++.|||++.++ .+.++||+.++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.9e-10 Score=101.87 Aligned_cols=158 Identities=24% Similarity=0.346 Sum_probs=101.5
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--------ccccccCCCCcC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------ITTRIAGTTGYL 154 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~g~~~y~ 154 (307)
+....=+.+++.|+.|+|.. +++||++|.|++|.++.++..||++|+.+......... ..-.......|.
T Consensus 99 e~~f~nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ 176 (700)
T KOG2137|consen 99 EDGFANLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFL 176 (700)
T ss_pred cHhhhhhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccc
Confidence 33444456777999999976 38999999999999999999999999988755442110 011122344699
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+...+.++|+||+|+++|.+..|..+.....+.. ..+...... .+.....+......++.+=+
T Consensus 177 apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~~~~~~-------~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 177 APEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYSFSRNL-------LNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred cchhhccccccccccceeeeeEEEEEecCCcchhhccCCc----chhhhhhcc-------cccccccccccCcHHHHHHH
Confidence 9999998888899999999999999996554422211111 000111111 11111111122233355555
Q ss_pred HhccccccCCCCCHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.+..+..-||++..+..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 5579999999997776653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.3e-08 Score=81.99 Aligned_cols=120 Identities=23% Similarity=0.237 Sum_probs=83.8
Q ss_pred ccCCCCEEEEEEccccChH----------------------hHHHHHHHHHHHhcCCCC--CccceeeEEEeCCeeEEEE
Q 021774 3 TLTNGRRIAVKPLSAESKQ----------------------GVREFITEIMTLSNVRHP--NLVELIGCCVQGTRRILVY 58 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~ 58 (307)
...+|.++|||..+....+ ......+|.+.|++|... .|++.+++ +...+||
T Consensus 111 ~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvM 186 (304)
T COG0478 111 IDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVM 186 (304)
T ss_pred ECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeee
Confidence 3567999999966532100 112245899999999655 67776544 4557999
Q ss_pred eccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCC
Q 021774 59 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 138 (307)
Q Consensus 59 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 138 (307)
|+++|..|...- +.....-.++..|++-+..+-.. ||+|||+++-||+++++|.++++||-.+....+
T Consensus 187 e~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 187 EYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred ehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCcccccCCC
Confidence 999997665543 12233344555566666655566 999999999999999999999999988765433
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.7e-08 Score=77.97 Aligned_cols=113 Identities=19% Similarity=0.294 Sum_probs=73.9
Q ss_pred CCCEEEEEEccccChHhHHHHH---------HHHHHHhcCC---CCCccceeeEEEe-----CCeeEEEEeccCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFI---------TEIMTLSNVR---HPNLVELIGCCVQ-----GTRRILVYEYVENNSLDR 68 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~ 68 (307)
+|..+++|..+....-..+.|. +++..+.++. --....++.+... ....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 5788899988765433222222 3333333332 2233333333332 234468999999987766
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 69 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
+.. ++. .++..+++++..||+. |++|||.+|+|++++++ .++++||+..+
T Consensus 133 ~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred chh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 531 222 2556788889999999 99999999999999855 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.1e-07 Score=74.42 Aligned_cols=125 Identities=16% Similarity=0.146 Sum_probs=91.2
Q ss_pred CCCEEEEEEcccc---C---hHhHHHHHHHHHHHhcCCC--CCccceeeEEEe----CCeeEEEEeccCC-CCHHHHhcc
Q 021774 6 NGRRIAVKPLSAE---S---KQGVREFITEIMTLSNVRH--PNLVELIGCCVQ----GTRRILVYEYVEN-NSLDRVLLG 72 (307)
Q Consensus 6 ~g~~vavK~~~~~---~---~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~----~~~~~lv~e~~~~-~sL~~~l~~ 72 (307)
+|..+-||.-... + +-...-|.+|+..|++|.. -.++++..+... ....+||+|-++| .+|.+++..
T Consensus 40 ~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~ 119 (216)
T PRK09902 40 NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQ 119 (216)
T ss_pred CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhc
Confidence 3556788866522 1 3345679999999999843 235565533222 2245899997754 689888733
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--eEEeeccCccc
Q 021774 73 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--PKIGDFGLAKL 135 (307)
Q Consensus 73 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~ 135 (307)
.. -...+......++.+++.+++-||+. |+.|+|+.+.||+++.++. +.++||.-++.
T Consensus 120 ~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 120 HA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 21 22456777788999999999999999 9999999999999986667 99999987763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.1e-07 Score=86.61 Aligned_cols=81 Identities=20% Similarity=0.306 Sum_probs=57.1
Q ss_pred CCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeec
Q 021774 51 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF 130 (307)
Q Consensus 51 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~df 130 (307)
.+...++|||++|..+.+.... ....++...+.....++. +..+-.. |++|.|.+|.||+++.++++.+.||
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhc---CccccCCCccceEEecCCcEEEEcC
Confidence 4566899999999988887421 123344444433333322 2333345 9999999999999999999999999
Q ss_pred cCcccCCCC
Q 021774 131 GLAKLFPDN 139 (307)
Q Consensus 131 g~~~~~~~~ 139 (307)
|+...++..
T Consensus 310 Gi~g~l~~~ 318 (517)
T COG0661 310 GIVGRLDPK 318 (517)
T ss_pred cceecCCHH
Confidence 999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.2e-07 Score=71.85 Aligned_cols=104 Identities=21% Similarity=0.284 Sum_probs=82.1
Q ss_pred HHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 021774 27 ITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 105 (307)
Q Consensus 27 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 105 (307)
..|.-+++.+.+ +++++++|+|- .++|+|+...+++...- ..-..-...+|..+.+|+.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 458888998865 69999999993 36899999876554220 0001223478999999999999999999986555
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
.+.-.|++++|+-+++++++|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 678889999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.3e-06 Score=69.50 Aligned_cols=125 Identities=15% Similarity=0.124 Sum_probs=73.8
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCC--CccceeeEEEeCCeeEEEEeccCCCC-HHHHh-------------
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHP--NLVELIGCCVQGTRRILVYEYVENNS-LDRVL------------- 70 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~s-L~~~l------------- 70 (307)
|..+++|...... ......+|+++++.+..- .+.+++++....+...+|||+++|.+ +...+
T Consensus 22 ~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~ 99 (226)
T TIGR02172 22 TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKI 99 (226)
T ss_pred CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHH
Confidence 5577889877543 223468899999998533 35788888888888889999999863 22111
Q ss_pred --------ccCCCCCCCCCH--HHHHHHHH-------HHHH-HHHHHhcCC-CCCeeeCCCCCCcEEECCCCceEEeecc
Q 021774 71 --------LGATKANIKLNW--EKRSDICV-------GIAK-GLAFLHEEL-VPHIVHRDIKASNILLDQEFNPKIGDFG 131 (307)
Q Consensus 71 --------~~~~~~~~~~~~--~~~~~i~~-------~i~~-~l~~LH~~~-~~~i~H~dlkp~Nill~~~~~~kl~dfg 131 (307)
+........+.. ......+. .+.. ...+|.... .+.++|+|+.|.||++++++ +.++||+
T Consensus 100 la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe 178 (226)
T TIGR02172 100 FAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLG 178 (226)
T ss_pred HHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEech
Confidence 111001111110 00000000 0111 122222111 23678999999999999888 9999999
Q ss_pred Ccc
Q 021774 132 LAK 134 (307)
Q Consensus 132 ~~~ 134 (307)
.+.
T Consensus 179 ~a~ 181 (226)
T TIGR02172 179 DFG 181 (226)
T ss_pred hcC
Confidence 775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.7e-06 Score=71.00 Aligned_cols=125 Identities=16% Similarity=0.079 Sum_probs=76.1
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHh---------------
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL--------------- 70 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--------------- 70 (307)
+.+++||...... ...+.+|+++++.+ ++--+.+++++....+..++|||+++|.++....
T Consensus 22 ~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~ 98 (244)
T cd05150 22 NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEA 98 (244)
T ss_pred CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHH
Confidence 4678888876543 34567789988888 3455678888877767789999999998876442
Q ss_pred ----ccCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHhcC----CCCCeeeCCCCCCcEEEC
Q 021774 71 ----LGATKANIKLNW--EKRSDICV--------------------GIAKGLAFLHEE----LVPHIVHRDIKASNILLD 120 (307)
Q Consensus 71 ----~~~~~~~~~~~~--~~~~~i~~--------------------~i~~~l~~LH~~----~~~~i~H~dlkp~Nill~ 120 (307)
+........+.. ........ .+...+..|-.. ..+.++|+|+.|.||+++
T Consensus 99 l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~ 178 (244)
T cd05150 99 LRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVD 178 (244)
T ss_pred HHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEe
Confidence 110000111110 00000000 011112222111 134689999999999999
Q ss_pred CCCceEEeeccCcc
Q 021774 121 QEFNPKIGDFGLAK 134 (307)
Q Consensus 121 ~~~~~kl~dfg~~~ 134 (307)
+++.+.|+||+.+.
T Consensus 179 ~~~~~~iIDwe~a~ 192 (244)
T cd05150 179 PGKFSGFIDLGRLG 192 (244)
T ss_pred CCcEEEEEEccccc
Confidence 98778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.1e-06 Score=79.88 Aligned_cols=81 Identities=20% Similarity=0.237 Sum_probs=55.3
Q ss_pred CCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC----CCceE
Q 021774 51 GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ----EFNPK 126 (307)
Q Consensus 51 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----~~~~k 126 (307)
.....++|||++|..+.++-. -....++...+..-+.+...-+-+ .. |++|.|-+|.||++.. ++.+.
T Consensus 274 st~RVLtME~~~G~~i~Dl~~---i~~~gi~~~~i~~~l~~~~~~qIf--~~---GffHaDPHPGNilv~~~~~~~~~iv 345 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDA---IDKRGISPHDILNKLVEAYLEQIF--KT---GFFHADPHPGNILVRPNPEGDEEIV 345 (538)
T ss_pred CcceEEEEEecCCccCCCHHH---HHHcCCCHHHHHHHHHHHHHHHHH--hc---CCccCCCCCCcEEEecCCCCCccEE
Confidence 346789999999987766531 123345555554444443322222 33 8999999999999984 66799
Q ss_pred EeeccCcccCCCC
Q 021774 127 IGDFGLAKLFPDN 139 (307)
Q Consensus 127 l~dfg~~~~~~~~ 139 (307)
+.|||+.......
T Consensus 346 llDhGl~~~is~~ 358 (538)
T KOG1235|consen 346 LLDHGLYAVISHK 358 (538)
T ss_pred EEcccccccccHH
Confidence 9999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4e-06 Score=68.31 Aligned_cols=123 Identities=21% Similarity=0.262 Sum_probs=80.6
Q ss_pred cCCCCEEEEEEccccChHhH---------HH---------------HHHHHHHHhcCC--CCCccceeeEEEeCCeeEEE
Q 021774 4 LTNGRRIAVKPLSAESKQGV---------RE---------------FITEIMTLSNVR--HPNLVELIGCCVQGTRRILV 57 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~---------~~---------------~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 57 (307)
-.++..+|||+++....... .+ ..+|+.-|+++. +=.+++-+++. ...+|
T Consensus 69 ~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLv 144 (268)
T COG1718 69 TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLV 144 (268)
T ss_pred cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEE
Confidence 35688999999886421110 11 135777777763 33445544443 33699
Q ss_pred EeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccC
Q 021774 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136 (307)
Q Consensus 58 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 136 (307)
|||+.... ..........+.......+..++++.+.-|-. . ++||+||+..|||+. ++.+.++|+|.+...
T Consensus 145 MEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 145 MEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred EEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 99995421 10111122223333566778888888888877 6 999999999999999 889999999998765
Q ss_pred CC
Q 021774 137 PD 138 (307)
Q Consensus 137 ~~ 138 (307)
.+
T Consensus 217 ~h 218 (268)
T COG1718 217 DH 218 (268)
T ss_pred CC
Confidence 43
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.2e-07 Score=83.32 Aligned_cols=149 Identities=23% Similarity=0.192 Sum_probs=110.5
Q ss_pred HHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEeccCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 021774 26 FITEIMTLSNVRHPN-LVELIGCCVQGTRRILVYEYVENN-SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 103 (307)
Q Consensus 26 ~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 103 (307)
..-++++|.+++||| .+..++-+..+...++.++++.++ +-.... ......+...+...+...-+++++++|+.
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~- 355 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS- 355 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC---ChhhHhhhhhhhhhhhhhhcccccccccc-
Confidence 345889999999999 677777777778889999999776 221111 11222344455566777778899999987
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhC
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg 183 (307)
.-+|+| ||+..+ +..+.+||+....+.... ......++..|+|||+...+.+..+.|+|++|.-.-+|--|
T Consensus 356 --~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~ 426 (829)
T KOG0576|consen 356 --YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG 426 (829)
T ss_pred --cccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence 558888 666654 678999999887665432 34556789999999999999999999999999877777766
Q ss_pred CCCC
Q 021774 184 RNSG 187 (307)
Q Consensus 184 ~~p~ 187 (307)
.+|-
T Consensus 427 ~pPr 430 (829)
T KOG0576|consen 427 LPPR 430 (829)
T ss_pred CCCC
Confidence 6553
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.1e-05 Score=60.82 Aligned_cols=117 Identities=18% Similarity=0.245 Sum_probs=81.2
Q ss_pred CCCCEEEEEEccccC----------------hHhHHHHHHHHHHHhcCC------CCCccceeeEEEeCCeeEEEEeccC
Q 021774 5 TNGRRIAVKPLSAES----------------KQGVREFITEIMTLSNVR------HPNLVELIGCCVQGTRRILVYEYVE 62 (307)
Q Consensus 5 ~~g~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~ 62 (307)
++....+||+..... ....+++.+|+....++. +.+|.+++|+...+....+|+|.+.
T Consensus 21 P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~ 100 (199)
T PF10707_consen 21 PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIR 100 (199)
T ss_pred CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEE
Confidence 345567888887654 122455667776666665 8899999999999999999999875
Q ss_pred C------CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----ceEEee-cc
Q 021774 63 N------NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGD-FG 131 (307)
Q Consensus 63 ~------~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~d-fg 131 (307)
+ .+|.+++. ...++. . +...+-+-..||-++ +|+.+|++|+||++..+. .++|+| ||
T Consensus 101 d~dG~~s~TL~~~l~-----~~~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 101 DADGNISPTLEDYLK-----EGGLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLG 168 (199)
T ss_pred CCCCCcCccHHHHHH-----cCCccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeCCC
Confidence 3 46788872 223444 2 334444556677788 999999999999995332 477777 44
Q ss_pred Cc
Q 021774 132 LA 133 (307)
Q Consensus 132 ~~ 133 (307)
..
T Consensus 169 ~~ 170 (199)
T PF10707_consen 169 EK 170 (199)
T ss_pred Cc
Confidence 33
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.3e-05 Score=63.63 Aligned_cols=126 Identities=19% Similarity=0.178 Sum_probs=69.3
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCC--CCccceeeEEEe---CCeeEEEEeccCCCCHHH-------------
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRH--PNLVELIGCCVQ---GTRRILVYEYVENNSLDR------------- 68 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~---~~~~~lv~e~~~~~sL~~------------- 68 (307)
+..+++|..... .....+.+|+.+++.+.. ..+.+++.+... ....+++|++++|..+..
T Consensus 20 ~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~ 97 (239)
T PF01636_consen 20 DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQ 97 (239)
T ss_dssp TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHH
T ss_pred CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccccccccccccccccccc
Confidence 358999987754 345677788888888842 246677765543 335689999999988877
Q ss_pred ---Hh---ccCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc----CCCCCeeeCCCCCCc
Q 021774 69 ---VL---LGATKANIKLNWEK---------RSDI------------CVGIAK-GLAFLHE----ELVPHIVHRDIKASN 116 (307)
Q Consensus 69 ---~l---~~~~~~~~~~~~~~---------~~~i------------~~~i~~-~l~~LH~----~~~~~i~H~dlkp~N 116 (307)
.+ +........+.... .... ...+.. .+..+++ .....++|+|+.|.|
T Consensus 98 ~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~N 177 (239)
T PF01636_consen 98 LGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGN 177 (239)
T ss_dssp HHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGG
T ss_pred chhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEecccccc
Confidence 11 11100111111100 0000 111222 3333332 123479999999999
Q ss_pred EEEC-CCCceEEeeccCcc
Q 021774 117 ILLD-QEFNPKIGDFGLAK 134 (307)
Q Consensus 117 ill~-~~~~~kl~dfg~~~ 134 (307)
|+++ +++.+-|+||+.+.
T Consensus 178 il~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 178 ILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEESSTTEEEE--GTT-E
T ss_pred ceeeeccceeEEEecccce
Confidence 9999 66667799998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.8e-05 Score=63.10 Aligned_cols=59 Identities=20% Similarity=0.209 Sum_probs=37.5
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCC---CccceeeEEEeCC---eeEEEEeccCCCCHH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHP---NLVELIGCCVQGT---RRILVYEYVENNSLD 67 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~---~~~lv~e~~~~~sL~ 67 (307)
|..+++|...... ....+.+|++++..+... .+.++++.....+ ..+++|++++|.++.
T Consensus 18 ~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 18 GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 4467788655422 234688899999888432 3455555443322 347899999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.4e-05 Score=65.80 Aligned_cols=124 Identities=17% Similarity=0.124 Sum_probs=69.3
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEeccCCCCHHHH---------------
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN-LVELIGCCVQGTRRILVYEYVENNSLDRV--------------- 69 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~sL~~~--------------- 69 (307)
+|..+++|...........+...|.++++.+.... ..++++... .++||||++|..+...
T Consensus 18 ~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l 93 (256)
T TIGR02721 18 PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALL 93 (256)
T ss_pred CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHH
Confidence 46788898765433222123577999998885332 345554432 3689999998765321
Q ss_pred --hccCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHhcC-----CCCCeeeCCCCCCcEEECCCCceEEeeccC
Q 021774 70 --LLGATKANIKLNWEK-RSDICVGI---------AKGLAFLHEE-----LVPHIVHRDIKASNILLDQEFNPKIGDFGL 132 (307)
Q Consensus 70 --l~~~~~~~~~~~~~~-~~~i~~~i---------~~~l~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~dfg~ 132 (307)
++........++... +.....++ ...+..+-.. ....++|+|+.|.||++++++ +.|+||+.
T Consensus 94 ~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~ 172 (256)
T TIGR02721 94 HQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEY 172 (256)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccc
Confidence 122111122222221 11111111 1112222111 123689999999999999877 78999998
Q ss_pred cc
Q 021774 133 AK 134 (307)
Q Consensus 133 ~~ 134 (307)
+.
T Consensus 173 a~ 174 (256)
T TIGR02721 173 AS 174 (256)
T ss_pred cC
Confidence 75
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=71.15 Aligned_cols=128 Identities=20% Similarity=0.274 Sum_probs=76.9
Q ss_pred CEEEEEEccccC-hHhHHHHHHHHHHHhcCC-CCCc--cceeeEEEeC---CeeEEEEeccCCCCHHH------------
Q 021774 8 RRIAVKPLSAES-KQGVREFITEIMTLSNVR-HPNL--VELIGCCVQG---TRRILVYEYVENNSLDR------------ 68 (307)
Q Consensus 8 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~sL~~------------ 68 (307)
..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. ...|+|||+++|..+.+
T Consensus 66 ~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~ 145 (822)
T PLN02876 66 KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRR 145 (822)
T ss_pred eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHH
Confidence 467888765432 122346889999999994 6654 8888887764 35789999998864321
Q ss_pred --------H---hccCCCCC-------CCCC--HHHHHHHHH---------------HHHHHHHHHhcCCC--------C
Q 021774 69 --------V---LLGATKAN-------IKLN--WEKRSDICV---------------GIAKGLAFLHEELV--------P 105 (307)
Q Consensus 69 --------~---l~~~~~~~-------~~~~--~~~~~~i~~---------------~i~~~l~~LH~~~~--------~ 105 (307)
. ++...... .... ..++..|.. .+...+.+|..+.+ +
T Consensus 146 ~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~ 225 (822)
T PLN02876 146 AIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGT 225 (822)
T ss_pred HHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCc
Confidence 1 11111110 0001 112222211 23344667755443 2
Q ss_pred CeeeCCCCCCcEEECC-CCc-eEEeeccCccc
Q 021774 106 HIVHRDIKASNILLDQ-EFN-PKIGDFGLAKL 135 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~-~~~-~kl~dfg~~~~ 135 (307)
.++|+|+++.||+++. ++. +-|.||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 5999999999999985 334 46899998753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00015 Score=70.79 Aligned_cols=199 Identities=20% Similarity=0.233 Sum_probs=131.8
Q ss_pred HHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE----EEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 021774 23 VREFITEIMTLSNVRHPNLVELIGCCVQGTRRI----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAF 98 (307)
Q Consensus 23 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 98 (307)
+.-...|+..+.+..|+|+..+++|........ +..+++.+-++...+ ..-..++......+..++.+||+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHH
Confidence 334456788888899999999999887654332 455677777777766 344567788888899999999999
Q ss_pred HhcCCCCCeeeCCCCCC---cEEECCCCceEEe--eccCcccCCCCcccccccccCCCCcCCcccccCCcc--cccCcee
Q 021774 99 LHEELVPHIVHRDIKAS---NILLDQEFNPKIG--DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVY 171 (307)
Q Consensus 99 LH~~~~~~i~H~dlkp~---Nill~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~Dv~ 171 (307)
+|+. ...|.-+..+ +...+..+.+.++ ||+.+...+....... ..-...|.++|....... ....|+|
T Consensus 302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHH
Confidence 9998 6666655555 4445566666666 8888876655332211 122345677776665544 4457999
Q ss_pred ehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHH
Q 021774 172 SFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQV 251 (307)
Q Consensus 172 slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v 251 (307)
++|..+..+..|..+..... .+...++. .... .+.....+|+..++++|+++.++
T Consensus 377 ~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~----~~~~---~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSA------------------VPVSLLDV----LSTS---ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHHhhhhhcCccccccc------------------chhhhhcc----ccch---hhhhhhhhhcchhhhhccchhhh
Confidence 99999999988754422110 00011111 0111 24455667999999999999999
Q ss_pred HHHH
Q 021774 252 IKML 255 (307)
Q Consensus 252 ~~~L 255 (307)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 7654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00017 Score=59.79 Aligned_cols=30 Identities=23% Similarity=0.349 Sum_probs=26.5
Q ss_pred CCeeeCCCCCCcEEECC-CCceEEeeccCcc
Q 021774 105 PHIVHRDIKASNILLDQ-EFNPKIGDFGLAK 134 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~ 134 (307)
..++|+|+.+.||++++ ++.+.|+||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 36899999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00043 Score=59.53 Aligned_cols=57 Identities=14% Similarity=0.026 Sum_probs=40.9
Q ss_pred CEEEEEEccccChHhHHHHHHHHHHHhcCC-C--CCccceeeEEEeC---CeeEEEEeccCCCCH
Q 021774 8 RRIAVKPLSAESKQGVREFITEIMTLSNVR-H--PNLVELIGCCVQG---TRRILVYEYVENNSL 66 (307)
Q Consensus 8 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~sL 66 (307)
.++++|..+... ....|..|++.|+.+. + -.++++++++... +..++|||+++|.++
T Consensus 38 ~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 38 GNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 356777754311 2246889999999884 2 4788999888643 567999999998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00029 Score=60.75 Aligned_cols=123 Identities=19% Similarity=0.168 Sum_probs=70.8
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCC-CccceeeEEEeCCeeEEEEeccCCCCHHHH----------------
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHP-NLVELIGCCVQGTRRILVYEYVENNSLDRV---------------- 69 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---------------- 69 (307)
++.+++|+...... ...+..+|++++..+... -..++++++.. .+|+||++|.++...
T Consensus 29 ~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~ 103 (302)
T cd05156 29 PRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTLTTEELRDPDISAEIARRMA 103 (302)
T ss_pred CCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcCCHhHcCCcHHHHHHHHHHH
Confidence 57899998765432 223457788888888432 23455655532 368999988766431
Q ss_pred -hccCCCCC--C---CCC--HHHHHHH--------------------------HHHHHHHHHHHhc------CCCCCeee
Q 021774 70 -LLGATKAN--I---KLN--WEKRSDI--------------------------CVGIAKGLAFLHE------ELVPHIVH 109 (307)
Q Consensus 70 -l~~~~~~~--~---~~~--~~~~~~i--------------------------~~~i~~~l~~LH~------~~~~~i~H 109 (307)
++...... . ..+ +..+..+ ...+...+..+-. .....++|
T Consensus 104 ~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH 183 (302)
T cd05156 104 KLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEAKYLRFLLESTSEESGSPVVFCH 183 (302)
T ss_pred HhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHHHHHHHHHhhccCCCCCCceEEe
Confidence 11111110 0 111 1111111 1122223334432 13447899
Q ss_pred CCCCCCcEEECCC----CceEEeeccCcc
Q 021774 110 RDIKASNILLDQE----FNPKIGDFGLAK 134 (307)
Q Consensus 110 ~dlkp~Nill~~~----~~~kl~dfg~~~ 134 (307)
+|+.+.||+++++ +.+.++||..+.
T Consensus 184 ~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 184 NDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred cCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 9999999999985 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0013 Score=56.60 Aligned_cols=128 Identities=17% Similarity=0.265 Sum_probs=75.9
Q ss_pred CCEEEEEEccc--cChHhHHHHHHHHHHHhcCC--CCCccceeeEEEeCC--eeEEEEeccCCCCHHHHh----------
Q 021774 7 GRRIAVKPLSA--ESKQGVREFITEIMTLSNVR--HPNLVELIGCCVQGT--RRILVYEYVENNSLDRVL---------- 70 (307)
Q Consensus 7 g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l---------- 70 (307)
+++++|. ... ..........+|+++++.+. ---+...++.|.++. ..++||++++|..+.+.+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6777777 331 22344456678888888873 334566777787776 679999999984322211
Q ss_pred -----------ccCCCCCCC-------CCHHHHHHHHHH--------------HHHHHHHHhcCCC-----CCeeeCCCC
Q 021774 71 -----------LGATKANIK-------LNWEKRSDICVG--------------IAKGLAFLHEELV-----PHIVHRDIK 113 (307)
Q Consensus 71 -----------~~~~~~~~~-------~~~~~~~~i~~~--------------i~~~l~~LH~~~~-----~~i~H~dlk 113 (307)
+.-...+.. ....++..+..+ ......+|+++.+ +.++|||+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 000000000 001111111111 1223445554432 568999999
Q ss_pred CCcEEECCCCceEEeeccCccc
Q 021774 114 ASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 114 p~Nill~~~~~~kl~dfg~~~~ 135 (307)
+.|++++.++-+=+.||+++..
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCEEEeCCCeeEEEecccccc
Confidence 9999999998899999999974
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0031 Score=54.14 Aligned_cols=126 Identities=19% Similarity=0.217 Sum_probs=71.4
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCC--CccceeeE------EEeCCeeEEEEeccCCCCHHH---------
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP--NLVELIGC------CVQGTRRILVYEYVENNSLDR--------- 68 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e~~~~~sL~~--------- 68 (307)
++..+++|+..... ......|++++..+.+. .+.+++.. ....+..++|+++++|..+..
T Consensus 36 ~~~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~l 112 (296)
T cd05153 36 DSGRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQI 112 (296)
T ss_pred CCCcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHH
Confidence 34578889877522 24466677777777332 24454432 123445689999999876421
Q ss_pred --H---hccCCCC---C----CCCCHHHHH----------HHHHHHHHHHHHHhc----CCCCCeeeCCCCCCcEEECCC
Q 021774 69 --V---LLGATKA---N----IKLNWEKRS----------DICVGIAKGLAFLHE----ELVPHIVHRDIKASNILLDQE 122 (307)
Q Consensus 69 --~---l~~~~~~---~----~~~~~~~~~----------~i~~~i~~~l~~LH~----~~~~~i~H~dlkp~Nill~~~ 122 (307)
. ++..... . ....|.... .....+..++.++.+ ..+.+++|+|+.|.||+++++
T Consensus 113 g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~ 192 (296)
T cd05153 113 GEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGD 192 (296)
T ss_pred HHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCC
Confidence 0 1110000 0 011121110 011223344555543 123479999999999999987
Q ss_pred CceEEeeccCcc
Q 021774 123 FNPKIGDFGLAK 134 (307)
Q Consensus 123 ~~~kl~dfg~~~ 134 (307)
+.+.|.||+.+.
T Consensus 193 ~~~~iIDfe~a~ 204 (296)
T cd05153 193 ELSGVIDFYFAC 204 (296)
T ss_pred ceEEEeehhhhc
Confidence 777899999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0015 Score=57.46 Aligned_cols=124 Identities=19% Similarity=0.247 Sum_probs=71.0
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEeccCCCCHHHH----------------
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN-LVELIGCCVQGTRRILVYEYVENNSLDRV---------------- 69 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---------------- 69 (307)
++.|++|.........++ -..|..+++.+..-+ -.++++.+... .|.+|+++.++...
T Consensus 65 ~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~ 139 (344)
T PLN02236 65 GRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLR 139 (344)
T ss_pred CCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHH
Confidence 468999988765433333 367899988884333 34566655332 58999988776421
Q ss_pred -hccCCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----hc-CCCCCeeeCCCCCCcEEECC-CC
Q 021774 70 -LLGATKANI--KLNWEKRSDICVGI-----------------AKGLAFL----HE-ELVPHIVHRDIKASNILLDQ-EF 123 (307)
Q Consensus 70 -l~~~~~~~~--~~~~~~~~~i~~~i-----------------~~~l~~L----H~-~~~~~i~H~dlkp~Nill~~-~~ 123 (307)
++....... ...+..+.++..++ ...+..| .. .....++|+|+++.||++++ ++
T Consensus 140 ~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~ 219 (344)
T PLN02236 140 EFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR 219 (344)
T ss_pred HHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC
Confidence 111111111 11233333333221 1112222 21 11236899999999999986 46
Q ss_pred ceEEeeccCccc
Q 021774 124 NPKIGDFGLAKL 135 (307)
Q Consensus 124 ~~kl~dfg~~~~ 135 (307)
.+.++||..+..
T Consensus 220 ~~~lID~Eya~~ 231 (344)
T PLN02236 220 AITIIDYEYASY 231 (344)
T ss_pred cEEEEeehhccc
Confidence 799999988763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0054 Score=53.28 Aligned_cols=32 Identities=25% Similarity=0.333 Sum_probs=27.0
Q ss_pred CCCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 103 LVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 103 ~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
.+.+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 35589999999999999866556799999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0064 Score=52.55 Aligned_cols=31 Identities=26% Similarity=0.356 Sum_probs=27.5
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
+.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4589999999999999988777899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0014 Score=55.92 Aligned_cols=57 Identities=23% Similarity=0.225 Sum_probs=36.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEeccCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTRRILVYEYVENN 64 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 64 (307)
.+++.+.||.-.. .....|..|++-|+.| ..-.+++++++....+..++|+||++.+
T Consensus 38 ~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4577899997772 2224577788888877 3457889999998888889999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0021 Score=49.92 Aligned_cols=109 Identities=18% Similarity=0.225 Sum_probs=73.8
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
|..+|+|+-..+++ ...+..|+++|..+.--++ .++|.|..+ ++.|||+.|..|..+.... +..+
T Consensus 45 ~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~-------~rk~- 110 (201)
T COG2112 45 GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG-------DRKH- 110 (201)
T ss_pred CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc-------cHHH-
Confidence 55899998876543 3568899999999875554 445544433 3459999998888876211 2233
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCC-CCcEEECCCCceEEeeccCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIK-ASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlk-p~Nill~~~~~~kl~dfg~~~~ 135 (307)
+..++++---|-.. ||-|+.|+ |...+|..++.+.|+||..+..
T Consensus 111 ---l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 111 ---LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred ---HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 33455555555566 99999987 4444444455999999998873
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0032 Score=53.50 Aligned_cols=30 Identities=30% Similarity=0.514 Sum_probs=25.2
Q ss_pred CeeeCCCCCCcEEECCCCc-eEEeeccCccc
Q 021774 106 HIVHRDIKASNILLDQEFN-PKIGDFGLAKL 135 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~-~kl~dfg~~~~ 135 (307)
.++|+|+++.||++++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997555 46999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0053 Score=54.70 Aligned_cols=59 Identities=15% Similarity=0.091 Sum_probs=40.0
Q ss_pred CCC-CEEEEEEcccc------C-hHhHHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeccCCCC
Q 021774 5 TNG-RRIAVKPLSAE------S-KQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVYEYVENNS 65 (307)
Q Consensus 5 ~~g-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~s 65 (307)
.+| +.|+||.-... + +-..+++..|.+.|+.+. ..++++++.+ +.+..++|||++++..
T Consensus 48 ~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 48 TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 455 48999975422 1 223466788888888872 3467888876 4466789999998643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00037 Score=62.70 Aligned_cols=47 Identities=23% Similarity=0.324 Sum_probs=38.8
Q ss_pred HHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhc
Q 021774 24 REFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLL 71 (307)
Q Consensus 24 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~ 71 (307)
.+.+....+++.+.|+|....+++.... ....+|+|++ +.||++.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 5577889999999999999998887644 3567899999 779999984
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.11 E-value=5.1e-05 Score=75.85 Aligned_cols=159 Identities=13% Similarity=0.011 Sum_probs=111.5
Q ss_pred HHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-
Q 021774 28 TEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV- 104 (307)
Q Consensus 28 ~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~- 104 (307)
.|...+++..|+++...+.-... ...-+..++++.+|.+.+.+.++-.....+...-+.....+...+..-+|....
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34444555678877665544432 234478999999999999986655444444444444333443666666665542
Q ss_pred -CCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhC
Q 021774 105 -PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183 (307)
Q Consensus 105 -~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg 183 (307)
.-.+|+++++-|.+|..+.+++++++|+.+.... .....+...+++-|++|+....-.++.++|+|..|+.+|++..|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 2358999999999999999999999999984332 22234455667778889987777888889999999999999887
Q ss_pred CCCC
Q 021774 184 RNSG 187 (307)
Q Consensus 184 ~~p~ 187 (307)
..++
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 6553
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0008 Score=54.78 Aligned_cols=123 Identities=17% Similarity=0.156 Sum_probs=60.2
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeccCCCCHHHH----------------
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRV---------------- 69 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---------------- 69 (307)
+++|+|++....+ ...-.-..|..+++.+.. ..-.++++++.. ..|.+|++|.+|..-
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 5789999888663 333456778888888854 333555655422 257788877654320
Q ss_pred -hccCCC---CCCCCCHHHHHHH----------------------HHHHHHHHHHHhc----C-CCCCeeeCCCCCCcEE
Q 021774 70 -LLGATK---ANIKLNWEKRSDI----------------------CVGIAKGLAFLHE----E-LVPHIVHRDIKASNIL 118 (307)
Q Consensus 70 -l~~~~~---~~~~~~~~~~~~i----------------------~~~i~~~l~~LH~----~-~~~~i~H~dlkp~Nil 118 (307)
++.... ....--|..+..+ +..+..-+..+.+ . .+..++|.|+.+.||+
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 011001 0000112222222 0111222222211 1 1126789999999999
Q ss_pred E-CCCCceEEeeccCcc
Q 021774 119 L-DQEFNPKIGDFGLAK 134 (307)
Q Consensus 119 l-~~~~~~kl~dfg~~~ 134 (307)
+ +.++.++++||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0049 Score=53.56 Aligned_cols=127 Identities=16% Similarity=0.191 Sum_probs=82.8
Q ss_pred ccCCCCEEEEEEcccc-----ChH--------------------hHHH-HHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 021774 3 TLTNGRRIAVKPLSAE-----SKQ--------------------GVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRIL 56 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~-----~~~--------------------~~~~-~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 56 (307)
+..+|..+|||+++.. +.+ .++- ..+|++-|++++...|.-.--... ...+|
T Consensus 164 t~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlL--k~hVL 241 (520)
T KOG2270|consen 164 TEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILL--KNHVL 241 (520)
T ss_pred ecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceee--ecceE
Confidence 4568899999988753 100 0000 136888888886555432111111 13368
Q ss_pred EEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccC
Q 021774 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136 (307)
Q Consensus 57 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 136 (307)
||+++..-... ........++...+..+-.+++.-+.-|.+.+ ++||.||+--|+|+. +|.++++|.+.+...
T Consensus 242 VM~FlGrdgw~----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 242 VMEFLGRDGWA----APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred eeeeccCCCCc----CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEEEEEccccccC
Confidence 99999431111 11223445677778888888888888888764 999999999999986 468999999988755
Q ss_pred CC
Q 021774 137 PD 138 (307)
Q Consensus 137 ~~ 138 (307)
.+
T Consensus 315 DH 316 (520)
T KOG2270|consen 315 DH 316 (520)
T ss_pred CC
Confidence 44
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0052 Score=53.68 Aligned_cols=124 Identities=12% Similarity=0.177 Sum_probs=68.5
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeccCCCCHHHH----------------
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSLDRV---------------- 69 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~~---------------- 69 (307)
+..|++|+........ -+-.+|..+++.+..-++ +++++++. . . +|.+|++|.+|..-
T Consensus 42 ~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~ 116 (330)
T PLN02421 42 EVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQSFINARTLTPSDMRKPKVAAEIAKELR 116 (330)
T ss_pred CceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-C-c--EeehhhcCCCCChHHCCCHHHHHHHHHHHH
Confidence 3488999877543322 234678888888854444 45665552 2 2 58999987765321
Q ss_pred -hccCCCCCC-CC-CHHHHHHHHHHH----------------------HH---HHHHHh-cC-CCCCeeeCCCCCCcEEE
Q 021774 70 -LLGATKANI-KL-NWEKRSDICVGI----------------------AK---GLAFLH-EE-LVPHIVHRDIKASNILL 119 (307)
Q Consensus 70 -l~~~~~~~~-~~-~~~~~~~i~~~i----------------------~~---~l~~LH-~~-~~~~i~H~dlkp~Nill 119 (307)
++....... .. .|..+.++..++ .. .+..+. .. .+.-.+|.|+.+.||++
T Consensus 117 ~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~ 196 (330)
T PLN02421 117 RLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLML 196 (330)
T ss_pred HHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEE
Confidence 121111111 11 233332222221 11 111121 11 12247899999999999
Q ss_pred CC-CCceEEeeccCccc
Q 021774 120 DQ-EFNPKIGDFGLAKL 135 (307)
Q Consensus 120 ~~-~~~~kl~dfg~~~~ 135 (307)
++ ++.++++||..+..
T Consensus 197 ~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 197 NEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eCCCCcEEEEcccccCC
Confidence 75 57899999998853
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.043 Score=47.40 Aligned_cols=30 Identities=27% Similarity=0.364 Sum_probs=26.0
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 348999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0058 Score=53.00 Aligned_cols=71 Identities=23% Similarity=0.269 Sum_probs=57.2
Q ss_pred eeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccC
Q 021774 53 RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 132 (307)
Q Consensus 53 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~ 132 (307)
..|++|++. |+++... ....+.++..++.+.+..+.-+..+. ..-|||+.-.||+|+ +|+|-|+||.+
T Consensus 300 y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 456777766 5555432 12457889999999999999888764 678999999999999 99999999999
Q ss_pred ccc
Q 021774 133 AKL 135 (307)
Q Consensus 133 ~~~ 135 (307)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 984
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.029 Score=48.54 Aligned_cols=32 Identities=22% Similarity=0.262 Sum_probs=28.7
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
..+++|+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44899999999999999999999999998863
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.018 Score=50.10 Aligned_cols=126 Identities=26% Similarity=0.385 Sum_probs=70.0
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCC------ccceeeEEE--eC--CeeEEEEeccCCCCHHH-------
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN------LVELIGCCV--QG--TRRILVYEYVENNSLDR------- 68 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~--~~--~~~~lv~e~~~~~sL~~------- 68 (307)
+|+. +||+.... ....+...|+..++.|.-.. +...-|-.. -. ...+.+++|++|..+..
T Consensus 48 ~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~ 124 (331)
T COG2334 48 DGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQL 124 (331)
T ss_pred CCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHH
Confidence 4444 99988865 23345666777777772111 222222111 12 36778999999987772
Q ss_pred ------------HhccCC----CCCCCCCHH-----------------HHHHHHHHHHHHHHHHhcCCCCC---eeeCCC
Q 021774 69 ------------VLLGAT----KANIKLNWE-----------------KRSDICVGIAKGLAFLHEELVPH---IVHRDI 112 (307)
Q Consensus 69 ------------~l~~~~----~~~~~~~~~-----------------~~~~i~~~i~~~l~~LH~~~~~~---i~H~dl 112 (307)
...+.. .......|. .+..+...+...+..+-...+.+ +||+|+
T Consensus 125 ~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~ 204 (331)
T COG2334 125 EELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDL 204 (331)
T ss_pred HHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCC
Confidence 001100 001112332 22222223333333333333334 899999
Q ss_pred CCCcEEECCCCc-eEEeeccCcc
Q 021774 113 KASNILLDQEFN-PKIGDFGLAK 134 (307)
Q Consensus 113 kp~Nill~~~~~-~kl~dfg~~~ 134 (307)
.|.||+++.+.. +-+.||+-+.
T Consensus 205 ~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 205 HPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CccceeEcCCCCeeeEEEccccc
Confidence 999999999886 8899999775
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.032 Score=45.48 Aligned_cols=58 Identities=21% Similarity=0.239 Sum_probs=43.3
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEeccCCCCHH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNV---RHPNLVELIGCCVQGTRRILVYEYVENNSLD 67 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 67 (307)
..++.||+=. ......|..|+.-|..| +.-.+.+++.+..+..+.|+|+||++-+.+.
T Consensus 39 ~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 4467777544 33345677777777766 4567899999999999999999999876655
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.067 Score=47.79 Aligned_cols=56 Identities=13% Similarity=0.057 Sum_probs=36.7
Q ss_pred CCCEEEEEEcccc-----C--hHhHHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeccCC
Q 021774 6 NGRRIAVKPLSAE-----S--KQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVYEYVEN 63 (307)
Q Consensus 6 ~g~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 63 (307)
++..++||.-... . +....+-..|++.|+.+. ..++++++.++. +..+++||++++
T Consensus 54 ~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 54 SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeecCC
Confidence 3456889966522 1 123445555677777663 347888888877 446789999977
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.14 Score=44.75 Aligned_cols=29 Identities=28% Similarity=0.355 Sum_probs=24.7
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..+++|+|+.+.||+++ + .+.|+||+-+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 44789999999999995 3 57899999776
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.062 Score=43.07 Aligned_cols=85 Identities=25% Similarity=0.329 Sum_probs=58.9
Q ss_pred HHHHHHHHHHhcC---CCCCc--cceeeEEEeCC------------------eeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 24 REFITEIMTLSNV---RHPNL--VELIGCCVQGT------------------RRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 24 ~~~~~e~~~l~~l---~h~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..|..|.+...+| .+.++ ++++||..-.. ...||.||++... .+
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~ 165 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL 165 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc
Confidence 3577888888777 35566 89999875321 1246777765532 12
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA 133 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~ 133 (307)
.. +-+.++.+-+..+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 166 ~~----~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QI----RDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ch----hHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 22 2356677778899999 9999999999986 2488999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.0058 Score=52.28 Aligned_cols=94 Identities=16% Similarity=0.153 Sum_probs=65.2
Q ss_pred HHHHHHHhcCC-CC-CccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 021774 27 ITEIMTLSNVR-HP-NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV 104 (307)
Q Consensus 27 ~~e~~~l~~l~-h~-~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 104 (307)
.+|+..|+.|. |. -|++.+ +.+..++|||++.|-.|.+..+ .....+ +...+..-+--|-.+
T Consensus 158 ~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv~la~~-- 221 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIVRLANH-- 221 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHHHHHHc--
Confidence 46888888873 32 244444 3446689999999987766531 112233 344444555566677
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCcccCC
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAKLFP 137 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 137 (307)
|+||+|..-=||++++++.++++||-......
T Consensus 222 -GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 222 -GLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred -CceecccchheeEEecCCCEEEeechHhhccC
Confidence 99999999999999999999999998665443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.12 Score=52.23 Aligned_cols=32 Identities=31% Similarity=0.420 Sum_probs=27.0
Q ss_pred CCCeeeCCCCCCcEEECCCC--ceE-EeeccCccc
Q 021774 104 VPHIVHRDIKASNILLDQEF--NPK-IGDFGLAKL 135 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~--~~k-l~dfg~~~~ 135 (307)
+.++||+|+.+.||+++.++ ++. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 45899999999999998875 555 999998863
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.23 Score=45.26 Aligned_cols=55 Identities=13% Similarity=0.172 Sum_probs=35.0
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeccCCCCH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSL 66 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL 66 (307)
++.|++++......... .-..|..+++.+...+| .++++.+. .+.|.+|++|.+|
T Consensus 138 ~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~efi~g~~l 193 (442)
T PTZ00296 138 RRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEEWLYGDPL 193 (442)
T ss_pred CceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEEeeCCccC
Confidence 56888998876544333 34567888877754444 34555442 3468999988744
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.032 Score=44.15 Aligned_cols=28 Identities=21% Similarity=0.278 Sum_probs=24.9
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..+|+|+.|.|+++++++ ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 458999999999998877 9999999885
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.16 Score=45.23 Aligned_cols=28 Identities=29% Similarity=0.210 Sum_probs=23.8
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..+|.|+.+.||+.++ +.+.++||..+.
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEecccc
Confidence 6799999999998754 469999998775
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.049 Score=44.18 Aligned_cols=88 Identities=17% Similarity=0.132 Sum_probs=56.7
Q ss_pred HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 021774 24 REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEEL 103 (307)
Q Consensus 24 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 103 (307)
..|..+++++.++. .|+++..= +.....+|.|+|..... . ...++..=+.+|.-.|+.
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~----~~N~i~agi~~L~~fH~~- 160 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------N----FSNFITAGIKDLMDFHSE- 160 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------c----hhHHHHHhHHHHHHhhcc-
Confidence 45677888887764 34444411 23345688998833110 0 011122224677788854
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCc
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLA 133 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~ 133 (307)
..+.+|||..|+|||-|..|.+||.|=+..
T Consensus 161 ~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 161 NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 338999999999999999999999996644
|
The function of this family is unknown. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.089 Score=45.50 Aligned_cols=52 Identities=23% Similarity=0.244 Sum_probs=32.6
Q ss_pred HHHHHHHHHHHHHHHhcCC-CCCeeeCCCCCCcEEECCC------------------CceEEeeccCcccC
Q 021774 85 RSDICVGIAKGLAFLHEEL-VPHIVHRDIKASNILLDQE------------------FNPKIGDFGLAKLF 136 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~-~~~i~H~dlkp~Nill~~~------------------~~~kl~dfg~~~~~ 136 (307)
+.-++.|+|.-.--+.+.. ..+.+|-||||+||||-++ -.++|.||.+++..
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 4446667655443243432 3478999999999999432 22567777777643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 307 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-151
Identities = 108/259 (41%), Positives = 162/259 (62%), Gaps = 4/259 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
G L +G +AVK L E QG +F TE+ +S H NL+ L G C+ T R+LVY Y
Sbjct: 49 GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ N S+ L ++ L+W KR I +G A+GLA+LH+ P I+HRD+KA+NILLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+EF +GDFGLAKL TH+TT + GT G++APEY+ G+ + K DV+ +GV++LE+
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228
Query: 181 ISGRNS--GKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFC 237
I+G+ + + + LL+W L +E+K LVD +L G Y E+ + ++VA C
Sbjct: 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLC 288
Query: 238 TQAAASRRPQMNQVIKMLT 256
TQ++ RP+M++V++ML
Sbjct: 289 TQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-133
Identities = 96/260 (36%), Positives = 142/260 (54%), Gaps = 14/260 (5%)
Query: 2 GTLTNGRRIAVKPLSA----ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 57
G + N +AVK L+A +++ ++F EI ++ +H NLVEL+G G LV
Sbjct: 50 GYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
Y Y+ N SL L L+W R I G A G+ FLHE H +HRDIK++NI
Sbjct: 109 YVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI 164
Query: 118 LLDQEFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
LLD+ F KI DFGLA+ T +T+RI GTT Y+APE L G++T K+D+YSFGV+
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVV 223
Query: 177 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE-LVDPELGEYPPNEIIRYMKVAF 235
+LEII+G + LL+ ++ EEK +E +D ++ + + VA
Sbjct: 224 LLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS 281
Query: 236 FCTQAAASRRPQMNQVIKML 255
C ++RP + +V ++L
Sbjct: 282 QCLHEKKNKRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 374 bits (962), Expect = e-131
Identities = 108/264 (40%), Positives = 163/264 (61%), Gaps = 5/264 (1%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G L +G ++A+K + ES QG+ EF TEI TLS RHP+LV LIG C + IL+Y+Y+
Sbjct: 58 GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
EN +L R L G+ + ++WE+R +IC+G A+GL +LH I+HRD+K+ NILLD+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDE 174
Query: 122 EFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
F PKI DFG++K + + TH++T + GT GY+ PEY + G+LT K+DVYSFGV++ E+
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 181 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQ 239
+ R++ + L EWA + H + ++VDP L + P + ++ A C
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 240 AAASRRPQMNQVIKMLTKNIRLNE 263
++ RP M V+ L +RL E
Sbjct: 295 LSSEDRPSMGDVLWKLEYALRLQE 318
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-77
Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 30/276 (10%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG----TRRILVYEYV 61
+AVK + KQ + E+ +L ++H N+++ IG +G L+ +
Sbjct: 46 LNEYVAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV-------PHIVHRDIKA 114
E SL L ++W + I +A+GLA+LHE++ P I HRDIK+
Sbjct: 105 EKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGG-----QLTMKA 168
N+LL I DFGLA F + T GT Y+APE + G ++
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 169 DVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-----DPEL-GEY 222
D+Y+ G+++ E+ S + + E Q E E+V P L +
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW 279
Query: 223 PPNEIIRYM-KVAFFCTQAAASRRPQMNQVIKMLTK 257
+ + + + C A R V + +T+
Sbjct: 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-60
Identities = 61/296 (20%), Positives = 108/296 (36%), Gaps = 43/296 (14%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-----LVYEY 60
+ R +AVK S ++Q I + + H N+ I + T LV EY
Sbjct: 35 DERPVAVKVFSFANRQNFINE-KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV------PHIVHRDIKA 114
N SL + L T +W + + +GLA+LH EL P I HRD+ +
Sbjct: 94 YPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 115 SNILLDQEFNPKIGDFGLAKLF-------PDNITHITTRIAGTTGYLAPEYVLG------ 161
N+L+ + I DFGL+ P + GT Y+APE + G
Sbjct: 149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRD 208
Query: 162 -GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD---- 216
+ D+Y+ G++ EI R + + ++ + + ++ ++
Sbjct: 209 XESALKQVDMYALGLIYWEIFM-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR 267
Query: 217 ----PELGE-YPPNEII--RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
P+ E + N + + C A R + + + + + E
Sbjct: 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-56
Identities = 75/253 (29%), Positives = 121/253 (47%), Gaps = 23/253 (9%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
+ +A+K + +ES++ + FI E+ LS V HPN+V+L G C+ LV EY E S
Sbjct: 30 RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGS 85
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN- 124
L VL GA + C+ ++G+A+LH ++HRD+K N+LL
Sbjct: 86 LYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
KI DFG A +I T G+ ++APE G + K DV+S+G+++ E+I+ R
Sbjct: 145 LKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 185 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244
+ ++ W +H + P L + P I M C S+
Sbjct: 201 KP----FDEIGGPAFRIMWAVHNGTR------PPLIKNLPKPIESLMTR---CWSKDPSQ 247
Query: 245 RPQMNQVIKMLTK 257
RP M +++K++T
Sbjct: 248 RPSMEEIVKIMTH 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 68/258 (26%), Positives = 121/258 (46%), Gaps = 31/258 (12%)
Query: 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+G +AVK L + + V EF+ E+ + +RHPN+V +G Q +V EY+
Sbjct: 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL R+L + A +L+ +R + +AKG+ +LH P IVHR++K+ N+L+D+++
Sbjct: 119 GSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY 176
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+ DFGL++L + AGT ++APE + K+DVYSFGV++ E+ +
Sbjct: 177 TVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 184 R------NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237
+ N + + K E+ ++ ++ C
Sbjct: 236 QQPWGNLNPAQVVAAVGFKCKR-----------------LEIPRNLNPQVAAIIEG---C 275
Query: 238 TQAAASRRPQMNQVIKML 255
+RP ++ +L
Sbjct: 276 WTNEPWKRPSFATIMDLL 293
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-52
Identities = 64/268 (23%), Positives = 121/268 (45%), Gaps = 38/268 (14%)
Query: 5 TNGRRIAVKPLSAESKQG-------VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 57
+ +A+K L +G +EF E+ +SN+ HPN+V+L G R +V
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MV 99
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
E+V L LL + W + + + IA G+ ++ + P IVHRD+++ NI
Sbjct: 100 MEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNI 155
Query: 118 LLDQ-----EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL---TMKAD 169
L K+ DFGL++ H + + G ++APE +G + T KAD
Sbjct: 156 FLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKAD 210
Query: 170 VYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229
YSF +++ I+ +G+ + + + +++ + +E P + E P +
Sbjct: 211 TYSFAMILYTIL----TGEGPFDEYSYGKIKFINMIREEGL-----RPTIPEDCPPRLRN 261
Query: 230 YMKVAFFCTQAAASRRPQMNQVIKMLTK 257
+++ C +RP + ++K L++
Sbjct: 262 VIEL---CWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-52
Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 34/264 (12%)
Query: 6 NGRRIAVKPL----SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G +AVK + Q + E + ++HPN++ L G C++ LV E+
Sbjct: 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L+RVL + ++ + + V IA+G+ +LH+E + I+HRD+K+SNIL+ Q
Sbjct: 89 RGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143
Query: 122 EFNP--------KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
+ KI DFGLA+ + AG ++APE + + +DV+S+
Sbjct: 144 KVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 174 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233
GVL+ E++ +G+ + ++ L A+ + + + P + M+
Sbjct: 201 GVLLWELL----TGEVPFRGID--GLAVAYGVAMNKLA-----LPIPSTCPEPFAKLMED 249
Query: 234 AFFCTQAAASRRPQMNQVIKMLTK 257
C RP ++ LT
Sbjct: 250 ---CWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 63/297 (21%), Positives = 119/297 (40%), Gaps = 33/297 (11%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G + +K L ++ R F+ E+ + + HPN+++ IG + R + EY++
Sbjct: 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
+L ++ + + W +R IA G+A+LH +I+HRD+ + N L+ + N
Sbjct: 93 TLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKN 146
Query: 125 PKIGDFGLAKLFPDNITHITTR-------------IAGTTGYLAPEYVLGGQLTMKADVY 171
+ DFGLA+L D T + G ++APE + G K DV+
Sbjct: 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206
Query: 172 SFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231
SFG+++ EII N +++ L+ P PP +
Sbjct: 207 SFGIVLCEIIGRVN----ADPDYLPRTMDFG---LNVRGFLDRYCPP--NCPP----SFF 253
Query: 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSS 288
+ C +RP ++ L + +R++ G + + ++
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWL-ETLRMHLAGHLPLGPQLEQLDRGFWETYRRGE 309
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-49
Identities = 69/278 (24%), Positives = 106/278 (38%), Gaps = 34/278 (12%)
Query: 6 NGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRI----LVYEY 60
G ++AVK + RE TEI +RH N++ I ++GT L+ +Y
Sbjct: 59 RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV-----PHIVHRDIKAS 115
EN SL L + L+ + + GL LH E+ P I HRD+K+
Sbjct: 117 HENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIAGTTGYLAPEYVLGGQLTM------ 166
NIL+ + I D GLA F + + GT Y+ PE VL L
Sbjct: 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSY 230
Query: 167 -KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD----PELGE 221
AD+YSFG+++ E+ SG + + E+ + P
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 222 YPPNEII--RYMKVAFFCTQAAASRRPQMNQVIKMLTK 257
++ + K+ C + R +V K L K
Sbjct: 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-49
Identities = 54/260 (20%), Positives = 108/260 (41%), Gaps = 32/260 (12%)
Query: 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYV 61
G I VK L S + R+F E L HPN++ ++G C L+ ++
Sbjct: 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
SL VL N ++ + + +A+G+AFLH L P I + + ++++D+
Sbjct: 92 PYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE 148
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ----LTMKADVYSFGVLV 177
+ +I + F + ++APE L + AD++SF VL+
Sbjct: 149 DMTARISMADVKFSF------QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLL 201
Query: 178 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237
E+++ + + ++ +E ++ E P + + + MK+ C
Sbjct: 202 WELVTR----EVPFADLS--NMEIGMKVALEGL-----RPTIPPGISPHVSKLMKI---C 247
Query: 238 TQAAASRRPQMNQVIKMLTK 257
++RP+ + ++ +L K
Sbjct: 248 MNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-48
Identities = 64/252 (25%), Positives = 120/252 (47%), Gaps = 25/252 (9%)
Query: 11 AVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
AVK L+ + Q ++ F E+ L RH N++ +G I V ++ E +SL
Sbjct: 50 AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYH 108
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
L + K +K DI A+G+ +LH I+HRD+K++NI L ++ KIG
Sbjct: 109 HLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIG 162
Query: 129 DFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQL----TMKADVYSFGVLVLEIISG 183
DFGLA + +H +++G+ ++APE V+ Q + ++DVY+FG+++ E+++G
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 184 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243
+ + +N + + + +L ++ P + R M C +
Sbjct: 222 QLP----YSNIN-NRDQIIEMVGRGSLSPDL--SKVRSNCPKRMKRLMA---ECLKKKRD 271
Query: 244 RRPQMNQVIKML 255
RP +++ +
Sbjct: 272 ERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-48
Identities = 57/262 (21%), Positives = 100/262 (38%), Gaps = 36/262 (13%)
Query: 11 AVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
A++ + E ++ ++ F E+M RH N+V +G C+ ++ + +L
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128
V+ A I L+ K I I KG+ +LH I+H+D+K+ N+ D I
Sbjct: 119 VV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVIT 171
Query: 129 DFGLAKL----FPDNITHITTRIAGTTGYLAPEYVLGGQL---------TMKADVYSFGV 175
DFGL + G +LAPE + + +DV++ G
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 176 LVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
+ E+ + + + WQ+ KP ++G EI +
Sbjct: 232 IWYELHAREWP----FKTQPAEAI--IWQMGTGMKPN---LSQIGM--GKEISDILL--- 277
Query: 236 FCTQAAASRRPQMNQVIKMLTK 257
FC RP +++ ML K
Sbjct: 278 FCWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 42/282 (14%)
Query: 6 NGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQG----TRRILVYEY 60
G +AVK S+ ++ RE TE+ +RH N++ I + T+ L+ Y
Sbjct: 30 QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV-----PHIVHRDIKAS 115
E SL L L+ I + IA GLA LH E+ P I HRD+K+
Sbjct: 88 HEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIAGTTGYLAPEYVLGGQL-------T 165
NIL+ + I D GLA + + + GT Y+APE VL +
Sbjct: 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSY 201
Query: 166 MKADVYSFGVLVLEIISGRNSGKA----------MWGQMNKFLLEWAWQLHQEEKPLELV 215
+ D+++FG+++ E+ S + F +++P +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIP 260
Query: 216 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257
+ + + + MK C S R ++ K LTK
Sbjct: 261 NRWFSDPTLTSLAKLMKE---CWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 69/282 (24%), Positives = 108/282 (38%), Gaps = 42/282 (14%)
Query: 6 NGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRI----LVYEY 60
G +AVK S+ ++ RE EI +RH N++ I + LV +Y
Sbjct: 64 RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV-----PHIVHRDIKAS 115
E+ SL L T + E + + A GLA LH E+V P I HRD+K+
Sbjct: 122 HEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHIT---TRIAGTTGYLAPEYVLGGQLTM------ 166
NIL+ + I D GLA I GT Y+APE VL + M
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESF 235
Query: 167 -KADVYSFGVLVLEIISGRNSG----------KAMWGQMNKFLLEWAWQLHQEEKPLELV 215
+AD+Y+ G++ EI + G + Q+ +P +
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP-NIP 294
Query: 216 DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257
+ + + M+ C A + R ++ K L++
Sbjct: 295 NRWQSCEALRVMAKIMRE---CWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 18/185 (9%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVEN 63
G +AVK L +++ +R+F EI L +++H N+V+ G C RR L+ EY+
Sbjct: 38 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 97
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL L + +++ K I KG+ +L + +HRD+ NIL++ E
Sbjct: 98 GSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENEN 151
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADVYSFGVLV 177
KIGDFGL K+ P + + G APE + + ++ +DV+SFGV++
Sbjct: 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVL 207
Query: 178 LEIIS 182
E+ +
Sbjct: 208 YELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 18/185 (9%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVEN 63
G +AVK L +++ +R+F EI L +++H N+V+ G C RR L+ EY+
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL L + +++ K I KG+ +L + +HRD+ NIL++ E
Sbjct: 129 GSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENEN 182
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADVYSFGVLV 177
KIGDFGL K+ P + + + G APE + + ++ +DV+SFGV++
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVL 238
Query: 178 LEIIS 182
E+ +
Sbjct: 239 YELFT 243
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-35
Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 16/186 (8%)
Query: 6 NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR----ILVYE 59
+A +K + F E L ++HPN+V + +LV E
Sbjct: 50 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
+ + +L L K + + C I KGL FLH P I+HRD+K NI +
Sbjct: 110 LMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFI 164
Query: 120 DQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
+ KIGD GLA L + + GT ++APE DVY+FG+ +L
Sbjct: 165 TGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEK-YDESVDVYAFGMCML 220
Query: 179 EIISGR 184
E+ +
Sbjct: 221 EMATSE 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 31/270 (11%)
Query: 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVE 62
G ++AVK L E + + EI L N+ H N+V+ G C + L+ E++
Sbjct: 49 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
+ SL L K+N +++ V I KG+ +L VHRD+ A N+L++ E
Sbjct: 109 SGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE 162
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADVYSFGVL 176
KIGDFGL K + + T + APE ++ + + +DV+SFGV
Sbjct: 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY----APECLMQSKFYIASDVWSFGVT 218
Query: 177 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG---EYP---PNEIIRY 230
+ E+++ +S + K + Q+ + + + G P P+E+ +
Sbjct: 219 LHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-VNTL--KEGKRLPCPPNCPDEVYQL 275
Query: 231 MKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260
M+ C + S R +I+ ++
Sbjct: 276 MRK---CWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 15/188 (7%)
Query: 1 MGTL-TNGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY 58
G L + +AVK +F+ E L HPN+V LIG C Q +V
Sbjct: 132 SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 59 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
E V+ L +L + + A G+ +L + +HRD+ A N L
Sbjct: 192 ELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCL 245
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY----LAPEYVLGGQLTMKADVYSFG 174
+ ++ KI DFG+++ D + G APE + G+ + ++DV+SFG
Sbjct: 246 VTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302
Query: 175 VLVLEIIS 182
+L+ E S
Sbjct: 303 ILLWETFS 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 76/266 (28%), Positives = 114/266 (42%), Gaps = 33/266 (12%)
Query: 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVEN 63
G +AVK L A+ Q + EI L + H ++++ GCC LV EYV
Sbjct: 60 GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL L + + + I +G+A+LH + H +HRD+ A N+LLD +
Sbjct: 120 GSLRDYL----PRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDR 171
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVL 178
KIGDFGLAK P+ + R G APE + + +DV+SFGV +
Sbjct: 172 LVKIGDFGLAKAVPEGHEYYRVR---EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 179 EIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY---PPN---EIIRYM 231
E+++ +S + + Q+ EL+ E GE P E+ M
Sbjct: 229 ELLTHCDSSQSPPTKFLELIGIAQ-GQMTVLRL-TELL--ERGERLPRPDKCPAEVYHLM 284
Query: 232 KVAFFCTQAAASRRPQMNQVIKMLTK 257
K C + AS RP +I +L
Sbjct: 285 KN---CWETEASFRPTFENLIPILKT 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVEN 63
G +AVK L R+F EI L + +V+ G R+ LV EY+ +
Sbjct: 51 TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L L + +L+ + I KG+ +L VHRD+ A NIL++ E
Sbjct: 111 GCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEA 164
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADVYSFGVLV 177
+ KI DFGLAKL P + + R G APE + + ++DV+SFGV++
Sbjct: 165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----APESLSDNIFSRQSDVWSFGVVL 220
Query: 178 LEIIS 182
E+ +
Sbjct: 221 YELFT 225
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-34
Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 8/184 (4%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
L+N RIA+K + + + EI +++H N+V+ +G + + E V
Sbjct: 44 LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL LL + +K N + I +GL +LH+ IVHRDIK N+L++
Sbjct: 104 GSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYS 159
Query: 124 -NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEI 180
KI DFG +K T GT Y+APE + G AD++S G ++E+
Sbjct: 160 GVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218
Query: 181 ISGR 184
+G+
Sbjct: 219 ATGK 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 43/281 (15%)
Query: 9 RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L S+ ++F E L+ ++H ++V G C +G ++V+EY+ + L+R
Sbjct: 73 LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 132
Query: 69 VL-----------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
L G A L + + +A G+ +L H VHRD+ N
Sbjct: 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNC 189
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYS 172
L+ Q KIGDFG+++ +I G L PE +L + T ++DV+S
Sbjct: 190 LVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245
Query: 173 FGVLVLEIIS-GRNSGKAM--WGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229
FGV++ EI + G+ + N ++ Q + E+P P E+
Sbjct: 246 FGVVLWEIFTYGK-----QPWYQLSNTEAIDCITQGRELERP---------RACPPEVYA 291
Query: 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPG 270
M+ C Q +R + V L + L G
Sbjct: 292 IMRG---CWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 329
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 45/183 (24%), Positives = 89/183 (48%), Gaps = 7/183 (3%)
Query: 1 MGTLTN-GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
G +AVK L ++ + V EF+ E + ++HPNLV+L+G C + ++ E
Sbjct: 238 EGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
++ +L L + + + I+ + +L ++ + +HR++ A N L+
Sbjct: 297 FMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLV 351
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
+ K+ DFGL++L + + APE + + ++K+DV++FGVL+ E
Sbjct: 352 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 180 IIS 182
I +
Sbjct: 412 IAT 414
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 19/188 (10%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
G +A+K + S EFI E + N+ H LV+L G C + ++ EY
Sbjct: 42 YGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ N L L + ++ ++C + + + +L + +HRD+ A N L++
Sbjct: 101 MANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVN 154
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAPEYVLGGQLTMKADVYSFG 174
+ K+ DFGL++ D+ T G+ + PE ++ + + K+D+++FG
Sbjct: 155 DQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWS---PPEVLMYSKFSSKSDIWAFG 208
Query: 175 VLVLEIIS 182
VL+ EI S
Sbjct: 209 VLMWEIYS 216
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 10/181 (5%)
Query: 7 GRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
++A+K + E ++ ++ F E+ S + H N+V +I + LV EY+E
Sbjct: 36 NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
+L + +++ L+ + + I G+ H+ IVHRDIK NIL+D
Sbjct: 96 PTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNK 148
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
KI DFG+AK + T + GT Y +PE G D+YS G+++ E++ G
Sbjct: 149 TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208
Query: 184 R 184
Sbjct: 209 E 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 59/188 (31%), Positives = 93/188 (49%), Gaps = 19/188 (10%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
M T ++AVK + S V F+ E + ++H LV+L + I + E+
Sbjct: 206 MATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI-ITEF 263
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ SL L + L K D IA+G+AF+ + + +HRD++A+NIL+
Sbjct: 264 MAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 318
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAPEYVLGGQLTMKADVYSFG 174
KI DFGLA++ DN T G T APE + G T+K+DV+SFG
Sbjct: 319 ASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWT---APEAINFGSFTIKSDVWSFG 372
Query: 175 VLVLEIIS 182
+L++EI++
Sbjct: 373 ILLMEIVT 380
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-32
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 19/188 (10%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+G N ++A+K + + +FI E + + HP LV+L G C++ LV E+
Sbjct: 26 LGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+E+ L L E +C+ + +G+A+L E ++HRD+ A N L+
Sbjct: 85 MEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVG 138
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAPEYVLGGQLTMKADVYSFG 174
+ K+ DFG+ + D+ T GT +PE + + K+DV+SFG
Sbjct: 139 ENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWA---SPEVFSFSRYSSKSDVWSFG 192
Query: 175 VLVLEIIS 182
VL+ E+ S
Sbjct: 193 VLMWEVFS 200
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-32
Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 19/188 (10%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+G +AVK + S EF E T+ + HP LV+ G C + +V EY
Sbjct: 26 LGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ N L L K L + ++C + +G+AFL +HRD+ A N L+D
Sbjct: 85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVD 138
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAPEYVLGGQLTMKADVYSFG 174
++ K+ DFG+ + D+ GT + APE + + K+DV++FG
Sbjct: 139 RDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWS---APEVFHYFKYSSKSDVWAFG 192
Query: 175 VLVLEIIS 182
+L+ E+ S
Sbjct: 193 ILMWEVFS 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 49/189 (25%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYE 59
+G G ++AVK + ++ + F+ E ++ +RH NLV+L+G V+ + +V E
Sbjct: 211 LGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
Y+ SL L ++ + + + + + + +L + VHRD+ A N+L+
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLV 322
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAPEYVLGGQLTMKADVYSF 173
++ K+ DFGL K ++ T APE + + + K+DV+SF
Sbjct: 323 SEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT---APEALREKKFSTKSDVWSF 372
Query: 174 GVLVLEIIS 182
G+L+ EI S
Sbjct: 373 GILLWEIYS 381
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 47/189 (24%), Positives = 76/189 (40%), Gaps = 32/189 (16%)
Query: 9 RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+ +K L + F +S + H +LV G CV G ILV E+V+ SLD
Sbjct: 42 EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--- 125
L K I + W+ ++ +A + FL E ++H ++ A NILL +E +
Sbjct: 102 YLKKN-KNCINILWKL--EVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTG 155
Query: 126 -----KIGDFGLAKLFPDNITHITTRIAGTTGY------LAPEYVL-GGQLTMKADVYSF 173
K+ D G++ + + PE + L + D +SF
Sbjct: 156 NPPFIKLSDPGISIT-----------VLPKDILQERIPWVPPECIENPKNLNLATDKWSF 204
Query: 174 GVLVLEIIS 182
G + EI S
Sbjct: 205 GTTLWEICS 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 68/188 (36%), Positives = 97/188 (51%), Gaps = 19/188 (10%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
MG ++AVK L S F+ E + ++H LV L Q I + EY
Sbjct: 31 MGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEY 88
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+EN SL L T + IKL K D+ IA+G+AF+ E + +HRD++A+NIL+
Sbjct: 89 MENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVS 143
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAPEYVLGGQLTMKADVYSFG 174
+ KI DFGLA+L DN T G T APE + G T+K+DV+SFG
Sbjct: 144 DTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT---APEAINYGTFTIKSDVWSFG 197
Query: 175 VLVLEIIS 182
+L+ EI++
Sbjct: 198 ILLTEIVT 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 11 AVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
A+K L + E + E +++V +P++ L+G C+ T ++ + + + L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY 106
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
+ + + + + CV IAKG+ +L + +VHRD+ A N+L+ + KI D
Sbjct: 107 VR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160
Query: 130 FGLAKLFPDNITHITTR-----IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
FGLAKL I A E +L T ++DV+S+GV V E+++
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 49/181 (27%), Positives = 93/181 (51%), Gaps = 17/181 (9%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+A+K L A +++ +F+ E + H N++ L G + +++ EY+EN +LD
Sbjct: 75 PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 134
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI 127
+ L + + + + + + GIA G+ +L + VHRD+ A NIL++ K+
Sbjct: 135 KFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKV 188
Query: 128 GDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
DFGL+++ D+ T G T APE + + T +DV+SFG+++ E++
Sbjct: 189 SDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVM 244
Query: 182 S 182
+
Sbjct: 245 T 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 69/267 (25%), Positives = 118/267 (44%), Gaps = 40/267 (14%)
Query: 9 RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68
+AVK L + ++F E L+N++H ++V+ G C G I+V+EY+++ L++
Sbjct: 47 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 106
Query: 69 VL------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
L +A +L + I IA G+ +L + H VHRD+ N
Sbjct: 107 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRN 163
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVY 171
L+ KIGDFG+++ ++ G L PE ++ + T ++DV+
Sbjct: 164 CLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 219
Query: 172 SFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230
SFGV++ EI + GK W Q+ N ++E Q E+P P E+
Sbjct: 220 SFGVILWEIFT---YGKQPWFQLSNTEVIECITQGRVLERP---------RVCPKEVYDV 267
Query: 231 MKVAFFCTQAAASRRPQMNQVIKMLTK 257
M C Q +R + ++ K+L
Sbjct: 268 MLG---CWQREPQQRLNIKEIYKILHA 291
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 7/182 (3%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
MGT R+A+K L + F+ E + +RH LV+L + I V EY
Sbjct: 202 MGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEY 259
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ SL L + L + D+ IA G+A++ + VHRD++A+NIL+
Sbjct: 260 MSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG 314
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ K+ DFGLA+L DN + APE L G+ T+K+DV+SFG+L+ E+
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 181 IS 182
+
Sbjct: 375 TT 376
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 16/187 (8%)
Query: 7 GRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVEL--IGCCVQGTRRI--LVYE 59
R +AVK L A F E + + HP +V + G + +V E
Sbjct: 37 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
YV+ +L ++ + ++ ++ + L F H+ I+HRD+K +NI++
Sbjct: 97 YVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMI 149
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITT--RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
K+ DFG+A+ D+ +T + GT YL+PE G + ++DVYS G ++
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 178 LEIISGR 184
E+++G
Sbjct: 210 YEVLTGE 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 7/182 (3%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
MGT R+A+K L + F+ E + +RH LV+L + I V EY
Sbjct: 285 MGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEY 342
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ SL L + L + D+ IA G+A++ + VHRD++A+NIL+
Sbjct: 343 MSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG 397
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ K+ DFGLA+L DN + APE L G+ T+K+DV+SFG+L+ E+
Sbjct: 398 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 181 IS 182
+
Sbjct: 458 TT 459
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-32
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 23/193 (11%)
Query: 1 MGTLTNGRR---IAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI 55
G + +AVK L E E + E + + +P +V +IG C + +
Sbjct: 35 KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
V E E L++ L + N + + ++ ++ G+ +L EE + VHRD+ A
Sbjct: 95 -VMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL-EES--NFVHRDLAAR 146
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKAD 169
N+LL + KI DFGL+K + + + G APE + + + K+D
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYYKFSSKSD 202
Query: 170 VYSFGVLVLEIIS 182
V+SFGVL+ E S
Sbjct: 203 VWSFGVLMWEAFS 215
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI--------- 55
+ R A+K + ++ + ++E+M L+++ H +V ++ +
Sbjct: 29 LDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87
Query: 56 ----LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 110
+ EY EN +L D + N+ ++ + I + L+++H + I+HR
Sbjct: 88 STLFIQMEYCENGTLYDLI----HSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHR 140
Query: 111 DIKASNILLDQEFNPKIGDFGLAKLF--------------PDNITHITTRIAGTTGYLAP 156
D+K NI +D+ N KIGDFGLAK P + ++T+ I GT Y+A
Sbjct: 141 DLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVAT 199
Query: 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAM 190
E + G G K D+YS G++ E+I ++G
Sbjct: 200 EVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 64/266 (24%), Positives = 112/266 (42%), Gaps = 33/266 (12%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL-VYEYVENNSL 66
AVK L+ V +F+TE + + + HPN++ L+G C++ L V Y+++ L
Sbjct: 55 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
+ + + +AKG+ +L + VHRD+ A N +LD++F K
Sbjct: 115 RNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVK 168
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYL------APEYVLGGQLTMKADVYSFGVLVLEI 180
+ DFGLA+ D + TG A E + + T K+DV+SFGVL+ E+
Sbjct: 169 VADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 181 IS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
++ G + + Q + +P EY P+ + M C
Sbjct: 226 MTRGA---PPYPDVNTFDITVYLLQGRRLLQP---------EYCPDPLYEVMLK---CWH 270
Query: 240 AAASRRPQMNQVIKMLTKNIRLNEEE 265
A RP ++++ ++ E
Sbjct: 271 PKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 17/179 (9%)
Query: 11 AVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
A+K L A +++ R+F++E + HPN++ L G +G ++V EY+EN SLD
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
L + + + + G+ G+ +L + VHRD+ A N+L+D K+ D
Sbjct: 141 LR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194
Query: 130 FGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
FGL+++ D+ T G T APE + + +DV+SFGV++ E+++
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 46/182 (25%), Positives = 67/182 (36%), Gaps = 13/182 (7%)
Query: 6 NGRRIAVK--PLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVE 62
+GR AVK + + E+ + V +HP V L +G L E
Sbjct: 81 DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG 140
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
+ L + LA LH + +VH D+K +NI L
Sbjct: 141 PSLQQHCE----AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPR 193
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
K+GDFGL + G Y+APE +L G ADV+S G+ +LE+
Sbjct: 194 GRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVAC 250
Query: 183 GR 184
Sbjct: 251 NM 252
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 21/193 (10%)
Query: 1 MGTLTNGRR----IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI 55
G L + +A+K L +++ R+F+ E + HPN++ L G + +
Sbjct: 63 SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
+V EY+EN SLD L K + + + + GIA G+ +L + VHRD+ A
Sbjct: 123 IVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAAR 176
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKAD 169
NIL++ K+ DFGL ++ D+ T G T +PE + + T +D
Sbjct: 177 NILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASD 232
Query: 170 VYSFGVLVLEIIS 182
V+S+G+++ E++S
Sbjct: 233 VWSYGIVLWEVMS 245
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 43/184 (23%), Positives = 81/184 (44%), Gaps = 7/184 (3%)
Query: 4 LTNGRRIAVKPL---SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
L +G +A+K + + + I EI L + HPN+++ ++ +V E
Sbjct: 54 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ L R++ K + V + L +H ++HRDIK +N+ +
Sbjct: 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFIT 170
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
K+GD GL + F T + + GT Y++PE + K+D++S G L+ E+
Sbjct: 171 ATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229
Query: 181 ISGR 184
+ +
Sbjct: 230 AALQ 233
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 10/183 (5%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+GR+ +K +S S + E E+ L+N++HPN+V+ + +V +Y E
Sbjct: 47 EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106
Query: 63 NNSLDRVLLGATKANIKLNWEKR-SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L + + + E + D V I L +H+ I+HRDIK+ NI L +
Sbjct: 107 GGDLFKRINAQKGVLFQ---EDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTK 160
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ ++GDFG+A++ + I GT YL+PE K+D+++ G ++ E+
Sbjct: 161 DGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219
Query: 182 SGR 184
+ +
Sbjct: 220 TLK 222
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 1 MGTLTNGRR---IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL 56
G ++ +A+K L K E + E + + +P +V LIG C Q +L
Sbjct: 28 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
V E L + L+G + ++ +++ ++ G+ +L EE + VHRD+ A N
Sbjct: 87 VMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL-EEK--NFVHRDLAARN 140
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADV 170
+LL KI DFGL+K + ++ T R AG APE + + + ++DV
Sbjct: 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINFRKFSSRSDV 196
Query: 171 YSFGVLVLEIIS 182
+S+GV + E +S
Sbjct: 197 WSYGVTMWEALS 208
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 19/186 (10%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
R+A+K ++ S + EF+ E + ++V L+G QG +++ E + L
Sbjct: 57 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116
Query: 68 ------RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
R + + K + IA G+A+L+ VHRD+ A N ++ +
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVL 176
+F KIGDFG+ + +I G G L +PE + G T +DV+SFGV+
Sbjct: 174 DFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229
Query: 177 VLEIIS 182
+ EI +
Sbjct: 230 LWEIAT 235
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-31
Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 1 MGTLTNGRR---IAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRIL 56
G ++ +A+K L +++ E + E + + +P +V LIG C Q +L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 412
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
V E L + L+ ++ +++ ++ G+ +L EE + VHR++ A N
Sbjct: 413 VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL-EEK--NFVHRNLAARN 466
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG------TTGYLAPEYVLGGQLTMKADV 170
+LL KI DFGL+K + ++ T R AG APE + + + ++DV
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINFRKFSSRSDV 522
Query: 171 YSFGVLVLEIIS 182
+S+GV + E +S
Sbjct: 523 WSYGVTMWEALS 534
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 46/188 (24%), Positives = 81/188 (43%), Gaps = 21/188 (11%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G + AVK L + E++ + + P +V L G +G + E +
Sbjct: 80 KQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
E SL +++ K L ++ +GL +LH I+H D+KA N+LL
Sbjct: 133 EGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSS 185
Query: 122 EFNP-KIGDFGLAKLFPDNITHITTR----IAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
+ + + DFG A + + I GT ++APE V+G K D++S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 177 VLEIISGR 184
+L +++G
Sbjct: 246 MLHMLNGC 253
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 70/284 (24%), Positives = 109/284 (38%), Gaps = 36/284 (12%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
++AVK L S+Q +F+ E + +S H N+V IG +Q R ++ E + L
Sbjct: 62 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 121
Query: 68 RVLL---GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L L + IA G +L E H +HRDI A N LL
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 178
Query: 125 P---KIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVL 176
KIGDFG+A+ +I + G L PE + G T K D +SFGVL
Sbjct: 179 GRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 177 VLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
+ EI S G + N+ +LE+ + + P + P + R M
Sbjct: 235 LWEIFSLGY---MPYPSKSNQEVLEFVTSGGRMDPP---------KNCPGPVYRIMTQ-- 280
Query: 236 FCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSS 279
C Q RP +++ + + + + + +
Sbjct: 281 -CWQHQPEDRPNFAIILERI-EYCTQDPDVINTALPIEYGPLVE 322
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-31
Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 17/188 (9%)
Query: 1 MGTLTNGR-RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
G +AVK L ++ + V EF+ E + ++HPNLV+L+G C + ++ E
Sbjct: 31 EGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
++ +L L + + + I+ + +L ++ + +HRD+ A N L+
Sbjct: 90 FMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLV 144
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFG 174
+ K+ DFGL++L + T A APE + + ++K+DV++FG
Sbjct: 145 GENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 199
Query: 175 VLVLEIIS 182
VL+ EI +
Sbjct: 200 VLLWEIAT 207
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 7/186 (3%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--VYEY 60
++G+ + K + ++ + ++E+ L ++HPN+V + T L V EY
Sbjct: 29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE--ELVPHIVHRDIKASNIL 118
E L V+ TK L+ E + + L H + ++HRD+K +N+
Sbjct: 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
LD + N K+GDFGLA++ + + T + GT Y++PE + K+D++S G L+
Sbjct: 149 LDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 179 EIISGR 184
E+ +
Sbjct: 208 ELCALM 213
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 25/192 (13%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+A+K L + EF E M + ++HPN+V L+G + +++ Y + L
Sbjct: 41 AVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLH 100
Query: 68 RVL------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
L L + IA G+ +L H+VH+D+
Sbjct: 101 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATR 157
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADV 170
N+L+ + N KI D GL + + L APE ++ G+ ++ +D+
Sbjct: 158 NVLVYDKLNVKISDLGLFR----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 213
Query: 171 YSFGVLVLEIIS 182
+S+GV++ E+ S
Sbjct: 214 WSYGVVLWEVFS 225
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 17/178 (9%)
Query: 11 AVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
A+K L + + +E + E +++V +P++ L+G C+ T ++ + + + L
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY 106
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
+ + + + + CV IAKG+ +L + +VHRD+ A N+L+ + KI D
Sbjct: 107 VR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160
Query: 130 FGLAKLFPDNITHITTR-----IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
FGLAKL I A E +L T ++DV+S+GV V E+++
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 42/274 (15%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYE 59
+G G ++AVK + ++ + F+ E ++ +RH NLV+L+G V+ + +V E
Sbjct: 39 LGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
Y+ SL L ++ + + + + + + +L + VHRD+ A N+L+
Sbjct: 96 YMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLV 150
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGT------TGYLAPEYVLGGQLTMKADVYSF 173
++ K+ DFGL K ++ T APE + + + K+DV+SF
Sbjct: 151 SEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT---APEALREKKFSTKSDVWSF 200
Query: 174 GVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232
G+L+ EI S GR K ++ + ++ + P + P + MK
Sbjct: 201 GILLWEIYSFGR---VPYPRIPLKDVVPRVEKGYKMDAP---------DGCPPAVYEVMK 248
Query: 233 VAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 266
C A+ RP Q+ + L ++I+ +E L
Sbjct: 249 N---CWHLDAAMRPSFLQLREQL-EHIKTHELHL 278
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 70/284 (24%), Positives = 108/284 (38%), Gaps = 36/284 (12%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
++AVK L S+Q +F+ E + +S H N+V IG +Q R ++ E + L
Sbjct: 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 162
Query: 68 ---RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---Q 121
R L + IA G +L E H +HRDI A N LL
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 219
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVL 176
KIGDFG+A+ +I G L PE + G T K D +SFGVL
Sbjct: 220 GRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275
Query: 177 VLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
+ EI S G + N+ +LE+ + + P + P + R M
Sbjct: 276 LWEIFSLGY---MPYPSKSNQEVLEFVTSGGRMDPP---------KNCPGPVYRIMTQ-- 321
Query: 236 FCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSS 279
C Q RP +++ + + + + + +
Sbjct: 322 -CWQHQPEDRPNFAIILERI-EYCTQDPDVINTALPIEYGPLVE 363
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 10/230 (4%)
Query: 7 GRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
G +A K + E K +R I E+ L P +V G + E+++ S
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
LD+VL K ++ + + + + KGL +L E+ I+HRD+K SNIL++
Sbjct: 118 LDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI 171
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
K+ DFG++ D++ + + + GT Y++PE + G ++++D++S G+ ++E+ GR
Sbjct: 172 KLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 186 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
+ + + + E P P R F
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIF 278
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 43/278 (15%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
++AVK L + ++E+ +S++ +H N+V L+G C G +++ EY L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 67 ----------DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
AN + +A+G+AFL + + +HRD+ A N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVY 171
+LL KIGDFGLA+ +I + + I L APE + T+++DV+
Sbjct: 195 VLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 172 SFGVLVLEIIS-GRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228
S+G+L+ EI S G N G + + K + + +Q +P + P I
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG----YQMAQP---------AFAPKNIY 297
Query: 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 266
M+ C + RP Q+ L + + + E
Sbjct: 298 SIMQA---CWALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 33/163 (20%), Positives = 70/163 (42%), Gaps = 13/163 (7%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88
E+ ++++++ + G ++YEY+EN+S+ + + +
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 89 CV----GIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT 144
+ +++H E +I HRD+K SNIL+D+ K+ DFG ++ D
Sbjct: 153 IKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-G 209
Query: 145 TRIAGTTGYLAPEYVLGGQLTM---KADVYSFGVLVLEIISGR 184
+ GT ++ PE + + K D++S G+ + +
Sbjct: 210 S--RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-30
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
G+ +A++ ++ + + I EI+ + ++PN+V + + G +V EY+ S
Sbjct: 44 TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L V+ ++ + + +C + L FLH ++HRDIK+ NILL + +
Sbjct: 104 LTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSV 155
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+ DFG + +T + GT ++APE V K D++S G++ +E+I G
Sbjct: 156 KLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-30
Identities = 57/290 (19%), Positives = 117/290 (40%), Gaps = 35/290 (12%)
Query: 11 AVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRV 69
+K + +S +Q + ++ + ++ H ++V L+G C + ++ V +Y+ SL
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDH 104
Query: 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGD 129
+ + L + + V IAKG+ +L E +VHR++ A N+LL ++ D
Sbjct: 105 VR---QHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD 158
Query: 130 FGLAKLFPDNITHITTR-----IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-G 183
FG+A L P + + I A E + G+ T ++DV+S+GV V E+++ G
Sbjct: 159 FGVADLLPPDDKQLLYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 184 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243
+ G + + + + +P + ++ M C +
Sbjct: 215 A---EPYAGLRLAEVPDLLEKGERLAQP---------QICTIDVYMVMVK---CWMIDEN 259
Query: 244 RRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQ 293
RP ++ T+ R L + + G ++ L+
Sbjct: 260 IRPTFKELANEFTRMARDPPRYLVIKR--ESGPGIAPGPEPHGLTNKKLE 307
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 35/277 (12%)
Query: 1 MGTLTNGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI 55
G + + A+K LS Q V F+ E + + + HPN++ LIG +
Sbjct: 39 HGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98
Query: 56 L-VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
+ Y+ + L + + + + + +A+G+ +L E+ VHRD+ A
Sbjct: 99 HVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAA 152
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKAD 169
N +LD+ F K+ DFGLA+ D + L A E + + T K+D
Sbjct: 153 RNCMLDESFTVKVADFGLARDILDR--EYYSVQQHRHARLPVKWTALESLQTYRFTTKSD 210
Query: 170 VYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228
V+SFGVL+ E+++ G L + Q + +P EY P+ +
Sbjct: 211 VWSFGVLLWELLTRGA---PPYRHIDPFDLTHFLAQGRRLPQP---------EYCPDSLY 258
Query: 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
+ M+ C +A + RP ++ + + + +
Sbjct: 259 QVMQQ---CWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 47/282 (16%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
+AVK L ++E+ LS + H N+V L+G C G +++ EY L
Sbjct: 55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 67 ------DRVLLGATKANIKLNWEKRS--------DICVGIAKGLAFLHEELVPHIVHRDI 112
R +K + + + +AKG+AFL + + +HRD+
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDL 171
Query: 113 KASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMK 167
A NILL KI DFGLA+ +I + + + L APE + T +
Sbjct: 172 AARNILLTHGRITKICDFGLAR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227
Query: 168 ADVYSFGVLVLEIIS-GRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 224
+DV+S+G+ + E+ S G + G + + K + E + P E+ P
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG----FRMLSP---------EHAP 274
Query: 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 266
E+ MK C A +RP Q+++++ K I + +
Sbjct: 275 AEMYDIMKT---CWDADPLKRPTFKQIVQLIEKQISESTNHI 313
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 13/184 (7%)
Query: 4 LTNGRRIAVKPLSAE--SKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+ +A+K L K GV + E+ S++RHPN++ L G TR L+ EY
Sbjct: 31 KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
++ R L + K + ++ + +A L++ H + ++HRDIK N+LL
Sbjct: 91 APLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLG 143
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
KI DFG + P + GT YL PE + G K D++S GVL E
Sbjct: 144 SAGELKIADFGWSVHAPSS-RRTDL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200
Query: 181 ISGR 184
+ G+
Sbjct: 201 LVGK 204
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 20/197 (10%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR----ILVYE 59
L +G A+K + +Q E E HPN++ L+ C++ L+
Sbjct: 51 LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRS-DICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
+ + +L + L E + + +GI +GL +H HRD+K +NIL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLT-EDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNIL 166
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIA--------GTTGYLAPEYV---LGGQLTMK 167
L E P + D G ++ + T Y APE + +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 168 ADVYSFGVLVLEIISGR 184
DV+S G ++ ++ G
Sbjct: 227 TDVWSLGCVLYAMMFGE 243
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 45/178 (25%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
+GR++AVK + +Q E++ + + +H N+VE+ + G ++ E+++ +
Sbjct: 69 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L ++ ++LN E+ + +C + + LA+LH + ++HRDIK+ +ILL +
Sbjct: 129 LTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRV 180
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+ DFG ++ + + GT ++APE + + D++S G++V+E++ G
Sbjct: 181 KLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 65/265 (24%), Positives = 111/265 (41%), Gaps = 31/265 (11%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL-VYEYVENNSL 66
AVK L+ V +F+TE + + + HPN++ L+G C++ L V Y+++ L
Sbjct: 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178
Query: 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
+ + + +AKG+ FL + VHRD+ A N +LD++F K
Sbjct: 179 RNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVK 232
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEII 181
+ DFGLA+ D T L A E + + T K+DV+SFGVL+ E++
Sbjct: 233 VADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 182 S-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240
+ G + + Q + +P EY P+ + M C
Sbjct: 291 TRGA---PPYPDVNTFDITVYLLQGRRLLQP---------EYCPDPLYEVMLK---CWHP 335
Query: 241 AASRRPQMNQVIKMLTKNIRLNEEE 265
A RP ++++ ++ E
Sbjct: 336 KAEMRPSFSELVSRISAIFSTFIGE 360
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 12/182 (6%)
Query: 7 GRRIAVKPLSAE--SKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
R +A+K +S S R E T ++ P++V + + + +
Sbjct: 59 ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L +L + L + I I L H HRD+K NIL+ +
Sbjct: 119 VDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADD 171
Query: 124 NPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
+ DFG+A D +T GT Y+APE T +AD+Y+ ++ E ++
Sbjct: 172 FAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230
Query: 183 GR 184
G
Sbjct: 231 GS 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 13/184 (7%)
Query: 4 LTNGRRIAVKPLSAE--SKQGVREFI-TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
N +A+K L K+GV + EI S++RHPN++ + R L+ E+
Sbjct: 36 KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
L + L + + + + ++ + +A L + HE ++HRDIK N+L+
Sbjct: 96 APRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMG 148
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ KI DFG + P T GT YL PE + G K D++ GVL E
Sbjct: 149 YKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205
Query: 181 ISGR 184
+ G
Sbjct: 206 LVGM 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 66/277 (23%), Positives = 125/277 (45%), Gaps = 42/277 (15%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
+AVK L + +++ + + ++E+ + + +H N++ L+G C Q ++ EY +L
Sbjct: 69 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 67 DRVLLGATKANIKLNWEKRS------------DICVGIAKGLAFLHEELVPHIVHRDIKA 114
L ++ +++ +A+G+ +L + +HRD+ A
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKAD 169
N+L+ + KI DFGLA+ +I +I T G L APE + T ++D
Sbjct: 186 RNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 170 VYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228
V+SFGVL+ EI + G + + + + L + + H+ +KP NE+
Sbjct: 242 VWSFGVLMWEIFTL---GGSPYPGIPVEELFKLLKEGHRMDKP---------ANCTNELY 289
Query: 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
M+ C A S+RP Q+++ L + + L E
Sbjct: 290 MMMRD---CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 66/277 (23%), Positives = 125/277 (45%), Gaps = 42/277 (15%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
+AVK L + +++ + + ++E+ + + +H N++ L+G C Q ++ EY +L
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 67 DRVLLGATKANIKLNWEKRS------------DICVGIAKGLAFLHEELVPHIVHRDIKA 114
L ++ +++ +A+G+ +L + +HRD+ A
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKAD 169
N+L+ + KI DFGLA+ +I +I T G L APE + T ++D
Sbjct: 232 RNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287
Query: 170 VYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228
V+SFGVL+ EI + G + + + + L + + H+ +KP NE+
Sbjct: 288 VWSFGVLMWEIFTL---GGSPYPGIPVEELFKLLKEGHRMDKP---------ANCTNELY 335
Query: 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
M+ C A S+RP Q+++ L + + L E
Sbjct: 336 MMMRD---CWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 43/189 (22%), Positives = 83/189 (43%), Gaps = 22/189 (11%)
Query: 9 RIAVKPL--SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI------LVYEY 60
++AVK L + + EF+ E + HP++ +L+G ++ + ++ +
Sbjct: 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 61 VENNSLDRVLLGATKAN--IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
+++ L LL + L + V IA G+ +L + +HRD+ A N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCM 169
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSF 173
L ++ + DFGL++ I G L A E + T+ +DV++F
Sbjct: 170 LAEDMTVCVADFGLSR----KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 174 GVLVLEIIS 182
GV + EI++
Sbjct: 226 GVTMWEIMT 234
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-29
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 16/191 (8%)
Query: 1 MGTLT--NGRRIAV-----KPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR 53
G +G+ ++V KP + + +FI E+ + ++ H NL+ L G +
Sbjct: 36 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM 95
Query: 54 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
++ V E SL L + + L S V +A+G+ +L + +HRD+
Sbjct: 96 KM-VTELAPLGSLLDRLRK-HQGHFLL--GTLSRYAVQVAEGMGYLESK---RFIHRDLA 148
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY--LAPEYVLGGQLTMKADVY 171
A N+LL KIGDFGL + P N H + + APE + + +D +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 172 SFGVLVLEIIS 182
FGV + E+ +
Sbjct: 209 MFGVTLWEMFT 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 45/188 (23%), Positives = 88/188 (46%), Gaps = 21/188 (11%)
Query: 9 RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYV 61
++AVK + + S++ + EF++E + + HPN++ L+G C++ + +++ ++
Sbjct: 64 KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 62 ENNSLDRVLLGATKANIKLNWEKRS--DICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
+ L LL + + ++ V IA G+ +L + +HRD+ A N +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCML 180
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFG 174
+ + DFGL+K I G + A E + T K+DV++FG
Sbjct: 181 RDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 175 VLVLEIIS 182
V + EI +
Sbjct: 237 VTMWEIAT 244
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-29
Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 22/192 (11%)
Query: 1 MGTLTNGR----RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI 55
G TN + +AVK + + +F++E + + N+ HP++V+LIG + I
Sbjct: 30 EGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
+ E L L L + I K +A+L + VHRDI
Sbjct: 90 -IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVR 142
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADV 170
NIL+ K+GDFGL++ D + L +PE + + T +DV
Sbjct: 143 NILVASPECVKLGDFGLSRYIEDEDY-----YKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 171 YSFGVLVLEIIS 182
+ F V + EI+S
Sbjct: 198 WMFAVCMWEILS 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 46/280 (16%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILV-YEYVENNS 65
+AVK L + R ++E+ L ++ H N+V L+G C + ++V E+ + +
Sbjct: 59 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 66 LDRVLLGATKANIKLNWEKRS------------DICVGIAKGLAFLHEELVPHIVHRDIK 113
L L + +AKG+ FL +HRD+
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKA 168
A NILL ++ KI DFGLA+ +I + L APE + T+++
Sbjct: 176 ARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 231
Query: 169 DVYSFGVLVLEIIS-GRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN 225
DV+SFGVL+ EI S G + G + + + L E + P +Y
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAP---------DYTTP 278
Query: 226 EIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
E+ + M C S+RP +++++ L ++ N ++
Sbjct: 279 EMYQTMLD---CWHGEPSQRPTFSELVEHLGNLLQANAQQ 315
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 18/180 (10%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+A+K S +F+ E +T+ HP++V+LIG + I + E L
Sbjct: 45 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELR 103
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKI 127
L L+ ++ LA+L + VHRDI A N+L+ K+
Sbjct: 104 SFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL 157
Query: 128 GDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS 182
GDFGL++ D+ + G L APE + + T +DV+ FGV + EI+
Sbjct: 158 GDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
G+ +A+K + ES ++E I EI + P++V+ G + T +V EY S
Sbjct: 53 TGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
+ ++ N L ++ + I KGL +LH +HRDIKA NILL+ E +
Sbjct: 111 VSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHA 164
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
K+ DFG+A D + T I GT ++APE + AD++S G+ +E+ G
Sbjct: 165 KLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 17/187 (9%)
Query: 4 LTNGRRIAVKPLSAES--KQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
A K + K RE EI ++ H ++V G +V E
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122
Query: 61 VENNSLDRVLLGATKANIKLN-WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
SL + K L E R I G +LH ++HRD+K N+ L
Sbjct: 123 CRRRSLLELH----KRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFL 174
Query: 120 DQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLV 177
+++ KIGDFGLA K+ D + GT Y+APE VL + + + DV+S G ++
Sbjct: 175 NEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIM 231
Query: 178 LEIISGR 184
++ G+
Sbjct: 232 YTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-28
Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 15/186 (8%)
Query: 4 LTNGRRIAVKPLSAES--KQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
A K + K RE EI ++ H ++V G +V E
Sbjct: 37 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
SL + K L + I G +LH ++HRD+K N+ L+
Sbjct: 97 CRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLN 149
Query: 121 QEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVL 178
++ KIGDFGLA K+ D + GT Y+APE VL + + + DV+S G ++
Sbjct: 150 EDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMY 206
Query: 179 EIISGR 184
++ G+
Sbjct: 207 TLLVGK 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 33/200 (16%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
+AVK L E S +F E ++ +PN+V+L+G C G L++EY+ L+
Sbjct: 79 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 68 RVLLGATKANIKLNWEKRSD--------------------ICVGIAKGLAFLHEELVPHI 107
L + + I +A G+A+L E
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGG 162
VHRD+ N L+ + KI DFGL++ NI A + PE +
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYKADGNDAIPIRWMPPESIFYN 251
Query: 163 QLTMKADVYSFGVLVLEIIS 182
+ T ++DV+++GV++ EI S
Sbjct: 252 RYTTESDVWAYGVVLWEIFS 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 38/205 (18%), Positives = 70/205 (34%), Gaps = 33/205 (16%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEY 60
+G A+K + + E+ + + +H ++V + ++ EY
Sbjct: 33 RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
SL + + + D+ + + +GL ++H +VH DIK SNI +
Sbjct: 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFIS 149
Query: 121 QEFNP-------------------KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161
+ P KIGD G G + +LA E VL
Sbjct: 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-----GDSRFLANE-VLQ 203
Query: 162 GQL--TMKADVYSFGVLVLEIISGR 184
KAD+++ + V+
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAE 228
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 68/311 (21%), Positives = 122/311 (39%), Gaps = 49/311 (15%)
Query: 1 MGTLTNG---RRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRI 55
+ A+K + SK R+F E+ L + HPN++ L+G C
Sbjct: 43 KARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRS------------DICVGIAKGLAFLHEEL 103
L EY + +L L + + + +A+G+ +L ++
Sbjct: 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK- 161
Query: 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEY 158
+HRD+ A NIL+ + + KI DFGL++ + T G L A E
Sbjct: 162 --QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV------KKTMGRLPVRWMAIES 212
Query: 159 VLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 217
+ T +DV+S+GVL+ EI+S G G G L E Q ++ EKP
Sbjct: 213 LNYSVYTTNSDVWSYGVLLWEIVSLG---GTPYCGMTCAELYEKLPQGYRLEKP------ 263
Query: 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSES 277
+E+ M+ C + RP Q++ L + + + + L++
Sbjct: 264 ---LNCDDEVYDLMRQ---CWREKPYERPSFAQILVSLNRMLEERKTYVNT-TLYEKFTY 316
Query: 278 SSVGTSDKKSS 288
+ + S ++++
Sbjct: 317 AGIDCSAEEAA 327
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL- 66
+AVK L S +R+ ++E L V HP++++L G C Q +L+ EY + SL
Sbjct: 55 TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 67 -----------DRVLLGATKANIKLNWEKRS--------DICVGIAKGLAFLHEELVPHI 107
+ G ++ + L+ I++G+ +L E +
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KL 171
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGG 162
VHRD+ A NIL+ + KI DFGL++ ++ + + + G + A E +
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSR----DVYEEDSYVKRSQGRIPVKWMAIESLFDH 227
Query: 163 QLTMKADVYSFGVLVLEIIS 182
T ++DV+SFGVL+ EI++
Sbjct: 228 IYTTQSDVWSFGVLLWEIVT 247
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 43/208 (20%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGC----------------C 48
+G+ +K + +++ RE + L+ + H N+V GC
Sbjct: 34 IDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89
Query: 49 VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 108
+ + E+ + +L++ + + KL+ ++ I KG+ ++H + ++
Sbjct: 90 SKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLI 144
Query: 109 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA 168
+RD+K SNI L KIGDFGL ++ TR GT Y++PE + +
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEV 202
Query: 169 DVYSFGVLVLEIISGRNSGKAMWGQMNK 196
D+Y+ G+++ E++ ++
Sbjct: 203 DLYALGLILAELLHVCDTAFETSKFFTD 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 47/185 (25%), Positives = 74/185 (40%), Gaps = 22/185 (11%)
Query: 6 NGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVEL--IGCCVQGTRRILVY---E 59
NGR + +K L + + E L+ V HP++V++ + Y E
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
YV SL R KL + + I L++LH +V+ D+K NI+L
Sbjct: 165 YVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIML 215
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
+E K+ D G I + GT G+ APE V G T+ D+Y+ G +
Sbjct: 216 TEE-QLKLIDLGAVS----RINS-FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
Query: 180 IISGR 184
+
Sbjct: 269 LTLDL 273
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-28
Identities = 46/184 (25%), Positives = 93/184 (50%), Gaps = 12/184 (6%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G A K + +S++ + ++I EI L+ HP +V+L+G + ++ E+
Sbjct: 42 ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
++D ++ + + L + +C + + L FLH + I+HRD+KA N+L+ E +
Sbjct: 102 AVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGD 155
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-----MKADVYSFGVLVLE 179
++ DFG++ + + I GT ++APE V+ + KAD++S G+ ++E
Sbjct: 156 IRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
Query: 180 IISG 183
+
Sbjct: 215 MAQI 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 20/191 (10%)
Query: 1 MGTLTNGRR----IAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI 55
G + +A+K S +F+ E +T+ HP++V+LIG + I
Sbjct: 408 QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
+ E L L L+ ++ LA+L + VHRDI A
Sbjct: 468 -IMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAAR 520
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTR----IAGTTGYLAPEYVLGGQLTMKADVY 171
N+L+ K+GDFGL++ D+ + ++ I APE + + T +DV+
Sbjct: 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINFRRFTSASDVW 576
Query: 172 SFGVLVLEIIS 182
FGV + EI+
Sbjct: 577 MFGVCMWEILM 587
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 26/193 (13%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
++AVK L ++ +++ + + I+E+ + + +H N++ L+G C Q ++ EY +L
Sbjct: 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 67 ------------DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
+ + +L+ + +A+G+ +L + +HRD+ A
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGGQLTMKAD 169
N+L+ ++ KI DFGLA+ +I HI T G L APE + T ++D
Sbjct: 220 RNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 170 VYSFGVLVLEIIS 182
V+SFGVL+ EI +
Sbjct: 276 VWSFGVLLWEIFT 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 10/181 (5%)
Query: 4 LTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+ +A+K + E + + + EI LS P + + G ++ T+ ++ EY+
Sbjct: 44 NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
S +L + L+ + + I I KGL +LH E +HRDIKA+N+LL +
Sbjct: 104 GGSALDLL----EPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH 155
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
K+ DFG+A D T + GT ++APE + KAD++S G+ +E+
Sbjct: 156 GEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 183 G 183
G
Sbjct: 215 G 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 46/189 (24%), Positives = 75/189 (39%), Gaps = 21/189 (11%)
Query: 6 NGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
+ R +AVK + E RE +++ S+ HPN++ + + E
Sbjct: 47 DNRDVAVKRILPECFSFADRE--VQLLRESD-EHPNVIRYFCTEKDRQFQYIAIELCAAT 103
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----- 119
+ V + + + + GLA LH +IVHRD+K NIL+
Sbjct: 104 LQEYVE----QKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNA 156
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLG---GQLTMKADVYSFG 174
+ I DFGL K + R + GT G++APE + T D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 175 VLVLEIISG 183
+ +IS
Sbjct: 217 CVFYYVISE 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 4 LTNGRRIAVKPLSAES--KQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+ G +A+K + ++ K G+ + + E+ ++HP+++EL LV E
Sbjct: 33 IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
N ++R L K + + I G+ +LH I+HRD+ SN+LL
Sbjct: 93 CHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLT 146
Query: 121 QEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVL 178
+ N KI DFGLA +L + H T + GT Y++PE + +++DV+S G +
Sbjct: 147 RNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE-IATRSAHGLESDVWSLGCMFY 203
Query: 179 EIISGR 184
++ GR
Sbjct: 204 TLLIGR 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 68/287 (23%), Positives = 113/287 (39%), Gaps = 52/287 (18%)
Query: 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSL 66
++AVK L + ++E+ ++ + H N+V L+G C L++EY L
Sbjct: 77 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 67 -------------------DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 107
++ L + L +E +AKG+ FL +
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL-----APEYVLGG 162
VHRD+ A N+L+ KI DFGLA+ +I + + L APE + G
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYVVRGNARLPVKWMAPESLFEG 249
Query: 163 QLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL 219
T+K+DV+S+G+L+ EI S G N G + K + + ++P
Sbjct: 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG----FKMDQP-------- 297
Query: 220 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEEL 266
Y EI M+ C + +RP + L + EE +
Sbjct: 298 -FYATEEIYIIMQS---CWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 52/275 (18%), Positives = 98/275 (35%), Gaps = 51/275 (18%)
Query: 6 NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGC---------CVQGTRR 54
+ A+K L + + E+ L+ + HP +V + +
Sbjct: 29 DDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 55 ILVY---EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD 111
+ +Y + +L + + I + IA+ + FLH + ++HRD
Sbjct: 88 VYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRD 143
Query: 112 IKASNILLDQEFNPKIGDFGLAKLF-----------PDNITHITTRIAGTTGYLAPEYVL 160
+K SNI + K+GDFGL P T GT Y++PE +
Sbjct: 144 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203
Query: 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG 220
G + K D++S G+++ E++ QM + + K P
Sbjct: 204 GNSYSHKVDIFSLGLILFELLY------PFSTQMERVRT---LTDVRNLKF----PPLFT 250
Query: 221 EYPPNE--IIRYMKVAFFCTQAAASRRPQMNQVIK 253
+ P E +++ M + RP+ +I+
Sbjct: 251 QKYPCEYVMVQDM------LSPSPMERPEAINIIE 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 45/185 (24%), Positives = 87/185 (47%), Gaps = 11/185 (5%)
Query: 6 NGRRIAVKPLSAESKQGVREFI-TEI-MTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+G+ +AVK + A ++ + ++ +++ V P V G + + E + +
Sbjct: 31 SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-D 89
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SLD+ + + I V I K L LH +L ++HRD+K SN+L++
Sbjct: 90 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALG 147
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL----TMKADVYSFGVLVLE 179
K+ DFG++ D++ AG Y+APE + ++K+D++S G+ ++E
Sbjct: 148 QVKMCDFGISGYLVDDVAKDID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
Query: 180 IISGR 184
+ R
Sbjct: 206 LAILR 210
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 12/186 (6%)
Query: 6 NGRRIAVKPLSAESKQGVREFI-TEI-MTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+G+ +AVK + + + ++ + ++ + + + P +V+ G + + E + +
Sbjct: 46 SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-S 104
Query: 64 NSLDRVLLGATKANIKLNWEKR-SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
S D+ + E+ I + K L L E L I+HRDIK SNILLD+
Sbjct: 105 TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRS 162
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL----TMKADVYSFGVLVL 178
N K+ DFG++ D+I TR AG Y+APE + +++DV+S G+ +
Sbjct: 163 GNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 179 EIISGR 184
E+ +GR
Sbjct: 221 ELATGR 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 40/195 (20%), Positives = 78/195 (40%), Gaps = 25/195 (12%)
Query: 6 NGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL--VELIGCCVQGTRRILVYEYV 61
+ A+K L Q + + EI L+ ++ + + L + +V E
Sbjct: 51 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N L+ L K ++ +R + + + +H+ IVH D+K +N L+
Sbjct: 110 GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD 162
Query: 122 EFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLG-----------GQLTMKAD 169
K+ DFG+A + T + GT Y+ PE + +++ K+D
Sbjct: 163 G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 170 VYSFGVLVLEIISGR 184
V+S G ++ + G+
Sbjct: 222 VWSLGCILYYMTYGK 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-27
Identities = 69/308 (22%), Positives = 107/308 (34%), Gaps = 27/308 (8%)
Query: 5 TNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELI------GCCVQGTRRILV 57
G ++A+K E RE EI + + HPN+V +L
Sbjct: 37 DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
EY E L R L + L + I+ L +LHE I+HRD+K NI
Sbjct: 97 MEYCEGGDL-RKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENI 152
Query: 118 LLDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFG 174
+L KI D G AK T + GT YLAPE + + T+ D +SFG
Sbjct: 153 VLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 175 VLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234
L E I+G W + Q H + + + + + +
Sbjct: 211 TLAFECITGFRPFLPNWQPV---------QWHGKVREKSNEHIVVYDDLTGAVKFSSVLP 261
Query: 235 FFCTQAAASRRPQMNQVIKMLTKNI--RLNEEELTAPGLFQDSESSSVGTSDKKSSDSTL 292
+ + ML + R + + G FQ +S + +
Sbjct: 262 TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSG 321
Query: 293 QMSSVPVT 300
++ + PVT
Sbjct: 322 RVHTYPVT 329
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 41/192 (21%), Positives = 71/192 (36%), Gaps = 17/192 (8%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G + V+ L A S + V E+ HPN+V + +V ++
Sbjct: 49 KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
S + L+ + +N + I G+ K L ++H VHR +KAS+IL+
Sbjct: 109 AYGSA-KDLICTHFMD-GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISV 163
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRI------AGTTGYLAPEYVLGGQL---TMKADVYS 172
+ + + +L+PE VL L K+D+YS
Sbjct: 164 DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYS 222
Query: 173 FGVLVLEIISGR 184
G+ E+ +G
Sbjct: 223 VGITACELANGH 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 25/200 (12%)
Query: 1 MGTLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL--VELIGCCVQGTRRIL 56
+ A+K L Q + + EI L+ ++ + + L + +
Sbjct: 27 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
V E N L+ L K ++ +R + + + +H+ IVH D+K +N
Sbjct: 87 VMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN 138
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLG-----------GQL 164
L+ K+ DFG+A + T + GT Y+ PE + ++
Sbjct: 139 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 197
Query: 165 TMKADVYSFGVLVLEIISGR 184
+ K+DV+S G ++ + G+
Sbjct: 198 SPKSDVWSLGCILYYMTYGK 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 12/175 (6%)
Query: 6 NGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
+G +K ++ S+ + + EI L ++ HPN++++ +V E E
Sbjct: 46 SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105
Query: 65 SL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---D 120
L +R++ + L+ +++ + LA+ H + H+VH+D+K NIL
Sbjct: 106 ELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTS 161
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
KI DFGLA+LF + +T AGT Y+APE V +T K D++S GV
Sbjct: 162 PHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGV 213
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 52/188 (27%), Positives = 88/188 (46%), Gaps = 22/188 (11%)
Query: 4 LTNGRRIAVK--PLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+ N +A+K S + ++ I E+ L +RHPN ++ GC ++ LV EY
Sbjct: 76 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
++ D + + L + + + G +GLA+LH +++HRD+KA NILL
Sbjct: 136 CLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS 188
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLGGQLT---MKADVYSFGV 175
+ K+GDFG A + + GT ++APE +L K DV+S G+
Sbjct: 189 EPGLVKLGDFGSA-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
Query: 176 LVLEIISG 183
+E+
Sbjct: 242 TCIELAER 249
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 39/200 (19%), Positives = 77/200 (38%), Gaps = 25/200 (12%)
Query: 1 MGTLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNL--VELIGCCVQGTRRIL 56
+ A+K L Q + + EI L+ ++ + + L + +
Sbjct: 74 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
V E N L+ L K ++ +R + + + +H+ IVH D+K +N
Sbjct: 134 VMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN 185
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLG-----------GQL 164
L+ K+ DFG+A + T + G Y+ PE + ++
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 165 TMKADVYSFGVLVLEIISGR 184
+ K+DV+S G ++ + G+
Sbjct: 245 SPKSDVWSLGCILYYMTYGK 264
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-26
Identities = 42/277 (15%), Positives = 84/277 (30%), Gaps = 24/277 (8%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
N ++ +K + + L ++ + +LV E +
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 66 L-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L + + L + + + + +H+ I+H DIK N +L F
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210
Query: 125 P-----------KIGDFGLA---KLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADV 170
+ D G + KLFP T + T+G+ E + + D
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTI-FTAKC-ETSGFQCVEMLSNKPWNYQIDY 268
Query: 171 YSFGVLVLEIISGR----NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226
+ V ++ G + F + E + L P+ P +
Sbjct: 269 FGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
Query: 227 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 263
++R F R N++I +L + R +
Sbjct: 329 LLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 365
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 45/175 (25%), Positives = 70/175 (40%), Gaps = 15/175 (8%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
R A K + + V F EI + ++ HPN++ L T LV E
Sbjct: 32 GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91
Query: 65 SL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---D 120
L +RV+ + I + +A+ H+ ++ HRD+K N L
Sbjct: 92 ELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDS 143
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
+ K+ DFGLA F + GT Y++P+ VL G + D +S GV
Sbjct: 144 PDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 46/255 (18%), Positives = 90/255 (35%), Gaps = 42/255 (16%)
Query: 16 SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVL---LG 72
S + +I + N V + + + +L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 73 ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGL 132
+ I + IA+ + FLH + ++HRD+K SNI + K+GDFGL
Sbjct: 158 LEDREHGVCL----HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 210
Query: 133 AK-----------LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
L P T GT Y++PE + G + K D++S G+++ E++
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE--IIRYMKVAFFCTQ 239
++ M + + + + P + P E +++ M
Sbjct: 271 YSFSTQ------MERVRI--ITDVRNLKFP-----LLFTQKYPQEHMMVQDM------LS 311
Query: 240 AAASRRPQMNQVIKM 254
+ + RP+ +I+
Sbjct: 312 PSPTERPEATDIIEN 326
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 48/195 (24%), Positives = 73/195 (37%), Gaps = 21/195 (10%)
Query: 5 TNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYV 61
G A+K + S + E L + H N+V+L + T R +L+ E+
Sbjct: 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-- 119
SL VL L + + + G+ L E IVHR+IK NI+
Sbjct: 92 PCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVI 147
Query: 120 --DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM--------KAD 169
D + K+ DFG A+ D+ + GT YL P+ L D
Sbjct: 148 GEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVD 205
Query: 170 VYSFGVLVLEIISGR 184
++S GV +G
Sbjct: 206 LWSIGVTFYHAATGS 220
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+ AVK ++ + + E+ L + HPN+++L + +V E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 63 NNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-- 119
L D ++ + + + I + G+ ++H+ +IVHRD+K NILL
Sbjct: 105 GGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLES 156
Query: 120 -DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
+++ + KI DFGL+ F N GT Y+APE VL G K DV+S GV
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 9e-25
Identities = 21/212 (9%), Positives = 45/212 (21%), Gaps = 42/212 (19%)
Query: 7 GRRIAVK---PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC----------VQGTR 53
A+K + S+ + + + + E VQ
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 54 RI----------------LVYEYVENN--SLDRVLLGATKANIKLNWEKRSDICVGIAKG 95
L+ + L L + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 96 LAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155
A L + +VH N+ + + +GD + A
Sbjct: 207 AANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYA 258
Query: 156 PEYVLGGQ---LTMKADVYSFGVLVLEIISGR 184
P L T + + G+ + +
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 13/191 (6%)
Query: 4 LTNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
++A+K ++ E Q + E + EI +S HPN+V V LV + +
Sbjct: 37 APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96
Query: 63 NNSLDRVLLGATK----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
S+ ++ + L+ + I + +GL +LH+ +HRD+KA NIL
Sbjct: 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNIL 153
Query: 119 LDQEFNPKIGDFGL-AKLFPDNITHITTR---IAGTTGYLAPEYVL-GGQLTMKADVYSF 173
L ++ + +I DFG+ A L GT ++APE + KAD++SF
Sbjct: 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 174 GVLVLEIISGR 184
G+ +E+ +G
Sbjct: 214 GITAIELATGA 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 29/189 (15%)
Query: 5 TNGRRIAVK--------PLSAESKQGVREFI-TEIMTLSNV-RHPNLVELIGCCVQGTRR 54
+ AVK SAE Q +RE E+ L V HPN+++L T
Sbjct: 40 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99
Query: 55 ILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
LV++ ++ L D + + L+ ++ I + + + LH+ +IVHRD+K
Sbjct: 100 FLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLK 151
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM------- 166
NILLD + N K+ DFG + + GT YLAPE ++ +
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPE-IIECSMNDNHPGYGK 208
Query: 167 KADVYSFGV 175
+ D++S GV
Sbjct: 209 EVDMWSTGV 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 18/187 (9%)
Query: 5 TNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G+ AVK +S + K + E+ L + HPN+++L LV E
Sbjct: 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108
Query: 62 ENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL- 119
L D ++ + + + + I + G+ ++H+ IVHRD+K N+LL
Sbjct: 109 TGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLE 160
Query: 120 --DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
++ N +I DFGL+ F + GT Y+APE VL G K DV+S GV++
Sbjct: 161 SKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
Query: 178 LEIISGR 184
++SG
Sbjct: 218 YILLSGC 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 47/196 (23%), Positives = 72/196 (36%), Gaps = 23/196 (11%)
Query: 5 TNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYV 61
G A+K + S + E L + H N+V+L + T R +L+ E+
Sbjct: 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 62 ENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL- 119
SL L L + + + G+ L E IVHR+IK NI+
Sbjct: 92 PCGSLYTV--LEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRV 146
Query: 120 ---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM--------KA 168
D + K+ DFG A+ D+ + GT YL P+ L
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 169 DVYSFGVLVLEIISGR 184
D++S GV +G
Sbjct: 205 DLWSIGVTFYHAATGS 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
A+K ++ S + + E+ L + HPN+++L LV E +
Sbjct: 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 63 NNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-- 119
L D ++ +K N + I + G+ +LH+ +IVHRD+K N+LL
Sbjct: 120 GGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLES 171
Query: 120 -DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
+++ KI DFGL+ +F + GT Y+APE VL + K DV+S GV++
Sbjct: 172 KEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228
Query: 179 EIISGR 184
+++G
Sbjct: 229 ILLAGY 234
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 5e-24
Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DR 68
I K LSA Q + E ++HPN+V L + + LV++ V L +
Sbjct: 39 INTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 95
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--- 125
++ A + S I + +A+ H IVHR++K N+LL +
Sbjct: 96 IV-----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV 147
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGV 175
K+ DFGLA D+ AGT GYL+PE VL + D+++ GV
Sbjct: 148 KLADFGLAIEVNDS--EAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGV 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-24
Identities = 46/186 (24%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 6 NGRRIAVKPLSAESKQGVREFIT-EIMTL-SNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
G IAVK + + + I ++ + + P +V+ G + T + E +
Sbjct: 49 TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
+++ + + + V I K L +L E+ ++HRD+K SNILLD+
Sbjct: 108 TCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERG 162
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE-----YVLGGQLTMKADVYSFGVLVL 178
K+ DFG++ D+ R AG Y+APE ++ADV+S G+ ++
Sbjct: 163 QIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 179 EIISGR 184
E+ +G+
Sbjct: 221 ELATGQ 226
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-24
Identities = 53/204 (25%), Positives = 80/204 (39%), Gaps = 32/204 (15%)
Query: 6 NGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
GR +AVK + + E +++T S HPN++ + E N
Sbjct: 38 QGRPVAVKRMLIDFCDIALME--IKLLTES-DDHPNVIRYYCSETTDRFLYIALELCNLN 94
Query: 65 SLDRVLL-GATKANIKLNWEKR-SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-- 120
D V + N+KL E + IA G+A LH I+HRD+K NIL+
Sbjct: 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTS 151
Query: 121 -----------QEFNPKIGDFGLAKLFPDNITHITTR---IAGTTGYLAPEYVLGG---- 162
+ I DFGL K + T +GT+G+ APE +
Sbjct: 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ 211
Query: 163 ---QLTMKADVYSFGVLVLEIISG 183
+LT D++S G + I+S
Sbjct: 212 TKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 9/171 (5%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DR 68
+ V ++ + E ++HP++VEL+ +V+E+++ L
Sbjct: 57 VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 116
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--- 125
++ A + S I + L + H+ +I+HRD+K +LL + N
Sbjct: 117 IV-KRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
K+G FG+A ++ R+ GT ++APE V DV+ GV+
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 52/190 (27%), Positives = 83/190 (43%), Gaps = 19/190 (10%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRI------LVY 58
G+ A+K + E EI L H N+ G ++ LV
Sbjct: 48 TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106
Query: 59 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
E+ S+ L+ TK N L E + IC I +GL+ LH+ ++HRDIK N+L
Sbjct: 107 EFCGAGSVTD-LIKNTKGN-TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVL 161
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-----MKADVYSF 173
L + K+ DFG++ + T I GT ++APE + + K+D++S
Sbjct: 162 LTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 174 GVLVLEIISG 183
G+ +E+ G
Sbjct: 221 GITAIEMAEG 230
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+ AVK ++ + + E+ L + HPN+++L + +V E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 63 NNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-- 119
L D ++ + + + I + G+ ++H+ +IVHRD+K NILL
Sbjct: 105 GGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLES 156
Query: 120 -DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
+++ + KI DFGL+ F N GT Y+APE VL G K DV+S GV++
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILY 213
Query: 179 EIISGR 184
++SG
Sbjct: 214 ILLSGT 219
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 1e-23
Identities = 29/191 (15%), Positives = 67/191 (35%), Gaps = 23/191 (12%)
Query: 9 RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC--VQGTRRILVYEYVENNSL 66
R+ + + + FI + + + ++ + + R +Y +++N
Sbjct: 128 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 187
Query: 67 DRV--LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
LL + + L R + + + + LA LH +VH ++ +I+LDQ
Sbjct: 188 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGG 244
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL-----------GGQLTMKADVYSF 173
+ F D +++ + G+ PE +T D ++
Sbjct: 245 VFLTGFEHLV--RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299
Query: 174 GVLVLEIISGR 184
G+++ I
Sbjct: 300 GLVIYWIWCAD 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 52/188 (27%), Positives = 81/188 (43%), Gaps = 28/188 (14%)
Query: 5 TNGRRIAVK-------PLSAESKQGVREFI-TEIMTLSNVR-HPNLVELIGCCVQGTRRI 55
G AVK LS E + VRE E L V HP+++ LI +
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 56 LVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
LV++ + L D + + L+ ++ I + + ++FLH +IVHRD+K
Sbjct: 177 LVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKP 228
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTM-------K 167
NILLD ++ DFG + + GT GYLAPE +L + +
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPE-ILKCSMDETHPGYGKE 285
Query: 168 ADVYSFGV 175
D+++ GV
Sbjct: 286 VDLWACGV 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 5 TNGRRIAVK-------------PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG 51
A+K + ++ E EI L ++ HPN+++L
Sbjct: 59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 52 TRRILVYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHR 110
LV E+ E L ++++ K + ++I I G+ +LH+ +IVHR
Sbjct: 119 KYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHKH---NIVHR 170
Query: 111 DIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMK 167
DIK NILL + N KI DFGL+ F + + GT Y+APE VL + K
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPE-VLKKKYNEK 227
Query: 168 ADVYSFGVLVLEIISGR 184
DV+S GV++ ++ G
Sbjct: 228 CDVWSCGVIMYILLCGY 244
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 12/173 (6%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
G ++A K + + E EI ++ + H NL++L +LV EYV+ L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 67 -DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
DR+ + L I +G+ +H+ +I+H D+K NIL
Sbjct: 174 FDRI----IDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAK 226
Query: 126 --KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
KI DFGLA+ + GT +LAPE V ++ D++S GV+
Sbjct: 227 QIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 16/185 (8%)
Query: 5 TNGRRIAVKPLSAESKQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+A+K + E ++G I E+ L +++H N+V L LV+EY++
Sbjct: 25 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 64 ---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
LD N+KL + +GLA+ H ++HRD+K N+L++
Sbjct: 85 DLKQYLDDCGNIINMHNVKL-------FLFQLLRGLAYCHR---QKVLHRDLKPQNLLIN 134
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLE 179
+ K+ DFGLA+ + T Y P+ +LG + + D++ G + E
Sbjct: 135 ERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYE 193
Query: 180 IISGR 184
+ +GR
Sbjct: 194 MATGR 198
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-23
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 12/173 (6%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
GR K ++ EI ++ + HP L+ L +L+ E++ L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 67 -DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
DR+ + K++ + + +GL +HE IVH DIK NI+ + +
Sbjct: 136 FDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS 188
Query: 126 --KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
KI DFGLA + I T + APE V + D+++ GVL
Sbjct: 189 SVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 16/173 (9%)
Query: 10 IAVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-D 67
I + A + RE I E+ L V H N++ L T +L+ E V L D
Sbjct: 45 IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-- 125
+ L+ E+ + I G+ +LH + I H D+K NI+L + P
Sbjct: 105 FLA-----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156
Query: 126 --KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
K+ DFGLA D I GT ++APE V L ++AD++S GV+
Sbjct: 157 HIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 12/174 (6%)
Query: 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL 66
G A K + + EI T+S +RHP LV L +++YE++ L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 67 -DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
++V + K++ ++ + + KGL +HE + VH D+K NI+ + +
Sbjct: 242 FEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSN 294
Query: 126 --KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
K+ DFGL GT + APE G + D++S GVL
Sbjct: 295 ELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 6e-23
Identities = 48/175 (27%), Positives = 73/175 (41%), Gaps = 15/175 (8%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
G+ A+K + EI L ++H N+V L T LV + V
Sbjct: 32 LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG 91
Query: 65 SL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---D 120
L DR+L + S + + + +LHE IVHRD+K N+L +
Sbjct: 92 ELFDRIL-----ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPE 143
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
+ I DFGL+K+ + I + GT GY+APE + + D +S GV
Sbjct: 144 ENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-23
Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 23/189 (12%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFIT---EIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
GR +A+K S + + V+ EI L +RH NLV L+ C + R LV+E
Sbjct: 48 DTGRIVAIKKFLESDD-DKMVK--KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104
Query: 60 YVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
+V++ L+ G ++ I G+ F H +I+HRDIK N
Sbjct: 105 FVDHTILDDLELFPNGLDYQVVQK-------YLFQIINGIGFCHSH---NIIHRDIKPEN 154
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGV 175
IL+ Q K+ DFG A+ +A T Y APE ++G + DV++ G
Sbjct: 155 ILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGC 213
Query: 176 LVLEIISGR 184
LV E+ G
Sbjct: 214 LVTEMFMGE 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-23
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DR 68
I K LSA Q + E ++HPN+V L + + LV++ V L +
Sbjct: 62 INTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--- 125
++ A + S I + +A+ H IVHR++K N+LL +
Sbjct: 119 IV-----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV 170
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
K+ DFGLA D+ AGT GYL+PE + + D+++ GV
Sbjct: 171 KLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 36/177 (20%), Positives = 71/177 (40%), Gaps = 17/177 (9%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
++ + K + + V+ EI L+ RH N++ L ++++E++
Sbjct: 28 SSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIFEFIS 84
Query: 63 NNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-D 120
+ +R+ + +LN + + + L FLH +I H DI+ NI+
Sbjct: 85 GLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQT 137
Query: 121 QEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
+ + KI +FG A+ + Y APE ++ D++S G L
Sbjct: 138 RRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 19/178 (10%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
AVK + + E EI+ L +HPN++ L G +V E ++
Sbjct: 45 ATNMEFAVKIIDKSKRDPTEE--IEIL-LRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101
Query: 65 SL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-DQE 122
L D++L + + S + I K + +LH + +VHRD+K SNIL D+
Sbjct: 102 ELLDKIL-----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDES 153
Query: 123 FNP---KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVL 176
NP +I DFG AK + T T ++APE VL Q D++S GVL
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPE-VLERQGYDAACDIWSLGVL 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 16/173 (9%)
Query: 10 IAVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-D 67
I + LS+ + RE I E+ L +RHPN++ L T +L+ E V L D
Sbjct: 38 IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-- 125
+ L ++ + I G+ +LH + I H D+K NI+L + P
Sbjct: 98 FLA-----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP 149
Query: 126 --KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
K+ DFG+A + I GT ++APE V L ++AD++S GV+
Sbjct: 150 RIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 29/185 (15%), Positives = 62/185 (33%), Gaps = 12/185 (6%)
Query: 9 RIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSL 66
R+ + + + FI + + + ++ + R +Y +++N
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 67 DRV--LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
LL + + L R + + + + LA LH +VH ++ +I+LDQ
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGG 249
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-----LTMKADVYSFGVLVLE 179
+ F + R A + GQ +T D ++ G+ +
Sbjct: 250 VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 180 IISGR 184
I
Sbjct: 310 IWCAD 314
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 16/173 (9%)
Query: 10 IAVKPLSAESKQGVREFI-TEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-D 67
I + A + RE I E+ L V HPN++ L T +L+ E V L D
Sbjct: 45 IKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD 104
Query: 68 RVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-- 125
+ L+ E+ + I G+ +LH + I H D+K NI+L + P
Sbjct: 105 FLA-----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156
Query: 126 --KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
K+ DFGLA D I GT ++APE V L ++AD++S GV+
Sbjct: 157 HIKLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 40/204 (19%), Positives = 79/204 (38%), Gaps = 26/204 (12%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRR-------- 54
+ +GR A+K L + ++ R I E+ + + HPN+V+ G
Sbjct: 50 VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 55 ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
+L+ E + ++ L ++ L+ + I + + +H P I+HRD+K
Sbjct: 110 LLLTELCKGQLVE--FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKV 166
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA-----------GTTGYLAPEYV---L 160
N+LL + K+ DFG A + + T Y PE +
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226
Query: 161 GGQLTMKADVYSFGVLVLEIISGR 184
+ K D+++ G ++ + +
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 53/186 (28%), Positives = 93/186 (50%), Gaps = 17/186 (9%)
Query: 5 TNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+ GR +A+K + ++ +G+ I EI L + HPN+V LI LV+E++E
Sbjct: 43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102
Query: 63 N---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
LD G + IK+ + +G+A H+ I+HRD+K N+L+
Sbjct: 103 KDLKKVLDENKTGLQDSQIKI-------YLYQLLRGVAHCHQH---RILHRDLKPQNLLI 152
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVL 178
+ + K+ DFGLA+ F + T + T Y AP+ ++G + + D++S G +
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211
Query: 179 EIISGR 184
E+I+G+
Sbjct: 212 EMITGK 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 11 AVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
A K L+ + ++G + + E L+ V +V L T LV + +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 68 RVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
+ + N E R+ I GL LH+ +I++RD+K N+LLD + N +
Sbjct: 274 YHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
I D GLA T AGT G++APE +LG + D ++ GV + E+I+ R
Sbjct: 330 ISDLGLAVELKAGQTKTKGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-22
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFIT---EIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
G+ +A+K S + ++ EI L ++HPNLV L+ + R LV+E
Sbjct: 26 DTGQIVAIKKFLESED-DPVIK--KIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82
Query: 60 YVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
Y ++ LDR G + +K I + + F H+ + +HRD+K N
Sbjct: 83 YCDHTVLHELDRYQRGVPEHLVK-------SITWQTLQAVNFCHKH---NCIHRDVKPEN 132
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGV 175
IL+ + K+ DFG A+L + +A T Y +PE ++G DV++ G
Sbjct: 133 ILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPVDVWAIGC 191
Query: 176 LVLEIISGR 184
+ E++SG
Sbjct: 192 VFAELLSGV 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 48/186 (25%), Positives = 76/186 (40%), Gaps = 30/186 (16%)
Query: 7 GRRIAVK--------PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LV 57
+++A+K SA TEI L + HP ++++ +V
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN--FFDAEDYYIV 92
Query: 58 YEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
E +E L D+V N +L + + +LHE I+HRD+K N
Sbjct: 93 LELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPEN 144
Query: 117 ILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL----TMKAD 169
+LL +++ KI DFG +K+ + + + GT YLAPE VL D
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVD 201
Query: 170 VYSFGV 175
+S GV
Sbjct: 202 CWSLGV 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 28/189 (14%)
Query: 5 TNGRRIAVK--------PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL 56
+++A++ SA TEI L + HP ++++ +
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYI 216
Query: 57 VYEYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
V E +E L D+V+ N +L + + +LHE I+HRD+K
Sbjct: 217 VLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPE 268
Query: 116 NILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL----TMKA 168
N+LL +++ KI DFG +K+ + + + GT YLAPE VL
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPE-VLVSVGTAGYNRAV 325
Query: 169 DVYSFGVLV 177
D +S GV++
Sbjct: 326 DCWSLGVIL 334
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-22
Identities = 55/187 (29%), Positives = 100/187 (53%), Gaps = 15/187 (8%)
Query: 5 TNGRRIAVKPLSAESKQGVREFIT---EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
T G +A+K + +S++G T EI + ++H N+V L + LV+E++
Sbjct: 28 TTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 62 EN---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
+N +D +G T ++LN K + +GLAF HE I+HRD+K N+L
Sbjct: 86 DNDLKKYMDSRTVGNTPRGLELNLVKY--FQWQLLQGLAFCHEN---KILHRDLKPQNLL 140
Query: 119 LDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLV 177
+++ K+GDFGLA+ F + ++ + T Y AP+ ++G + + D++S G ++
Sbjct: 141 INKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199
Query: 178 LEIISGR 184
E+I+G+
Sbjct: 200 AEMITGK 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-22
Identities = 53/178 (29%), Positives = 75/178 (42%), Gaps = 12/178 (6%)
Query: 11 AVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
A K L + ++G + E L V +V L LV + L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 68 RVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPK 126
+ +A E R+ I GL LH E IV+RD+K NILLD + +
Sbjct: 273 FHIYHMGQAGFP---EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR 326
Query: 127 IGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
I D GLA P+ T GT GY+APE V + T D ++ G L+ E+I+G+
Sbjct: 327 ISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-22
Identities = 42/186 (22%), Positives = 80/186 (43%), Gaps = 17/186 (9%)
Query: 5 TNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+A+K + + +GV + EI L ++H N+V L + LV+E+ +
Sbjct: 25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 63 N---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
D +K + KGL F H +++HRD+K N+L+
Sbjct: 85 QDLKKYFDSCNGDLDPEIVKS-------FLFQLLKGLGFCHSR---NVLHRDLKPQNLLI 134
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVL 178
++ K+ +FGLA+ F + + + T Y P+ + G +L + D++S G +
Sbjct: 135 NRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 179 EIISGR 184
E+ +
Sbjct: 194 ELANAG 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-22
Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 18/176 (10%)
Query: 5 TNGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+ A+K L K+ VR TEI L + HPN+++L T LV E V
Sbjct: 76 GTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132
Query: 64 NSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--- 119
L DR++ + +D I + +A+LHE IVHRD+K N+L
Sbjct: 133 GELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATP 184
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
+ KI DFGL+K+ + + GT GY APE + G + D++S G+
Sbjct: 185 APDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 8e-22
Identities = 53/229 (23%), Positives = 80/229 (34%), Gaps = 53/229 (23%)
Query: 5 TNGRRIAVK-----PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
A+K + + + V TE+ + + HPN+ L LV E
Sbjct: 49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVME 108
Query: 60 YVENNSL-DRVLLGATKANIKLNWEKR--------------------------------- 85
L D++ + + K +
Sbjct: 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK 168
Query: 86 --SDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--DQEFNPKIGDFGLAKLFPDN-- 139
S+I I L +LH + I HRDIK N L ++ F K+ DFGL+K F
Sbjct: 169 LISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 140 -ITHITTRIAGTTGYLAPEYVLGGQL---TMKADVYSFGVLVLEIISGR 184
+ T AGT ++APE VL K D +S GVL+ ++ G
Sbjct: 226 GEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 5 TNGRRIAVK------PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVY 58
+ G + A K S+ + E+ L ++HPN++ L T IL+
Sbjct: 34 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 59 EYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
E V L D + L E+ ++ I G+ +LH I H D+K NI
Sbjct: 94 ELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENI 145
Query: 118 LLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
+L P KI DFGLA + I GT ++APE V L ++AD++S
Sbjct: 146 MLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 203
Query: 174 GVL 176
GV+
Sbjct: 204 GVI 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 1e-21
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 27 ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN---NSLDRVLLGATKANIKLNWE 83
I EI L ++H N+V+L R +LV+E+++ LD G K
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS--- 104
Query: 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 143
+ + G+A+ H+ ++HRD+K N+L+++E KI DFGLA+ F +
Sbjct: 105 ----FLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 144 TTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 184
T I T Y AP+ ++G + + D++S G + E+++G
Sbjct: 158 THEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 45/171 (26%), Positives = 70/171 (40%), Gaps = 18/171 (10%)
Query: 10 IAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSL-DR 68
I K LSA Q + E ++HPN+V L + L+++ V L +
Sbjct: 44 INTKKLSARDHQKLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED 100
Query: 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNP 125
++ A + S I + + H+ +VHR++K N+LL +
Sbjct: 101 IV-----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAV 152
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGV 175
K+ DFGLA AGT GYL+PE VL D+++ GV
Sbjct: 153 KLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGV 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 19/178 (10%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVEN 63
+ + AVK +S + ++ EI L HPN+V+L LV E +
Sbjct: 34 KSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90
Query: 64 NSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--- 119
L +R+ + + S I + ++ +H+ +VHRD+K N+L
Sbjct: 91 GELFERIK-----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDE 142
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVL 176
+ KI DFG A+L P + + T T Y APE +L D++S GV+
Sbjct: 143 NDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPE-LLNQNGYDESCDLWSLGVI 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 29/182 (15%)
Query: 4 LTNGRRIAVK----PLSAESKQGVREFIT---EIMTLSNVRHPNLVELIGCCVQGTRRIL 56
+ +A+K +E+K G+ T EI L + HPN++ L+ + L
Sbjct: 32 KNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89
Query: 57 VYEYVEN---NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
V++++E + L T ++IK + +GL +LH+ I+HRD+K
Sbjct: 90 VFDFMETDLEVIIKDNSLVLTPSHIKA-------YMLMTLQGLEYLHQH---WILHRDLK 139
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
+N+LLD+ K+ DFGLAK F T ++ T Y APE + G A +Y
Sbjct: 140 PNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFG------ARMYGV 192
Query: 174 GV 175
GV
Sbjct: 193 GV 194
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-21
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 15/179 (8%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYV 61
+ G+ A K + E + EI L + P ++ L + IL+ EY
Sbjct: 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111
Query: 62 ENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL- 119
+ L + ++ + I +G+ +LH+ +IVH D+K NILL
Sbjct: 112 AGGEIFSLCL---PELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLS 165
Query: 120 --DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
+ KI DFG+++ I GT YLAPE + +T D+++ G++
Sbjct: 166 SIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRR--ILVYEYVENNSL-DRVLLGATKANIKLNWEKR 85
EI L + HPN+V+L+ +V+E V + + L L+ ++
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQA 139
Query: 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 145
+ KG+ +LH + I+HRDIK SN+L+ ++ + KI DFG++ F + ++
Sbjct: 140 RFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 146 RIAGTTGYLAPEYVLGGQLT---MKADVYSFGV 175
GT ++APE + + DV++ GV
Sbjct: 197 T-VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 43/191 (22%), Positives = 76/191 (39%), Gaps = 27/191 (14%)
Query: 6 NGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEY 60
R A+K L + V E +S + HP V+L Q ++ Y
Sbjct: 54 TSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFVKLYFTF-QDDEKLYFGLSY 111
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVG------IAKGLAFLHEELVPHIVHRDIKA 114
+N L + + D I L +LH + I+HRD+K
Sbjct: 112 AKNGELLKYI----------RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKP 158
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTR-IAGTTGYLAPEYVLGGQLTMKADVYSF 173
NILL+++ + +I DFG AK+ GT Y++PE + +D+++
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 218
Query: 174 GVLVLEIISGR 184
G ++ ++++G
Sbjct: 219 GCIIYQLVAGL 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+AVK + + E I EI + H N+V+ G +G + L EY
Sbjct: 29 RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 63 NNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L DR+ +I + + G+ +LH I HRDIK N+LLD+
Sbjct: 89 GGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIA-GTTGYLAPEYVLGGQL--TMKADVYSFGVLVL 178
N KI DFGLA +F N GT Y+APE +L + DV+S G+++
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLT 199
Query: 179 EIISGR 184
+++G
Sbjct: 200 AMLAGE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 34/195 (17%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI------LVYE 59
+G +A+K + + + RE + + + H N+V L + LV +
Sbjct: 78 SGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHRDIKA 114
YV + RV ++A L I V + + LA++H I HRDIK
Sbjct: 134 YVPET-VYRVARHYSRAKQTL-----PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKP 184
Query: 115 SNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKAD 169
N+LLD + K+ DFG AK N+++I +R Y APE + G T D
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDYTSSID 239
Query: 170 VYSFGVLVLEIISGR 184
V+S G ++ E++ G+
Sbjct: 240 VWSAGCVLAELLLGQ 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 30/198 (15%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR-------IL 56
+ G +A+K + + + RE + + L+ + HPN+V+L R +
Sbjct: 45 KSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHRD 111
V EYV + L R + + I + + + + LH ++ HRD
Sbjct: 104 VMEYVPDT-LHRCCRNYYRRQVAP-----PPILIKVFLFQLIRSIGCLHLP-SVNVCHRD 156
Query: 112 IKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-TM 166
IK N+L+++ K+ DFG AK N+ +I +R Y APE + G Q T
Sbjct: 157 IKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTT 211
Query: 167 KADVYSFGVLVLEIISGR 184
D++S G + E++ G
Sbjct: 212 AVDIWSVGCIFAEMMLGE 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 54/183 (29%), Positives = 81/183 (44%), Gaps = 14/183 (7%)
Query: 7 GRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
+AVK + + E I EI + H N+V+ G +G + L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 66 L-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L DR+ +I + + G+ +LH I HRDIK N+LLD+ N
Sbjct: 92 LFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDN 143
Query: 125 PKIGDFGLAKLFPDNITHITTRIA-GTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEII 181
KI DFGLA +F N GT Y+APE +L + DV+S G+++ ++
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAML 202
Query: 182 SGR 184
+G
Sbjct: 203 AGE 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 23/191 (12%)
Query: 5 TNGRRIAVKPLSAES-KQGV-REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+A+K + E ++GV I E+ L ++H N++EL R L++EY E
Sbjct: 57 VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 63 NNSLDRVL---LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
N+ L + + + IK + G+ F H +HRD+K N+LL
Sbjct: 117 ND-LKKYMDKNPDVSMRVIKS-------FLYQLINGVNFCHS---RRCLHRDLKPQNLLL 165
Query: 120 DQEFNP-----KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSF 173
KIGDFGLA+ F I T I T Y PE +LG + + D++S
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSI 224
Query: 174 GVLVLEIISGR 184
+ E++
Sbjct: 225 ACIWAEMLMKT 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 26/197 (13%)
Query: 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRI-LVYEY 60
+ + A+K + S RE I L ++HPN++ L + R++ L+++Y
Sbjct: 46 KDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101
Query: 61 VENNSLDRVL-----LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
E++ L ++ A K ++L + I G+ +LH ++HRD+K +
Sbjct: 102 AEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPA 157
Query: 116 NILLDQEFNP----KIGDFGLAKLF--PDN-ITHITTRIAGTTGYLAPEYVLGGQL-TMK 167
NIL+ E KI D G A+LF P + + + T Y APE +LG + T
Sbjct: 158 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKA 216
Query: 168 ADVYSFGVLVLEIISGR 184
D+++ G + E+++
Sbjct: 217 IDIWAIGCIFAELLTSE 233
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-20
Identities = 48/190 (25%), Positives = 72/190 (37%), Gaps = 26/190 (13%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVE 62
L + AVK + + E+ L + H N++ELI + R LV+E +
Sbjct: 35 LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 63 NNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-- 119
S+ + N + S + +A L FLH I HRD+K NIL
Sbjct: 95 GGSILSHIH-----KRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEH 146
Query: 120 -DQEFNPKIGDFGLAKLFPDNITHITTR------IAGTTGYLAPEYVLGGQLTM------ 166
+Q KI DF L N G+ Y+APE V+
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE-VVEAFSEEASIYDK 205
Query: 167 KADVYSFGVL 176
+ D++S GV+
Sbjct: 206 RCDLWSLGVI 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-20
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 14/182 (7%)
Query: 7 GRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
GR +A+K + + +++ E+ + + HPN+V+L L+ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 65 SL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
+ D + A+ ++ ++ I + + H++ IVHRD+KA N+LLD +
Sbjct: 100 EVFDYL-----VAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADM 151
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIIS 182
N KI DFG + F + G Y APE G + + DV+S GV++ ++S
Sbjct: 152 NIKIADFGFSNEFTVG-GKLDAF-CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 183 GR 184
G
Sbjct: 210 GS 211
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-20
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 30/196 (15%)
Query: 5 TNGRRIAVKPLSAES-KQGV-----REFITEIMTLSNVRHPNLVELIGCCVQGTRRI--- 55
GR +A+K + ++ ++G+ RE + + L HPN+V L C
Sbjct: 35 NGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93
Query: 56 --LVYEYVENNSLDRVL-----LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 108
LV+E+V+ + L L G IK D+ + +GL FLH +V
Sbjct: 94 LTLVFEHVDQD-LTTYLDKVPEPGVPTETIK-------DMMFQLLRGLDFLHSH---RVV 142
Query: 109 HRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKA 168
HRD+K NIL+ K+ DFGLA+++ + +T+ + T Y APE +L
Sbjct: 143 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV-TLWYRAPEVLLQSSYATPV 200
Query: 169 DVYSFGVLVLEIISGR 184
D++S G + E+ +
Sbjct: 201 DLWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 48/197 (24%), Positives = 76/197 (38%), Gaps = 29/197 (14%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFIT----EIMTLSNVRHPNLVELIGCCVQGTRR--ILV 57
R AVK L + + + EI L +RH N+++L+ ++ +V
Sbjct: 27 SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86
Query: 58 YEYVENNS---LDRVLLGATKANIKLN-WEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
EY LD V + + + GL +LH + IVH+DIK
Sbjct: 87 MEYCVCGMQEMLDSVPEK------RFPVCQAH-GYFCQLIDGLEYLHSQ---GIVHKDIK 136
Query: 114 ASNILLDQEFNPKIGDFGLAKLF----PDNITHITTRIAGTTGYLAPEYVLGGQL--TMK 167
N+LL KI G+A+ D+ T+ G+ + PE G K
Sbjct: 137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TS--QGSPAFQPPEIANGLDTFSGFK 193
Query: 168 ADVYSFGVLVLEIISGR 184
D++S GV + I +G
Sbjct: 194 VDIWSAGVTLYNITTGL 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 33/201 (16%)
Query: 4 LTNGRRIAVKPLSAES-KQGVREFIT---EIMTLSNVRHPNLVELIGCCVQGTRRI---- 55
G+++A+K + E+ K+G IT EI L ++H N+V LI C
Sbjct: 39 RKTGQKVALKKVLMENEKEGFP--ITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96
Query: 56 ----LVYEYVENN---SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIV 108
LV+++ E++ L VL+ T + IK + + GL ++H I+
Sbjct: 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-------RVMQMLLNGLYYIHRN---KIL 146
Query: 109 HRDIKASNILLDQEFNPKIGDFGLAKLF----PDNITHITTRIAGTTGYLAPEYVLGGQL 164
HRD+KA+N+L+ ++ K+ DFGLA+ F T R+ T Y PE +LG +
Sbjct: 147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERD 205
Query: 165 -TMKADVYSFGVLVLEIISGR 184
D++ G ++ E+ +
Sbjct: 206 YGPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 54/199 (27%), Positives = 84/199 (42%), Gaps = 31/199 (15%)
Query: 4 LTNGRRIAVKPLSAES-KQGVREF-IT---EI---MTLSNVRHPNLVELIGCCVQGTRRI 55
+G +A+K + + G I+ E+ L HPN+V L+ C
Sbjct: 31 PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90
Query: 56 -----LVYEYVENNSLDRVL-----LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 105
LV+E+V+ + L L G IK D+ +GL FLH
Sbjct: 91 EIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIK-------DLMRQFLRGLDFLHAN--- 139
Query: 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165
IVHRD+K NIL+ K+ DFGLA+++ + +T + T Y APE +L
Sbjct: 140 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVV-TLWYRAPEVLLQSTYA 197
Query: 166 MKADVYSFGVLVLEIISGR 184
D++S G + E+ +
Sbjct: 198 TPVDMWSVGCIFAEMFRRK 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 23/181 (12%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC---VQGTRRI-LVYEY 60
G++ A+K L +S + +E + P++V ++ G R + ++ E
Sbjct: 52 RTGQKCALKLLY-DSPKARQEV--DHH-WQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107
Query: 61 VENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
+E L R+ + + + ++I I + FLH +I HRD+K N+L
Sbjct: 108 MEGGELFSRIQ---ERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLY 161
Query: 120 ---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGV 175
+++ K+ DFG AK N + T T Y+APE VLG + D++S GV
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAPE-VLGPEKYDKSCDMWSLGV 217
Query: 176 L 176
+
Sbjct: 218 I 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I GL +H +V+RD+K +NILLD+ + +I D GLA F H GT
Sbjct: 301 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS-VGTH 354
Query: 152 GYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 184
GY+APE + G AD +S G ++ +++ G
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 34/199 (17%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI------ 55
L +A+K + + + RE + + V+HPN+V+L +
Sbjct: 59 AKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEELVPHIVHR 110
LV EYV + R K + + + + + LA++H I HR
Sbjct: 115 LVLEYVPET-VYRASRHYAKLKQTM-----PMLLIKLYMYQLLRSLAYIHSI---GICHR 165
Query: 111 DIKASNILLDQEFNP-KIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-T 165
DIK N+LLD K+ DFG AK+ N+++I +R Y APE + G T
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNYT 220
Query: 166 MKADVYSFGVLVLEIISGR 184
D++S G ++ E++ G+
Sbjct: 221 TNIDIWSTGCVMAELMQGQ 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 19/187 (10%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYV 61
+ A+K ++ + + VR E+ + + HP LV L Q + +V + +
Sbjct: 39 TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLL 97
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLD 120
L R L + N+ E+ + + + L +L + I+HRD+K NILLD
Sbjct: 98 LGGDL-RYHL---QQNVHFK-EETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLD 149
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL---TMKADVYSFGVLV 177
+ + I DF +A + P T +AGT Y+APE + + D +S GV
Sbjct: 150 EHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207
Query: 178 LEIISGR 184
E++ GR
Sbjct: 208 YELLRGR 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 4 LTNGRRIAVKPLSAES--KQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRR--ILVY 58
G ++AVK L+ + V I EI L RHP++++L V T +V
Sbjct: 33 QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ--VISTPTDFFMVM 90
Query: 59 EYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
EYV L D + + ++ + + I + + H +VHRD+K N+
Sbjct: 91 EYVSGGELFDYIC-----KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENV 142
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGV 175
LLD N KI DFGL+ + D T+ G+ Y APE V+ G+L + D++S GV
Sbjct: 143 LLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGV 199
Query: 176 LVLEIISGR 184
++ ++ G
Sbjct: 200 ILYALLCGT 208
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 18/184 (9%)
Query: 6 NGRRIAVKPLS----AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
+G A+K L + KQ + + E L V P LV+L + +V EYV
Sbjct: 65 SGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ L + + E + I +LH +++RD+K N+L+D
Sbjct: 124 AGGEMFSHLRRIGRFS-----EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID 175
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
Q+ ++ DFG AK T + GT LAPE +L D ++ GVL+ E+
Sbjct: 176 QQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 181 ISGR 184
+G
Sbjct: 232 AAGY 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-19
Identities = 21/221 (9%), Positives = 54/221 (24%), Gaps = 56/221 (25%)
Query: 7 GRRIAVK---PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
R++A+ P ++E ++ + LS + P + ++ ++V E++
Sbjct: 56 DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL V + + +A H + S + + +
Sbjct: 116 GSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDG 166
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ + + + D+ G + ++
Sbjct: 167 DVVLAYP---------------------ATMPDA-------NPQDDIRGIGASLYALLVN 198
Query: 184 RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 224
R W L + + P
Sbjct: 199 R----------------WPLPEAGVRSGLAPAERDTAGQPI 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 60/192 (31%), Positives = 83/192 (43%), Gaps = 30/192 (15%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYV 61
GR A+K L E +K V +TE L N RHP L L Q R+ V EY
Sbjct: 172 TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYA 230
Query: 62 ENNSL------DRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKA 114
L +RV E R+ I L +LH E ++V+RD+K
Sbjct: 231 NGGELFFHLSRERVFS-----------EDRARFYGAEIVSALDYLHSEK--NVVYRDLKL 277
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYS 172
N++LD++ + KI DFGL K + I GT YLAPE + D +
Sbjct: 278 ENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 173 FGVLVLEIISGR 184
GV++ E++ GR
Sbjct: 335 LGVVMYEMMCGR 346
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 17/163 (10%)
Query: 29 EIMTLSNVRH--PNLVELIGCCVQGTRRILVYEYVENNS--LDRVLLGATKANIKLNWEK 84
E++ L V ++ L+ + +L+ E E D + L E
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEEL 150
Query: 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHI 143
+ + + H ++HRDIK NIL+D K+ DFG L D +
Sbjct: 151 ARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT- 206
Query: 144 TTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRN 185
GT Y PE++ + A V+S G+L+ +++ G
Sbjct: 207 DF--DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 15/161 (9%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRILVYE-YVENNSL-DRVLLGATKANIKLNWEKRS 86
EI LS V H N+++++ LV E + L + + +L+ S
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-----RHPRLDEPLAS 133
Query: 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 146
I + + +L + I+HRDIK NI++ ++F K+ DFG A T
Sbjct: 134 YIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF- 189
Query: 147 IAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGRN 185
GT Y APE VL G + +++S GV + ++ N
Sbjct: 190 -CGTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 22/181 (12%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC---VQGTRRI-LVYEY 60
+ A+K L K RE E+ + P++V ++ G + + +V E
Sbjct: 85 RTQEKFALKMLQDCPKAR-RE--VELH-WRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 61 VENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
++ L R+ + + + S+I I + + +LH +I HRD+K N+L
Sbjct: 141 LDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLY 194
Query: 120 ---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGV 175
K+ DFG AK + + T T Y+APE VLG + D++S GV
Sbjct: 195 TSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPE-VLGPEKYDKSCDMWSLGV 251
Query: 176 L 176
+
Sbjct: 252 I 252
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-18
Identities = 58/185 (31%), Positives = 90/185 (48%), Gaps = 20/185 (10%)
Query: 6 NGRRIAVKPLS----AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEY 60
NGR A+K L KQ V E + LS V HP ++ + G Q ++I ++ +Y
Sbjct: 30 NGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFIIRMWGTF-QDAQQIFMIMDY 87
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILL 119
+E L +L + + + + L +LH + I++RD+K NILL
Sbjct: 88 IEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILL 139
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
D+ + KI DFG AK PD +T + GT Y+APE V D +SFG+L+ E
Sbjct: 140 DKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 195
Query: 180 IISGR 184
+++G
Sbjct: 196 MLAGY 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 19/178 (10%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+AVK + E + E + EI+ ++RHPN+V + T ++ EY
Sbjct: 42 KLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99
Query: 63 NNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L +R+ + + ++ + G+++ H I HRD+K N LLD
Sbjct: 100 GGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDG 151
Query: 122 EFNP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGV 175
P KI DFG +K + +T GT Y+APE VL Q ADV+S GV
Sbjct: 152 SPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE-VLLRQEYDGKIADVWSCGV 206
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCV---QGTRRILVYEY 60
TN ++ VK L K+ + EI L N+R PN++ L V LV+E+
Sbjct: 59 TNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLA-DIVKDPVSRTPALVFEH 114
Query: 61 VENNSLDRVLLGATKANIK-LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
V N ++ T +I+ +E I K L + H I+HRD+K N+++
Sbjct: 115 VNNTDFKQLYQTLTDYDIRFYMYE--------ILKALDYCHSM---GIMHRDVKPHNVMI 163
Query: 120 DQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLV 177
D E ++ D+GLA+ F R+A + + PE ++ Q+ D++S G ++
Sbjct: 164 DHEHRKLRLIDWGLAE-FYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCML 221
Query: 178 LEIISGR 184
+I +
Sbjct: 222 ASMIFRK 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 52/168 (30%), Positives = 73/168 (43%), Gaps = 28/168 (16%)
Query: 27 ITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIK 79
+TE L N RHP L L Q R+ V EY L +RV
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------- 103
Query: 80 LNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 138
E+R+ I L +LH +V+RDIK N++LD++ + KI DFGL K +
Sbjct: 104 ---EERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---E 154
Query: 139 NITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
I+ GT YLAPE + D + GV++ E++ GR
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 44/189 (23%), Positives = 78/189 (41%), Gaps = 18/189 (9%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYV 61
+ A+K L+ + F E L N + L Q + LV +Y
Sbjct: 98 ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYY 156
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLD 120
L +L +K +L E+ + + + + +H+ H VHRDIK NIL+D
Sbjct: 157 VGGDLLTLL---SKFEDRLP-EEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMD 209
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-----TMKADVYSFGV 175
+ ++ DFG ++ T ++ GT Y++PE + + + D +S GV
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 176 LVLEIISGR 184
+ E++ G
Sbjct: 270 CMYEMLYGE 278
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 28/191 (14%)
Query: 6 NGRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVELIGC-CVQGTRRI--- 55
R +A+K LS +K+ RE ++ + V H N++ L+ Q +
Sbjct: 49 LERNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104
Query: 56 --LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
+V E ++ N L +V+ ++L+ E+ S + + G+ LH I+HRD+K
Sbjct: 105 VYIVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 154
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
SNI++ + KI DFGLA+ + + T T Y APE +LG D++S
Sbjct: 155 PSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212
Query: 174 GVLVLEIISGR 184
G ++ E+I G
Sbjct: 213 GCIMGEMIKGG 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 28/168 (16%)
Query: 27 ITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIK 79
E L V+HP +V+LI Q ++ L+ EY+ L + + +
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM-------- 119
Query: 80 LNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 138
E + + I+ L LH++ I++RD+K NI+L+ + + K+ DFGL K
Sbjct: 120 ---EDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--- 170
Query: 139 NITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
+I +T GT Y+APE ++ D +S G L+ ++++G
Sbjct: 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 16/186 (8%)
Query: 4 LTNGRRIAVKPLSAE--SKQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+++A+K +S + K + + EI L +RHP++++L T ++V EY
Sbjct: 31 YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
D ++ ++ ++ I + + H IVHRD+K N+LLD
Sbjct: 91 AGGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLD 142
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGVLVL 178
N KI DFGL+ + D T+ G+ Y APE V+ G+L + DV+S G+++
Sbjct: 143 DNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLY 199
Query: 179 EIISGR 184
++ GR
Sbjct: 200 VMLVGR 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 42/166 (25%), Positives = 63/166 (37%), Gaps = 21/166 (12%)
Query: 29 EIMTLSNVR----HPNLVELIGCCVQGTRRILVYEYVENNS--LDRVLLGATKANIKLNW 82
E+ L V HP ++ L+ +LV E D + K +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLG--- 137
Query: 83 EKRS-DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLFPDNI 140
E S + + H +VHRDIK NIL+D K+ DFG L D
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194
Query: 141 THITTRIAGTTGYLAPEYVLGGQLT-MKADVYSFGVLVLEIISGRN 185
GT Y PE++ Q + A V+S G+L+ +++ G
Sbjct: 195 YTDF---DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 4 LTNGRRIAVKPLSAES--KQGVREFIT-EIMTLSNVRHPNLVELIGCCVQGTRR--ILVY 58
G ++AVK L+ + V I EI L RHP++++L V T +V
Sbjct: 38 ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ--VISTPSDIFMVM 95
Query: 59 EYVENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
EYV L D + N +L+ ++ + I G+ + H +VHRD+K N+
Sbjct: 96 EYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENV 147
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL--TMKADVYSFGV 175
LLD N KI DFGL+ + D T+ G+ Y APE V+ G+L + D++S GV
Sbjct: 148 LLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSSGV 204
Query: 176 LVLEIISGR 184
++ ++ G
Sbjct: 205 ILYALLCGT 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 32/193 (16%)
Query: 6 NGRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI---- 55
G ++A+K L +K+ RE + L ++RH N++ L+
Sbjct: 49 TGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMRHENVIGLLDVFTPDETLDDFTD 104
Query: 56 --LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
LV ++ + L +++ K KL ++ + + KGL ++H I+HRD+K
Sbjct: 105 FYLVMPFMGTD-LGKLM----KHE-KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLK 155
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQL-TMKADVY 171
N+ ++++ KI DFGLA+ +T ++ TR Y APE +L T D++
Sbjct: 156 PGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIW 210
Query: 172 SFGVLVLEIISGR 184
S G ++ E+I+G+
Sbjct: 211 SVGCIMAEMITGK 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-17
Identities = 50/168 (29%), Positives = 77/168 (45%), Gaps = 28/168 (16%)
Query: 27 ITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIK 79
E L V HP +V+L Q ++ L+ +++ L + +
Sbjct: 74 KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-------- 124
Query: 80 LNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPD 138
E+ + +A L LH I++RD+K NILLD+E + K+ DFGL+K
Sbjct: 125 ---EEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--- 175
Query: 139 NITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
+I H GT Y+APE V T AD +SFGVL+ E+++G
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
I L LH+ I++RDIK NILLD + + DFGL+K F + T GT
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 152 GYLAPEYVLGGQL--TMKADVYSFGVLVLEIISGR 184
Y+AP+ V GG D +S GVL+ E+++G
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-17
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 28/191 (14%)
Query: 6 NGRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR----- 54
R +A+K LS +K+ RE ++ + V H N++ L+
Sbjct: 86 LDRNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 55 -ILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
LV E ++ N L +V+ ++L+ E+ S + + G+ LH I+HRD+K
Sbjct: 142 VYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLK 191
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
SNI++ + KI DFGLA+ + + T T Y APE +LG D++S
Sbjct: 192 PSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 174 GVLVLEIISGR 184
G ++ E++ +
Sbjct: 250 GCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 33/193 (17%)
Query: 6 NGRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI---- 55
+G ++A+K LS +K+ RE ++ L +++H N++ L+ +
Sbjct: 48 SGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLKHMQHENVIGLLDVFTPASSLRNFYD 103
Query: 56 --LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
LV +++ + L +++ +K + EK + + KGL ++H +VHRD+K
Sbjct: 104 FYLVMPFMQTD-LQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLK 153
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQL-TMKADVY 171
N+ ++++ KI DFGLA+ +T + TR Y APE +L D++
Sbjct: 154 PGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIW 208
Query: 172 SFGVLVLEIISGR 184
S G ++ E+++G+
Sbjct: 209 SVGCIMAEMLTGK 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 149
IA GL FL + I++RD+K N++LD E + KI DFG+ K +NI T G
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCG 504
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T Y+APE + D ++FGVL+ E+++G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 149
IA L +LH +IV+RD+K NILLD + + + DFGL K +NI H T+ G
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCG 201
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T YLAPE + D + G ++ E++ G
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 45/191 (23%), Positives = 73/191 (38%), Gaps = 20/191 (10%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYV 61
G+ A+K ++ + V F E L N + +L Q + LV EY
Sbjct: 85 TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYY 143
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVG-IAKGLAFLHEELVPHIVHRDIKASNILLD 120
L +L +K ++ + + + I + +H VHRDIK NILLD
Sbjct: 144 VGGDLLTLL---SKFGERIP-AEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLD 196
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVY-------SF 173
+ + ++ DFG + T + GT YL+PE + Y +
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 174 GVLVLEIISGR 184
GV E+ G+
Sbjct: 257 GVFAYEMFYGQ 267
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 149
IA GL FL + I++RD+K N++LD E + KI DFG+ K ++ T T G
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-T--FCG 183
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T Y+APE + D ++FGVL+ E+++G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 31/174 (17%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151
+AKG+ FL +HRD+ A NILL ++ KI DFGLA+ +I +
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254
Query: 152 GYL-----APEYVLGGQLTMKADVYSFGVLVLEIIS-GRN--SGKAMWGQMNKFLLEWAW 203
L APE + T+++DV+SFGVL+ EI S G + G + + + L E
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-- 312
Query: 204 QLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257
+ P +Y E+ + M C S+RP +++++ L
Sbjct: 313 --TRMRAP---------DYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGN 352
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 52/160 (32%), Positives = 74/160 (46%), Gaps = 28/160 (17%)
Query: 35 NVRHPNLVELIGCCVQGTRRI-LVYEYVENNSL------DRVLLGATKANIKLNWEKRSD 87
HP LV L C Q R+ V EYV L R L E+ +
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----------EEHAR 113
Query: 88 ICVG-IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHIT 144
I+ L +LHE I++RD+K N+LLD E + K+ D+G+ K L P + T T
Sbjct: 114 FYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-T 169
Query: 145 TRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
GT Y+APE + G D ++ GVL+ E+++GR
Sbjct: 170 --FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 149
I+ L +LHE I++RD+K N+LLD E + K+ D+G+ K L P + T T G
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-T--FCG 215
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T Y+APE + G D ++ GVL+ E+++GR
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 44/195 (22%), Positives = 72/195 (36%), Gaps = 33/195 (16%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYV 61
+ A+K LS + F E ++ P +V+L Q R + +V EY+
Sbjct: 93 TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYM 151
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAK--------GLAFLHEELVPHIVHRDIK 113
L +N D+ A+ L +H +HRD+K
Sbjct: 152 PGGDL-------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVK 195
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG----GQLTMKAD 169
N+LLD+ + K+ DFG GT Y++PE + G + D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 170 VYSFGVLVLEIISGR 184
+S GV + E++ G
Sbjct: 256 WWSVGVFLYEMLVGD 270
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-16
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK--LFPDNITHITTRIAG 149
I L FLH++ I++RD+K N+LLD E + K+ DFG+ K + T T G
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-T--FCG 186
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T Y+APE + D ++ GVL+ E++ G
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-16
Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 8/95 (8%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAG 149
I GL FLH + IV+RD+K NILLD++ + KI DFG+ K +N+ T G
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCG 180
Query: 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
T Y+APE +LG + D +SFGVL+ E++ G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 49/202 (24%), Positives = 78/202 (38%), Gaps = 36/202 (17%)
Query: 5 TNGRRIAVK--PLSAESKQGVREFIT---------EIMTLSNVRHPNLVELIGCCVQGTR 53
+ G +A+K + + V EI L++ HPN++ L V
Sbjct: 44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 54 RI-----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVG-----IAKGLAFLHEEL 103
LV E + + L +V I S + I GL LHE
Sbjct: 104 PAMHKLYLVTELMRTD-LAQV--------IHDQRIVISPQHIQYFMYHILLGLHVLHEA- 153
Query: 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163
+VHRD+ NILL + I DF LA+ + + T + Y APE V+ +
Sbjct: 154 --GVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVT-HRWYRAPELVMQFK 209
Query: 164 LTMKA-DVYSFGVLVLEIISGR 184
K D++S G ++ E+ + +
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 66/227 (29%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI---------- 55
+G+R A+K + + + RE + + + H N+++L+
Sbjct: 31 SGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86
Query: 56 ----------------------------LVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87
++ EYV + L +VL ++ +
Sbjct: 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT-LHKVLKSFIRSGRSI-----PM 140
Query: 88 ICVG-----IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-KIGDFGLAKLF---PD 138
+ + + + F+H I HRDIK N+L++ + N K+ DFG AK
Sbjct: 141 NLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP 197
Query: 139 NITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 184
++ +I +R Y APE +LG T D++S G + E+I G+
Sbjct: 198 SVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 22/164 (13%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRI------LVYEYVENNSLDRVLLGATKANIKLNW 82
E+ L +++H N++ L+ LV + + L+ ++ K KL
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIV----KCQ-KLTD 131
Query: 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT- 141
+ + I +GL ++H I+HRD+K SN+ ++++ KI DFGLA+ D +T
Sbjct: 132 DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 142 HITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEIISGR 184
++ TR Y APE +L D++S G ++ E+++GR
Sbjct: 189 YVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 28/193 (14%)
Query: 6 NGRRIAVKPLSA-----ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI----- 55
N R+A+K +S ++ +RE I L RH N++ + T
Sbjct: 51 NKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
+V + +E + L ++L K L+ + I +GL ++H +++HRD+K S
Sbjct: 107 IVQDLMETD-LYKLL----KTQH-LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPS 157
Query: 116 NILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQLTMKA-DVY 171
N+LL+ + KI DFGLA++ D+ +T +A T Y APE +L + K+ D++
Sbjct: 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIW 216
Query: 172 SFGVLVLEIISGR 184
S G ++ E++S R
Sbjct: 217 SVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 39/199 (19%), Positives = 84/199 (42%), Gaps = 33/199 (16%)
Query: 6 NGRRIAVKPLSA-----ESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI----- 55
G +A+K + + + +RE I L + +H N++ + +
Sbjct: 35 TGEIVAIKKIEPFDKPLFALRTLRE----IKILKHFKHENIITIFNIQRPDSFENFNEVY 90
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
++ E ++ + L RV+ + L+ + + + LH +++HRD+K S
Sbjct: 91 IIQELMQTD-LHRVI----STQM-LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPS 141
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGT---TGYL------APEYVLGGQL-T 165
N+L++ + K+ DFGLA++ ++ + ++ APE +L +
Sbjct: 142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYS 201
Query: 166 MKADVYSFGVLVLEIISGR 184
DV+S G ++ E+ R
Sbjct: 202 RAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 29/198 (14%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI---------- 55
+R+A+K + Q V+ + EI + + H N+V++ ++
Sbjct: 35 CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94
Query: 56 ----LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD 111
+V EY+E + L VL + L E + +GL ++H +++HRD
Sbjct: 95 NSVYIVQEYMETD-LANVL----EQG-PLLEEHARLFMYQLLRGLKYIHSA---NVLHRD 145
Query: 112 IKASNILLDQEF-NPKIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-TM 166
+K +N+ ++ E KIGDFGLA++ + H++ + T Y +P +L T
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTK 204
Query: 167 KADVYSFGVLVLEIISGR 184
D+++ G + E+++G+
Sbjct: 205 AIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 24/172 (13%)
Query: 6 NGRRIAVKPLS------AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI---- 55
+ +A+K ++ + K+ +RE I L+ ++ ++ L +
Sbjct: 50 TEKNVAIKKVNRMFEDLIDCKRILRE----ITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105
Query: 56 -LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
+V E +++ L ++ K I L E I + G F+HE I+HRD+K
Sbjct: 106 YIVLEIADSD-LKKLF----KTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKP 157
Query: 115 SNILLDQEFNPKIGDFGLA-KLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165
+N LL+Q+ + K+ DFGLA + + T+I + L QLT
Sbjct: 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 14/98 (14%)
Query: 94 KGLAFLHEELVPHIVHRDIKASNILLDQEFNP------KIGDFGLAKLFPDNIT-HITTR 146
GL ++H I+H DIK N+L++ +P KI D G A + ++ T I TR
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 147 IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
Y +PE +LG AD++S L+ E+I+G
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-12
Identities = 36/180 (20%), Positives = 67/180 (37%), Gaps = 41/180 (22%)
Query: 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC---VQGTRRI-LVYEY 60
+ A+K L + + RE E+ + P++V ++ G + + +V E
Sbjct: 41 RTQEKFALKMLQ-DCPKARRE--VELH-WRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96
Query: 61 VENNSL-DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
++ L R+ + + + S+I I + + +LH +I HRD+K N+L
Sbjct: 97 LDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLY 150
Query: 120 ---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL 176
K+ DFG A E G + D++S GV+
Sbjct: 151 TSKRPNAILKLTDFG----------------------FAKE-TTGEKYDKSCDMWSLGVI 187
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 24/110 (21%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 29 EIMTLSNVRHPNLVELIGCCVQGTRRI-----LVYEYVENNSLDRVLLGATKANIKLNWE 83
EI L+ + H ++V+++ + +V E +++ ++ + + L
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF----RTPVYLTEL 156
Query: 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLA 133
+ + G+ ++H I+HRD+K +N L++Q+ + K+ DFGLA
Sbjct: 157 HIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 31/147 (21%), Positives = 47/147 (31%), Gaps = 57/147 (38%)
Query: 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILL---------------------------- 119
I + +GL +LH + I+H DIK NILL
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 120 ---------------------DQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157
++ KI D G A + T I TR Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLE 263
Query: 158 YVLGGQLTMKADVYSFGVLVLEIISGR 184
++G AD++S + E+ +G
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 22/131 (16%)
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
+YE ++ N L + I + L LH+ I+H D+K N
Sbjct: 185 LYELIKKNKFQGFSLPLVRK-----------FAHSILQCLDALHKN---RIIHCDLKPEN 230
Query: 117 ILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
ILL Q+ K+ DFG + + T+I +R Y APE +LG + M D++S
Sbjct: 231 ILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSL 285
Query: 174 GVLVLEIISGR 184
G ++ E+++G
Sbjct: 286 GCILAELLTGY 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 33/180 (18%)
Query: 29 EIMTLSNVR-HPNLVELIGCCV-QGTRRI-LVYEYVENNSLDRVLLGATKANIKLNWEKR 85
EIM L+ + H N+V L+ R + LV++Y+E + L V+ +ANI L +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVI----RANI-LEPVHK 111
Query: 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 145
+ + K + +LH ++HRD+K SNILL+ E + K+ DFGL++ F +
Sbjct: 112 QYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 146 RIAGT--------------TGYL------APEYVLGGQL-TMKADVYSFGVLVLEIISGR 184
T Y+ APE +LG T D++S G ++ EI+ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP--KIGDFGLAKLFPDNI-THITTRIA 148
+ L FL + I+H D+K NILL KI DFG + I +I +R
Sbjct: 166 MCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223
Query: 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
Y +PE +LG + D++S G +++E+ +G
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 35/152 (23%), Positives = 58/152 (38%), Gaps = 27/152 (17%)
Query: 96 LAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAKLFPDNITHI------TTRI 147
L ++HE VH DIKA+N+LL + ++ D+GL+ + N H
Sbjct: 164 LEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 148 AGTTGYLAPEYV-----LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA 202
GT E+ G L+ ++DV G +L + G K W Q K +
Sbjct: 221 NGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCG----KLPWEQNLKDPVAVQ 271
Query: 203 WQLHQ--EEKPLELVDPELGEYPPNEIIRYMK 232
+E P ++ EI +++
Sbjct: 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLV 303
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 15/50 (30%), Positives = 24/50 (48%), Gaps = 5/50 (10%)
Query: 96 LAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAKLFPDNITHI 143
L FLHE VH ++ A NI +D E ++ +G A + + H+
Sbjct: 172 LEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 6e-08
Identities = 30/223 (13%), Positives = 60/223 (26%), Gaps = 57/223 (25%)
Query: 6 NGRRIAVK--PLSA------ESKQGVREFITEIMTLSNV---------RHPNLVELIGC- 47
+ +A+K + ++ E + EI+ + R + L
Sbjct: 42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101
Query: 48 CVQGTRR---ILVYEY--VENNSLDRVLLGATKANI-------------------KLNWE 83
CVQG+ + +++ S + + +
Sbjct: 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLA 161
Query: 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF------- 136
I + LA L HRD+ N+LL + K+ K
Sbjct: 162 TAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL 219
Query: 137 -PDNITHITTRIAGTTGYL-----APEYVLGGQLTMKADVYSF 173
I + +R+ + E + G + D+Y
Sbjct: 220 QVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 18/50 (36%), Positives = 27/50 (54%), Gaps = 5/50 (10%)
Query: 96 LAFLHEELVPHIVHRDIKASNILLDQEFNPKI--GDFGLAKLFPDNITHI 143
L ++HE VH DIKASN+LL+ + ++ D+GLA + H
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 35/170 (20%), Positives = 62/170 (36%), Gaps = 37/170 (21%)
Query: 4 LTNGRRIAVKPLSAESKQGVREF-ITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYV 61
L +A+K +S+ L + P + G +V E
Sbjct: 31 LYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV---YYFGPCGKYNAMVLE-- 85
Query: 62 ENNSLDRVLLGATKANIKLNWEKRS-------DICVGIAKGLAFLHEELVPHIVHRDIKA 114
LLG + ++ + R+ I + + + ++H + ++++RD+K
Sbjct: 86 --------LLGPSLEDL-FDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKP 133
Query: 115 SNILLDQEFNPK-----IGDFGLAKLFPDNIT--HITTR----IAGTTGY 153
N L+ + N I DF LAK + D T HI R + GT Y
Sbjct: 134 ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 39/171 (22%), Positives = 70/171 (40%), Gaps = 39/171 (22%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEY 60
L N +++A+K P +++ Q E L+ PN+ +G +LV +
Sbjct: 32 LLNNQQVAIKFEPRRSDAPQLRDE-YRTYKLLAGCTGIPNV---YYFGQEGLHNVLVID- 86
Query: 61 VENNSLDRVLLGATKANIKLNWEKRS-------DICVGIAKGLAFLHEELVPHIVHRDIK 113
LLG + ++ L+ R + + +HE+ +V+RDIK
Sbjct: 87 ---------LLGPSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIK 133
Query: 114 ASNILLDQEFNPK-----IGDFGLAKLFPDNIT--HITTR----IAGTTGY 153
N L+ + + + DFG+ K + D +T HI R ++GT Y
Sbjct: 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 28/112 (25%), Positives = 40/112 (35%), Gaps = 28/112 (25%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-------------------KIGDFGL 132
+ L FLHE + H D+K NIL ++ DFG
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 133 AKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
A ++ T + TR Y PE +L DV+S G ++ E G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 31/112 (27%), Positives = 45/112 (40%), Gaps = 28/112 (25%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-------------------KIGDFGL 132
I K + FLH + H D+K NIL Q K+ DFG
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 133 AKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
A ++ T ++TR Y APE +L + DV+S G +++E G
Sbjct: 184 ATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 6e-06
Identities = 38/249 (15%), Positives = 75/249 (30%), Gaps = 61/249 (24%)
Query: 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136
I NW RSD I + + EL + + + ++L N K F
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA-----WNAF 262
Query: 137 PDNI---THITTRIAGTTGYLAPEY--------------------VLGGQLTMKAD---- 169
N+ +TTR T +L+ +L L +
Sbjct: 263 --NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320
Query: 170 -VYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227
V + L II+ G A W W+ +K +++ L P E
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDN---------WKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 228 -IRYMKVAFFCTQAAASRRPQMN---QVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTS 283
+ +++ F P + ++ ++ ++ ++ + S+
Sbjct: 372 RKMFDRLSVF--------PPSAHIPTILLSLIWFDVIKSDVMVVV----NKLHKYSLVEK 419
Query: 284 DKKSSDSTL 292
K S ++
Sbjct: 420 QPKESTISI 428
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 2e-05
Identities = 29/172 (16%), Positives = 59/172 (34%), Gaps = 42/172 (24%)
Query: 14 PLSAES-KQGVREFITE------IMTLSNVRHPNLVEL--IGC-CVQGTRRILVYEYVEN 63
L S + +R + ++ L NV++ + C + TR V +++
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 64 N-----SLDRVLLGATKANIK---LNW------EKRSDICVGIAKGLAFLHEELVPHIVH 109
SLD + T +K L + + ++ + L+ + E + +
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
Query: 110 RD-------------IKAS-NILLDQEFNPKIGDFGLAKLFPDNITHITTRI 147
D I++S N+L E+ +FP + HI T +
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS---VFPPS-AHIPTIL 391
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 32/118 (27%), Positives = 48/118 (40%), Gaps = 34/118 (28%)
Query: 92 IAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP-------------------------K 126
I K L +L + + H D+K NILLD + K
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 127 IGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ DFG A D + I TR Y APE +L + +D++SFG ++ E+ +G
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 36/168 (21%), Positives = 63/168 (37%), Gaps = 35/168 (20%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
+ G +A+K + + Q E + + + C +G ++V E
Sbjct: 31 IAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGG--VGIPTIRWCGAEGDYNVMVME-- 85
Query: 62 ENNSLDRVLLGATKANIKLNWEKRS-------DICVGIAKGLAFLHEELVPHIVHRDIKA 114
LLG + ++ N+ R + + + ++H + + +HRD+K
Sbjct: 86 --------LLGPSLEDL-FNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKP 133
Query: 115 SNILLDQEFNPK---IGDFGLAKLFPDNIT--HITTR----IAGTTGY 153
N L+ I DFGLAK + D T HI R + GT Y
Sbjct: 134 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 35/168 (20%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
+ +A+K + + Q + E L + + V+G +LV +
Sbjct: 29 IQTNEEVAIKLENVKTKHPQLLYESKI-YRILQGG--TGIPNVRWFGVEGDYNVLVMD-- 83
Query: 62 ENNSLDRVLLGATKANIKLNWEKRS-------DICVGIAKGLAFLHEELVPHIVHRDIKA 114
LLG + ++ N+ R + + + F+H + +HRDIK
Sbjct: 84 --------LLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKP 131
Query: 115 SNILLDQEFNPK---IGDFGLAKLFPDNIT--HITTR----IAGTTGY 153
N L+ I DFGLAK + D T HI R + GT Y
Sbjct: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 307 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.57 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.31 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.17 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.84 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.55 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.33 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.79 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.82 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=381.21 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=196.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC---------C
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT---------K 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~ 75 (307)
.+|..||||+++..+....++|.+|+++|++++|||||+++++|.+.+..++|||||++|+|.+++.... .
T Consensus 41 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~ 120 (299)
T 4asz_A 41 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120 (299)
T ss_dssp --CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----
T ss_pred CCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccC
Confidence 3578899999998777777899999999999999999999999999999999999999999999995432 2
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYL 154 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~ 154 (307)
....++|..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++........ ......||+.||
T Consensus 121 ~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ym 197 (299)
T 4asz_A 121 PPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197 (299)
T ss_dssp CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhc
Confidence 345699999999999999999999999 9999999999999999999999999999865443222 233456899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
|||++.+..|+.++|||||||++|||+| |+.||..... ..+...+. ..... ..+......+.++
T Consensus 198 APE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~---~~~~~---------~~p~~~~~~~~~l 262 (299)
T 4asz_A 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECIT---QGRVL---------QRPRTCPQEVYEL 262 (299)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHH---HTCCC---------CCCTTCCHHHHHH
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH---cCCCC---------CCCccchHHHHHH
Confidence 9999999999999999999999999999 8999865432 22222221 11111 1122334468889
Q ss_pred HHhccccccCCCCCHHHHHHHHHhccc
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+.+||+.||++|||+.+|.+.|+++.+
T Consensus 263 i~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 263 MLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=382.34 Aligned_cols=239 Identities=25% Similarity=0.385 Sum_probs=189.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---------
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------- 75 (307)
.+|+.||||+++..+....++|.+|+++|++++|||||+++++|.+.+..++|||||++|+|.+++.....
T Consensus 69 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~ 148 (329)
T 4aoj_A 69 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148 (329)
T ss_dssp --CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC--------
T ss_pred CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccc
Confidence 35789999999987777778999999999999999999999999999999999999999999999965432
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCC
Q 021774 76 --ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTG 152 (307)
Q Consensus 76 --~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 152 (307)
....++|..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....... .......||+.
T Consensus 149 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ 225 (329)
T 4aoj_A 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225 (329)
T ss_dssp ---CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGG
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCccccccc
Confidence 234699999999999999999999999 999999999999999999999999999987644322 23345679999
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
|||||++.+..++.++|||||||++|||+| |+.||..... ..+...+.. .... ..+......+.
T Consensus 226 ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~---g~~~---------~~p~~~~~~~~ 290 (329)
T 4aoj_A 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCITQ---GREL---------ERPRACPPEVY 290 (329)
T ss_dssp GCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHHH---TCCC---------CCCTTCCHHHH
T ss_pred ccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc---CCCC---------CCcccccHHHH
Confidence 999999999999999999999999999999 8999865432 122222211 1111 11222334578
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 291 ~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 291 AIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 889999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=375.73 Aligned_cols=236 Identities=22% Similarity=0.378 Sum_probs=191.0
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--------
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 75 (307)
.+|+.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..++|||||++|+|.+++.....
T Consensus 54 ~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~ 133 (308)
T 4gt4_A 54 EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133 (308)
T ss_dssp --CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC---
T ss_pred CCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccc
Confidence 457889999997653 34567899999999999999999999999999999999999999999999954321
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCC
Q 021774 76 ----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGT 150 (307)
Q Consensus 76 ----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~ 150 (307)
....++|..++.++.||+.||+|||++ +|+||||||+||||++++++||+|||+++...... ........||
T Consensus 134 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp --CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred cccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccC
Confidence 124589999999999999999999999 99999999999999999999999999998654322 2234456789
Q ss_pred CCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 151 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
+.|+|||++.++.|+.++|||||||++|||+| |..||..... ..+...+ ...... ..+..+...
T Consensus 211 ~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~i----~~~~~~--------~~p~~~~~~ 275 (308)
T 4gt4_A 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMI----RNRQVL--------PCPDDCPAW 275 (308)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHHH----HTTCCC--------CCCTTCCHH
T ss_pred CcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC--------CCcccchHH
Confidence 99999999999999999999999999999999 8889865432 2222222 111111 112334456
Q ss_pred HHHHHHhccccccCCCCCHHHHHHHHHhc
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
+.+++.+||+.||++||||.+|++.|+..
T Consensus 276 ~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 276 VYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 88899999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=367.16 Aligned_cols=235 Identities=24% Similarity=0.406 Sum_probs=184.3
Q ss_pred CEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 8 RRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 8 ~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
..||||+++.. +....+.|.+|++++++++|||||++++++.+ +..++|||||+||+|.+++.. ....+++..+
T Consensus 59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~ 134 (307)
T 3omv_A 59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQL 134 (307)
T ss_dssp SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHH
T ss_pred CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHH
Confidence 36999998754 45667889999999999999999999998865 567999999999999999843 3456999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCcccccC---
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLG--- 161 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~--- 161 (307)
+.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++...... ........||+.|||||++.+
T Consensus 135 ~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~ 211 (307)
T 3omv_A 135 IDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211 (307)
T ss_dssp HHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSS
T ss_pred HHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCC
Confidence 99999999999999999 99999999999999999999999999998765432 223455789999999999864
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..|+.++|||||||++|||+||+.||....... .+. ....... ..+.+...+......+.+++.+||+.|
T Consensus 212 ~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~----~~~~~~~----~~p~~~~~~~~~~~~l~~li~~cl~~d 281 (307)
T 3omv_A 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QII----FMVGRGY----ASPDLSKLYKNCPKAMKRLVADCVKKV 281 (307)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HHHHTTC----CCCCSTTSCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHH----HHHhcCC----CCCCcccccccchHHHHHHHHHHcCCC
Confidence 468999999999999999999999986543321 111 1111111 112222333444556888999999999
Q ss_pred cCCCCCHHHHHHHHHhcc
Q 021774 242 ASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~ 259 (307)
|++|||+.+|++.|+.+.
T Consensus 282 P~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 282 KEERPLFPQILSSIELLQ 299 (307)
T ss_dssp STTSCCHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHh
Confidence 999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-55 Score=376.44 Aligned_cols=229 Identities=23% Similarity=0.370 Sum_probs=188.9
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|+.||||+++.. +....+.+.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++.. ..+..++
T Consensus 46 ~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~ 123 (350)
T 4b9d_A 46 TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQ 123 (350)
T ss_dssp TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCC
T ss_pred CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCC
Confidence 357999999999754 445567899999999999999999999999999999999999999999999843 2345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+||||++++.+||+|||+++..... ........||+.|+|||++.+
T Consensus 124 e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 124 EDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHHHHHHSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-cccccccCCCccccCHHHHCC
Confidence 999999999999999999999 9999999999999999999999999999876432 122345679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..|+.++|||||||++|||+||+.||..... ..+ .......... ..+......+.+++.+||+.|
T Consensus 200 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~---~~~i~~~~~~---------~~~~~~s~~~~~li~~~L~~d 264 (350)
T 4b9d_A 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNL---VLKIISGSFP---------PVSLHYSYDLRSLVSQLFKRN 264 (350)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH---HHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHH---HHHHHcCCCC---------CCCccCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999865432 111 1122222111 111223345888999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||+.|+++
T Consensus 265 P~~R~s~~e~l~ 276 (350)
T 4b9d_A 265 PRDRPSVNSILE 276 (350)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhHCcCHHHHhc
Confidence 999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=368.60 Aligned_cols=227 Identities=22% Similarity=0.386 Sum_probs=187.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|+|||||+||+|.+++.. ..+++..
T Consensus 97 ~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~ 171 (346)
T 4fih_A 97 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQ 171 (346)
T ss_dssp TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHH
T ss_pred CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHH
Confidence 57999999999765444456688999999999999999999999999999999999999999999842 4599999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++.+..... ......||+.|+|||++.+..|
T Consensus 172 ~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 172 IAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccccccCcCcCCHHHHCCCCC
Confidence 999999999999999999 999999999999999999999999999987654322 2455789999999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|||||||++|||++|+.||..... ......+. . ... +.+ .........+.+++.+||+.||++
T Consensus 248 ~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~---~-~~~-----~~~-~~~~~~s~~~~dli~~~L~~dP~~ 314 (346)
T 4fih_A 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR---D-NLP-----PRL-KNLHKVSPSLKGFLDRLLVRDPAQ 314 (346)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH---H-SSC-----CCC-SCGGGSCHHHHHHHHHHSCSSTTT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH---c-CCC-----CCC-CccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999999865432 11111111 1 111 111 111233345888999999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
|||+.|+++
T Consensus 315 R~ta~e~l~ 323 (346)
T 4fih_A 315 RATAAELLK 323 (346)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=364.88 Aligned_cols=231 Identities=23% Similarity=0.301 Sum_probs=186.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||+++.+.. ..+|+.++++++|||||++++++.+++..|+|||||+||+|.+++. ....+++..
T Consensus 81 ~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~~ 151 (336)
T 4g3f_A 81 QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDR 151 (336)
T ss_dssp TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH----HHSSCCHHH
T ss_pred CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH----HcCCCCHHH
Confidence 5689999999985421 2479999999999999999999999999999999999999999994 345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCccc----ccccccCCCCcCCcccc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITH----ITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~ 159 (307)
+..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++.+...... ......||+.|||||++
T Consensus 152 ~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~ 228 (336)
T 4g3f_A 152 ALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228 (336)
T ss_dssp HHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHH
Confidence 999999999999999999 999999999999999987 5999999999877543221 12346799999999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+..|+.++|||||||++|||+||+.||........ .. ......... ...++.....+.+++.+||+
T Consensus 229 ~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~~~~~~-------~~~~~~~s~~~~~li~~~L~ 295 (336)
T 4g3f_A 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL---KIASEPPPI-------REIPPSCAPLTAQAIQEGLR 295 (336)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH---HHHHSCCGG-------GGSCTTSCHHHHHHHHHHTC
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHcCCCCc-------hhcCccCCHHHHHHHHHHcc
Confidence 999999999999999999999999999975443221 11 111111111 11223334458888999999
Q ss_pred cccCCCCCHHHHHHHHHhccc
Q 021774 240 AAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~~~~~ 260 (307)
.||.+|||+.|+++.|...++
T Consensus 296 ~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 296 KEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999998887764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=351.94 Aligned_cols=225 Identities=24% Similarity=0.344 Sum_probs=179.8
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|..||+|.+... .....+.|.+|+++|++++|||||++++++.+ .+..|+|||||+||+|.+++. ...
T Consensus 49 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~----~~~ 124 (290)
T 3fpq_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFK 124 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH----HHS
T ss_pred CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH----hcC
Confidence 46889999998754 45556789999999999999999999999875 346799999999999999994 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
.+++..+..++.||+.||+|||++ + |+||||||+||||+. ++.+||+|||+++..... ......||+.|||
T Consensus 125 ~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---~~~~~~GTp~YmA 198 (290)
T 3fpq_A 125 VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMA 198 (290)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---ccCCcccCccccC
Confidence 799999999999999999999998 7 999999999999974 789999999999865432 2345689999999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+ .|+.++|||||||++|||+||+.||....... . ..............+ ......+.+++.
T Consensus 199 PE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~----~~~~i~~~~~~~~~~-------~~~~~~~~~li~ 264 (290)
T 3fpq_A 199 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--Q----IYRRVTSGVKPASFD-------KVAIPEVKEIIE 264 (290)
T ss_dssp GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--H----HHHHHTTTCCCGGGG-------GCCCHHHHHHHH
T ss_pred HHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--H----HHHHHHcCCCCCCCC-------ccCCHHHHHHHH
Confidence 998865 69999999999999999999999986433211 1 112222211111111 112234788899
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
+||+.||++|||+.++++
T Consensus 265 ~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=369.92 Aligned_cols=227 Identities=22% Similarity=0.394 Sum_probs=187.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+|||||+||+|.+++. ...+++..
T Consensus 174 ~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~-----~~~l~e~~ 248 (423)
T 4fie_A 174 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQ 248 (423)
T ss_dssp TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH-----HSCCCHHH
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh-----ccCCCHHH
Confidence 5699999999986654455678999999999999999999999999999999999999999999984 23599999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+++.+..... .....+||+.|||||++.+..|
T Consensus 249 ~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y 324 (423)
T 4fie_A 249 IAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPY 324 (423)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCCEECTTTCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccccccCcCcCCHHHHCCCCC
Confidence 999999999999999999 999999999999999999999999999987654322 3455789999999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|||||||++|||++|+.||...... .....+ .. ... +.+ .........+.+++.+||+.||++
T Consensus 325 ~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i---~~-~~~-----~~~-~~~~~~s~~~~dli~~~L~~dP~~ 391 (423)
T 4fie_A 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMI---RD-NLP-----PRL-KNLHKVSPSLKGFLDRLLVRDPAQ 391 (423)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---HH-SCC-----CCC-SCTTSSCHHHHHHHHHHSCSSTTT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH---Hc-CCC-----CCC-cccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999999998654321 111111 11 111 111 011122345788999999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
|||+.|+++
T Consensus 392 R~ta~ell~ 400 (423)
T 4fie_A 392 RATAAELLK 400 (423)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=367.61 Aligned_cols=240 Identities=26% Similarity=0.371 Sum_probs=192.3
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCC-CCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCC-------
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRH-PNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATK------- 75 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~------- 75 (307)
.++.||||.++... ....+.|.+|+++|.+++| ||||+++++|... +..++|||||++|+|.+++.....
T Consensus 93 ~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~ 172 (353)
T 4ase_A 93 TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 172 (353)
T ss_dssp CEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC--
T ss_pred CCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccc
Confidence 45689999998653 4456789999999999955 8999999999765 568999999999999999964322
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccC
Q 021774 76 -----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAG 149 (307)
Q Consensus 76 -----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g 149 (307)
....+++..++.++.|||.||+|||++ +|+||||||+||||++++.+||+|||+++....... .......|
T Consensus 173 ~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~g 249 (353)
T 4ase_A 173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249 (353)
T ss_dssp -----CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEE
T ss_pred cchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccc
Confidence 134589999999999999999999999 999999999999999999999999999987654332 23455678
Q ss_pred CCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 150 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
|+.|||||++.+..|+.++|||||||++|||+| |+.||....... .+.... ..+.. +. .+.....
T Consensus 250 t~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~~~~~i----~~g~~-----~~---~p~~~~~ 315 (353)
T 4ase_A 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRL----KEGTR-----MR---APDYTTP 315 (353)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHH----HHTCC-----CC---CCTTCCH
T ss_pred cccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----HcCCC-----CC---CCccCCH
Confidence 999999999999999999999999999999998 899986543221 122211 11111 11 1222334
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+.+++.+||+.||++|||+.+|++.|+++++.+
T Consensus 316 ~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 316 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 5788889999999999999999999999887643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=358.95 Aligned_cols=226 Identities=21% Similarity=0.312 Sum_probs=187.4
Q ss_pred cCCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+.||||++... .....+.+.+|+++|++++||||+++++++.+++..|+|||||+||+|.+++. ..+.+
T Consensus 54 ~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~----~~~~l 129 (311)
T 4aw0_A 54 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSF 129 (311)
T ss_dssp TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HHSSC
T ss_pred CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH----HcCCC
Confidence 357999999999754 23445779999999999999999999999999999999999999999999983 34579
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCcccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~ 159 (307)
++..+..++.||+.||+|||++ ||+||||||+||||++++.+||+|||+++.+.... .......+||+.|+|||++
T Consensus 130 ~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl 206 (311)
T 4aw0_A 130 DETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHH
Confidence 9999999999999999999999 99999999999999999999999999999775432 2335567899999999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+..|+.++|||||||++|||+||+.||..... ..+.. ...... . .++......+.+++.+||+
T Consensus 207 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~---~i~~~~-~---------~~p~~~s~~~~dli~~lL~ 270 (311)
T 4aw0_A 207 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFA---KIIKLE-Y---------DFPEKFFPKARDLVEKLLV 270 (311)
T ss_dssp HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHTC-C---------CCCTTCCHHHHHHHHHHSC
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHcCC-C---------CCCcccCHHHHHHHHHHcc
Confidence 999999999999999999999999999865322 11221 111111 1 1112223457889999999
Q ss_pred cccCCCCCHHHHH
Q 021774 240 AAASRRPQMNQVI 252 (307)
Q Consensus 240 ~~p~~RPs~~~v~ 252 (307)
.||++|||++|++
T Consensus 271 ~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 271 LDATKRLGCEEME 283 (311)
T ss_dssp SSGGGSTTSGGGT
T ss_pred CCHhHCcChHHHc
Confidence 9999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=345.69 Aligned_cols=224 Identities=24% Similarity=0.342 Sum_probs=173.4
Q ss_pred cCCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+.||||+++.. .......+.+|++++++++||||+++++++.+.+..|+||||+ +|+|.+++. ....+
T Consensus 35 ~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~----~~~~l 109 (275)
T 3hyh_A 35 TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV----QRDKM 109 (275)
T ss_dssp TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH----HSCSC
T ss_pred CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH----HcCCC
Confidence 357999999998754 2344567999999999999999999999999999999999999 679998883 34579
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ ||+||||||+||||++++++||+|||+++...... ......||+.|+|||++.
T Consensus 110 ~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~ 184 (275)
T 3hyh_A 110 SEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVIS 184 (275)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHS
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--ccCCeeECcccCChhhhc
Confidence 9999999999999999999999 99999999999999999999999999998664432 234568999999999999
Q ss_pred CCcc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..+ +.++||||+||++|||+||+.||..... ..+...+ .. ... .+ +......+.+++.+||+
T Consensus 185 ~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i---~~-~~~------~~---p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNI---SN-GVY------TL---PKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HH-TCC------CC---CTTSCHHHHHHHHHHSC
T ss_pred CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---Hc-CCC------CC---CCCCCHHHHHHHHHHcc
Confidence 8876 5799999999999999999999865321 1121111 11 111 11 11223457888999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||++|||+.|+++
T Consensus 249 ~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 249 VNPLNRISIHEIMQ 262 (275)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHc
Confidence 99999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=351.51 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=180.4
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|+.||||+++...... ..+..|+..+.+++||||+++++++.+++ ..++||||+++|+|.+++.. ..++
T Consensus 25 ~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~ 98 (303)
T 3hmm_A 25 RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVT 98 (303)
T ss_dssp TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBC
T ss_pred CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCC
Confidence 58899999997543221 22334566667889999999999998754 57999999999999999942 3589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCc
Q 021774 82 WEKRSDICVGIAKGLAFLHEEL-----VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGY 153 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y 153 (307)
|..+++++.|++.||+|||++. .++|+||||||+||||++++++||+|||+++........ ......||+.|
T Consensus 99 ~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~y 178 (303)
T 3hmm_A 99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccc
Confidence 9999999999999999999752 338999999999999999999999999999876443222 23346799999
Q ss_pred CCcccccCC------cccccCceeehHHHHHHHHhCCCCCCccccchh---------HHHHHHHHHHhhcCCcccccCCC
Q 021774 154 LAPEYVLGG------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---------KFLLEWAWQLHQEEKPLELVDPE 218 (307)
Q Consensus 154 ~aPE~~~~~------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 218 (307)
+|||++.+. .++.++|||||||++|||+||..|+........ ..... ........ ..++.
T Consensus 179 mAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~----~~rp~ 253 (303)
T 3hmm_A 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE-MRKVVCEQ----KLRPN 253 (303)
T ss_dssp CCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH-HHHHHTTS----CCCCC
T ss_pred cCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH-HHHHHhcc----cCCCC
Confidence 999998764 578899999999999999999876543221100 00111 11111111 12222
Q ss_pred CCCC--CHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 219 LGEY--PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 219 ~~~~--~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
++.. .......+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 254 ~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 254 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2211 23456678899999999999999999999999988764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=354.06 Aligned_cols=219 Identities=25% Similarity=0.251 Sum_probs=172.6
Q ss_pred CCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+|+.||||+++... ......+.+|+++|++++||||+++++++.+++..|+|||||+||+|.+++. ....+++.
T Consensus 51 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~~l~e~ 126 (304)
T 3ubd_A 51 ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEE 126 (304)
T ss_dssp TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH----HHCCCCHH
T ss_pred CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH----hcCCCCHH
Confidence 57899999987542 2233468899999999999999999999999999999999999999999984 34579999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++...... .......||+.|+|||++.+..
T Consensus 127 ~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~ 202 (304)
T 3ubd_A 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRG 202 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSC
T ss_pred HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-ccccccccCcccCCHHHhccCC
Confidence 9999999999999999999 99999999999999999999999999998654322 2234578999999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
|+.++|||||||++|||+||+.||..... ..+...+ .... . .++......+.+++.+||+.||+
T Consensus 203 y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i---~~~~-~---------~~p~~~s~~~~~li~~~L~~dP~ 266 (304)
T 3ubd_A 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMI---LKAK-L---------GMPQFLSPEAQSLLRMLFKRNPA 266 (304)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHCC-C---------CCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHH---HcCC-C---------CCCCcCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999865432 1122111 1111 1 11122234578899999999999
Q ss_pred CCCCH
Q 021774 244 RRPQM 248 (307)
Q Consensus 244 ~RPs~ 248 (307)
+|||+
T Consensus 267 ~R~ta 271 (304)
T 3ubd_A 267 NRLGA 271 (304)
T ss_dssp GSTTC
T ss_pred HCCCC
Confidence 99985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=342.84 Aligned_cols=228 Identities=19% Similarity=0.301 Sum_probs=170.4
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------------eeEEEEeccCCCCHHHHhc
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------------RRILVYEYVENNSLDRVLL 71 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~sL~~~l~ 71 (307)
.+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+ ..|+|||||+||+|.+++.
T Consensus 28 ~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~ 107 (299)
T 4g31_A 28 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107 (299)
T ss_dssp TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHH
T ss_pred CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHH
Confidence 578999999987553 444568999999999999999999999987654 3689999999999999995
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---------
Q 021774 72 GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------- 142 (307)
Q Consensus 72 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--------- 142 (307)
... .....++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++.+......
T Consensus 108 ~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~ 183 (299)
T 4g31_A 108 GRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183 (299)
T ss_dssp TCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC------------------
T ss_pred hcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCcccccccccccc
Confidence 321 223456777899999999999999999 9999999999999999999999999999876543221
Q ss_pred --ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCC
Q 021774 143 --ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELG 220 (307)
Q Consensus 143 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (307)
......||+.|||||++.+..|+.++|||||||++|||++ ||..... ......... .... +
T Consensus 184 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~~~~~~~~~-~~~~--------p 246 (299)
T 4g31_A 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----RVRTLTDVR-NLKF--------P 246 (299)
T ss_dssp --------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHHHHHH-TTCC--------C
T ss_pred ccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----HHHHHHHHh-cCCC--------C
Confidence 1234579999999999999999999999999999999996 5532211 111111111 1111 1
Q ss_pred CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.........+.+++.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 247 PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223344677999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=332.67 Aligned_cols=259 Identities=42% Similarity=0.736 Sum_probs=218.2
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+.++|+.||||++........+.+.+|++++++++||||+++++++...+..++||||+++++|.+++.........++
T Consensus 58 ~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 137 (321)
T 2qkw_B 58 GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137 (321)
T ss_dssp EECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCC
T ss_pred EEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccC
Confidence 34567999999999877666677899999999999999999999999999999999999999999999865544555799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~ 160 (307)
+..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....... ........|+..|+|||++.
T Consensus 138 ~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 214 (321)
T 2qkw_B 138 WEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhc
Confidence 999999999999999999999 99999999999999999999999999998654322 22233456899999999998
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC-CCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..++.++||||||+++|||+||+.||....+........+.............+++.+ ....+.....+.+++.+||+
T Consensus 215 ~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 294 (321)
T 2qkw_B 215 KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294 (321)
T ss_dssp HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTC
T ss_pred CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcC
Confidence 88999999999999999999999999876655444444455444455555555555554 34567888899999999999
Q ss_pred cccCCCCCHHHHHHHHHhccccCc
Q 021774 240 AAASRRPQMNQVIKMLTKNIRLNE 263 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~~~~~~~~ 263 (307)
.||++|||+.+|++.|+.+++.++
T Consensus 295 ~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 295 LSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CCcccCcCHHHHHHHHHHHhhccc
Confidence 999999999999999999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=338.37 Aligned_cols=238 Identities=20% Similarity=0.310 Sum_probs=181.2
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe------CCeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.. .+..|+|||||+ |+|.+++ ..
T Consensus 77 ~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i----~~ 151 (398)
T 4b99_A 77 LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQII----HS 151 (398)
T ss_dssp TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHH----TS
T ss_pred CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHH----Hh
Confidence 57999999999754 34556778999999999999999999999764 357899999995 6799988 34
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc---ccccccccCCCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI---THITTRIAGTTGY 153 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~g~~~y 153 (307)
...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.+.... ........||+.|
T Consensus 152 ~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y 228 (398)
T 4b99_A 152 SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228 (398)
T ss_dssp SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHh
Confidence 56799999999999999999999999 99999999999999999999999999998764422 2234557899999
Q ss_pred CCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccc--------------cCCC
Q 021774 154 LAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL--------------VDPE 218 (307)
Q Consensus 154 ~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~ 218 (307)
+|||++.+. .++.++||||+||++|||++|+.||..... ......+............ +.+.
T Consensus 229 ~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 305 (398)
T 4b99_A 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPR 305 (398)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCC
T ss_pred cCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCc
Confidence 999998875 568999999999999999999999865432 1222222222111110000 0000
Q ss_pred CC----CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 219 LG----EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 219 ~~----~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.. ...+.....+.+|+.+||..||.+|||+.|+++
T Consensus 306 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 306 QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000112345788999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=325.03 Aligned_cols=257 Identities=42% Similarity=0.719 Sum_probs=210.6
Q ss_pred cccCCCCEEEEEEccccCh-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESK-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
|...+|+.||||++..... .....+.+|++++++++||||+++++++...+..++||||+++|+|.+++.........+
T Consensus 49 ~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 128 (326)
T 3uim_A 49 GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128 (326)
T ss_dssp ECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCC
T ss_pred EEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCC
Confidence 3456799999999986532 223468999999999999999999999999999999999999999999997766666679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++..+||+||||||+||+++.++.+||+|||++...............||..|+|||++.
T Consensus 129 ~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (326)
T 3uim_A 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208 (326)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhc
Confidence 99999999999999999999986668999999999999999999999999999887655444455567999999999998
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCcccc--chhHHHHHHHHHHhhcCCcccccCCCC-CCCCHHHHHHHHHHHHhc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWG--QMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c 237 (307)
+..++.++||||||+++|+|++|..||..... ........+..............+..+ ..........+.+++.+|
T Consensus 209 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 288 (326)
T 3uim_A 209 TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLC 288 (326)
T ss_dssp HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHH
T ss_pred cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHH
Confidence 88999999999999999999999999853221 112223333333333444444444443 456778889999999999
Q ss_pred cccccCCCCCHHHHHHHHHhc
Q 021774 238 TQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~~L~~~ 258 (307)
|+.||.+|||+.+|++.|++.
T Consensus 289 l~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 289 TQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TCSCGGGSCCHHHHHHHHHTS
T ss_pred hCcCCccCCCHHHHHHHhcCc
Confidence 999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=343.99 Aligned_cols=229 Identities=22% Similarity=0.301 Sum_probs=187.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|++........+.+.+|+++|++++||||+++++++.+.+..|+|||||+||+|.+++. .....+++..
T Consensus 180 ~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~---~~~~~l~e~~ 256 (573)
T 3uto_A 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDE 256 (573)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHT---CTTSCEEHHH
T ss_pred CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHH---HhCCCCCHHH
Confidence 5799999999987766666789999999999999999999999999999999999999999999883 2345799999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC--CceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE--FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+.... ......||+.|+|||++.+.
T Consensus 257 ~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~ 331 (573)
T 3uto_A 257 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGK 331 (573)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCC
Confidence 999999999999999999 99999999999999854 889999999999875432 23456799999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.|+.++|||||||++|||++|..||...... .... ........ ..++.... ....+.+|+.+||+.||
T Consensus 332 ~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~---~i~~~~~~--~~~~~~~~----~s~~~~dli~~~L~~dp 399 (573)
T 3uto_A 332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLR---NVKSCDWN--MDDSAFSG----ISEDGKDFIRKLLLADP 399 (573)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHTTCCC--CCSGGGTT----SCHHHHHHHHTTSCSSG
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---HHHhCCCC--CCcccccC----CCHHHHHHHHHHccCCh
Confidence 9999999999999999999999998654321 1111 11111110 00111112 23357889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
.+|||+.|+++
T Consensus 400 ~~R~t~~e~l~ 410 (573)
T 3uto_A 400 NTRMTIHQALE 410 (573)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHhc
Confidence 99999999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=323.67 Aligned_cols=175 Identities=27% Similarity=0.375 Sum_probs=149.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+++.||+|.+.... ...++.+|+++|+++ +||||+++++++.+.+..|+||||++||+|.+++. .+++.
T Consensus 47 ~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~ 117 (361)
T 4f9c_A 47 GPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQ 117 (361)
T ss_dssp SCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHH
T ss_pred CCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHH
Confidence 357889999887543 235678999999998 79999999999999999999999999999999982 48999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCCccc--------------------
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITH-------------------- 142 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~-------------------- 142 (307)
.+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+++........
T Consensus 118 ~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (361)
T 4f9c_A 118 EVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCS 194 (361)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---------------
T ss_pred HHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccc
Confidence 9999999999999999999 99999999999999877 79999999999865432211
Q ss_pred -------ccccccCCCCcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccc
Q 021774 143 -------ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMW 191 (307)
Q Consensus 143 -------~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~ 191 (307)
......||+.|+|||++.+. .|+.++||||+||++|||+||+.||....
T Consensus 195 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp -----------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 12345799999999999875 58999999999999999999999986443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=341.93 Aligned_cols=227 Identities=20% Similarity=0.212 Sum_probs=180.0
Q ss_pred cCCCCEEEEEEccccC------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 4 LTNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
..+|+.||||+++... .........++.+++.++||||++++++|.+.+..|+||||++||+|.+++. ..
T Consensus 211 ~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~----~~ 286 (689)
T 3v5w_A 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QH 286 (689)
T ss_dssp TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HH
T ss_pred CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH----hc
Confidence 3579999999987431 1222233445677788899999999999999999999999999999999993 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..+++..+..++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+++.+.... ....+||+.|+|||
T Consensus 287 ~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPE 360 (689)
T 3v5w_A 287 GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPE 360 (689)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC---CCSCCSCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC---CCCccCCcCccCHH
Confidence 5799999999999999999999999 99999999999999999999999999998765432 34568999999999
Q ss_pred cccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
++.+ ..|+.++|+|||||++|||++|..||..........+.. ....... .++......+.+++.+
T Consensus 361 vl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~~----------~~p~~~S~~a~dLI~~ 427 (689)
T 3v5w_A 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMAV----------ELPDSFSPELRSLLEG 427 (689)
T ss_dssp HHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCCC----------CCCTTSCHHHHHHHHH
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCCC----------CCCccCCHHHHHHHHH
Confidence 9964 579999999999999999999999997644332221111 1111111 1122233457889999
Q ss_pred ccccccCCCCC-----HHHHHH
Q 021774 237 CTQAAASRRPQ-----MNQVIK 253 (307)
Q Consensus 237 c~~~~p~~RPs-----~~~v~~ 253 (307)
||+.||.+|++ +++|++
T Consensus 428 lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 428 LLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HTCSCGGGCTTCSSSTHHHHTT
T ss_pred HccCCHhHCCCCCCCCHHHHhc
Confidence 99999999998 677764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=316.72 Aligned_cols=237 Identities=26% Similarity=0.481 Sum_probs=191.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+...+....+.|.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ....+++..
T Consensus 33 ~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 109 (310)
T 3s95_A 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQ 109 (310)
T ss_dssp TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHH
T ss_pred CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHH
Confidence 46899999998877777778999999999999999999999999999999999999999999999943 345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc-------------cccccCCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-------------TTRIAGTT 151 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-------------~~~~~g~~ 151 (307)
+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......... .....||+
T Consensus 110 ~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 186 (310)
T 3s95_A 110 RVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186 (310)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCG
T ss_pred HHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCc
Confidence 999999999999999999 99999999999999999999999999998765432211 12457899
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
.|+|||++.+..++.++||||||+++|||++|..|+............. ....... . .++.....+.
T Consensus 187 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~---------~---~~~~~~~~l~ 253 (310)
T 3s95_A 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFLDR---------Y---CPPNCPPSFF 253 (310)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHHHH---------T---CCTTCCTTHH
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccccc---------c---CCCCCCHHHH
Confidence 9999999999999999999999999999999998876543322110000 0000000 0 0111223478
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+++.+||+.||++|||+.++++.|+.+..
T Consensus 254 ~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 254 PITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 88999999999999999999999988764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=312.74 Aligned_cols=238 Identities=29% Similarity=0.471 Sum_probs=182.8
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ....+++.
T Consensus 59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 137 (309)
T 3p86_A 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDER 137 (309)
T ss_dssp TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHH
T ss_pred CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHH
Confidence 5789999998765 34556789999999999999999999999999999999999999999999984321 12248999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
.++.++.|++.||+|||++ | |+||||||+||+++.++.+||+|||++....... .......||..|+|||++.+
T Consensus 138 ~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 213 (309)
T 3p86_A 138 RRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRD 213 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcC
Confidence 9999999999999999999 8 9999999999999999999999999998654322 22344678999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|||++|..||....... ... ........ ...+......+.+++.+||+.|
T Consensus 214 ~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~---~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~d 279 (309)
T 3p86_A 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVA---AVGFKCKR--------LEIPRNLNPQVAAIIEGCWTNE 279 (309)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH---HHHHSCCC--------CCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhcCCC--------CCCCccCCHHHHHHHHHHccCC
Confidence 999999999999999999999999986543211 111 11111111 1112223345888999999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|.+|||+.++++.|+.+++..
T Consensus 280 P~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 280 PWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp GGGSCCHHHHHHHHHHHHC--
T ss_pred hhhCcCHHHHHHHHHHHHHhC
Confidence 999999999999999988644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=318.58 Aligned_cols=239 Identities=25% Similarity=0.420 Sum_probs=193.3
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 75 (307)
.+|..||||+++.. .......+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 190 (370)
T 2psq_A 111 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190 (370)
T ss_dssp TCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC------
T ss_pred CcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccc
Confidence 35668999999865 345567899999999999 899999999999999999999999999999999865432
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccC
Q 021774 76 -----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAG 149 (307)
Q Consensus 76 -----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g 149 (307)
....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++....... .......+
T Consensus 191 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 267 (370)
T 2psq_A 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267 (370)
T ss_dssp -----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTS
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCc
Confidence 124589999999999999999999999 999999999999999999999999999987654322 22334557
Q ss_pred CCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 150 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
+..|+|||++.+..++.++|||||||++|||+| |..||....... +.. ....... ...+.....
T Consensus 268 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~--------~~~~~~~~~ 332 (370)
T 2psq_A 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK----LLKEGHR--------MDKPANCTN 332 (370)
T ss_dssp CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCC--------CCCCTTSCH
T ss_pred ccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhcCCC--------CCCCCCCCH
Confidence 788999999999999999999999999999999 888886543221 111 1111111 111223334
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
.+.+++.+||+.||.+||++.++++.|++++..
T Consensus 333 ~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 588899999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=309.12 Aligned_cols=228 Identities=22% Similarity=0.404 Sum_probs=186.8
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
..+|+.||||.+..........+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ..+++.
T Consensus 42 ~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~ 116 (297)
T 3fxz_A 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEG 116 (297)
T ss_dssp TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHH
T ss_pred CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHH
Confidence 357899999998766555567789999999999999999999999999999999999999999999843 358999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..
T Consensus 117 ~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 192 (297)
T 3fxz_A 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA 192 (297)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcCCC
Confidence 9999999999999999999 999999999999999999999999999987654332 234467899999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++||||||+++|||++|..||........ . . ......... ...+......+.+++.+||+.||+
T Consensus 193 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~-~---~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~ 259 (297)
T 3fxz_A 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L-Y---LIATNGTPE-------LQNPEKLSAIFRDFLNRCLEMDVE 259 (297)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H-H---HHHHHCSCC-------CSCGGGSCHHHHHHHHHHSCSSTT
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H---HHHhCCCCC-------CCCccccCHHHHHHHHHHccCChh
Confidence 99999999999999999999999865432111 1 1 111111110 011223344578899999999999
Q ss_pred CCCCHHHHHH
Q 021774 244 RRPQMNQVIK 253 (307)
Q Consensus 244 ~RPs~~~v~~ 253 (307)
+|||+.++++
T Consensus 260 ~Rps~~ell~ 269 (297)
T 3fxz_A 260 KRGSAKELLQ 269 (297)
T ss_dssp TSCCHHHHTT
T ss_pred HCcCHHHHhh
Confidence 9999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=311.75 Aligned_cols=236 Identities=27% Similarity=0.435 Sum_probs=189.1
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..
T Consensus 76 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 152 (325)
T 3kul_A 76 RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQ 152 (325)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHH
T ss_pred CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHH
Confidence 3456999999865 455567899999999999999999999999999999999999999999999842 345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 162 (307)
++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++......... ......+|..|+|||++.+.
T Consensus 153 ~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 229 (325)
T 3kul_A 153 LVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229 (325)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC
Confidence 999999999999999999 9999999999999999999999999999877543222 22334457789999999989
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..||...... .+.. . ....... ..+......+.+++.+||+.|
T Consensus 230 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~---~-~~~~~~~--------~~~~~~~~~l~~li~~~l~~d 294 (325)
T 3kul_A 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVIS---S-VEEGYRL--------PAPMGCPHALHQLMLDCWHKD 294 (325)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH---H-HHTTCCC--------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHH---H-HHcCCCC--------CCCCCcCHHHHHHHHHHccCC
Confidence 99999999999999999999 99998654321 1111 1 1111110 112223345888999999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|.+|||+.+|++.|+.+++..
T Consensus 295 p~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 295 RAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp GGGSCCHHHHHHHHHHHHHSC
T ss_pred hhhCcCHHHHHHHHHHHHhCc
Confidence 999999999999999988654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=308.71 Aligned_cols=239 Identities=24% Similarity=0.341 Sum_probs=186.9
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++. ....++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~ 109 (294)
T 4eqm_A 34 ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLS 109 (294)
T ss_dssp TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHCSCC
T ss_pred CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH----hcCCCC
Confidence 46889999988543 34556789999999999999999999999999999999999999999999984 334699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...............||+.|+|||++.+
T Consensus 110 ~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 110 VDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC
Confidence 999999999999999999999 99999999999999999999999999998765544444455679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|+||+.||....... ............ .. ..........+.+++.+||+.|
T Consensus 187 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~-~~----~~~~~~~~~~l~~li~~~l~~d 255 (294)
T 4eqm_A 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSVPN-VT----TDVRKDIPQSLSNVILRATEKD 255 (294)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCCCC-HH----HHSCTTSCHHHHHHHHHHSCSS
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccCCC-cc----hhcccCCCHHHHHHHHHHhcCC
Confidence 999999999999999999999999986543211 111111111110 00 0111223345888999999999
Q ss_pred cCCCC-CHHHHHHHHHhcccc
Q 021774 242 ASRRP-QMNQVIKMLTKNIRL 261 (307)
Q Consensus 242 p~~RP-s~~~v~~~L~~~~~~ 261 (307)
|.+|| +++++.+.|+.++..
T Consensus 256 p~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 256 KANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp GGGSCSSHHHHHHHHHTSSSS
T ss_pred HhHccccHHHHHHHHHHHHhh
Confidence 99998 899999999887753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=304.29 Aligned_cols=251 Identities=18% Similarity=0.226 Sum_probs=197.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++..... ...+.+|+++++++ +|+|++++++++......++||||+ +++|.+++.. .+..+++.
T Consensus 33 ~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~ 106 (298)
T 1csn_A 33 LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVK 106 (298)
T ss_dssp TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHH
T ss_pred CCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHH
Confidence 6789999998875432 24578899999999 8999999999999999999999999 9999999943 24469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-----eEEeeccCcccCCCCccc------ccccccCCCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-----PKIGDFGLAKLFPDNITH------ITTRIAGTTG 152 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~dfg~~~~~~~~~~~------~~~~~~g~~~ 152 (307)
.+..++.|++.||+|||++ ||+||||||+||+++.++. +||+|||++......... ......||..
T Consensus 107 ~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~ 183 (298)
T 1csn_A 107 TVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred HHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcc
Confidence 9999999999999999999 9999999999999987776 999999999876543221 2345678999
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
|+|||++.+..++.++||||||+++|||++|+.||........................... .......+.+
T Consensus 184 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~ 255 (298)
T 1csn_A 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL--------CAGFPEEFYK 255 (298)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH--------TTTSCHHHHH
T ss_pred cCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH--------HhhCcHHHHH
Confidence 99999999999999999999999999999999999775443333332222222211111111 1112345888
Q ss_pred HHHhccccccCCCCCHHHHHHHHHhccccCccccCCCCCc
Q 021774 233 VAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLF 272 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~ 272 (307)
++.+||+.||.+||++.+|++.|+++++........+..|
T Consensus 256 li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 256 YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp HHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred HHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 8999999999999999999999999887554444444444
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.94 Aligned_cols=241 Identities=17% Similarity=0.218 Sum_probs=193.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++..... ...+.+|+++++++ +||||+++++++...+..++||||+ +++|.+++... ...+++.
T Consensus 32 ~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~ 105 (330)
T 2izr_A 32 YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLK 105 (330)
T ss_dssp TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHH
T ss_pred CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHH
Confidence 5788999999875432 24588999999999 9999999999999999999999999 99999998432 4579999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-----eEEeeccCcccCCCCccc------ccccccCCCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-----PKIGDFGLAKLFPDNITH------ITTRIAGTTG 152 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~dfg~~~~~~~~~~~------~~~~~~g~~~ 152 (307)
.++.++.|++.||+|||++ ||+||||||+|||++.++. +||+|||++..+...... ......||..
T Consensus 106 ~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~ 182 (330)
T 2izr_A 106 TVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCcc
Confidence 9999999999999999999 9999999999999999887 999999999876443221 1245679999
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
|+|||++.+..++.++|||||||++|||++|..||........................ .. +....+ .+.+
T Consensus 183 y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~----~~~~~p----~~~~ 253 (330)
T 2izr_A 183 YMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI-EV----LCENFP----EMAT 253 (330)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-HH----HTTTCH----HHHH
T ss_pred ccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-HH----HhccCh----HHHH
Confidence 99999999999999999999999999999999999765443322222222221111111 00 011112 6888
Q ss_pred HHHhccccccCCCCCHHHHHHHHHhccccCc
Q 021774 233 VAFFCTQAAASRRPQMNQVIKMLTKNIRLNE 263 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~ 263 (307)
++..||+.||.+||++.+|.+.|+++.....
T Consensus 254 li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 254 YLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 8899999999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=304.14 Aligned_cols=238 Identities=24% Similarity=0.397 Sum_probs=192.0
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+..+++..||+|+++.... ....+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ....++
T Consensus 27 ~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 102 (268)
T 3sxs_A 27 GKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLE 102 (268)
T ss_dssp EEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCC
T ss_pred EEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCC
Confidence 3456778899999986532 236789999999999999999999999999999999999999999999843 234699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++...............++..|+|||++.+
T Consensus 103 ~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 179 (268)
T 3sxs_A 103 PSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY 179 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc
Confidence 999999999999999999999 99999999999999999999999999998776554444444556778999999998
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|+|+| |..||....... .. ......... . .+......+.+++.+||+.
T Consensus 180 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~~~~~~~---~------~~~~~~~~l~~li~~~l~~ 244 (268)
T 3sxs_A 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VV---LKVSQGHRL---Y------RPHLASDTIYQIMYSCWHE 244 (268)
T ss_dssp SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---HHHHTTCCC---C------CCTTSCHHHHHHHHHTTCS
T ss_pred cCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HH---HHHHcCCCC---C------CCCcChHHHHHHHHHHcCC
Confidence 899999999999999999999 998886543211 11 111111110 0 0111223578889999999
Q ss_pred ccCCCCCHHHHHHHHHhcccc
Q 021774 241 AASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~~~ 261 (307)
||.+|||+.++++.|+.+...
T Consensus 245 ~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 245 LPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SGGGSCCHHHHHHHHGGGCC-
T ss_pred ChhhCcCHHHHHHHHHHhhhc
Confidence 999999999999999887653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=314.07 Aligned_cols=242 Identities=24% Similarity=0.388 Sum_probs=187.6
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++........+.+.+|++++++++||||+++++++... ...++||||+++++|.+++.. ....+++
T Consensus 37 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 113 (295)
T 3ugc_A 37 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH 113 (295)
T ss_dssp SCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCH
T ss_pred CCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCH
Confidence 46889999999887777778899999999999999999999998653 568999999999999999843 2345999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCccccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~ 160 (307)
..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......... ......++..|+|||++.
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 114 IKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence 99999999999999999999 9999999999999999999999999999876543221 223344667799999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchh---------HHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---------KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
+..++.++||||||+++|||+||..|+........ ................ ...+......+.
T Consensus 191 ~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~ 262 (295)
T 3ugc_A 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR--------LPRPDGCPDEIY 262 (295)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC--------CCCCTTCCHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc--------CCCCcCcCHHHH
Confidence 99999999999999999999999988765432110 0011111111111111 111223345688
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+++.+||+.||.+|||+.++++.|+++.+
T Consensus 263 ~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 263 MIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 89999999999999999999999988764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=305.64 Aligned_cols=236 Identities=24% Similarity=0.403 Sum_probs=191.4
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ....+++
T Consensus 30 ~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 105 (269)
T 4hcu_A 30 YWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAA 105 (269)
T ss_dssp EETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCH
T ss_pred EecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCH
Confidence 345788999999986532 236789999999999999999999999999999999999999999999843 3446899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++...............++..|+|||++.+.
T Consensus 106 ~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (269)
T 4hcu_A 106 ETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 182 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCC
Confidence 99999999999999999999 999999999999999999999999999987655433334445567789999999988
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|+|++ |..||...... .... . ...... . ..+......+.+++.+||+.|
T Consensus 183 ~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~---~-~~~~~~-----~---~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE---D-ISTGFR-----L---YKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHTTCC-----C---CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---H-HhcCcc-----C---CCCCcCCHHHHHHHHHHccCC
Confidence 99999999999999999999 88888654321 1111 1 111110 0 111122345788899999999
Q ss_pred cCCCCCHHHHHHHHHhccc
Q 021774 242 ASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~ 260 (307)
|.+||++.++++.|+++..
T Consensus 248 p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 248 PEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred cccCcCHHHHHHHHHHHHH
Confidence 9999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=318.30 Aligned_cols=234 Identities=24% Similarity=0.342 Sum_probs=187.9
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.||||.++.. .......|.+|++++++++||||+++++++...+..++||||+++|+|.+++.. .+..+++..
T Consensus 138 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~ 214 (377)
T 3cbl_A 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKT 214 (377)
T ss_dssp TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHH
T ss_pred CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHH
Confidence 6899999999865 344456789999999999999999999999999999999999999999999842 334689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccc-ccccCCCCcCCcccccCCc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~ 163 (307)
++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.......... ....++..|+|||++.+..
T Consensus 215 ~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 215 LLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC
Confidence 999999999999999999 999999999999999999999999999986544322111 1223566799999999899
Q ss_pred ccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
++.++|||||||++|||+| |..|+....... ... ........ ..+......+.+++.+||+.||
T Consensus 292 ~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP 356 (377)
T 3cbl_A 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TRE----FVEKGGRL--------PCPELCPDAVFRLMEQCWAYEP 356 (377)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHH----HHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC--------CCCCCCCHHHHHHHHHHcCCCc
Confidence 9999999999999999998 888876543211 111 11111110 1112223457788899999999
Q ss_pred CCCCCHHHHHHHHHhccc
Q 021774 243 SRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 243 ~~RPs~~~v~~~L~~~~~ 260 (307)
++|||+.+|++.|+++.+
T Consensus 357 ~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 357 GQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=308.94 Aligned_cols=224 Identities=24% Similarity=0.368 Sum_probs=184.4
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++... +....+.+.+|++++++++||||+++++++...+..++||||+++++|.+++. ....+++
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~ 113 (328)
T 3fe3_A 38 LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV----AHGRMKE 113 (328)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH----HHCCCCH
T ss_pred CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH----HcCCCCH
Confidence 57999999998754 45556788999999999999999999999999999999999999999999983 3356999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+.
T Consensus 114 ~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 188 (328)
T 3fe3_A 114 KEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGK 188 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--ccccccCCcceeCcccccCC
Confidence 99999999999999999999 99999999999999999999999999998664432 23456799999999999887
Q ss_pred ccc-ccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLT-MKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.+. .++|||||||++|+|++|+.||...... .+.. ....... ..+......+.+++.+||+.|
T Consensus 189 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~---~i~~~~~----------~~p~~~s~~~~~li~~~L~~d 252 (328)
T 3fe3_A 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRE---RVLRGKY----------RIPFYMSTDCENLLKRFLVLN 252 (328)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCC----------CCCTTSCHHHHHHHHHHCCSS
T ss_pred CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC----------CCCCCCCHHHHHHHHHHCCCC
Confidence 765 7999999999999999999998654321 1111 1111111 111122345778899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.++++
T Consensus 253 P~~R~t~~eil~ 264 (328)
T 3fe3_A 253 PIKRGTLEQIMK 264 (328)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhHCcCHHHHhc
Confidence 999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.96 Aligned_cols=236 Identities=27% Similarity=0.433 Sum_probs=180.4
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|..||||.++.. .....+.|.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ....+++..
T Consensus 72 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~ 148 (373)
T 2qol_A 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQ 148 (373)
T ss_dssp CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHH
T ss_pred CceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHH
Confidence 5778999999865 445567899999999999999999999999999999999999999999999943 345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 162 (307)
++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+.
T Consensus 149 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (373)
T 2qol_A 149 LVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225 (373)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC
Confidence 999999999999999999 9999999999999999999999999999876543221 12223456789999999989
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |+.||..... ..+.... ...... ..+......+.+++.+||+.|
T Consensus 226 ~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i----~~~~~~--------~~~~~~~~~l~~li~~cl~~d 290 (373)
T 2qol_A 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAV----DEGYRL--------PPPMDCPAALYQLMLDCWQKD 290 (373)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHH----HTTEEC--------CCCTTCBHHHHHHHHHHTCSS
T ss_pred CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC--------CCCccccHHHHHHHHHHhCcC
Confidence 99999999999999999998 9998865432 1111111 111100 111223345888999999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|.+||++.+|++.|+++++..
T Consensus 291 p~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 291 RNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp GGGSCCHHHHHHHHHHHHHCG
T ss_pred hhhCcCHHHHHHHHHHHHhCc
Confidence 999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=302.76 Aligned_cols=227 Identities=22% Similarity=0.419 Sum_probs=186.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++. ...+++..
T Consensus 68 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~ 142 (321)
T 2c30_A 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQ 142 (321)
T ss_dssp TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHH
T ss_pred CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHH
Confidence 3799999999987665666789999999999999999999999999999999999999999999983 34699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........ ......||..|+|||++.+..+
T Consensus 143 ~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2c30_A 143 IATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLY 218 (321)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCC
Confidence 999999999999999999 999999999999999999999999999987654322 2344678999999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+++|||++|+.||...... .... ...... . +.+ .........+.+++.+||+.||++
T Consensus 219 ~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~---~~~~~~-~-----~~~-~~~~~~~~~l~~li~~~l~~dp~~ 285 (321)
T 2c30_A 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMK---RLRDSP-P-----PKL-KNSHKVSPVLRDFLERMLVRDPQE 285 (321)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHHSS-C-----CCC-TTGGGSCHHHHHHHHHHSCSSTTT
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHhcCC-C-----CCc-CccccCCHHHHHHHHHHccCChhh
Confidence 99999999999999999999998654321 1111 111111 1 111 011223345788899999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
|||+.++++
T Consensus 286 Rps~~ell~ 294 (321)
T 2c30_A 286 RATAQELLD 294 (321)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=310.66 Aligned_cols=242 Identities=26% Similarity=0.412 Sum_probs=188.5
Q ss_pred cCCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+.||||++.... ......+.+|++++++++||||+++++++... +..++||||+++++|.+++.. ....+
T Consensus 47 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~ 123 (302)
T 4e5w_A 47 DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKI 123 (302)
T ss_dssp SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTC
T ss_pred CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccC
Confidence 3578999999998553 34557899999999999999999999999876 668999999999999999843 23458
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCCccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEY 158 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~ 158 (307)
++..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++........ .......||..|+|||+
T Consensus 124 ~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 200 (302)
T 4e5w_A 124 NLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200 (302)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCee
Confidence 9999999999999999999999 999999999999999999999999999987755432 22344567888999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccch--------hHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM--------NKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
+.+..++.++||||||+++|+|+||..|+....... ................. ...+......+
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l 272 (302)
T 4e5w_A 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR--------LPCPPNCPDEV 272 (302)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCC--------CCCCTTCCHHH
T ss_pred ecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCC--------CCCCCCCCHHH
Confidence 999999999999999999999999998764332110 00011111111111111 11222334568
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
.+++.+||+.||.+|||+.++++.|++++
T Consensus 273 ~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 273 YQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 88999999999999999999999998875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=322.54 Aligned_cols=239 Identities=26% Similarity=0.392 Sum_probs=191.1
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+.+++..||||.++... ...+.|.+|++++++++||||+++++++. .+..++||||+++|+|.+++... ....++
T Consensus 207 ~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~ 282 (454)
T 1qcf_A 207 ATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQP 282 (454)
T ss_dssp EEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCC
T ss_pred EEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCC
Confidence 445678899999998654 34578999999999999999999999986 56789999999999999999432 223688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..............++..|+|||++.+
T Consensus 283 ~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 359 (454)
T 1qcf_A 283 LPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359 (454)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc
Confidence 999999999999999999999 99999999999999999999999999998765432222333456778999999998
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|||+| |+.||..... ..+...... .... ..+......+.+++.+||+.
T Consensus 360 ~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~---~~~~---------~~~~~~~~~l~~li~~cl~~ 424 (454)
T 1qcf_A 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALER---GYRM---------PRPENCPEELYNIMMRCWKN 424 (454)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHH---TCCC---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc---CCCC---------CCCCCCCHHHHHHHHHHccC
Confidence 899999999999999999999 9998865432 112221111 1111 01122334588899999999
Q ss_pred ccCCCCCHHHHHHHHHhccccC
Q 021774 241 AASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
||++|||+.+|++.|+++....
T Consensus 425 dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 425 RPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp SGGGSCCHHHHHHHHHTSSSSS
T ss_pred ChhHCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999887543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.61 Aligned_cols=238 Identities=28% Similarity=0.421 Sum_probs=192.2
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 75 (307)
.+|..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 130 (314)
T 2ivs_A 51 AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130 (314)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC--
T ss_pred cCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccc
Confidence 35688999999865 355567899999999999999999999999999999999999999999999965432
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-
Q 021774 76 ------------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH- 142 (307)
Q Consensus 76 ------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 142 (307)
....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.........
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 207 (314)
T 2ivs_A 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207 (314)
T ss_dssp --------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE
T ss_pred cccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccce
Confidence 123489999999999999999999999 9999999999999999999999999999876543222
Q ss_pred ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 143 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
......++..|+|||++.+..++.++||||||+++|||++ |..||....... +.. ........ .
T Consensus 208 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~--------~ 272 (314)
T 2ivs_A 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER---LFN----LLKTGHRM--------E 272 (314)
T ss_dssp CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC--------C
T ss_pred eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HhhcCCcC--------C
Confidence 2334456788999999999999999999999999999999 998886544322 111 11111110 1
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
.+......+.+++.+||+.||.+||++.++++.|++++.
T Consensus 273 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 273 RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 112233458889999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=310.66 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=190.6
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC-------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------- 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------- 76 (307)
.+|+.||||+++.. .......+.+|+.++++++||||+++++++...+..++||||+++++|.+++......
T Consensus 75 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 154 (343)
T 1luf_A 75 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154 (343)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccccc
Confidence 45689999999865 3455678999999999999999999999999999999999999999999998653211
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-c
Q 021774 77 -------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-H 142 (307)
Q Consensus 77 -------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 142 (307)
...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++........ .
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (343)
T 1luf_A 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231 (343)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred ccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCcccc
Confidence 25689999999999999999999999 999999999999999999999999999976543221 1
Q ss_pred ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 143 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
......++..|+|||++.+..++.++||||||+++|||+| |..||...... .+. ......... .
T Consensus 232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~--------~ 296 (343)
T 1luf_A 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVI----YYVRDGNIL--------A 296 (343)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH----HHHHTTCCC--------C
T ss_pred ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH---HHH----HHHhCCCcC--------C
Confidence 2334567889999999998899999999999999999999 88888654321 111 111111111 1
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+......+.+++.+||+.||.+||++.+|++.|+++....
T Consensus 297 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 297 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 12223345888899999999999999999999999887543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=302.14 Aligned_cols=237 Identities=22% Similarity=0.377 Sum_probs=191.5
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
++..++..||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ....++
T Consensus 43 ~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 118 (283)
T 3gen_A 43 GKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQ 118 (283)
T ss_dssp EEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCC
T ss_pred EEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCC
Confidence 3456778899999986532 236789999999999999999999999999999999999999999999843 235699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++...............++..|+|||++.+
T Consensus 119 ~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (283)
T 3gen_A 119 TQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 195 (283)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc
Confidence 999999999999999999999 99999999999999999999999999998765543333344556778999999998
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|+|+| |+.||....... ... . ...... ... +......+.+++.+||+.
T Consensus 196 ~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~---~-~~~~~~-----~~~---~~~~~~~l~~li~~~l~~ 260 (283)
T 3gen_A 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE---H-IAQGLR-----LYR---PHLASEKVYTIMYSCWHE 260 (283)
T ss_dssp CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---H-HHTTCC-----CCC---CTTCCHHHHHHHHHTTCS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHH---H-HhcccC-----CCC---CCcCCHHHHHHHHHHccC
Confidence 899999999999999999998 998986543211 111 1 111110 001 111224578889999999
Q ss_pred ccCCCCCHHHHHHHHHhccc
Q 021774 241 AASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~~ 260 (307)
||.+|||+.++++.|.+++.
T Consensus 261 ~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 261 KADERPTFKILLSNILDVMD 280 (283)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999988764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=312.28 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=192.1
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEE--eCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|+.||||++........+.+.+|++++++++||||+++++++. +....++||||+++++|.+++.. ....++
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 125 (327)
T 3lxl_A 49 DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLD 125 (327)
T ss_dssp SSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH---HGGGCC
T ss_pred CCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh---cccCCC
Confidence 3568899999998877777788999999999999999999999987 45678999999999999999843 234599
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~ 159 (307)
+..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......... ......|+..|+|||++
T Consensus 126 ~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (327)
T 3lxl_A 126 ASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHh
Confidence 999999999999999999999 9999999999999999999999999999877543322 23345577889999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhH--------HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
.+..++.++||||||+++|+|++|..|+......... ............... ...+......+.
T Consensus 203 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~ 274 (327)
T 3lxl_A 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR--------LPAPPACPAEVH 274 (327)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC--------CCCCTTCCHHHH
T ss_pred ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC--------CCCCCcccHHHH
Confidence 9999999999999999999999999887543321100 000111111111111 111233345588
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+++.+||+.||.+|||+.++++.|+.+....
T Consensus 275 ~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 275 ELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 8999999999999999999999999887543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.72 Aligned_cols=239 Identities=28% Similarity=0.438 Sum_probs=184.8
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+.+++..||||.++.... ..+.|.+|++++++++||||+++++++.+ +..++||||+++|+|.+++... .+..++
T Consensus 203 ~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~ 278 (452)
T 1fmk_A 203 GTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLR 278 (452)
T ss_dssp EEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCC
T ss_pred EEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCC
Confidence 4456677899999986542 34679999999999999999999999876 6789999999999999999421 234589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..............++..|+|||++.+
T Consensus 279 ~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 355 (452)
T 1fmk_A 279 LPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355 (452)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc
Confidence 999999999999999999999 99999999999999999999999999998765443333334456788999999998
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|||+| |..||...... ..... ....... ..+......+.+++.+||+.
T Consensus 356 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i~~~~~~--------~~~~~~~~~l~~li~~cl~~ 420 (452)
T 1fmk_A 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VERGYRM--------PCPPECPESLHDLMCQCWRK 420 (452)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTCCC--------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC--------CCCCCCCHHHHHHHHHHccC
Confidence 899999999999999999999 88887654321 11111 1111110 11223344588899999999
Q ss_pred ccCCCCCHHHHHHHHHhccccC
Q 021774 241 AASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
||++|||+.+|++.|+.+....
T Consensus 421 dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 421 EPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCS
T ss_pred ChhhCcCHHHHHHHHHHHhccC
Confidence 9999999999999999887544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=309.04 Aligned_cols=240 Identities=28% Similarity=0.393 Sum_probs=189.1
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++... ......+.+|++++++++||||+++++++.+. ...++||||+++++|.+++.. ..++
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~ 132 (318)
T 3lxp_A 58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIG 132 (318)
T ss_dssp -CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCC
T ss_pred CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCC
Confidence 368899999998653 45567899999999999999999999999884 678999999999999999832 3489
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~ 159 (307)
+..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......... ......++..|+|||++
T Consensus 133 ~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 209 (318)
T 3lxp_A 133 LAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHh
Confidence 999999999999999999999 9999999999999999999999999999877554321 23345577889999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhH--------HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
.+..++.++||||||+++|+|+||..||......... ............... ...+......+.
T Consensus 210 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~ 281 (318)
T 3lxp_A 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER--------LPRPDKCPAEVY 281 (318)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC--------CCCCTTCCHHHH
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC--------CCCCccccHHHH
Confidence 9999999999999999999999999987654221100 000011111111111 111223345688
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+++.+||+.||.+|||+.++++.|+.+..
T Consensus 282 ~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 282 HLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999988764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=298.68 Aligned_cols=248 Identities=36% Similarity=0.578 Sum_probs=199.8
Q ss_pred CCCEEEEEEcccc----ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAE----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... ....++
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 131 (307)
T 2nru_A 53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLS 131 (307)
T ss_dssp SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCC
T ss_pred CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCC
Confidence 6889999988753 23445789999999999999999999999999999999999999999999985322 234689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~ 160 (307)
+..++.++.|++.||.|||++ |++||||||+||+++.++.++|+|||++......... ......|+..|+|||++.
T Consensus 132 ~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc
Confidence 999999999999999999999 9999999999999999999999999999876543222 233457899999999876
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh-cCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-EEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+ .++.++||||||+++|+|++|..||........ +..+...... .......++..+..........+.+++.+||+
T Consensus 209 ~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 285 (307)
T 2nru_A 209 G-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLH 285 (307)
T ss_dssp T-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTC
T ss_pred C-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcC
Confidence 5 688999999999999999999999875433211 1111111111 12223444555666778888889999999999
Q ss_pred cccCCCCCHHHHHHHHHhccc
Q 021774 240 AAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~~~~~ 260 (307)
.||.+|||+.+|++.|+++..
T Consensus 286 ~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 286 EKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSTTTSCCHHHHHHHHHHHC-
T ss_pred CCcccCcCHHHHHHHHHHHhc
Confidence 999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.37 Aligned_cols=229 Identities=23% Similarity=0.315 Sum_probs=181.3
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++ .....+++.
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~ 105 (323)
T 3tki_A 30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEP 105 (323)
T ss_dssp TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGS----BTTTBCCHH
T ss_pred CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHH----hhcCCCCHH
Confidence 478999999987543 233456889999999999999999999999999999999999999999988 345569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..+.... ........||..|+|||++.+.
T Consensus 106 ~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 182 (323)
T 3tki_A 106 DAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccC
Confidence 9999999999999999999 99999999999999999999999999998654322 2223456789999999999887
Q ss_pred cc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.+ +.++|||||||++|+|++|..||......... ... ........ .........+.+++.+||+.|
T Consensus 183 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~----~~~~~~~~--------~~~~~~~~~~~~li~~~L~~d 249 (323)
T 3tki_A 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKEKKTYL--------NPWKKIDSAPLALLHKILVEN 249 (323)
T ss_dssp SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH----HHTTCTTS--------TTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH----HhcccccC--------CccccCCHHHHHHHHHHccCC
Confidence 65 78999999999999999999998765432211 111 11111000 001223345778999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.++++
T Consensus 250 P~~R~t~~eil~ 261 (323)
T 3tki_A 250 PSARITIPDIKK 261 (323)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhh
Confidence 999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=322.43 Aligned_cols=234 Identities=23% Similarity=0.386 Sum_probs=191.1
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+|..||||.++.... ..+.|.+|++++++++||||+++++++......++||||+++|+|.+++... ....+++..+
T Consensus 244 ~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~ 320 (495)
T 1opk_A 244 YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVL 320 (495)
T ss_dssp GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHH
T ss_pred CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHH
Confidence 378999999986532 3578999999999999999999999999999999999999999999999532 3346899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
+.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..............++..|+|||++.+..++
T Consensus 321 ~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 397 (495)
T 1opk_A 321 LYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397 (495)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCC
Confidence 99999999999999999 999999999999999999999999999997755433333445567789999999999999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++|||||||++|||+| |..||....... +... ....... ..+......+.+++.+||+.||.+
T Consensus 398 ~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~ 462 (495)
T 1opk_A 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDYRM--------ERPEGCPEKVYELMRACWQWNPSD 462 (495)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCC--------CCCCCCCHHHHHHHHHHcCcChhH
Confidence 99999999999999999 888876543221 1111 1111110 112223345788899999999999
Q ss_pred CCCHHHHHHHHHhccc
Q 021774 245 RPQMNQVIKMLTKNIR 260 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~ 260 (307)
|||+.+|++.|+.++.
T Consensus 463 RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 463 RPSFAEIHQAFETMFQ 478 (495)
T ss_dssp SCCHHHHHHHHHTSCS
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=311.46 Aligned_cols=240 Identities=26% Similarity=0.423 Sum_probs=193.4
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------ 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------ 76 (307)
.++..||||+++.. .......+.+|+++++++ +||||+++++++...+..++||||+++|+|.+++......
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 178 (382)
T 3tt0_A 99 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178 (382)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCC
T ss_pred ccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccc
Confidence 34568999999865 345567899999999999 9999999999999999999999999999999998654321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccC
Q 021774 77 ------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAG 149 (307)
Q Consensus 77 ------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g 149 (307)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .......+
T Consensus 179 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 255 (382)
T 3tt0_A 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255 (382)
T ss_dssp CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCC
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCC
Confidence 24599999999999999999999999 999999999999999999999999999987654322 22344557
Q ss_pred CCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 150 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
+..|+|||++.+..++.++|||||||++|||++ |..||...... .+. ......... ..+.....
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~~~----~~~~~~~~~--------~~~~~~~~ 320 (382)
T 3tt0_A 256 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELF----KLLKEGHRM--------DKPSNCTN 320 (382)
T ss_dssp GGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHHHTTCCC--------CCCSSCCH
T ss_pred CcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC--------CCCccCCH
Confidence 788999999999999999999999999999999 88887644321 111 111111111 11122334
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+.+++.+||+.||.+|||+.+|++.|++++...
T Consensus 321 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 321 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 5888999999999999999999999999988644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=301.90 Aligned_cols=232 Identities=24% Similarity=0.344 Sum_probs=175.5
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+..||+|.++.. .......+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ....+++..+
T Consensus 43 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~ 118 (281)
T 1mp8_A 43 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASL 118 (281)
T ss_dssp CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHH
T ss_pred ceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHH
Confidence 557999998764 3455678999999999999999999999974 5678999999999999999843 3346899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
+.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...............++..|+|||++.+..++
T Consensus 119 ~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (281)
T 1mp8_A 119 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195 (281)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCC
Confidence 99999999999999999 999999999999999999999999999987655433333445567789999999888999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++||||||+++|||++ |..||....... ..... ..... ...+......+.+++.+||+.||.+
T Consensus 196 ~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~ 260 (281)
T 1mp8_A 196 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGER--------LPMPPNCPPTLYSLMTKCWAYDPSR 260 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----HcCCC--------CCCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999999999997 888886543321 11111 11111 0112233345788999999999999
Q ss_pred CCCHHHHHHHHHhccc
Q 021774 245 RPQMNQVIKMLTKNIR 260 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~ 260 (307)
|||+.++++.|++++.
T Consensus 261 Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 261 RPRFTELKAQLSTILE 276 (281)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=299.42 Aligned_cols=236 Identities=25% Similarity=0.346 Sum_probs=180.7
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhc--CCCCCccceeeEEEeC----CeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
+|+.||||++... ....+..|.+++.. ++||||+++++++... ...++||||+++|+|.+++. ...
T Consensus 30 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~ 101 (301)
T 3q4u_A 30 QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTT 101 (301)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-----TCC
T ss_pred CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-----hcc
Confidence 6889999998754 33456667777666 7999999999987653 45789999999999999993 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc---ccccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLH--------EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIA 148 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~ 148 (307)
+++..++.++.|++.||+||| ++ +|+||||||+|||++.++.+||+|||++.......... .....
T Consensus 102 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 178 (301)
T 3q4u_A 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178 (301)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccc
Confidence 899999999999999999999 88 99999999999999999999999999997654432221 23347
Q ss_pred CCCCcCCcccccCC------cccccCceeehHHHHHHHHhC----------CCCCCccccchhHHHHHHHHHHhhcCCcc
Q 021774 149 GTTGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISG----------RNSGKAMWGQMNKFLLEWAWQLHQEEKPL 212 (307)
Q Consensus 149 g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (307)
||..|+|||++.+. .++.++||||||+++|||+|| ..||.......... .. ..........
T Consensus 179 gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~-~~-~~~~~~~~~~- 255 (301)
T 3q4u_A 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF-ED-MRKVVCVDQQ- 255 (301)
T ss_dssp CCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HH-HHHHHTTSCC-
T ss_pred cccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch-hh-hhHHHhccCC-
Confidence 89999999999876 567899999999999999999 77775543322111 11 1111111110
Q ss_pred cccCCCCC--CCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhc
Q 021774 213 ELVDPELG--EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 213 ~~~~~~~~--~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
.+... .........+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 256 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 256 ---RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp ---CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11111 11234667789999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.87 Aligned_cols=240 Identities=27% Similarity=0.357 Sum_probs=189.4
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC---CCCCC
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---ANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~ 80 (307)
.+|+.||||+++.. .......+.+|+.++++++||||+++++++.+....++||||+++|+|.+++..... ....+
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 178 (367)
T 3l9p_A 99 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178 (367)
T ss_dssp -CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCC
T ss_pred CcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccc
Confidence 45778999999755 455556799999999999999999999999999999999999999999999855432 22458
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccCCCC-cccccccccCCCCcCCc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDN-ITHITTRIAGTTGYLAP 156 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aP 156 (307)
++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..... .........||..|+||
T Consensus 179 ~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 179 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence 9999999999999999999999 999999999999999555 4999999999754221 11223345678899999
Q ss_pred ccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
|++.+..++.++|||||||++|||+| |..||...... .+... ....... ..+......+.+++.
T Consensus 256 E~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~----i~~~~~~--------~~~~~~~~~l~~li~ 320 (367)
T 3l9p_A 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF----VTSGGRM--------DPPKNCPGPVYRIMT 320 (367)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----HHTTCCC--------CCCTTCCHHHHHHHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC--------CCCccCCHHHHHHHH
Confidence 99998899999999999999999998 88888654321 11111 1111110 111222345788899
Q ss_pred hccccccCCCCCHHHHHHHHHhccccC
Q 021774 236 FCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+||+.||.+||++.+|++.|+.+.+..
T Consensus 321 ~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 321 QCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 999999999999999999998877543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=296.82 Aligned_cols=249 Identities=22% Similarity=0.229 Sum_probs=193.5
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||||+++++|.+++.... ....++
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 110 (319)
T 4euu_A 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLP 110 (319)
T ss_dssp TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCC
T ss_pred CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCC
Confidence 458999999998643 344567889999999999999999999998765 7799999999999999995432 223499
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
+..++.++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||++........ .....||..|+|||
T Consensus 111 ~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE 185 (319)
T 4euu_A 111 ESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPD 185 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc--eeecccCCCccCHH
Confidence 999999999999999999999 99999999999999 7788899999999987654322 23456899999999
Q ss_pred ccc--------CCcccccCceeehHHHHHHHHhCCCCCCccccch-hHHHHHHHHHHhhcCCcccc------------cC
Q 021774 158 YVL--------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLEL------------VD 216 (307)
Q Consensus 158 ~~~--------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~------------~~ 216 (307)
++. +..++.++|||||||++|||++|..||....... .................... .-
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 4euu_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (319)
T ss_dssp HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccC
Confidence 886 5788999999999999999999999986543322 22222222222111111100 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 217 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
+............+.+++.+||+.||++|||+.|+++...+..
T Consensus 266 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1112445667777889999999999999999999999887654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=309.05 Aligned_cols=240 Identities=25% Similarity=0.379 Sum_probs=189.9
Q ss_pred cCCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCC----
Q 021774 4 LTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKA---- 76 (307)
Q Consensus 4 ~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~---- 76 (307)
..+|+.||||+++.. .....+.+.+|+++++++ +||||+++++++.+.+ ..++||||+++|+|.+++......
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~ 128 (359)
T 3vhe_A 49 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128 (359)
T ss_dssp TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSC
T ss_pred cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccccc
Confidence 456789999999865 344557899999999999 8999999999998765 489999999999999999654321
Q ss_pred ----------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 021774 77 ----------------------------------------------------------NIKLNWEKRSDICVGIAKGLAF 98 (307)
Q Consensus 77 ----------------------------------------------------------~~~~~~~~~~~i~~~i~~~l~~ 98 (307)
...+++..++.++.|++.||+|
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 208 (359)
T 3vhe_A 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208 (359)
T ss_dssp C------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHH
Confidence 1228999999999999999999
Q ss_pred HhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcccccCCcccccCceeehHHHH
Q 021774 99 LHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177 (307)
Q Consensus 99 LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l 177 (307)
||++ +|+||||||+||+++.++.+||+|||++........ .......||..|+|||++.+..++.++||||||+++
T Consensus 209 LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 285 (359)
T 3vhe_A 209 LASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285 (359)
T ss_dssp HHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHH
Confidence 9999 999999999999999999999999999986644322 233445678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHH
Q 021774 178 LEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 178 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~ 256 (307)
|||+| |..||....... .+.... ...... ..+......+.+++.+||+.||.+|||+.++++.|+
T Consensus 286 ~ellt~g~~p~~~~~~~~--~~~~~~----~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 286 WEIFSLGASPYPGVKIDE--EFCRRL----KEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp HHHTTTSCCSSTTCCCSH--HHHHHH----HHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCCCccchhH--HHHHHH----HcCCCC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 99998 999986543321 111111 111110 111122345788889999999999999999999999
Q ss_pred hccc
Q 021774 257 KNIR 260 (307)
Q Consensus 257 ~~~~ 260 (307)
+++.
T Consensus 352 ~~~~ 355 (359)
T 3vhe_A 352 NLLQ 355 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8774
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=308.10 Aligned_cols=257 Identities=15% Similarity=0.160 Sum_probs=189.9
Q ss_pred CCCEEEEEEccccChHhH-----------HHHHHHHHHHhcCCCCCccceeeEEEeC----CeeEEEEeccCCCCHHHHh
Q 021774 6 NGRRIAVKPLSAESKQGV-----------REFITEIMTLSNVRHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVL 70 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l 70 (307)
.++.||||++........ ..+..|+..+..++||||+++++++... ...++||||+ |++|.+++
T Consensus 64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~ 142 (364)
T 3op5_A 64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY 142 (364)
T ss_dssp TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHH
T ss_pred cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHH
Confidence 468899999876542211 1234566677888999999999998865 4579999999 99999998
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCCceEEeeccCcccCCCCccc------
Q 021774 71 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEFNPKIGDFGLAKLFPDNITH------ 142 (307)
Q Consensus 71 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~dfg~~~~~~~~~~~------ 142 (307)
.. ....+++..++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+++.+......
T Consensus 143 ~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 216 (364)
T 3op5_A 143 EA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216 (364)
T ss_dssp HH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCC
T ss_pred Hh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccC
Confidence 43 345699999999999999999999999 999999999999998 8899999999999876543211
Q ss_pred ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCC
Q 021774 143 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 222 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (307)
......||..|+|||++.+..++.++|||||||++|||+||+.||........ ........... .....+++.+.
T Consensus 217 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~-- 291 (364)
T 3op5_A 217 PKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK--YVRDSKIRYRE-NIASLMDKCFP-- 291 (364)
T ss_dssp SSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHHHHHHH-CHHHHHHHHSC--
T ss_pred cccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH--HHHHHHHHhhh-hHHHHHHHhcc--
Confidence 11334599999999999999999999999999999999999999976433221 11111111111 11111111110
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccCccccCCCCCccc
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQD 274 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~~ 274 (307)
.......+.+++..||+.+|.+||++.+|++.|++++.........+..|..
T Consensus 292 ~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 292 AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV 343 (364)
T ss_dssp TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence 0112235778888899999999999999999999988755444444444443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.87 Aligned_cols=225 Identities=28% Similarity=0.316 Sum_probs=183.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++.. .......+.+|++++++++||||+++++++...+..++||||++||+|..++. ....++
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~ 103 (337)
T 1o6l_A 28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT 103 (337)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSCCC
T ss_pred CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCCC
Confidence 46899999999754 23345678899999999999999999999999999999999999999999883 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+
T Consensus 104 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 104 EERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSS
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcC
Confidence 999999999999999999999 99999999999999999999999999998643322 22345679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|..||..... ..+...+ ..... .++......+.+++.+||+.|
T Consensus 180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i---~~~~~----------~~p~~~s~~~~~li~~lL~~d 243 (337)
T 1o6l_A 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI---LMEEI----------RFPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHCCC----------CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHH---HcCCC----------CCCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999865322 1111111 11111 111222345788899999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|.+|| ++.++++
T Consensus 244 P~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 244 PKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTTSTTCSTTTHHHHHT
T ss_pred HHHhcCCCCCCHHHHHc
Confidence 99999 8998875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=305.40 Aligned_cols=232 Identities=20% Similarity=0.281 Sum_probs=184.1
Q ss_pred CCCCEEEEEEccccC-----hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++|++|.+.+......+..
T Consensus 47 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 126 (351)
T 3c0i_A 47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV 126 (351)
T ss_dssp TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCC
T ss_pred CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCC
Confidence 568999999986431 123567999999999999999999999999999999999999999998887544444556
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---eEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++........ ......||+.|+||
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aP 202 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAP 202 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe-eecCCcCCcCccCH
Confidence 89999999999999999999999 9999999999999987655 99999999987654322 23445799999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
|++.+..++.++|||||||++|+|++|..||.... ..+.... ....... .+.. .......+.+++.+
T Consensus 203 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i---~~~~~~~---~~~~---~~~~s~~~~~li~~ 269 (351)
T 3c0i_A 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGI---IKGKYKM---NPRQ---WSHISESAKDLVRR 269 (351)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHH---HHTCCCC---CHHH---HTTSCHHHHHHHHH
T ss_pred HHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHH---HcCCCCC---Cccc---cccCCHHHHHHHHH
Confidence 99999999999999999999999999999986532 1111111 1111000 0000 01123457889999
Q ss_pred ccccccCCCCCHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~ 253 (307)
||+.||.+|||+.++++
T Consensus 270 ~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 270 MLMLDPAERITVYEALN 286 (351)
T ss_dssp HTCSSTTTSCCHHHHHT
T ss_pred HCCCChhHCcCHHHHhc
Confidence 99999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=303.49 Aligned_cols=231 Identities=26% Similarity=0.383 Sum_probs=181.2
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
+||+|.+... .......+.+|+.++++++||||+++++++.... .++|+|++.+|+|.+++.. ....+++..++.
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~ 121 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLN 121 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHH
Confidence 4688888654 3455678999999999999999999999998765 6789999999999999843 345699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......+|..|+|||++.+..++.
T Consensus 122 ~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 198 (327)
T 3poz_A 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198 (327)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCc
Confidence 999999999999999 9999999999999999999999999999876543222 233445678999999999999999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++|||||||++|||+| |..||........ .. ....... ...+......+.+++.+||+.||.+|
T Consensus 199 ~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R 263 (327)
T 3poz_A 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGER--------LPQPPICTIDVYMIMVKCWMIDADSR 263 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCC--------CCCCTTBCHHHHHHHHHHTCSCGGGS
T ss_pred hhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HH----HHHcCCC--------CCCCccCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999999 9999865443221 11 1111111 01122334468889999999999999
Q ss_pred CCHHHHHHHHHhcccc
Q 021774 246 PQMNQVIKMLTKNIRL 261 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~~ 261 (307)
|++.++++.|+.+.+.
T Consensus 264 ps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 264 PKFRELIIEFSKMARD 279 (327)
T ss_dssp CCHHHHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHHHhh
Confidence 9999999999988754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=306.26 Aligned_cols=227 Identities=23% Similarity=0.333 Sum_probs=184.0
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+.||+|..++. ....++
T Consensus 38 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~ 113 (384)
T 4fr4_A 38 DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFK 113 (384)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----TTCCCC
T ss_pred CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH----hcCCCC
Confidence 468899999987542 3345678999999999999999999999999999999999999999999983 445699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++....... ......||+.|+|||++.+
T Consensus 114 ~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 114 EETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--ceeccCCCccccCCeeecc
Confidence 999999999999999999999 99999999999999999999999999998765432 2345679999999999864
Q ss_pred ---CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 162 ---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 162 ---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
..++.++|||||||++|||++|..||................ ... ..++......+.+++.+||
T Consensus 189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~----------~~~p~~~s~~~~~li~~lL 255 (384)
T 4fr4_A 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TTV----------VTYPSAWSQEMVSLLKKLL 255 (384)
T ss_dssp CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HCC----------CCCCTTSCHHHHHHHHHHS
T ss_pred CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hcc----------cCCCCcCCHHHHHHHHHHh
Confidence 458999999999999999999999987544333222222111 111 1112223345888999999
Q ss_pred ccccCCCCC-HHHHHH
Q 021774 239 QAAASRRPQ-MNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs-~~~v~~ 253 (307)
+.||.+||+ +.+|..
T Consensus 256 ~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 256 EPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CSSGGGSCCSHHHHHT
T ss_pred cCCHhHhcccHHHHHc
Confidence 999999998 676653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=305.49 Aligned_cols=245 Identities=28% Similarity=0.399 Sum_probs=186.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.|+.||||++...... ...+..|+.++++++||||+++++++.... ..++||||+++|+|.+++.. ..++
T Consensus 46 ~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~ 119 (322)
T 3soc_A 46 LNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVS 119 (322)
T ss_dssp TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBC
T ss_pred CCCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCC
Confidence 3788999999765433 345667999999999999999999998754 46999999999999999943 3489
Q ss_pred HHHHHHHHHHHHHHHHHHhcCC-------CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCc
Q 021774 82 WEKRSDICVGIAKGLAFLHEEL-------VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGY 153 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~-------~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y 153 (307)
+..+..++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+++........ ......||..|
T Consensus 120 ~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y 199 (322)
T 3soc_A 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGG
T ss_pred HHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccc
Confidence 9999999999999999999751 228999999999999999999999999999876543222 23346789999
Q ss_pred CCcccccC-----CcccccCceeehHHHHHHHHhCCCCCCccccchhH----------HHHHHHHHHhhcCCcccccCCC
Q 021774 154 LAPEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK----------FLLEWAWQLHQEEKPLELVDPE 218 (307)
Q Consensus 154 ~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~ 218 (307)
+|||++.+ ..++.++|||||||++|||+||+.||......... ........... ... .+.
T Consensus 200 ~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~ 274 (322)
T 3soc_A 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH-KKK----RPV 274 (322)
T ss_dssp CCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTT-SCC----CCC
T ss_pred cCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhc-ccC----CCC
Confidence 99999886 36678899999999999999999998654332111 01111111111 111 111
Q ss_pred CCC--CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 219 LGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 219 ~~~--~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
+.. ........+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 275 LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111 1224556689999999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=293.11 Aligned_cols=230 Identities=27% Similarity=0.471 Sum_probs=181.4
Q ss_pred CCCCEEEEEEccccCh----H---hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAESK----Q---GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~----~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||+|++..... . ..+.+.+|++++++++||||+++++++.+.. ++||||+++++|.+++. ...
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~---~~~ 116 (287)
T 4f0f_A 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL---DKA 116 (287)
T ss_dssp TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHH---CTT
T ss_pred CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHh---ccc
Confidence 4789999999865421 1 1167899999999999999999999986655 69999999999988874 344
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCc-----eEEeeccCcccCCCCcccccccccCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFN-----PKIGDFGLAKLFPDNITHITTRIAGT 150 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~g~ 150 (307)
..+++..++.++.|++.||+|||++ + ++||||||+||+++.++. +||+|||++...... .....|+
T Consensus 117 ~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~g~ 189 (287)
T 4f0f_A 117 HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGN 189 (287)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC----EECCCCC
T ss_pred CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc----ccccCCC
Confidence 5799999999999999999999999 8 999999999999988776 999999999854332 3446789
Q ss_pred CCcCCccccc--CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 151 TGYLAPEYVL--GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 151 ~~y~aPE~~~--~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
..|+|||++. ...++.++||||||+++|||++|+.||........... . ........ + ..+.....
T Consensus 190 ~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~---~~~~~~~~-----~---~~~~~~~~ 257 (287)
T 4f0f_A 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-N---MIREEGLR-----P---TIPEDCPP 257 (287)
T ss_dssp CTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-H---HHHHSCCC-----C---CCCTTSCH
T ss_pred ccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-H---HHhccCCC-----C---CCCcccCH
Confidence 9999999984 45688999999999999999999999875443322111 1 11111111 1 11223334
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhc
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 258 RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 588899999999999999999999999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=305.12 Aligned_cols=229 Identities=24% Similarity=0.276 Sum_probs=186.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|+++.........+.+|++++++++||||+++++++...+..++||||+++++|.+++.. ....+++..
T Consensus 112 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~ 188 (373)
T 2x4f_A 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELD 188 (373)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHH
T ss_pred CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHH
Confidence 56899999999877666677899999999999999999999999999999999999999999988842 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE--CCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL--DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++..+..... .....||+.|+|||++.+.
T Consensus 189 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 263 (373)
T 2x4f_A 189 TILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYD 263 (373)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccccCCCcEeChhhccCC
Confidence 999999999999999999 99999999999999 6678899999999987654322 2345689999999999988
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|||||||++|||++|..||...... .... ........ ........ ....+.+++.+||+.||
T Consensus 264 ~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~---~i~~~~~~--~~~~~~~~----~~~~~~~li~~~L~~dp 331 (373)
T 2x4f_A 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLN---NILACRWD--LEDEEFQD----ISEEAKEFISKLLIKEK 331 (373)
T ss_dssp BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHTCCC--SCSGGGTT----SCHHHHHHHHTTSCSSG
T ss_pred CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhccCC--CChhhhcc----CCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999998654321 1111 11111110 00011112 23458889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
.+|||+.++++
T Consensus 332 ~~Rps~~e~l~ 342 (373)
T 2x4f_A 332 SWRISASEALK 342 (373)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCCCHHHHhc
Confidence 99999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=293.45 Aligned_cols=237 Identities=26% Similarity=0.447 Sum_probs=176.7
Q ss_pred CCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 7 GRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 7 g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
...||+|+++.. .....+.|.+|+.++++++||||+++++++ .....++||||+++++|.+++. .....+++..
T Consensus 46 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 121 (289)
T 3og7_A 46 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKK 121 (289)
T ss_dssp SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHT---TC---CCHHH
T ss_pred cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHh---hccCCCCHHH
Confidence 456999998755 355567899999999999999999999965 4556899999999999999983 3445699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCccccc---
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVL--- 160 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~--- 160 (307)
++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++....... ........|+..|+|||++.
T Consensus 122 ~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 198 (289)
T 3og7_A 122 LIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198 (289)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC---
T ss_pred HHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccC
Confidence 999999999999999999 99999999999999999999999999998654321 22234457899999999886
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++||||||+++|+|++|+.||....... .+...... .... +............+.+++.+||+.
T Consensus 199 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~~l~~ 268 (289)
T 3og7_A 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGR----GSLS----PDLSKVRSNCPKRMKRLMAECLKK 268 (289)
T ss_dssp -CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHH----TSCC----CCTTSSCTTSCHHHHHHHHHHTCS
T ss_pred CCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhcc----cccC----cchhhccccCCHHHHHHHHHHccC
Confidence 5678889999999999999999999987543321 11111111 1111 111122223345688899999999
Q ss_pred ccCCCCCHHHHHHHHHhccc
Q 021774 241 AASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~~ 260 (307)
||.+|||+.++++.|+++.+
T Consensus 269 ~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 269 KRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SGGGSCCHHHHHHHHHHTTC
T ss_pred ChhhCCCHHHHHHHHHHHhh
Confidence 99999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=303.68 Aligned_cols=228 Identities=23% Similarity=0.280 Sum_probs=183.3
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|++... .......+.+|++++++++||||+++++++.+.+..++||||++||+|.+++. ....+++
T Consensus 52 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~ 127 (362)
T 2bdw_A 52 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSE 127 (362)
T ss_dssp TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT----TCSCCCH
T ss_pred CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH----HcCCCCH
Confidence 46899999999754 34556778999999999999999999999999999999999999999999883 3456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....... ......||+.|+|||++
T Consensus 128 ~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~ 202 (362)
T 2bdw_A 128 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVL 202 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHH
Confidence 99999999999999999999 999999999999998654 59999999998765432 23346799999999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+..++.++|||||||++|+|++|..||..... ..+...+.. .... ...+. .......+.+++.+||+
T Consensus 203 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~---~~~~--~~~~~----~~~~~~~~~~li~~~L~ 270 (362)
T 2bdw_A 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKA---GAYD--YPSPE----WDTVTPEAKSLIDSMLT 270 (362)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---TCCC--CCTTG----GGGSCHHHHHHHHHHSC
T ss_pred ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh---CCCC--CCccc----ccCCCHHHHHHHHHHcC
Confidence 998999999999999999999999999865322 112111111 1100 00000 11223457889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+||++.++++
T Consensus 271 ~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 271 VNPKKRITADQALK 284 (362)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=296.36 Aligned_cols=226 Identities=24% Similarity=0.374 Sum_probs=182.0
Q ss_pred CEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 8 RRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 8 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.
T Consensus 41 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~ 117 (289)
T 4fvq_A 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLE 117 (289)
T ss_dssp EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHH
T ss_pred hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHH
Confidence 57999999876666678899999999999999999999999999999999999999999999943 334489999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--------eEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--------PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
++.|++.||+|||++ +++||||||+||+++.++. +||+|||++..... .....|+..|+|||++
T Consensus 118 i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 118 VAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECI 189 (289)
T ss_dssp HHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHH
T ss_pred HHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccccccC-----ccccCCcCcccCHHHh
Confidence 999999999999999 9999999999999998887 99999999975433 2234578899999999
Q ss_pred cC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 LG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 ~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.+ ..++.++||||||+++|||++|..|+........ .. ........ + +......+.+++.+||
T Consensus 190 ~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~----~~~~~~~~-------~---~~~~~~~l~~li~~~l 253 (289)
T 4fvq_A 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KL----QFYEDRHQ-------L---PAPKAAELANLINNCM 253 (289)
T ss_dssp HCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH----HHHHTTCC-------C---CCCSSCTTHHHHHHHS
T ss_pred CCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HH----HHhhccCC-------C---CCCCCHHHHHHHHHHc
Confidence 87 6789999999999999999996555433322111 11 11111100 0 0011123778888999
Q ss_pred ccccCCCCCHHHHHHHHHhccc
Q 021774 239 QAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+.||.+|||+.++++.|++++.
T Consensus 254 ~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 254 DYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CSSGGGSCCHHHHHHHHHTCC-
T ss_pred CCChhHCcCHHHHHHHHHHhcC
Confidence 9999999999999999998875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.38 Aligned_cols=228 Identities=25% Similarity=0.285 Sum_probs=183.4
Q ss_pred CCCCEEEEEEccccCh------HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.++.... .....+.+|+.++++++||||+++++++.+.+..++||||++||+|.+++ ....
T Consensus 35 ~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l----~~~~ 110 (361)
T 2yab_A 35 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKE 110 (361)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH----TTCS
T ss_pred CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH----HhcC
Confidence 4689999999876432 13467899999999999999999999999999999999999999999998 3445
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----ceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....... ......||+.|+
T Consensus 111 ~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~ 185 (361)
T 2yab_A 111 SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFV 185 (361)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEE
Confidence 799999999999999999999999 999999999999998877 79999999998765432 234467999999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++|||||||++|+|++|..||...... ..... ....... +++.. .......+.+++
T Consensus 186 aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~----i~~~~~~--~~~~~---~~~~s~~~~~li 253 (361)
T 2yab_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLAN----ITAVSYD--FDEEF---FSQTSELAKDFI 253 (361)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH----HHTTCCC--CCHHH---HTTSCHHHHHHH
T ss_pred CchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhcCCC--CCchh---ccCCCHHHHHHH
Confidence 999999989999999999999999999999998654321 11111 1111100 00000 011234578899
Q ss_pred HhccccccCCCCCHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~ 253 (307)
.+||..||.+|||+.++++
T Consensus 254 ~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 254 RKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHSCSSTTTSCCHHHHHT
T ss_pred HHHCCCChhHCcCHHHHhc
Confidence 9999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=315.45 Aligned_cols=229 Identities=25% Similarity=0.365 Sum_probs=184.5
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||+++|+|.+++... ....+++..
T Consensus 215 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~ 290 (450)
T 1k9a_A 215 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDC 290 (450)
T ss_dssp TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHH
T ss_pred cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHH
Confidence 47799999998654 4467999999999999999999999988765 789999999999999999532 223478999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..+
T Consensus 291 ~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 363 (450)
T 1k9a_A 291 LLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKF 363 (450)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcCCCC
Confidence 999999999999999999 9999999999999999999999999999854332 122356789999999999999
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++||||||+++|||+| |..||....... +.. ....... . ..+......+.+++.+||+.||.
T Consensus 364 ~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~-----~---~~p~~~~~~l~~li~~cl~~dp~ 428 (450)
T 1k9a_A 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYK-----M---DAPDGCPPAVYDVMKNCWHLDAA 428 (450)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTCC-----C---CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCC-----C---CCCCcCCHHHHHHHHHHcCCChh
Confidence 999999999999999998 999886543322 111 1111111 0 11223344588889999999999
Q ss_pred CCCCHHHHHHHHHhccc
Q 021774 244 RRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~~~ 260 (307)
+|||+.++++.|+.+..
T Consensus 429 ~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 429 TRPTFLQLREQLEHIRT 445 (450)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHH
Confidence 99999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=303.57 Aligned_cols=224 Identities=23% Similarity=0.332 Sum_probs=181.5
Q ss_pred cCCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++||||+ +|+|.+++. ....+
T Consensus 31 ~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~----~~~~l 105 (336)
T 3h4j_B 31 YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV----EKKRM 105 (336)
T ss_dssp TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH----HHCSC
T ss_pred CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH----HcCCC
Confidence 3578999999987532 222357889999999999999999999999999999999999 778888873 33569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||.|||++ ||+||||||+||++++++.+||+|||++....... ......||+.|+|||++.
T Consensus 106 ~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~ 180 (336)
T 3h4j_B 106 TEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVIN 180 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSC
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--ccccccCCcCcCCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999998765432 234457999999999998
Q ss_pred CCcc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..+ +.++||||||+++|+|++|..||....... ....+.......+......+.+++.+||+
T Consensus 181 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKKVNSCVYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCCCCSSCCCCCTTSCHHHHHHHHTTSC
T ss_pred CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHHcCCCCCcccCCHHHHHHHHHHcC
Confidence 8776 689999999999999999999986532210 01111111112222334457889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+|||+.++++
T Consensus 245 ~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 245 ADPMQRITIQEIRR 258 (336)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred CChhHCcCHHHHHh
Confidence 99999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=298.18 Aligned_cols=236 Identities=24% Similarity=0.393 Sum_probs=190.2
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
+..+++.||+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ....+++
T Consensus 28 ~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~ 103 (267)
T 3t9t_A 28 YWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAA 103 (267)
T ss_dssp EETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCH
T ss_pred EecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCH
Confidence 345788999999986532 236789999999999999999999999999999999999999999999843 3346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++...............++..|+|||++.+.
T Consensus 104 ~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 180 (267)
T 3t9t_A 104 ETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180 (267)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCC
Confidence 99999999999999999999 999999999999999999999999999987654332233345567789999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|+|++ |..||...... .... . ...... . ..+......+.+++.+||+.|
T Consensus 181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~-i~~~~~-----~---~~~~~~~~~l~~li~~~l~~~ 245 (267)
T 3t9t_A 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE---D-ISTGFR-----L---YKPRLASTHVYQIMNHCWRER 245 (267)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHTTCC-----C---CCCTTSCHHHHHHHHHHTCSS
T ss_pred CccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHH---H-HhcCCc-----C---CCCccCcHHHHHHHHHHccCC
Confidence 89999999999999999999 88887653321 1111 1 111111 0 011122345788899999999
Q ss_pred cCCCCCHHHHHHHHHhccc
Q 021774 242 ASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~ 260 (307)
|.+||++.++++.|+++..
T Consensus 246 p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 246 PEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999988764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.90 Aligned_cols=234 Identities=24% Similarity=0.377 Sum_probs=185.4
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
++..||||+++... ....+.|.+|+++|++++||||+++++++.. +..++||||+++|+|.+++. .....+++..
T Consensus 362 ~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~ 437 (613)
T 2ozo_A 362 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSN 437 (613)
T ss_dssp CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHT---TCTTTSCHHH
T ss_pred CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHh---hccCCCCHHH
Confidence 46679999998653 3456789999999999999999999999976 56899999999999999984 2345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 162 (307)
++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........ ......++..|+|||++.+.
T Consensus 438 ~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~ 514 (613)
T 2ozo_A 438 VAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514 (613)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC
Confidence 999999999999999999 9999999999999999999999999999876543222 12233456789999999989
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|||||||++|||+| |+.||....... +... ....... ..+......+.+++.+||+.|
T Consensus 515 ~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~----i~~~~~~--------~~p~~~~~~l~~li~~cl~~d 579 (613)
T 2ozo_A 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQGKRM--------ECPPECPPELYALMSDCWIYK 579 (613)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHH----HHTTCCC--------CCCTTCCHHHHHHHHHTTCSS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCC--------CCCCcCCHHHHHHHHHHcCCC
Confidence 99999999999999999998 999987654321 1111 1111111 112233456888999999999
Q ss_pred cCCCCCHHHHHHHHHhcccc
Q 021774 242 ASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~ 261 (307)
|++||++.+|++.|+.+...
T Consensus 580 P~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 580 WEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp TTTSCCHHHHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=303.70 Aligned_cols=229 Identities=21% Similarity=0.254 Sum_probs=185.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+++++|.+++. .....+++..
T Consensus 74 ~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~l~~~~ 150 (387)
T 1kob_A 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAE 150 (387)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHH
T ss_pred CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHH---hhcCCCCHHH
Confidence 4688999999987766566789999999999999999999999999999999999999999999983 2345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC--CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||++........ .....||..|+|||++.+.
T Consensus 151 ~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 225 (387)
T 1kob_A 151 VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDRE 225 (387)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc--eeeeccCCCccCchhccCC
Confidence 999999999999999999 9999999999999974 46799999999987654322 2345789999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|||||||++|||++|..||...... .... ........ .+... .......+.+++.+||+.||
T Consensus 226 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~i~~~~~~---~~~~~---~~~~s~~~~~li~~~L~~dP 293 (387)
T 1kob_A 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVKRCDWE---FDEDA---FSSVSPEAKDFIKNLLQKEP 293 (387)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHHCCCC---CCSST---TTTSCHHHHHHHHTTSCSSG
T ss_pred CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCCC---CCccc---cccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999998654321 1111 11111110 11111 11223458889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
.+|||+.++++
T Consensus 294 ~~Rpt~~ell~ 304 (387)
T 1kob_A 294 RKRLTVHDALE 304 (387)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCcCHHHHhh
Confidence 99999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=300.10 Aligned_cols=238 Identities=18% Similarity=0.178 Sum_probs=179.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ...++
T Consensus 57 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~ 132 (309)
T 2h34_A 57 VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLA 132 (309)
T ss_dssp TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCC
T ss_pred CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCC
Confidence 46889999999754 234457899999999999999999999999999999999999999999999842 34689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...............|+..|+|||++.+
T Consensus 133 ~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 133 PPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC
Confidence 999999999999999999999 99999999999999999999999999998765543333445678999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|||++|..||...... . ............ ....+.....+.+++.+||+.|
T Consensus 210 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~---~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~d 276 (309)
T 2h34_A 210 SHATYRADIYALTCVLYECLTGSPPYQGDQLS----V---MGAHINQAIPRP------STVRPGIPVAFDAVIARGMAKN 276 (309)
T ss_dssp ----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----H---HHHHHHSCCCCG------GGTSTTCCTHHHHHHHHHTCSS
T ss_pred CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----H---HHHHhccCCCCc------cccCCCCCHHHHHHHHHhccCC
Confidence 99999999999999999999999998653221 1 111111111100 0111222235788899999999
Q ss_pred cCCCC-CHHHHHHHHHhccccC
Q 021774 242 ASRRP-QMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RP-s~~~v~~~L~~~~~~~ 262 (307)
|++|| +++++++.|+..+...
T Consensus 277 P~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 277 PEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHHhHHHHHHHHHHHHHhh
Confidence 99999 9999999999877544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=299.38 Aligned_cols=228 Identities=25% Similarity=0.274 Sum_probs=183.2
Q ss_pred CCCCEEEEEEccccCh------HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++++|.+++. ...
T Consensus 34 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~ 109 (326)
T 2y0a_A 34 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKE 109 (326)
T ss_dssp TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT----TSS
T ss_pred CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH----hcC
Confidence 4689999999875421 135779999999999999999999999999999999999999999999983 445
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----ceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++....... ......||+.|+
T Consensus 110 ~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~ 184 (326)
T 2y0a_A 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFV 184 (326)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS--CCCCCCSCTTTC
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC--ccccccCCcCcC
Confidence 799999999999999999999999 999999999999999887 79999999998765332 233457899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++|||||||++|+|++|..||...... ......... ....... ........+.+++
T Consensus 185 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~-~~~~~~~--------~~~~~~~~~~~li 252 (326)
T 2y0a_A 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAV-NYEFEDE--------YFSNTSALAKDFI 252 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHT-CCCCCHH--------HHTTSCHHHHHHH
T ss_pred CceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHhc-CCCcCcc--------ccccCCHHHHHHH
Confidence 999999889999999999999999999999998654321 111111110 0000000 0011233577889
Q ss_pred HhccccccCCCCCHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~ 253 (307)
.+||+.||.+|||+.++++
T Consensus 253 ~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 253 RRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCCCHHHHhc
Confidence 9999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=302.77 Aligned_cols=233 Identities=25% Similarity=0.376 Sum_probs=179.2
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
+||+|.+... .......+.+|+.++++++||||+++++++.... .++|++++.+|+|.+++.. ....+++..++.
T Consensus 46 kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~ 121 (327)
T 3lzb_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLN 121 (327)
T ss_dssp EEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHH
T ss_pred EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHH
Confidence 3577777544 3455678999999999999999999999998765 7889999999999999843 345699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++......... ......++..|+|||++.+..++.
T Consensus 122 i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 198 (327)
T 3lzb_A 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198 (327)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCCh
Confidence 999999999999999 9999999999999999999999999999876543222 233345677899999999999999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++||||||+++|||++ |..||........ .. ....... ...+......+.+++.+||+.||.+|
T Consensus 199 ~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~----~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R 263 (327)
T 3lzb_A 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGER--------LPQPPICTIDVYMIMRKCWMIDADSR 263 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHcCCC--------CCCCccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999 9999876543221 11 1111111 01122233458889999999999999
Q ss_pred CCHHHHHHHHHhccccCc
Q 021774 246 PQMNQVIKMLTKNIRLNE 263 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~~~~ 263 (307)
|++.++++.|+++.+...
T Consensus 264 ps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 264 PKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp CCHHHHHHHHHHHHTSHH
T ss_pred cCHHHHHHHHHHHHhCcC
Confidence 999999999998886543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=309.60 Aligned_cols=229 Identities=20% Similarity=0.243 Sum_probs=184.5
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++||+|.+.+. ....+++
T Consensus 34 ~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~e 109 (444)
T 3soa_A 34 LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSE 109 (444)
T ss_dssp TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH----HCSCCCH
T ss_pred CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH----HcCCCCH
Confidence 578899999987653 3445678999999999999999999999999999999999999999998884 3456999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++........ ......||+.|+|||++
T Consensus 110 ~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l 185 (444)
T 3soa_A 110 ADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVL 185 (444)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHh
Confidence 99999999999999999999 999999999999998 467899999999987654322 23446799999999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+..++.++|||||||++|+|++|..||..... ..+...+. . ... ....+.... ....+.+++.+||+
T Consensus 186 ~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~---~-~~~-~~~~~~~~~----~s~~~~~li~~~L~ 253 (444)
T 3soa_A 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIK---A-GAY-DFPSPEWDT----VTPEAKDLINKMLT 253 (444)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH---H-TCC-CCCTTTTTT----SCHHHHHHHHHHSC
T ss_pred cCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHH---h-CCC-CCCcccccc----CCHHHHHHHHHHcC
Confidence 999999999999999999999999999865332 11211111 1 111 011111112 23457889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+|||+.++++
T Consensus 254 ~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 254 INPSKRITAAEALK 267 (444)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CChhHCCCHHHHhc
Confidence 99999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=294.84 Aligned_cols=235 Identities=25% Similarity=0.369 Sum_probs=190.6
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|..||||+++.. .......+.+|++++++++||||+++++++ ..+..++||||+++++|.+++. .....+++..
T Consensus 36 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 111 (287)
T 1u59_A 36 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSN 111 (287)
T ss_dssp CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHT---TCTTTSCHHH
T ss_pred CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHH---hCCccCCHHH
Confidence 5778999999875 345667899999999999999999999999 5567899999999999999984 2345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 162 (307)
++.++.|++.||.|||++ |++||||||+||+++.++.++|+|||++......... ......++..|+|||++.+.
T Consensus 112 ~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 112 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC
Confidence 999999999999999999 9999999999999999999999999999877543322 12334567889999999888
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||+| |..||...... ..... ...... ...+......+.+++.+||+.|
T Consensus 189 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~~~~--------~~~~~~~~~~l~~li~~~l~~~ 253 (287)
T 1u59_A 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKR--------MECPPECPPELYALMSDCWIYK 253 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCC--------CCCCTTCCHHHHHHHHHTTCSS
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HhcCCc--------CCCCCCcCHHHHHHHHHHcCCC
Confidence 99999999999999999998 99998654332 11111 111111 1112233446888999999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|.+||++.++++.|+.+....
T Consensus 254 p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 254 WEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp GGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999887543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=297.51 Aligned_cols=240 Identities=23% Similarity=0.340 Sum_probs=181.3
Q ss_pred ccCCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 3 TLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+..+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++. .....+
T Consensus 41 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~ 116 (311)
T 3niz_A 41 KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD---ENKTGL 116 (311)
T ss_dssp EETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHH---TCTTCC
T ss_pred EECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHH---hccCCC
Confidence 34578999999987542 23346788999999999999999999999999999999999975 7877773 234569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ ......||..|+|||++.
T Consensus 117 ~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~ 192 (311)
T 3niz_A 117 QDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLM 192 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhc
Confidence 9999999999999999999999 999999999999999999999999999987653322 233456899999999987
Q ss_pred C-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc----------------ccCCC-CCCC
Q 021774 161 G-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE----------------LVDPE-LGEY 222 (307)
Q Consensus 161 ~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~-~~~~ 222 (307)
+ ..++.++|||||||++|+|++|+.||........ ............... ..... ....
T Consensus 193 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (311)
T 3niz_A 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSI 269 (311)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHH
T ss_pred CCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHh
Confidence 6 5689999999999999999999999876544322 111212111111100 00000 0000
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.....+.+++.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 270 IPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp STTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1122345788999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=303.16 Aligned_cols=236 Identities=21% Similarity=0.380 Sum_probs=177.0
Q ss_pred EEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCee------EEEEeccCCCCHHHHhccCCC--CCC
Q 021774 9 RIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATK--ANI 78 (307)
Q Consensus 9 ~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~--~~~ 78 (307)
.||||+++.. .....+.+.+|++++++++||||+++++++...... ++||||+++++|.+++..... ...
T Consensus 53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 132 (323)
T 3qup_A 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132 (323)
T ss_dssp EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence 7999999865 345567899999999999999999999999887655 899999999999999854332 223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
.+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......... ......++..|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 589999999999999999999999 9999999999999999999999999999876443221 223345677899999
Q ss_pred cccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
.+.+..++.++|||||||++|||++ |..||....... ... ....... ...+......+.+++.+
T Consensus 210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~--------~~~~~~~~~~l~~li~~ 274 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN----YLIGGNR--------LKQPPECMEEVYDLMYQ 274 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC--------CCCCTTCCHHHHHHHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----HHhcCCC--------CCCCCccCHHHHHHHHH
Confidence 9999999999999999999999999 888886543321 111 1111111 11122333458889999
Q ss_pred ccccccCCCCCHHHHHHHHHhccccC
Q 021774 237 CTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
||+.||.+|||+.++++.|++++.-.
T Consensus 275 ~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 275 CWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HccCChhhCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999988643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=297.41 Aligned_cols=228 Identities=21% Similarity=0.245 Sum_probs=184.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||++|++|.+++. .....+++..
T Consensus 28 ~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~ 103 (321)
T 1tki_A 28 SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNERE 103 (321)
T ss_dssp TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT---SSSCCCCHHH
T ss_pred CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHH---hcCCCCCHHH
Confidence 468899999987554 334678899999999999999999999999999999999999999999983 2335699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC--CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.|++.||.|||++ ||+||||||+||+++. ++.+||+|||++....... ......|++.|+|||++.+.
T Consensus 104 ~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 104 IVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCC
Confidence 999999999999999999 9999999999999987 7899999999998765432 23445789999999999998
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++||||||+++|+|++|..||...... .... ......... +... .+.....+.+++.+||+.||
T Consensus 179 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i~~~~~~~---~~~~---~~~~s~~~~~li~~~L~~dp 246 (321)
T 1tki_A 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE---NIMNAEYTF---DEEA---FKEISIEAMDFVDRLLVKER 246 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHTCCCC---CHHH---HTTSCHHHHHHHHTTSCSSG
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHH---HHHcCCCCC---Chhh---hccCCHHHHHHHHHHcCCCh
Confidence 8999999999999999999999998654321 1111 111111100 0000 01123458889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
.+|||+.++++
T Consensus 247 ~~Rpt~~e~l~ 257 (321)
T 1tki_A 247 KSRMTASEALQ 257 (321)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHhc
Confidence 99999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=304.95 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=187.4
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------ 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------ 76 (307)
.++..||||.++.. .......+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++......
T Consensus 73 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 152 (344)
T 1rjb_A 73 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152 (344)
T ss_dssp SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----
T ss_pred CcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcccccccccc
Confidence 35668999999854 234456799999999999 9999999999999999999999999999999999543321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-c
Q 021774 77 -------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-H 142 (307)
Q Consensus 77 -------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 142 (307)
...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++........ .
T Consensus 153 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 229 (344)
T 1rjb_A 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229 (344)
T ss_dssp ----------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE
T ss_pred chhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccce
Confidence 13489999999999999999999999 999999999999999999999999999986543322 2
Q ss_pred ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 143 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
......|++.|+|||++.+..++.++||||||+++|||+| |..||........ .. ........ . .
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~-----~---~ 295 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--FY----KLIQNGFK-----M---D 295 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH----HHHHTTCC-----C---C
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH--HH----HHHhcCCC-----C---C
Confidence 2334557788999999988899999999999999999998 9988865433211 11 11111111 0 1
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+......+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus 296 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 296 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 11222345888899999999999999999999999887643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=301.02 Aligned_cols=234 Identities=25% Similarity=0.408 Sum_probs=182.4
Q ss_pred CEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 8 RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 8 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
..||||.++.. .......+.+|++++++++||||+++++++...+..++||||+++++|.+++.. ....+++..++
T Consensus 74 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~ 150 (333)
T 1mqb_A 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLV 150 (333)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHH
T ss_pred ccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHH
Confidence 46999999865 344556799999999999999999999999999999999999999999999843 34568999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCCcc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......... ......++..|+|||++.+..+
T Consensus 151 ~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 151 GMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 9999999999999999 9999999999999999999999999999876543221 1223345778999999999999
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++||||||+++|||++ |..||..... ..+.. ........ ..+......+.+++.+||+.||.
T Consensus 228 ~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~----~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~ 292 (333)
T 1mqb_A 228 TSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMK----AINDGFRL--------PTPMDCPSAIYQLMMQCWQQERA 292 (333)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----HHHTTCCC--------CCCTTCBHHHHHHHHHHTCSSTT
T ss_pred CchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHHCCCcC--------CCcccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999 9998864432 11111 11111110 01122334578889999999999
Q ss_pred CCCCHHHHHHHHHhccccC
Q 021774 244 RRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~~~~~ 262 (307)
+||++.++++.|+++++..
T Consensus 293 ~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 293 RRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TSCCHHHHHHHHHHHHHSG
T ss_pred hCcCHHHHHHHHHHHHhcc
Confidence 9999999999999888644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=297.89 Aligned_cols=241 Identities=19% Similarity=0.308 Sum_probs=183.3
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .......+.+|+.++++++||||+++++++...+..++||||+++++|.+++.........++
T Consensus 55 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (310)
T 2wqm_A 55 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134 (310)
T ss_dssp TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCC
T ss_pred CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCC
Confidence 57899999998753 355567899999999999999999999999999999999999999999999865444566799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+
T Consensus 135 ~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 135 ERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------------------CCSSCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCC
Confidence 999999999999999999999 999999999999999999999999999986644321 2234568899999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..||........ ..... ........ .. .......+.+++.+||+.|
T Consensus 211 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~----~~---~~~~~~~l~~li~~~l~~d 278 (310)
T 2wqm_A 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKK-IEQCDYPP----LP---SDHYSEELRQLVNMCINPD 278 (310)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----HHHHH-HHTTCSCC----CC---TTTSCHHHHHHHHHHTCSS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----HHHHH-hhcccCCC----Cc---ccccCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999864332211 11111 11111110 00 1122335788899999999
Q ss_pred cCCCCCHHHHHHHHHhcccc
Q 021774 242 ASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~ 261 (307)
|.+|||+.+|++.|+++...
T Consensus 279 p~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 279 PEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHHHh
Confidence 99999999999999988753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=323.54 Aligned_cols=239 Identities=28% Similarity=0.438 Sum_probs=190.4
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+..++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++... .+..++
T Consensus 286 ~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~ 361 (535)
T 2h8h_A 286 GTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLR 361 (535)
T ss_dssp EEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCC
T ss_pred EEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCC
Confidence 4456677899999986542 34679999999999999999999999876 6789999999999999999421 234589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..............++..|+|||++.+
T Consensus 362 ~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 438 (535)
T 2h8h_A 362 LPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 438 (535)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc
Confidence 999999999999999999999 99999999999999999999999999998765432222333456778999999998
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++|||||||++|||+| |..||...... .+... ....... ..+......+.+++.+||+.
T Consensus 439 ~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~----i~~~~~~--------~~~~~~~~~l~~li~~cl~~ 503 (535)
T 2h8h_A 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VERGYRM--------PCPPECPESLHDLMCQCWRK 503 (535)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHH----HHTTCCC--------CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC--------CCCCCCCHHHHHHHHHHcCC
Confidence 899999999999999999999 88887654321 11111 1111110 11122334578889999999
Q ss_pred ccCCCCCHHHHHHHHHhccccC
Q 021774 241 AASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
||++|||+.+|++.|+.++...
T Consensus 504 dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 504 EPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp SGGGSCCHHHHHHHHHTSSCCC
T ss_pred ChhHCcCHHHHHHHHHHHhhcc
Confidence 9999999999999999887544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=292.71 Aligned_cols=228 Identities=29% Similarity=0.482 Sum_probs=173.7
Q ss_pred CCCEEEEEEccccC----hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|+.||||+++... ....+.+.+|++++++++||||+++++++...+..++||||+++++|.+++. ...++
T Consensus 29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~ 103 (271)
T 3dtc_A 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIP 103 (271)
T ss_dssp TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-----SSCCC
T ss_pred cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-----cCCCC
Confidence 47899999987542 2335678999999999999999999999999999999999999999999982 44699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCC---eeeCCCCCCcEEECC--------CCceEEeeccCcccCCCCcccccccccCC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPH---IVHRDIKASNILLDQ--------EFNPKIGDFGLAKLFPDNITHITTRIAGT 150 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~---i~H~dlkp~Nill~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~g~ 150 (307)
+..+..++.|++.||+|||++ + ++||||||+||+++. ++.++|+|||++....... .....|+
T Consensus 104 ~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~ 177 (271)
T 3dtc_A 104 PDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGA 177 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CC
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCc
Confidence 999999999999999999999 7 999999999999986 6789999999998654432 2245689
Q ss_pred CCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 151 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
..|+|||++.+..++.++||||||+++|+|++|+.||........ ........... ..+......+
T Consensus 178 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--------~~~~~~~~~~ 243 (271)
T 3dtc_A 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMNKLAL--------PIPSTCPEPF 243 (271)
T ss_dssp GGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTSCCCC--------CCCTTCCHHH
T ss_pred cceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcCCCCC--------CCCcccCHHH
Confidence 999999999988999999999999999999999999865432111 11111111110 1122233458
Q ss_pred HHHHHhccccccCCCCCHHHHHHHHHhc
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~~L~~~ 258 (307)
.+++.+||+.||.+|||+.++++.|+++
T Consensus 244 ~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 244 AKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 8899999999999999999999999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=299.18 Aligned_cols=240 Identities=24% Similarity=0.406 Sum_probs=190.8
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA------ 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------ 76 (307)
.+|..||||+++.. .......+.+|+++++++ +||||+++++++...+..++||||+++++|.+++......
T Consensus 65 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 144 (334)
T 2pvf_A 65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144 (334)
T ss_dssp ---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC
T ss_pred ccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccc
Confidence 46788999999865 345567899999999999 8999999999999999999999999999999999654321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccC
Q 021774 77 ------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAG 149 (307)
Q Consensus 77 ------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g 149 (307)
...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++......... ......+
T Consensus 145 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 221 (334)
T 2pvf_A 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221 (334)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCC
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCc
Confidence 23489999999999999999999999 9999999999999999999999999999876543221 2334456
Q ss_pred CCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 150 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
+..|+|||++.+..++.++||||||+++|||++ |..||..... ..+...... .... ..+.....
T Consensus 222 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~----~~~~--------~~~~~~~~ 286 (334)
T 2pvf_A 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFKLLKE----GHRM--------DKPANCTN 286 (334)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHH----TCCC--------CCCTTCCH
T ss_pred ccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HHHHHHHhc----CCCC--------CCCccCCH
Confidence 788999999998899999999999999999999 8888765422 111111111 1110 11122334
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+.+++.+||+.||.+||++.++++.|++++...
T Consensus 287 ~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 5888899999999999999999999999988643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=298.74 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=192.2
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-------
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 75 (307)
.+|+.||||.++... ....+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 130 (313)
T 1t46_A 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (313)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred chhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccc
Confidence 457899999998653 34557899999999999 999999999999999999999999999999999854332
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccc
Q 021774 76 -------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRI 147 (307)
Q Consensus 76 -------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 147 (307)
....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......... .....
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 207 (313)
T 1t46_A 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (313)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred cccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCC
Confidence 123589999999999999999999999 9999999999999999999999999999876554322 23344
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHH
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
.++..|+|||++.+..++.++||||||+++|||+| |..||........ ....... ... .. .+...
T Consensus 208 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~----~~~-----~~---~~~~~ 273 (313)
T 1t46_A 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FYKMIKE----GFR-----ML---SPEHA 273 (313)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HHHHHHH----TCC-----CC---CCTTS
T ss_pred CCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--HHHHhcc----CCC-----CC---CcccC
Confidence 56788999999998899999999999999999999 8888865443211 1111111 110 00 11122
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
...+.+++.+||+.||.+|||+.++++.|++++..
T Consensus 274 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 34578889999999999999999999999988753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=299.82 Aligned_cols=240 Identities=20% Similarity=0.271 Sum_probs=189.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||++..........+.+|++++++++||||+++++++.. ....++||||+++++|.+++......+..+
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 131 (317)
T 2buj_A 52 HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131 (317)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCC
T ss_pred CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCC
Confidence 5789999999987777777889999999999999999999999873 347789999999999999986544456779
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--------ccccccCCCC
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--------ITTRIAGTTG 152 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--------~~~~~~g~~~ 152 (307)
++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++......... ......|+..
T Consensus 132 ~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 208 (317)
T 2buj_A 132 TEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208 (317)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999 9999999999999999999999999998765432111 1123457899
Q ss_pred cCCcccccCCc---ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 153 YLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 153 y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
|+|||++.+.. ++.++||||||+++|||++|..||......... .. ........ .+. .......
T Consensus 209 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~----~~~~~~~~----~~~----~~~~~~~ 275 (317)
T 2buj_A 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA----LAVQNQLS----IPQ----SPRHSSA 275 (317)
T ss_dssp GCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH----HHHHCC------CCC----CTTSCHH
T ss_pred cCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh----HHhhccCC----CCc----cccCCHH
Confidence 99999987643 688999999999999999999998543221111 10 01111000 011 1222345
Q ss_pred HHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 276 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 276 LWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred HHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 8889999999999999999999999987653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=300.72 Aligned_cols=228 Identities=19% Similarity=0.314 Sum_probs=178.6
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-------------------------------
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------------------------------- 52 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------------------------- 52 (307)
.+|+.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 29 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (332)
T 3qd2_B 29 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108 (332)
T ss_dssp TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------
T ss_pred CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccc
Confidence 478999999997543 345578999999999999999999999987654
Q ss_pred --------------------------eeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 021774 53 --------------------------RRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPH 106 (307)
Q Consensus 53 --------------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 106 (307)
..++||||+++++|.+++.... .....++..++.++.|++.||+|||++ |
T Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ 184 (332)
T 3qd2_B 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSK---G 184 (332)
T ss_dssp -----------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHHHHHhC---C
Confidence 3799999999999999995432 234467778999999999999999999 9
Q ss_pred eeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-----------cccccccCCCCcCCcccccCCcccccCceeehHH
Q 021774 107 IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-----------HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175 (307)
Q Consensus 107 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 175 (307)
|+||||||+||+++.++.+||+|||++........ .......||..|+|||++.+..++.++||||||+
T Consensus 185 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 264 (332)
T 3qd2_B 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264 (332)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHH
T ss_pred eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHH
Confidence 99999999999999999999999999987755421 1223456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 176 LVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 176 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++|||++|..|+... .... ....... ...........+.+++.+||+.||.+|||+.++++
T Consensus 265 il~el~~~~~~~~~~--------~~~~-~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 265 ILFELLYSFSTQMER--------VRII-TDVRNLK--------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHSCCCCHHHH--------HHHH-HHHHTTC--------CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHH--------HHHH-HHhhccC--------CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 999999987653211 1111 1111111 11112334455788999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=292.84 Aligned_cols=239 Identities=19% Similarity=0.266 Sum_probs=182.0
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++... .......+.+|+.++++++||||+++++++.+.+..++||||+++ ++.+.+. .....+++
T Consensus 25 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~l~~ 100 (292)
T 3o0g_A 25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD---SCNGDLDP 100 (292)
T ss_dssp TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH---HTTTCCCH
T ss_pred CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHH---hCCCCCCH
Confidence 46899999998754 234456788999999999999999999999999999999999976 5555542 23456999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+.
T Consensus 101 ~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 176 (292)
T 3o0g_A 101 EIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cccCCccccCCcChHHHcCC
Confidence 99999999999999999999 999999999999999999999999999987653322 23445689999999999876
Q ss_pred c-ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc----------------ccCCCCCCCCHH
Q 021774 163 Q-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE----------------LVDPELGEYPPN 225 (307)
Q Consensus 163 ~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~ 225 (307)
. ++.++|||||||++|||++|..|+...... .................. .....+....+.
T Consensus 177 ~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (292)
T 3o0g_A 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254 (292)
T ss_dssp SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTT
T ss_pred CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccc
Confidence 5 799999999999999999998886433221 122222222211110000 000111122233
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 255 LNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 4456788999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=293.49 Aligned_cols=238 Identities=29% Similarity=0.434 Sum_probs=189.5
Q ss_pred ccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 3 TLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
...++..||||.++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++... .+..+++
T Consensus 33 ~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~ 108 (279)
T 1qpc_A 33 YYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTI 108 (279)
T ss_dssp EETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCH
T ss_pred EEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcC--CCCCCCH
Confidence 456678999999875432 34678999999999999999999999864 4689999999999999998321 1236899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||++...............++..|+|||++.+.
T Consensus 109 ~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 185 (279)
T 1qpc_A 109 NKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccC
Confidence 99999999999999999999 999999999999999999999999999987765443334445567889999999988
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||++ |..||...... .... . ...... . ..+......+.+++.+||+.|
T Consensus 186 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---~-~~~~~~-----~---~~~~~~~~~l~~li~~~l~~~ 250 (279)
T 1qpc_A 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ---N-LERGYR-----M---VRPDNCPEELYQLMRLCWKER 250 (279)
T ss_dssp EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH---H-HHTTCC-----C---CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHH---H-HhcccC-----C---CCcccccHHHHHHHHHHhccC
Confidence 99999999999999999999 88887653321 1111 1 111110 0 011222345888899999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|++|||+.++++.|+++....
T Consensus 251 p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 251 PEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp GGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999887543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=295.74 Aligned_cols=234 Identities=23% Similarity=0.383 Sum_probs=192.2
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+|..||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ....+++..+
T Consensus 37 ~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~ 113 (288)
T 3kfa_A 37 YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVL 113 (288)
T ss_dssp GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHH
T ss_pred CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHH
Confidence 47889999998654 34567999999999999999999999999999999999999999999998532 3456899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
+.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++...............++..|+|||++.+..++
T Consensus 114 ~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 190 (288)
T 3kfa_A 114 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190 (288)
T ss_dssp HHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCC
Confidence 99999999999999999 999999999999999999999999999988766544444556678889999999988999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++||||||+++|+|++ |..||....... .... ...... . ..+......+.+++.+||+.||.+
T Consensus 191 ~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~----~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~ 255 (288)
T 3kfa_A 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDYR-----M---ERPEGCPEKVYELMRACWQWNPSD 255 (288)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhccCC-----C---CCCCCCCHHHHHHHHHHhCCChhh
Confidence 99999999999999999 888876543321 1111 111110 0 111223345888999999999999
Q ss_pred CCCHHHHHHHHHhccc
Q 021774 245 RPQMNQVIKMLTKNIR 260 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~ 260 (307)
|||+.++++.|+.++.
T Consensus 256 Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 256 RPSFAEIHQAFETMFQ 271 (288)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999988775
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=297.01 Aligned_cols=222 Identities=27% Similarity=0.363 Sum_probs=183.1
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||++||+|.+++. ....++
T Consensus 29 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~ 104 (318)
T 1fot_A 29 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP 104 (318)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HTSSCC
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH----HcCCCC
Confidence 478999999997542 2345678899999999999999999999999999999999999999999984 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...... .....||+.|+|||++.+
T Consensus 105 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 105 NPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcC
Confidence 999999999999999999999 9999999999999999999999999999875432 334679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|..||...... ... ........ .++......+.+++.+|++.|
T Consensus 178 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~---~~i~~~~~----------~~p~~~~~~~~~li~~lL~~d 241 (318)
T 1fot_A 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTY---EKILNAEL----------RFPPFFNEDVKDLLSRLITRD 241 (318)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHHCCC----------CCCTTSCHHHHHHHHHHTCSC
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCC----------CCCCCCCHHHHHHHHHHhccC
Confidence 99999999999999999999999998653221 111 11111111 111222345788899999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|.+|| +++++++
T Consensus 242 p~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTTCTTSSTTTTHHHHT
T ss_pred HHHcCCCcCCCHHHHhc
Confidence 99999 8888874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=294.14 Aligned_cols=252 Identities=17% Similarity=0.228 Sum_probs=192.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC-VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++...... ..+.+|+.++++++|++++..+.++ ...+..++||||+ +++|.+++.. ....+++.
T Consensus 32 ~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~ 105 (296)
T 3uzp_A 32 AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLK 105 (296)
T ss_dssp TTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHH
T ss_pred CCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHH
Confidence 67899999998755322 4588999999999888766666555 5677889999999 9999999842 34469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCceEEeeccCcccCCCCccc------ccccccCCCCcC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYL 154 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~ 154 (307)
.+..++.|++.||+|||++ +++||||||+||+++ .++.+||+|||++......... ......|+..|+
T Consensus 106 ~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 182 (296)
T 3uzp_A 106 TVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccC
Confidence 9999999999999999999 999999999999994 8889999999999876543221 124567899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++||||||+++|||++|+.||......................... .+ .......+.+++
T Consensus 183 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~l~~li 254 (296)
T 3uzp_A 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-VL-------CKGYPSEFATYL 254 (296)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-HH-------TTTSCHHHHHHH
T ss_pred ChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-HH-------HhhCCHHHHHHH
Confidence 9999999999999999999999999999999987644322221222111111111100 00 011223588889
Q ss_pred HhccccccCCCCCHHHHHHHHHhccccCccccCCCCCcc
Q 021774 235 FFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ 273 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~ 273 (307)
.+||+.||.+|||+.+|++.|+++..........+..|+
T Consensus 255 ~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 255 NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred HHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 999999999999999999999998876655444555454
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=304.54 Aligned_cols=242 Identities=19% Similarity=0.217 Sum_probs=182.4
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++... ....+++
T Consensus 50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~ 127 (389)
T 3gni_B 50 PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNE 127 (389)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCH
T ss_pred CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCH
Confidence 46899999999755 3455677889999999999999999999999999999999999999999998542 2345999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc------cccccccCCCCcCCc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYLAP 156 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aP 156 (307)
..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+........ .......||..|+||
T Consensus 128 ~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 204 (389)
T 3gni_B 128 LAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204 (389)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCH
Confidence 99999999999999999999 999999999999999999999999998865432211 112334688899999
Q ss_pred ccccC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh---c-------------------CCcc
Q 021774 157 EYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ---E-------------------EKPL 212 (307)
Q Consensus 157 E~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~-------------------~~~~ 212 (307)
|++.+ ..++.++|||||||++|||++|+.||........ +......... . ....
T Consensus 205 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (389)
T 3gni_B 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLS 282 (389)
T ss_dssp HHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC---------------------------------
T ss_pred HHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCccccccccccccccccccccccccccc
Confidence 99987 5789999999999999999999999865433211 1000000000 0 0000
Q ss_pred cc----------cCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 213 EL----------VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 213 ~~----------~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.. .+.............+.+++.+||+.||.+|||+.++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 283 DSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 000000112233456888999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=298.54 Aligned_cols=242 Identities=24% Similarity=0.396 Sum_probs=189.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++........+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++.. ....+++
T Consensus 68 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 144 (326)
T 2w1i_A 68 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH 144 (326)
T ss_dssp SCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCH
T ss_pred CCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCH
Confidence 468899999998776667788999999999999999999999987654 67999999999999999843 2345899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCccccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~ 160 (307)
..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......... ......++..|+|||++.
T Consensus 145 ~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 221 (326)
T 2w1i_A 145 IKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc
Confidence 99999999999999999999 9999999999999999999999999999877554322 123345677899999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchh---------HHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN---------KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
+..++.++||||||+++|||+||..|+........ ................. ..+......+.
T Consensus 222 ~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~ 293 (326)
T 2w1i_A 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--------PRPDGCPDEIY 293 (326)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC--------CCCTTCCHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC--------CCCCcccHHHH
Confidence 88999999999999999999999988654321100 00111111111111110 11222334588
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus 294 ~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 294 MIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999987753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=294.03 Aligned_cols=235 Identities=31% Similarity=0.507 Sum_probs=178.1
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
.|+.||||.+.... ..+.|.+|++++++++||||+++++++.+ ..++||||+++++|.+++.... ....+++..+
T Consensus 30 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 104 (307)
T 2eva_A 30 RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHA 104 (307)
T ss_dssp TTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHH
T ss_pred CCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHH
Confidence 47889999997543 34679999999999999999999998763 4789999999999999985322 2234789999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-eEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN-PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+.++.|++.||+|||+....||+||||||+||+++.++. +||+|||++...... .....|+..|+|||++.+..+
T Consensus 105 ~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 180 (307)
T 2eva_A 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNY 180 (307)
T ss_dssp HHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCC
Confidence 999999999999999921119999999999999988886 799999999755432 233468999999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+++|||++|+.||......... ..+........ . ........+.+++.+||+.||.+
T Consensus 181 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~------~---~~~~~~~~l~~li~~~l~~dp~~ 247 (307)
T 2eva_A 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGTRP------P---LIKNLPKPIESLMTRCWSKDPSQ 247 (307)
T ss_dssp CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHHHTTCCC------C---CBTTCCHHHHHHHHHHTCSSGGG
T ss_pred CcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHHhcCCCC------C---cccccCHHHHHHHHHHhcCChhh
Confidence 99999999999999999999998654322111 11111111111 1 11122335788899999999999
Q ss_pred CCCHHHHHHHHHhccccC
Q 021774 245 RPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~~~ 262 (307)
|||+.++++.|+.+.+..
T Consensus 248 Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 248 RPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp SCCHHHHHHHHHHHGGGC
T ss_pred CcCHHHHHHHHHHHHHhc
Confidence 999999999999887644
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=294.07 Aligned_cols=234 Identities=26% Similarity=0.364 Sum_probs=185.8
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++++|.+++.. ...+++
T Consensus 42 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~ 116 (291)
T 1xbb_A 42 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKD 116 (291)
T ss_dssp SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCH
T ss_pred CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCH
Confidence 346789999998653 33457899999999999999999999999 66778999999999999999843 346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCccccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~ 160 (307)
..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++......... ......++..|+|||++.
T Consensus 117 ~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 193 (291)
T 1xbb_A 117 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc
Confidence 99999999999999999999 9999999999999999999999999999876544322 122344667899999999
Q ss_pred CCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..++.++||||||+++|+|++ |..||...... .+. ........ ...+......+.+++.+||+
T Consensus 194 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~--------~~~~~~~~~~l~~li~~~l~ 258 (291)
T 1xbb_A 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGER--------MGCPAGCPREMYDLMNLCWT 258 (291)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCC--------CCCCTTCCHHHHHHHHHHTC
T ss_pred cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCC--------CCCCCCCCHHHHHHHHHHcC
Confidence 8899999999999999999999 99998654321 111 11111111 11122333458889999999
Q ss_pred cccCCCCCHHHHHHHHHhcccc
Q 021774 240 AAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 240 ~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
.||.+||++.++++.|++++..
T Consensus 259 ~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 259 YDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999988753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=297.89 Aligned_cols=239 Identities=23% Similarity=0.364 Sum_probs=189.6
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC------CCC
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------ANI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~ 78 (307)
+++.||||.+... .......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..... ...
T Consensus 54 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 133 (322)
T 1p4o_A 54 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133 (322)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCC
Confidence 4678999999865 344556799999999999999999999999999999999999999999999853221 124
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE 157 (307)
.+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ .......++..|+|||
T Consensus 134 ~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChh
Confidence 578999999999999999999999 999999999999999999999999999986543221 1223345678899999
Q ss_pred cccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
++.+..++.++||||||+++|+|++ |..||...... .... ....... ...+......+.+++.+
T Consensus 211 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~~~--------~~~~~~~~~~l~~li~~ 275 (322)
T 1p4o_A 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR----FVMEGGL--------LDKPDNCPDMLFELMRM 275 (322)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH----HHHTTCC--------CCCCTTCCHHHHHHHHH
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH----HHHcCCc--------CCCCCCCCHHHHHHHHH
Confidence 9998899999999999999999999 78887654321 1111 1111111 11122233457888999
Q ss_pred ccccccCCCCCHHHHHHHHHhccccC
Q 021774 237 CTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
||+.||.+|||+.++++.|++.+...
T Consensus 276 ~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 276 CWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HcCCCcccCcCHHHHHHHHHHhhccC
Confidence 99999999999999999999877533
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=293.60 Aligned_cols=233 Identities=22% Similarity=0.301 Sum_probs=183.1
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++||||+++++|.+++.. ....+++..+
T Consensus 40 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~ 115 (281)
T 3cc6_A 40 KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLER---NKNSLKVLTL 115 (281)
T ss_dssp EEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HTTTCCHHHH
T ss_pred cceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHh---ccccCCHHHH
Confidence 346999999865 34556789999999999999999999999765 456899999999999999843 2345899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...............++..|+|||++.+..++
T Consensus 116 ~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 192 (281)
T 3cc6_A 116 VLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192 (281)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCC
Confidence 99999999999999999 999999999999999999999999999987655433333445577889999999888999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++||||||+++|||+| |+.||....... ....... .... ..+......+.+++.+||+.||.+
T Consensus 193 ~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~---~~~~---------~~~~~~~~~l~~li~~~l~~~p~~ 257 (281)
T 3cc6_A 193 TASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK---GDRL---------PKPDLCPPVLYTLMTRCWDYDPSD 257 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH---TCCC---------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred chhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc---CCCC---------CCCCCCCHHHHHHHHHHccCCchh
Confidence 99999999999999998 999986543322 1111111 1110 011122345888899999999999
Q ss_pred CCCHHHHHHHHHhcccc
Q 021774 245 RPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~~ 261 (307)
||++.++++.|+++...
T Consensus 258 Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 258 RPRFTELVCSLSDVYQM 274 (281)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHh
Confidence 99999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=297.16 Aligned_cols=237 Identities=21% Similarity=0.393 Sum_probs=179.2
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhccCC--CC
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLLGAT--KA 76 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~--~~ 76 (307)
++..||+|.++.. .....+.+.+|+.++++++||||+++++++...+ ..++||||+++++|.+++.... ..
T Consensus 61 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~ 140 (313)
T 3brb_A 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140 (313)
T ss_dssp CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTS
T ss_pred ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcC
Confidence 4558999998755 3455678999999999999999999999998755 3499999999999999984332 23
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCC
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLA 155 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~a 155 (307)
...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........ .......++..|+|
T Consensus 141 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 217 (313)
T 3brb_A 141 PKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217 (313)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred CccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence 45699999999999999999999999 999999999999999999999999999986644322 12233456778999
Q ss_pred cccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
||.+.+..++.++||||||+++|+|++ |..||....... ..... . .... ...+......+.+++
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~---~-~~~~--------~~~~~~~~~~l~~li 282 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYL---L-HGHR--------LKQPEDCLDELYEIM 282 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH---H-TTCC--------CCCBTTCCHHHHHHH
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHH---H-cCCC--------CCCCccccHHHHHHH
Confidence 999999999999999999999999999 888876543321 11111 1 1111 011122334588899
Q ss_pred HhccccccCCCCCHHHHHHHHHhccc
Q 021774 235 FFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
.+||+.||.+||++.++++.|++++.
T Consensus 283 ~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 283 YSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 99999999999999999999998875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=298.94 Aligned_cols=227 Identities=26% Similarity=0.346 Sum_probs=179.5
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .......+.+|..+++++ +||||+++++++.+.+..++||||++||+|.+++. ....+
T Consensus 32 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~l 107 (345)
T 3a8x_A 32 KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKL 107 (345)
T ss_dssp TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSC
T ss_pred CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCC
Confidence 46889999999754 345566788999999988 89999999999999999999999999999999984 33469
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 108 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 183 (345)
T 3a8x_A 108 PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILR 183 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccC
Confidence 9999999999999999999999 99999999999999999999999999998643221 2244567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhH--HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+..++.++|||||||++|||++|+.||......... ............... ..+......+.+++.+||
T Consensus 184 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~~p~~~s~~~~~li~~lL 254 (345)
T 3a8x_A 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------RIPRSLSVKAASVLKSFL 254 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---------CCCTTSCHHHHHHHHHHT
T ss_pred CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---------CCCCCCCHHHHHHHHHHh
Confidence 999999999999999999999999998642211100 001111111111111 112223345788899999
Q ss_pred ccccCCCCCH
Q 021774 239 QAAASRRPQM 248 (307)
Q Consensus 239 ~~~p~~RPs~ 248 (307)
+.||.+||++
T Consensus 255 ~~dP~~R~~~ 264 (345)
T 3a8x_A 255 NKDPKERLGC 264 (345)
T ss_dssp CSSTTTSTTC
T ss_pred cCCHhHCCCC
Confidence 9999999996
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=300.93 Aligned_cols=222 Identities=23% Similarity=0.282 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||++||+|.+++. ....++
T Consensus 64 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~ 139 (350)
T 1rdq_E 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS 139 (350)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHCCCC
T ss_pred CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH----HcCCCC
Confidence 468999999987542 2345678899999999999999999999999999999999999999999984 234689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...... .....||+.|+|||++.+
T Consensus 140 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 140 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcC
Confidence 999999999999999999999 9999999999999999999999999999876443 234578999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|..||..... ..... ..... .. .++......+.+++.+||+.|
T Consensus 213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~---~i~~~-~~---------~~p~~~~~~~~~li~~lL~~d 276 (350)
T 1rdq_E 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE---KIVSG-KV---------RFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHC-CC---------CCCTTCCHHHHHHHHHHSCSC
T ss_pred CCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHH---HHHcC-CC---------CCCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999865422 11111 11111 11 111223345888999999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|.+||+ +.++++
T Consensus 277 p~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 277 LTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTTCTTSSTTTTHHHHT
T ss_pred HHhccCCccCCHHHHHh
Confidence 999998 888864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=304.59 Aligned_cols=227 Identities=26% Similarity=0.350 Sum_probs=177.3
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++.. .......+..|..++.++ +||||+++++++.+.+..++||||++||+|..++. ....+
T Consensus 75 ~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~----~~~~l 150 (396)
T 4dc2_A 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKL 150 (396)
T ss_dssp TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSC
T ss_pred CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH----HcCCC
Confidence 46789999999754 233345688899999887 89999999999999999999999999999999884 34569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++..... ........||+.|+|||++.
T Consensus 151 ~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~ 226 (396)
T 4dc2_A 151 PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILR 226 (396)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC-CCccccccCCcccCCchhhc
Confidence 9999999999999999999999 9999999999999999999999999999853322 12345567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhH--HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+..++.++|||||||++|||++|+.||......... ............... .++......+.+++.+||
T Consensus 227 ~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~~p~~~s~~~~~li~~lL 297 (396)
T 4dc2_A 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------RIPRSLSVKAASVLKSFL 297 (396)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---------CCCTTSCHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---------CCCCcCCHHHHHHHHHHh
Confidence 999999999999999999999999998643221110 001111111111111 112223345788999999
Q ss_pred ccccCCCCCH
Q 021774 239 QAAASRRPQM 248 (307)
Q Consensus 239 ~~~p~~RPs~ 248 (307)
+.||.+||++
T Consensus 298 ~~dP~~R~~~ 307 (396)
T 4dc2_A 298 NKDPKERLGC 307 (396)
T ss_dssp CSCTTTSTTC
T ss_pred cCCHhHcCCC
Confidence 9999999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.90 Aligned_cols=252 Identities=16% Similarity=0.168 Sum_probs=190.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccc---------------eeeEEEe-CCeeEEEEeccCCCCHHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVE---------------LIGCCVQ-GTRRILVYEYVENNSLDRV 69 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~ 69 (307)
+|+.||||.+... ..+.+|++++++++||||++ +++++.. ....++||||+ +++|.++
T Consensus 74 ~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 147 (352)
T 2jii_A 74 QKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSA 147 (352)
T ss_dssp ---CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHH
T ss_pred cCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHH
Confidence 5889999998744 35788999999999999887 6778776 67889999999 9999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC--ceEEeeccCcccCCCCccc-----
Q 021774 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF--NPKIGDFGLAKLFPDNITH----- 142 (307)
Q Consensus 70 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~----- 142 (307)
+... ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..+......
T Consensus 148 l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 222 (352)
T 2jii_A 148 LDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222 (352)
T ss_dssp HHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCT
T ss_pred HHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccc
Confidence 9532 235799999999999999999999999 999999999999999998 8999999999876532211
Q ss_pred -ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 143 -ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 143 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
......||..|+|||++.+..++.++||||||+++|||++|+.||......... +........... ....+...
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~-- 297 (352)
T 2jii_A 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED-IMKQKQKFVDKP--GPFVGPCG-- 297 (352)
T ss_dssp TSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-HHHHHHHHHHSC--CCEECTTS--
T ss_pred cccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH-HHHHHHhccCCh--hhhhhhcc--
Confidence 123357899999999999999999999999999999999999998765432221 222111111111 11111110
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccCccccCCCCCcc
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ 273 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~ 273 (307)
........+.+++.+||+.||.+||++.+|++.|++++.........|..|.
T Consensus 298 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 298 HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 0011224588888999999999999999999999999876654444444443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=294.48 Aligned_cols=252 Identities=17% Similarity=0.228 Sum_probs=190.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCC-VQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++...... ..+.+|+.++++++|++++..+.++ ...+..++||||+ +++|.+++.. ....+++.
T Consensus 32 ~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~ 105 (296)
T 4hgt_A 32 AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLK 105 (296)
T ss_dssp TTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHH
T ss_pred CCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHH
Confidence 57889999987654322 3578899999999888766666655 6777889999999 9999999842 34469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCceEEeeccCcccCCCCcc------cccccccCCCCcC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYL 154 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~ 154 (307)
.+..++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||++........ .......|+..|+
T Consensus 106 ~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 182 (296)
T 4hgt_A 106 TVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCcccc
Confidence 9999999999999999999 99999999999999 7889999999999987654322 1223567899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++|||||||++|+|++|+.||........................ .... .. ....+.+++
T Consensus 183 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~----~~~~l~~li 254 (296)
T 4hgt_A 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLC---KG----YPSEFATYL 254 (296)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHHT---TT----SCHHHHHHH
T ss_pred chHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hhhh---cc----CCHHHHHHH
Confidence 999999999999999999999999999999999765433222222211111111110 0000 11 123588889
Q ss_pred HhccccccCCCCCHHHHHHHHHhccccCccccCCCCCcc
Q 021774 235 FFCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQ 273 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~ 273 (307)
.+||+.||++|||+.+|++.|++++.........+..|+
T Consensus 255 ~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 255 NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 999999999999999999999998875544444444443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=302.73 Aligned_cols=225 Identities=27% Similarity=0.329 Sum_probs=178.8
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||+++.. .......+..|.++++.+ +||||+++++++.+.+..++||||++||+|..++. ....+
T Consensus 46 ~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~ 121 (353)
T 3txo_A 46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRF 121 (353)
T ss_dssp TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSC
T ss_pred CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCC
Confidence 46899999999754 234456788999999988 79999999999999999999999999999999983 34569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 122 ~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 122 DEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC-ccccccCCCcCeEChhhcC
Confidence 9999999999999999999999 99999999999999999999999999998543322 2344567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|+.||...... .+.. ....... .++......+.+++.+||+.
T Consensus 198 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~~~----------~~p~~~~~~~~~li~~lL~~ 261 (353)
T 3txo_A 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFE---AILNDEV----------VYPTWLHEDATGILKSFMTK 261 (353)
T ss_dssp HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCC----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHH---HHHcCCC----------CCCCCCCHHHHHHHHHHhhh
Confidence 889999999999999999999999998654321 1111 1111111 11122334578889999999
Q ss_pred ccCCCCCH------HHHHH
Q 021774 241 AASRRPQM------NQVIK 253 (307)
Q Consensus 241 ~p~~RPs~------~~v~~ 253 (307)
||.+||++ .++++
T Consensus 262 dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 262 NPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SGGGSTTSGGGTCTHHHHT
T ss_pred CHHHccCCcccCCHHHHhh
Confidence 99999998 66664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=288.60 Aligned_cols=229 Identities=22% Similarity=0.390 Sum_probs=183.8
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|+.||||+++.. +....+.+.+|+.++++++||||+++++++.+. ...++||||+++++|.+++... ....++
T Consensus 32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~ 109 (271)
T 3kmu_A 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVD 109 (271)
T ss_dssp TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC--SSCCCC
T ss_pred CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc--ccCCCC
Confidence 4789999999865 345567899999999999999999999999887 7789999999999999999532 233589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||+...... ....||+.|+|||++
T Consensus 110 ~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~ 180 (271)
T 3kmu_A 110 QSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEAL 180 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhh
Confidence 999999999999999999999 8 99999999999999999999999888764322 234678999999999
Q ss_pred cCCcccc---cCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 160 LGGQLTM---KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 160 ~~~~~~~---~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
.+..++. ++||||||+++|||++|+.||....... . .......... + ..+......+.+++.+
T Consensus 181 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~---~~~~~~~~~~-----~---~~~~~~~~~~~~li~~ 246 (271)
T 3kmu_A 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---I---GMKVALEGLR-----P---TIPPGISPHVSKLMKI 246 (271)
T ss_dssp HSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---H---HHHHHHSCCC-----C---CCCTTCCHHHHHHHHH
T ss_pred ccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---H---HHHHHhcCCC-----C---CCCCCCCHHHHHHHHH
Confidence 8766554 7999999999999999999986543211 1 1111111111 1 1122233458888899
Q ss_pred ccccccCCCCCHHHHHHHHHhcc
Q 021774 237 CTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
||+.||.+|||+.++++.|+++.
T Consensus 247 ~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 247 CMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HcCCChhhCcCHHHHHHHHHHhh
Confidence 99999999999999999998765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.46 Aligned_cols=234 Identities=25% Similarity=0.383 Sum_probs=175.7
Q ss_pred CEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 8 RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 8 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
..||+|.++.. .......|.+|+.++++++||||+++++++.. ++..++||||+++|+|.+++. .....+++..+
T Consensus 118 ~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~ 194 (373)
T 3c1x_A 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDL 194 (373)
T ss_dssp EEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHH---CTTCCCBHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHh---hcccCCCHHHH
Confidence 36899998754 34556789999999999999999999998765 457899999999999999994 33456889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCcCCcccccCC
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~ 162 (307)
+.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+.
T Consensus 195 ~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 271 (373)
T 3c1x_A 195 IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271 (373)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC
Confidence 99999999999999999 9999999999999999999999999999866433211 12334567789999999999
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||+| |.+||........ .... . ..... ..+......+.+++.+||+.|
T Consensus 272 ~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~---~-~~~~~--------~~p~~~~~~l~~li~~cl~~d 336 (373)
T 3c1x_A 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL---L-QGRRL--------LQPEYCPDPLYEVMLKCWHPK 336 (373)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHH---H-TTCCC--------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHH---H-cCCCC--------CCCCCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999 5666654332211 1111 1 11110 011122345788899999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|++||++.++++.|++++...
T Consensus 337 p~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 337 AEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp GGGSCCHHHHHHHHHHHHHTC
T ss_pred hhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999887543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=290.84 Aligned_cols=236 Identities=24% Similarity=0.337 Sum_probs=186.2
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCee-EEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR-ILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++||||+.+++|.+++.. ....+++..
T Consensus 49 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~ 125 (298)
T 3pls_A 49 RIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKD 125 (298)
T ss_dssp EEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHH
T ss_pred eeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHH
Confidence 337999998764 345567899999999999999999999999876655 999999999999999843 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc---cccccccCCCCcCCcccccC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~ 161 (307)
++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+
T Consensus 126 ~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (298)
T 3pls_A 126 LISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202 (298)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc
Confidence 999999999999999999 999999999999999999999999999986644321 12234567789999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..|+....... .+.... ...... ..+......+.+++.+||+.|
T Consensus 203 ~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~----~~~~~~--------~~~~~~~~~l~~li~~~l~~~ 268 (298)
T 3pls_A 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFL----AQGRRL--------PQPEYCPDSLYQVMQQCWEAD 268 (298)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHH----HTTCCC--------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHh----hcCCCC--------CCCccchHHHHHHHHHHccCC
Confidence 999999999999999999999665543322211 111111 111110 111122345888899999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|.+|||+.++++.|++++...
T Consensus 269 p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 269 PAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp GGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhCcCHHHHHHHHHHHHHHH
Confidence 999999999999999887543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.16 Aligned_cols=236 Identities=23% Similarity=0.323 Sum_probs=176.0
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe----eEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR----RILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||+++.. .......+.+|+.++++++||||+++++++..... .++||||++|++|.+++. ..
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~ 110 (311)
T 3ork_A 35 RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TE 110 (311)
T ss_dssp TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH----HH
T ss_pred CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH----hc
Confidence 57889999999764 34455678999999999999999999999886543 399999999999999984 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLA 155 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~a 155 (307)
..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ .......||..|+|
T Consensus 111 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a 187 (311)
T 3ork_A 111 GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187 (311)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCC
Confidence 4689999999999999999999999 999999999999999999999999999987654322 22334568999999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+..++.++||||||+++|||++|+.||....... ............... ........+.+++.
T Consensus 188 PE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~l~~li~ 255 (311)
T 3ork_A 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPPSA------RHEGLSADLDAVVL 255 (311)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCHHH------HSTTCCHHHHHHHH
T ss_pred HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCccc------ccCCCCHHHHHHHH
Confidence 999999999999999999999999999999986543211 111222211111000 00112345788899
Q ss_pred hccccccCCCCCHHHHH-HHHHhcc
Q 021774 236 FCTQAAASRRPQMNQVI-KMLTKNI 259 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~-~~L~~~~ 259 (307)
+||+.||.+||+..+++ ..+.+..
T Consensus 256 ~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 256 KALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHhcCHhhChhhHHHHHHHHHHHh
Confidence 99999999999765554 4554443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=300.48 Aligned_cols=227 Identities=24% Similarity=0.335 Sum_probs=167.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||+++++|.+++. ....+++..
T Consensus 76 ~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~ 149 (349)
T 2w4o_A 76 GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV----EKGYYSERD 149 (349)
T ss_dssp TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT----TCSSCCHHH
T ss_pred CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH----hcCCCCHHH
Confidence 357899999998543 33568899999999999999999999999999999999999999999983 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.|++.||.|||++ ||+||||||+||+++. ++.+||+|||++....... ......||..|+|||++.+
T Consensus 150 ~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 150 AADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--ccccccCCCCccCHHHhcC
Confidence 999999999999999999 9999999999999975 8899999999998654322 2334568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|..||....... ... ........ ....+ ........+.+++.+||+.|
T Consensus 225 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~i~~~~~-~~~~~----~~~~~~~~~~~li~~~L~~d 293 (349)
T 2w4o_A 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF----RRILNCEY-YFISP----WWDEVSLNAKDLVRKLIVLD 293 (349)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHH----HHHHTTCC-CCCTT----TTTTSCHHHHHHHHTTSCSS
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHH----HHHHhCCC-ccCCc----hhhhCCHHHHHHHHHHccCC
Confidence 999999999999999999999999986543321 111 11111111 11111 11223345888999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||+.++++
T Consensus 294 P~~Rpt~~e~l~ 305 (349)
T 2w4o_A 294 PKKRLTTFQALQ 305 (349)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHhc
Confidence 999999999876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=292.57 Aligned_cols=226 Identities=22% Similarity=0.296 Sum_probs=176.5
Q ss_pred CCCCEEEEEEccccCh--------------------------HhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEE
Q 021774 5 TNGRRIAVKPLSAESK--------------------------QGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRIL 56 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 56 (307)
.+|+.||||++..... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 115 (298)
T 2zv2_A 36 NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYM 115 (298)
T ss_dssp TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEE
T ss_pred CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEE
Confidence 4688999999875421 123568899999999999999999999987 568899
Q ss_pred EEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccC
Q 021774 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLF 136 (307)
Q Consensus 57 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 136 (307)
||||+++++|.+++ ....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 116 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 187 (298)
T 2zv2_A 116 VFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187 (298)
T ss_dssp EEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCCEEEecCCCcccc
Confidence 99999999998764 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCcccccccccCCCCcCCcccccCCc---ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc
Q 021774 137 PDNITHITTRIAGTTGYLAPEYVLGGQ---LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE 213 (307)
Q Consensus 137 ~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (307)
..... ......||..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ..+. .........
T Consensus 188 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~---~~~~~~~~~-- 258 (298)
T 2zv2_A 188 KGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---MCLH---SKIKSQALE-- 258 (298)
T ss_dssp SSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCCCC--
T ss_pred ccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---HHHH---HHHhcccCC--
Confidence 54322 233457899999999987654 47889999999999999999999865322 1111 111111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 214 LVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.... ....+.+++.+||+.||++|||+.++++
T Consensus 259 --~~~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 259 --FPDQPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp --CCSSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 011112 2235888999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=300.29 Aligned_cols=233 Identities=21% Similarity=0.215 Sum_probs=162.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++++|.+++. ....+++.
T Consensus 34 ~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~ 106 (325)
T 3kn6_A 34 KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSET 106 (325)
T ss_dssp TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HCSCCCHH
T ss_pred CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHH----hcCCCCHH
Confidence 46899999999743 3456789999999996 9999999999999999999999999999999984 34569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
.+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++........ ......||..|+|||++.
T Consensus 107 ~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~ 182 (325)
T 3kn6_A 107 EASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCFTLHYAAPELLN 182 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------
T ss_pred HHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccccCCCcCccCHHHhc
Confidence 9999999999999999999 999999999999997665 799999999986654322 234456899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++||||||+++|+|++|..||......................... ... .........+.+++.+||+.
T Consensus 183 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~---~~~~~~s~~~~~li~~~L~~ 257 (325)
T 3kn6_A 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEG---EAWKNVSQEAKDLIQGLLTV 257 (325)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCS---HHHHTSCHHHHHHHHHHHCC
T ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCc---ccccCCCHHHHHHHHHHCCC
Confidence 9999999999999999999999999987543321100001111111111110 000 00012344588899999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
||.+|||+.++++
T Consensus 258 dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 258 DPNKRLKMSGLRY 270 (325)
T ss_dssp CTTTCCCTTTSTT
T ss_pred ChhHCCCHHHHhc
Confidence 9999999998853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=306.92 Aligned_cols=224 Identities=25% Similarity=0.367 Sum_probs=183.5
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++||||++||+|.+++. ....++
T Consensus 39 ~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~l~ 114 (476)
T 2y94_A 39 LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC----KNGRLD 114 (476)
T ss_dssp TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT----SSSSCC
T ss_pred CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH----hcCCCC
Confidence 478999999997542 2335678999999999999999999999999999999999999999999983 455799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+
T Consensus 115 ~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 115 EKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--cccccCCCcCeEChhhccC
Confidence 999999999999999999999 99999999999999999999999999998765432 2334579999999999988
Q ss_pred Ccc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..+ +.++|||||||++|+|++|..||...... .+. ........ ..+......+.+++.+||+.
T Consensus 190 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~----~~i~~~~~---------~~p~~~s~~~~~Li~~~L~~ 253 (476)
T 2y94_A 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLF----KKICDGIF---------YTPQYLNPSVISLLKHMLQV 253 (476)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHH----HHHHTTCC---------CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCCc---------CCCccCCHHHHHHHHHHcCC
Confidence 765 68999999999999999999998654321 111 11111111 01111223578889999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
||.+|||+.++++
T Consensus 254 dP~~Rpt~~eil~ 266 (476)
T 2y94_A 254 DPMKRATIKDIRE 266 (476)
T ss_dssp STTTSCCHHHHHT
T ss_pred CchhCcCHHHHHh
Confidence 9999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=298.74 Aligned_cols=241 Identities=18% Similarity=0.200 Sum_probs=184.1
Q ss_pred CCCEEEEEEccccChH-----------hHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHh
Q 021774 6 NGRRIAVKPLSAESKQ-----------GVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVL 70 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l 70 (307)
++..||||+....... ....+.+|+..++.++||||+++++++.. ....++||||+ +++|.+++
T Consensus 64 ~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 142 (345)
T 2v62_A 64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142 (345)
T ss_dssp GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC
T ss_pred ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHH
Confidence 5788999988765321 11236678899999999999999999988 77889999999 99999998
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC--ceEEeeccCcccCCCCcc------c
Q 021774 71 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF--NPKIGDFGLAKLFPDNIT------H 142 (307)
Q Consensus 71 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~------~ 142 (307)
. ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.+..... .
T Consensus 143 ~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 215 (345)
T 2v62_A 143 G----QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215 (345)
T ss_dssp B----GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCC
T ss_pred H----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhc
Confidence 4 233799999999999999999999999 999999999999998887 999999999987643211 1
Q ss_pred ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCC
Q 021774 143 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEY 222 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (307)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ................. ....
T Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~-- 290 (345)
T 2v62_A 216 PRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--VQTAKTNLLDELPQSVL-KWAP-- 290 (345)
T ss_dssp GGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--HHHHHHHHHHTTTHHHH-HHSC--
T ss_pred cccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--HHHHHHhhcccccHHHH-hhcc--
Confidence 124457899999999999999999999999999999999999998653332221 11111111111111000 0000
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
.......+.+++.+||+.||.+||++.+|++.|++..
T Consensus 291 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 291 SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 0022335888889999999999999999999997643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=322.78 Aligned_cols=231 Identities=26% Similarity=0.387 Sum_probs=183.4
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
+++.||||+++.. .....+.+.+|++++++++||||+++++++.. +..++||||+++|+|.+++. ....+++.
T Consensus 395 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~----~~~~l~~~ 469 (635)
T 4fl3_A 395 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ----QNRHVKDK 469 (635)
T ss_dssp CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH----HCTTCCHH
T ss_pred cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh----hCCCCCHH
Confidence 4678999999864 34456789999999999999999999999864 45789999999999999993 34568999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCCcccccC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~ 161 (307)
.++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+..... .......++..|+|||++.+
T Consensus 470 ~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 470 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546 (635)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC
Confidence 9999999999999999999 999999999999999999999999999987654332 12233456788999999999
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++|||||||++|||++ |+.||....... +. ......... ..+......+.+++.+||+.
T Consensus 547 ~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~~--------~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEKGERM--------GCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTTCCC--------CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC--------CCCCCCCHHHHHHHHHHcCC
Confidence 999999999999999999998 999986543321 11 111111111 11223335588888999999
Q ss_pred ccCCCCCHHHHHHHHHhcc
Q 021774 241 AASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~ 259 (307)
||++||++.+|++.|+++.
T Consensus 612 dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 612 DVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp STTTSCCHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHH
Confidence 9999999999999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=292.34 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=179.7
Q ss_pred ccCCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 3 TLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
...+|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++ +|.+++.. ....+
T Consensus 22 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~ 97 (288)
T 1ob3_A 22 QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGL 97 (288)
T ss_dssp EETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT---STTCC
T ss_pred EcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh---cccCC
Confidence 34578999999987553 23346788999999999999999999999999999999999976 89988843 33568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ ......||..|+|||++.
T Consensus 98 ~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~ 173 (288)
T 1ob3_A 98 ESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLM 173 (288)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccccccccccccCchhee
Confidence 9999999999999999999999 999999999999999999999999999986543221 223456899999999987
Q ss_pred CC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc--------ccccCCCCC--------CCC
Q 021774 161 GG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP--------LELVDPELG--------EYP 223 (307)
Q Consensus 161 ~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--------~~~ 223 (307)
+. .++.++|||||||++|||++|..||...... ............... ....++... ...
T Consensus 174 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
T 1ob3_A 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250 (288)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHh
Confidence 64 5899999999999999999999998654321 111112121111100 000111110 111
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
......+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 251 KGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 223345788999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=305.94 Aligned_cols=231 Identities=21% Similarity=0.156 Sum_probs=181.9
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++... ......+.+|..++.+++||||+++++++.+.+..|+||||++||+|.+++.. .+..++
T Consensus 84 ~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~ 160 (412)
T 2vd5_A 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIP 160 (412)
T ss_dssp TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCC
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh---cCCCCC
Confidence 478999999997532 22334588999999999999999999999999999999999999999999842 234699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++..............||+.|+|||++.
T Consensus 161 ~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~ 237 (412)
T 2vd5_A 161 AEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237 (412)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhh
Confidence 999999999999999999999 9999999999999999999999999999877654443344568999999999987
Q ss_pred ------CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 161 ------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 161 ------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
+..++.++|||||||++|||++|+.||...... .....+......... +.. .......+.+++
T Consensus 238 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~~~-----p~~---~~~~s~~~~dli 306 (412)
T 2vd5_A 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVHYKEHLSL-----PLV---DEGVPEEARDFI 306 (412)
T ss_dssp HHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHCCC-----C-------CCCHHHHHHH
T ss_pred cccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccCcCC-----Ccc---ccCCCHHHHHHH
Confidence 457899999999999999999999998654321 111111111100000 111 112234588899
Q ss_pred HhccccccCCC---CCHHHHHH
Q 021774 235 FFCTQAAASRR---PQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~R---Ps~~~v~~ 253 (307)
.+||. +|.+| |+++++++
T Consensus 307 ~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 307 QRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHcC-ChhhcCCCCCHHHHhc
Confidence 99999 99998 68998865
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=306.31 Aligned_cols=232 Identities=20% Similarity=0.174 Sum_probs=183.4
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++... ......+.+|..++..++||||+++++++.+.+..++||||++||+|.+++.. ....++
T Consensus 97 ~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~ 173 (437)
T 4aw2_A 97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLP 173 (437)
T ss_dssp TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCC
T ss_pred CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCC
Confidence 357899999997532 12223488999999999999999999999999999999999999999999943 245699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..............||+.|+|||++.
T Consensus 174 e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 250 (437)
T 4aw2_A 174 EEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250 (437)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhh
Confidence 999999999999999999999 9999999999999999999999999999877655444445578999999999987
Q ss_pred ----CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 161 ----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 161 ----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
...++.++|||||||++|||++|+.||...... .....+......... + .........+.+++.+
T Consensus 251 ~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~-----p---~~~~~~s~~~~dLi~~ 319 (437)
T 4aw2_A 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKERFQF-----P---TQVTDVSENAKDLIRR 319 (437)
T ss_dssp HHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHCCC-----C---SSCCCSCHHHHHHHHT
T ss_pred cccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhccccccC-----C---cccccCCHHHHHHHHH
Confidence 567899999999999999999999998654321 111111111110000 1 1111123347888999
Q ss_pred ccccccCC--CCCHHHHHH
Q 021774 237 CTQAAASR--RPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~--RPs~~~v~~ 253 (307)
|+..+|++ ||+++++++
T Consensus 320 lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 320 LICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp TSSCGGGCTTTTTTHHHHT
T ss_pred HhcccccccCCCCHHHHhC
Confidence 99888888 999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=301.60 Aligned_cols=251 Identities=22% Similarity=0.223 Sum_probs=194.1
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++... ......+.+|++++++++||||+++++++...+ ..++||||+++|+|.+++.... ....++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~ 110 (396)
T 4eut_A 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLP 110 (396)
T ss_dssp TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCC
T ss_pred CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCC
Confidence 458999999998643 344567889999999999999999999998765 7799999999999999985422 223399
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
+..++.++.|++.||+|||++ ||+||||||+|||+ +.++.+||+|||++....... ......||..|+|||
T Consensus 111 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE 185 (396)
T 4eut_A 111 ESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPD 185 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC--ccccccCCccccCHH
Confidence 999999999999999999999 99999999999999 777889999999998765432 233456899999999
Q ss_pred cccC--------CcccccCceeehHHHHHHHHhCCCCCCccccch-hHHHHHHHHHHhhcCCcccc------------cC
Q 021774 158 YVLG--------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM-NKFLLEWAWQLHQEEKPLEL------------VD 216 (307)
Q Consensus 158 ~~~~--------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~------------~~ 216 (307)
++.+ ..++.++|||||||++|||++|+.||....... .................... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (396)
T 4eut_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (396)
T ss_dssp HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccC
Confidence 8865 567889999999999999999999986543321 22222212111111100000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 217 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
+............+.+++.+||+.||++||++.++++.+.+++..
T Consensus 266 ~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 112334566777888999999999999999999999999888753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=288.33 Aligned_cols=226 Identities=23% Similarity=0.345 Sum_probs=162.2
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ....++
T Consensus 34 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 110 (278)
T 3cok_A 34 HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFS 110 (278)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCC
T ss_pred cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCC
Confidence 578999999987542 22346789999999999999999999999999999999999999999999843 335689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+
T Consensus 111 ~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 111 ENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-cceeccCCCCcCCcchhcC
Confidence 999999999999999999999 999999999999999999999999999987653322 1234568899999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|+.||........ + ... .. .+.. .+......+.+++.+||+.|
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-----~~~---~~---~~~~---~~~~~~~~~~~li~~~l~~d 250 (278)
T 3cok_A 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L-----NKV---VL---ADYE---MPSFLSIEAKDLIHQLLRRN 250 (278)
T ss_dssp -----CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C---CS---SCCC---CCTTSCHHHHHHHHHHSCSS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H-----HHH---hh---cccC---CccccCHHHHHHHHHHcccC
Confidence 8899999999999999999999999865432110 0 000 00 0111 11223345788999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.++++
T Consensus 251 p~~Rps~~~~l~ 262 (278)
T 3cok_A 251 PADRLSLSSVLD 262 (278)
T ss_dssp GGGSCCHHHHTT
T ss_pred HhhCCCHHHHhc
Confidence 999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=298.86 Aligned_cols=230 Identities=24% Similarity=0.380 Sum_probs=180.1
Q ss_pred EEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHH
Q 021774 10 IAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDI 88 (307)
Q Consensus 10 vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i 88 (307)
||+|.+.... ......+.+|+.++++++||||+++++++. ++..++||||+.+|+|.+++.. ....+++..+..+
T Consensus 45 v~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~ 120 (325)
T 3kex_A 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNW 120 (325)
T ss_dssp EEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHH
T ss_pred EEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHH
Confidence 8888776442 233456788999999999999999999886 4568899999999999999843 3456899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCccccc
Q 021774 89 CVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMK 167 (307)
Q Consensus 89 ~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~ 167 (307)
+.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++........ ......|+..|+|||++.+..++.+
T Consensus 121 ~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (325)
T 3kex_A 121 GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ 197 (325)
T ss_dssp HHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChh
Confidence 99999999999999 9999999999999999999999999999987554322 2344567789999999998899999
Q ss_pred CceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCC
Q 021774 168 ADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRP 246 (307)
Q Consensus 168 ~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RP 246 (307)
+||||||+++|||+| |..||........ ... ....... ..+......+.+++.+||+.||.+||
T Consensus 198 ~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rp 262 (325)
T 3kex_A 198 SDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDL----LEKGERL--------AQPQICTIDVYMVMVKCWMIDENIRP 262 (325)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHH----HHTTCBC--------CCCTTBCTTTTHHHHHHTCSCTTTSC
T ss_pred hHhHHhHHHHHHHHhCCCCCccccCHHHH---HHH----HHcCCCC--------CCCCcCcHHHHHHHHHHcCCChhhCc
Confidence 999999999999999 9999876443221 111 1111110 00111222367788899999999999
Q ss_pred CHHHHHHHHHhcccc
Q 021774 247 QMNQVIKMLTKNIRL 261 (307)
Q Consensus 247 s~~~v~~~L~~~~~~ 261 (307)
++.++++.|+.+.+.
T Consensus 263 s~~el~~~l~~~~~~ 277 (325)
T 3kex_A 263 TFKELANEFTRMARD 277 (325)
T ss_dssp CHHHHHHHHHHHTTS
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999988754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=294.60 Aligned_cols=237 Identities=24% Similarity=0.256 Sum_probs=178.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++..........+.+|++++.++ +||||+++++++.+.+..++||||+++++|.+++.. ...+++.
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~ 111 (316)
T 2ac3_A 36 ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNEL 111 (316)
T ss_dssp SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHH
T ss_pred CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHH
Confidence 46899999999876555667899999999985 899999999999999999999999999999999843 3468999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---eEEeeccCcccCCCCcc------cccccccCCCCcC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNIT------HITTRIAGTTGYL 154 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~ 154 (307)
.+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++........ .......||..|+
T Consensus 112 ~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 188 (316)
T 2ac3_A 112 EASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGC
T ss_pred HHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCcc
Confidence 9999999999999999999 9999999999999998776 99999999976532211 1123345899999
Q ss_pred CcccccC-----CcccccCceeehHHHHHHHHhCCCCCCccccchh--------HHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 155 APEYVLG-----GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN--------KFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 155 aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
|||++.+ ..++.++|||||||++|||++|..||........ ................. .......
T Consensus 189 aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~- 266 (316)
T 2ac3_A 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDKDWA- 266 (316)
T ss_dssp CHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCHHHHT-
T ss_pred ChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc-cCchhcc-
Confidence 9999875 5688999999999999999999999875432210 00001111111111110 0000001
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+||+.||.+|||+.++++
T Consensus 267 ---~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 267 ---HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp ---TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 12345788999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=295.36 Aligned_cols=240 Identities=25% Similarity=0.379 Sum_probs=189.9
Q ss_pred cCCCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCCC----
Q 021774 4 LTNGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATKA---- 76 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~---- 76 (307)
..+|+.||||+++... ......+.+|+.+++++ +||||+++++++...+ ..++||||+++++|.+++......
T Consensus 54 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 133 (316)
T 2xir_A 54 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133 (316)
T ss_dssp TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC
T ss_pred cccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccc
Confidence 3567899999998653 44556799999999999 7999999999988765 589999999999999999543321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccc
Q 021774 77 --------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 147 (307)
Q Consensus 77 --------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 147 (307)
...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........ ......
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 210 (316)
T 2xir_A 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210 (316)
T ss_dssp -------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTE
T ss_pred cccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCC
Confidence 12388999999999999999999999 999999999999999999999999999987654322 223445
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHH
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
.|+..|+|||++.+..++.++||||||+++|+|+| |..||....... .+.... ...... ..+...
T Consensus 211 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~----~~~~~~--------~~~~~~ 276 (316)
T 2xir_A 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRL----KEGTRM--------RAPDYT 276 (316)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHHH----HHTCCC--------CCCTTC
T ss_pred CcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHHHh----ccCccC--------CCCCCC
Confidence 67889999999998899999999999999999998 998886543221 111111 111110 011122
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
...+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3457888999999999999999999999998875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=300.36 Aligned_cols=238 Identities=25% Similarity=0.410 Sum_probs=188.1
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--------
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------- 75 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 75 (307)
.+..||+|.+... .......+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 75 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 154 (333)
T 2i1m_A 75 AVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154 (333)
T ss_dssp CCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC---
T ss_pred chhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccc
Confidence 3458999999865 345567899999999999 899999999999999999999999999999999853221
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCC
Q 021774 76 --ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTG 152 (307)
Q Consensus 76 --~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~ 152 (307)
....+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ .......++..
T Consensus 155 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T 2i1m_A 155 AIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231 (333)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGG
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCcc
Confidence 134589999999999999999999999 999999999999999999999999999986543322 12334456778
Q ss_pred cCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 153 YLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 153 y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
|+|||++.+..++.++||||||+++|||+| |..||........ ....... ... ... +......+.
T Consensus 232 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~~~----~~~-----~~~---~~~~~~~l~ 297 (333)
T 2i1m_A 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYKLVKD----GYQ-----MAQ---PAFAPKNIY 297 (333)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHHHHHH----TCC-----CCC---CTTCCHHHH
T ss_pred ccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHHHHhc----CCC-----CCC---CCCCCHHHH
Confidence 999999998899999999999999999999 8888765433221 1111111 110 001 111234578
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+++.+||+.||.+|||+.+|++.|+++..
T Consensus 298 ~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 298 SIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 88999999999999999999999988764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.16 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=182.4
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--CCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK--ANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~ 81 (307)
.+|+.||+|.++... ......+.+|++++++++||||+++++++...+..++||||++ ++|.+++..... ....++
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~ 106 (317)
T 2pmi_A 28 TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLE 106 (317)
T ss_dssp SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCC
T ss_pred CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCC
Confidence 468999999987553 2334678899999999999999999999999999999999997 599988744322 224589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++........ ......||..|+|||++.+
T Consensus 107 ~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 107 LNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-cCCCCcccccccCchHhhC
Confidence 999999999999999999999 999999999999999999999999999987643322 2334568999999999876
Q ss_pred -CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc---c-----cccCCCCC----C-------
Q 021774 162 -GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---L-----ELVDPELG----E------- 221 (307)
Q Consensus 162 -~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~----~------- 221 (307)
..++.++|||||||++|||++|+.||....... .............. . ....+... .
T Consensus 183 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (317)
T 2pmi_A 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ 259 (317)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHG
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhc
Confidence 468999999999999999999999986543321 12222221111000 0 00000000 0
Q ss_pred --CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 --YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 --~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
........+.+++.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 260 PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00112345888999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=297.75 Aligned_cols=229 Identities=21% Similarity=0.247 Sum_probs=170.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||++..... ....+.+|+.++++++||||+++++++...+..++||||+++|+|.+++. ....+++..
T Consensus 43 ~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~ 117 (361)
T 3uc3_A 43 LTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC----NAGRFSEDE 117 (361)
T ss_dssp TTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCHHH
T ss_pred CCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH----hcCCCCHHH
Confidence 4688999999975432 22568899999999999999999999999999999999999999999983 334699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--eEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.|++.||+|||++ ||+||||||+||+++.++. +||+|||+++..... .......||+.|+|||++.+.
T Consensus 118 ~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 192 (361)
T 3uc3_A 118 ARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQ 192 (361)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCCCCCcCCCCcCChhhhcCC
Confidence 999999999999999999 9999999999999987765 999999999743322 123445689999999999887
Q ss_pred ccccc-CceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMK-ADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~-~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.+ +|||||||++|+|++|+.||........ ............... +.... ....+.+++.+||+.|
T Consensus 193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~----~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKYSI----PDDIR----ISPECCHLISRIFVAD 262 (361)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCCCC----CTTSC----CCHHHHHHHHHHSCSC
T ss_pred CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCCCC----CCcCC----CCHHHHHHHHHHccCC
Confidence 77655 8999999999999999999875433211 111111111111000 00011 2235788999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.++++
T Consensus 263 P~~Rps~~ell~ 274 (361)
T 3uc3_A 263 PATRISIPEIKT 274 (361)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhHCcCHHHHHh
Confidence 999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=286.38 Aligned_cols=228 Identities=23% Similarity=0.298 Sum_probs=183.0
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++++|.+.+. ....+++
T Consensus 29 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~----~~~~~~~ 104 (284)
T 3kk8_A 29 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSE 104 (284)
T ss_dssp TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCH
T ss_pred CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH----hcCCCCH
Confidence 46899999998754 34556778999999999999999999999999999999999999999988873 3356899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---eEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
..+..++.|++.||.|||++ |++||||||+||+++.++. +||+|||++........ .....|+..|+|||++
T Consensus 105 ~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~ 179 (284)
T 3kk8_A 105 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVL 179 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhh
Confidence 99999999999999999999 9999999999999987665 99999999987654322 2345689999999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+..++.++||||||+++|+|++|..||...... ...... ...... ...+..... ...+.+++.+||+
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~---~~~~~~--~~~~~~~~~----~~~~~~li~~~l~ 247 (284)
T 3kk8_A 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQI---KAGAYD--YPSPEWDTV----TPEAKSLIDSMLT 247 (284)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCCC--CCTTTTTTS----CHHHHHHHHHHSC
T ss_pred cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHH---Hhcccc--CCchhhccc----CHHHHHHHHHHcc
Confidence 9999999999999999999999999998654321 111111 111110 011111122 2347888999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||++|||+.++++
T Consensus 248 ~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 248 VNPKKRITADQALK 261 (284)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.44 Aligned_cols=225 Identities=23% Similarity=0.289 Sum_probs=172.7
Q ss_pred CCCCEEEEEEccccC----hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||++|++|.+++. ....+
T Consensus 43 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~ 118 (327)
T 3a62_A 43 NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE----REGIF 118 (327)
T ss_dssp TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH----HHSSC
T ss_pred CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH----hCCCC
Confidence 578999999998642 2344568899999999999999999999999999999999999999999983 33468
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....... .......||..|+|||++.
T Consensus 119 ~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 194 (327)
T 3a62_A 119 MEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILM 194 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCc
Confidence 9999999999999999999999 99999999999999999999999999997543322 1234457899999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++||||||+++|||++|..||...... .....+ ..... ..++.....+.+++.+||+.
T Consensus 195 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~~~~~----------~~p~~~~~~~~~li~~~L~~ 258 (327)
T 3a62_A 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKI---LKCKL----------NLPPYLTQEARDLLKKLLKR 258 (327)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH---HHTCC----------CCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HhCCC----------CCCCCCCHHHHHHHHHHHhc
Confidence 989999999999999999999999998654321 111111 11110 11122234578889999999
Q ss_pred ccCCCC-----CHHHHHH
Q 021774 241 AASRRP-----QMNQVIK 253 (307)
Q Consensus 241 ~p~~RP-----s~~~v~~ 253 (307)
||.+|| ++.++++
T Consensus 259 dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 259 NAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CGGGSTTSSTTTHHHHHH
T ss_pred CHhhccCCCCCCHHHHHc
Confidence 999999 6777765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=306.48 Aligned_cols=230 Identities=18% Similarity=0.185 Sum_probs=182.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||++||+|.+++.. ..++
T Consensus 92 ~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~ 166 (410)
T 3v8s_A 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVP 166 (410)
T ss_dssp TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCC
T ss_pred CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCC
Confidence 468899999987531 12234578999999999999999999999999999999999999999999842 3589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++..............||+.|+|||++.+
T Consensus 167 e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 167 EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhc
Confidence 999999999999999999999 99999999999999999999999999998776554444456789999999999976
Q ss_pred Cc----ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 162 GQ----LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 162 ~~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
.. ++.++|||||||++|||++|+.||...... .....+........ -+.... ....+.+++.+|
T Consensus 244 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~-----~p~~~~----~s~~~~~li~~l 311 (410)
T 3v8s_A 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKNSLT-----FPDDND----ISKEAKNLICAF 311 (410)
T ss_dssp TTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHHHCC-----CCTTCC----CCHHHHHHHHHH
T ss_pred cCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhcccccc-----CCCccc----ccHHHHHHHHHH
Confidence 54 889999999999999999999998654321 11111111110000 011111 223478888999
Q ss_pred cccccCC--CCCHHHHHHH
Q 021774 238 TQAAASR--RPQMNQVIKM 254 (307)
Q Consensus 238 ~~~~p~~--RPs~~~v~~~ 254 (307)
|..+|.+ ||++++|++.
T Consensus 312 L~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 312 LTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp SSCGGGCTTSSCHHHHHTS
T ss_pred ccChhhhCCCCCHHHHhcC
Confidence 9999988 9999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=293.24 Aligned_cols=241 Identities=23% Similarity=0.313 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|..++. ....+++
T Consensus 26 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~ 101 (311)
T 4agu_A 26 DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR----YQRGVPE 101 (311)
T ss_dssp TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH----TSSCCCH
T ss_pred CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh----hhcCCCH
Confidence 458999999886543 3445678899999999999999999999999999999999999999999873 3456899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG- 161 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 161 (307)
..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+
T Consensus 102 ~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 177 (311)
T 4agu_A 102 HLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGD 177 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcC
Confidence 99999999999999999999 999999999999999999999999999987654322 2334568899999999876
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHH--------HHHhhcCCcc---cccCCCCC----CCCHHH
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWA--------WQLHQEEKPL---ELVDPELG----EYPPNE 226 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~~----~~~~~~ 226 (307)
..++.++||||||+++|+|++|..||............... .......... ...++... ...+..
T Consensus 178 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 4agu_A 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI 257 (311)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccc
Confidence 57899999999999999999999998665432221111100 0000000000 00000000 000123
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.+++.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 258 SYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 345788999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=293.46 Aligned_cols=237 Identities=26% Similarity=0.381 Sum_probs=185.0
Q ss_pred CCCE--EEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC-------
Q 021774 6 NGRR--IAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------- 74 (307)
Q Consensus 6 ~g~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------- 74 (307)
+|.. ||+|.++.. .......+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++....
T Consensus 49 ~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 128 (327)
T 1fvr_A 49 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128 (327)
T ss_dssp TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHH
T ss_pred CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccc
Confidence 4554 499988754 344456789999999999 99999999999999999999999999999999995432
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccC
Q 021774 75 -----KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAG 149 (307)
Q Consensus 75 -----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g 149 (307)
.....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...... .......+
T Consensus 129 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~ 203 (327)
T 1fvr_A 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRL 203 (327)
T ss_dssp HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE--CCC----C
T ss_pred ccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCcccccc--ccccCCCC
Confidence 2234689999999999999999999999 9999999999999999999999999999743221 11233456
Q ss_pred CCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 150 TTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 150 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
+..|+|||++.+..++.++||||||+++|||+| |..||....... + ......... . ..+.....
T Consensus 204 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~----~~~~~~~~~-----~---~~~~~~~~ 268 (327)
T 1fvr_A 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----YEKLPQGYR-----L---EKPLNCDD 268 (327)
T ss_dssp CTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHGGGTCC-----C---CCCTTBCH
T ss_pred CccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---H----HHHhhcCCC-----C---CCCCCCCH
Confidence 788999999998899999999999999999998 999986543211 1 111111111 0 11222334
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+.+++.+||+.||.+|||+.++++.|.+++...
T Consensus 269 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 269 EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 5888999999999999999999999999888644
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.66 Aligned_cols=232 Identities=25% Similarity=0.383 Sum_probs=181.7
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEE-eCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
.||+|.++.. .......+.+|+.++++++||||+++++++. .++..++||||+++++|.+++. .....+++..++
T Consensus 55 ~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~ 131 (298)
T 3f66_A 55 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLI 131 (298)
T ss_dssp EEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHH---CTTCCCCHHHHH
T ss_pred EEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHH---hcccCCCHHHHH
Confidence 5899988764 4455678999999999999999999999865 4557899999999999999994 234568999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCcCCcccccCCc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..
T Consensus 132 ~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (298)
T 3f66_A 132 GFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208 (298)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC
Confidence 9999999999999999 9999999999999999999999999999876543221 223345677899999999889
Q ss_pred ccccCceeehHHHHHHHHhCC-CCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
++.++||||||+++|+|++|. +|+....... ... .... .... ..+......+.+++.+||+.||
T Consensus 209 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~---~~~~-~~~~--------~~~~~~~~~l~~li~~~l~~~p 273 (298)
T 3f66_A 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---YLLQ-GRRL--------LQPEYCPDPLYEVMLKCWHPKA 273 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH---HHHT-TCCC--------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HHhc-CCCC--------CCCccCCHHHHHHHHHHcCCCh
Confidence 999999999999999999954 4444332211 111 1111 1110 0011122458888999999999
Q ss_pred CCCCCHHHHHHHHHhcccc
Q 021774 243 SRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 243 ~~RPs~~~v~~~L~~~~~~ 261 (307)
.+|||+.++++.|++++..
T Consensus 274 ~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 274 EMRPSFSELVSRISAIFST 292 (298)
T ss_dssp GGSCCHHHHHHHHHHHHHT
T ss_pred hhCcCHHHHHHHHHHHHHh
Confidence 9999999999999988763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.24 Aligned_cols=230 Identities=24% Similarity=0.353 Sum_probs=178.0
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++......+..+++.
T Consensus 45 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 124 (285)
T 3is5_A 45 SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124 (285)
T ss_dssp TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHH
T ss_pred cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHH
Confidence 468899999987653 3445788999999999999999999999999999999999999999999885544445679999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
.+..++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||++....... ......|+..|+|||++.
T Consensus 125 ~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~ 199 (285)
T 3is5_A 125 YVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK 199 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhc
Confidence 9999999999999999999 99999999999999 456789999999998664432 234456899999999875
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++||||||+++|||++|+.||....... ... .......... ...... ...+.+++.+||+.
T Consensus 200 -~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~---~~~~~~~~~~---~~~~~~----~~~~~~li~~~L~~ 265 (285)
T 3is5_A 200 -RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQ---KATYKEPNYA---VECRPL----TPQAVDLLKQMLTK 265 (285)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCCCCC---C--CCC----CHHHHHHHHHHTCS
T ss_pred -cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHh---hhccCCcccc---cccCcC----CHHHHHHHHHHccC
Confidence 568899999999999999999999986543211 111 1111111110 011112 23477889999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
||.+|||+.++++
T Consensus 266 dP~~Rps~~e~l~ 278 (285)
T 3is5_A 266 DPERRPSAAQVLH 278 (285)
T ss_dssp CTTTSCCHHHHHT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=310.08 Aligned_cols=225 Identities=27% Similarity=0.308 Sum_probs=173.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++.. .......+.+|++++++++||||+++++++...+..++||||+++|+|.+++. ....++
T Consensus 171 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~ 246 (446)
T 4ejn_A 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS----RERVFS 246 (446)
T ss_dssp TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH----HHSCCC
T ss_pred CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH----hcCCCC
Confidence 56899999999754 33445678899999999999999999999999999999999999999999883 345689
Q ss_pred HHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
+..+..++.||+.||+|||+ + ||+||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 247 ~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 322 (446)
T 4ejn_A 247 EDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLE 322 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-cccccccCCccccCHhhcC
Confidence 99999999999999999998 8 99999999999999999999999999998643322 2234567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|+.||...... .+...+ ..... .++......+.+++.+||+.
T Consensus 323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~~~~~----------~~p~~~~~~~~~li~~~L~~ 386 (446)
T 4ejn_A 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LMEEI----------RFPRTLGPEAKSLLSGLLKK 386 (446)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHCCC----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHH---HhCCC----------CCCccCCHHHHHHHHHHccc
Confidence 999999999999999999999999998654321 111111 11111 11122234578899999999
Q ss_pred ccCCCC-----CHHHHHH
Q 021774 241 AASRRP-----QMNQVIK 253 (307)
Q Consensus 241 ~p~~RP-----s~~~v~~ 253 (307)
||.+|| ++.++++
T Consensus 387 dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 387 DPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp STTTSTTCSTTTHHHHHT
T ss_pred CHHHhCCCCCCCHHHHHh
Confidence 999999 9999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=296.25 Aligned_cols=239 Identities=25% Similarity=0.321 Sum_probs=185.5
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhc--CCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSN--VRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
+|+.||||++... ....+.+|++++.. ++||||+++++++.... ..++||||+++|+|.+++.. ..
T Consensus 64 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~ 135 (342)
T 1b6c_B 64 RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YT 135 (342)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CC
T ss_pred cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cC
Confidence 5889999999743 33567888998887 79999999999998876 78999999999999999842 35
Q ss_pred CCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---cccccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLH--------EELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIA 148 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~ 148 (307)
+++..++.++.|++.||+||| ++ +++||||||+||+++.++.+||+|||++......... ......
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (342)
T 1b6c_B 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212 (342)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCC
Confidence 899999999999999999999 88 9999999999999999999999999999866443222 234457
Q ss_pred CCCCcCCcccccCC------cccccCceeehHHHHHHHHhC----------CCCCCccccchhHHHHHHHHHHhhcCCcc
Q 021774 149 GTTGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISG----------RNSGKAMWGQMNKFLLEWAWQLHQEEKPL 212 (307)
Q Consensus 149 g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (307)
|+..|+|||++.+. .++.++||||||+++|||+|| ..||......... ...+. .......
T Consensus 213 gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~-~~~~~~~-- 288 (342)
T 1b6c_B 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMR-KVVCEQK-- 288 (342)
T ss_dssp CCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHH-HHHTTSC--
T ss_pred cCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc-HHHHH-HHHHHHH--
Confidence 89999999998775 445789999999999999999 5666544322110 11111 1111111
Q ss_pred cccCCCCCC--CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 213 ELVDPELGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 213 ~~~~~~~~~--~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
..+.+.. ........+.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus 289 --~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 289 --LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp --CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 1111111 1235667789999999999999999999999999988753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=298.15 Aligned_cols=234 Identities=23% Similarity=0.206 Sum_probs=177.9
Q ss_pred CCCCEEEEEEcccc-----ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC---
Q 021774 5 TNGRRIAVKPLSAE-----SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA--- 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--- 76 (307)
.+|+.||+|++... +....+.+.+|++++++++||||+++++++.+.+..++||||++||+|.+++......
T Consensus 49 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~ 128 (345)
T 3hko_A 49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128 (345)
T ss_dssp TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTT
T ss_pred CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccc
Confidence 56889999988643 2345578999999999999999999999999999999999999999999998421111
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC
Q 021774 77 ---------------------------------NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123 (307)
Q Consensus 77 ---------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~ 123 (307)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~ 205 (345)
T 3hko_A 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205 (345)
T ss_dssp EEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCC
Confidence 22346778889999999999999999 999999999999998776
Q ss_pred --ceEEeeccCcccCCCCc---ccccccccCCCCcCCcccccC--CcccccCceeehHHHHHHHHhCCCCCCccccchhH
Q 021774 124 --NPKIGDFGLAKLFPDNI---THITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK 196 (307)
Q Consensus 124 --~~kl~dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~ 196 (307)
.+||+|||++..+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 206 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-- 283 (345)
T 3hko_A 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-- 283 (345)
T ss_dssp SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--
Confidence 89999999998653321 112345678999999999875 678899999999999999999999986543221
Q ss_pred HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 197 FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
. ............ .+. .......+.+++.+||+.||.+||++.++++
T Consensus 284 -~---~~~~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 284 -T---ISQVLNKKLCFE--NPN----YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp -H---HHHHHHCCCCTT--SGG----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred -H---HHHHHhcccccC--Ccc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 111111111100 011 1112345888999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=296.25 Aligned_cols=224 Identities=29% Similarity=0.447 Sum_probs=179.4
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .......+.+|++++++++||||+++++++...+..++||||+. |+|.+++.. ....++
T Consensus 77 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~ 152 (348)
T 1u5q_A 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQ 152 (348)
T ss_dssp TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCC
T ss_pred cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCC
Confidence 57899999998754 23445678999999999999999999999999999999999997 578877732 235689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
+..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..... .....||+.|+|||++.
T Consensus 153 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~~~~gt~~y~aPE~~~~ 224 (348)
T 1u5q_A 153 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILA 224 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CCcccCCcceeCHhhhcc
Confidence 999999999999999999999 999999999999999999999999999986543 23457899999999884
Q ss_pred --CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 --GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 --~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+..++.++|||||||++|||++|+.||....... ............ . ........+.+++.+||
T Consensus 225 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~~~------~--~~~~~~~~l~~li~~~l 290 (348)
T 1u5q_A 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESPA------L--QSGHWSEYFRNFVDSCL 290 (348)
T ss_dssp TSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCCC------C--CCTTSCHHHHHHHHHHT
T ss_pred ccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCCC------C--CCCCCCHHHHHHHHHHc
Confidence 5678999999999999999999999986543211 111112211110 0 01112234778889999
Q ss_pred ccccCCCCCHHHHHHH
Q 021774 239 QAAASRRPQMNQVIKM 254 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~ 254 (307)
+.||.+|||+.++++.
T Consensus 291 ~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 291 QKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CSSGGGSCCHHHHTTC
T ss_pred ccChhhCcCHHHHhhC
Confidence 9999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.91 Aligned_cols=241 Identities=19% Similarity=0.278 Sum_probs=189.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++...... ..+..|+++++.++| +++..+..++...+..++||||+ +++|.+++.. ....+++.
T Consensus 30 ~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~ 103 (483)
T 3sv0_A 30 QTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLK 103 (483)
T ss_dssp TTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHH
T ss_pred CCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHH
Confidence 56899999988754322 357889999999976 56677777778888999999999 9999999842 34569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCceEEeeccCcccCCCCccc------ccccccCCCCcC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITH------ITTRIAGTTGYL 154 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~ 154 (307)
.++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++.+...... ......||..|+
T Consensus 104 ~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 180 (483)
T 3sv0_A 104 TVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180 (483)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCcccc
Confidence 9999999999999999999 99999999999999 58899999999999876543221 123567999999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++|||||||++|||++|+.||............................ ..+ ...+.+++
T Consensus 181 aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~----~~~----p~~l~~li 252 (483)
T 3sv0_A 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC----RGY----PTEFASYF 252 (483)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH----TTS----CHHHHHHH
T ss_pred CHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh----cCC----cHHHHHHH
Confidence 9999999999999999999999999999999998765543333332222222111111110 111 23578888
Q ss_pred HhccccccCCCCCHHHHHHHHHhccccC
Q 021774 235 FFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
..||+.+|++||++.+|++.|++++...
T Consensus 253 ~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 253 HYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 9999999999999999999999887543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=308.16 Aligned_cols=227 Identities=25% Similarity=0.343 Sum_probs=184.3
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++.... ......+..|++++++++||||+++++++...+..|+||||++||+|.+++.........++
T Consensus 208 ~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~ 287 (543)
T 3c4z_A 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287 (543)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCC
T ss_pred CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhccccccc
Confidence 468999999997542 23456788999999999999999999999999999999999999999999865544456799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++........ ......||+.|+|||++.+
T Consensus 288 e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 288 EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-ccccccCCccccChhhhcC
Confidence 999999999999999999999 999999999999999999999999999987654322 2334579999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchh-HHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN-KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++|||||||++|||++|+.||........ ..+.. ...... . .++......+.+++.+||+.
T Consensus 364 ~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~~~-~---------~~p~~~s~~~~~li~~lL~~ 430 (543)
T 3c4z_A 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLEQA-V---------TYPDKFSPASKDFCEALLQK 430 (543)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHHCC-C---------CCCTTSCHHHHHHHHHHSCS
T ss_pred CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhhcc-c---------CCCcccCHHHHHHHHHhccC
Confidence 9999999999999999999999999876432211 11111 111111 0 11222334578889999999
Q ss_pred ccCCCCCH
Q 021774 241 AASRRPQM 248 (307)
Q Consensus 241 ~p~~RPs~ 248 (307)
||.+||++
T Consensus 431 dP~~R~~~ 438 (543)
T 3c4z_A 431 DPEKRLGF 438 (543)
T ss_dssp SGGGSCCC
T ss_pred CHhHCCCC
Confidence 99999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=293.58 Aligned_cols=230 Identities=21% Similarity=0.251 Sum_probs=179.6
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|+++... ......+.+|+.+++++ +||||+++++++...+..++||||+++++|.+++.. .....++
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~ 129 (327)
T 3lm5_A 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVS 129 (327)
T ss_dssp TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCC
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCC
Confidence 468999999987642 33457789999999999 579999999999999999999999999999998832 2345699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
+..++.++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||++....... ......|++.|+|||+
T Consensus 130 ~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~ 204 (327)
T 3lm5_A 130 ENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEI 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCee
Confidence 999999999999999999999 9999999999999988 7899999999998765432 2234578999999999
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+.+..++.++||||||+++|+|++|..||....... ....... .. .. ... .........+.+++.+||
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~-~~-~~---~~~----~~~~~~~~~~~~li~~~L 272 (327)
T 3lm5_A 205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYLNISQ-VN-VD---YSE----ETFSSVSQLATDFIQSLL 272 (327)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH-TC-CC---CCT----TTTTTSCHHHHHHHHHHS
T ss_pred ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHh-cc-cc---cCc----hhhcccCHHHHHHHHHHc
Confidence 999999999999999999999999999986543211 1111111 00 00 001 111223345788899999
Q ss_pred ccccCCCCCHHHHHH
Q 021774 239 QAAASRRPQMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~ 253 (307)
+.||.+|||+.++++
T Consensus 273 ~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 273 VKNPEKRPTAEICLS 287 (327)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred CCChhhCcCHHHHhC
Confidence 999999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=291.19 Aligned_cols=228 Identities=25% Similarity=0.281 Sum_probs=183.1
Q ss_pred CCCCEEEEEEccccCh------HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.++.... .....+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~ 110 (321)
T 2a2a_A 35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKE 110 (321)
T ss_dssp TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCS
T ss_pred CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH----hcC
Confidence 4689999999876421 135679999999999999999999999999999999999999999999984 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----ceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.+++..+..++.|++.||+|||++ |++||||||+||+++.++ .++|+|||++....... ......|+..|+
T Consensus 111 ~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~ 185 (321)
T 2a2a_A 111 SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFV 185 (321)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC--CCCCCCSCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc--cccccCCCCCcc
Confidence 689999999999999999999999 999999999999999888 79999999998765432 223456899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++||||||+++|+|++|..||...... .... . ...... ..++.. .......+.+++
T Consensus 186 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~---~-i~~~~~--~~~~~~---~~~~~~~~~~li 253 (321)
T 2a2a_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA---N-ITSVSY--DFDEEF---FSHTSELAKDFI 253 (321)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHTTCC--CCCHHH---HTTCCHHHHHHH
T ss_pred CcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHH---H-HHhccc--ccChhh---hcccCHHHHHHH
Confidence 999999999999999999999999999999998654321 1111 1 111110 000000 011223578899
Q ss_pred HhccccccCCCCCHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~ 253 (307)
.+||+.||.+|||+.++++
T Consensus 254 ~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 254 RKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HTTSCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=299.13 Aligned_cols=224 Identities=26% Similarity=0.339 Sum_probs=180.8
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||+++... ......+..|.+++..+ +||||+++++++.+.+..++||||++||+|.+++. ....+
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~ 115 (345)
T 1xjd_A 40 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKF 115 (345)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSC
T ss_pred CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH----HcCCC
Confidence 468899999997542 23456678899999876 99999999999999999999999999999999984 33568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 116 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 191 (345)
T 1xjd_A 116 DLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILL 191 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhc
Confidence 9999999999999999999999 99999999999999999999999999998543221 2244567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||..... ..+...+ ... . +. ++......+.+++.+||+.
T Consensus 192 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i---~~~-~------~~---~p~~~s~~~~~li~~lL~~ 255 (345)
T 1xjd_A 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSI---RMD-N------PF---YPRWLEKEAKDLLVKLFVR 255 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHC-C------CC---CCTTSCHHHHHHHHHHSCS
T ss_pred CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH---HhC-C------CC---CCcccCHHHHHHHHHHhcC
Confidence 99999999999999999999999999865332 1111111 111 1 11 1112234578889999999
Q ss_pred ccCCCCCHH-HHH
Q 021774 241 AASRRPQMN-QVI 252 (307)
Q Consensus 241 ~p~~RPs~~-~v~ 252 (307)
||.+||++. +++
T Consensus 256 dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 256 EPEKRLGVRGDIR 268 (345)
T ss_dssp SGGGSBTTBSCGG
T ss_pred CHhHcCCChHHHH
Confidence 999999997 554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=285.82 Aligned_cols=227 Identities=20% Similarity=0.243 Sum_probs=182.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++. ....+++..
T Consensus 32 ~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 107 (277)
T 3f3z_A 32 GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESD 107 (277)
T ss_dssp TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHCSCCHHH
T ss_pred CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH----HcCCCCHHH
Confidence 3577899999987655556789999999999999999999999999999999999999999999883 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.|++.||.|||++ |++||||||+||++ +.++.++|+|||++....... ......|+..|+|||++.+
T Consensus 108 ~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 108 AARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhcc
Confidence 999999999999999999 99999999999999 788899999999998765432 2334568999999998865
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
. ++.++||||||+++|+|++|..||....... ... ........... .... .....+.+++.+||+.|
T Consensus 183 ~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~~~~~~~~~--~~~~----~~~~~~~~li~~~l~~d 249 (277)
T 3f3z_A 183 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VML---KIREGTFTFPE--KDWL----NVSPQAESLIRRLLTKS 249 (277)
T ss_dssp C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCCCCCH--HHHT----TSCHHHHHHHHHHTCSS
T ss_pred c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhCCCCCCc--hhhh----cCCHHHHHHHHHHccCC
Confidence 4 8999999999999999999999986543211 111 11111110000 0000 12345788999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.++++
T Consensus 250 p~~R~s~~~~l~ 261 (277)
T 3f3z_A 250 PKQRITSLQALE 261 (277)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=292.85 Aligned_cols=225 Identities=21% Similarity=0.305 Sum_probs=183.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ....++
T Consensus 64 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~l~ 139 (335)
T 2owb_A 64 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALT 139 (335)
T ss_dssp TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH----HHCSCC
T ss_pred CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh----ccCCCC
Confidence 45789999998754 34556788999999999999999999999999999999999999999999883 335689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+
T Consensus 140 ~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 140 EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-cccccCCCccccCHHHhcc
Confidence 999999999999999999999 999999999999999999999999999987653322 2334568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..||....... .. ........ .+ +......+.+++.+||+.|
T Consensus 216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~~~-------~~---~~~~~~~~~~li~~~l~~d 279 (335)
T 2owb_A 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY---LRIKKNEY-------SI---PKHINPVAASLIQKMLQTD 279 (335)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHTCC-------CC---CTTSCHHHHHHHHHHTCSS
T ss_pred CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHhcCCC-------CC---CccCCHHHHHHHHHHccCC
Confidence 889999999999999999999999986543211 11 11111111 01 1122235778899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+||++.++++
T Consensus 280 p~~Rps~~ell~ 291 (335)
T 2owb_A 280 PTARPTINELLN 291 (335)
T ss_dssp GGGSCCGGGGGG
T ss_pred hhHCcCHHHHhc
Confidence 999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=289.98 Aligned_cols=233 Identities=24% Similarity=0.346 Sum_probs=184.4
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++||||+++++|.+++.........+
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 108 (279)
T 2w5a_A 29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108 (279)
T ss_dssp TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCC
T ss_pred CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCC
Confidence 46899999999754 34556789999999999999999999998864 568899999999999999986544445569
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCC-----eeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPH-----IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++........ ......|+..|+|
T Consensus 109 ~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~a 184 (279)
T 2w5a_A 109 DEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMS 184 (279)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc-cccccCCCccccC
Confidence 9999999999999999999999 8 99999999999999999999999999987654321 2234568999999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+..++.++||||||+++|+|++|..||..... ..+.... ...... ..+......+.+++.
T Consensus 185 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i----~~~~~~--------~~~~~~~~~l~~li~ 249 (279)
T 2w5a_A 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI----REGKFR--------RIPYRYSDELNEIIT 249 (279)
T ss_dssp HHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCCC--------CCCTTSCHHHHHHHH
T ss_pred hHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHH----hhcccc--------cCCcccCHHHHHHHH
Confidence 9999998999999999999999999999999865432 1111111 111110 111223345888999
Q ss_pred hccccccCCCCCHHHHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIKMLT 256 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~ 256 (307)
+||+.||.+||++.+|++.+.
T Consensus 250 ~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 250 RMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHTCSSGGGSCCHHHHHTSTT
T ss_pred HHcCCCcccCCCHHHHHhChh
Confidence 999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=296.10 Aligned_cols=220 Identities=22% Similarity=0.289 Sum_probs=180.3
Q ss_pred cCCCCEEEEEEccccCh--------HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCC-CHHHHhccCC
Q 021774 4 LTNGRRIAVKPLSAESK--------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN-SLDRVLLGAT 74 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~ 74 (307)
..+|+.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++||||+.+| +|.+++.
T Consensus 46 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~--- 122 (335)
T 3dls_A 46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--- 122 (335)
T ss_dssp TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH---
T ss_pred CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH---
Confidence 35688999999875421 12345778999999999999999999999999999999999766 9999983
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++........ .....||..|+
T Consensus 123 -~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~ 196 (335)
T 3dls_A 123 -RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYC 196 (335)
T ss_dssp -TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC--BCEECSCGGGC
T ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc--eeccCCCcccc
Confidence 445699999999999999999999999 999999999999999999999999999987654322 33467899999
Q ss_pred CcccccCCcc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
|||++.+..+ +.++||||||+++|+|++|..||....... . ... ..+......+.++
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~-----~~~-----~~~~~~~~~l~~l 254 (335)
T 3dls_A 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------E-----AAI-----HPPYLVSKELMSL 254 (335)
T ss_dssp CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------T-----TCC-----CCSSCCCHHHHHH
T ss_pred ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------h-----hcc-----CCCcccCHHHHHH
Confidence 9999988776 789999999999999999999986532110 0 000 0111123457888
Q ss_pred HHhccccccCCCCCHHHHHHH
Q 021774 234 AFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~ 254 (307)
+.+||+.||++|||+.++++.
T Consensus 255 i~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.03 Aligned_cols=243 Identities=25% Similarity=0.353 Sum_probs=180.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcC--CCCCccceeeEEEeC----CeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV--RHPNLVELIGCCVQG----TRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
+|+.||||++.... ...+..|.+++..+ +||||+++++++... ...++||||+++|+|.+++.. ..
T Consensus 59 ~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~ 130 (337)
T 3mdy_A 59 RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TT 130 (337)
T ss_dssp TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CC
T ss_pred CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cC
Confidence 47899999987433 24455666666655 999999999999987 788999999999999999832 35
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc---cccccCCC
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEEL-----VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI---TTRIAGTT 151 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g~~ 151 (307)
+++..++.++.|++.||+|||++. .+||+||||||+||+++.++.+||+|||++..+....... .....||.
T Consensus 131 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 210 (337)
T 3mdy_A 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210 (337)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCc
Confidence 899999999999999999999751 2389999999999999999999999999998765432221 23457899
Q ss_pred CcCCcccccCCccccc------CceeehHHHHHHHHhC----------CCCCCccccchhHHHHHHHHHHhhcCCccccc
Q 021774 152 GYLAPEYVLGGQLTMK------ADVYSFGVLVLEIISG----------RNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV 215 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~------~Dv~slG~~l~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (307)
.|+|||++.+...... +|||||||++|||+|| ..||.......... .. ......... .
T Consensus 211 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~-~~-~~~~~~~~~----~ 284 (337)
T 3mdy_A 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY-ED-MREIVCIKK----L 284 (337)
T ss_dssp GGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HH-HHHHHTTSC----C
T ss_pred ceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch-hh-hHHHHhhhc----c
Confidence 9999999987665554 9999999999999999 55554433222111 00 111111111 1
Q ss_pred CCCCCC--CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 216 DPELGE--YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 216 ~~~~~~--~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+.... ........+.+++.+||+.||.+|||+.+|++.|+.+.+..
T Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 285 RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 111111 11256677999999999999999999999999999887644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=285.92 Aligned_cols=224 Identities=27% Similarity=0.375 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|..||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ....++
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~----~~~~~~ 107 (279)
T 3fdn_A 32 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFD 107 (279)
T ss_dssp TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HHSSCC
T ss_pred cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH----hcCCCC
Confidence 457789999986542 2334678899999999999999999999999999999999999999999983 334689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||++...... ......|+..|+|||++.+
T Consensus 108 ~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 108 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc---cccccCCCCCccCHhHhcc
Confidence 999999999999999999999 9999999999999999999999999988654332 2234568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..||....... ... ...... . ..+......+.+++.+||+.|
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~~~-------~---~~~~~~~~~~~~li~~~l~~~ 245 (279)
T 3fdn_A 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK---RISRVE-------F---TFPDFVTEGARDLISRLLKHN 245 (279)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHHTC-------C---CCCTTSCHHHHHHHHHHCCSS
T ss_pred CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHH---HHHhCC-------C---CCCCcCCHHHHHHHHHHhccC
Confidence 999999999999999999999999986543211 111 111111 0 111222345778899999999
Q ss_pred cCCCCCHHHHHHH
Q 021774 242 ASRRPQMNQVIKM 254 (307)
Q Consensus 242 p~~RPs~~~v~~~ 254 (307)
|.+|||+.++++.
T Consensus 246 p~~Rps~~e~l~h 258 (279)
T 3fdn_A 246 PSQRPMLREVLEH 258 (279)
T ss_dssp GGGSCCHHHHHHC
T ss_pred hhhCCCHHHHhhC
Confidence 9999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.02 Aligned_cols=228 Identities=23% Similarity=0.275 Sum_probs=178.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++..... .+.+|++++.++ +||||+++++++.+.+..++||||++||+|.+++. ....+++.
T Consensus 45 ~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~ 116 (342)
T 2qr7_A 45 ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSER 116 (342)
T ss_dssp TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCTTCCHH
T ss_pred CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH----HcCCCCHH
Confidence 4688999999975432 245688888888 89999999999999999999999999999999883 34569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC----CceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE----FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
.+..++.||+.||+|||++ ||+||||||+||++.++ +.+||+|||++........ ......||..|+|||++
T Consensus 117 ~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 117 EASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVL 192 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHh
Confidence 9999999999999999999 99999999999998543 3499999999987644322 23445789999999999
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+..++.++|||||||++|||++|..||..........+...+.. .... .. ..........+.+++.+||+
T Consensus 193 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----~~~~--~~---~~~~~~~s~~~~~li~~~L~ 263 (342)
T 2qr7_A 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS----GKFS--LS---GGYWNSVSDTAKDLVSKMLH 263 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH----CCCC--CC---STTTTTSCHHHHHHHHHHTC
T ss_pred cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc----CCcc--cC---ccccccCCHHHHHHHHHHCC
Confidence 888899999999999999999999999875433222222222211 1110 00 01112233457889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||++||++.++++
T Consensus 264 ~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 264 VDPHQRLTAALVLR 277 (342)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=294.75 Aligned_cols=239 Identities=27% Similarity=0.360 Sum_probs=186.9
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC---CCCC
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA---NIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~---~~~~ 80 (307)
.+|+.||||.+... .......+.+|+.++++++||||+++++++......++||||+++++|.+++...... ...+
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 137 (327)
T 2yfx_A 58 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137 (327)
T ss_dssp --CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSC
T ss_pred CccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccc
Confidence 46789999999754 4455678999999999999999999999999999999999999999999999654322 2458
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcc-cccccccCCCCcCCc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAP 156 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aP 156 (307)
++..++.++.|++.||.|||++ |++||||||+||+++. +..++|+|||++........ .......|+..|+||
T Consensus 138 ~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 138 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCH
Confidence 9999999999999999999999 9999999999999984 44699999999975433221 223345678899999
Q ss_pred ccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
|++.+..++.++||||||+++|+|+| |..||...... ..... ....... ..+......+.+++.
T Consensus 215 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~~~~--------~~~~~~~~~l~~li~ 279 (327)
T 2yfx_A 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF----VTSGGRM--------DPPKNCPGPVYRIMT 279 (327)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----HHTTCCC--------CCCTTCCHHHHHHHH
T ss_pred hHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHH----HhcCCCC--------CCCCCCCHHHHHHHH
Confidence 99988899999999999999999998 88887653221 11111 1111110 111222345788999
Q ss_pred hccccccCCCCCHHHHHHHHHhcccc
Q 021774 236 FCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
+||+.||.+||++.++++.|+.+...
T Consensus 280 ~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 280 QCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 99999999999999999999877653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=295.40 Aligned_cols=230 Identities=20% Similarity=0.315 Sum_probs=176.0
Q ss_pred ccCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 3 TLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRH--PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
...+|+.||||++... .......+.+|+.++++++| |||+++++++...+..++|||+ .+++|.+++. ...
T Consensus 29 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~----~~~ 103 (343)
T 3dbq_A 29 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK----KKK 103 (343)
T ss_dssp ECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHH----HSC
T ss_pred EeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHH----hcC
Confidence 3467899999998754 45556789999999999976 9999999999999999999995 5889999984 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||++......... ......||+.|+|||
T Consensus 104 ~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 179 (343)
T 3dbq_A 104 SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHH
Confidence 689999999999999999999999 999999999999997 678999999999876543222 234567999999999
Q ss_pred cccC-----------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHH
Q 021774 158 YVLG-----------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226 (307)
Q Consensus 158 ~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
++.+ ..++.++|||||||++|||++|+.||......... .......... . ..+...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~-----~---~~~~~~ 246 (343)
T 3dbq_A 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHE-----I---EFPDIP 246 (343)
T ss_dssp HHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHCTTSC-----C---CCCCCS
T ss_pred HHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-----HHHHhcCCcc-----c---CCcccC
Confidence 9864 67889999999999999999999998654332111 1111111110 1 111112
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
...+.+++.+||+.||.+|||+.++++.
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2357788899999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=286.99 Aligned_cols=226 Identities=27% Similarity=0.410 Sum_probs=184.7
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++......++||||+++++|.+++. ...+++.
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~ 119 (303)
T 3a7i_A 45 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDET 119 (303)
T ss_dssp TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-----TSCCCHH
T ss_pred CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-----cCCCCHH
Confidence 468899999987653 3456789999999999999999999999999999999999999999999983 3468999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..
T Consensus 120 ~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 195 (303)
T 3a7i_A 120 QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSA 195 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCccCCCcCccCHHHHhcCC
Confidence 9999999999999999999 999999999999999999999999999987654322 233456889999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++||||||+++|+|++|..|+....... ..... .... . +.+ .......+.+++.+||+.||.
T Consensus 196 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~~~~-~-----~~~---~~~~~~~l~~li~~~l~~dp~ 260 (303)
T 3a7i_A 196 YDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLI---PKNN-P-----PTL---EGNYSKPLKEFVEACLNKEPS 260 (303)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---HHSC-C-----CCC---CSSCCHHHHHHHHHHCCSSGG
T ss_pred CCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHh---hcCC-C-----CCC---ccccCHHHHHHHHHHcCCChh
Confidence 9999999999999999999999986543211 11111 1111 1 111 112233578889999999999
Q ss_pred CCCCHHHHHHH
Q 021774 244 RRPQMNQVIKM 254 (307)
Q Consensus 244 ~RPs~~~v~~~ 254 (307)
+|||+.++++.
T Consensus 261 ~Rps~~~ll~~ 271 (303)
T 3a7i_A 261 FRPTAKELLKH 271 (303)
T ss_dssp GSCCHHHHTTC
T ss_pred hCcCHHHHhhC
Confidence 99999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=285.10 Aligned_cols=229 Identities=24% Similarity=0.337 Sum_probs=183.1
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++ .....+++.
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l----~~~~~~~~~ 105 (276)
T 2yex_A 30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEP 105 (276)
T ss_dssp TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHH
T ss_pred CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHH----hhccCCCHH
Confidence 468999999987542 344577899999999999999999999999999999999999999999988 344569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||.|||++ |++||||+|+||+++.++.++|+|||++..+..... .......|+..|+|||++.+.
T Consensus 106 ~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (276)
T 2yex_A 106 DAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCS
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcC
Confidence 9999999999999999999 999999999999999999999999999986543221 223445689999999999876
Q ss_pred cc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.+ +.++||||||+++|+|++|..||......... ...+ ....... .........+.+++.+||+.|
T Consensus 183 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~----~~~~~~~--------~~~~~~~~~~~~li~~~l~~~ 249 (276)
T 2yex_A 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----KEKKTYL--------NPWKKIDSAPLALLHKILVEN 249 (276)
T ss_dssp SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHH----HTTCTTS--------TTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHh----hhccccc--------CchhhcCHHHHHHHHHHCCCC
Confidence 65 78999999999999999999998765432211 1111 1111000 001122345778999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.++++
T Consensus 250 p~~Rps~~~il~ 261 (276)
T 2yex_A 250 PSARITIPDIKK 261 (276)
T ss_dssp TTTSCCHHHHTT
T ss_pred chhCCCHHHHhc
Confidence 999999999865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=287.91 Aligned_cols=223 Identities=18% Similarity=0.265 Sum_probs=178.0
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||.++.. .......+.+|+..+.++ +||||+++++++.+.+..++||||+++++|.+++.........++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 113 (289)
T 1x8b_A 34 LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK 113 (289)
T ss_dssp TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCC
T ss_pred CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCC
Confidence 37899999998864 234456788999999999 999999999999999999999999999999999955433345689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-------------------CceEEeeccCcccCCCCccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-------------------FNPKIGDFGLAKLFPDNITH 142 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-------------------~~~kl~dfg~~~~~~~~~~~ 142 (307)
+..+..++.||+.||+|||++ ||+||||||+||+++.+ ..++|+|||.+......
T Consensus 114 ~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--- 187 (289)
T 1x8b_A 114 EAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--- 187 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---
Confidence 999999999999999999999 99999999999999844 47999999999876543
Q ss_pred ccccccCCCCcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 143 ITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
....|+..|+|||++.+. .++.++||||||+++|+|++|.+++.... .. ........ ..
T Consensus 188 --~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~-----~~~~~~~~--------~~ 247 (289)
T 1x8b_A 188 --QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----QW-----HEIRQGRL--------PR 247 (289)
T ss_dssp --CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----HH-----HHHHTTCC--------CC
T ss_pred --cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----HH-----HHHHcCCC--------CC
Confidence 223589999999998875 66789999999999999999987653321 01 11111111 11
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+......+.+++.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 248 IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 12223345888899999999999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.62 Aligned_cols=224 Identities=25% Similarity=0.286 Sum_probs=180.7
Q ss_pred CCCEEEEEEccccC---hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 6 NGRRIAVKPLSAES---KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 6 ~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
+|+.||||+++... ......+..|.+++..+ +||||+++++++.+.+..++||||++||+|.+++. ....++
T Consensus 44 ~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~~ 119 (353)
T 2i0e_A 44 TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK 119 (353)
T ss_dssp EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCC
T ss_pred CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH----hcCCCC
Confidence 47889999997542 23456788999999998 89999999999999999999999999999999984 334699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+
T Consensus 120 ~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 120 EPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcC
Confidence 999999999999999999999 99999999999999999999999999998643221 22445679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||++|+.||..... ..+...+ .... . .++......+.+++.+||+.|
T Consensus 196 ~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i---~~~~-~---------~~p~~~s~~~~~li~~lL~~d 259 (353)
T 2i0e_A 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSI---MEHN-V---------AYPKSMSKEAVAICKGLMTKH 259 (353)
T ss_dssp CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHCC-C---------CCCTTSCHHHHHHHHHHTCSC
T ss_pred CCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHH---HhCC-C---------CCCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999999865322 1111111 1111 1 112223345888999999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|.+||+ +.++++
T Consensus 260 P~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 260 PGKRLGCGPEGERDIKE 276 (353)
T ss_dssp TTSCTTCSTTHHHHHHT
T ss_pred HHHcCCCCCCCHHHHhc
Confidence 999996 466654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=299.39 Aligned_cols=229 Identities=18% Similarity=0.225 Sum_probs=171.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhc-CCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSN-VRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....++||||++||+|.+++... ....
T Consensus 85 ~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~ 157 (400)
T 1nxk_A 85 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQA 157 (400)
T ss_dssp TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----C
T ss_pred CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh--CCCC
Confidence 46889999998732 346778888755 489999999999876 56789999999999999998532 2346
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
+++..+..++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++...... ......||..|+||
T Consensus 158 l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 158 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAP 232 (400)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC--ccccCCCCCCccCH
Confidence 99999999999999999999999 9999999999999987 7889999999998664322 23456789999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchh-HHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN-KFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
|++.+..++.++|||||||++|||++|..||........ ........ ..... ...+... .....+.+++.
T Consensus 233 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~~--~~~~~~~----~~s~~~~~li~ 303 (400)
T 1nxk_A 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYE--FPNPEWS----EVSEEVKMLIR 303 (400)
T ss_dssp GGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCCC--CCTTTTT----TSCHHHHHHHH
T ss_pred hhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCccc--CCCcccc----cCCHHHHHHHH
Confidence 999999999999999999999999999999865433211 00111111 11100 0011111 22345888999
Q ss_pred hccccccCCCCCHHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~ 254 (307)
+||+.||.+|||+.++++.
T Consensus 304 ~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 304 NLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=288.17 Aligned_cols=227 Identities=22% Similarity=0.286 Sum_probs=180.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.++.........+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ....+++..
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~ 107 (304)
T 2jam_A 32 LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKD 107 (304)
T ss_dssp TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSCCCHHH
T ss_pred CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHH----HcCCCCHHH
Confidence 4789999999986654445678899999999999999999999999999999999999999999883 234689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.|++.||.|||++ |++||||||+||++ +.++.++|+|||++...... ......|+..|+|||++.+
T Consensus 108 ~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 108 ASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSS
T ss_pred HHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhcc
Confidence 999999999999999999 99999999999999 78889999999999754332 2234568999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..||..... ..+..... . ... .. .. .........+.+++.+||+.|
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~---~-~~~-~~-~~---~~~~~~~~~~~~li~~~l~~d 249 (304)
T 2jam_A 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIK---E-GYY-EF-ES---PFWDDISESAKDFICHLLEKD 249 (304)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH---H-CCC-CC-CT---TTTTTSCHHHHHHHHHHHCSS
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---c-CCC-CC-Cc---cccccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999865432 11111111 1 111 00 01 111222345888999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+||++.++++
T Consensus 250 p~~Rps~~~~l~ 261 (304)
T 2jam_A 250 PNERYTCEKALS 261 (304)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhHCcCHHHHhc
Confidence 999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.21 Aligned_cols=231 Identities=26% Similarity=0.356 Sum_probs=180.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++... .....+++..
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 123 (295)
T 2clq_A 45 SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQT 123 (295)
T ss_dssp TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHH
T ss_pred CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHH
Confidence 568899999998766666678999999999999999999999999999999999999999999998542 1234567899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
+..++.|++.||.|||++ |++||||||+||+++. ++.++|+|||++........ ......|+..|+|||++.+..
T Consensus 124 ~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 199 (295)
T 2clq_A 124 IGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGP 199 (295)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGG
T ss_pred HHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccccCCCccccChhhhcCCC
Confidence 999999999999999999 9999999999999987 89999999999987654221 223456889999999987643
Q ss_pred --ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 164 --LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 164 --~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
++.++||||||+++|+|++|+.||........ ... ...... ..+. .+......+.+++.+||+.|
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---~~~~~~------~~~~---~~~~~~~~~~~li~~~l~~d 266 (295)
T 2clq_A 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMF---KVGMFK------VHPE---IPESMSAEAKAFILKCFEPD 266 (295)
T ss_dssp GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHH---HHHHHC------CCCC---CCTTSCHHHHHHHHHTTCSS
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHH---hhcccc------cccc---ccccCCHHHHHHHHHHccCC
Confidence 78999999999999999999999864322111 111 111110 0111 12223345788899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++||++.+++.
T Consensus 267 p~~Rps~~~ll~ 278 (295)
T 2clq_A 267 PDKRACANDLLV 278 (295)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=284.77 Aligned_cols=227 Identities=20% Similarity=0.326 Sum_probs=182.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe----------------CCeeEEEEeccCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----------------GTRRILVYEYVENNSLDR 68 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~sL~~ 68 (307)
.+|+.||+|.++... ..+.+|++++++++||||+++++++.. ....++||||+++++|.+
T Consensus 34 ~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (284)
T 2a19_B 34 IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109 (284)
T ss_dssp TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHH
T ss_pred CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHH
Confidence 378999999998654 346789999999999999999998865 345789999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccccccc
Q 021774 69 VLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIA 148 (307)
Q Consensus 69 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 148 (307)
++... ....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........ .....
T Consensus 110 ~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 182 (284)
T 2a19_B 110 WIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSK 182 (284)
T ss_dssp HHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCC
T ss_pred HHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheecccccc--ccccC
Confidence 98532 235689999999999999999999999 999999999999999999999999999987654322 23456
Q ss_pred CCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 149 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
|+..|+|||++.+..++.++||||||+++|+|++|..|+.... . .......... . .....
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~-~~~~~~~~~~--------~---~~~~~ 242 (284)
T 2a19_B 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------K-FFTDLRDGII--------S---DIFDK 242 (284)
T ss_dssp SCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------H-HHHHHHTTCC--------C---TTSCH
T ss_pred CcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------H-HHHHhhcccc--------c---ccCCH
Confidence 8999999999999899999999999999999999987753211 0 1111111111 1 11223
Q ss_pred HHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
.+.+++.+||+.||.+||++.++++.|..+.+..
T Consensus 243 ~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 4778889999999999999999999998876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=288.98 Aligned_cols=229 Identities=25% Similarity=0.363 Sum_probs=176.6
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.||||.++... ..+.+.+|++++++++||||+++++++... +..++||||+++++|.+++... ....+++..
T Consensus 43 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~ 118 (278)
T 1byg_A 43 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDC 118 (278)
T ss_dssp TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHH
T ss_pred cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHH
Confidence 47899999998543 346789999999999999999999997655 4789999999999999998432 122388999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++...... .....++..|+|||++.+..+
T Consensus 119 ~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 191 (278)
T 1byg_A 119 LLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKF 191 (278)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCCCCC
Confidence 999999999999999999 9999999999999999999999999999855432 223456889999999988899
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++||||||+++|+|+| |..||....... .. ........ . ..+......+.+++.+||+.||.
T Consensus 192 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~~p~ 256 (278)
T 1byg_A 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYK-----M---DAPDGCPPAVYEVMKNCWHLDAA 256 (278)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCC-----C---CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCC-----C---CCcccCCHHHHHHHHHHhcCChh
Confidence 999999999999999998 998886543221 11 11111111 1 11222334588889999999999
Q ss_pred CCCCHHHHHHHHHhccc
Q 021774 244 RRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~~~ 260 (307)
+||++.++++.|+++..
T Consensus 257 ~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 257 MRPSFLQLREQLEHIKT 273 (278)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHHHHHh
Confidence 99999999999988753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=308.33 Aligned_cols=229 Identities=24% Similarity=0.286 Sum_probs=185.1
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++.... ......+.+|+++|++++||||+++++++.+.+..++||||++||+|.+++... ....++
T Consensus 207 ~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~ 284 (576)
T 2acx_A 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFP 284 (576)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS--SSCCCC
T ss_pred CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc--CCCCCC
Confidence 478999999987532 234467889999999999999999999999999999999999999999988432 234599
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++........ .....||+.|+|||++.+
T Consensus 285 e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 285 EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc--ccccCCCccccCHHHHcC
Confidence 999999999999999999999 999999999999999999999999999987654322 234579999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhH-HHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK-FLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++|||||||++|||++|..||......... .+..... . .. . .++......+.+++.+||+.
T Consensus 360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~---~-~~------~---~~p~~~s~~~~dLI~~lL~~ 426 (576)
T 2acx_A 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---E-VP------E---EYSERFSPQARSLCSQLLCK 426 (576)
T ss_dssp CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH---H-CC------C---CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh---c-cc------c---cCCccCCHHHHHHHHHhccC
Confidence 99999999999999999999999999765432221 1111111 1 10 0 11122334588899999999
Q ss_pred ccCCCC-----CHHHHHH
Q 021774 241 AASRRP-----QMNQVIK 253 (307)
Q Consensus 241 ~p~~RP-----s~~~v~~ 253 (307)
||.+|| ++.+|++
T Consensus 427 dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 427 DPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SGGGSTTCSSSHHHHHHT
T ss_pred CHHHcCCCCCCCHHHHHh
Confidence 999999 7788864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.10 Aligned_cols=176 Identities=27% Similarity=0.354 Sum_probs=153.6
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-----CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||||+++.. ......+..|+++++++. ||||+++++++...+..++||||+ +++|.+++... ....
T Consensus 58 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~ 133 (360)
T 3llt_A 58 DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNG 133 (360)
T ss_dssp TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCC
T ss_pred CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCC
Confidence 46889999999743 344466788999999886 999999999999999999999999 99999998532 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-------------------------CCceEEeeccCcc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-------------------------EFNPKIGDFGLAK 134 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------------------------~~~~kl~dfg~~~ 134 (307)
+++..+..++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||++.
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~ 210 (360)
T 3llt_A 134 FHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCce
Confidence 89999999999999999999999 9999999999999975 7889999999998
Q ss_pred cCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccc
Q 021774 135 LFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW 191 (307)
Q Consensus 135 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 191 (307)
..... .....||..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 211 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 211 FKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp ETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 65442 234568999999999999999999999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=305.32 Aligned_cols=171 Identities=23% Similarity=0.376 Sum_probs=141.6
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||++... .....+++.+|+.+|++++||||+++++++... ...|+|||++ +++|.+++. ..
T Consensus 76 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~ 150 (458)
T 3rp9_A 76 LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR----TP 150 (458)
T ss_dssp C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH----SS
T ss_pred CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc----cC
Confidence 46889999998753 445567899999999999999999999999543 5689999998 569999883 44
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc----------------
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---------------- 141 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---------------- 141 (307)
..+++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++.......
T Consensus 151 ~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 227 (458)
T 3rp9_A 151 VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227 (458)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC----------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccc
Confidence 5699999999999999999999999 999999999999999999999999999987643211
Q ss_pred ----------cccccccCCCCcCCcccc-cCCcccccCceeehHHHHHHHHhC
Q 021774 142 ----------HITTRIAGTTGYLAPEYV-LGGQLTMKADVYSFGVLVLEIISG 183 (307)
Q Consensus 142 ----------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg 183 (307)
.......||..|+|||++ .+..++.++|||||||++|||++|
T Consensus 228 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp -----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 123445789999999976 456799999999999999999994
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=298.90 Aligned_cols=230 Identities=19% Similarity=0.302 Sum_probs=176.7
Q ss_pred ccCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 3 TLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVR--HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
...+|+.||||++... .......+.+|+.++++++ ||||+++++++...+..++||| +.+++|.+++.. ..
T Consensus 76 ~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~ 150 (390)
T 2zmd_A 76 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KK 150 (390)
T ss_dssp ECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH----CS
T ss_pred EcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh----cC
Confidence 3456899999998754 4556678999999999995 5999999999999999999999 568899999843 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||++..+...... ......||+.|+|||
T Consensus 151 ~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE 226 (390)
T 2zmd_A 151 SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226 (390)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChH
Confidence 688999999999999999999999 999999999999995 578999999999876543222 234567999999999
Q ss_pred cccC-----------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHH
Q 021774 158 YVLG-----------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226 (307)
Q Consensus 158 ~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
++.+ ..++.++|||||||++|||++|..||........ ........... .......
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~--- 293 (390)
T 2zmd_A 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAIIDPNHE-----IEFPDIP--- 293 (390)
T ss_dssp HHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHHCTTSC-----CCCCCCS---
T ss_pred HhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHHHhCcccc-----CCCCccc---
Confidence 9865 3688999999999999999999999865433211 11111111110 1111111
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
...+.+++.+||+.||.+||++.++++.
T Consensus 294 ~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 294 EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2357788899999999999999999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.00 Aligned_cols=225 Identities=20% Similarity=0.292 Sum_probs=183.5
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ....++
T Consensus 38 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~ 113 (294)
T 2rku_A 38 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALT 113 (294)
T ss_dssp TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHCSCC
T ss_pred CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH----hcCCCC
Confidence 35889999988754 34556788999999999999999999999999999999999999999999883 334689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+
T Consensus 114 ~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 114 EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccccccCCCCcCCcchhcc
Confidence 999999999999999999999 999999999999999999999999999987653322 2334568999999999998
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..||....... . ...... ... . .+......+.+++.+||+.|
T Consensus 190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~~-~~~------~---~~~~~~~~~~~li~~~l~~~ 253 (294)
T 2rku_A 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---T---YLRIKK-NEY------S---IPKHINPVAASLIQKMLQTD 253 (294)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHT-TCC------C---CCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHhh-ccC------C---CccccCHHHHHHHHHHcccC
Confidence 889999999999999999999999986543211 1 111111 110 0 11122235778899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||+.++++
T Consensus 254 p~~Rps~~~ll~ 265 (294)
T 2rku_A 254 PTARPTINELLN 265 (294)
T ss_dssp GGGSCCGGGGGG
T ss_pred hhhCcCHHHHhh
Confidence 999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=292.86 Aligned_cols=235 Identities=19% Similarity=0.251 Sum_probs=169.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEE--------eCCeeEEEEeccCCCCHHHHhccCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCV--------QGTRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
.+|+.||||++..........+.+|+.+++++. ||||+++++++. .....++||||+. |+|.+++....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~- 128 (337)
T 3ll6_A 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME- 128 (337)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-
T ss_pred CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-
Confidence 478999999997776666778999999999995 999999999995 3345789999995 68988874322
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-----------
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH----------- 142 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~----------- 142 (307)
....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||++.........
T Consensus 129 ~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 205 (337)
T 3ll6_A 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205 (337)
T ss_dssp TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccch
Confidence 344699999999999999999999999 8 999999999999999999999999999876543221
Q ss_pred ccccccCCCCcCCcccc---cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC
Q 021774 143 ITTRIAGTTGYLAPEYV---LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL 219 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (307)
......|+..|+|||++ .+..++.++||||||+++|+|++|..||...... . ....... .+..
T Consensus 206 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~----~~~~~~~----~~~~ 271 (337)
T 3ll6_A 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------R----IVNGKYS----IPPH 271 (337)
T ss_dssp ------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------------CC----CCTT
T ss_pred hhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH------H----hhcCccc----CCcc
Confidence 11234588999999988 5667899999999999999999999998543211 0 0000000 0000
Q ss_pred CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 220 GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 220 ~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
... ...+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 272 ~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 272 DTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp CCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111 123677888999999999999999999999887644
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.27 Aligned_cols=232 Identities=25% Similarity=0.312 Sum_probs=182.9
Q ss_pred CCCCEEEEEEccccC----hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES----KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||||+++... ......+.+|+++++++ +||||+++++++...+..++||||+++++|.+++.. ...
T Consensus 80 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~ 155 (355)
T 1vzo_A 80 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RER 155 (355)
T ss_dssp TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSC
T ss_pred CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCC
Confidence 478999999987532 22335677899999999 799999999999999999999999999999999842 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+............||..|+|||++
T Consensus 156 ~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 156 FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhh
Confidence 89999999999999999999999 999999999999999999999999999987655444444556799999999999
Q ss_pred cC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 160 LG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 160 ~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
.+ ..++.++|||||||++|||++|..||......... ........... + ..+......+.+++.+|
T Consensus 233 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~-------~---~~~~~~~~~~~~li~~~ 300 (355)
T 1vzo_A 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE-------P---PYPQEMSALAKDLIQRL 300 (355)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC-------C---CCCTTSCHHHHHHHHHH
T ss_pred cCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC-------C---CCCcccCHHHHHHHHHH
Confidence 86 35789999999999999999999998654322111 11111111111 1 11222334578899999
Q ss_pred cccccCCCC-----CHHHHHHHH
Q 021774 238 TQAAASRRP-----QMNQVIKML 255 (307)
Q Consensus 238 ~~~~p~~RP-----s~~~v~~~L 255 (307)
|+.||.+|| ++.++++..
T Consensus 301 L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 301 LMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSG
T ss_pred hhhCHHHhcCCCCCCHHHHHcCc
Confidence 999999999 899987643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=292.98 Aligned_cols=239 Identities=28% Similarity=0.395 Sum_probs=178.4
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|..+.. ....+++
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~ 123 (331)
T 4aaa_A 48 DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL----FPNGLDY 123 (331)
T ss_dssp TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH----STTCCCH
T ss_pred CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh----hccCCCH
Confidence 45889999988654 34445678899999999999999999999999999999999999999998862 3446999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........ ......|+..|+|||++.+.
T Consensus 124 ~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 124 QVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCC
Confidence 99999999999999999999 999999999999999999999999999986544322 23345689999999998875
Q ss_pred -cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHH----------HHhhcCC-cccccCCCCCC------CCH
Q 021774 163 -QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW----------QLHQEEK-PLELVDPELGE------YPP 224 (307)
Q Consensus 163 -~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~-~~~~~~~~~~~------~~~ 224 (307)
.++.++||||||+++|+|++|+.||........ +..... ....... ......+.... ..+
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (331)
T 4aaa_A 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYP 277 (331)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHST
T ss_pred CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhccc
Confidence 789999999999999999999999865433211 111110 0000000 00000111100 011
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+||+.||.+|||+.++++
T Consensus 278 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 278 KLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred chhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 23456889999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=280.86 Aligned_cols=225 Identities=24% Similarity=0.338 Sum_probs=178.7
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.++..||+|.+... +....+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++. ...
T Consensus 49 ~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~ 124 (290)
T 1t4h_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFK 124 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH----HHS
T ss_pred CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH----Hcc
Confidence 46788999988754 45566789999999999999999999999875 356799999999999999984 335
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEEC-CCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
.+++..+..++.|++.||.|||++ + ++||||||+||+++ .++.+||+|||++....... .....|+..|+|
T Consensus 125 ~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~a 198 (290)
T 1t4h_A 125 VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMA 198 (290)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS---BEESCSSCCCCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc---cccccCCcCcCC
Confidence 689999999999999999999999 8 99999999999997 78999999999997654432 234568999999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+ .++.++||||||+++|+|++|+.||........ . . ............ .......+.+++.
T Consensus 199 PE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~---~-~~~~~~~~~~~~-------~~~~~~~l~~li~ 264 (290)
T 1t4h_A 199 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---Y-RRVTSGVKPASF-------DKVAIPEVKEIIE 264 (290)
T ss_dssp GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---H-HHHTTTCCCGGG-------GGCCCHHHHHHHH
T ss_pred HHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--H---H-HHHhccCCcccc-------CCCCCHHHHHHHH
Confidence 998764 589999999999999999999999865433211 1 1 111111111111 1112235888999
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
+||+.||.+|||+.++++
T Consensus 265 ~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 265 GCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCChhhCCCHHHHhh
Confidence 999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=294.41 Aligned_cols=239 Identities=22% Similarity=0.375 Sum_probs=181.2
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ...+++.
T Consensus 56 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~ 131 (360)
T 3eqc_A 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQ 131 (360)
T ss_dssp TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHH
T ss_pred CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHH
Confidence 46899999999865 455567899999999999999999999999999999999999999999999843 3468999
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||+|||+ + ||+||||||+||+++.++.++|+|||++..... .......|+..|+|||++.+.
T Consensus 132 ~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 205 (360)
T 3eqc_A 132 ILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGT 205 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HC----CCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc---ccccCCCCCCCeECHHHHcCC
Confidence 999999999999999998 6 899999999999999999999999999875422 122345789999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhc---------CCc--------------cc----cc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQE---------EKP--------------LE----LV 215 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~--------------~~----~~ 215 (307)
.++.++||||||+++|+|++|+.||..................... ... .. ..
T Consensus 206 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
T 3eqc_A 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285 (360)
T ss_dssp CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHh
Confidence 9999999999999999999999998754332111100000000000 000 00 00
Q ss_pred CCCCCCC-CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 216 DPELGEY-PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 216 ~~~~~~~-~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....... .......+.+++.+||+.||.+|||+.++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 1112345888999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=284.35 Aligned_cols=223 Identities=23% Similarity=0.312 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.. ...++
T Consensus 37 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~ 112 (284)
T 2vgo_A 37 QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFD 112 (284)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCC
T ss_pred CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCC
Confidence 357889999986532 22346789999999999999999999999999999999999999999999843 34689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++....... .....|+..|+|||++.+
T Consensus 113 ~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 113 EQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhcc
Confidence 999999999999999999999 99999999999999999999999999997654322 234568899999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++||||||+++|+|++|..||....... . ...... .. .. .+......+.+++.+||+.|
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~-~~------~~---~~~~~~~~~~~li~~~l~~~ 250 (284)
T 2vgo_A 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---T---HRRIVN-VD------LK---FPPFLSDGSKDLISKLLRYH 250 (284)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHT-TC------CC---CCTTSCHHHHHHHHHHSCSS
T ss_pred CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---H---HHHHhc-cc------cC---CCCcCCHHHHHHHHHHhhcC
Confidence 999999999999999999999999986543211 1 111111 11 11 11222345788899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+||++.++++
T Consensus 251 p~~Rps~~~ll~ 262 (284)
T 2vgo_A 251 PPQRLPLKGVME 262 (284)
T ss_dssp GGGSCCHHHHHT
T ss_pred HhhCCCHHHHhh
Confidence 999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.32 Aligned_cols=237 Identities=25% Similarity=0.343 Sum_probs=176.7
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCC--eeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGT--RRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||||++... .......+.+|+.+++++. ||||+++++++...+ ..|+||||++ ++|..++.. ..
T Consensus 32 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~ 105 (388)
T 3oz6_A 32 RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NI 105 (388)
T ss_dssp TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TC
T ss_pred CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CC
Confidence 56899999998643 4555677889999999996 999999999998654 6899999997 589998842 36
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-------------------
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI------------------- 140 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~------------------- 140 (307)
+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.+....
T Consensus 106 ~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (388)
T 3oz6_A 106 LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182 (388)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccc
Confidence 89999999999999999999999 99999999999999999999999999998653311
Q ss_pred -ccccccccCCCCcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccc--c-
Q 021774 141 -THITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL--V- 215 (307)
Q Consensus 141 -~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~- 215 (307)
........||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+............ +
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~p~~~~~~~~~ 259 (388)
T 3oz6_A 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN---QLERIIGVIDFPSNEDVESIQ 259 (388)
T ss_dssp -------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHHTSC
T ss_pred ccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHhcc
Confidence 112334578999999999887 678999999999999999999999986543211 11111111110000000 0
Q ss_pred ------------------CCCCCCCC-------------HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 216 ------------------DPELGEYP-------------PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 216 ------------------~~~~~~~~-------------~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
........ ......+.+++.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 00000000 022345788999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=294.51 Aligned_cols=233 Identities=23% Similarity=0.307 Sum_probs=180.9
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||++... .....+.+.+|++++++++||||+++++++.... ..++||||+ +++|.+++..
T Consensus 48 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---- 122 (367)
T 1cm8_A 48 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---- 122 (367)
T ss_dssp TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH----
T ss_pred CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc----
Confidence 56899999998653 3455678899999999999999999999998663 459999999 8899999842
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++..... .....+|..|+||
T Consensus 123 -~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aP 194 (367)
T 1cm8_A 123 -EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAP 194 (367)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCT
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCH
Confidence 4689999999999999999999999 9999999999999999999999999999875432 3345689999999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC------------------cccccCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK------------------PLELVDP 217 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~ 217 (307)
|++.+ ..++.++|||||||++|||++|+.||....... ....+........ .......
T Consensus 195 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (367)
T 1cm8_A 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271 (367)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC
T ss_pred HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCC
Confidence 99887 679999999999999999999999986543211 1111111110000 0000001
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+....+.....+.+++.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 272 DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 111122233455888999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.40 Aligned_cols=231 Identities=13% Similarity=0.141 Sum_probs=184.1
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-CCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-ANIK 79 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~ 79 (307)
..+|+.||||+++.... ..+..|++++++++ |+||+++++++...+..++||||+++|+|.+++..... ....
T Consensus 92 ~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 168 (365)
T 3e7e_A 92 AKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168 (365)
T ss_dssp --CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCS
T ss_pred cccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccC
Confidence 45789999999986543 45677777777775 99999999999999999999999999999999854322 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-----------CCceEEeeccCcccCCC-Ccccccccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-----------EFNPKIGDFGLAKLFPD-NITHITTRI 147 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----------~~~~kl~dfg~~~~~~~-~~~~~~~~~ 147 (307)
+++..++.++.||+.||+|||++ ||+||||||+||||+. ++.+||+|||++..+.. .........
T Consensus 169 l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 245 (365)
T 3e7e_A 169 MPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCS
T ss_pred CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeee
Confidence 99999999999999999999999 9999999999999998 89999999999975432 122234556
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHH
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (307)
.||..|+|||++.+..++.++|||||||++|||+||+.||........ .+...+...+ ..
T Consensus 246 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------------~~~~~~~~~~--~~ 305 (365)
T 3e7e_A 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------------------KPEGLFRRLP--HL 305 (365)
T ss_dssp SCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------------------EECSCCTTCS--SH
T ss_pred cCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------------------eechhccccC--cH
Confidence 799999999999999999999999999999999999999754332110 0111111111 13
Q ss_pred HHHHHHHHhccccccCCC-CCHHHHHHHHHhccc
Q 021774 228 IRYMKVAFFCTQAAASRR-PQMNQVIKMLTKNIR 260 (307)
Q Consensus 228 ~~~~~l~~~c~~~~p~~R-Ps~~~v~~~L~~~~~ 260 (307)
..+.+++..|++.+|.+| |++.++.+.|++.+.
T Consensus 306 ~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 306 DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 345667777999999998 788999988888775
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=289.37 Aligned_cols=237 Identities=24% Similarity=0.398 Sum_probs=167.5
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccC----CCCCCC
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGA----TKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~ 79 (307)
.+|+.||||.+.... ......+.+|+.++++++||||+++++++...+..++||||+++++|.+++... ......
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 117 (303)
T 2vwi_A 38 PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117 (303)
T ss_dssp ---CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCS
T ss_pred CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCC
Confidence 368899999987543 344567889999999999999999999999999999999999999999988431 113456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc----cccccccCCCCcCC
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT----HITTRIAGTTGYLA 155 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~g~~~y~a 155 (307)
+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++........ .......|+..|+|
T Consensus 118 ~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~a 194 (303)
T 2vwi_A 118 LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194 (303)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccC
Confidence 89999999999999999999999 999999999999999999999999999986643211 12234568999999
Q ss_pred cccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc---ccccCCCCCCCCHHHHHHHH
Q 021774 156 PEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP---LELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 156 PE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (307)
||++.+ ..++.++||||||+++|||++|..||........ . . ........ ....++.. .......+.
T Consensus 195 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~---~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 265 (303)
T 2vwi_A 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--L-M---LTLQNDPPSLETGVQDKEM---LKKYGKSFR 265 (303)
T ss_dssp HHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H-H---HHHTSSCCCTTC-----CC---CCCCCHHHH
T ss_pred HHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--H-H---HHhccCCCccccccccchh---hhhhhHHHH
Confidence 998876 5688999999999999999999999865433211 1 1 11111111 00111111 112234578
Q ss_pred HHHHhccccccCCCCCHHHHHH
Q 021774 232 KVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+++.+||+.||.+||++.++++
T Consensus 266 ~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 266 KMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhh
Confidence 8899999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.00 Aligned_cols=220 Identities=14% Similarity=0.107 Sum_probs=168.5
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHH---HHHhcCCCCCcccee-------eEEEeCC-----------------ee
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEI---MTLSNVRHPNLVELI-------GCCVQGT-----------------RR 54 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~~-----------------~~ 54 (307)
.+|+.||||++... .....+.+.+|+ +.+++++||||++++ +++...+ ..
T Consensus 96 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 175 (377)
T 3byv_A 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175 (377)
T ss_dssp CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESE
T ss_pred CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEE
Confidence 56999999998743 344567899999 555566899999998 6666553 27
Q ss_pred EEEEeccCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeecc
Q 021774 55 ILVYEYVENNSLDRVLLGATK---ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFG 131 (307)
Q Consensus 55 ~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg 131 (307)
++||||+ +|+|.+++..... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 176 ~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG 251 (377)
T 3byv_A 176 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFE 251 (377)
T ss_dssp EEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEech
Confidence 8999999 6799999853211 112344688899999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCcccccccccCCCCcCCcccccCC-----------cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHH
Q 021774 132 LAKLFPDNITHITTRIAGTTGYLAPEYVLGG-----------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 200 (307)
Q Consensus 132 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 200 (307)
+++.... ......| ..|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 252 ~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~------ 320 (377)
T 3byv_A 252 HLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG------ 320 (377)
T ss_dssp GCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------C------
T ss_pred hheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccccc------
Confidence 9986433 2334567 999999999877 89999999999999999999999985432110
Q ss_pred HHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 201 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.. ..+....... ...+.+++.+||+.||.+|||+.++++
T Consensus 321 ---------~~-~~~~~~~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 321 ---------GS-EWIFRSCKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp ---------CS-GGGGSSCCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ---------ch-hhhhhhccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 00 1111111222 245788899999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.18 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=178.0
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHH--HhcCCCCCccceeeEEEe-----CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMT--LSNVRHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
+|+.||||++..... ..+..|.++ +..++||||+++++++.. ....++||||+++|+|.+++.. .
T Consensus 35 ~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~ 106 (336)
T 3g2f_A 35 DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----H 106 (336)
T ss_dssp TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----C
T ss_pred CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----c
Confidence 578999999975432 344445555 445899999999986643 2356899999999999999842 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-------cccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEEL------VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-------HITT 145 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------~~~~ 145 (307)
..++..++.++.||+.||+|||++. .+||+||||||+|||++.++.+||+|||++..+..... ....
T Consensus 107 ~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~ 186 (336)
T 3g2f_A 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186 (336)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------C
T ss_pred ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccc
Confidence 3588999999999999999999862 22899999999999999999999999999987654221 1223
Q ss_pred cccCCCCcCCcccccC-------CcccccCceeehHHHHHHHHhCCCCCCccccchh--H----------HHHHHHHHHh
Q 021774 146 RIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMN--K----------FLLEWAWQLH 206 (307)
Q Consensus 146 ~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~--~----------~~~~~~~~~~ 206 (307)
...||..|+|||++.+ ..++.++|||||||++|||++|..|+........ . ...... ...
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 265 (336)
T 3g2f_A 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ-VLV 265 (336)
T ss_dssp CTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHH-HHH
T ss_pred cCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHH-hhh
Confidence 4568999999999887 4677899999999999999999776533221100 0 000000 111
Q ss_pred hcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 207 QEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
........+ +............+.+++.+||+.||++|||+.++++.|++++...
T Consensus 266 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 266 SREKQRPKF-PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp TTSCCCCCC-CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred cccccCCCC-CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 111111111 1111223346667999999999999999999999999999988544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.16 Aligned_cols=222 Identities=23% Similarity=0.268 Sum_probs=171.7
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .......+..|+..+.++ +||||+++++++.+.+..++||||+ +++|.+++.. .+..++
T Consensus 80 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~l~ 155 (311)
T 3p1a_A 80 EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA---WGASLP 155 (311)
T ss_dssp TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---HCSCCC
T ss_pred CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh---cCCCCC
Confidence 37899999988654 334444566666666655 9999999999999999999999999 6799888743 245699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....... ......||..|+|||++.+
T Consensus 156 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 156 EAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC--CCcccCCCccccCHhHhcC
Confidence 999999999999999999999 99999999999999999999999999998765432 2334568999999998876
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|||||||++|||++|..++..... +........... ........+.+++.+||+.|
T Consensus 231 -~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~-------~~~~~~~~l~~li~~~L~~d 292 (311)
T 3p1a_A 231 -SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPE-------FTAGLSSELRSVLVMMLEPD 292 (311)
T ss_dssp -CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCHH-------HHTTSCHHHHHHHHHHSCSS
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCcc-------cccCCCHHHHHHHHHHcCCC
Confidence 789999999999999999999765433211 111111111100 01122345888999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||+.++++
T Consensus 293 P~~Rpt~~ell~ 304 (311)
T 3p1a_A 293 PKLRATAEALLA 304 (311)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhhCcCHHHHHh
Confidence 999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=295.69 Aligned_cols=222 Identities=24% Similarity=0.273 Sum_probs=169.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMT-LSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||+++... ......+..|..+ ++.++||||+++++++.+.+..|+||||++||+|.+++. ....+
T Consensus 61 ~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~----~~~~~ 136 (373)
T 2r5t_A 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ----RERCF 136 (373)
T ss_dssp TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSC
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH----hcCCC
Confidence 468899999997542 2334556777776 467899999999999999999999999999999999983 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 137 ~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 212 (373)
T 2r5t_A 137 LEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLH 212 (373)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-CccccccCCccccCHHHhC
Confidence 9999999999999999999999 99999999999999999999999999998533221 2244567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||...... .... ....... .+++.....+.+++.+||+.
T Consensus 213 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~~~----------~~~~~~~~~~~~li~~lL~~ 276 (373)
T 2r5t_A 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NILNKPL----------QLKPNITNSARHLLEGLLQK 276 (373)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHH---HHHHSCC----------CCCSSSCHHHHHHHHHHTCS
T ss_pred CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHHhccc----------CCCCCCCHHHHHHHHHHccc
Confidence 999999999999999999999999998653321 1111 1111110 11122234578889999999
Q ss_pred ccCCCCCHHH
Q 021774 241 AASRRPQMNQ 250 (307)
Q Consensus 241 ~p~~RPs~~~ 250 (307)
||.+||++.+
T Consensus 277 dp~~R~~~~~ 286 (373)
T 2r5t_A 277 DRTKRLGAKD 286 (373)
T ss_dssp SGGGSTTTTT
T ss_pred CHHhCCCCCC
Confidence 9999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=284.70 Aligned_cols=238 Identities=24% Similarity=0.304 Sum_probs=177.8
Q ss_pred CCCCEEEEEEccccC-----hHhHHHHHHHHHHHhcC---CCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHhc
Q 021774 5 TNGRRIAVKPLSAES-----KQGVREFITEIMTLSNV---RHPNLVELIGCCVQGT-----RRILVYEYVENNSLDRVLL 71 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~ 71 (307)
.+|+.||||++.... ......+.+|+.+++++ +||||+++++++.... ..++|||++. ++|.+++.
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 110 (308)
T 3g33_A 32 HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLD 110 (308)
T ss_dssp TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHH
T ss_pred CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHh
Confidence 568999999987432 11124566777777766 5999999999998765 5789999996 59999985
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCC
Q 021774 72 GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTT 151 (307)
Q Consensus 72 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~ 151 (307)
.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ......||.
T Consensus 111 ~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~ 183 (308)
T 3g33_A 111 KA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTL 183 (308)
T ss_dssp TC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCC
T ss_pred hc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc--ccCCccccc
Confidence 32 233499999999999999999999999 99999999999999999999999999998765432 234467899
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc----------ccCCCC--
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE----------LVDPEL-- 219 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~-- 219 (307)
.|+|||++.+..++.++|||||||++|||++|+.||....... ................ .+.+..
T Consensus 184 ~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (308)
T 3g33_A 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPR 260 (308)
T ss_dssp SSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCC
T ss_pred cccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhccchhhccccccCCCCCC
Confidence 9999999999999999999999999999999999986543321 1222222111110000 000000
Q ss_pred --CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 220 --GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 220 --~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.....+.+++.+||+.||++|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 261 PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0001123345788999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=285.75 Aligned_cols=231 Identities=25% Similarity=0.386 Sum_probs=179.3
Q ss_pred EEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 9 RIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 9 ~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
.||||+++.. .....+.+.+|++++++++||||+++++++.... .++||||+++++|.+++.. ....+++..+
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~ 123 (291)
T 1u46_A 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTL 123 (291)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHH
T ss_pred EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh---ccCCcCHHHH
Confidence 6899998754 2345678999999999999999999999998765 7899999999999999843 2356899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCCc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~ 163 (307)
..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......... ......++..|+|||++.+..
T Consensus 124 ~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 124 SRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC
Confidence 99999999999999999 9999999999999999999999999999877543322 223455777899999999889
Q ss_pred ccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
++.++||||||+++|+|++ |..||...... ... .......... ..+......+.+++.+||+.||
T Consensus 201 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p 266 (291)
T 1u46_A 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL---HKIDKEGERL--------PRPEDCPQDIYNVMVQCWAHKP 266 (291)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTSCCCC--------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHH---HHHHccCCCC--------CCCcCcCHHHHHHHHHHccCCc
Confidence 9999999999999999999 99998654321 111 1111111110 0112233458889999999999
Q ss_pred CCCCCHHHHHHHHHhccc
Q 021774 243 SRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 243 ~~RPs~~~v~~~L~~~~~ 260 (307)
.+|||+.++++.|+++..
T Consensus 267 ~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 267 EDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp GGSCCHHHHHHHHHHHC-
T ss_pred ccCcCHHHHHHHHHHhCc
Confidence 999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=281.78 Aligned_cols=233 Identities=24% Similarity=0.274 Sum_probs=181.7
Q ss_pred CCCCEEEEEEccccC------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++. ...
T Consensus 28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~ 103 (283)
T 3bhy_A 28 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKE 103 (283)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHS
T ss_pred CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH----hcC
Confidence 368999999887542 1235779999999999999999999999999999999999999999999984 245
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----ceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++....... ......|+..|+
T Consensus 104 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~ 178 (283)
T 3bhy_A 104 SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFV 178 (283)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC--cccccCCCcCcc
Confidence 689999999999999999999999 999999999999998877 79999999998765432 223456889999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++||||||+++|+|++|..||....... ... ........ ..... .......+.+++
T Consensus 179 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~--~~~~~---~~~~~~~~~~li 246 (283)
T 3bhy_A 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLT----NISAVNYD--FDEEY---FSNTSELAKDFI 246 (283)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH----HHHTTCCC--CCHHH---HTTCCHHHHHHH
T ss_pred CcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHH----HhHhcccC--Ccchh---cccCCHHHHHHH
Confidence 9999998899999999999999999999999986543211 111 11111100 00000 011234578899
Q ss_pred HhccccccCCCCCHHHHHH--HHHhc
Q 021774 235 FFCTQAAASRRPQMNQVIK--MLTKN 258 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~--~L~~~ 258 (307)
.+||+.||.+||++.++++ .++..
T Consensus 247 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 247 RRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999987 44443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=293.21 Aligned_cols=238 Identities=21% Similarity=0.299 Sum_probs=173.9
Q ss_pred CCCCEEEEEEccccChH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||+++..... ....+.+|++++++++||||+++++++...+..++||||++ ++|.+++.. .+..+++.
T Consensus 25 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~ 100 (324)
T 3mtl_A 25 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMH 100 (324)
T ss_dssp TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHH
T ss_pred CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHH
Confidence 46889999999755322 12245689999999999999999999999999999999997 489888743 34568999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC-C
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-G 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 162 (307)
.+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....... .......||..|+|||++.+ .
T Consensus 101 ~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~ 176 (324)
T 3mtl_A 101 NVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGST 176 (324)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCC
Confidence 9999999999999999999 99999999999999999999999999998654322 22334567999999999876 5
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc---cccC---------CCC-----CCCCHH
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---ELVD---------PEL-----GEYPPN 225 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~~-----~~~~~~ 225 (307)
.++.++|||||||++|+|++|+.||....... ............... .... +.. ....+.
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (324)
T 3mtl_A 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPR 253 (324)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTT
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCC
Confidence 68999999999999999999999986543321 222222221111000 0000 000 000112
Q ss_pred HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 226 EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 226 ~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+.+++.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 254 LDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 2345788999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=312.73 Aligned_cols=232 Identities=24% Similarity=0.355 Sum_probs=183.1
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+..||+|.++.. .......|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.. ....+++..+
T Consensus 418 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~ 493 (656)
T 2j0j_A 418 AMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASL 493 (656)
T ss_dssp CEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHH
T ss_pred cEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHH
Confidence 567999998764 3455578999999999999999999999985 4568999999999999999842 3446899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
+.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...............++..|+|||++.+..++
T Consensus 494 ~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 570 (656)
T 2j0j_A 494 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570 (656)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCC
Confidence 99999999999999999 999999999999999999999999999987755443334445677889999999888999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++||||||+++|||++ |..||...... ...... ...... ..++.....+.+++.+||+.||.+
T Consensus 571 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i---~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~ 635 (656)
T 2j0j_A 571 SASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---ENGERL---------PMPPNCPPTLYSLMTKCWAYDPSR 635 (656)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred chhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH---HcCCCC---------CCCccccHHHHHHHHHHcCCChhH
Confidence 99999999999999997 88887654321 121111 111111 112223345888999999999999
Q ss_pred CCCHHHHHHHHHhccc
Q 021774 245 RPQMNQVIKMLTKNIR 260 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~ 260 (307)
|||+.+|++.|++++.
T Consensus 636 RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 636 RPRFTELKAQLSTILE 651 (656)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999988764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=298.72 Aligned_cols=175 Identities=26% Similarity=0.396 Sum_probs=146.4
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||+++.. .....+++.+|+.+|++++||||+++++++... ...|+||||+. ++|.+++. ..
T Consensus 49 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~ 123 (432)
T 3n9x_A 49 NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK----TP 123 (432)
T ss_dssp TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH----SS
T ss_pred CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh----cc
Confidence 46889999999754 445567899999999999999999999999876 57899999995 59999983 44
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc----------------
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---------------- 141 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---------------- 141 (307)
..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.......
T Consensus 124 ~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 200 (432)
T 3n9x_A 124 IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200 (432)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC---------------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccccccccccc
Confidence 5699999999999999999999999 999999999999999999999999999987654321
Q ss_pred -----cccccccCCCCcCCcccc-cCCcccccCceeehHHHHHHHHhCCCCC
Q 021774 142 -----HITTRIAGTTGYLAPEYV-LGGQLTMKADVYSFGVLVLEIISGRNSG 187 (307)
Q Consensus 142 -----~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~ 187 (307)
.......||..|+|||++ .+..++.++|||||||++|||++|..|+
T Consensus 201 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 123556789999999986 4567999999999999999999865443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=291.45 Aligned_cols=238 Identities=21% Similarity=0.254 Sum_probs=171.2
Q ss_pred cCCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|+.||||+++... ......+.+|+.++++++||||+++++++.+.+..++||||+++ +|.+++. ....++
T Consensus 56 ~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~----~~~~~~ 130 (329)
T 3gbz_A 56 TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVS 130 (329)
T ss_dssp TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH----HCTTCC
T ss_pred CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHh----hcCCCC
Confidence 3578899999997653 23345688999999999999999999999999999999999975 9999983 334689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-----CCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-----DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
+..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++........ ......||..|+||
T Consensus 131 ~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 131 MRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPP 206 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCH
Confidence 999999999999999999999 99999999999999 4455699999999986643322 23345679999999
Q ss_pred ccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc--------ccC---CCCCCCC-
Q 021774 157 EYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE--------LVD---PELGEYP- 223 (307)
Q Consensus 157 E~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~- 223 (307)
|++.+. .++.++|||||||++|||++|..||....... ................ ... +......
T Consensus 207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
T 3gbz_A 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL 283 (329)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCH
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccH
Confidence 999874 58999999999999999999999986543211 1111111111100000 000 0000000
Q ss_pred -----HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 -----PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 -----~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
......+.+++.+||+.||.+|||+.++++
T Consensus 284 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 012345788999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=285.47 Aligned_cols=227 Identities=26% Similarity=0.411 Sum_probs=183.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||.+.... ....+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ....+++..
T Consensus 52 ~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~ 126 (314)
T 3com_A 52 ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDE 126 (314)
T ss_dssp TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHH
T ss_pred CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHH
Confidence 458999999987543 336788999999999999999999999999999999999999999999842 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||++.+..+
T Consensus 127 ~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 202 (314)
T 3com_A 127 IATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGY 202 (314)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCB
T ss_pred HHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCccCCCCCccChhhcCCCCC
Confidence 999999999999999999 999999999999999999999999999987654322 2334568899999999999899
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++||||||+++|+|++|..||........ .......... .. ..+......+.+++.+||+.||.+
T Consensus 203 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~-~~------~~~~~~~~~l~~li~~~l~~dp~~ 269 (314)
T 3com_A 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPTNPPP-TF------RKPELWSDNFTDFVKQCLVKSPEQ 269 (314)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCC-CC------SSGGGSCHHHHHHHHHHTCSCTTT
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCc-cc------CCcccCCHHHHHHHHHHccCChhh
Confidence 9999999999999999999999865432111 1111111110 00 111223345888999999999999
Q ss_pred CCCHHHHHH
Q 021774 245 RPQMNQVIK 253 (307)
Q Consensus 245 RPs~~~v~~ 253 (307)
|||+.++++
T Consensus 270 Rpt~~~ll~ 278 (314)
T 3com_A 270 RATATQLLQ 278 (314)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHHh
Confidence 999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=288.88 Aligned_cols=239 Identities=22% Similarity=0.296 Sum_probs=178.5
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEe--------CCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||||++.... ......+.+|++++++++||||+++++++.. .+..++||||+++ +|...+.
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~--- 115 (351)
T 3mi9_A 40 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS--- 115 (351)
T ss_dssp TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHH---
T ss_pred CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHh---
Confidence 578999999886543 2334568899999999999999999999987 4468999999975 7777663
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc---ccccccccCCC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI---THITTRIAGTT 151 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~g~~ 151 (307)
.....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..+.... ........||.
T Consensus 116 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 192 (351)
T 3mi9_A 116 NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192 (351)
T ss_dssp CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCG
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCccccc
Confidence 3345699999999999999999999999 99999999999999999999999999998765322 12234456899
Q ss_pred CcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc---cc--------cCC--
Q 021774 152 GYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---EL--------VDP-- 217 (307)
Q Consensus 152 ~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~~~-- 217 (307)
.|+|||++.+ ..++.++|||||||++|||++|..||....... ............... .. +..
T Consensus 193 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (351)
T 3mi9_A 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPEVWPNVDNYELYEKLELVK 269 (351)
T ss_dssp GGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCS
T ss_pred CccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhhccccccchhhccccccc
Confidence 9999998876 457999999999999999999999987643322 222222211111100 00 000
Q ss_pred CCCCCCHHH------HHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNE------IIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~------~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
......... ...+.+++.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 270 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000111 234778999999999999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=291.29 Aligned_cols=228 Identities=23% Similarity=0.368 Sum_probs=180.4
Q ss_pred CCCCEEEEEEccccC--------hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC
Q 021774 5 TNGRRIAVKPLSAES--------KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
.+|+.||||++.... ......+.+|+.+++++ +||||+++++++......++||||++|++|.+++.
T Consensus 117 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---- 192 (365)
T 2y7j_A 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---- 192 (365)
T ss_dssp TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH----
T ss_pred CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH----
Confidence 479999999887542 12245688999999999 89999999999999999999999999999999984
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
....+++..+..++.||+.||.|||++ |++||||||+||+++.++.++|+|||++....... ......||+.|+|
T Consensus 193 ~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~a 267 (365)
T 2y7j_A 193 EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLA 267 (365)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccC
Confidence 335699999999999999999999999 99999999999999999999999999998765432 2344678999999
Q ss_pred cccccC------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 156 PEYVLG------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 156 PE~~~~------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
||++.+ ..++.++|||||||++|+|++|..||..... ......... ...... .+... .....
T Consensus 268 PE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i~~---~~~~~~--~~~~~----~~~~~ 335 (365)
T 2y7j_A 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLRMIME---GQYQFS--SPEWD----DRSST 335 (365)
T ss_dssp HHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---TCCCCC--HHHHS----SSCHH
T ss_pred hhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh---CCCCCC--Ccccc----cCCHH
Confidence 998863 3588999999999999999999999865322 111111111 110000 00001 12234
Q ss_pred HHHHHHhccccccCCCCCHHHHHH
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+.+++.+||+.||.+|||+.++++
T Consensus 336 ~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 336 VKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc
Confidence 788999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.00 Aligned_cols=234 Identities=22% Similarity=0.286 Sum_probs=173.8
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||++... .......+.+|+.+++.++||||+++++++... ...++||||+++ +|.+.+.
T Consensus 85 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~----- 158 (464)
T 3ttj_A 85 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----- 158 (464)
T ss_dssp TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT-----
T ss_pred CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh-----
Confidence 46889999999754 455567889999999999999999999999755 356999999976 5666662
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..... .......||..|+||
T Consensus 159 -~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aP 232 (464)
T 3ttj_A 159 -MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAP 232 (464)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----C--CCC----CCCTTCCH
T ss_pred -hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--cccCCCcccccccCH
Confidence 2389999999999999999999999 9999999999999999999999999999866442 223446789999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc----------ccc--CCCCCCC--
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL----------ELV--DPELGEY-- 222 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~--~~~~~~~-- 222 (307)
|++.+..++.++|||||||++|||++|+.||....... ....+.......... ..+ .+.....
T Consensus 233 E~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (464)
T 3ttj_A 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 309 (464)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCH
T ss_pred HHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCCh
Confidence 99999999999999999999999999999986543211 111111111000000 000 0000000
Q ss_pred ---------------CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 ---------------PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 ---------------~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.......+.+++.+||+.||++|||+.|+++
T Consensus 310 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 310 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112456889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=301.87 Aligned_cols=227 Identities=25% Similarity=0.334 Sum_probs=179.4
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..||+|++.... ......+.+|+.++++++||||+++++++.+....++||||+++|+|.+.+. ....+++
T Consensus 60 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~ 135 (494)
T 3lij_A 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII----HRMKFNE 135 (494)
T ss_dssp TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHSSCCH
T ss_pred CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH----HcCCCCH
Confidence 468899999987542 3335678999999999999999999999999999999999999999988873 3356899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||++..+.... ......||+.|+|||++
T Consensus 136 ~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l 210 (494)
T 3lij_A 136 VDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVL 210 (494)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHH
Confidence 99999999999999999999 99999999999999764 459999999998765432 23446799999999987
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
. ..++.++|||||||++|+|++|..||...... .+...+ ...... ...+.... ....+.+++.+||+
T Consensus 211 ~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i---~~~~~~--~~~~~~~~----~s~~~~~li~~~L~ 277 (494)
T 3lij_A 211 R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKV---EKGKYT--FDSPEWKN----VSEGAKDLIKQMLQ 277 (494)
T ss_dssp T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCCC--CCSGGGTT----SCHHHHHHHHHHTC
T ss_pred c-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCCCC--CCchhccc----CCHHHHHHHHHHCC
Confidence 6 46899999999999999999999998654331 111111 111111 00111112 22357889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+|||+.++++
T Consensus 278 ~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 278 FDSQRRISAQQALE 291 (494)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCccHHHHhc
Confidence 99999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=281.23 Aligned_cols=224 Identities=24% Similarity=0.351 Sum_probs=173.7
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||.+.... ......+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ...++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~ 109 (276)
T 2h6d_A 34 LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVE 109 (276)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCC
T ss_pred CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCC
Confidence 368999999987542 23456789999999999999999999999999999999999999999999843 34689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++....... ......|+..|+|||++.+
T Consensus 110 ~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 110 EMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--ceecccCCccccCHHHHcC
Confidence 999999999999999999999 99999999999999999999999999998765432 1234568899999999987
Q ss_pred Ccc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..+ +.++||||||+++|+|++|..||..... ..... ....... ..+......+.+++.+||+.
T Consensus 185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~ 248 (276)
T 2h6d_A 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFK----KIRGGVF---------YIPEYLNRSVATLLMHMLQV 248 (276)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCC---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHH----HhhcCcc---------cCchhcCHHHHHHHHHHccC
Confidence 765 6899999999999999999999865322 11111 1111110 01112234577889999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
||.+|||+.++++
T Consensus 249 ~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 249 DPLKRATIKDIRE 261 (276)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCCCHHHHHh
Confidence 9999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=289.83 Aligned_cols=239 Identities=22% Similarity=0.294 Sum_probs=179.0
Q ss_pred CCCCEEEEEEccccCh-----HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK-----QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+++ +|.+++. .....
T Consensus 33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~ 108 (346)
T 1ua2_A 33 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK---DNSLV 108 (346)
T ss_dssp SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHT---TCCSS
T ss_pred CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHH---hcCcC
Confidence 4689999999975421 1124678999999999999999999999999999999999976 8988883 33456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ ......||..|+|||++
T Consensus 109 ~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 109 LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELL 184 (346)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc-cCCcccccccccCchHh
Confidence 88999999999999999999999 999999999999999999999999999987654322 23345789999999998
Q ss_pred cCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccccc------C----CCCCCCC-----
Q 021774 160 LGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV------D----PELGEYP----- 223 (307)
Q Consensus 160 ~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~----~~~~~~~----- 223 (307)
.+. .++.++|||||||++|||++|.+|+..... ......+............. + ......+
T Consensus 185 ~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (346)
T 1ua2_A 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 261 (346)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred hCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhh
Confidence 764 588999999999999999999988765432 11222222221111100000 0 0001111
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
......+.+++.+||+.||.+|||+.++++.
T Consensus 262 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 262 SAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 2223568889999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=303.35 Aligned_cols=227 Identities=24% Similarity=0.318 Sum_probs=182.4
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .......+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++. ....++
T Consensus 49 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~ 124 (484)
T 3nyv_A 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFS 124 (484)
T ss_dssp TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCB
T ss_pred CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH----hcCCCC
Confidence 47899999998654 23456789999999999999999999999999999999999999999999883 345699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL---DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
+..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++..+.... ......||+.|+|||+
T Consensus 125 ~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~ 199 (484)
T 3nyv_A 125 EVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEV 199 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc--ccccCCCCccccCcee
Confidence 999999999999999999999 99999999999999 567889999999998765432 2344568999999998
Q ss_pred ccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 159 ~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+.+ .++.++|||||||++|+|++|..||...... .....+ ........ .+. .......+.+++.+||
T Consensus 200 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i---~~~~~~~~--~~~----~~~~s~~~~~li~~~L 266 (484)
T 3nyv_A 200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKV---EKGKYTFE--LPQ----WKKVSESAKDLIRKML 266 (484)
T ss_dssp HHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHCCCCCC--SGG----GGGSCHHHHHHHHHHT
T ss_pred ecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HcCCCCCC--Ccc----cccCCHHHHHHHHHHC
Confidence 876 6899999999999999999999998654321 111111 11111100 000 1123345788999999
Q ss_pred ccccCCCCCHHHHHH
Q 021774 239 QAAASRRPQMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~ 253 (307)
+.||.+|||+.++++
T Consensus 267 ~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 267 TYVPSMRISARDALD 281 (484)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred CCChhHCcCHHHHhh
Confidence 999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=301.60 Aligned_cols=227 Identities=23% Similarity=0.319 Sum_probs=179.2
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++... .......+.+|++++++++||||+++++++.+....++||||+.+++|.+.+. ....+++
T Consensus 45 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~ 120 (486)
T 3mwu_A 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSE 120 (486)
T ss_dssp TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCH
T ss_pred CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHH----hcCCCCH
Confidence 46899999998643 22345678999999999999999999999999999999999999999988873 3356999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
..+..++.||+.||.|||++ ||+||||||+||+++ .++.+||+|||++..+.... ......||+.|+|||++
T Consensus 121 ~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~ 195 (486)
T 3mwu_A 121 HDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVL 195 (486)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGG
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHh
Confidence 99999999999999999999 999999999999995 45679999999998665432 23445789999999988
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+ .++.++|||||||++|+|++|..||..... ......+ ........ .+. .......+.+++.+||+
T Consensus 196 ~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i---~~~~~~~~--~~~----~~~~s~~~~~li~~~L~ 262 (486)
T 3mwu_A 196 RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRV---ETGKYAFD--LPQ----WRTISDDAKDLIRKMLT 262 (486)
T ss_dssp GS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHTCCCSC--SGG----GGGSCHHHHHHHHHHTC
T ss_pred CC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhCCCCCC--Ccc----cCCCCHHHHHHHHHHcC
Confidence 76 589999999999999999999999865432 1111111 11111100 001 11223457889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+|||+.++++
T Consensus 263 ~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 263 FHPSLRITATQCLE 276 (486)
T ss_dssp SSTTTSCCHHHHHH
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.76 Aligned_cols=228 Identities=22% Similarity=0.314 Sum_probs=168.9
Q ss_pred CCCCEEEEEEccccC--------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||++.... ......+.+|+++|++++||||+++++++. .+..++||||+++++|.+++ ..
T Consensus 158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l----~~ 232 (419)
T 3i6u_A 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKV----VG 232 (419)
T ss_dssp TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGT----SS
T ss_pred CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHH----hc
Confidence 568899999987531 122235789999999999999999999975 45679999999999999887 34
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccCCCCcccccccccCCCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIAGTTGY 153 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 153 (307)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...... ......||+.|
T Consensus 233 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y 307 (419)
T 3i6u_A 233 NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTY 307 (419)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccceecCCCc--cccccCCCCCc
Confidence 56799999999999999999999999 999999999999997654 49999999998765432 23446789999
Q ss_pred CCcccccC---CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 154 LAPEYVLG---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 154 ~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
+|||++.+ ..++.++|||||||++|+|++|..||........ +.. ........ .. + .........+
T Consensus 308 ~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~----~i~~~~~~-~~-~---~~~~~~~~~~ 376 (419)
T 3i6u_A 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----QITSGKYN-FI-P---EVWAEVSEKA 376 (419)
T ss_dssp CCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----HHHTTCCC-CC-H---HHHTTSCHHH
T ss_pred cCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----HHhcCCCC-CC-c---hhhcccCHHH
Confidence 99998853 5788999999999999999999999865433211 111 11111100 00 0 0001123458
Q ss_pred HHHHHhccccccCCCCCHHHHHH
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+++.+||+.||.+|||+.++++
T Consensus 377 ~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 377 LDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhC
Confidence 88999999999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=290.47 Aligned_cols=234 Identities=24% Similarity=0.370 Sum_probs=176.4
Q ss_pred CEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 8 RRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 8 ~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
..||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..+
T Consensus 56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~ 132 (319)
T 2y4i_B 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKT 132 (319)
T ss_dssp SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHH
T ss_pred CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHH
Confidence 458999987542 23345678899999999999999999999999999999999999999999842 3346899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc----ccccccccCCCCcCCcccccC
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI----THITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+.++.|++.||+|||++ |++||||||+||+++ ++.++|+|||++....... ........|+..|+|||++.+
T Consensus 133 ~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 133 RQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred HHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence 99999999999999999 999999999999998 6799999999987653211 112233458889999998864
Q ss_pred ---------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 162 ---------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 162 ---------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
..++.++||||||+++|||++|..||....... . ....... ....... ... ...+.+
T Consensus 209 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~---~~~~~~~-~~~~~~~---~~~----~~~l~~ 274 (319)
T 2y4i_B 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---I---IWQMGTG-MKPNLSQ---IGM----GKEISD 274 (319)
T ss_dssp BSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---H---HHHHHTT-CCCCCCC---SSC----CTTHHH
T ss_pred ccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHhccC-CCCCCCc---CCC----CHHHHH
Confidence 357889999999999999999999986543211 1 1111111 1111100 011 223778
Q ss_pred HHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 233 VAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
++.+||+.||.+|||+.++++.|+++.+..
T Consensus 275 li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 275 ILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 889999999999999999999999887654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=286.41 Aligned_cols=229 Identities=23% Similarity=0.414 Sum_probs=176.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||+|.+..........+.+|++++++++||||+++++++...+..++||||+++++|.+++.. ....+++..
T Consensus 42 ~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~ 118 (302)
T 2j7t_A 42 ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQ 118 (302)
T ss_dssp TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHH
T ss_pred CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHH
Confidence 35889999999877666678899999999999999999999999999999999999999999998843 234689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc-----
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV----- 159 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----- 159 (307)
+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++...... ........|+..|+|||++
T Consensus 119 ~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 194 (302)
T 2j7t_A 119 IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETM 194 (302)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccccccccCChhhcCCeeeccccC
Confidence 999999999999999999 9999999999999999999999999987532111 0112335688999999988
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+..++.++||||||+++|+|++|..|+....... . ........... . ..+......+.+++.+||+
T Consensus 195 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~~~~~~~-~------~~~~~~~~~l~~li~~~l~ 261 (302)
T 2j7t_A 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---V---LLKIAKSDPPT-L------LTPSKWSVEFRDFLKIALD 261 (302)
T ss_dssp TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHHSCCCC-C------SSGGGSCHHHHHHHHHHSC
T ss_pred CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HHHHhccCCcc-c------CCccccCHHHHHHHHHHcc
Confidence 35678899999999999999999999986543211 1 11111111110 0 1112233458889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+|||+.++++
T Consensus 262 ~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 262 KNPETRPSAAQLLE 275 (302)
T ss_dssp SCTTTSCCHHHHTT
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=280.17 Aligned_cols=228 Identities=22% Similarity=0.307 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccccC---------hHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES---------KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||||.+.... ......+.+|+++++++. ||||+++++++...+..++||||+++++|.+++.
T Consensus 40 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--- 116 (298)
T 1phk_A 40 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--- 116 (298)
T ss_dssp TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---
T ss_pred CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHh---
Confidence 468899999987542 233467889999999995 9999999999999999999999999999999984
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..+..++.|++.||.|||++ |++||||+|+||+++.++.++|+|||++....... ......|+..|+
T Consensus 117 -~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~ 190 (298)
T 1phk_A 117 -EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYL 190 (298)
T ss_dssp -HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGC
T ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCc--ccccccCCcccc
Confidence 235689999999999999999999999 99999999999999999999999999998765432 233456889999
Q ss_pred Cccccc------CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 155 APEYVL------GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 155 aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
|||++. ...++.++||||||+++|+|++|..||...... ...... ...... ...+. ......
T Consensus 191 aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~---~~~~~~--~~~~~----~~~~~~ 258 (298)
T 1phk_A 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRMI---MSGNYQ--FGSPE----WDDYSD 258 (298)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCCC--CCTTT----GGGSCH
T ss_pred CHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHHHH---hcCCcc--cCccc----ccccCH
Confidence 999885 456889999999999999999999998653321 111111 111110 00011 123344
Q ss_pred HHHHHHHhccccccCCCCCHHHHHH
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.+++.+||+.||.+|||+.++++
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 259 TVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHccCCcccCCCHHHHHh
Confidence 5888999999999999999999865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.65 Aligned_cols=233 Identities=24% Similarity=0.313 Sum_probs=167.1
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
..+|+.||||++... +......+.+|++++++++||||+++++++... ...++|||++ +++|.+++.
T Consensus 51 ~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---- 125 (367)
T 2fst_X 51 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---- 125 (367)
T ss_dssp TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------
T ss_pred CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh----
Confidence 356889999999753 345567889999999999999999999999754 5679999999 789998873
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..... .....||..|+|
T Consensus 126 -~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~a 197 (367)
T 2fst_X 126 -CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRA 197 (367)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc----CCCcCcCcCccC
Confidence 24699999999999999999999999 9999999999999999999999999999865432 334578999999
Q ss_pred cccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccC--------------CCCC
Q 021774 156 PEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD--------------PELG 220 (307)
Q Consensus 156 PE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~ 220 (307)
||++.+ ..++.++|||||||++|||++|+.||....... ....+........ ...+. +...
T Consensus 198 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~ 273 (367)
T 2fst_X 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG-AELLKKISSESARNYIQSLTQMP 273 (367)
T ss_dssp HHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCC-HHHHTTCCCHHHHHHHHTSCCCC
T ss_pred hHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC-HHHHHHhhhHHHHHHHhccCCCC
Confidence 999887 678999999999999999999999986543211 1111111111000 00000 0000
Q ss_pred CC-----CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 EY-----PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ~~-----~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.. .+.....+.+++.+||+.||.+|||+.++++
T Consensus 274 ~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 274 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 0112345788999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=287.71 Aligned_cols=234 Identities=18% Similarity=0.255 Sum_probs=181.7
Q ss_pred CCCEEEEEEccccChHh-----------------HHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQG-----------------VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDR 68 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 68 (307)
+|+.||||.+....... ...+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 132 (348)
T 2pml_X 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK 132 (348)
T ss_dssp TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSE
T ss_pred CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHH
Confidence 78899999987542111 1779999999999999999999999999999999999999999999
Q ss_pred H------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc
Q 021774 69 V------LLGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT 141 (307)
Q Consensus 69 ~------l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 141 (307)
+ +.. .....+++..+..++.|++.||.|||+ + |++||||+|+||+++.++.++|+|||++......
T Consensus 133 ~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 205 (348)
T 2pml_X 133 FDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-- 205 (348)
T ss_dssp ESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred HHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCcEEEeccccccccccc--
Confidence 8 421 225679999999999999999999999 9 9999999999999999999999999999876443
Q ss_pred cccccccCCCCcCCcccccCC-cccc-cCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccC---
Q 021774 142 HITTRIAGTTGYLAPEYVLGG-QLTM-KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD--- 216 (307)
Q Consensus 142 ~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 216 (307)
......|+..|+|||++.+. .++. ++||||||+++|||++|..||....... ... ............+
T Consensus 206 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~~i~~~~~~~~~~~~~ 278 (348)
T 2pml_X 206 -KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--ELF----NNIRTKNIEYPLDRNH 278 (348)
T ss_dssp -EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HHH----HHHTSCCCCCCCSSSS
T ss_pred -cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHH----HHHhccCcCCccchhh
Confidence 23445689999999999887 6766 9999999999999999999987544311 111 1111111100000
Q ss_pred ---C----CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 217 ---P----ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 217 ---~----~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+ ............+.+++.+||+.||.+|||+.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 279 FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp STTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000001233456888999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=280.38 Aligned_cols=234 Identities=19% Similarity=0.255 Sum_probs=178.7
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+.||||+++... .+.+.+|+.++++++ ||||+++++++.+ ....++||||+.+++|.+++. .+
T Consensus 58 ~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~ 127 (330)
T 3nsz_A 58 ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TL 127 (330)
T ss_dssp TTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GC
T ss_pred CCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-------hC
Confidence 3578999999998544 356889999999996 9999999999998 667899999999999999872 38
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++........ .....|+..|+|||++
T Consensus 128 ~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~ 202 (330)
T 3nsz_A 128 TDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELL 202 (330)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhh
Confidence 8999999999999999999999 999999999999999776 899999999987654322 3345688899999998
Q ss_pred cC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHH--------HHhhcCC--------------cccccC
Q 021774 160 LG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW--------QLHQEEK--------------PLELVD 216 (307)
Q Consensus 160 ~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~--------------~~~~~~ 216 (307)
.+ ..++.++|||||||++|+|++|+.||......... +..... ....... ......
T Consensus 203 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (330)
T 3nsz_A 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281 (330)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGG
T ss_pred cCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchh
Confidence 77 67899999999999999999999998543332111 111000 0000000 000000
Q ss_pred CCC-CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 217 PEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 217 ~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
... ..........+.+++.+||+.||.+|||+.++++
T Consensus 282 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp GGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0111123456889999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=279.30 Aligned_cols=237 Identities=21% Similarity=0.336 Sum_probs=177.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEE--------------eCCeeEEEEeccCCCCHHHHh
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV--------------QGTRRILVYEYVENNSLDRVL 70 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~l 70 (307)
.+|+.||||++...+....+.+.+|++++++++||||+++++++. .....++||||++ |+|.+++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 112 (320)
T 2i6l_A 34 DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL 112 (320)
T ss_dssp TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHH
T ss_pred CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHh
Confidence 358899999998777777788999999999999999999999874 3467899999997 5999998
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCceEEeeccCcccCCCCcc--cccccc
Q 021774 71 LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNIT--HITTRI 147 (307)
Q Consensus 71 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 147 (307)
. ...+++..+..++.|++.||+|||++ |++||||||+||+++ +++.+||+|||++........ ......
T Consensus 113 ~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 184 (320)
T 2i6l_A 113 E-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184 (320)
T ss_dssp T-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGG
T ss_pred h-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccc
Confidence 3 34689999999999999999999999 999999999999997 567999999999987643211 122345
Q ss_pred cCCCCcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhh-----------cCCcc---
Q 021774 148 AGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQ-----------EEKPL--- 212 (307)
Q Consensus 148 ~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~--- 212 (307)
.++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......... .....
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (320)
T 2i6l_A 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILESIPVVHEEDRQELLSVIPVYIR 261 (320)
T ss_dssp GSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHSCCCCHHHHHHHHTTSCHHHH
T ss_pred cccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCchhhhhhhhhcCccccc
Confidence 67889999998865 6789999999999999999999999875432111 111111000 00000
Q ss_pred -cccCCC--CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 213 -ELVDPE--LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 213 -~~~~~~--~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+. +....+.....+.+++.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 262 NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 00011123345888999999999999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=284.62 Aligned_cols=228 Identities=22% Similarity=0.306 Sum_probs=174.8
Q ss_pred CCCCEEEEEEccccC--------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||.+.... ......+.+|++++++++||||+++++++...+ .++||||+++++|.+++ ..
T Consensus 33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~----~~ 107 (322)
T 2ycf_A 33 KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV----VG 107 (322)
T ss_dssp TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHH----ST
T ss_pred CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHH----hc
Confidence 468899999987532 122345889999999999999999999987665 79999999999999988 34
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---eEEeeccCcccCCCCcccccccccCCCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGY 153 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 153 (307)
...+++..+..++.||+.||.|||++ |++||||||+||+++.++. +||+|||++....... ......|+..|
T Consensus 108 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y 182 (322)
T 2ycf_A 108 NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTY 182 (322)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCc
Confidence 56799999999999999999999999 9999999999999987665 9999999998765432 22345689999
Q ss_pred CCccccc---CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHH
Q 021774 154 LAPEYVL---GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRY 230 (307)
Q Consensus 154 ~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
+|||++. ...++.++||||||+++|+|++|..||........ +...... .... . .+.. .......+
T Consensus 183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~----~~~~-~-~~~~---~~~~~~~~ 251 (322)
T 2ycf_A 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS----GKYN-F-IPEV---WAEVSEKA 251 (322)
T ss_dssp CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH----TCCC-C-CHHH---HTTSCHHH
T ss_pred cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh----Cccc-c-Cchh---hhhcCHHH
Confidence 9999874 46788999999999999999999999865433211 1111111 1000 0 0000 01123457
Q ss_pred HHHHHhccccccCCCCCHHHHHH
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+++.+||+.||.+||++.++++
T Consensus 252 ~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 252 LDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcccCHhhCCCHHHHhh
Confidence 88999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.75 Aligned_cols=227 Identities=25% Similarity=0.337 Sum_probs=179.8
Q ss_pred CCCCEEEEEEccccCh-------------HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhc
Q 021774 5 TNGRRIAVKPLSAESK-------------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLL 71 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~ 71 (307)
.+|+.||||++..... .....+.+|+.++++++||||+++++++.+....++||||++||+|.+++.
T Consensus 59 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 138 (504)
T 3q5i_A 59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII 138 (504)
T ss_dssp TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH
Confidence 4688999999875421 235678999999999999999999999999999999999999999998883
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---ceEEeeccCcccCCCCccccccccc
Q 021774 72 GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---NPKIGDFGLAKLFPDNITHITTRIA 148 (307)
Q Consensus 72 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~ 148 (307)
....+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..+.... ......
T Consensus 139 ----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~ 209 (504)
T 3q5i_A 139 ----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRL 209 (504)
T ss_dssp ----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCC
T ss_pred ----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC--cccccc
Confidence 335699999999999999999999999 999999999999998776 69999999998765432 234457
Q ss_pred CCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 149 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+...+ ......... +... ....
T Consensus 210 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i---~~~~~~~~~--~~~~----~~s~ 276 (504)
T 3q5i_A 210 GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKKV---EKGKYYFDF--NDWK----NISD 276 (504)
T ss_dssp SCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHCCCCCCH--HHHT----TSCH
T ss_pred CCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HcCCCCCCc--cccC----CCCH
Confidence 999999999876 46899999999999999999999998654321 111111 111110000 0001 1224
Q ss_pred HHHHHHHhccccccCCCCCHHHHHH
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.+++.+||+.||.+|||+.++++
T Consensus 277 ~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 277 EAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhc
Confidence 5888999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=284.92 Aligned_cols=234 Identities=24% Similarity=0.301 Sum_probs=170.8
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..++||||+++ +|.+++.
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 121 (371)
T 2xrw_A 48 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----- 121 (371)
T ss_dssp TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH-----
T ss_pred CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh-----
Confidence 46889999998753 3455677899999999999999999999998665 77999999975 7888773
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++....... ......||..|+||
T Consensus 122 -~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aP 195 (371)
T 2xrw_A 122 -MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAP 195 (371)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCH
T ss_pred -hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc--ccCCceecCCccCH
Confidence 2488999999999999999999999 99999999999999999999999999998654321 23345789999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHh-------------------hcCCcc-----
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH-------------------QEEKPL----- 212 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~----- 212 (307)
|++.+..++.++|||||||++|+|++|+.||....... ......... ......
T Consensus 196 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (371)
T 2xrw_A 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSF 272 (371)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCH
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccch
Confidence 99999999999999999999999999999986543211 111010000 000000
Q ss_pred -cccC----CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 213 -ELVD----PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 213 -~~~~----~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.... +............+.+++.+||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 273 EKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000 0000001123567889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=280.14 Aligned_cols=228 Identities=23% Similarity=0.383 Sum_probs=171.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe-------------CCeeEEEEeccCCCCHHHHhc
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ-------------GTRRILVYEYVENNSLDRVLL 71 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~ 71 (307)
.+|+.||||.+... ......+.+|+.++++++||||+++++++.+ .+..++||||+++++|.+++.
T Consensus 29 ~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 107 (303)
T 1zy4_A 29 LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107 (303)
T ss_dssp TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHH
T ss_pred CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhh
Confidence 47899999998643 3455789999999999999999999999875 346789999999999999994
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-----------
Q 021774 72 GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI----------- 140 (307)
Q Consensus 72 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----------- 140 (307)
. ....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 108 ~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 181 (303)
T 1zy4_A 108 S---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181 (303)
T ss_dssp H---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------
T ss_pred c---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccc
Confidence 3 345678899999999999999999999 99999999999999999999999999998664321
Q ss_pred --ccccccccCCCCcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCC
Q 021774 141 --THITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDP 217 (307)
Q Consensus 141 --~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (307)
........|+..|+|||++.+. .++.++||||||+++|+|++ |+..... .... . ........ ...
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--~~~~---~-~~~~~~~~--~~~- 249 (303)
T 1zy4_A 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--RVNI---L-KKLRSVSI--EFP- 249 (303)
T ss_dssp ------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHHH---H-HHHHSTTC--CCC-
T ss_pred ccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--HHHH---H-Hhcccccc--ccC-
Confidence 1122345688999999998764 68999999999999999998 3322111 1111 1 11111110 011
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..........+.+++.+||+.||.+|||+.++++
T Consensus 250 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 250 --PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1222334455788999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=278.73 Aligned_cols=231 Identities=23% Similarity=0.370 Sum_probs=166.8
Q ss_pred CCCCEEEEEEccccC-h-HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES-K-QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||+++... . .....+.++...++.++||||+++++++.+.+..++||||+++ +|.+++......+..+++
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~ 108 (290)
T 3fme_A 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPE 108 (290)
T ss_dssp TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCH
T ss_pred CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCH
Confidence 578899999997652 2 2333455566667888999999999999999999999999975 888877544445677999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc---
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV--- 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~--- 159 (307)
..+..++.|++.||+|||++. |++||||||+||+++.++.+||+|||++........ .....|+..|+|||++
T Consensus 109 ~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~ 184 (290)
T 3fme_A 109 DILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPE 184 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCC
T ss_pred HHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccccc--ccccCCCccccChhhcChh
Confidence 999999999999999999831 899999999999999999999999999987654322 2334689999999996
Q ss_pred -cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 160 -LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 160 -~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
.+..++.++||||||+++|+|++|+.||....... ..+ .......... . ........+.+++.+||
T Consensus 185 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~~~~~~~~------~--~~~~~~~~~~~li~~~l 251 (290)
T 3fme_A 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQL----KQVVEEPSPQ------L--PADKFSAEFVDFTSQCL 251 (290)
T ss_dssp TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHH----HHHHHSCCCC------C--CTTTSCHHHHHHHHHHT
T ss_pred hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHH----HHHhccCCCC------c--ccccCCHHHHHHHHHHh
Confidence 45678999999999999999999999986432211 111 1111111111 0 01122345788999999
Q ss_pred ccccCCCCCHHHHHH
Q 021774 239 QAAASRRPQMNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~ 253 (307)
+.||.+|||+.++++
T Consensus 252 ~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 252 KKNSKERPTYPELMQ 266 (290)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred hcChhhCcCHHHHHh
Confidence 999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=293.24 Aligned_cols=229 Identities=9% Similarity=0.011 Sum_probs=160.8
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHH---HHHhcCCCCCcccee-------eEEEeC-----------------Cee
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEI---MTLSNVRHPNLVELI-------GCCVQG-----------------TRR 54 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~-----------------~~~ 54 (307)
.+|+.||||++.... ......+.+|+ ..|+. +||||++++ +++... ...
T Consensus 85 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (371)
T 3q60_A 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY 163 (371)
T ss_dssp TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEE
T ss_pred CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeE
Confidence 478999999998753 24455677885 55555 799987755 455433 337
Q ss_pred EEEEeccCCCCHHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEe
Q 021774 55 ILVYEYVENNSLDRVLLGATKANIKLNWEKR------SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIG 128 (307)
Q Consensus 55 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~ 128 (307)
++||||++ ++|.+++... +..+.+..+ ..++.||+.||+|||++ ||+||||||+||||+.++.+||+
T Consensus 164 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~ 236 (371)
T 3q60_A 164 LLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLG 236 (371)
T ss_dssp EEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEEC
T ss_pred EEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEE
Confidence 99999998 7999999542 223455555 77889999999999999 99999999999999999999999
Q ss_pred eccCcccCCCCcccccccccCCCCcCCcccccC--CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHh
Q 021774 129 DFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH 206 (307)
Q Consensus 129 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 206 (307)
|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||+||+.||.......... .
T Consensus 237 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~ 304 (371)
T 3q60_A 237 DVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------W 304 (371)
T ss_dssp CGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------C
T ss_pred ecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------h
Confidence 99999866432 224456799999999987 679999999999999999999999987664322110 0
Q ss_pred hcCCcccccCCCC-CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 207 QEEKPLELVDPEL-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 207 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
............. ..........+.+++.+||+.||++|||+.++++
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 0111233456888999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.44 Aligned_cols=228 Identities=24% Similarity=0.400 Sum_probs=173.0
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEe------CCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||++..... ....+.+|+.+++++ +||||+++++++.. .+..++||||+++++|.+++... ..
T Consensus 47 ~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~ 123 (326)
T 2x7f_A 47 KTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KG 123 (326)
T ss_dssp TTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GG
T ss_pred CCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--cc
Confidence 4789999999875432 336788999999999 89999999999987 46889999999999999998542 23
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++........ ......|+..|+|||
T Consensus 124 ~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE 199 (326)
T 2x7f_A 124 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPE 199 (326)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChh
Confidence 5689999999999999999999999 999999999999999999999999999986543221 223456899999999
Q ss_pred ccc-----CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 158 YVL-----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 158 ~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
++. +..++.++||||||+++|+|++|..||........ .......... ... .......+.+
T Consensus 200 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~-~~~-------~~~~~~~l~~ 265 (326)
T 2x7f_A 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIPRNPAP-RLK-------SKKWSKKFQS 265 (326)
T ss_dssp HHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCC-CCS-------CSCSCHHHHH
T ss_pred hhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhhcCccc-cCC-------ccccCHHHHH
Confidence 986 46788999999999999999999999865432111 1111111111 000 1112235788
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||+.||.+||++.++++
T Consensus 266 li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 266 FIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccChhhCCCHHHHhh
Confidence 899999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.40 Aligned_cols=225 Identities=24% Similarity=0.297 Sum_probs=182.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||+++.. .......+..|.+++..+ +||+|+++++++.+.+..|+||||++||+|..++. ....+
T Consensus 364 ~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~----~~~~~ 439 (674)
T 3pfq_A 364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRF 439 (674)
T ss_dssp SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHH----HHSSC
T ss_pred CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHH----hcCCC
Confidence 46888999998753 223456788999999988 79999999999999999999999999999999984 33469
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 440 ~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 440 KEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-cccccccCCCcccCHhhhc
Confidence 9999999999999999999999 99999999999999999999999999998643322 2245578999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|..||..... ..+.. .... ... .++......+.+++.+||+.
T Consensus 516 ~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~---~i~~-~~~---------~~p~~~s~~~~~li~~lL~~ 579 (674)
T 3pfq_A 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ---SIME-HNV---------AYPKSMSKEAVAICKGLMTK 579 (674)
T ss_dssp CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHS-SCC---------CCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHH---HHHh-CCC---------CCCccCCHHHHHHHHHHccC
Confidence 99999999999999999999999999865432 11111 1111 111 12223344588899999999
Q ss_pred ccCCCCCH-----HHHHH
Q 021774 241 AASRRPQM-----NQVIK 253 (307)
Q Consensus 241 ~p~~RPs~-----~~v~~ 253 (307)
||.+||++ ++|++
T Consensus 580 dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 580 HPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSTTCTTCSTTHHHHHHS
T ss_pred CHHHCCCCCCCcHHHHhc
Confidence 99999997 66653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.09 Aligned_cols=239 Identities=22% Similarity=0.235 Sum_probs=171.9
Q ss_pred ccCCCCEEEEEEcccc-----------ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeEEEEeccCCCCH
Q 021774 3 TLTNGRRIAVKPLSAE-----------SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSL 66 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL 66 (307)
+..+|+.||||++... +....+.+.+|++++++++||||+++++++... ...++||||+. |+|
T Consensus 42 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l 120 (362)
T 3pg1_A 42 VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDL 120 (362)
T ss_dssp ECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEH
T ss_pred ECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCH
Confidence 4566999999988643 123347899999999999999999999998643 36799999997 588
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccccccc
Q 021774 67 DRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTR 146 (307)
Q Consensus 67 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 146 (307)
.+++. .....+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....... ....
T Consensus 121 ~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 192 (362)
T 3pg1_A 121 AQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTH 192 (362)
T ss_dssp HHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC--------------
T ss_pred HHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCccccccccc--ccce
Confidence 88774 3445699999999999999999999999 99999999999999999999999999997544322 2334
Q ss_pred ccCCCCcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC---------------
Q 021774 147 IAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--------------- 210 (307)
Q Consensus 147 ~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------- 210 (307)
..|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .............
T Consensus 193 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 269 (362)
T 3pg1_A 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---QLNKIVEVVGTPKIEDVVMFSSPSARDY 269 (362)
T ss_dssp ---CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHHHTSCHHHHHH
T ss_pred ecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChHHhhhccchhhhHH
Confidence 568889999999877 678999999999999999999999987543211 1111111111000
Q ss_pred ----cccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 211 ----PLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 211 ----~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.............+.....+.+++.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp TTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000000000111122345788999999999999999999976
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=276.75 Aligned_cols=228 Identities=22% Similarity=0.261 Sum_probs=176.4
Q ss_pred CCCCEEEEEEccccC----hHhHHHHHHHHHHHhcCCCCCccceeeEEE--eCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES----KQGVREFITEIMTLSNVRHPNLVELIGCCV--QGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|+++... ......+.+|++++++++||||+++++++. +....++||||++++ |.+++.. ....
T Consensus 28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~ 104 (305)
T 2wtk_C 28 ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDS--VPEK 104 (305)
T ss_dssp TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHH--STTC
T ss_pred CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHh--Cccc
Confidence 468899999997542 234577999999999999999999999985 445789999999876 7666643 2345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++....... ........|+..|+|||
T Consensus 105 ~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 181 (305)
T 2wtk_C 105 RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181 (305)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChh
Confidence 699999999999999999999999 99999999999999999999999999998765322 22234456899999999
Q ss_pred cccCCc--ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 158 YVLGGQ--LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 158 ~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
++.+.. ++.++||||||+++|||++|..||...... .... . ...... ..+......+.+++.
T Consensus 182 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~-i~~~~~---------~~~~~~~~~l~~li~ 245 (305)
T 2wtk_C 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFE---N-IGKGSY---------AIPGDCGPPLSDLLK 245 (305)
T ss_dssp HHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---H-HHHCCC---------CCCSSSCHHHHHHHH
T ss_pred hccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHH---H-HhcCCC---------CCCCccCHHHHHHHH
Confidence 987643 478999999999999999999998653221 1111 1 111111 111122345778899
Q ss_pred hccccccCCCCCHHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~~ 254 (307)
+||+.||.+|||+.++++.
T Consensus 246 ~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 246 GMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHTCSSTTTSCCHHHHHHS
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.58 Aligned_cols=231 Identities=23% Similarity=0.301 Sum_probs=169.6
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC---C
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK---L 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~---~ 80 (307)
.+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+.+..++||||+. |+|.+++......... .
T Consensus 37 ~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~ 112 (434)
T 2rio_A 37 FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQ 112 (434)
T ss_dssp SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC----------
T ss_pred ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhc
Confidence 568999999987532 35678899999886 89999999999999999999999995 5999999543322211 1
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-------------CceEEeeccCcccCCCCccc---cc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-------------FNPKIGDFGLAKLFPDNITH---IT 144 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-------------~~~kl~dfg~~~~~~~~~~~---~~ 144 (307)
++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||++......... ..
T Consensus 113 ~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 189 (434)
T 2rio_A 113 KEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189 (434)
T ss_dssp --CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------
T ss_pred cchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeee
Confidence 3334678999999999999999 99999999999999654 47999999999877553221 12
Q ss_pred ccccCCCCcCCcccccC-------CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccC
Q 021774 145 TRIAGTTGYLAPEYVLG-------GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD 216 (307)
Q Consensus 145 ~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (307)
....||..|+|||++.+ ..++.++|||||||++|||+| |..||........ ..........
T Consensus 190 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--------~i~~~~~~~~--- 258 (434)
T 2rio_A 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--------NIIRGIFSLD--- 258 (434)
T ss_dssp -----CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--------HHHHTCCCCC---
T ss_pred cCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--------HHhcCCCCcc---
Confidence 34579999999999865 568999999999999999999 8888865433221 1111111100
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 217 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.............+.+++.+||+.||.+|||+.+|++
T Consensus 259 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 259 EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0011123455677889999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=284.94 Aligned_cols=237 Identities=24% Similarity=0.310 Sum_probs=179.3
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||++... .......+.+|++++++++||||+++++++... ...++|||++. ++|.+++. ..
T Consensus 50 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~-----~~ 123 (364)
T 3qyz_A 50 LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK-----TQ 123 (364)
T ss_dssp TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHH-----HC
T ss_pred CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHH-----hC
Confidence 46889999999754 344557899999999999999999999999765 36799999996 59999883 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAP 156 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aP 156 (307)
.+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++......... ......||..|+||
T Consensus 124 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 200 (364)
T 3qyz_A 124 HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCC
Confidence 589999999999999999999999 9999999999999999999999999999876543221 12445789999999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc---------------cccCC-C-
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL---------------ELVDP-E- 218 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~-~- 218 (307)
|++.+ ..++.++|||||||++|+|++|+.||........ .............. ..... .
T Consensus 201 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (364)
T 3qyz_A 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277 (364)
T ss_dssp HHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC
T ss_pred HHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCC
Confidence 98765 4589999999999999999999999865443221 11111111000000 00000 0
Q ss_pred -CCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 219 -LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 219 -~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.....+.+++.+||+.||.+|||+.++++
T Consensus 278 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00001122345788999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.76 Aligned_cols=231 Identities=22% Similarity=0.343 Sum_probs=175.0
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCee------EEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR------ILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||++... .......+.+|+.++++++||||+++++++...+.. ++||||+. ++|.+++
T Consensus 65 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------ 137 (371)
T 4exu_A 65 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM------ 137 (371)
T ss_dssp TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT------
T ss_pred CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHh------
Confidence 46899999999764 345567889999999999999999999999877655 99999996 5888887
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
...+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++...... .....||..|+||
T Consensus 138 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aP 210 (371)
T 4exu_A 138 GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAP 210 (371)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCH
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC----cCCcccCccccCH
Confidence 23489999999999999999999999 9999999999999999999999999999865432 3345689999999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccc---------------c----C
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL---------------V----D 216 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~----~ 216 (307)
|++.+ ..++.++|||||||++|+|++|+.||....... ............ .... + .
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (371)
T 4exu_A 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVP-GTEFVQKLNDKAAKSYIQSLPQTPR 286 (371)
T ss_dssp HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-CHHHHTTCSCHHHHHHHHHSCCCCC
T ss_pred HHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-cHHHHHHhhhhhhhhhhhccCCCcc
Confidence 99887 678999999999999999999999986543211 111111111000 0000 0 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 217 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.......+.....+.+++.+||+.||.+|||+.++++
T Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 287 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000011123456888999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=289.37 Aligned_cols=237 Identities=23% Similarity=0.259 Sum_probs=174.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||++..... .+.+|++++++++||||+++++++... ...++||||+++ +|.+++........
T Consensus 77 ~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~ 151 (420)
T 1j1b_A 77 DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151 (420)
T ss_dssp TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTC
T ss_pred CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccC
Confidence 4689999999875422 234799999999999999999998642 135799999976 67766643334556
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.||+.||+|||++ ||+||||||+||||+.+ +.+||+|||+++.+..... .....||..|+|||
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE 226 (420)
T 1j1b_A 152 TLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPE 226 (420)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHH
Confidence 799999999999999999999999 99999999999999965 5689999999987644322 23456899999999
Q ss_pred cccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHh---------hcCCcccccCCCCCC------
Q 021774 158 YVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLH---------QEEKPLELVDPELGE------ 221 (307)
Q Consensus 158 ~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~------ 221 (307)
++.+. .++.++|||||||++|||++|+.||...... ..+........ ..........+.+..
T Consensus 227 ~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 304 (420)
T 1j1b_A 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 304 (420)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHH
T ss_pred HHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHh
Confidence 98764 7899999999999999999999998754322 11221111100 000011111111111
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+.+.....+.+|+.+||+.||.+||++.++++
T Consensus 305 ~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 305 FRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 11223456889999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.10 Aligned_cols=243 Identities=20% Similarity=0.299 Sum_probs=168.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCC-----CCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGAT-----KAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-----~~~ 77 (307)
.+|+.||||++..... ...+.+|+.+|++++||||+++++++.. ....++||||+.+ +|.+++.... ...
T Consensus 46 ~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 122 (405)
T 3rgf_A 46 KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122 (405)
T ss_dssp SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-----
T ss_pred CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccc
Confidence 3578999999985432 2467899999999999999999999965 6688999999965 7877763221 122
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCceEEeeccCcccCCCCcc--cccccccCCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL----DQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTT 151 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~ 151 (307)
..+++..+..++.||+.||+|||++ ||+||||||+|||| +.++.+||+|||+++.+..... .......||.
T Consensus 123 ~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~ 199 (405)
T 3rgf_A 123 VQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199 (405)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecC
Confidence 3589999999999999999999999 99999999999999 6778999999999987654321 2234467899
Q ss_pred CcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccch------hHHHHHHHHHHhhcCCcc--ccc-------
Q 021774 152 GYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQM------NKFLLEWAWQLHQEEKPL--ELV------- 215 (307)
Q Consensus 152 ~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~--~~~------- 215 (307)
.|+|||++.+. .++.++|||||||++|||++|..||....... .......+.......... ..+
T Consensus 200 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 279 (405)
T 3rgf_A 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHS 279 (405)
T ss_dssp TTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHH
T ss_pred cccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchh
Confidence 99999999874 58999999999999999999999986443211 011111111111100000 000
Q ss_pred -------CCCCCCCC---------HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 216 -------DPELGEYP---------PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 216 -------~~~~~~~~---------~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
........ ......+.+|+.+||+.||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 280 TLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001235778999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.28 Aligned_cols=240 Identities=21% Similarity=0.283 Sum_probs=180.4
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC--------CCCccceeeEEE----eCCeeEEEEeccCCCCHHHHhc
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR--------HPNLVELIGCCV----QGTRRILVYEYVENNSLDRVLL 71 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~ 71 (307)
..+|+.||||+++.. ......+.+|++++++++ |+||+++++++. .....++||||+ +++|.+.+.
T Consensus 59 ~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~ 136 (397)
T 1wak_A 59 IQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII 136 (397)
T ss_dssp TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHH
T ss_pred cCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHH
Confidence 356889999999744 344567889999999885 788999999988 456789999999 556655553
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----------------------------
Q 021774 72 GATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF---------------------------- 123 (307)
Q Consensus 72 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---------------------------- 123 (307)
. .....+++..+..++.||+.||+|||++. ||+||||||+||||+.++
T Consensus 137 ~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (397)
T 1wak_A 137 K--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212 (397)
T ss_dssp H--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC-----------------
T ss_pred h--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCcccc
Confidence 2 23356999999999999999999999842 799999999999999775
Q ss_pred ---------------------ceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHh
Q 021774 124 ---------------------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182 (307)
Q Consensus 124 ---------------------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt 182 (307)
.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|||+|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (397)
T 1wak_A 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288 (397)
T ss_dssp ----CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhh
Confidence 7999999999876433 234568999999999999999999999999999999999
Q ss_pred CCCCCCccccch---hHHHHHHHHHHhhcC---------CcccccCC--------------------CCCCCCHHHHHHH
Q 021774 183 GRNSGKAMWGQM---NKFLLEWAWQLHQEE---------KPLELVDP--------------------ELGEYPPNEIIRY 230 (307)
Q Consensus 183 g~~p~~~~~~~~---~~~~~~~~~~~~~~~---------~~~~~~~~--------------------~~~~~~~~~~~~~ 230 (307)
|+.||....... ............... .....+.. .....+......+
T Consensus 289 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (397)
T 1wak_A 289 GDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF 368 (397)
T ss_dssp SSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHH
T ss_pred CCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHH
Confidence 999987544321 111111111111100 00000000 0012345667789
Q ss_pred HHHHHhccccccCCCCCHHHHHH
Q 021774 231 MKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 231 ~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+++.+||+.||++|||+.++++
T Consensus 369 ~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 369 TDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHGGGGCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccChhhcCCHHHHhh
Confidence 99999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.28 Aligned_cols=237 Identities=22% Similarity=0.268 Sum_probs=177.3
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC--------------------------------
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-------------------------------- 51 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------------------------------- 51 (307)
..+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 29 ~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (383)
T 3eb0_A 29 IESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVI 104 (383)
T ss_dssp TTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------------------------------
T ss_pred CCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccccccccc
Confidence 35789999998875432 234799999999999999999998543
Q ss_pred ------CeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCc
Q 021774 52 ------TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFN 124 (307)
Q Consensus 52 ------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~ 124 (307)
...++||||++ ++|.+.+......+..+++..+..++.||+.||+|||++ ||+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~ 180 (383)
T 3eb0_A 105 VNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNT 180 (383)
T ss_dssp -----CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTE
T ss_pred ccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCc
Confidence 34789999997 488887754445567899999999999999999999999 999999999999997 6889
Q ss_pred eEEeeccCcccCCCCcccccccccCCCCcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHH
Q 021774 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW 203 (307)
Q Consensus 125 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 203 (307)
+||+|||++........ .....|+..|+|||++.+. .++.++|||||||++|||++|+.||....... .+....
T Consensus 181 ~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~- 255 (383)
T 3eb0_A 181 LKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID--QLVRII- 255 (383)
T ss_dssp EEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-
T ss_pred EEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH--HHHHHH-
Confidence 99999999987644322 2345678999999988775 58999999999999999999999987543321 111111
Q ss_pred HHhhcC----------CcccccCCCCC------CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 204 QLHQEE----------KPLELVDPELG------EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 204 ~~~~~~----------~~~~~~~~~~~------~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...... ......-+... ..+......+.+++.+||+.||.+|||+.++++
T Consensus 256 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 256 QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111100 00000001100 012223445888999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=275.43 Aligned_cols=227 Identities=23% Similarity=0.334 Sum_probs=178.7
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++... .......+.+|++++++++||||+++++++.+.+..++|||++++++|.+++. ....+++
T Consensus 45 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~ 120 (287)
T 2wei_A 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSE 120 (287)
T ss_dssp TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHSSCCH
T ss_pred CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHH----hcCCCCH
Confidence 36899999998654 23446789999999999999999999999999999999999999999988873 2346899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
..++.++.|++.||.|||++ |++||||||+||+++.+ +.+||+|||++........ .....|+..|+|||++
T Consensus 121 ~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~ 195 (287)
T 2wei_A 121 HDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVL 195 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc--cccccCcccccChHHh
Confidence 99999999999999999999 99999999999999764 4699999999986654321 2234578899999988
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+ .++.++||||||+++|+|++|..||...... .... .......... .+..... ...+.+++.+||+
T Consensus 196 ~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~~~~~~~~~~--~~~~~~~----~~~~~~li~~~l~ 262 (287)
T 2wei_A 196 RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK---RVETGKYAFD--LPQWRTI----SDDAKDLIRKMLT 262 (287)
T ss_dssp TT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCCCCC--SGGGTTS----CHHHHHHHHHHTC
T ss_pred cC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHcCCCCCC--chhhhhc----CHHHHHHHHHHcc
Confidence 75 4889999999999999999999998654321 1111 1111111100 0111122 2357889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+|||+.++++
T Consensus 263 ~dp~~Rps~~ell~ 276 (287)
T 2wei_A 263 FHPSLRITATQCLE 276 (287)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cChhhCcCHHHHhc
Confidence 99999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=282.40 Aligned_cols=234 Identities=20% Similarity=0.256 Sum_probs=180.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCC------CccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHP------NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||+++.. ......+.+|++++++++|+ +++++++++...+..++||||+ +++|.+++... ...
T Consensus 38 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~ 113 (339)
T 1z57_A 38 AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN--GFL 113 (339)
T ss_dssp TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTC
T ss_pred CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc--CCC
Confidence 46889999999754 33456788999999888655 4999999999999999999999 88999988432 234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-------------------CCceEEeeccCcccCCCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-------------------EFNPKIGDFGLAKLFPDN 139 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------------------~~~~kl~dfg~~~~~~~~ 139 (307)
.+++..+..++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||++......
T Consensus 114 ~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 114 PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc
Confidence 689999999999999999999999 9999999999999987 668999999999865432
Q ss_pred cccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc------
Q 021774 140 ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE------ 213 (307)
Q Consensus 140 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 213 (307)
.....||..|+|||++.+..++.++|||||||++|||++|..||......... ........ ..+..
T Consensus 191 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~-~~p~~~~~~~~ 262 (339)
T 1z57_A 191 ----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL---AMMERILG-PLPKHMIQKTR 262 (339)
T ss_dssp ----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH---HHHHHHHC-SCCHHHHHHCS
T ss_pred ----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhC-CCCHHHHhhcc
Confidence 23456899999999999989999999999999999999999998654332211 11111110 00000
Q ss_pred ---c---------------------cC--CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 214 ---L---------------------VD--PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 214 ---~---------------------~~--~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
. .. .............+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 263 KRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0 00 0001123345677889999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=286.43 Aligned_cols=237 Identities=19% Similarity=0.255 Sum_probs=177.6
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||.+... .......+.+|++++++++||||+++++++... ...++||||+. ++|.+++.. .
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~ 107 (353)
T 2b9h_A 34 PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----Q 107 (353)
T ss_dssp TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----C
T ss_pred CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----c
Confidence 46889999999754 345556788999999999999999999998764 67899999996 589998842 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---------ccccccC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---------ITTRIAG 149 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~g 149 (307)
.+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......... ......|
T Consensus 108 ~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~g 184 (353)
T 2b9h_A 108 MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184 (353)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccc
Confidence 689999999999999999999999 9999999999999999999999999999876532211 1223468
Q ss_pred CCCcCCcccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccccc-------------
Q 021774 150 TTGYLAPEYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV------------- 215 (307)
Q Consensus 150 ~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 215 (307)
|..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .................
T Consensus 185 t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (353)
T 2b9h_A 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIGTPHSDNDLRCIESPRAREYIK 261 (353)
T ss_dssp CGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCSTTTTTTCCCHHHHHHHH
T ss_pred cccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCchhccccccccchhhHHhh
Confidence 999999998765 6789999999999999999999999865432111 11111111110000000
Q ss_pred ------CCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 216 ------DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 216 ------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+....+.....+.+++.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 262 SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000001123345788999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=289.14 Aligned_cols=176 Identities=23% Similarity=0.287 Sum_probs=150.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC------CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV------RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||+++.. ......+.+|+++++.+ +|+||+++++++...+..++||||+. ++|.+++... ...
T Consensus 120 ~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~ 195 (429)
T 3kvw_A 120 KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN--KFQ 195 (429)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT--TTC
T ss_pred CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc--cCC
Confidence 45889999999854 33345677788888776 57899999999999999999999995 5899888542 234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--eEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN--PKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
.+++..+..++.||+.||+|||++ +|+||||||+||||+.++. +||+|||++...... .....||..|+||
T Consensus 196 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aP 268 (429)
T 3kvw_A 196 GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAP 268 (429)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCc----ccccCCCCCccCh
Confidence 589999999999999999999999 9999999999999999987 999999999765432 2345789999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccc
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW 191 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 191 (307)
|++.+..++.++|||||||++|||+||..||....
T Consensus 269 E~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999999999986543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=281.32 Aligned_cols=232 Identities=22% Similarity=0.328 Sum_probs=175.7
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe------eEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR------RILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||.+... .......+.+|+.++++++||||+++++++..... .++||||+. ++|.+++
T Consensus 47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------ 119 (353)
T 3coi_A 47 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM------ 119 (353)
T ss_dssp TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTT------
T ss_pred CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHh------
Confidence 46899999998754 34456788999999999999999999999987654 499999996 5888776
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
...+++..+..++.||+.||+|||++ |++||||||+||+++.++.+||+|||++...... .....|+..|+||
T Consensus 120 ~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aP 192 (353)
T 3coi_A 120 GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAP 192 (353)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCH
Confidence 22489999999999999999999999 9999999999999999999999999999865432 2345689999999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC------------------CcccccCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE------------------KPLELVDP 217 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~ 217 (307)
|++.+ ..++.++||||||+++|+|++|+.||....... ............ ........
T Consensus 193 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (353)
T 3coi_A 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 269 (353)
T ss_dssp HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSC
T ss_pred HHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCc
Confidence 99877 678999999999999999999999986543211 111111110000 00000011
Q ss_pred CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+....+.....+.+++.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 270 DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112222344556888999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.10 Aligned_cols=230 Identities=20% Similarity=0.298 Sum_probs=174.4
Q ss_pred ccCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 3 TLTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVR--HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 3 ~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
...+|+.||||++... .......+.+|++++++++ |+||+++++++...+..++||| +.+++|.+++. ...
T Consensus 48 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~----~~~ 122 (313)
T 3cek_A 48 LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK----KKK 122 (313)
T ss_dssp ECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHH----HCS
T ss_pred EcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHH----hcC
Confidence 3456899999998754 3556678999999999996 5999999999999999999999 55889999984 334
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.|++.||.|||++ +++||||||+||++++ +.+||+|||++......... ......|+..|+|||
T Consensus 123 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (313)
T 3cek_A 123 SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198 (313)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHH
Confidence 689999999999999999999999 9999999999999964 89999999999876543221 223456899999999
Q ss_pred cccC-----------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHH
Q 021774 158 YVLG-----------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226 (307)
Q Consensus 158 ~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
++.+ ..++.++||||||+++|||++|..||......... .......... ..... ..
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~-----~~~~~---~~ 265 (313)
T 3cek_A 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAIIDPNHE-----IEFPD---IP 265 (313)
T ss_dssp HHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHCTTSC-----CCCCC---CS
T ss_pred HHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-----HHHHHhcccc-----cCCcc---cc
Confidence 9865 46788999999999999999999998654332111 1111111110 11111 11
Q ss_pred HHHHHHHHHhccccccCCCCCHHHHHHH
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQVIKM 254 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~v~~~ 254 (307)
...+.+++.+||+.||.+||++.++++.
T Consensus 266 ~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 266 EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2457788889999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=280.85 Aligned_cols=238 Identities=23% Similarity=0.328 Sum_probs=177.3
Q ss_pred CCCCEEEEEEccccC--hHhHHHHHHHHHHHhcC---CCCCccceeeEEE-----eCCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCV-----QGTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||||+++... ......+.+|+.+++++ +||||+++++++. .....++||||+. ++|.+++...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~- 112 (326)
T 1blx_A 35 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV- 112 (326)
T ss_dssp TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS-
T ss_pred CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc-
Confidence 468899999887542 11223456677776665 8999999999987 4567899999997 5999998532
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...... .......|+..|+
T Consensus 113 -~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~ 186 (326)
T 1blx_A 113 -PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYR 186 (326)
T ss_dssp -CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTC
T ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCC--CCcccccccccee
Confidence 234589999999999999999999999 9999999999999999999999999999865432 2234467899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc----------ccc----CCCCC
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL----------ELV----DPELG 220 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~----~~~~~ 220 (307)
|||++.+..++.++||||||+++|+|++|+.||...... ................ ... ...+.
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 1blx_A 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 263 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGG
T ss_pred CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhh
Confidence 999999989999999999999999999999998654322 1111121111110000 000 00011
Q ss_pred CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.........+.+++.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 264 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112233445788999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=280.68 Aligned_cols=239 Identities=19% Similarity=0.235 Sum_probs=177.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe-------eEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR-------RILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||++.... .....+.++++.+..++||||+++++++..... .++||||+++ +|...+.......
T Consensus 46 ~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~ 123 (360)
T 3e3p_A 46 STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ 123 (360)
T ss_dssp TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTT
T ss_pred CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcc
Confidence 468999999886543 223457788888999999999999999976433 7899999976 5555543333456
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLH--EELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
..+++..+..++.|++.||.||| ++ ||+||||||+|||++. ++.+||+|||++........ .....||..|+
T Consensus 124 ~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~ 198 (360)
T 3e3p_A 124 VAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYR 198 (360)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCccee
Confidence 67899999999999999999999 88 9999999999999996 89999999999987654322 23456899999
Q ss_pred CcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC------------CcccccCC----
Q 021774 155 APEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE------------KPLELVDP---- 217 (307)
Q Consensus 155 aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~---- 217 (307)
|||++.+. .++.++|||||||++|||++|+.||....... ............ ......+.
T Consensus 199 aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
T 3e3p_A 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIP 275 (360)
T ss_dssp CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCC
T ss_pred CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHHcCCCCHHHHHhcccchhhccccccccCC
Confidence 99998765 48999999999999999999999987543221 111111111000 00000000
Q ss_pred ---CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 218 ---ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 218 ---~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+..........+.+++.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 276 WSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 011222234567889999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=287.28 Aligned_cols=227 Identities=22% Similarity=0.286 Sum_probs=168.2
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..+|+.||||++..... ..+.+|+++|+++ +||||+++++++.+....++|||++. |+|.+++... ...+.+
T Consensus 45 ~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~---~~~~~~ 117 (432)
T 3p23_A 45 MFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK---DFAHLG 117 (432)
T ss_dssp ESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS---SCCCCS
T ss_pred EeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc---CCCccc
Confidence 35789999999875432 2356799999999 89999999999999999999999996 5999998533 233445
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-----CCceEEeeccCcccCCCCcc--cccccccCCCCcCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLA 155 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~a 155 (307)
..++.++.||+.||+|||++ ||+||||||+||+++. ...+||+|||++........ .......||..|+|
T Consensus 118 ~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~A 194 (432)
T 3p23_A 118 LEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194 (432)
T ss_dssp SCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCC
T ss_pred hhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccC
Confidence 56678999999999999999 9999999999999953 23588999999987654321 22344679999999
Q ss_pred cccccC---CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 156 PEYVLG---GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 156 PE~~~~---~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
||++.+ ..++.++|||||||++|||+| |..||........ ........... ..........+.
T Consensus 195 PE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--------~~~~~~~~~~~-----~~~~~~~~~~~~ 261 (432)
T 3p23_A 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--------NILLGACSLDC-----LHPEKHEDVIAR 261 (432)
T ss_dssp GGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--------HHHTTCCCCTT-----SCTTCHHHHHHH
T ss_pred hhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--------HHHhccCCccc-----cCccccccHHHH
Confidence 999873 567889999999999999999 8888754332111 11111111111 111223445577
Q ss_pred HHHHhccccccCCCCCHHHHHH
Q 021774 232 KVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+++.+||+.||.+|||+.++++
T Consensus 262 ~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 262 ELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCHhhCCCHHHHHh
Confidence 8999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=279.11 Aligned_cols=229 Identities=19% Similarity=0.238 Sum_probs=151.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||++.... . ...+....++.+.||||+++++++.. ....++||||+++|+|.+++... ....+
T Consensus 52 ~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l 125 (336)
T 3fhr_A 52 RTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAF 125 (336)
T ss_dssp TTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC---CCCC
T ss_pred CCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc--CCCCC
Confidence 468999999987532 1 12233334566799999999999976 44579999999999999999532 23469
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE---FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
++..++.++.|++.||.|||++ |++||||||+||+++.+ +.+||+|||++....... .....||..|+|||
T Consensus 126 ~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 126 TEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPE 199 (336)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc---cccCCCCcCccChh
Confidence 9999999999999999999999 99999999999999764 459999999998654322 23456789999999
Q ss_pred cccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
++.+..++.++||||||+++|+|++|..||......... ........... .....+.. ......+.+++.+|
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~li~~~ 271 (336)
T 3fhr_A 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQ-YGFPNPEW----SEVSEDAKQLIRLL 271 (336)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCCTTTS----TTCCHHHHHHHHHH
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhccc-cccCchhh----ccCCHHHHHHHHHH
Confidence 998899999999999999999999999998654332110 00000000000 00000111 12334578899999
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
|+.||.+|||+.++++
T Consensus 272 L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 272 LKTDPTERLTITQFMN 287 (336)
T ss_dssp SCSSGGGSCCHHHHHH
T ss_pred CCCChhHCcCHHHHhc
Confidence 9999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.74 Aligned_cols=238 Identities=21% Similarity=0.287 Sum_probs=178.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-----------CCCccceeeEEEeCC----eeEEEEeccCCCCHHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----------HPNLVELIGCCVQGT----RRILVYEYVENNSLDRV 69 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~ 69 (307)
.+|+.||||++... ......+.+|+.++++++ ||||+++++++...+ ..++|||++ +++|.++
T Consensus 42 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 119 (373)
T 1q8y_A 42 VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119 (373)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHH
T ss_pred CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHH
Confidence 57889999999753 334467889999999885 899999999998654 789999999 8899999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC------CCCceEEeeccCcccCCCCcccc
Q 021774 70 LLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD------QEFNPKIGDFGLAKLFPDNITHI 143 (307)
Q Consensus 70 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~------~~~~~kl~dfg~~~~~~~~~~~~ 143 (307)
+... ....+++..+..++.||+.||+|||++. ||+||||||+|||++ ..+.+||+|||++......
T Consensus 120 ~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---- 191 (373)
T 1q8y_A 120 IKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 191 (373)
T ss_dssp HHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----
T ss_pred HHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----
Confidence 8542 2345899999999999999999999842 899999999999994 4457999999999876543
Q ss_pred cccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccch----hHHHHHHHHHHhhcCC---------
Q 021774 144 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM----NKFLLEWAWQLHQEEK--------- 210 (307)
Q Consensus 144 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~--------- 210 (307)
.....||..|+|||++.+..++.++|||||||++|||+||..||....... ...+.... .......
T Consensus 192 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~ 270 (373)
T 1q8y_A 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII-ELLGELPSYLLRNGKY 270 (373)
T ss_dssp CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH-HHHCSCCHHHHHHCTT
T ss_pred CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH-HhcCCCCHHHHhccch
Confidence 233568999999999999999999999999999999999999987543211 11111111 1110000
Q ss_pred ---------cccccC-----------CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 211 ---------PLELVD-----------PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 211 ---------~~~~~~-----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+. ......+......+.+++.+||+.||.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 271 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 000000 0012345667788999999999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=285.95 Aligned_cols=237 Identities=23% Similarity=0.273 Sum_probs=172.4
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
..++..||+|++..... ...+|++++++++||||+++++++.... ..++||||++++ +...+.......
T Consensus 61 ~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~ 135 (394)
T 4e7w_A 61 LVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLK 135 (394)
T ss_dssp ETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTT
T ss_pred ECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhc
Confidence 44566689998764422 1236999999999999999999996543 378999999774 444332222345
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
..+++..+..++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+++....... .....||..|+||
T Consensus 136 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aP 210 (394)
T 4e7w_A 136 QTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAP 210 (394)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--CCSSCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC--CcccccCcCccCH
Confidence 6799999999999999999999999 999999999999998 799999999999987644322 2345678999999
Q ss_pred ccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcC----------CcccccCCCCCC----
Q 021774 157 EYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEE----------KPLELVDPELGE---- 221 (307)
Q Consensus 157 E~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---- 221 (307)
|++.+. .++.++|||||||++|||++|+.||....... .+.... ...... ......-+....
T Consensus 211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (394)
T 4e7w_A 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEII-KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFS 287 (394)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHH
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCCHHHHHhhChhhhhhccccccCCcHH
Confidence 998765 58999999999999999999999987543221 111111 111000 000000011100
Q ss_pred --CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 --YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 --~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+.+.....+.+++.+||+.||.+|||+.++++
T Consensus 288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 288 KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 11123346889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=275.90 Aligned_cols=176 Identities=22% Similarity=0.280 Sum_probs=148.8
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CC-----CccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HP-----NLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||+++.. ......+..|+++++.++ |+ +|+++++++...+..++||||+. ++|.+++... ...
T Consensus 77 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~ 152 (382)
T 2vx3_A 77 VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFR 152 (382)
T ss_dssp TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT--TTS
T ss_pred CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc--CcC
Confidence 46889999999843 344567788999988884 55 49999999999999999999995 5999988542 224
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhc--CCCCCeeeCCCCCCcEEEC--CCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHE--ELVPHIVHRDIKASNILLD--QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~--~~~~~i~H~dlkp~Nill~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.+++..+..++.|++.||.|||+ . ||+||||||+|||++ .++.+||+|||++...... .....||..|+
T Consensus 153 ~~~~~~~~~i~~qi~~al~~lH~~~~---~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~ 225 (382)
T 2vx3_A 153 GVSLNLTRKFAQQMCTALLFLATPEL---SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYR 225 (382)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHTSTTT---CEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHhccCCC---CEEcCCCCcccEEEecCCCCcEEEEeccCceecccc----cccccCCcccc
Confidence 58999999999999999999994 5 999999999999995 4778999999999876543 23457899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccc
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMW 191 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 191 (307)
|||++.+..++.++|||||||++|||+||+.||....
T Consensus 226 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999999999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.68 Aligned_cols=233 Identities=25% Similarity=0.393 Sum_probs=157.7
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC-CCCCCCC
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIM-TLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT-KANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~ 81 (307)
.+|+.||||.++.. .......+..|+. +++.++||||+++++++...+..++||||+++ +|.+++.... .....++
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 123 (327)
T 3aln_A 45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIP 123 (327)
T ss_dssp TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCC
T ss_pred CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCc
Confidence 46889999999765 3344455666666 67778999999999999999999999999975 8877763211 1245689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc--
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV-- 159 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~-- 159 (307)
+..+..++.|++.||.|||++. |++||||||+||+++.++.+||+|||++........ .....|+..|+|||++
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~ 199 (327)
T 3aln_A 124 EEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDP 199 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc--cccCCCCccccCceeecc
Confidence 9999999999999999999842 899999999999999999999999999986644321 2334689999999998
Q ss_pred --cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC-CCCCHHHHHHHHHHHHh
Q 021774 160 --LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 160 --~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~ 236 (307)
.+..++.++||||||+++|+|++|..||....... ..... ......+.+ ..........+.+++.+
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~ 268 (327)
T 3aln_A 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------DQLTQ--VVKGDPPQLSNSEEREFSPSFINFVNL 268 (327)
T ss_dssp ------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CC--CCCSCCCCCCCCSSCCCCHHHHHHHHH
T ss_pred ccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------HHHHH--HhcCCCCCCCCcccccCCHHHHHHHHH
Confidence 45678999999999999999999999986432110 00000 000000111 11111233458889999
Q ss_pred ccccccCCCCCHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~ 253 (307)
||+.||.+||++.++++
T Consensus 269 ~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 269 CLTKDESKRPKYKELLK 285 (327)
T ss_dssp HTCSSGGGSCCHHHHTT
T ss_pred HhhCChhhCcCHHHHHh
Confidence 99999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=272.07 Aligned_cols=228 Identities=26% Similarity=0.396 Sum_probs=165.5
Q ss_pred CCCCEEEEEEccccC-hH-hHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAES-KQ-GVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|+.||||++.... .. ....+.++..+++.++||||+++++++...+..++||||+ ++.+..+.. .....+++
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~---~~~~~~~~ 123 (318)
T 2dyl_A 48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK---RMQGPIPE 123 (318)
T ss_dssp TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHH---HHTSCCCH
T ss_pred cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHH---HhccCCCH
Confidence 468999999997653 22 2334555566788889999999999999999999999999 666666652 22456899
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc-
Q 021774 83 EKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL- 160 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 160 (307)
..+..++.|++.||.|||+ + |++||||||+||+++.++.+||+|||++....... ......|+..|+|||++.
T Consensus 124 ~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 198 (318)
T 2dyl_A 124 RILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDP 198 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--cccccCCCccccChhhccc
Confidence 9999999999999999998 7 89999999999999999999999999997654432 223456899999999984
Q ss_pred ----CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 161 ----GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 161 ----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
...++.++||||||+++|||++|..||....... ... .......... .+.... ....+.+++.+
T Consensus 199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~~~~~~~~~~---~~~~~~----~~~~l~~li~~ 266 (318)
T 2dyl_A 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVL---TKVLQEEPPL---LPGHMG----FSGDFQSFVKD 266 (318)
T ss_dssp -------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH---HHHHHSCCCC---CCSSSC----CCHHHHHHHHH
T ss_pred ccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHH---HHHhccCCCC---CCccCC----CCHHHHHHHHH
Confidence 4568899999999999999999999986533211 111 1111111110 011111 22347888999
Q ss_pred ccccccCCCCCHHHHHH
Q 021774 237 CTQAAASRRPQMNQVIK 253 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~ 253 (307)
||+.||.+||++.++++
T Consensus 267 ~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 267 CLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HTCSCTTTSCCHHHHTT
T ss_pred HccCChhHCcCHHHHhh
Confidence 99999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=277.35 Aligned_cols=232 Identities=18% Similarity=0.218 Sum_probs=176.3
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCC------ccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN------LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
++.||||+++.. ......+.+|++++++++|++ ++.+++++...+..++||||+ +++|.+++.. .....+
T Consensus 45 ~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~ 120 (355)
T 2eu9_A 45 KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPY 120 (355)
T ss_dssp TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCC
T ss_pred ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCC
Confidence 468999999754 344567888999999886655 899999999999999999999 5567666632 223468
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-------------------CCCCceEEeeccCcccCCCCcc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL-------------------DQEFNPKIGDFGLAKLFPDNIT 141 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-------------------~~~~~~kl~dfg~~~~~~~~~~ 141 (307)
++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++......
T Consensus 121 ~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 195 (355)
T 2eu9_A 121 PLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-- 195 (355)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--
Confidence 9999999999999999999999 99999999999999 56788999999999865433
Q ss_pred cccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccc-------
Q 021774 142 HITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL------- 214 (307)
Q Consensus 142 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 214 (307)
.....||..|+|||++.+..++.++|||||||++|||++|..||........ ......... ..+...
T Consensus 196 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~-~~p~~~~~~~~~~ 269 (355)
T 2eu9_A 196 --HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH---LVMMEKILG-PIPSHMIHRTRKQ 269 (355)
T ss_dssp --CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC-CCCHHHHHHCSCG
T ss_pred --ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcC-CCcHHHhhhccch
Confidence 2345689999999999999999999999999999999999999875433221 111111110 000000
Q ss_pred ---cC--------------------C--CCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 215 ---VD--------------------P--ELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 215 ---~~--------------------~--~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.. + ............+.+++.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 270 KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0 001112334557889999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=278.74 Aligned_cols=217 Identities=23% Similarity=0.328 Sum_probs=170.4
Q ss_pred CCCCEEEEEEccccCh------HhHHHHHHHHHHHhcC----CCCCccceeeEEEeCCeeEEEEec-cCCCCHHHHhccC
Q 021774 5 TNGRRIAVKPLSAESK------QGVREFITEIMTLSNV----RHPNLVELIGCCVQGTRRILVYEY-VENNSLDRVLLGA 73 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~ 73 (307)
.+|+.||||++..... .....+.+|+.++.++ +||||+++++++...+..++|||+ +.+++|.+++..
T Consensus 54 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~- 132 (312)
T 2iwi_A 54 TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE- 132 (312)
T ss_dssp TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-
T ss_pred cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-
Confidence 4688999999975432 1223456799999888 899999999999999999999999 789999999843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCceEEeeccCcccCCCCcccccccccCCCC
Q 021774 74 TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTG 152 (307)
Q Consensus 74 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~ 152 (307)
...+++..++.++.|++.||.|||++ |++||||||+||+++ .++.+||+|||++....... .....|+..
T Consensus 133 ---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~ 203 (312)
T 2iwi_A 133 ---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRV 203 (312)
T ss_dssp ---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTT
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCccc
Confidence 34689999999999999999999999 999999999999998 88999999999998765432 234568999
Q ss_pred cCCcccccCCcc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 153 YLAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 153 y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
|+|||++.+..+ +.++||||||+++|||++|+.||..... ...... ..+......+.
T Consensus 204 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~----------~~~~~~~~~~~ 261 (312)
T 2iwi_A 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ILEAEL----------HFPAHVSPDCC 261 (312)
T ss_dssp TSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHTCC----------CCCTTSCHHHH
T ss_pred ccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hhhhcc----------CCcccCCHHHH
Confidence 999999877665 4589999999999999999999854211 001100 11122334578
Q ss_pred HHHHhccccccCCCCCHHHHHH
Q 021774 232 KVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+++.+||+.||++|||+.++++
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.49 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=186.0
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe------CCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.+|+.||||+++.. .......+.+|++++++++||||+++++++.. .+..++||||++||+|.+++.... ..
T Consensus 37 ~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~ 115 (676)
T 3qa8_A 37 DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NC 115 (676)
T ss_dssp TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CT
T ss_pred CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cC
Confidence 46899999998765 45566789999999999999999999998765 667799999999999999985432 23
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---eEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN---PKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
..+++..+..++.|++.||+|||++ ||+||||||+||+++.++. ++|+|||++....... ......|+..|+
T Consensus 116 ~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~ 190 (676)
T 3qa8_A 116 CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYL 190 (676)
T ss_dssp TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccccccccc--ccccccCCcccC
Confidence 4688999999999999999999999 9999999999999987765 9999999998765432 234467899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhH--HHHHHHHH-HhhcCCcc-----cccCCCCCCCCHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--FLLEWAWQ-LHQEEKPL-----ELVDPELGEYPPNE 226 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~ 226 (307)
|||++.+..++.++||||||+++|+|++|..||......... ........ ........ ....+.........
T Consensus 191 APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~l 270 (676)
T 3qa8_A 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL 270 (676)
T ss_dssp SSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGG
T ss_pred ChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhh
Confidence 999999999999999999999999999999998653211000 00000000 00000000 00001112344556
Q ss_pred HHHHHHHHHhccccccCCCCCHHH-----HHHHHHhccc
Q 021774 227 IIRYMKVAFFCTQAAASRRPQMNQ-----VIKMLTKNIR 260 (307)
Q Consensus 227 ~~~~~~l~~~c~~~~p~~RPs~~~-----v~~~L~~~~~ 260 (307)
...+.+++.+||+.||++|||+.+ +.+.+..++.
T Consensus 271 s~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 271 AGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp HHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 778999999999999999999977 4455665554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=279.24 Aligned_cols=218 Identities=20% Similarity=0.298 Sum_probs=175.7
Q ss_pred cCCCCEEEEEEccccCh------HhHHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeccCC-CCHHHHhccCC
Q 021774 4 LTNGRRIAVKPLSAESK------QGVREFITEIMTLSNVR--HPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGAT 74 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~ 74 (307)
..+|+.||||.+..... .....+.+|+.++++++ |+||+++++++...+..++|||++.+ ++|.+++.
T Consensus 65 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~--- 141 (320)
T 3a99_A 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--- 141 (320)
T ss_dssp TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---
T ss_pred CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHh---
Confidence 35688999999875421 12245678999999995 69999999999999999999999976 89999984
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCceEEeeccCcccCCCCcccccccccCCCCc
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 153 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 153 (307)
....+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+||+|||++....... .....|+..|
T Consensus 142 -~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y 214 (320)
T 3a99_A 142 -ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 214 (320)
T ss_dssp -HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGG
T ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccC
Confidence 245689999999999999999999999 999999999999998 78899999999998765432 2345689999
Q ss_pred CCcccccCCcc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 154 LAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 154 ~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
+|||++.+..+ +.++||||||+++|||++|+.||..... ....... ........+.+
T Consensus 215 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~~~~----------~~~~~~~~~~~ 272 (320)
T 3a99_A 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVF----------FRQRVSSECQH 272 (320)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCCCC----------CSSCCCHHHHH
T ss_pred CChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhccccc----------ccccCCHHHHH
Confidence 99999887665 7889999999999999999999854211 0111100 01112235788
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||+.||.+|||+.++++
T Consensus 273 li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=292.48 Aligned_cols=216 Identities=24% Similarity=0.321 Sum_probs=172.6
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----eEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTR-----RILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
+|+.||||.+... .......+.+|++++++++||||+++++++...+. .|+||||++|++|.+++. . .
T Consensus 105 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~----~--~ 178 (681)
T 2pzi_A 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----Q--K 178 (681)
T ss_dssp TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC--------C--C
T ss_pred CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh----C--C
Confidence 6899999998754 44556688999999999999999999999987665 699999999999988762 1 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+||+|||++...... ....||+.|+|||++
T Consensus 179 l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~ 249 (681)
T 2pzi_A 179 LPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIV 249 (681)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHH
Confidence 99999999999999999999999 99999999999999885 8999999999876543 345689999999988
Q ss_pred cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 160 LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 160 ~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
.+.. +.++|||||||++|+|++|..|+....... .. . ..........+.+++.+||+
T Consensus 250 ~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~-----~--~~~~~~~~~~l~~li~~~l~ 306 (681)
T 2pzi_A 250 RTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LP-----E--DDPVLKTYDSYGRLLRRAID 306 (681)
T ss_dssp HHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CC-----T--TCHHHHHCHHHHHHHHHHTC
T ss_pred cCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------cc-----c--cccccccCHHHHHHHhhhcc
Confidence 7654 889999999999999999987765322110 00 0 00011223457889999999
Q ss_pred cccCCCCC-HHHHHHHHHhcc
Q 021774 240 AAASRRPQ-MNQVIKMLTKNI 259 (307)
Q Consensus 240 ~~p~~RPs-~~~v~~~L~~~~ 259 (307)
.||.+||+ ++++...|...+
T Consensus 307 ~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 307 PDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp SSGGGSCSSHHHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHHHH
Confidence 99999995 666776666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=262.53 Aligned_cols=208 Identities=10% Similarity=0.100 Sum_probs=162.5
Q ss_pred CCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++.... ......+.+|+..+.+++||||+++++++...+..|+||||++|++|.+++.. + ..
T Consensus 54 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~--~~ 127 (286)
T 3uqc_A 54 ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S--PS 127 (286)
T ss_dssp TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C--CC
T ss_pred CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C--CC
Confidence 458899999998652 44557899999999999999999999999999999999999999999999832 1 35
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
...+.+++.|++.||+|||++ ||+||||||+||+++.++.+||++++ |++
T Consensus 128 ~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------------------~~~------ 177 (286)
T 3uqc_A 128 PVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------------------TMP------ 177 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------------------CCT------
T ss_pred hHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------------------ccC------
Confidence 567899999999999999999 99999999999999999999998443 333
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCC---CCCCHHHHHHHHHHHHhcc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPEL---GEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~c~ 238 (307)
.++.++|||||||++|||+||+.||......... . .......... ....+.....+.+++.+||
T Consensus 178 -~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~----------~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 244 (286)
T 3uqc_A 178 -DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL----------A--PAERDTAGQPIEPADIDRDIPFQISAVAARSV 244 (286)
T ss_dssp -TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS----------E--ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHH
T ss_pred -CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh----------H--HHHHHhccCCCChhhcccCCCHHHHHHHHHHc
Confidence 3688999999999999999999998754321100 0 0000000000 0011223345888999999
Q ss_pred ccccCCCCCHHHHHHHHHhccccC
Q 021774 239 QAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 239 ~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+.||.+| |+.++++.|+++....
T Consensus 245 ~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 245 QGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCccC-CHHHHHHHHHHHhccC
Confidence 9999999 9999999999877543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=257.14 Aligned_cols=204 Identities=18% Similarity=0.268 Sum_probs=158.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHH-hcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTL-SNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||+|+++.. ..+.+|++++ +.++||||+++++++.. ....++||||+++++|.+++.. .....
T Consensus 41 ~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~ 113 (299)
T 3m2w_A 41 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQA 113 (299)
T ss_dssp TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCC
T ss_pred CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCC
Confidence 56899999998742 3567888888 55599999999999987 6678999999999999999854 23346
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
+++..+..++.|++.||+|||++ |++||||||+||+++. ++.++|+|||++....
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------- 171 (299)
T 3m2w_A 114 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------- 171 (299)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------------------
Confidence 99999999999999999999999 9999999999999998 7889999999886432
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCC----HHHHHHHHH
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYP----PNEIIRYMK 232 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 232 (307)
+..++.++|||||||++|||++|..||....... ...... ..+.......+ ......+.+
T Consensus 172 ----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T 3m2w_A 172 ----GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGMK-TRIRMGQYEFPNPEWSEVSEEVKM 235 (299)
T ss_dssp ----TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC-CSSCTTCCSSCHHHHTTSCHHHHH
T ss_pred ----cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----------hhHHHH-HHHhhccccCCchhcccCCHHHHH
Confidence 2457889999999999999999999986532211 000000 01101111111 123456888
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||+.||.+|||+.++++
T Consensus 236 li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 236 LIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcccChhhCCCHHHHhc
Confidence 999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=271.63 Aligned_cols=220 Identities=15% Similarity=0.129 Sum_probs=160.9
Q ss_pred cCCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCC-CCccc---------ee------------eEEEe-----CCe
Q 021774 4 LTNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRH-PNLVE---------LI------------GCCVQ-----GTR 53 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~---------~~------------~~~~~-----~~~ 53 (307)
..+|+.||||+++... ....+.+.+|+.+++.+.| +|... .+ .++.. ...
T Consensus 100 ~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (413)
T 3dzo_A 100 QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179 (413)
T ss_dssp TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCS
T ss_pred cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccc
Confidence 4579999999988432 2335779999999999976 32211 11 11111 224
Q ss_pred eEEEEeccCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeec
Q 021774 54 RILVYEYVENNSLDRVLLGA---TKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDF 130 (307)
Q Consensus 54 ~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~df 130 (307)
.+++|+++ +++|.+++... ......+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 180 ~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DF 255 (413)
T 3dzo_A 180 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 255 (413)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCG
T ss_pred eEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEec
Confidence 56777776 67999887321 22345688899999999999999999999 9999999999999999999999999
Q ss_pred cCcccCCCCcccccccccCCCCcCCcccc----------cCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHH
Q 021774 131 GLAKLFPDNITHITTRIAGTTGYLAPEYV----------LGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLE 200 (307)
Q Consensus 131 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 200 (307)
|+++..... .....| ..|+|||++ .+..++.++|||||||++|||+||+.||.......
T Consensus 256 G~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~------ 324 (413)
T 3dzo_A 256 EHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG------ 324 (413)
T ss_dssp GGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS------
T ss_pred cceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh------
Confidence 999865432 344567 999999998 55678899999999999999999999986543211
Q ss_pred HHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHH
Q 021774 201 WAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 252 (307)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~ 252 (307)
.....+. .....+ ..+.+++.+||+.||++||++.+++
T Consensus 325 ---------~~~~~~~-~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 325 ---------GSEWIFR-SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp ---------CSGGGGS-SCCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ---------hHHHHHh-hcccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence 0111111 111222 4588889999999999999977764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=257.32 Aligned_cols=219 Identities=12% Similarity=0.106 Sum_probs=160.8
Q ss_pred CCCEEEEEEccccC--------hHhHHHHHHHHHHHhcCC---------CCCccceeeEEE-----------------e-
Q 021774 6 NGRRIAVKPLSAES--------KQGVREFITEIMTLSNVR---------HPNLVELIGCCV-----------------Q- 50 (307)
Q Consensus 6 ~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~~~~~~~-----------------~- 50 (307)
+|+.||||++.... ....+.+.+|++++++++ ||||+++.+++. .
T Consensus 42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~ 121 (336)
T 2vuw_A 42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121 (336)
T ss_dssp TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence 68899999997542 223467888999888875 777777766643 2
Q ss_pred ------------CCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeeCCCCCCcE
Q 021774 51 ------------GTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-EELVPHIVHRDIKASNI 117 (307)
Q Consensus 51 ------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Ni 117 (307)
.+..++||||+++|++.+.+. ...+++..+..++.||+.||+||| ++ +|+||||||+||
T Consensus 122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NI 193 (336)
T 2vuw_A 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNV 193 (336)
T ss_dssp TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGE
T ss_pred ccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHE
Confidence 678899999999997655552 245899999999999999999999 89 999999999999
Q ss_pred EECCCC--------------------ceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHH-
Q 021774 118 LLDQEF--------------------NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVL- 176 (307)
Q Consensus 118 ll~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~- 176 (307)
||+.++ .+||+|||+++..... ...||..|+|||++.+.. +.++||||||++
T Consensus 194 Ll~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~ 266 (336)
T 2vuw_A 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKE 266 (336)
T ss_dssp EEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHH
T ss_pred EEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCC
Confidence 999887 8999999999865432 347899999999998766 889999998777
Q ss_pred HHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHH
Q 021774 177 VLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVI 252 (307)
Q Consensus 177 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~ 252 (307)
.+++++|..|+.... ................ ........+.....+.+++.+||+.| |+.+++
T Consensus 267 ~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 267 NNNRWGEYHPYSNVL------WLHYLTDKMLKQMTFK--TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HTTCTTSCCTHHHHH------HHHHHHHHHHHTCCCS--SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CcccccccCCCcchh------hhhHHHHhhhhhhccC--cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 777888888763210 0011111111010000 00011123456677999999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=264.78 Aligned_cols=167 Identities=18% Similarity=0.175 Sum_probs=126.5
Q ss_pred CCCEEEEEEcccc----------ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC
Q 021774 6 NGRRIAVKPLSAE----------SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 6 ~g~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.|+.+|+|++... .....++|.+|+++|+++ +|+||+++++++.+++..||||||++|++|.+++.
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~--- 334 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA--- 334 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH---
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH---
Confidence 4888999998753 123346799999999999 79999999999999999999999999999999993
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.+..++.. +|+.||+.||+|+|++ ||+||||||+||||++++++||+|||+++....... ......||+.|+
T Consensus 335 -~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~Ym 406 (569)
T 4azs_A 335 -AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVF 406 (569)
T ss_dssp -TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHH
T ss_pred -hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhc
Confidence 34566665 4789999999999999 999999999999999999999999999987654332 244567999999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCC
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGR 184 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~ 184 (307)
|||++.+ .+..++|+||+|+++++|.++.
T Consensus 407 APE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 407 VNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHC------------------CCCCTTH
T ss_pred cHHHhCC-CCCCcccccccccchhhhcccc
Confidence 9998875 4677899999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=213.66 Aligned_cols=165 Identities=16% Similarity=0.145 Sum_probs=136.6
Q ss_pred CCCEEEEEEccccC--------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCC
Q 021774 6 NGRRIAVKPLSAES--------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKAN 77 (307)
Q Consensus 6 ~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~ 77 (307)
.|+.+++|...... ....+++.+|++++++++||||+++..++...+..++||||++|++|.+++..
T Consensus 358 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----- 432 (540)
T 3en9_A 358 LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----- 432 (540)
T ss_dssp SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----
T ss_pred CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----
Confidence 67888999764331 11235689999999999999999777777788888999999999999999832
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc------cccccCCC
Q 021774 78 IKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI------TTRIAGTT 151 (307)
Q Consensus 78 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~g~~ 151 (307)
+..++.|++.||.|||++ +|+||||||+|||++. ++||+|||+++......... .....||+
T Consensus 433 -------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~ 500 (540)
T 3en9_A 433 -------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTH 500 (540)
T ss_dssp -------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHC
T ss_pred -------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCC
Confidence 558999999999999999 9999999999999998 99999999999876532221 23567999
Q ss_pred CcCCcccccC--CcccccCceeehHHHHHHHHhCCCCC
Q 021774 152 GYLAPEYVLG--GQLTMKADVYSFGVLVLEIISGRNSG 187 (307)
Q Consensus 152 ~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~ 187 (307)
.|+|||++.. ..|+..+|+|+..+-..+-+-++.++
T Consensus 501 ~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 501 HEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp GGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999999987 67888999999998888877665543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-22 Score=169.20 Aligned_cols=125 Identities=18% Similarity=0.113 Sum_probs=99.3
Q ss_pred cCCCCEEEEEEccccCh------------------HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCC
Q 021774 4 LTNGRRIAVKPLSAESK------------------QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s 65 (307)
..+|+.||||.++.... .....+.+|++++++++ | +++.+++.. +..++||||++|++
T Consensus 111 ~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~ 186 (282)
T 1zar_A 111 SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKE 186 (282)
T ss_dssp ETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEE
T ss_pred eCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCc
Confidence 45789999999974321 13457899999999998 5 666665544 55699999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccc
Q 021774 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT 145 (307)
Q Consensus 66 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 145 (307)
|.+ +. . .....++.|++.||.|||++ ||+||||||+|||++ ++.+||+|||++..
T Consensus 187 L~~-l~---~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------- 241 (282)
T 1zar_A 187 LYR-VR---V-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------- 241 (282)
T ss_dssp GGG-CC---C-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCEE----------
T ss_pred HHH-cc---h-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCeE----------
Confidence 988 41 1 12446999999999999999 999999999999999 99999999999973
Q ss_pred cccCCCCcCCcccccC
Q 021774 146 RIAGTTGYLAPEYVLG 161 (307)
Q Consensus 146 ~~~g~~~y~aPE~~~~ 161 (307)
+..+.|||++..
T Consensus 242 ----~~~~~a~e~l~r 253 (282)
T 1zar_A 242 ----VGEEGWREILER 253 (282)
T ss_dssp ----TTSTTHHHHHHH
T ss_pred ----CCCCCHHHHHHH
Confidence 334688987743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=139.60 Aligned_cols=116 Identities=19% Similarity=0.221 Sum_probs=88.4
Q ss_pred CCCCE--EEEEEccccChH------------------------hHHHHHHHHHHHhcCCCCCc--cceeeEEEeCCeeEE
Q 021774 5 TNGRR--IAVKPLSAESKQ------------------------GVREFITEIMTLSNVRHPNL--VELIGCCVQGTRRIL 56 (307)
Q Consensus 5 ~~g~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~l 56 (307)
.+|+. ||||+++..... ....+.+|+++|.++.|+++ +.++++ +..++
T Consensus 70 ~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~l 145 (258)
T 1zth_A 70 FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVL 145 (258)
T ss_dssp ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEE
T ss_pred CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEE
Confidence 57888 999987543111 11357899999999987754 444432 35689
Q ss_pred EEeccCC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeeCCCCCCcEEECCCCceEEeec
Q 021774 57 VYEYVEN-N----SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLH-EELVPHIVHRDIKASNILLDQEFNPKIGDF 130 (307)
Q Consensus 57 v~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~~~kl~df 130 (307)
||||+.+ | +|.++... .++..+..++.|++.||.||| +. ||+||||||+|||++. .++|+||
T Consensus 146 VmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~--~~~liDF 213 (258)
T 1zth_A 146 LMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID--KVYFIDM 213 (258)
T ss_dssp EEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS--SEEECCC
T ss_pred EEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC--cEEEEEC
Confidence 9999942 3 78776521 224457789999999999999 99 9999999999999998 9999999
Q ss_pred cCcccC
Q 021774 131 GLAKLF 136 (307)
Q Consensus 131 g~~~~~ 136 (307)
|++...
T Consensus 214 G~a~~~ 219 (258)
T 1zth_A 214 GQAVTL 219 (258)
T ss_dssp TTCEET
T ss_pred cccccC
Confidence 999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2e-15 Score=131.53 Aligned_cols=121 Identities=15% Similarity=0.152 Sum_probs=83.3
Q ss_pred cccCCCCEEEEEEccccC-----------------hHh-H----HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 021774 2 GTLTNGRRIAVKPLSAES-----------------KQG-V----REFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~-----------------~~~-~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 59 (307)
+...+|+.||||+++... ... . -...+|+..|.++.+.++.-..-+... ..++|||
T Consensus 114 a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~--~~~LVME 191 (397)
T 4gyi_A 114 VADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS--RHTIVMS 191 (397)
T ss_dssp EECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE--TTEEEEE
T ss_pred EECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc--CceEEEE
Confidence 345689999999875320 000 0 012356777777755444222222222 2379999
Q ss_pred ccCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----------ceEEee
Q 021774 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----------NPKIGD 129 (307)
Q Consensus 60 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----------~~kl~d 129 (307)
|++|++|..+.. . .....++.|++.+|.+||+. |||||||||.|||+++++ .+.|+|
T Consensus 192 ~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 192 LVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp CCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred ecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 999988866531 1 12356789999999999999 999999999999998876 389999
Q ss_pred ccCcccCC
Q 021774 130 FGLAKLFP 137 (307)
Q Consensus 130 fg~~~~~~ 137 (307)
|+.+....
T Consensus 259 ~~Q~V~~~ 266 (397)
T 4gyi_A 259 FPQMVSMD 266 (397)
T ss_dssp CTTCEETT
T ss_pred eCCcccCC
Confidence 99887543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=109.46 Aligned_cols=120 Identities=12% Similarity=0.025 Sum_probs=93.0
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|+.+++|+...........+.+|+++++.+ .+..+.++++++...+..++|||+++|.+|.+.+. . ...
T Consensus 36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~----~-----~~~ 106 (263)
T 3tm0_A 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE----D-----EQS 106 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----T-----TTC
T ss_pred CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC----C-----ccc
Confidence 4688999988753212224588899999988 46788999999999999999999999999988641 1 112
Q ss_pred HHHHHHHHHHHHHHHhcCC--------------------------------------------------------CCCee
Q 021774 85 RSDICVGIAKGLAFLHEEL--------------------------------------------------------VPHIV 108 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~--------------------------------------------------------~~~i~ 108 (307)
...++.+++++|+.||+.. ...++
T Consensus 107 ~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~ 186 (263)
T 3tm0_A 107 PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFS 186 (263)
T ss_dssp HHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEE
T ss_pred HHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEE
Confidence 3467889999999999821 13589
Q ss_pred eCCCCCCcEEECCCCceEEeeccCcc
Q 021774 109 HRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 109 H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
|||++|.||+++++..+.|+||+.+.
T Consensus 187 HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 187 HGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCcCcEEEECCcEEEEEEchhcc
Confidence 99999999999876556799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=3.5e-11 Score=100.04 Aligned_cols=115 Identities=17% Similarity=0.111 Sum_probs=85.8
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPN--LVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..++||..... ....+..|+++++.+.+.+ +.+++++....+..++|||+++|.+|. .. . ..
T Consensus 42 ~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~----~---~~- 108 (264)
T 1nd4_A 42 QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS----H---LA- 108 (264)
T ss_dssp TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS----C---CC-
T ss_pred CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC----c---CC-
Confidence 45778999987654 2245778999998884334 567899888888889999999998874 21 1 11
Q ss_pred HHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------CCCe
Q 021774 83 EKRSDICVGIAKGLAFLHEEL-------------------------------------------------------VPHI 107 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~-------------------------------------------------------~~~i 107 (307)
...++.+++.+|+.||+.. ...+
T Consensus 109 --~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 186 (264)
T 1nd4_A 109 --PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVV 186 (264)
T ss_dssp --HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEE
T ss_pred --HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEE
Confidence 2256778888888888752 1129
Q ss_pred eeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 108 VHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 108 ~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
+|||++|.||++++++.+.|+||+.+.
T Consensus 187 ~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 187 THGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp ECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=4.1e-10 Score=98.26 Aligned_cols=123 Identities=15% Similarity=0.228 Sum_probs=91.1
Q ss_pred CCEEEEEEcc--ccC-hHhHHHHHHHHHHHhcCC--CCCccceeeEEEeC---CeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 7 GRRIAVKPLS--AES-KQGVREFITEIMTLSNVR--HPNLVELIGCCVQG---TRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 7 g~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
+..+++|+.. ... ......+.+|+++++.+. +..+++++.++.+. ...++|||+++|..+.+.. -.
T Consensus 61 ~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~ 134 (359)
T 3dxp_A 61 GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LP 134 (359)
T ss_dssp SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CT
T ss_pred CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cc
Confidence 4678888776 332 122346788999999885 45688999988776 3478999999997764311 12
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEEL------------------------------------------------------- 103 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------------------- 103 (307)
.++......++.+++++|+.||+..
T Consensus 135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 214 (359)
T 3dxp_A 135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD 214 (359)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence 3678888899999999999999731
Q ss_pred CCCeeeCCCCCCcEEECCCCc--eEEeeccCccc
Q 021774 104 VPHIVHRDIKASNILLDQEFN--PKIGDFGLAKL 135 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~ 135 (307)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 237999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=5e-10 Score=95.42 Aligned_cols=166 Identities=19% Similarity=0.230 Sum_probs=107.2
Q ss_pred CEEEEEEccccChHhHHHHHHHHHHHhcC-CCCC--ccceeeEEEeCC---eeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 8 RRIAVKPLSAESKQGVREFITEIMTLSNV-RHPN--LVELIGCCVQGT---RRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 8 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..++||+.... .....+.+|+++|+.+ .+.. +.+++.+....+ ..|+||++++|.+|..... ..++
T Consensus 41 ~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~ 112 (304)
T 3sg8_A 41 RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL------NNLP 112 (304)
T ss_dssp TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH------HTSC
T ss_pred CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc------ccCC
Confidence 56888876532 3456788999999887 3333 455555543333 3478999999988865331 2366
Q ss_pred HHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------------CCC
Q 021774 82 WEKRSDICVGIAKGLAFLHEEL-------------------------------------------------------VPH 106 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------------------~~~ 106 (307)
......++.+++..|+.||+.. .+.
T Consensus 113 ~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 192 (304)
T 3sg8_A 113 KQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPC 192 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCE
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCce
Confidence 7777888888888888888621 135
Q ss_pred eeeCCCCCCcEEECC--CCceEEeeccCcccCCCCcccccccccCCCCc---CCcccccC--------------Cccccc
Q 021774 107 IVHRDIKASNILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGY---LAPEYVLG--------------GQLTMK 167 (307)
Q Consensus 107 i~H~dlkp~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y---~aPE~~~~--------------~~~~~~ 167 (307)
++|+|+++.||++++ +..+.|+||+.+..-.. ..... ....+ ..|+.... ......
T Consensus 193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~----~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~ 267 (304)
T 3sg8_A 193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFI----SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMK 267 (304)
T ss_dssp EECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHH----TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHH
T ss_pred eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHH----HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHH
Confidence 799999999999988 45578999998864321 11100 00111 22222110 011223
Q ss_pred CceeehHHHHHHHHhCCCC
Q 021774 168 ADVYSFGVLVLEIISGRNS 186 (307)
Q Consensus 168 ~Dv~slG~~l~elltg~~p 186 (307)
.+.|++|.++|.+.+|..+
T Consensus 268 ~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp HHHHHHHHHHHHHHTTCHH
T ss_pred HHHHHHHHHHHHHHcCCHH
Confidence 5889999999999999754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=3.6e-08 Score=82.27 Aligned_cols=118 Identities=17% Similarity=0.108 Sum_probs=86.4
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+|..++||+-... ....+..|+..|+.+. +-.+.++++++.+.+..++|||+++|.++.+..... ...
T Consensus 49 ~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~--------~~~ 117 (272)
T 4gkh_A 49 NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY--------PDS 117 (272)
T ss_dssp TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--------GGG
T ss_pred CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--------HHH
Confidence 4667899976632 3456788999998883 445788999999999999999999998887765211 112
Q ss_pred HHHHHHHHHHHHHHHhcCCC-------------------------------------------------------CCeee
Q 021774 85 RSDICVGIAKGLAFLHEELV-------------------------------------------------------PHIVH 109 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~-------------------------------------------------------~~i~H 109 (307)
...+..+++..|+.||+... +.++|
T Consensus 118 ~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 197 (272)
T 4gkh_A 118 GENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTH 197 (272)
T ss_dssp HHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEc
Confidence 23455666666666665321 23789
Q ss_pred CCCCCCcEEECCCCceEEeeccCcc
Q 021774 110 RDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 110 ~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
||+.+.||+++.++.+-|+||+.+.
T Consensus 198 GDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 198 GDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp SCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCCeEEEECCeEEEEEECcccc
Confidence 9999999999987767799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=3.5e-07 Score=77.84 Aligned_cols=121 Identities=19% Similarity=0.208 Sum_probs=83.0
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCC---CccceeeEEE-eCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHP---NLVELIGCCV-QGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
|..++||+-. .......+..|+++|+.+.+. .+.+++.++. ..+..++|||+++|.++..... ..++.
T Consensus 39 g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~ 110 (306)
T 3tdw_A 39 NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM------AVLPD 110 (306)
T ss_dssp TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH------TTSCH
T ss_pred CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh------hhCCH
Confidence 5678888743 334456789999999998542 4677777775 3456789999999988876321 11344
Q ss_pred HHHHHHHHHHHHHHHHHhcC---------------------------------------------------------CCC
Q 021774 83 EKRSDICVGIAKGLAFLHEE---------------------------------------------------------LVP 105 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~---------------------------------------------------------~~~ 105 (307)
.....++.+++..|+.||+. ..+
T Consensus 111 ~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~ 190 (306)
T 3tdw_A 111 DAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTP 190 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCC
Confidence 44555555555555555543 123
Q ss_pred CeeeCCCCCCcEEECC---CCc-eEEeeccCccc
Q 021774 106 HIVHRDIKASNILLDQ---EFN-PKIGDFGLAKL 135 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~---~~~-~kl~dfg~~~~ 135 (307)
.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 5699999999999987 455 47999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=7.8e-07 Score=77.28 Aligned_cols=61 Identities=10% Similarity=0.075 Sum_probs=41.4
Q ss_pred CCEEEEEEccccCh--H-hHHHHHHHHHHHhcCC-C--CCccceeeEEEeC---CeeEEEEeccCCCCHH
Q 021774 7 GRRIAVKPLSAESK--Q-GVREFITEIMTLSNVR-H--PNLVELIGCCVQG---TRRILVYEYVENNSLD 67 (307)
Q Consensus 7 g~~vavK~~~~~~~--~-~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~sL~ 67 (307)
|+.+++|....... . ....+..|+.+++.+. + -.+.+++.++.+. ...++|||+++|.++.
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 66889997654320 0 1135678888888873 3 3578888887665 3568999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=9.2e-05 Score=63.47 Aligned_cols=30 Identities=23% Similarity=0.356 Sum_probs=27.4
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 489999999999999888889999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=5.4e-05 Score=64.27 Aligned_cols=122 Identities=16% Similarity=0.088 Sum_probs=77.9
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeccCCCCHH--------H---Hhc
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVR---HPNLVELIGCCVQGTRRILVYEYVENNSLD--------R---VLL 71 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~--------~---~l~ 71 (307)
++..++||+.... ....+..|++.|+.+. ...++++++++...+..++|||+++|..+. . .++
T Consensus 58 ~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH 134 (312)
T 3jr1_A 58 EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLH 134 (312)
T ss_dssp SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHH
T ss_pred CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHH
Confidence 4678889977633 3456888999998883 367889999988888899999999987642 1 122
Q ss_pred cCCC-CCC-----------------CCCHHHHH---HHH----------------HHHHHHH-HHHhc-CCCCCeeeCCC
Q 021774 72 GATK-ANI-----------------KLNWEKRS---DIC----------------VGIAKGL-AFLHE-ELVPHIVHRDI 112 (307)
Q Consensus 72 ~~~~-~~~-----------------~~~~~~~~---~i~----------------~~i~~~l-~~LH~-~~~~~i~H~dl 112 (307)
.... ... .-+|.... ++. .++++.+ ..|.. ...+.++|+|+
T Consensus 135 ~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~ 214 (312)
T 3jr1_A 135 QIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNL 214 (312)
T ss_dssp HCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSC
T ss_pred cCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCC
Confidence 2111 000 11354321 111 1122222 23421 23468999999
Q ss_pred CCCcEEECCCCceEEeecc
Q 021774 113 KASNILLDQEFNPKIGDFG 131 (307)
Q Consensus 113 kp~Nill~~~~~~kl~dfg 131 (307)
.+.|++++.++ +.|.|+.
T Consensus 215 ~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 215 WIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp SGGGEEEETTE-EEECSCC
T ss_pred CcCcEeecCCC-eEEEcCc
Confidence 99999999887 8899974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=8.7e-05 Score=65.27 Aligned_cols=29 Identities=21% Similarity=0.369 Sum_probs=25.3
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
.++|||+.+.|||++.+ .++++||..+..
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 89999999999999876 489999987763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.0002 Score=59.98 Aligned_cols=59 Identities=22% Similarity=0.320 Sum_probs=40.3
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-C--CCccceeeEEEeCCeeEEEEeccCCCCH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-H--PNLVELIGCCVQGTRRILVYEYVENNSL 66 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL 66 (307)
+.||+.|+||+...........|..|++.|+.|. . -.+++++++ + ..++|||+++++..
T Consensus 36 l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 36 LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERPP 97 (288)
T ss_dssp ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCCC
T ss_pred ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccCC
Confidence 5689999999876554433345788999988873 2 235566654 2 23789999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00045 Score=59.12 Aligned_cols=32 Identities=41% Similarity=0.376 Sum_probs=27.6
Q ss_pred CCCeeeCCCCCCcEEECCC----CceEEeeccCccc
Q 021774 104 VPHIVHRDIKASNILLDQE----FNPKIGDFGLAKL 135 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~----~~~kl~dfg~~~~ 135 (307)
...++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3489999999999999875 6799999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00056 Score=54.15 Aligned_cols=103 Identities=17% Similarity=0.135 Sum_probs=66.7
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc
Q 021774 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 143 (307)
Q Consensus 64 ~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 143 (307)
-||.++|. ..+.+++++++|.++.|.+.+|.-+-... .-..+=+.|..|+|..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 37888883 45678999999999999999988762210 111333457999999999988764 1110
Q ss_pred cccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCC
Q 021774 144 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNS 186 (307)
Q Consensus 144 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 186 (307)
.....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123467888653 3446777899999999999865443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00037 Score=61.77 Aligned_cols=76 Identities=11% Similarity=0.082 Sum_probs=44.0
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccc-cCCCCcCCcccccCC---cccccCceeehHHHHHHHH
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRI-AGTTGYLAPEYVLGG---QLTMKADVYSFGVLVLEII 181 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell 181 (307)
.++|||+++.|||++.++ +.++||+.+..-.. ........ .-...|.+|+..... .-....++......+|+.+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 899999999999998876 99999998874221 10100000 001235555544211 1122344456677777776
Q ss_pred hC
Q 021774 182 SG 183 (307)
Q Consensus 182 tg 183 (307)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00055 Score=59.68 Aligned_cols=124 Identities=19% Similarity=0.195 Sum_probs=74.3
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHH--------------H-
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDR--------------V- 69 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~--------------~- 69 (307)
+++.+++|+..... .....+.+|+++++.+. +.-..++++++.+ .+||||++|.+|.. .
T Consensus 81 ~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 81 EPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHH
T ss_pred CCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHH
Confidence 45789999864322 23455668999998883 3334667666543 28999999865431 0
Q ss_pred --hccCCCC-CCCC--CHHHHHHHHHHHHH-------------------HHHH----HhcC-CCCCeeeCCCCCCcEEEC
Q 021774 70 --LLGATKA-NIKL--NWEKRSDICVGIAK-------------------GLAF----LHEE-LVPHIVHRDIKASNILLD 120 (307)
Q Consensus 70 --l~~~~~~-~~~~--~~~~~~~i~~~i~~-------------------~l~~----LH~~-~~~~i~H~dlkp~Nill~ 120 (307)
++..... +... -+.++.++..++.. .+.. |... ....++|+|+.+.||+++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 1111111 1112 24555556544422 1222 2221 134689999999999998
Q ss_pred CC----CceEEeeccCcc
Q 021774 121 QE----FNPKIGDFGLAK 134 (307)
Q Consensus 121 ~~----~~~kl~dfg~~~ 134 (307)
.+ +.+.++||..+.
T Consensus 236 ~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 236 SEPENADSLMLVDFEYSS 253 (379)
T ss_dssp SCC---CCEEECCCTTCE
T ss_pred CCCCccCcEEEEecccCC
Confidence 76 689999999885
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0068 Score=51.45 Aligned_cols=28 Identities=32% Similarity=0.399 Sum_probs=24.8
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..++|||+++.||+++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 3789999999999999 4 89999998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00032 Score=59.12 Aligned_cols=30 Identities=23% Similarity=0.166 Sum_probs=25.4
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5667789999998863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00045 Score=61.39 Aligned_cols=54 Identities=11% Similarity=0.132 Sum_probs=34.6
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSL 66 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 66 (307)
++.+++|+...... ...+..|+.+++.+. +.-.+++++.+. + .+|+||++|.+|
T Consensus 105 ~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL 159 (429)
T ss_dssp CSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred CceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCccc
Confidence 57899998854211 134557888888884 333366776543 2 389999987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0013 Score=58.76 Aligned_cols=55 Identities=7% Similarity=0.066 Sum_probs=34.0
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeccCCCCH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSL 66 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL 66 (307)
+..+++|+......... +...|+.+++.+...++ .++++++ .+ .+||||++|.+|
T Consensus 133 ~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 133 QAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp TEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred CceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 46788988754322211 12578888888854444 6777766 22 359999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0013 Score=57.13 Aligned_cols=29 Identities=21% Similarity=0.356 Sum_probs=24.6
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..++|+|+.+.||+++.++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 3689999999999998655 8999998775
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.017 Score=48.73 Aligned_cols=43 Identities=21% Similarity=0.304 Sum_probs=31.5
Q ss_pred HHHHHHHHhcC----CCCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 92 IAKGLAFLHEE----LVPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 92 i~~~l~~LH~~----~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
+...+..+.+. .+.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 34445555431 23479999999999999877656899999775
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.33 E-value=0.023 Score=50.23 Aligned_cols=29 Identities=21% Similarity=0.400 Sum_probs=25.9
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
..++|+|+.+.||+ +.++.+.++||..+.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 36899999999999 778889999999886
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.38 E-value=0.38 Score=38.04 Aligned_cols=83 Identities=10% Similarity=0.121 Sum_probs=61.1
Q ss_pred CCCCccceeeEEEeCCeeEEEEeccCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeeCCCCC
Q 021774 37 RHPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLA-FLHEELVPHIVHRDIKA 114 (307)
Q Consensus 37 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlkp 114 (307)
.||++ -...-..++...+.++.-++ -++..+ ..++...+++++.+|+.... +++.. +|--|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeC
Confidence 67887 33444667776666665533 344433 24678889999999998887 66544 8889999
Q ss_pred CcEEECCCCceEEeeccCcc
Q 021774 115 SNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 115 ~Nill~~~~~~kl~dfg~~~ 134 (307)
+|++++.++.+++.-.|+-.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GGEEECTTCCEEESCCEETT
T ss_pred ceEEEeCCCcEEEEEcCCcc
Confidence 99999999999998877654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.37 E-value=0.18 Score=39.70 Aligned_cols=116 Identities=10% Similarity=0.118 Sum_probs=77.6
Q ss_pred CCCCccceeeEEEeCCeeEEEEeccC-CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 021774 37 RHPNLVELIGCCVQGTRRILVYEYVE-NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115 (307)
Q Consensus 37 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~ 115 (307)
.||+++.. .+...++...+.++.-+ +-++.. -..++...+++++.+|+....+++.. +|--|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~--------ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN--------IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG--------GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH--------HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 68888876 56666666666665443 222222 23577889999999999998776655 88899999
Q ss_pred cEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCc
Q 021774 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKA 189 (307)
Q Consensus 116 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~ 189 (307)
|++++.++.+++.-.|+-..+. |. ..+...=.-.+=|++..+++++..|..
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999998877644221 21 001111122556788888888776543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.79 E-value=0.09 Score=44.85 Aligned_cols=31 Identities=32% Similarity=0.356 Sum_probs=27.5
Q ss_pred CCeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 105 PHIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 105 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3799999999999999888899999987763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.82 E-value=0.36 Score=42.17 Aligned_cols=29 Identities=28% Similarity=0.402 Sum_probs=24.5
Q ss_pred CeeeCCCCCCcEEE------CCCCceEEeeccCcc
Q 021774 106 HIVHRDIKASNILL------DQEFNPKIGDFGLAK 134 (307)
Q Consensus 106 ~i~H~dlkp~Nill------~~~~~~kl~dfg~~~ 134 (307)
.++|+|+.+.||++ +++..+.++||..+.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 345679999999886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 307 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-62
Identities = 59/260 (22%), Positives = 117/260 (45%), Gaps = 21/260 (8%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G + + ++A + Q ++ F E+ L RH N++ +G + +V ++
Sbjct: 27 GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWC 85
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
E +SL L K K DI A+G+ +LH I+HRD+K++NI L +
Sbjct: 86 EGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHE 139
Query: 122 EFNPKIGDFGLAKLFP-DNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLV 177
+ KIGDFGLA + + +H +++G+ ++APE + + ++DVY+FG+++
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 178 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237
E+++G+ N+ + + + P+L + N ++ C
Sbjct: 200 YELMTGQ---LPYSNINNRDQIIFMVG-------RGYLSPDLSKVRSNCPKAMKRLMAEC 249
Query: 238 TQAAASRRPQMNQVIKMLTK 257
+ RP Q++ +
Sbjct: 250 LKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-59
Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 21/254 (8%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G ++AVK L + F+ E + ++H LV L Q ++ EY+
Sbjct: 32 GYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYM 89
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
EN SL L T + IKL K D+ IA+G+AF+ E + +HRD++A+NIL+
Sbjct: 90 ENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 144
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ KI DFGLA+L DN + APE + G T+K+DV+SFG+L+ EI+
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
+ G+ + M + E+ +V P + P E+ + M++ C +
Sbjct: 205 TH---GRIPYPGMT-----NPEVIQNLERGYRMVRP---DNCPEELYQLMRL---CWKER 250
Query: 242 ASRRPQMNQVIKML 255
RP + + +L
Sbjct: 251 PEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-57
Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 21/256 (8%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G N ++A+K + E +FI E + + HP LV+L G C++ LV+E++
Sbjct: 24 GYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
E+ L L E +C+ + +G+A+L E ++HRD+ A N L+ +
Sbjct: 83 EHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGE 136
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
K+ DFG+ + D+ +T + +PE + + K+DV+SFGVL+ E+
Sbjct: 137 NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
S GK + + + + L P L + + M C +
Sbjct: 197 SE---GKIPYENRS-----NSEVVEDISTGFRLYKPRL---ASTHVYQIMN---HCWKER 242
Query: 242 ASRRPQMNQVIKMLTK 257
RP +++++ L +
Sbjct: 243 PEDRPAFSRLLRQLAE 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-56
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 23/291 (7%)
Query: 4 LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+G +A K + E K +R I E+ L P +V G + E+++
Sbjct: 28 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
SLD+VL K ++ + + + + KGL +L E+ I+HRD+K SNIL++
Sbjct: 88 GGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSR 141
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
K+ DFG++ D + GT Y++PE + G ++++D++S G+ ++E+
Sbjct: 142 GEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 183 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242
GR + + + + E P P R F
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 243 SRRPQMNQ-----------VIKMLTKN--IRLNEEELTAPGLFQDSESSSV 280
+ P V K L KN R + ++L + S++ V
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 7e-56
Identities = 55/254 (21%), Positives = 105/254 (41%), Gaps = 21/254 (8%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G +A+K + E EFI E + N+ H LV+L G C + ++ EY+
Sbjct: 23 GKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
N L L + ++ ++C + + + +L +HRD+ A N L++
Sbjct: 82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVND 135
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ K+ DFGL++ D+ + + PE ++ + + K+D+++FGVL+ EI
Sbjct: 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
S GK + + + + L L P L ++ + + C
Sbjct: 196 SL---GKMPYERFTN-----SETAEHIAQGLRLYRPHL---ASEKVY---TIMYSCWHEK 241
Query: 242 ASRRPQMNQVIKML 255
A RP ++ +
Sbjct: 242 ADERPTFKILLSNI 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-55
Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 33/284 (11%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG----TRRILVYEYV 61
G +AVK S+ ++ EI +RH N++ I + T+ LV +Y
Sbjct: 25 RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELV-----PHIVHRDIKASN 116
E+ SL L + E + + A GLA LH E+V P I HRD+K+ N
Sbjct: 84 EHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138
Query: 117 ILLDQEFNPKIGDFGLAKLFP---DNITHITTRIAGTTGYLAPEYVLG------GQLTMK 167
IL+ + I D GLA D I GT Y+APE + + +
Sbjct: 139 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198
Query: 168 ADVYSFGVLVLEIISGRNSGKAM----WGQMNKFLLEWAWQLHQEEKPLELVDPEL-GEY 222
AD+Y+ G++ EI + G + + + + ++ + + P + +
Sbjct: 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 258
Query: 223 PPNEIIRYM-KVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE 265
E +R M K+ C A + R ++ K L+ +L+++E
Sbjct: 259 QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS---QLSQQE 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-54
Identities = 68/264 (25%), Positives = 109/264 (41%), Gaps = 21/264 (7%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
GT R+A+K L F+ E + +RH LV+L + +V EY+
Sbjct: 36 GTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYM 93
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
SL L G + L + D+ IA G+A++ + VHRD++A+NIL+ +
Sbjct: 94 SKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGE 148
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
K+ DFGLA+L DN + APE L G+ T+K+DV+SFG+L+ E+
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 182 SGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
+ G+ + M E Q+ + + PP + C +
Sbjct: 209 TK---GRVPYPGMV--NREVLDQVERGYRM---------PCPPECPESLHDLMCQCWRKE 254
Query: 242 ASRRPQMNQVIKMLTKNIRLNEEE 265
RP + L E +
Sbjct: 255 PEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 2e-52
Identities = 59/279 (21%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
+ +AVK L E+ ++ +F E ++ +PN+V+L+G C G L++E
Sbjct: 37 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96
Query: 60 YVENNSLDRVLLGATKANI--------------------KLNWEKRSDICVGIAKGLAFL 99
Y+ L+ L + + L+ ++ I +A G+A+L
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 100 HEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAK-LFPDNITHITTRIAGTTGYLAPEY 158
E VHRD+ N L+ + KI DFGL++ ++ + A ++ PE
Sbjct: 157 SE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 213
Query: 159 VLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPE 218
+ + T ++DV+++GV++ EI S L+ + + EE + D
Sbjct: 214 IFYNRYTTESDVWAYGVVLWEIFSYG--------------LQPYYGMAHEEVIYYVRDGN 259
Query: 219 LGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257
+ P N + + C + RP + ++L +
Sbjct: 260 ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 5e-52
Identities = 64/271 (23%), Positives = 114/271 (42%), Gaps = 33/271 (12%)
Query: 6 NGRRIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVEN 63
+AVK L + RE ++E+ LS + H N+V L+G C G +++ EY
Sbjct: 52 AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCY 111
Query: 64 NSLDRVL--------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVH 109
L L + L+ E +AKG+AFL + + +H
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIH 168
Query: 110 RDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTMKA 168
RD+ A NILL KI DFGLA+ ++ + + ++APE + T ++
Sbjct: 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 169 DVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228
DV+S+G+ + E+ S G + + M + +++ +E + P +
Sbjct: 229 DVWSYGIFLWELFSL---GSSPYPGMP--VDSKFYKMIKEGFRM--------LSPEHAPA 275
Query: 229 RYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259
+ C A +RP Q+++++ K I
Sbjct: 276 EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-52
Identities = 61/259 (23%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI-LVYEYVENN 64
G ++AVK + ++ + F+ E ++ +RH NLV+L+G V+ + +V EY+
Sbjct: 29 RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
SL L ++ L + + + + + +L + VHRD+ A N+L+ ++
Sbjct: 87 SLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNV 141
Query: 125 PKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
K+ DFGL K + APE + + + K+DV+SFG+L+ EI S
Sbjct: 142 AKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF- 196
Query: 185 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244
G+ + ++ L + ++ + K + P +V C A+
Sbjct: 197 --GRVPYPRIP--LKDVVPRVEKGYKM---------DAPDGCPPAVYEVMKNCWHLDAAM 243
Query: 245 RPQMNQVIKMLTKNIRLNE 263
RP Q+ + L ++I+ +E
Sbjct: 244 RPSFLQLREQL-EHIKTHE 261
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 7e-52
Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 6 NGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
+A+K L +++ E + E + + +P +V LIG C Q +LV E
Sbjct: 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 93
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L + L+G + ++ +++ ++ G+ +L E + VHRD+ A N+LL
Sbjct: 94 PLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHY 147
Query: 125 PKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
KI DFGL+K + ++ T R + APE + + + ++DV+S+GV + E +S
Sbjct: 148 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 207
Query: 183 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242
G+ + +M E + Q ++ E PP + C
Sbjct: 208 Y---GQKPYKKMK--GPEVMAFIEQGKRM---------ECPPECPPELYALMSDCWIYKW 253
Query: 243 SRRPQMNQVIKML 255
RP V + +
Sbjct: 254 EDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 61/253 (24%), Positives = 103/253 (40%), Gaps = 26/253 (10%)
Query: 7 GRRIAVKPLSAESKQG--VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENN 64
+ +AVK L E+ E + E + + +P +V +IG C + +LV E E
Sbjct: 34 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELG 92
Query: 65 SLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFN 124
L++ L + N + + ++ ++ G+ +L E + VHRD+ A N+LL +
Sbjct: 93 PLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHY 145
Query: 125 PKIGDFGLAKLFPDNITHITTR--IAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
KI DFGL+K + + + + APE + + + K+DV+SFGVL+ E S
Sbjct: 146 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205
Query: 183 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242
G+ + M E L + E+ P + C
Sbjct: 206 Y---GQKPYRGMK--GSEVTAMLEKGERM---------GCPAGCPREMYDLMNLCWTYDV 251
Query: 243 SRRPQMNQVIKML 255
RP V L
Sbjct: 252 ENRPGFAAVELRL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 22/256 (8%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL--VYE 59
++G+ + K + ++ + ++E+ L ++HPN+V + T L V E
Sbjct: 26 KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHE--ELVPHIVHRDIKASNI 117
Y E L V+ TK L+ E + + L H + ++HRD+K +N+
Sbjct: 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145
Query: 118 LLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
LD + N K+GDFGLA++ + T GT Y++PE + K+D++S G L+
Sbjct: 146 FLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 204
Query: 178 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237
E+ + + ++ L + + + EL NEII
Sbjct: 205 YELCALMP----PFTAFSQKELAGKIREGKFRRIPYRYSDEL-----NEIITR------M 249
Query: 238 TQAAASRRPQMNQVIK 253
RP + ++++
Sbjct: 250 LNLKDYHRPSVEEILE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 1e-51
Identities = 55/252 (21%), Positives = 115/252 (45%), Gaps = 20/252 (7%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
+AVK L ++ + V EF+ E + ++HPNLV+L+G C + ++ E++ +
Sbjct: 41 YSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
L L + +++ + I+ + +L + + +HRD+ A N L+ +
Sbjct: 100 LLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLV 154
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN 185
K+ DFGL++L + + APE + + ++K+DV++FGVL+ EI +
Sbjct: 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY-- 212
Query: 186 SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245
G + + ++ L ++L +++ + E P + ++ C Q S R
Sbjct: 213 -GMSPYPGID---LSQVYELLEKDYRM--------ERPEGCPEKVYELMRACWQWNPSDR 260
Query: 246 PQMNQVIKMLTK 257
P ++ +
Sbjct: 261 PSFAEIHQAFET 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 1e-51
Identities = 65/271 (23%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 3 TLTNGRRIAVKPL-SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
+A+K L S +++ R+F++E + HPN++ L G + T +++ E++
Sbjct: 50 PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
EN SLD + + + + + GIA G+ +L + + VHRD+ A NIL++
Sbjct: 110 ENGSLDSF---LRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNS 163
Query: 122 EFNPKIGDFGLAKLFPDNITHITTR----IAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177
K+ DFGL++ D+ + T + APE + + T +DV+S+G+++
Sbjct: 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223
Query: 178 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237
E++S G+ + M + + Q+ + P + ++ C
Sbjct: 224 WEVMSY---GERPYWDMTN--QDVINAIEQDYRL---------PPPMDCPSALHQLMLDC 269
Query: 238 TQAAASRRPQMNQVIKMLTKNIRLNEEELTA 268
Q + RP+ Q++ L K IR N L A
Sbjct: 270 WQKDRNHRPKFGQIVNTLDKMIR-NPNSLKA 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-51
Identities = 62/266 (23%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 2 GTLTNGRRIAVKPLSAESKQGVR-EFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+ +A+K L A + R +F+ E + H N++ L G + +++ EY
Sbjct: 31 SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+EN +LD+ + + + + + + GIA G+ +L + VHRD+ A NIL++
Sbjct: 91 MENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVN 144
Query: 121 QEFNPKIGDFGLAKLFPDNI--THITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
K+ DFGL+++ D+ T+ T+ + APE + + T +DV+SFG+++
Sbjct: 145 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 204
Query: 179 EIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238
E+++ W+L E + D P + ++ C
Sbjct: 205 EVMTYGER--------------PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 250
Query: 239 QAAASRRPQMNQVIKMLTKNIRLNEE 264
Q +RRP+ ++ +L K IR +
Sbjct: 251 QQERARRPKFADIVSILDKLIRAPDS 276
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 6e-51
Identities = 55/257 (21%), Positives = 107/257 (41%), Gaps = 33/257 (12%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
A K + +S++ + +++ EI L++ HPN+V+L+ ++ E+ +
Sbjct: 36 TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
+D V+ + L + +C L +LH+ I+HRD+KA NIL + +
Sbjct: 96 VDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDI 149
Query: 126 KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-----TMKADVYSFGVLVLEI 180
K+ DFG++ I + I GT ++APE V+ KADV+S G+ ++E+
Sbjct: 150 KLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208
Query: 181 ISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN--EIIRYMKVAFF 236
+ K + +P L P + N + ++
Sbjct: 209 AEIEPPHHELNPMRVLLK---------IAKSEPPTLAQPS--RWSSNFKDFLKK------ 251
Query: 237 CTQAAASRRPQMNQVIK 253
C + R +Q+++
Sbjct: 252 CLEKNVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-50
Identities = 69/293 (23%), Positives = 125/293 (42%), Gaps = 23/293 (7%)
Query: 7 GRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNS 65
+A+K L A S + +E + E +++V +P++ L+G C+ T +++
Sbjct: 38 KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCL 97
Query: 66 LDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNP 125
LD V + + + + CV IAKG+ +L + +VHRD+ A N+L+ +
Sbjct: 98 LDYV----REHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHV 150
Query: 126 KIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGR 184
KI DFGLAKL + + ++A E +L T ++DV+S+GV V E+++
Sbjct: 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF- 209
Query: 185 NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244
G + + E + L + E+ PP I + C A
Sbjct: 210 --GSKPYDGIP--ASEISSILEKGERL---------PQPPICTIDVYMIMVKCWMIDADS 256
Query: 245 RPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTSDKKSSDSTLQMSSV 297
RP+ ++I +K R + L G + S ++ ++ M V
Sbjct: 257 RPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDV 309
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-50
Identities = 66/258 (25%), Positives = 115/258 (44%), Gaps = 25/258 (9%)
Query: 5 TNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYVE 62
AVK L+ + G V +F+TE + + + HPN++ L+G C++ ++V Y++
Sbjct: 53 GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
+ L + + +AKG+ FL VHRD+ A N +LD++
Sbjct: 113 HGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEK 166
Query: 123 FNPKIGDFGLAKLFPDN---ITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
F K+ DFGLA+ D H T ++A E + + T K+DV+SFGVL+ E
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
Query: 180 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
+++ G + +N + L Q + L EY P+ + M C
Sbjct: 227 LMTR---GAPPYPDVN--TFDITVYLLQGRRLL------QPEYCPDPLYEVML---KCWH 272
Query: 240 AAASRRPQMNQVIKMLTK 257
A RP ++++ ++
Sbjct: 273 PKAEMRPSFSELVSRISA 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 9e-50
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 32/256 (12%)
Query: 4 LTNGRRIAVKPLSAESKQG---VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+ N +A+K +S KQ ++ I E+ L +RHPN ++ GC ++ LV EY
Sbjct: 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
++ D + L + + + G +GLA+LH +++HRD+KA NILL
Sbjct: 97 CLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS 149
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG---GQLTMKADVYSFGVLV 177
+ K+GDFG A + GT ++APE +L GQ K DV+S G+
Sbjct: 150 EPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 178 LEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237
+E+ + MN + + + Q E P + ++ C
Sbjct: 205 IELAERK----PPLFNMNA--MSALYHIAQNESP-----ALQSGHWSEYFRNFVDS---C 250
Query: 238 TQAAASRRPQMNQVIK 253
Q RP ++K
Sbjct: 251 LQKIPQDRPTSEVLLK 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-49
Identities = 59/255 (23%), Positives = 95/255 (37%), Gaps = 29/255 (11%)
Query: 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR----ILVYE 59
+A L +K + F E L ++HPN+V + +LV E
Sbjct: 33 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
+ + +L L K + + C I KGL FLH P I+HRD+K NI +
Sbjct: 93 LMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFI 147
Query: 120 DQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVL 178
+ KIGD GLA L + GT ++APE + + DVY+FG+ +L
Sbjct: 148 TGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCML 203
Query: 179 EIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238
E+ + + + ++ PE+ EII C
Sbjct: 204 EMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAIPEV-----KEIIEG------CI 250
Query: 239 QAAASRRPQMNQVIK 253
+ R + ++
Sbjct: 251 RQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 38/271 (14%)
Query: 7 GRRIAVKPLSAESKQGVRE-FITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENN 64
++AVK L ++ RE ++E+ ++ + H N+V L+G C L++EY
Sbjct: 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126
Query: 65 SLDRVL-------------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 105
L L L + L +E +AKG+ FL
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---K 183
Query: 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHIT-TRIAGTTGYLAPEYVLGGQL 164
VHRD+ A N+L+ KI DFGLA+ + ++ ++APE + G
Sbjct: 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 224
T+K+DV+S+G+L+ EI S G + + + ++L Q + + P
Sbjct: 244 TIKSDVWSYGILLWEIFSL---GVNPYPGIP--VDANFYKLIQNGFKM--------DQPF 290
Query: 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIKML 255
+ C + +RP + L
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 58/257 (22%), Positives = 98/257 (38%), Gaps = 25/257 (9%)
Query: 6 NGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+AVK L + + + +FI E+ + ++ H NL+ L G + ++ V E
Sbjct: 35 KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAP 93
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
SL K S V +A+G+ +L +HRD+ A N+LL
Sbjct: 94 LGSLLDR---LRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATR 147
Query: 123 FNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
KIGDFGL + P N H + + APE + + +D + FGV + E+
Sbjct: 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207
Query: 181 ISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240
+ G+ W +N + ++ +E + L P + V C
Sbjct: 208 FTY---GQEPWIGLN--GSQILHKIDKEGERLPR--------PEDCPQDIYNVMVQCWAH 254
Query: 241 AASRRPQMNQVIKMLTK 257
RP + L +
Sbjct: 255 KPEDRPTFVALRDFLLE 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 7e-49
Identities = 56/254 (22%), Positives = 97/254 (38%), Gaps = 25/254 (9%)
Query: 4 LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+AVK + + E EI + H N+V+ G +G + L EY
Sbjct: 27 RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
L + + +I + + G+ +LH I HRDIK N+LLD+
Sbjct: 87 GGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDER 139
Query: 123 FNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLEI 180
N KI DFGLA +F +N + ++ GT Y+APE + + DV+S G+++ +
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 181 ISGRNSGKAMWGQMNKFLLEWAWQLHQE-EKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
++G + W+ + P + +D ++
Sbjct: 200 LAGE---LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-----LALLHK------ILV 245
Query: 240 AAASRRPQMNQVIK 253
S R + + K
Sbjct: 246 ENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-48
Identities = 61/258 (23%), Positives = 105/258 (40%), Gaps = 31/258 (12%)
Query: 6 NGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+ +A+K L E + E+ S++RHPN++ L G TR L+ EY
Sbjct: 30 SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
++ R L + K + ++ + +A L++ H + ++HRDIK N+LL
Sbjct: 90 LGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSA 142
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
KI DFG + P + + GT YL PE + G K D++S GVL E +
Sbjct: 143 GELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199
Query: 183 GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242
G+ + + E + V ++I +
Sbjct: 200 GKP---PFEANTYQETYKRI--SRVEFTFPDFVTEGA-----RDLISR------LLKHNP 243
Query: 243 SRRPQMNQVIKM--LTKN 258
S+RP + +V++ +T N
Sbjct: 244 SQRPMLREVLEHPWITAN 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 34/288 (11%)
Query: 10 IAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLD 67
A+K + SK R+F E+ L + HPN++ L+G C L EY + +L
Sbjct: 40 AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 99
Query: 68 RVLLG------------ATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
L A L+ ++ +A+G+ +L + +HRD+ A
Sbjct: 100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAAR 156
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
NIL+ + + KI DFGL++ + R ++A E + T +DV+S+GV
Sbjct: 157 NILVGENYVAKIADFGLSRGQEVYVKKTMGR--LPVRWMAIESLNYSVYTTNSDVWSYGV 214
Query: 176 LVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
L+ EI+S G + M E +L Q + E P N +
Sbjct: 215 LLWEIVSL---GGTPYCGMT--CAELYEKLPQGYRL---------EKPLNCDDEVYDLMR 260
Query: 236 FCTQAAASRRPQMNQVIKMLTKNIRLNEEELTAPGLFQDSESSSVGTS 283
C + RP Q++ L + + L++ + + S
Sbjct: 261 QCWREKPYERPSFAQILVSL-NRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-47
Identities = 59/258 (22%), Positives = 102/258 (39%), Gaps = 22/258 (8%)
Query: 1 MGTLTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
M +A+K + VRE F+ E +T+ HP++V+LIG + I + E
Sbjct: 29 MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IME 87
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
L L+ ++ LA+L VHRDI A N+L+
Sbjct: 88 LCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLV 141
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
K+GDFGL++ D+ + ++ ++APE + + T +DV+ FGV + E
Sbjct: 142 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 201
Query: 180 IISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
I+ G + + + ++ E+ PPN + C
Sbjct: 202 ILMH---GVKPFQGVK--NNDVIGRIENGERL---------PMPPNCPPTLYSLMTKCWA 247
Query: 240 AAASRRPQMNQVIKMLTK 257
SRRP+ ++ L+
Sbjct: 248 YDPSRRPRFTELKAQLST 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-46
Identities = 52/252 (20%), Positives = 105/252 (41%), Gaps = 26/252 (10%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
+ G+ +A++ ++ + + I EI+ + ++PN+V + + G +V EY+
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
SL V+ ++ + + +C + L FLH ++HRDIK+ NILL +
Sbjct: 102 GSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG 153
Query: 124 NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISG 183
+ K+ DFG + +T + GT ++APE V K D++S G++ +E+I G
Sbjct: 154 SVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
Query: 184 RN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241
+ + +L EK + + + C
Sbjct: 213 EPPYLNENPLRALYLIATNGTPELQNPEK----LSAIF-----RDFLNR------CLDMD 257
Query: 242 ASRRPQMNQVIK 253
+R ++++
Sbjct: 258 VEKRGSAKELLQ 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-46
Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 27/268 (10%)
Query: 1 MGTLTNGRRIAVKPLS-AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
+ R+A+K ++ A S + EF+ E + ++V L+G QG +++ E
Sbjct: 44 VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103
Query: 60 YVENNSLDRVL------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
+ L L + + K + IA G+A+L+ VHRD+
Sbjct: 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLA 160
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPD-NITHITTRIAGTTGYLAPEYVLGGQLTMKADVYS 172
A N ++ ++F KIGDFG+ + + + + +++PE + G T +DV+S
Sbjct: 161 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 220
Query: 173 FGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV-DPELGEYPPNEIIRYM 231
FGV++ EI + E +Q E+ L V + L + P N
Sbjct: 221 FGVVLWEIATLA---------------EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 265
Query: 232 KVAFFCTQAAASRRPQMNQVIKMLTKNI 259
++ C Q RP ++I + + +
Sbjct: 266 ELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-44
Identities = 60/271 (22%), Positives = 119/271 (43%), Gaps = 32/271 (11%)
Query: 2 GTLTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYE 59
++AVK L ++ +++ + + I+E+ + + +H N++ L+G C Q ++ E
Sbjct: 40 DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 99
Query: 60 YVENNSLDRVL------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHI 107
Y +L L + +L+ + +A+G+ +L
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKC 156
Query: 108 VHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITT-RIAGTTGYLAPEYVLGGQLTM 166
+HRD+ A N+L+ ++ KI DFGLA+ + T ++APE + T
Sbjct: 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216
Query: 167 KADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNE 226
++DV+SFGVL+ EI + G + + + +E ++L +E + + P N
Sbjct: 217 QSDVWSFGVLLWEIFTL---GGSPYPGVP---VEELFKLLKEGHRM--------DKPSNC 262
Query: 227 IIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257
+ C A S+RP Q+++ L +
Sbjct: 263 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (382), Expect = 7e-44
Identities = 53/254 (20%), Positives = 99/254 (38%), Gaps = 26/254 (10%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
G A K + + EI T+S +RHP LV L +++YE++
Sbjct: 48 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L + + K++ ++ + + KGL +HE + VH D+K NI+ +
Sbjct: 108 GELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKR 161
Query: 124 NP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ K+ DFGL + T GT + APE G + D++S GVL ++
Sbjct: 162 SNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219
Query: 182 SGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239
SG + G+ + + + ++ + + + IR
Sbjct: 220 SGLSPFGGENDDETLRNVK---SCDWNMDDSAFSGISEDG-----KDFIRK------LLL 265
Query: 240 AAASRRPQMNQVIK 253
A + R ++Q ++
Sbjct: 266 ADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-43
Identities = 66/278 (23%), Positives = 116/278 (41%), Gaps = 32/278 (11%)
Query: 1 MGTLTNGRRIAVKPLSAESKQG-VREFITEIMTLS-NVRHPNLVELIGCCVQ-GTRRILV 57
+ R +AVK L + R ++E+ L H N+V L+G C + G +++
Sbjct: 37 IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96
Query: 58 YEYVENNSLDRVL------------LGATKANIKLNWEKRSDICVGIAKGLAFLHEELVP 105
E+ + +L L L E +AKG+ FL
Sbjct: 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---R 153
Query: 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI-TTRIAGTTGYLAPEYVLGGQL 164
+HRD+ A NILL ++ KI DFGLA+ + ++ ++APE +
Sbjct: 154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213
Query: 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 224
T+++DV+SFGVL+ EI S + + + + E + +E + D Y
Sbjct: 214 TIQSDVWSFGVLLWEIFSLG---ASPYPGVK--IDEEFCRRLKEGTRMRAPD-----YTT 263
Query: 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262
E+ + M C S+RP +++++ L ++ N
Sbjct: 264 PEMYQTMLD---CWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-43
Identities = 43/185 (23%), Positives = 78/185 (42%), Gaps = 11/185 (5%)
Query: 4 LTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
L R A+K L + V E +S + HP V+L + Y
Sbjct: 30 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+N L + + + + I L +LH I+HRD+K NILL+
Sbjct: 90 AKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLN 142
Query: 121 QEFNPKIGDFGLAKLF-PDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
++ + +I DFG AK+ P++ GT Y++PE + +D+++ G ++ +
Sbjct: 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202
Query: 180 IISGR 184
+++G
Sbjct: 203 LVAGL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 146 bits (369), Expect = 6e-42
Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 10/183 (5%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
GR K ++ EI ++ + HP L+ L +L+ E++
Sbjct: 51 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
L + + K++ + + +GL +HE IVH DIK NI+ + +
Sbjct: 111 GELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKK 164
Query: 124 NP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
KI DFGLA + I T + APE V + D+++ GVL ++
Sbjct: 165 ASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222
Query: 182 SGR 184
SG
Sbjct: 223 SGL 225
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 5e-40
Identities = 48/262 (18%), Positives = 97/262 (37%), Gaps = 27/262 (10%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIG-CCVQGTRRILVYEYVE 62
+ G +A+K ++K + E ++ + I C +G ++V E +
Sbjct: 29 IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL---L 119
+ D + K + + + + + ++H + + +HRD+K N L
Sbjct: 87 PSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLG 139
Query: 120 DQEFNPKIGDFGLAKLFPDNITHI------TTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
+ I DFGLAK + D TH + GT Y + LG + + + D+ S
Sbjct: 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199
Query: 174 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233
G +++ G + + + E EK + L + P+E Y+
Sbjct: 200 GYVLMYFNLGSLPWQGLKAATKRQKYERIS-----EKKMSTPIEVLCKGYPSEFATYLN- 253
Query: 234 AFFCTQAAASRRPQMNQVIKML 255
FC +P + + ++
Sbjct: 254 --FCRSLRFDDKPDYSYLRQLF 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (339), Expect = 2e-38
Identities = 57/270 (21%), Positives = 102/270 (37%), Gaps = 45/270 (16%)
Query: 4 LTNGRRIAVK--------PLSAESKQGVRE-FITEIMTLSNVR-HPNLVELIGCCVQGTR 53
+ AVK SAE Q +RE + E+ L V HPN+++L T
Sbjct: 25 KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84
Query: 54 RILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
LV++ ++ L L + L+ ++ I + + + LH+ +IVHRD+K
Sbjct: 85 FFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLK 137
Query: 114 ASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL------TMK 167
NILLD + N K+ DFG + + GT YLAPE + +
Sbjct: 138 PENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 195
Query: 168 ADVYSFGVLVLEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN 225
D++S GV++ +++G + + + + PE +Y
Sbjct: 196 VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM----------SGNYQFGSPEWDDYSDT 245
Query: 226 --EIIRYMKVAFFCTQAAASRRPQMNQVIK 253
+++ +R + +
Sbjct: 246 VKDLVSR------FLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 2e-38
Identities = 46/255 (18%), Positives = 91/255 (35%), Gaps = 27/255 (10%)
Query: 4 LTNGRRIAVKPLSAESKQGVRE-FITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
+ +A+K ++ ++ +G EI L ++HPN+V L G L+ + V
Sbjct: 31 KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
L + S + + + +LH+ + H + LD++
Sbjct: 91 GGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDED 146
Query: 123 FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS 182
I DFGL+K+ + + GT GY+APE + + D +S GV+ ++
Sbjct: 147 SKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
Query: 183 GRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN--EIIRYMKVAFFCT 238
G + + L + E P + + + IR+
Sbjct: 205 GYPPFYDENDAKLFEQIL----------KAEYEFDSPYWDDISDSAKDFIRH------LM 248
Query: 239 QAAASRRPQMNQVIK 253
+ +R Q ++
Sbjct: 249 EKDPEKRFTCEQALQ 263
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (336), Expect = 9e-38
Identities = 46/266 (17%), Positives = 100/266 (37%), Gaps = 29/266 (10%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVE 62
L N +++A+K S + E T + + + +G +LV + +
Sbjct: 27 LLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 84
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
+ D + K + + + + + +HE +V+RDIK N L+ +
Sbjct: 85 PSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRP 137
Query: 123 FNP-----KIGDFGLAKLFPDNITHI------TTRIAGTTGYLAPEYVLGGQLTMKADVY 171
+ + DFG+ K + D +T ++GT Y++ LG + + + D+
Sbjct: 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLE 197
Query: 172 SFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231
+ G + + + G G + ++ ++++ L EL P E +YM
Sbjct: 198 ALGHVFMYFLRGSLP---WQGLKAATNKQKYERIGEKKQSTPL--RELCAGFPEEFYKYM 252
Query: 232 KVAFFCTQAAASRRPQMNQVIKMLTK 257
+ A P + + + +K
Sbjct: 253 H---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 1e-37
Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 14/184 (7%)
Query: 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
NGR A+K L E + V E + LS V HP ++ + G + ++ +Y
Sbjct: 26 RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+E L + + + + + L +LH I++RD+K NILLD
Sbjct: 86 IEGGELFSL----LRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLD 138
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
+ + KI DFG AK PD + GT Y+APE V D +SFG+L+ E+
Sbjct: 139 KNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 194
Query: 181 ISGR 184
++G
Sbjct: 195 LAGY 198
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 38/184 (20%), Positives = 71/184 (38%), Gaps = 11/184 (5%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63
++ + K + + EI L+ RH N++ L ++++E++
Sbjct: 27 TSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF 123
+ + + +LN + + + L FLH +I H DI+ NI+
Sbjct: 86 LDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRR 139
Query: 124 NP--KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ KI +FG A+ Y APE ++ D++S G LV ++
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197
Query: 182 SGRN 185
SG N
Sbjct: 198 SGIN 201
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (330), Expect = 5e-37
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 16/190 (8%)
Query: 4 LTNGRRIAVKPLS---AESKQGVREFITEIMTLSNVRHPNLVELIGCCV----QGTRRIL 56
L R +AVK L A F E + + HP +V + G +
Sbjct: 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88
Query: 57 VYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASN 116
V EYV+ +L ++ + ++ ++ + L F H+ I+HRD+K +N
Sbjct: 89 VMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPAN 141
Query: 117 ILLDQEFNPKIGDFGLAKLFPDNITHI--TTRIAGTTGYLAPEYVLGGQLTMKADVYSFG 174
I++ K+ DFG+A+ D+ + T + GT YL+PE G + ++DVYS G
Sbjct: 142 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 201
Query: 175 VLVLEIISGR 184
++ E+++G
Sbjct: 202 CVLYEVLTGE 211
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-37
Identities = 54/183 (29%), Positives = 79/183 (43%), Gaps = 12/183 (6%)
Query: 6 NGRRIAVKPLS---AESKQGVREFITEIMTLS-NVRHPNLVELIGCCVQGTRRILVYEYV 61
+ A+K L V + E LS HP L + V EY+
Sbjct: 26 TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L + ++ K + + + I GL FLH IV+RD+K NILLD+
Sbjct: 86 NGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDK 138
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
+ + KI DFG+ K T GT Y+APE +LG + D +SFGVL+ E++
Sbjct: 139 DGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197
Query: 182 SGR 184
G+
Sbjct: 198 IGQ 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 7e-37
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 17/187 (9%)
Query: 6 NGRRIAVKPLS---AESKQGVREFITEIMT---LSNVRHPNLVELIGCCVQGTRRILVYE 59
G+ A+K L + KQG + E + +S P +V + + + +
Sbjct: 28 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
+ L L + + I GL +H +V+RD+K +NILL
Sbjct: 88 LMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILL 140
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVL 178
D+ + +I D GLA F H + GT GY+APE + G AD +S G ++
Sbjct: 141 DEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197
Query: 179 EIISGRN 185
+++ G +
Sbjct: 198 KLLRGHS 204
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-36
Identities = 61/269 (22%), Positives = 108/269 (40%), Gaps = 23/269 (8%)
Query: 4 LTNGRRIAVKPLSAESKQG-VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVE 62
N R+A+K +S Q + + EI L RH N++ + T + Y+
Sbjct: 30 NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89
Query: 63 NNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE 122
+ + L K L+ + I +GL ++H +++HRD+K SN+LL+
Sbjct: 90 THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTT 145
Query: 123 FNPKIGDFGLAKLFPDNITHIT--TRIAGTTGYLAPEYVLGGQLTM-KADVYSFGVLVLE 179
+ KI DFGLA++ + H T T Y APE +L + D++S G ++ E
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 180 IISGRN--SGKAMWGQMNKFL--------LEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229
++S R GK Q+N L + ++ + + L P + P N +
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 230 YMKVAFF-----CTQAAASRRPQMNQVIK 253
+R ++ Q +
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-35
Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 23/266 (8%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G +A+K L E++ I EI L + HPN+V+L+ + LV+E++
Sbjct: 24 KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+ + A + + +GLAF H ++HRD+K N+L++
Sbjct: 84 HQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINT 137
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG-GQLTMKADVYSFGVLVLEI 180
E K+ DFGLA+ F + T + T Y APE +LG + D++S G + E+
Sbjct: 138 EGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 181 ISGRN--SGKAMWGQMNKFL------LEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232
++ R G + Q+ + E W + P+ ++++ +
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 233 VAFF-----CTQAAASRRPQMNQVIK 253
++R +
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-34
Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 14/190 (7%)
Query: 3 TLTNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL 56
GR +A+K + ++ +RE + + L HPN+V L C
Sbjct: 29 LKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87
Query: 57 VYEYV--ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKA 114
+ E+ D + E D+ + +GL FLH +VHRD+K
Sbjct: 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKP 144
Query: 115 SNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFG 174
NIL+ K+ DFGLA+++ + T + T Y APE +L D++S G
Sbjct: 145 QNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202
Query: 175 VLVLEIISGR 184
+ E+ +
Sbjct: 203 CIFAEMFRRK 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (312), Expect = 2e-34
Identities = 53/267 (19%), Positives = 100/267 (37%), Gaps = 22/267 (8%)
Query: 2 GTLTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYE 59
G A+K L E + I EI L ++H N+V+L R +LV+E
Sbjct: 21 AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
+++ + + L + + G+A+ H+ ++HRD+K N+L+
Sbjct: 81 HLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLI 133
Query: 120 DQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLE 179
++E KI DFGLA+ F + T I + + + D++S G + E
Sbjct: 134 NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
Query: 180 IISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234
+++G S ++ + L + L DP Y P ++K
Sbjct: 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253
Query: 235 FF--------CTQAAASRRPQMNQVIK 253
+ ++R Q ++
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-34
Identities = 53/261 (20%), Positives = 107/261 (40%), Gaps = 23/261 (8%)
Query: 6 NGRRIAVKPLSAESKQG-----VREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+ +A+K + + R + EI L + HPN++ L+ + LV+++
Sbjct: 22 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+E + + ++ L + +GL +LH+ I+HRD+K +N+LLD
Sbjct: 82 METDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLD 134
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVLE 179
+ K+ DFGLAK F T ++ T Y APE + G ++ + D+++ G ++ E
Sbjct: 135 ENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYGVGVDMWAVGCILAE 193
Query: 180 IISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237
++ G + Q+ + P E P++ P +
Sbjct: 194 LLLRVPFLPGDSDLDQLTRI-------FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246
Query: 238 TQAAASRRPQMNQVIKMLTKN 258
+A+ ++ + + N
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFN 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-34
Identities = 54/314 (17%), Positives = 120/314 (38%), Gaps = 35/314 (11%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCC----VQGTRRILVY 58
+ A+K L Q + E+ + P++V ++ ++V
Sbjct: 34 KRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88
Query: 59 EYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNIL 118
E ++ L + + + + S+I I + + +LH +I HRD+K N+L
Sbjct: 89 ECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLL 143
Query: 119 LDQEFNP---KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
+ K+ DFG AK + + T T Y+APE + + D++S GV
Sbjct: 144 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGV 201
Query: 176 LVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPN--EIIRYMKV 233
++ ++ G + + + + E +PE E +IR
Sbjct: 202 IMYILLCGYP----PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN--- 254
Query: 234 AFFCTQAAASRRPQMNQVIKM--LTKNIRLNEEEL-TAPGLFQDSESSSVGTSDKKSSDS 290
+ ++R + + + + ++ ++ + L T+ L +D E + S+ +
Sbjct: 255 ---LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALA 311
Query: 291 TLQMSSVPVTITQV 304
T+++ + I ++
Sbjct: 312 TMRVDYEQIKIKKI 325
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-33
Identities = 40/191 (20%), Positives = 73/191 (38%), Gaps = 19/191 (9%)
Query: 4 LTNGRRIAVKPLSAESKQGVRE------FITEIMTLSNVR--HPNLVELIGCCVQGTRRI 55
+++ +A+K + + E E++ L V ++ L+ + +
Sbjct: 26 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
L+ E E + L E + + + H ++HRDIK
Sbjct: 86 LILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDE 139
Query: 116 NILLDQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSF 173
NIL+D K+ DFG L D + T GT Y PE++ + A V+S
Sbjct: 140 NILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 196
Query: 174 GVLVLEIISGR 184
G+L+ +++ G
Sbjct: 197 GILLYDMVCGD 207
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 7e-33
Identities = 69/318 (21%), Positives = 126/318 (39%), Gaps = 33/318 (10%)
Query: 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRR------ILVYE 59
+G +A+K + + + RE + + + H N+V L + LV +
Sbjct: 44 SGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 60 YVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILL 119
YV RV ++A L + + LA++H I HRDIK N+LL
Sbjct: 100 YVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLL 155
Query: 120 DQE-FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG-QLTMKADVYSFGVLV 177
D + K+ DFG AK +++ + Y APE + G T DV+S G ++
Sbjct: 156 DPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 178 LEIISGRN--SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235
E++ G+ G + Q+ + +++ +E+ + ++P + + KV
Sbjct: 214 AELLLGQPIFPGDSGVDQLVE-IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 236 FCTQAAASRRPQMNQVIKMLTKNI--RLNEEELTAPGLFQDSESSSVGTSDKKSSD---- 289
T A + ++L RL E A F + +V + + +
Sbjct: 273 PRTPPEA-----IALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN 327
Query: 290 -STLQMSSVPVTITQVTP 306
+T ++SS P T + P
Sbjct: 328 FTTQELSSNPPLATILIP 345
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 9e-33
Identities = 56/260 (21%), Positives = 93/260 (35%), Gaps = 31/260 (11%)
Query: 4 LTNGRRIAVKPL------SAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILV 57
+ G + A K + S+ + E+ L ++HPN++ L T IL+
Sbjct: 32 KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91
Query: 58 YEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNI 117
E V L L E+ ++ I G+ +LH I H D+K NI
Sbjct: 92 LELVAGGELFDF----LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENI 144
Query: 118 LLDQEFNP----KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSF 173
+L P KI DFGLA + I GT ++APE V L ++AD++S
Sbjct: 145 MLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202
Query: 174 GVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233
GV+ ++SG + Q L + E +++
Sbjct: 203 GVITYILLSGASPFLGDTKQE---------TLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 234 AFFCTQAAASRRPQMNQVIK 253
+R + ++
Sbjct: 254 ---LLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-32
Identities = 56/184 (30%), Positives = 75/184 (40%), Gaps = 11/184 (5%)
Query: 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
GR A+K L E +K V +TE L N RHP L L R V EY
Sbjct: 27 KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
L L E+ I L +LH +V+RDIK N++LD
Sbjct: 87 ANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLD 139
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
++ + KI DFGL K + GT YLAPE + D + GV++ E+
Sbjct: 140 KDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 181 ISGR 184
+ GR
Sbjct: 199 MCGR 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-32
Identities = 57/275 (20%), Positives = 112/275 (40%), Gaps = 34/275 (12%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRI------ 55
G+++A+K + E + + EI L ++H N+V LI C
Sbjct: 32 RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91
Query: 56 --LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIK 113
LV+++ E++ + +K + + + GL ++H I+HRD+K
Sbjct: 92 IYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMK 144
Query: 114 ASNILLDQEFNPKIGDFGLAKLF---PDNITHITTRIAGTTGYLAPEYVLGGQL-TMKAD 169
A+N+L+ ++ K+ DFGLA+ F ++ + T T Y PE +LG + D
Sbjct: 145 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID 204
Query: 170 VYSFGVLVLEIISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 224
++ G ++ E+ + N+ + +++ ++ EL Y
Sbjct: 205 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL-------YEK 257
Query: 225 NEIIRYMKVAFFCTQAAASRRPQMNQVI-KMLTKN 258
E+++ K A R P +I K+L +
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-30
Identities = 47/260 (18%), Positives = 93/260 (35%), Gaps = 18/260 (6%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
+A+K L + + + EI L ++H N+V L + LV+E+
Sbjct: 24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
+ + N L+ E + KGL F H +++HRD+K N+L+++
Sbjct: 84 DQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINR 136
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEII 181
K+ +FGLA+ F + + + + D++S G + E+
Sbjct: 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 182 SGRN---SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238
+ G + Q+ + + +E+ P P+ YP +
Sbjct: 197 NAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 239 QAAASRRPQMNQVIKMLTKN 258
A + + +L N
Sbjct: 256 NATG-----RDLLQNLLKCN 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-30
Identities = 56/293 (19%), Positives = 110/293 (37%), Gaps = 26/293 (8%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G ++A+K +S+ + E+ L ++RH N++ L+ ++
Sbjct: 40 GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
LG + KL ++ + + KGL ++H I+HRD+K N+ +++
Sbjct: 100 LVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNE 156
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEI 180
+ KI DFGLA+ +T T Y APE +L T D++S G ++ E+
Sbjct: 157 DCELKILDFGLARQADSEMTGYV----VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212
Query: 181 ISGR-----NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVD-----PELGEYPPNEIIRY 230
I+G+ + ++ K + Q + E + PEL + I+
Sbjct: 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272
Query: 231 MKVAFF-----CTQAAASRRPQMNQVIKM-LTKNIRLNEEELTAPGLFQDSES 277
A +R + + +++ E+E +
Sbjct: 273 ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDD 325
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (279), Expect = 5e-29
Identities = 44/184 (23%), Positives = 74/184 (40%), Gaps = 14/184 (7%)
Query: 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEY 60
+G A+K L + + + + E L V P LV+L + +V EY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V + L + + + I +LH +++RD+K N+L+D
Sbjct: 123 VAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID 175
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEI 180
Q+ ++ DFG AK + GT LAPE +L D ++ GVL+ E+
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 181 ISGR 184
+G
Sbjct: 232 AAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (265), Expect = 3e-27
Identities = 52/265 (19%), Positives = 101/265 (38%), Gaps = 25/265 (9%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRR--ILVYEY 60
+TN ++ VK L K+ + EI L N+R PN++ L R LV+E+
Sbjct: 57 ITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
V N ++ L I K L + H I+HRD+K N+++D
Sbjct: 114 VNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMID 163
Query: 121 QEFNP-KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL-TMKADVYSFGVLVL 178
E ++ D+GLA+ + + + + PE ++ Q+ D++S G ++
Sbjct: 164 HEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 179 EIISGRN---SGKAMWGQMNKF--LLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233
+I + G + Q+ + +L +K +DP + + +
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281
Query: 234 AFFCTQAAASRRPQMNQVIKMLTKN 258
++ + K+L +
Sbjct: 282 FVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 8e-27
Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 14/186 (7%)
Query: 6 NGRRIAVKPLS----AESKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEY 60
G+ A+K L + + TE L ++R P LV L T+ L+ +Y
Sbjct: 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110
Query: 61 VENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD 120
+ L L + + I L LH+ I++RDIK NILLD
Sbjct: 111 INGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLD 163
Query: 121 QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ--LTMKADVYSFGVLVL 178
+ + DFGL+K F + T GT Y+AP+ V GG D +S GVL+
Sbjct: 164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 223
Query: 179 EIISGR 184
E+++G
Sbjct: 224 ELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-25
Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 20/189 (10%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCV------QGTRRI 55
R +A+K +++ + E++ + V H N++ L+ +
Sbjct: 39 AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98
Query: 56 LVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKAS 115
LV E ++ N + ++L+ E+ S + + G+ LH I+HRD+K S
Sbjct: 99 LVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 148
Query: 116 NILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGV 175
NI++ + KI DFGLA+ + + T T Y APE +LG D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 176 LVLEIISGR 184
++ E++ +
Sbjct: 207 IMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 3e-24
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 10/184 (5%)
Query: 4 LTNGRRIAVK--PLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYV 61
G R+AVK +S + E+ L +++H N++ L+ +
Sbjct: 40 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99
Query: 62 ENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ 121
L L KL + + I +GL ++H I+HRD+K SN+ +++
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 156
Query: 122 EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ-LTMKADVYSFGVLVLEI 180
+ KI DFGLA+ D +T T Y APE +L D++S G ++ E+
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 181 ISGR 184
++GR
Sbjct: 213 LTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.7 bits (221), Expect = 5e-21
Identities = 56/301 (18%), Positives = 108/301 (35%), Gaps = 37/301 (12%)
Query: 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRIL-VYEYVE 62
+ N +A+K + + K EI L V + + ++L + +
Sbjct: 35 MVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93
Query: 63 NNSLDRVLLGATKANIKLNWEKRSD-----------ICVGIAKGLAFLHEELVPHIVHRD 111
N + V++ L K+ + I + GL ++H I+H D
Sbjct: 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTD 151
Query: 112 IKASNILLDQEFNP------KIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165
IK N+L++ +P KI D G A + ++ T+ T Y +PE +LG
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QTREYRSPEVLLGAPWG 207
Query: 166 MKADVYSFGVLVLEIISGR-----------NSGKAMWGQMNKFLLEWAWQLHQEEKPLEL 214
AD++S L+ E+I+G Q+ + L E L + K
Sbjct: 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT 267
Query: 215 VDPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRLNEEE-LTAPGLFQ 273
G +++ + T+ + + ++ L+ ++L+ + A GL
Sbjct: 268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
Query: 274 D 274
Sbjct: 328 H 328
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.0 bits (160), Expect = 1e-13
Identities = 29/190 (15%), Positives = 53/190 (27%), Gaps = 29/190 (15%)
Query: 2 GTLTNGRRIAVKPLSAES----------KQGVREFITEIMTLSNVRHPNLVELIGCCVQG 51
VK G F + + L +L G V
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV-- 76
Query: 52 TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRD 111
VY + N L ++ +++ + I + +A + IVH D
Sbjct: 77 ---PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAKFYH---RGIVHGD 128
Query: 112 IKASNILLDQEFNPKIGDFGLAKLF--PDNITHITTRIAGTTGYLAPEYVLGGQLTMKAD 169
+ N+L+ E I DF + + + Y + Y + D
Sbjct: 129 LSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------RTEKD 181
Query: 170 VYSFGVLVLE 179
+ S +L+
Sbjct: 182 INSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 307 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.72 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=354.60 Aligned_cols=238 Identities=24% Similarity=0.399 Sum_probs=181.7
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|...+|+.||||+++... ...++|.+|++++++++||||+++++++...+..++||||+++|+|.+++. .....++
T Consensus 24 ~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~~~~ 99 (263)
T d1sm2a_ 24 GYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFA 99 (263)
T ss_dssp EEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH---TTTTCCC
T ss_pred EEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhh---ccccCCC
Confidence 456788899999998643 334679999999999999999999999999999999999999999999884 3445689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..............||..|+|||++.+
T Consensus 100 ~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 100 AETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC
Confidence 999999999999999999999 99999999999999999999999999998776554444455678999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||+|+..|+..... ...+...+.. .... . .+......+.+++.+||+.|
T Consensus 177 ~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~---~~~~---~------~p~~~~~~l~~li~~cl~~~ 242 (263)
T d1sm2a_ 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDIST---GFRL---Y------KPRLASTHVYQIMNHCWKER 242 (263)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHH---TCCC---C------CCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHh---cCCC---C------CccccCHHHHHHHHHHccCC
Confidence 9999999999999999999996554433222 1122222211 1111 0 11122345788999999999
Q ss_pred cCCCCCHHHHHHHHHhccc
Q 021774 242 ASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~ 260 (307)
|++|||+++|++.|+++.+
T Consensus 243 p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 243 PEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHh
Confidence 9999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=350.20 Aligned_cols=236 Identities=26% Similarity=0.417 Sum_probs=183.6
Q ss_pred CEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 8 RRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 8 ~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
..||||+++.. +....+.|.+|+.++++++||||+++++++.+ +..++||||+++|+|.+++.. ....+++..+
T Consensus 31 ~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~ 106 (276)
T d1uwha_ 31 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKL 106 (276)
T ss_dssp SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHH
T ss_pred CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHH
Confidence 46999998754 45566789999999999999999999998754 567999999999999999842 3456999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCcccccC---
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVLG--- 161 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~--- 161 (307)
+.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... .......||+.|+|||++.+
T Consensus 107 ~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 183 (276)
T d1uwha_ 107 IDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccC
Confidence 99999999999999999 999999999999999999999999999987654322 23455679999999999864
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||+||+.||....... .+...... ... .+.+...+......+.+++.+||+.|
T Consensus 184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~----~~~----~p~~~~~~~~~~~~l~~li~~cl~~d 253 (276)
T d1uwha_ 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGR----GYL----SPDLSKVRSNCPKAMKRLMAECLKKK 253 (276)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHH----TSC----CCCGGGSCTTCCHHHHHHHHHHTCSS
T ss_pred CCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhc----CCC----CCcchhccccchHHHHHHHHHHcCCC
Confidence 358999999999999999999999987543321 11111111 111 11111222333446888999999999
Q ss_pred cCCCCCHHHHHHHHHhccc
Q 021774 242 ASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~ 260 (307)
|.+|||+.+|++.|+.+.+
T Consensus 254 p~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 254 RDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHH
Confidence 9999999999999988765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=351.41 Aligned_cols=238 Identities=29% Similarity=0.412 Sum_probs=191.0
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+.++|+.||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+++|+|.+++.. .....++
T Consensus 32 ~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~--~~~~~l~ 107 (272)
T d1qpca_ 32 GYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLT 107 (272)
T ss_dssp EEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--HHHHTCC
T ss_pred EEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhh--cCCCCCC
Confidence 556788899999997543 334679999999999999999999998754 567899999999999998732 2234599
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++..............|+..|+|||++.+
T Consensus 108 ~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 108 INKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC
Confidence 999999999999999999999 99999999999999999999999999999876655444556678999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
+.++.++|||||||++|||+||..|+...... ..+... ...... +. .+......+.+++.+||+.|
T Consensus 185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~----i~~~~~-----~~---~p~~~~~~l~~li~~cl~~~ 250 (272)
T d1qpca_ 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQN----LERGYR-----MV---RPDNCPEELYQLMRLCWKER 250 (272)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHH----HHTTCC-----CC---CCTTCCHHHHHHHHHHTCSS
T ss_pred CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHhcCC-----CC---CcccChHHHHHHHHHHcCCC
Confidence 99999999999999999999976654433221 111111 111111 11 11223345788999999999
Q ss_pred cCCCCCHHHHHHHHHhccc
Q 021774 242 ASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~ 260 (307)
|++|||+.+|++.|++...
T Consensus 251 P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 251 PEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHhhhhhh
Confidence 9999999999999988664
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-52 Score=353.01 Aligned_cols=232 Identities=27% Similarity=0.437 Sum_probs=180.3
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
.||||.+... +....+.|.+|+++|++++||||+++++++...+..++||||+++|+|.+++. .....+++..++.
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~ 132 (299)
T d1jpaa_ 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVG 132 (299)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeec---cccCCCCHHHHHH
Confidence 5899988764 45566789999999999999999999999999999999999999999999884 3345699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc----cccccCCCCcCCcccccCCc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI----TTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~ 163 (307)
++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......... .....||+.|+|||++.++.
T Consensus 133 i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 209 (299)
T d1jpaa_ 133 MLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209 (299)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC
Confidence 999999999999999 99999999999999999999999999998765432221 22345788999999999999
Q ss_pred ccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 164 LTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
++.++|||||||++|||+| |..||...... .+...+ ...... ..+......+.+++.+||+.||
T Consensus 210 ~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i---~~~~~~---------~~~~~~~~~l~~li~~cl~~~P 274 (299)
T d1jpaa_ 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAI---EQDYRL---------PPPMDCPSALHQLMLDCWQKDR 274 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTTCCC---------CCCTTCCHHHHHHHHHHTCSST
T ss_pred CCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcCCCC---------CCCccchHHHHHHHHHHcCCCH
Confidence 9999999999999999998 88888654321 122211 111111 1122334558889999999999
Q ss_pred CCCCCHHHHHHHHHhcccc
Q 021774 243 SRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 243 ~~RPs~~~v~~~L~~~~~~ 261 (307)
++|||+.+|++.|+++++.
T Consensus 275 ~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 275 NHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTSCCHHHHHHHHHHHHHS
T ss_pred hHCcCHHHHHHHHHHHhcC
Confidence 9999999999999988864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-52 Score=351.82 Aligned_cols=236 Identities=23% Similarity=0.363 Sum_probs=193.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||+++... ...++|.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++.. .....+++..
T Consensus 40 ~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~ 116 (287)
T d1opja_ 40 KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVV 116 (287)
T ss_dssp GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHH
T ss_pred CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHH
Confidence 358899999997543 3456799999999999999999999999999999999999999999999843 3345799999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++..............|+..|+|||++.+..+
T Consensus 117 ~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 193 (287)
T d1opja_ 117 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193 (287)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCC
Confidence 999999999999999999 99999999999999999999999999999876655554555678899999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|||||||++|||++|..|+...... ..+. ........ + ..+......+.+++.+||+.||++
T Consensus 194 ~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~----~~i~~~~~-----~---~~~~~~~~~l~~li~~cl~~dP~~ 259 (287)
T d1opja_ 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVY----ELLEKDYR-----M---ERPEGCPEKVYELMRACWQWNPSD 259 (287)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH----HHHHTTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHH----HHHhcCCC-----C---CCCccchHHHHHHHHHHcCCCHhH
Confidence 99999999999999999987775433321 1111 11111111 1 112223345888999999999999
Q ss_pred CCCHHHHHHHHHhccc
Q 021774 245 RPQMNQVIKMLTKNIR 260 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~ 260 (307)
|||+.+|++.|+.+.+
T Consensus 260 Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 260 RPSFAEIHQAFETMFQ 275 (287)
T ss_dssp SCCHHHHHHHHHHTTS
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999987754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=347.97 Aligned_cols=232 Identities=25% Similarity=0.385 Sum_probs=188.8
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
++..||||+++.. .....+.|.+|+++|++++||||+++++++.. +..++||||+++|+|.+++. .....+++..
T Consensus 35 ~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~ 110 (285)
T d1u59a_ 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEIPVSN 110 (285)
T ss_dssp CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHT---TCTTTSCHHH
T ss_pred CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhh---ccccCCCHHH
Confidence 3557999999765 45566789999999999999999999999865 46789999999999999973 3345799999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.||+.||+|||++ +|+||||||+||+|+.++.+||+|||+++.+...... ......||+.|+|||++.++
T Consensus 111 ~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (285)
T d1u59a_ 111 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187 (285)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC
Confidence 999999999999999999 9999999999999999999999999999977654322 23345688999999999999
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|||||||++|||+| |..||...... .+... ...+... ..++.....+.+++.+||+.|
T Consensus 188 ~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~~~~~~--------~~p~~~~~~l~~li~~cl~~~ 252 (285)
T d1u59a_ 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRM--------ECPPECPPELYALMSDCWIYK 252 (285)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCCC--------CCCTTCCHHHHHHHHHTTCSS
T ss_pred CCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC--------CCCCcCCHHHHHHHHHHcCCC
Confidence 99999999999999999998 89998754332 12211 1111111 112233345788999999999
Q ss_pred cCCCCCHHHHHHHHHhcc
Q 021774 242 ASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~ 259 (307)
|++|||+.+|.+.|+...
T Consensus 253 p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 253 WEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHH
Confidence 999999999999998654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=347.60 Aligned_cols=229 Identities=23% Similarity=0.320 Sum_probs=182.7
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||++||+|.+++ .....+++.
T Consensus 28 ~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l----~~~~~l~e~ 103 (271)
T d1nvra_ 28 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEP 103 (271)
T ss_dssp TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS----BTTTBCCHH
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHH----hcCCCCCHH
Confidence 568999999987653 334467899999999999999999999999999999999999999999988 345579999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCc-ccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNI-THITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.||+.||+|||++ ||+||||||+|||+++++++||+|||+++...... ........||+.|+|||++.+.
T Consensus 104 ~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~ 180 (271)
T d1nvra_ 104 DAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCC
Confidence 9999999999999999999 99999999999999999999999999998764432 2234556899999999999887
Q ss_pred cc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.+ +.++|||||||++|||+||+.||........... ......... .........+.+++.+||+.|
T Consensus 181 ~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-----~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~d 247 (271)
T d1nvra_ 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKTYL--------NPWKKIDSAPLALLHKILVEN 247 (271)
T ss_dssp SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-----HHHTTCTTS--------TTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-----HHhcCCCCC--------CccccCCHHHHHHHHHHcCCC
Confidence 76 6789999999999999999999875543222111 111111110 011122345778899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||++|+++
T Consensus 248 P~~R~t~~eil~ 259 (271)
T d1nvra_ 248 PSARITIPDIKK 259 (271)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhHCcCHHHHhc
Confidence 999999999854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=348.68 Aligned_cols=228 Identities=22% Similarity=0.408 Sum_probs=187.5
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
..+|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..|+||||++||+|.+++. ...+++.
T Consensus 42 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~-----~~~l~~~ 116 (293)
T d1yhwa1 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEG 116 (293)
T ss_dssp TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH-----HSCCCHH
T ss_pred CCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh-----ccCCCHH
Confidence 35799999999886654456789999999999999999999999999999999999999999999873 2359999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 163 (307)
.+..++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++.+..... ......||+.|+|||++.+..
T Consensus 117 ~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~ 192 (293)
T d1yhwa1 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA 192 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSC
T ss_pred HHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccccccCCCccChhhhcCCC
Confidence 9999999999999999999 999999999999999999999999999987654322 234567999999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++|||||||++|||+||+.||....... . ............ ..+......+.+++.+||+.||.
T Consensus 193 ~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~ 259 (293)
T d1yhwa1 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---A---LYLIATNGTPEL-------QNPEKLSAIFRDFLNRCLDMDVE 259 (293)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHHHCSCCC-------SSGGGSCHHHHHHHHHHTCSSTT
T ss_pred CCchhceehHhHHHHHHhhCCCCCCCCCHHH---H---HHHHHhCCCCCC-------CCcccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999986533211 1 111111111110 11223334588899999999999
Q ss_pred CCCCHHHHHH
Q 021774 244 RRPQMNQVIK 253 (307)
Q Consensus 244 ~RPs~~~v~~ 253 (307)
+|||+.|+++
T Consensus 260 ~R~s~~eil~ 269 (293)
T d1yhwa1 260 KRGSAKELLQ 269 (293)
T ss_dssp TSCCHHHHTT
T ss_pred HCcCHHHHhc
Confidence 9999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=343.24 Aligned_cols=234 Identities=23% Similarity=0.399 Sum_probs=193.3
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+.++++.||||+++.... ..++|.+|+.++++++||||+++++++.+++..++||||+++|+|..++. .....++
T Consensus 23 ~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~---~~~~~~~ 98 (258)
T d1k2pa_ 23 GKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQ 98 (258)
T ss_dssp EEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHH---SGGGCCC
T ss_pred EEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhh---ccccCCc
Confidence 5567888999999986543 34679999999999999999999999999999999999999999999873 3455689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+++++.|+++||+|||++ ||+||||||+||++++++.+||+|||+++..............||..|+|||++.+
T Consensus 99 ~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 99 TQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC
Confidence 999999999999999999999 99999999999999999999999999998776554444555678999999999999
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++|||||||++|||+| |+.||...... .+.. .. ...... ..+......+.+++.+||+.
T Consensus 176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~---~i-~~~~~~--------~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE---HI-AQGLRL--------YRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH---HH-HTTCCC--------CCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH---HH-HhCCCC--------CCcccccHHHHHHHHHHccC
Confidence 999999999999999999998 78888654321 1221 11 111110 11122334688899999999
Q ss_pred ccCCCCCHHHHHHHHHh
Q 021774 241 AASRRPQMNQVIKMLTK 257 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~ 257 (307)
||++|||+++|++.|.+
T Consensus 241 dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 241 KADERPTFKILLSNILD 257 (258)
T ss_dssp SGGGSCCHHHHHHHHHC
T ss_pred CHhHCcCHHHHHHHhhC
Confidence 99999999999998865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=347.32 Aligned_cols=231 Identities=26% Similarity=0.375 Sum_probs=184.0
Q ss_pred CCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 6 NGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 6 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.++.||||+++.. +....+.|.+|+++|++++||||+++++++.. +..++||||+++|+|.+++. ....+++.
T Consensus 33 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~----~~~~l~~~ 107 (277)
T d1xbba_ 33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ----QNRHVKDK 107 (277)
T ss_dssp SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH----HCTTCCHH
T ss_pred cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh----hccCCCHH
Confidence 3568999999754 34445789999999999999999999999865 45789999999999999983 34569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~ 161 (307)
.++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........ ......||+.|+|||++.+
T Consensus 108 ~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 184 (277)
T d1xbba_ 108 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcC
Confidence 9999999999999999999 9999999999999999999999999999876544322 2344678999999999999
Q ss_pred CcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 162 GQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
..++.++|||||||++|||+| |+.||...... .+... ...+... ..+......+.+++.+||+.
T Consensus 185 ~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~----i~~~~~~--------~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----LEKGERM--------GCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTCCC--------CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHH----HHcCCCC--------CCCcccCHHHHHHHHHHcCC
Confidence 999999999999999999998 89998754321 12111 1111111 11222334578899999999
Q ss_pred ccCCCCCHHHHHHHHHhcc
Q 021774 241 AASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 241 ~p~~RPs~~~v~~~L~~~~ 259 (307)
||++|||+.+|.+.|+...
T Consensus 250 dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp STTTSCCHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHH
Confidence 9999999999999887654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=351.85 Aligned_cols=234 Identities=24% Similarity=0.336 Sum_probs=176.0
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--GTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
..+|+.||||.+... +....+.+.+|++++++++||||+++++++.+ ++..|+||||++||+|.+++......+..
T Consensus 26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~ 105 (269)
T d2java1 26 KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 105 (269)
T ss_dssp TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCC
T ss_pred CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCC
Confidence 357899999998765 34556779999999999999999999999875 45679999999999999998655445667
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEEL--VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
+++..++.++.||+.||+|||++. ..+|+||||||+||||++++.+||+|||+++.+..... ......||+.|+|||
T Consensus 106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE 184 (269)
T d2java1 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPE 184 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC-ccccCCCCcccCCHH
Confidence 999999999999999999999871 01399999999999999999999999999987754322 234567999999999
Q ss_pred cccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
++.+..++.++|||||||++|||+||+.||..... ..+...+ .. .... ..+......+.+++.+|
T Consensus 185 ~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i---~~-~~~~--------~~~~~~s~~l~~li~~~ 249 (269)
T d2java1 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI---RE-GKFR--------RIPYRYSDELNEIITRM 249 (269)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH---HH-TCCC--------CCCTTSCHHHHHHHHHH
T ss_pred HHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHH---Hc-CCCC--------CCCcccCHHHHHHHHHH
Confidence 99999999999999999999999999999865332 1121111 11 1111 11222334588889999
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
|+.||.+|||+.|+++
T Consensus 250 L~~dp~~Rps~~ell~ 265 (269)
T d2java1 250 LNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred cCCChhHCcCHHHHHh
Confidence 9999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=343.55 Aligned_cols=223 Identities=26% Similarity=0.368 Sum_probs=184.7
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||+|++... .......+.+|++++++++||||+++++++.+++..++||||+++|+|.+++. ....++
T Consensus 29 ~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~----~~~~l~ 104 (263)
T d2j4za1 29 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFD 104 (263)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSCC
T ss_pred CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh----hcCCCC
Confidence 56899999998743 23345678999999999999999999999999999999999999999999983 345699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||++....... .....||+.|+|||++.+
T Consensus 105 e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 105 EQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc---ccccCCCCcccCHHHHcC
Confidence 999999999999999999999 99999999999999999999999999998665432 344679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||+||+.||...... .... .... ... .+ +......+.+++.+||+.|
T Consensus 179 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~---~i~~-~~~------~~---p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYK---RISR-VEF------TF---PDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHT-TCC------CC---CTTSCHHHHHHHHHHTCSS
T ss_pred CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHH---HHHc-CCC------CC---CccCCHHHHHHHHHHccCC
Confidence 99999999999999999999999998653321 1111 1111 111 11 1222345778899999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|++|||+.|+++
T Consensus 243 p~~R~t~~eil~ 254 (263)
T d2j4za1 243 PSQRPMLREVLE 254 (263)
T ss_dssp GGGSCCHHHHHT
T ss_pred HhHCcCHHHHHc
Confidence 999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=344.27 Aligned_cols=240 Identities=27% Similarity=0.409 Sum_probs=185.4
Q ss_pred cccCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
|+.++++.||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||||+++|+|..++... ....++
T Consensus 36 ~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~ 111 (285)
T d1fmka3 36 GTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLR 111 (285)
T ss_dssp EEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCC
T ss_pred EEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhc--ccccch
Confidence 567788899999997543 334679999999999999999999999854 5678999999999999988432 234699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
|..++.++.||+.||+|||++ +|+||||||+||||++++++||+|||+++..............||+.|+|||++.+
T Consensus 112 ~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 112 LPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC
Confidence 999999999999999999999 99999999999999999999999999998776554444555678999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||+||..|+...... ..+...+ ...... ..+......+.+++.+||+.|
T Consensus 189 ~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i---~~~~~~---------~~~~~~~~~l~~li~~cl~~d 254 (285)
T d1fmka3 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV---ERGYRM---------PCPPECPESLHDLMCQCWRKE 254 (285)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH---HTTCCC---------CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH---HhcCCC---------CCCcccCHHHHHHHHHHcccC
Confidence 99999999999999999999977665443321 1122211 111111 112223346888999999999
Q ss_pred cCCCCCHHHHHHHHHhccccC
Q 021774 242 ASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~~~~~ 262 (307)
|++||++++|+++|++.+...
T Consensus 255 P~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 255 PEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp GGGSCCHHHHHHHHHTTTSCS
T ss_pred HhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999877544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=347.04 Aligned_cols=229 Identities=23% Similarity=0.388 Sum_probs=186.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||+++.......+.|.+|+++|++++||||+++++++.+.+..++||||++||+|.+++.. ....+++..
T Consensus 35 ~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~ 111 (288)
T d2jfla1 35 ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQ 111 (288)
T ss_dssp TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHH
T ss_pred CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHH
Confidence 56899999999877666667899999999999999999999999999999999999999999998732 245699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc----
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL---- 160 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 160 (307)
+..++.||+.||.|||++ ||+||||||+|||++.++++||+|||++...... ........||+.|+|||++.
T Consensus 112 ~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~ 187 (288)
T d2jfla1 112 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETS 187 (288)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHHTCCCSCCTTCCHHHHTTCST
T ss_pred HHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-cccccccccccccCCHHHHhhccc
Confidence 999999999999999999 9999999999999999999999999999754322 11234567999999999884
Q ss_pred -CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccc
Q 021774 161 -GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQ 239 (307)
Q Consensus 161 -~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~ 239 (307)
+..|+.++|||||||++|||+||+.||....... .. ......... . ...+......+.+++.+||+
T Consensus 188 ~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~~~~~-~------~~~~~~~s~~~~~li~~~L~ 254 (288)
T d2jfla1 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAKSEPP-T------LAQPSRWSSNFKDFLKKCLE 254 (288)
T ss_dssp TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHHSCCC-C------CSSGGGSCHHHHHHHHHHSC
T ss_pred CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcCCCC-C------CCccccCCHHHHHHHHHHcc
Confidence 4568899999999999999999999987543322 11 111111111 0 01122334568889999999
Q ss_pred cccCCCCCHHHHHH
Q 021774 240 AAASRRPQMNQVIK 253 (307)
Q Consensus 240 ~~p~~RPs~~~v~~ 253 (307)
.||.+|||+.|+++
T Consensus 255 ~dp~~R~t~~ell~ 268 (288)
T d2jfla1 255 KNVDARWTTSQLLQ 268 (288)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=343.66 Aligned_cols=235 Identities=24% Similarity=0.375 Sum_probs=182.9
Q ss_pred CEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 8 RRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 8 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
..||||+++.. +.....+|.+|++++++++||||+++++++.+.+..++||||+.++++.+++. .....+++..++
T Consensus 37 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~ 113 (283)
T d1mqba_ 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLV 113 (283)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHH
T ss_pred EEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhh---cccccccHHHHH
Confidence 36999998765 44555679999999999999999999999999999999999999999998873 344569999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCCcc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........ ......||..|+|||++.+..+
T Consensus 114 ~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 190 (283)
T d1mqba_ 114 GMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190 (283)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCC
Confidence 9999999999999999 9999999999999999999999999999876543221 2334568899999999999999
Q ss_pred cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 165 TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 165 ~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
+.++|||||||++|||+||..|+...... ..+... ...... ...+......+.+++.+||+.||++
T Consensus 191 ~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~----i~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~ 256 (283)
T d1mqba_ 191 TSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA----INDGFR--------LPTPMDCPSAIYQLMMQCWQQERAR 256 (283)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH----HHTTCC--------CCCCTTCBHHHHHHHHHHTCSSTTT
T ss_pred CCcccccccHHHHHHHHhCCCCccccCCH--HHHHHH----HhccCC--------CCCchhhHHHHHHHHHHHCcCCHhH
Confidence 99999999999999999976665433221 112211 111111 1112233456888999999999999
Q ss_pred CCCHHHHHHHHHhccccC
Q 021774 245 RPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~~~ 262 (307)
|||+.+|++.|+++++.+
T Consensus 257 RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 257 RPKFADIVSILDKLIRAP 274 (283)
T ss_dssp SCCHHHHHHHHHHHHHSG
T ss_pred CcCHHHHHHHHHHHhhCc
Confidence 999999999999888643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=334.87 Aligned_cols=225 Identities=24% Similarity=0.343 Sum_probs=179.2
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||+|.+... .....+.|.+|+++|++++||||+++++++.+ ....++||||+++|+|.+++. ...
T Consensus 32 ~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~----~~~ 107 (270)
T d1t4ha_ 32 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFK 107 (270)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH----HHS
T ss_pred CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHh----ccc
Confidence 46889999998754 45556789999999999999999999999875 346799999999999999983 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEEC-CCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPH--IVHRDIKASNILLD-QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
.+++..+..++.||+.||+|||++ + |+||||||+||||+ +++.+||+|||+++..... ......||+.|+|
T Consensus 108 ~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~a 181 (270)
T d1t4ha_ 108 VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMA 181 (270)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCC
T ss_pred cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccC
Confidence 699999999999999999999998 7 99999999999996 5789999999999865432 2345679999999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAF 235 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
||++.+ .++.++|||||||++|||++|+.||....... .+ ............+ .......+.+++.
T Consensus 182 PE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~----~~~i~~~~~~~~~-------~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 182 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QI----YRRVTSGVKPASF-------DKVAIPEVKEIIE 247 (270)
T ss_dssp GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HH----HHHHTTTCCCGGG-------GGCCCHHHHHHHH
T ss_pred HHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HH----HHHHHcCCCCccc-------CccCCHHHHHHHH
Confidence 998875 59999999999999999999999986443211 11 1112111111111 1112234778899
Q ss_pred hccccccCCCCCHHHHHH
Q 021774 236 FCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 236 ~c~~~~p~~RPs~~~v~~ 253 (307)
+||+.||++|||+.|+++
T Consensus 248 ~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHhC
Confidence 999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=348.45 Aligned_cols=239 Identities=23% Similarity=0.384 Sum_probs=182.6
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||+|+++.. .......+.+|+.+|++++||||++++++|.+.+..++||||++||+|.+++. ....+++.
T Consensus 29 ~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~----~~~~l~~~ 104 (322)
T d1s9ja_ 29 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQ 104 (322)
T ss_dssp TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH----HHSSCCHH
T ss_pred CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh----hcCCCCHH
Confidence 56899999998765 34445689999999999999999999999999999999999999999999984 34569999
Q ss_pred HHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 84 KRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
.+..++.|++.||.|||+ + ||+||||||+||||++++++||+|||+++.... .......||+.|+|||++.+.
T Consensus 105 ~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~GT~~Y~APEvl~~~ 178 (322)
T d1s9ja_ 105 ILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGT 178 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HTC---CCSSCCCCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC---CccccccCCccccCchHHcCC
Confidence 999999999999999996 6 899999999999999999999999999986532 123456899999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC-------------------cc----cc----c
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK-------------------PL----EL----V 215 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~----~~----~ 215 (307)
.|+.++||||+||++|||++|+.||....................... .. .. .
T Consensus 179 ~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (322)
T d1s9ja_ 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258 (322)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhh
Confidence 999999999999999999999999875433221110000000000000 00 00 0
Q ss_pred CCCCCCCC-HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 216 DPELGEYP-PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 216 ~~~~~~~~-~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.......+ ......+.+++.+||+.||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000 012245788999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=342.86 Aligned_cols=226 Identities=20% Similarity=0.302 Sum_probs=182.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++.. .....+.+.+|++++++++||||+++++++.+++..|+||||++||+|.+++. ....++
T Consensus 31 ~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~----~~~~l~ 106 (288)
T d1uu3a_ 31 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD 106 (288)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HHSSCC
T ss_pred CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh----ccCCCC
Confidence 56899999998753 23345679999999999999999999999999999999999999999999883 345799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~ 160 (307)
+..+..++.|++.||+|||++ ||+||||||+|||+++++.+||+|||+++.+..... .......||+.|+|||++.
T Consensus 107 e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~ 183 (288)
T d1uu3a_ 107 ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeec
Confidence 999999999999999999999 999999999999999999999999999987754322 2344567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||+||+.||..... ..+.. .... ... .++......+.+++.+||+.
T Consensus 184 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~---~i~~-~~~---------~~p~~~s~~~~~li~~~L~~ 247 (288)
T d1uu3a_ 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQ---KIIK-LEY---------DFPEKFFPKARDLVEKLLVL 247 (288)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHT-TCC---------CCCTTCCHHHHHHHHTTSCS
T ss_pred cCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHH---HHHc-CCC---------CCCccCCHHHHHHHHHHccC
Confidence 99999999999999999999999999875422 11111 1111 111 11122334578899999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
||.+|||++|++.
T Consensus 248 dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 248 DATKRLGCEEMEG 260 (288)
T ss_dssp SGGGSTTSGGGTC
T ss_pred CHhHCcCHHHHcC
Confidence 9999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=339.42 Aligned_cols=228 Identities=22% Similarity=0.316 Sum_probs=168.7
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++.... ......+.+|+.+|++++||||+++++++.+++..|+||||++||+|.+++. ....+++.
T Consensus 32 ~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~----~~~~l~e~ 107 (307)
T d1a06a_ 32 RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTER 107 (307)
T ss_dssp TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----TCSCCCHH
T ss_pred CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh----cccCCCHH
Confidence 468999999987653 2334568899999999999999999999999999999999999999999983 34579999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD---QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
.+..++.||+.||+|||++ ||+||||||+||++. +++.+||+|||+++...... ......||+.|+|||++.
T Consensus 108 ~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~ 182 (307)
T d1a06a_ 108 DASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLA 182 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHT
T ss_pred HHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHc
Confidence 9999999999999999999 999999999999994 57889999999998654332 234467999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||++|+.||...... .+.. ........ ...+ ..+.....+.+++.+||+.
T Consensus 183 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~---~i~~~~~~--~~~~----~~~~~s~~~~~li~~~L~~ 250 (307)
T d1a06a_ 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFE---QILKAEYE--FDSP----YWDDISDSAKDFIRHLMEK 250 (307)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHTTCCC--CCTT----TTTTSCHHHHHHHHHHSCS
T ss_pred CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHH---HHhccCCC--CCCc----cccCCCHHHHHHHHHHccC
Confidence 999999999999999999999999998654321 1111 11111111 0001 1122234588899999999
Q ss_pred ccCCCCCHHHHHH
Q 021774 241 AASRRPQMNQVIK 253 (307)
Q Consensus 241 ~p~~RPs~~~v~~ 253 (307)
||.+|||+.|+++
T Consensus 251 dP~~R~s~~eil~ 263 (307)
T d1a06a_ 251 DPEKRFTCEQALQ 263 (307)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CHhHCcCHHHHhc
Confidence 9999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-50 Score=341.23 Aligned_cols=224 Identities=29% Similarity=0.459 Sum_probs=182.1
Q ss_pred cCCCCEEEEEEccccC---hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES---KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
..+|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..++|||||.+|+|..++. ....+
T Consensus 37 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~----~~~~l 112 (309)
T d1u5ra_ 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPL 112 (309)
T ss_dssp TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH----HTSCC
T ss_pred CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH----hCCCC
Confidence 3578899999987542 3445679999999999999999999999999999999999999999987662 34579
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||.|||++ ||+||||||+||||++++.+||+|||++..... .....||+.|+|||++.
T Consensus 113 ~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~ 184 (309)
T d1u5ra_ 113 QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184 (309)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-----CCccccCccccCHHHHh
Confidence 9999999999999999999999 999999999999999999999999999986543 23467999999999986
Q ss_pred C---CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 161 G---GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 161 ~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
+ ..|+.++|||||||++|||++|..||....... . .........+. .. .......+.+++.+|
T Consensus 185 ~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---~---~~~i~~~~~~~-~~-------~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A---LYHIAQNESPA-LQ-------SGHWSEYFRNFVDSC 250 (309)
T ss_dssp TTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHHSCCCC-CS-------CTTSCHHHHHHHHHH
T ss_pred ccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH---H---HHHHHhCCCCC-CC-------CCCCCHHHHHHHHHH
Confidence 4 468999999999999999999999986543211 1 11222221111 10 111234578889999
Q ss_pred cccccCCCCCHHHHHH
Q 021774 238 TQAAASRRPQMNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs~~~v~~ 253 (307)
|+.||.+|||+.++++
T Consensus 251 L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 251 LQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TCSSGGGSCCHHHHTT
T ss_pred CcCChhHCcCHHHHHh
Confidence 9999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=346.23 Aligned_cols=233 Identities=26% Similarity=0.371 Sum_probs=184.0
Q ss_pred CEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC----------
Q 021774 8 RRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK---------- 75 (307)
Q Consensus 8 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------- 75 (307)
..||+|.+... .......+.+|+.++.++ +||||+++++++.+.+..++||||+++|+|.+++.....
T Consensus 68 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (325)
T d1rjba_ 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147 (325)
T ss_dssp EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred eEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhc
Confidence 36999988754 334456789999999998 899999999999999999999999999999999965432
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccc
Q 021774 76 ---------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITT 145 (307)
Q Consensus 76 ---------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~ 145 (307)
....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 148 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 224 (325)
T d1rjba_ 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224 (325)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEET
T ss_pred cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeec
Confidence 123589999999999999999999999 9999999999999999999999999999866543322 234
Q ss_pred cccCCCCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCH
Q 021774 146 RIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPP 224 (307)
Q Consensus 146 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (307)
...||+.|+|||++.++.++.++|||||||++|||+| |..||....... .+. ........ + ..+.
T Consensus 225 ~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~--~~~----~~~~~~~~-----~---~~p~ 290 (325)
T d1rjba_ 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA--NFY----KLIQNGFK-----M---DQPF 290 (325)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHH----HHHHTTCC-----C---CCCT
T ss_pred cccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH--HHH----HHHhcCCC-----C---CCCC
Confidence 5668999999999999999999999999999999998 888886543321 111 11111111 1 1122
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHHHHHh
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTK 257 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~ 257 (307)
.....+.+++.+||+.||++|||++||++.|.-
T Consensus 291 ~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 333468889999999999999999999999853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-49 Score=341.77 Aligned_cols=229 Identities=22% Similarity=0.283 Sum_probs=187.5
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||++........+.+.+|+++|++++||||+++++++.+++..++||||++||+|.+++. .....+++..
T Consensus 49 ~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~---~~~~~l~e~~ 125 (350)
T d1koaa2 49 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDE 125 (350)
T ss_dssp TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---CTTSCBCHHH
T ss_pred CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHH---hhcCCCCHHH
Confidence 5689999999987766666789999999999999999999999999999999999999999999883 2345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC--CCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ--EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++.+.... ......||+.|+|||++.+.
T Consensus 126 ~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~ 200 (350)
T d1koaa2 126 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGK 200 (350)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc--ccceecCcccccCHHHHcCC
Confidence 999999999999999999 9999999999999964 6789999999998775433 23456799999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|||||||++|||+||+.||..... ......+ ....... .. ...+.....+.+++.+||+.||
T Consensus 201 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i---~~~~~~~---~~---~~~~~~s~~~~~li~~~L~~dP 268 (350)
T d1koaa2 201 PVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNV---KSCDWNM---DD---SAFSGISEDGKDFIRKLLLADP 268 (350)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HHTCCCS---CC---GGGGGCCHHHHHHHHHHCCSSG
T ss_pred CCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHH---HhCCCCC---Cc---ccccCCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999865422 1111111 1111100 00 0111223457889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
++|||+.|+++
T Consensus 269 ~~R~t~~eil~ 279 (350)
T d1koaa2 269 NTRMTIHQALE 279 (350)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHhc
Confidence 99999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=337.19 Aligned_cols=232 Identities=24% Similarity=0.358 Sum_probs=176.9
Q ss_pred CCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHH
Q 021774 7 GRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKR 85 (307)
Q Consensus 7 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~ 85 (307)
+..||||.++.. .....+.|.+|++++++++||||+++++++. ++..++||||+++|+|.+++. .....+++..+
T Consensus 35 ~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~ 110 (273)
T d1mp8a_ 35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ---VRKYSLDLASL 110 (273)
T ss_dssp CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH---HTTTTSCHHHH
T ss_pred eEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhh---ccCCCCCHHHH
Confidence 456899998754 3455678999999999999999999999985 467899999999999999873 34456899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCccc
Q 021774 86 SDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQLT 165 (307)
Q Consensus 86 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 165 (307)
+.++.||+.||.|||++ +++||||||+||++++++.+||+|||+++..............||+.|+|||++.+..++
T Consensus 111 ~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 111 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCC
Confidence 99999999999999999 999999999999999999999999999987665444445566789999999999999999
Q ss_pred ccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCC
Q 021774 166 MKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASR 244 (307)
Q Consensus 166 ~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 244 (307)
.++|||||||++|||+| |.+|+....... +...+ ...... ..++.....+.+++.+||+.||++
T Consensus 188 ~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~~~~~--------~~~~~~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 188 SASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGERL--------PMPPNCPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCCCC--------CCCCCCCHHHHHHHHHHcCCCHhH
Confidence 99999999999999998 788876554322 11111 111111 112233456888999999999999
Q ss_pred CCCHHHHHHHHHhccc
Q 021774 245 RPQMNQVIKMLTKNIR 260 (307)
Q Consensus 245 RPs~~~v~~~L~~~~~ 260 (307)
|||+.+|++.|+.++.
T Consensus 253 Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 253 RPRFTELKAQLSTILE 268 (273)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.7e-49 Score=340.38 Aligned_cols=229 Identities=21% Similarity=0.262 Sum_probs=187.7
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||+++.........+.+|+++|++++||||+++++++.+++..|+|||||+||+|.+++. ..+..+++..
T Consensus 52 ~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~---~~~~~l~e~~ 128 (352)
T d1koba_ 52 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAE 128 (352)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTT---CTTCCBCHHH
T ss_pred CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHH---hcCCCCCHHH
Confidence 5799999999987665556778899999999999999999999999999999999999999998873 3445699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLD--QEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.||+.||+|||++ ||+||||||+||||+ .++.+||+|||++..+.... ......||+.|+|||++.+.
T Consensus 129 ~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 203 (352)
T d1koba_ 129 VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDRE 203 (352)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--ceeeccCcccccCHHHHcCC
Confidence 999999999999999999 999999999999997 57899999999999876542 23446789999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAA 242 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p 242 (307)
.++.++|||||||++|||+||+.||...... .... ........ ... ...+.....+.+++.+||+.||
T Consensus 204 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~~~~~~---~~~---~~~~~~s~~~~~li~~~L~~dp 271 (352)
T d1koba_ 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVKRCDWE---FDE---DAFSSVSPEAKDFIKNLLQKEP 271 (352)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHHCCCC---CCS---STTTTSCHHHHHHHHTTSCSSG
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCCC---CCc---ccccCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999998654321 1111 11111111 001 1112233457889999999999
Q ss_pred CCCCCHHHHHH
Q 021774 243 SRRPQMNQVIK 253 (307)
Q Consensus 243 ~~RPs~~~v~~ 253 (307)
.+|||+.|+++
T Consensus 272 ~~R~s~~eil~ 282 (352)
T d1koba_ 272 RKRLTVHDALE 282 (352)
T ss_dssp GGSCCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-49 Score=337.67 Aligned_cols=237 Identities=24% Similarity=0.370 Sum_probs=188.5
Q ss_pred CCCCEEEEEEccccC-hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC---------
Q 021774 5 TNGRRIAVKPLSAES-KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT--------- 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------- 74 (307)
.+++.||||+++... .....+|.+|+++|++++||||+++++++...+..++||||+++|+|.+++....
T Consensus 41 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~ 120 (301)
T d1lufa_ 41 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120 (301)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccc
Confidence 467899999998653 4456789999999999999999999999999999999999999999999985322
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-
Q 021774 75 -----------KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH- 142 (307)
Q Consensus 75 -----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 142 (307)
.....+++..++.++.|++.||+|||++ +++||||||+||||+.++.+||+|||+++.+......
T Consensus 121 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~ 197 (301)
T d1lufa_ 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197 (301)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred cccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCcccc
Confidence 1223588999999999999999999999 9999999999999999999999999999865443222
Q ss_pred ccccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCC-CCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC
Q 021774 143 ITTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN-SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE 221 (307)
Q Consensus 143 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (307)
......|++.|+|||++.+..++.++|||||||++|||++|.. |+...... .+.. . ...+... .
T Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~---e~~~---~-v~~~~~~--------~ 262 (301)
T d1lufa_ 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---EVIY---Y-VRDGNIL--------A 262 (301)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH---H-HHTTCCC--------C
T ss_pred ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH---HHHH---H-HHcCCCC--------C
Confidence 2344668889999999999999999999999999999999964 55443221 1211 1 1222111 1
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhcc
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNI 259 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~ 259 (307)
.+......+.+++.+||+.+|++||||.+|++.|+++.
T Consensus 263 ~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 263 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 12233345888999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=330.30 Aligned_cols=228 Identities=25% Similarity=0.367 Sum_probs=176.8
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.|.+||||+++... ..+.|.+|++++++++||||+++++++.+. +..++||||+++|+|.+++... ....+++..
T Consensus 29 ~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~ 104 (262)
T d1byga_ 29 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDC 104 (262)
T ss_dssp TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHH
T ss_pred CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHH
Confidence 47899999997543 346799999999999999999999999654 5679999999999999998431 233589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccCCcc
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGGQL 164 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 164 (307)
+++++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++..... .....++..|+|||++.+..+
T Consensus 105 ~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~ 177 (262)
T d1byga_ 105 LLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKF 177 (262)
T ss_dssp HHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhCCCC
Confidence 999999999999999999 9999999999999999999999999999865432 233467889999999999999
Q ss_pred cccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 165 TMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 165 ~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
+.++|||||||++|||+| |+.|+...... .+...+ ..... + ..+......+.+++.+||+.||.
T Consensus 178 t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~-----~---~~~~~~~~~~~~li~~cl~~dP~ 242 (262)
T d1byga_ 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYK-----M---DAPDGCPPAVYEVMKNCWHLDAA 242 (262)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCC-----C---CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCC-----C---CCCccCCHHHHHHHHHHcccCHh
Confidence 999999999999999998 67776544322 122111 11111 1 12223334678899999999999
Q ss_pred CCCCHHHHHHHHHhcc
Q 021774 244 RRPQMNQVIKMLTKNI 259 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~~ 259 (307)
+|||+.+|++.|+++.
T Consensus 243 ~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 243 MRPSFLQLREQLEHIK 258 (262)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHH
Confidence 9999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=328.52 Aligned_cols=230 Identities=25% Similarity=0.382 Sum_probs=179.2
Q ss_pred CEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 8 RRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 8 ~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
..||||+++.. ..+..+.|.+|+.+|++++||||+++++++.+ ...++||||+++|++.+.+.. ....+++..
T Consensus 37 ~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~ 112 (273)
T d1u46a_ 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGT 112 (273)
T ss_dssp EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHH
T ss_pred EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHH
Confidence 36899998754 34456789999999999999999999999965 467899999999999988742 345699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc--ccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH--ITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~ 162 (307)
++.++.|++.||.|||++ +|+||||||+||+|+.++++||+|||+++........ ......|+..|+|||++.+.
T Consensus 113 ~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 189 (273)
T d1u46a_ 113 LSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189 (273)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC
Confidence 999999999999999999 9999999999999999999999999999987554322 23345678899999999999
Q ss_pred cccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++||||||+++|||+| |..||...... .. ........... ..+......+.+++.+||+.|
T Consensus 190 ~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~---~~~i~~~~~~~--------~~~~~~~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI---LHKIDKEGERL--------PRPEDCPQDIYNVMVQCWAHK 255 (273)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HHHHHTSCCCC--------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HH---HHHHHhCCCCC--------CCcccccHHHHHHHHHHcCCC
Confidence 99999999999999999998 89888654321 11 12222221111 111222345888999999999
Q ss_pred cCCCCCHHHHHHHHHhc
Q 021774 242 ASRRPQMNQVIKMLTKN 258 (307)
Q Consensus 242 p~~RPs~~~v~~~L~~~ 258 (307)
|++|||+.+|.+.|+++
T Consensus 256 p~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 256 PEDRPTFVALRDFLLEA 272 (273)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHhc
Confidence 99999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=329.54 Aligned_cols=228 Identities=25% Similarity=0.296 Sum_probs=183.4
Q ss_pred CCCCEEEEEEccccC------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||++||+|.+++. ...
T Consensus 33 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~----~~~ 108 (293)
T d1jksa_ 33 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKE 108 (293)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH----HHS
T ss_pred CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc----ccc
Confidence 579999999986431 2235789999999999999999999999999999999999999999999984 335
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----ceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF----NPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||++....... ......||+.|+
T Consensus 109 ~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~ 183 (293)
T d1jksa_ 109 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFV 183 (293)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGC
T ss_pred ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCccc
Confidence 699999999999999999999999 999999999999998776 49999999998765432 234467899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++|||||||++|||+||+.||....... ... .......... . ...+.....+.+++
T Consensus 184 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~~~~~~~---~---~~~~~~s~~~~~li 251 (293)
T d1jksa_ 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---NVSAVNYEFE---D---EYFSNTSALAKDFI 251 (293)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHTTCCCCC---H---HHHTTSCHHHHHHH
T ss_pred CHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHH---HHHhcCCCCC---c---hhcCCCCHHHHHHH
Confidence 9999999999999999999999999999999986543211 111 1111110000 0 00012234578899
Q ss_pred HhccccccCCCCCHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~ 253 (307)
.+||+.||.+|||++++++
T Consensus 252 ~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 252 RRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=333.89 Aligned_cols=225 Identities=28% Similarity=0.313 Sum_probs=185.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++.. .......+.+|+.+|++++||||+++++++.+.+..|+||||++||+|.+++. ....++
T Consensus 28 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~----~~~~~~ 103 (337)
T d1o6la_ 28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT 103 (337)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSCCC
T ss_pred CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh----cccCCc
Confidence 57999999999754 23345778999999999999999999999999999999999999999999983 455789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+|||++++|.+||+|||+++...... .......||+.|+|||++.+
T Consensus 104 e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 104 EERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSS
T ss_pred HHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-cccccceeCHHHhhhhhccC
Confidence 999999999999999999999 99999999999999999999999999998654432 23455789999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..|+.++|||||||++|||++|+.||..... ..+.. .... ... .++......+.+++.+||+.|
T Consensus 180 ~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~---~i~~-~~~---------~~p~~~s~~~~dli~~~L~~d 243 (337)
T d1o6la_ 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE---LILM-EEI---------RFPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHH-CCC---------CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHH---HHhc-CCC---------CCCccCCHHHHHHHHhhccCC
Confidence 9999999999999999999999999875432 11211 1111 111 112223345788999999999
Q ss_pred cCCCCC-----HHHHHH
Q 021774 242 ASRRPQ-----MNQVIK 253 (307)
Q Consensus 242 p~~RPs-----~~~v~~ 253 (307)
|.+||+ ++++++
T Consensus 244 P~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 244 PKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTTSTTCSTTTHHHHHT
T ss_pred chhhcccccccHHHHHc
Confidence 999995 777765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=330.78 Aligned_cols=233 Identities=25% Similarity=0.389 Sum_probs=186.5
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-TRRILVYEYVENNSLDRVLLGATKANIKLNWEKRS 86 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~ 86 (307)
.||||+++.. +.....+|.+|+++|++++||||++++|++... ...++||||+++|+|.+++. .....+++..++
T Consensus 57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~ 133 (311)
T d1r0pa_ 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLI 133 (311)
T ss_dssp EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHH---CTTCCCBHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhc---cccccchHHHHH
Confidence 5899999754 566678899999999999999999999998764 58899999999999999984 344567889999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCCCCcCCcccccCCc
Q 021774 87 DICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGTTGYLAPEYVLGGQ 163 (307)
Q Consensus 87 ~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~ 163 (307)
+++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++........ ......||..|+|||.+.+..
T Consensus 134 ~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 210 (311)
T d1r0pa_ 134 GFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210 (311)
T ss_dssp HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC
T ss_pred HHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC
Confidence 9999999999999999 9999999999999999999999999999876543222 233456889999999999999
Q ss_pred ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccC
Q 021774 164 LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAAS 243 (307)
Q Consensus 164 ~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~ 243 (307)
++.++||||||+++|||+||+.|+....... .+.... .....+ ..+......+.+++.+||+.||+
T Consensus 211 ~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i---~~g~~~---------~~p~~~~~~l~~li~~cl~~dP~ 276 (311)
T d1r0pa_ 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL---LQGRRL---------LQPEYCPDPLYEVMLKCWHPKAE 276 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH---HcCCCC---------CCcccCcHHHHHHHHHHcCCCHh
Confidence 9999999999999999999887765433211 111111 111111 11122234588899999999999
Q ss_pred CCCCHHHHHHHHHhcccc
Q 021774 244 RRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 244 ~RPs~~~v~~~L~~~~~~ 261 (307)
+||++.||++.|+++...
T Consensus 277 ~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 277 MRPSFSELVSRISAIFST 294 (311)
T ss_dssp GSCCHHHHHHHHHHHHHT
T ss_pred HCcCHHHHHHHHHHHHHh
Confidence 999999999999988753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=334.25 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=179.7
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCC-eeEEEEeccCCCCHHHHhccCCC------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGT-RRILVYEYVENNSLDRVLLGATK------ 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~------ 75 (307)
.+|+.||||+++.. .....+.+.+|...+.++ +|+||+.+++++...+ ..++||||+++|+|.+++.....
T Consensus 41 ~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~ 120 (299)
T d1ywna1 41 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120 (299)
T ss_dssp SCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC--
T ss_pred cCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccc
Confidence 45678999999864 344556788888888887 7899999999987654 67999999999999999854322
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-ccccccc
Q 021774 76 ------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRIA 148 (307)
Q Consensus 76 ------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~ 148 (307)
....+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....... .......
T Consensus 121 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 197 (299)
T d1ywna1 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197 (299)
T ss_dssp ---------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCC
T ss_pred cchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCcee
Confidence 134589999999999999999999999 999999999999999999999999999987654332 2344567
Q ss_pred CCCCcCCcccccCCcccccCceeehHHHHHHHHhCCC-CCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHH
Q 021774 149 GTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRN-SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227 (307)
Q Consensus 149 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (307)
||+.|+|||++.++.++.++|||||||++|||+||.. ||...... ..+.... ..+... ..+....
T Consensus 198 gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~~~~~----~~~~~~--------~~~~~~~ 263 (299)
T d1ywna1 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRL----KEGTRM--------RAPDYTT 263 (299)
T ss_dssp CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHHHHHH----HHTCCC--------CCCTTCC
T ss_pred eCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHHHHHH----hcCCCC--------CCCccCC
Confidence 9999999999999999999999999999999999754 55433221 1111111 111111 1112233
Q ss_pred HHHHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 228 IRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 228 ~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
..+.+++.+||+.||++|||+.+|++.|+++++.
T Consensus 264 ~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 4578899999999999999999999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-48 Score=331.11 Aligned_cols=222 Identities=27% Similarity=0.369 Sum_probs=184.2
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..|+||||++||+|..++ .....++
T Consensus 27 ~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~----~~~~~~~ 102 (316)
T d1fota_ 27 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFP 102 (316)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH----HHTSSCC
T ss_pred CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccc----ccccccc
Confidence 57999999998753 2334577999999999999999999999999999999999999999999988 3455688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+
T Consensus 103 ~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 103 NPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST 175 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTT
T ss_pred ccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----cccccCcccccCHHHHcC
Confidence 899999999999999999999 9999999999999999999999999999876543 345679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||+||+.||...... .+ ......... ..++.....+.+++.+||+.|
T Consensus 176 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~---~~~i~~~~~----------~~p~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KT---YEKILNAEL----------RFPPFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHHCCC----------CCCTTSCHHHHHHHHHHTCSC
T ss_pred CCCCchhhccccchhHHHHHhCCCCCCCcCHH---HH---HHHHHcCCC----------CCCCCCCHHHHHHHHHHhhhC
Confidence 99999999999999999999999998654321 11 111111111 111222345788899999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|.+|+ |++++++
T Consensus 240 p~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTTCTTSSTTTTHHHHT
T ss_pred HHhccccchhhHHHHHc
Confidence 99996 8999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=332.77 Aligned_cols=230 Identities=26% Similarity=0.396 Sum_probs=181.8
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHHHHH
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEKRSD 87 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~ 87 (307)
+||+|.++.. +....+.|.+|++++++++||||++++++|.++ ..++++|++.+|+|.+.+. .....+++..++.
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~ 115 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLN 115 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHH---HTSSSCCHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccc---ccccCCCHHHHHH
Confidence 6899988754 345567899999999999999999999999865 4577889999999988874 3456799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcccccCCcccc
Q 021774 88 ICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPEYVLGGQLTM 166 (307)
Q Consensus 88 i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 166 (307)
++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........ ......||..|+|||++.++.++.
T Consensus 116 i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 192 (317)
T d1xkka_ 116 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192 (317)
T ss_dssp HHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCCh
Confidence 999999999999999 9999999999999999999999999999977554332 234456899999999999999999
Q ss_pred cCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccccCCC
Q 021774 167 KADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAAASRR 245 (307)
Q Consensus 167 ~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 245 (307)
++|||||||++|||+| |..||....... +...... .... ..++.....+.+++.+||+.||.+|
T Consensus 193 ~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~---~~~~---------~~p~~~~~~~~~li~~cl~~dP~~R 257 (317)
T d1xkka_ 193 QSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK---GERL---------PQPPICTIDVYMIMVKCWMIDADSR 257 (317)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHH---TCCC---------CCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc---CCCC---------CCCcccCHHHHHHHHHhCCCChhhC
Confidence 9999999999999999 677776543322 2222211 1111 1122334468889999999999999
Q ss_pred CCHHHHHHHHHhccc
Q 021774 246 PQMNQVIKMLTKNIR 260 (307)
Q Consensus 246 Ps~~~v~~~L~~~~~ 260 (307)
||+.+|++.|..+.+
T Consensus 258 Ps~~eil~~l~~~~~ 272 (317)
T d1xkka_ 258 PKFRELIIEFSKMAR 272 (317)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999987764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=329.21 Aligned_cols=238 Identities=26% Similarity=0.420 Sum_probs=192.2
Q ss_pred CCCEEEEEEccccC-hHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC--------
Q 021774 6 NGRRIAVKPLSAES-KQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK-------- 75 (307)
Q Consensus 6 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------- 75 (307)
++..||||+++... ......+.+|...+.++ +||||++++++|.++...++||||+++|+|.+++.....
T Consensus 44 ~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~ 123 (299)
T d1fgka_ 44 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123 (299)
T ss_dssp CEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC-------
T ss_pred CceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccc
Confidence 34579999998653 45567889999999888 899999999999999999999999999999999954432
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCC
Q 021774 76 ----ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGT 150 (307)
Q Consensus 76 ----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~ 150 (307)
....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......|+
T Consensus 124 ~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 200 (299)
T d1fgka_ 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200 (299)
T ss_dssp -----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred cccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCC
Confidence 234689999999999999999999999 9999999999999999999999999999876543322 34456788
Q ss_pred CCcCCcccccCCcccccCceeehHHHHHHHHh-CCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHH
Q 021774 151 TGYLAPEYVLGGQLTMKADVYSFGVLVLEIIS-GRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIR 229 (307)
Q Consensus 151 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
+.|+|||++.++.|+.++|||||||++|||+| |..||...... .+. .....+... ..+......
T Consensus 201 ~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~~----~~i~~~~~~--------~~p~~~~~~ 265 (299)
T d1fgka_ 201 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---ELF----KLLKEGHRM--------DKPSNCTNE 265 (299)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHHHTTCCC--------CCCSSCCHH
T ss_pred hhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HHH----HHHHcCCCC--------CCCccchHH
Confidence 89999999999999999999999999999998 67776543321 111 222222111 112223345
Q ss_pred HHHHHHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 230 YMKVAFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 230 ~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
+.+++.+||+.||.+|||+.||++.|+++++.
T Consensus 266 l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 266 LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 88899999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.9e-48 Score=324.99 Aligned_cols=235 Identities=23% Similarity=0.327 Sum_probs=181.4
Q ss_pred cCCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCC
Q 021774 4 LTNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 4 ~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
..+|+.||||+++.. +......|.+|++++++++||||+++++++...+ ..|+||||++|++|.+++. .
T Consensus 29 ~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~----~ 104 (277)
T d1o6ya_ 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----T 104 (277)
T ss_dssp TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH----H
T ss_pred CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc----c
Confidence 357999999999754 3455668999999999999999999999998654 3789999999999999873 3
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcC
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYL 154 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~ 154 (307)
...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.++|+|||.+........ .......||+.|+
T Consensus 105 ~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~ 181 (277)
T d1o6ya_ 105 EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181 (277)
T ss_dssp HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCccccc
Confidence 45799999999999999999999999 999999999999999999999999999876543322 2344567999999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc-cccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL-ELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 233 (307)
|||++.+..++.++|||||||++|||+||+.||...... ............. .... +.....+.++
T Consensus 182 aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~-------~~~s~~l~~l 248 (277)
T d1o6ya_ 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPSARH-------EGLSADLDAV 248 (277)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCGGGTS-------SSCCHHHHHH
T ss_pred CHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCCchhc-------cCCCHHHHHH
Confidence 999999999999999999999999999999998654321 1122222222211 1111 1222458889
Q ss_pred HHhccccccCCCC-CHHHHHHHHHhc
Q 021774 234 AFFCTQAAASRRP-QMNQVIKMLTKN 258 (307)
Q Consensus 234 ~~~c~~~~p~~RP-s~~~v~~~L~~~ 258 (307)
+.+||+.||.+|| |+++++..|.++
T Consensus 249 i~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 249 VLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 9999999999999 899998888765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=323.39 Aligned_cols=233 Identities=25% Similarity=0.354 Sum_probs=183.2
Q ss_pred EEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC------------
Q 021774 9 RIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------------ 74 (307)
Q Consensus 9 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------ 74 (307)
.||||.++.. .....+.|.+|+++|+++ +||||+++++++.+.+..++||||+++|+|.+++....
T Consensus 39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 4788887644 344556899999999999 79999999999999999999999999999999985431
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
.....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++...... ......||..|+
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~ 193 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWM 193 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTC
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccccccccccccc--cccceecCCccc
Confidence 2346799999999999999999999999 99999999999999999999999999998654322 223456899999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCC-CCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRN-SGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKV 233 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
|||.+.+..++.++|||||||++|||++|.. |+..... ..+. ........ + ..+......+.++
T Consensus 194 aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~----~~i~~~~~-----~---~~~~~~~~~~~~l 258 (309)
T d1fvra_ 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----EKLPQGYR-----L---EKPLNCDDEVYDL 258 (309)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHGGGTCC-----C---CCCTTBCHHHHHH
T ss_pred chHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHhcCC-----C---CCCccCCHHHHHH
Confidence 9999999999999999999999999999765 5543321 1111 11111111 1 1122334568889
Q ss_pred HHhccccccCCCCCHHHHHHHHHhcccc
Q 021774 234 AFFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 234 ~~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
+.+||+.||++|||+.+|++.|+++++.
T Consensus 259 i~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 259 MRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=327.35 Aligned_cols=237 Identities=23% Similarity=0.353 Sum_probs=189.8
Q ss_pred CCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC------CCCC
Q 021774 6 NGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT------KANI 78 (307)
Q Consensus 6 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~ 78 (307)
+++.||||+++.. .......|.+|+.++++++||||+++++++..++..++||||+++|+|.+++.... ....
T Consensus 49 ~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~ 128 (308)
T d1p4oa_ 49 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128 (308)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccC
Confidence 4678999999764 34555679999999999999999999999999999999999999999999874322 1223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc-ccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH-ITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.|++.||.|||++ +|+||||||+||||++++++||+|||+++........ ......|++.|+|||
T Consensus 129 ~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 129 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence 478999999999999999999999 9999999999999999999999999999876543322 234456899999999
Q ss_pred cccCCcccccCceeehHHHHHHHHhCC-CCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHh
Q 021774 158 YVLGGQLTMKADVYSFGVLVLEIISGR-NSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFF 236 (307)
Q Consensus 158 ~~~~~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (307)
.+.+..++.++||||||+++|||+||. .|+...... .... .... ... ...+......+.+++.+
T Consensus 206 ~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~~---~i~~-~~~--------~~~p~~~~~~l~~li~~ 270 (308)
T d1p4oa_ 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR---FVME-GGL--------LDKPDNCPDMLFELMRM 270 (308)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH---HHHT-TCC--------CCCCTTCCHHHHHHHHH
T ss_pred HHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHh-CCC--------CCCcccchHHHHHHHHH
Confidence 999999999999999999999999985 555433221 1111 1111 111 11122233468889999
Q ss_pred ccccccCCCCCHHHHHHHHHhccc
Q 021774 237 CTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 237 c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
||+.+|.+|||+.+|++.|++.+.
T Consensus 271 cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 271 CWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCChhHCcCHHHHHHHHHHhcC
Confidence 999999999999999999988764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-47 Score=327.60 Aligned_cols=222 Identities=23% Similarity=0.279 Sum_probs=183.6
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||++... .......+.+|+++|++++||||+++++++.+.+..++||||+.||+|..++. ....++
T Consensus 64 ~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~----~~~~l~ 139 (350)
T d1rdqe_ 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS 139 (350)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHCCCC
T ss_pred CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHh----hcCCCC
Confidence 57999999998743 22345678999999999999999999999999999999999999999999883 334699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+
T Consensus 140 e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 140 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999999876543 334679999999999999
Q ss_pred CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 162 GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 162 ~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
..++.++|||||||++|||+||+.||..... ..+.. ...... . ..+......+.+++.+||+.|
T Consensus 213 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~---~i~~~~-~---------~~p~~~s~~~~~li~~~L~~d 276 (350)
T d1rdqe_ 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYE---KIVSGK-V---------RFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCC-C---------CCCTTCCHHHHHHHHHHSCSC
T ss_pred CCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHH---HHhcCC-C---------CCCccCCHHHHHHHHHHhhhC
Confidence 9999999999999999999999999865422 11111 111111 1 111222345788999999999
Q ss_pred cCCCC-----CHHHHHH
Q 021774 242 ASRRP-----QMNQVIK 253 (307)
Q Consensus 242 p~~RP-----s~~~v~~ 253 (307)
|.+|+ |++++++
T Consensus 277 P~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 277 LTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTTCTTSSTTTTHHHHT
T ss_pred HHhccccccccHHHHHc
Confidence 99994 8999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=327.82 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=191.0
Q ss_pred CCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCC-------
Q 021774 5 TNGRRIAVKPLSAE-SKQGVREFITEIMTLSNV-RHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATK------- 75 (307)
Q Consensus 5 ~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------- 75 (307)
.+++.||||+++.. .......|.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.+++.....
T Consensus 51 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~ 130 (311)
T d1t46a_ 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (311)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred CCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccc
Confidence 45778999999865 345556799999999999 799999999999999999999999999999999854332
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc-cccccc
Q 021774 76 -------ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT-HITTRI 147 (307)
Q Consensus 76 -------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 147 (307)
....+++..+..++.||+.||+|||++ +++||||||+||+++.++.++++|||+++....... ......
T Consensus 131 ~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~ 207 (311)
T d1t46a_ 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (311)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred ccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeec
Confidence 233589999999999999999999999 999999999999999999999999999997765432 234456
Q ss_pred cCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHH
Q 021774 148 AGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEI 227 (307)
Q Consensus 148 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (307)
.||+.|+|||++.+..++.++|||||||++|||+|+..|+....... ..+...... ... +. .+....
T Consensus 208 ~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~~~~i~~----~~~-----~~---~~~~~~ 274 (311)
T d1t46a_ 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKE----GFR-----ML---SPEHAP 274 (311)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHHHHH----TCC-----CC---CCTTSC
T ss_pred ccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhc----CCC-----CC---Cccccc
Confidence 78999999999999999999999999999999999554443322221 111111111 111 11 112233
Q ss_pred HHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 228 IRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 228 ~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
..+.+|+.+||+.||++|||+.+|+++|++++.
T Consensus 275 ~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 275 AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 458889999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-47 Score=319.49 Aligned_cols=228 Identities=22% Similarity=0.313 Sum_probs=182.8
Q ss_pred CCCCEEEEEEccccC---------hHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAES---------KQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+++..|+||||++||+|.+++.
T Consensus 26 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~--- 102 (277)
T d1phka_ 26 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--- 102 (277)
T ss_dssp TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---
T ss_pred CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH---
Confidence 578999999986542 123346889999999996 9999999999999999999999999999999994
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYL 154 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~ 154 (307)
....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...... ......||..|+
T Consensus 103 -~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~ 176 (277)
T d1phka_ 103 -EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYL 176 (277)
T ss_dssp -HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGC
T ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCC
Confidence 345799999999999999999999999 99999999999999999999999999999775532 234467999999
Q ss_pred CcccccC------CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHH
Q 021774 155 APEYVLG------GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEII 228 (307)
Q Consensus 155 aPE~~~~------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (307)
|||.+.+ ..++.++||||+||++|||+||+.||....... ... ........ ...+. .+....
T Consensus 177 ~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~---~i~~~~~~--~~~~~----~~~~s~ 244 (277)
T d1phka_ 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR---MIMSGNYQ--FGSPE----WDDYSD 244 (277)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCCC--CCTTT----GGGSCH
T ss_pred CHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHH---HHHhCCCC--CCCcc----cccCCH
Confidence 9998853 346889999999999999999999987543211 111 11111111 00111 123334
Q ss_pred HHHHHHHhccccccCCCCCHHHHHH
Q 021774 229 RYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 229 ~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHc
Confidence 5888999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=323.24 Aligned_cols=238 Identities=21% Similarity=0.257 Sum_probs=179.9
Q ss_pred CCCCEEEEEEccccCh-----HhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESK-----QGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
.+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+.++++..+. .....
T Consensus 21 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~----~~~~~ 96 (299)
T d1ua2a_ 21 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK----DNSLV 96 (299)
T ss_dssp SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT----TCCSS
T ss_pred CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh----hcccC
Confidence 4689999999875422 11246889999999999999999999999999999999999888777665 34567
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+++....... ......||+.|+|||++
T Consensus 97 l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~ 172 (299)
T d1ua2a_ 97 LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELL 172 (299)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-cccceecChhhccHHHH
Confidence 89999999999999999999999 999999999999999999999999999987654322 23345789999999988
Q ss_pred cCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccc---c-------CCCCCCCC-----
Q 021774 160 LGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLEL---V-------DPELGEYP----- 223 (307)
Q Consensus 160 ~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~----- 223 (307)
.+. .++.++|||||||++|||+||..||...... .....+............ . .......+
T Consensus 173 ~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
T d1ua2a_ 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249 (299)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred ccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhc
Confidence 754 5799999999999999999999988654322 222222222111100000 0 00001111
Q ss_pred HHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 224 PNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 224 ~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
+.....+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 250 SAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 122346888999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-46 Score=328.55 Aligned_cols=226 Identities=22% Similarity=0.241 Sum_probs=178.4
Q ss_pred CCCCEEEEEEccccC---hHhHHHH---HHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAES---KQGVREF---ITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||++.... ......+ .+++.+++.++||||+++++++.+.+..|+||||++||+|.+++. ...
T Consensus 27 ~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~----~~~ 102 (364)
T d1omwa3 27 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHG 102 (364)
T ss_dssp TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH----HHC
T ss_pred CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH----hcc
Confidence 469999999986431 1222233 345778888899999999999999999999999999999999983 345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEY 158 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 158 (307)
.+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.+.... .....||+.|+|||+
T Consensus 103 ~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~ 176 (364)
T d1omwa3 103 VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEV 176 (364)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC---CCSCCSCGGGCCHHH
T ss_pred cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc---ccccccccccchhHH
Confidence 688999999999999999999999 99999999999999999999999999998765432 344679999999999
Q ss_pred ccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhc
Q 021774 159 VLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFC 237 (307)
Q Consensus 159 ~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 237 (307)
+.. ..++.++|||||||++|||+||+.||..........+ ........ . ..+......+.+++.+|
T Consensus 177 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~~------~---~~~~~~s~~~~~li~~~ 243 (364)
T d1omwa3 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMA------V---ELPDSFSPELRSLLEGL 243 (364)
T ss_dssp HSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSCC------C---CCCSSSCHHHHHHHHHH
T ss_pred hhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccCC------C---CCCCCCCHHHHHHHHHH
Confidence 875 5689999999999999999999999876443222111 11111110 1 11122334588899999
Q ss_pred cccccCCCCC-----HHHHHH
Q 021774 238 TQAAASRRPQ-----MNQVIK 253 (307)
Q Consensus 238 ~~~~p~~RPs-----~~~v~~ 253 (307)
|+.||.+||| ++++++
T Consensus 244 L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 244 LQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp TCSSTTTSTTTSSSTHHHHHT
T ss_pred cccCHHHhCCCcccCHHHHHc
Confidence 9999999999 688864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=322.94 Aligned_cols=244 Identities=26% Similarity=0.325 Sum_probs=179.3
Q ss_pred CCCCEEEEEEccccChHhHHHHHH--HHHHHhcCCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFIT--EIMTLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||+++.... ..+.. |+..+.+++||||+++++++.+.+ ..++||||+++|+|.+++.. .
T Consensus 24 ~~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~ 95 (303)
T d1vjya_ 24 WRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----Y 95 (303)
T ss_dssp ETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----C
T ss_pred ECCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-----C
Confidence 3688999999975432 33444 455556789999999999998654 57899999999999999942 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCccc---ccccccCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEEL-----VPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITH---ITTRIAGT 150 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~ 150 (307)
.++|..++.++.|++.||+|||+.. ..||+||||||+||||+.++.+||+|||+++........ ......||
T Consensus 96 ~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt 175 (303)
T d1vjya_ 96 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecc
Confidence 5899999999999999999999621 129999999999999999999999999999876443221 23456799
Q ss_pred CCcCCcccccCC------cccccCceeehHHHHHHHHhCCCCCCccccchhH--------HHHHHHHHHhhcCCcccccC
Q 021774 151 TGYLAPEYVLGG------QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNK--------FLLEWAWQLHQEEKPLELVD 216 (307)
Q Consensus 151 ~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 216 (307)
+.|+|||++.+. .++.++|||||||++|||+||..|+......... .............. .+
T Consensus 176 ~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 251 (303)
T d1vjya_ 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LR 251 (303)
T ss_dssp GGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CC
T ss_pred cCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc----cC
Confidence 999999998754 3678999999999999999998776432211100 00111111111111 12
Q ss_pred CCCCCC--CHHHHHHHHHHHHhccccccCCCCCHHHHHHHHHhccc
Q 021774 217 PELGEY--PPNEIIRYMKVAFFCTQAAASRRPQMNQVIKMLTKNIR 260 (307)
Q Consensus 217 ~~~~~~--~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~~L~~~~~ 260 (307)
+.+... .......+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 252 p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 252 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 222111 23455678899999999999999999999999987764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=321.87 Aligned_cols=227 Identities=20% Similarity=0.238 Sum_probs=183.6
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
.+|+.||||.++..... ...+.+|+++|++++||||+++++++.+++..|+|||||+||+|.+++. ..+..+++..
T Consensus 28 ~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~---~~~~~l~e~~ 103 (321)
T d1tkia_ 28 SSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNERE 103 (321)
T ss_dssp TTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHT---SSSCCCCHHH
T ss_pred CCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHH---hcCCCCCHHH
Confidence 46889999999866533 3568899999999999999999999999999999999999999999983 2344699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC--CceEEeeccCcccCCCCcccccccccCCCCcCCcccccCC
Q 021774 85 RSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQE--FNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLGG 162 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 162 (307)
+..++.||+.||+|||++ ||+||||||+|||++.+ ..+||+|||++....... ......|++.|+|||.+.+.
T Consensus 104 ~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~ 178 (321)
T d1tkia_ 104 IVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--cccccccccccccchhccCC
Confidence 999999999999999999 99999999999999854 479999999998764432 23446789999999999999
Q ss_pred cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCc-ccccCCCCCCCCHHHHHHHHHHHHhccccc
Q 021774 163 QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKP-LELVDPELGEYPPNEIIRYMKVAFFCTQAA 241 (307)
Q Consensus 163 ~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~c~~~~ 241 (307)
.++.++|||||||++|+|++|..||...... .+.. ........ .... .. .....+.+++.+||..|
T Consensus 179 ~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~---~i~~~~~~~~~~~---~~----~~s~~~~~li~~~L~~d 245 (321)
T d1tkia_ 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE---NIMNAEYTFDEEA---FK----EISIEAMDFVDRLLVKE 245 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHTCCCCCHHH---HT----TSCHHHHHHHHTTSCSS
T ss_pred CCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCCCCChhh---cc----CCCHHHHHHHHHHccCC
Confidence 9999999999999999999999998654321 1111 11111110 0000 01 12234788999999999
Q ss_pred cCCCCCHHHHHH
Q 021774 242 ASRRPQMNQVIK 253 (307)
Q Consensus 242 p~~RPs~~~v~~ 253 (307)
|.+|||+.|+++
T Consensus 246 p~~R~s~~eil~ 257 (321)
T d1tkia_ 246 RKSRMTASEALQ 257 (321)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHhc
Confidence 999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=324.61 Aligned_cols=229 Identities=18% Similarity=0.206 Sum_probs=178.2
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEe----CCeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQ----GTRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
..+|+.||||+++.. ..+.+|+.++.++ +||||+++++++.+ +...|+|||||+||+|.+++.. ....
T Consensus 34 ~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~ 106 (335)
T d2ozaa1 34 KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQ 106 (335)
T ss_dssp TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCC
T ss_pred CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCC
Confidence 367899999998742 4567899987655 89999999999875 4578999999999999999843 2345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
.+++..+..++.||+.||+|||++ ||+||||||+|||+++ ++.+||+|||+++....... .....||+.|+|
T Consensus 107 ~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~a 181 (335)
T d2ozaa1 107 AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVA 181 (335)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC--CCCCSCCCSSCC
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCc--cccccCCcccCC
Confidence 699999999999999999999999 9999999999999985 45699999999987654322 345679999999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCC-CCHHHHHHHHHHH
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGE-YPPNEIIRYMKVA 234 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 234 (307)
||++.+..|+.++|||||||++|+|+||+.||......... ........... ..... ........+.+++
T Consensus 182 PE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~------~~~~~~~~~~~s~~~~~li 252 (335)
T d2ozaa1 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQ------YEFPNPEWSEVSEEVKMLI 252 (335)
T ss_dssp CCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS------SSCCTTHHHHSCHHHHHHH
T ss_pred cHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCC------CCCCCcccccCCHHHHHHH
Confidence 99999999999999999999999999999998654332110 00000000000 00110 1123345688999
Q ss_pred HhccccccCCCCCHHHHHH
Q 021774 235 FFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~ 253 (307)
.+||+.||++|||+.|++.
T Consensus 253 ~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 253 RNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHSCSSTTTSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHHc
Confidence 9999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=324.52 Aligned_cols=225 Identities=26% Similarity=0.328 Sum_probs=181.3
Q ss_pred CCCCEEEEEEcccc---ChHhHHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAE---SKQGVREFITEIMTLS-NVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 5 ~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
.+|+.||||+++.. .......+..|..++. .++||||+++++++.+++..|+||||+++|+|.+++. ....+
T Consensus 25 ~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~----~~~~~ 100 (320)
T d1xjda_ 25 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKF 100 (320)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH----HHSSC
T ss_pred CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh----ccCCC
Confidence 46899999999753 1233456777777765 6899999999999999999999999999999999983 44568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...... .......||+.|+|||++.
T Consensus 101 ~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~ 176 (320)
T d1xjda_ 101 DLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILL 176 (320)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHT
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHc
Confidence 9999999999999999999999 99999999999999999999999999998654432 2344567999999999999
Q ss_pred CCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcccc
Q 021774 161 GGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCTQA 240 (307)
Q Consensus 161 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~ 240 (307)
+..++.++|||||||++|||+||+.||...... .+...+ ....+ .. +......+.+++.+||+.
T Consensus 177 ~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i----~~~~~------~~---p~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSI----RMDNP------FY---PRWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHCCC------CC---CTTSCHHHHHHHHHHSCS
T ss_pred CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH----HcCCC------CC---CccCCHHHHHHHHHhccc
Confidence 999999999999999999999999998754321 121111 11111 11 112234578899999999
Q ss_pred ccCCCCCHH-HHHH
Q 021774 241 AASRRPQMN-QVIK 253 (307)
Q Consensus 241 ~p~~RPs~~-~v~~ 253 (307)
||.+||++. ++++
T Consensus 241 dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQ 254 (320)
T ss_dssp SGGGSBTTBSCGGG
T ss_pred CCCCCcCHHHHHHh
Confidence 999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=314.77 Aligned_cols=240 Identities=22% Similarity=0.279 Sum_probs=179.3
Q ss_pred cCCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|+.||||+++... ......+.+|+++|++++||||+++++++.+.+..|+||||+.++.+.... ......++
T Consensus 24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~l~ 100 (298)
T d1gz8a_ 24 KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIP 100 (298)
T ss_dssp TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH---HTTTTCCC
T ss_pred CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhh---hhcccCCC
Confidence 3679999999997542 234567899999999999999999999999999999999999765444433 23455699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.++...... .......||+.|+|||++..
T Consensus 101 e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 101 LPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhcc
Confidence 999999999999999999999 99999999999999999999999999998765432 22444678999999998877
Q ss_pred Cc-ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC--cccc---c---CCCC---CC-----CCH
Q 021774 162 GQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK--PLEL---V---DPEL---GE-----YPP 224 (307)
Q Consensus 162 ~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~---~~~~---~~-----~~~ 224 (307)
.. ++.++|||||||++|+|++|+.||...... .............. .... . .... .. ..+
T Consensus 177 ~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T d1gz8a_ 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253 (298)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHST
T ss_pred ccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhcc
Confidence 55 578999999999999999999998654321 11111111111100 0000 0 0000 00 011
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+||+.||.+|||+.|+++
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 254 PLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22345788999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-45 Score=311.08 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=181.4
Q ss_pred cccCCCCEEEEEEccccC--hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCC
Q 021774 2 GTLTNGRRIAVKPLSAES--KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIK 79 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~ 79 (307)
++.++|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..+++||++.++.+..+. .....
T Consensus 21 ~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~----~~~~~ 96 (286)
T d1ob3a_ 21 AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGG 96 (286)
T ss_dssp EEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH----TSTTC
T ss_pred EEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH----hhcCC
Confidence 446789999999997653 333578999999999999999999999999999999999999887777766 34567
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccc
Q 021774 80 LNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYV 159 (307)
Q Consensus 80 ~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 159 (307)
+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+........ ......|++.|+|||.+
T Consensus 97 l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~ 172 (286)
T d1ob3a_ 97 LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVL 172 (286)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHH
T ss_pred cchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccceecccchhhhHHHH
Confidence 99999999999999999999999 999999999999999999999999999987654322 23345688999999998
Q ss_pred cCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc------c--ccCCCC--------CCC
Q 021774 160 LGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL------E--LVDPEL--------GEY 222 (307)
Q Consensus 160 ~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~--~~~~~~--------~~~ 222 (307)
.+. .++.++|||||||++|||++|+.||...... ..+ ............. . ...... ...
T Consensus 173 ~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T d1ob3a_ 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQL-MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249 (286)
T ss_dssp TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH-HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGT
T ss_pred hCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHH-HHHHHhhCCCChhhccchhhhhhcccccccccCcchhhh
Confidence 764 5689999999999999999999998654321 111 1111111110000 0 000000 111
Q ss_pred CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 ~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+.....+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223345788999999999999999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=314.44 Aligned_cols=218 Identities=20% Similarity=0.291 Sum_probs=174.5
Q ss_pred cCCCCEEEEEEccccC------hHhHHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeccCC-CCHHHHhccCC
Q 021774 4 LTNGRRIAVKPLSAES------KQGVREFITEIMTLSNVR--HPNLVELIGCCVQGTRRILVYEYVEN-NSLDRVLLGAT 74 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~ 74 (307)
..+|+.||||+++... .....++.+|+.++++++ ||||+++++++.+.+..++||||+.+ +++.+++.
T Consensus 26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~--- 102 (273)
T d1xwsa_ 26 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--- 102 (273)
T ss_dssp TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---
T ss_pred CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh---
Confidence 3579999999987431 112234678999999986 89999999999999999999999976 67777773
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCceEEeeccCcccCCCCcccccccccCCCCc
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-EFNPKIGDFGLAKLFPDNITHITTRIAGTTGY 153 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y 153 (307)
....+++..+..++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||++...... ......||+.|
T Consensus 103 -~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y 175 (273)
T d1xwsa_ 103 -ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVY 175 (273)
T ss_dssp -HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGG
T ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceecccc---cccccccCCCc
Confidence 345799999999999999999999999 9999999999999985 478999999999875443 23456799999
Q ss_pred CCcccccCCcc-cccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHH
Q 021774 154 LAPEYVLGGQL-TMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMK 232 (307)
Q Consensus 154 ~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
+|||++.+..+ +.++|||||||++|||+||+.||.... ........ + +......+.+
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~~---~-------~~~~s~~~~~ 233 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF---F-------RQRVSSECQH 233 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC---C-------SSCCCHHHHH
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcccC---C-------CCCCCHHHHH
Confidence 99999987665 677999999999999999999986421 01111110 1 1112245788
Q ss_pred HHHhccccccCCCCCHHHHHH
Q 021774 233 VAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 233 l~~~c~~~~p~~RPs~~~v~~ 253 (307)
++.+||+.||++|||++|+++
T Consensus 234 li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHhc
Confidence 999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-44 Score=304.38 Aligned_cols=242 Identities=20% Similarity=0.279 Sum_probs=188.3
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
..+|+.||||+++.... ...+.+|++.++.++ |+|++.+++++......++||||+ +++|.+++. ..+..+++
T Consensus 27 ~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~---~~~~~~~~ 100 (293)
T d1csna_ 27 LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLD---LCGRKFSV 100 (293)
T ss_dssp TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHH---HTTTCCCH
T ss_pred CCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHH---hhccchhh
Confidence 35789999998865432 234678999999995 589999999999999999999999 789999884 33456999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-----CCceEEeeccCcccCCCCccc------ccccccCCC
Q 021774 83 EKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ-----EFNPKIGDFGLAKLFPDNITH------ITTRIAGTT 151 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~ 151 (307)
..+..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+++.+...... ......||+
T Consensus 101 ~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 101 KTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEch
Confidence 99999999999999999999 9999999999999964 567999999999876543221 234467999
Q ss_pred CcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHH
Q 021774 152 GYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYM 231 (307)
Q Consensus 152 ~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
.|+|||++.+..++.++|||||||++|||+||..||........................... ....+ ..+.
T Consensus 178 ~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l----~~~~p----~~l~ 249 (293)
T d1csna_ 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL----CAGFP----EEFY 249 (293)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH----TTTSC----HHHH
T ss_pred hhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh----cCCCC----HHHH
Confidence 999999999999999999999999999999999999765443332222222221111111111 11222 3477
Q ss_pred HHHHhccccccCCCCCHHHHHHHHHhccccC
Q 021774 232 KVAFFCTQAAASRRPQMNQVIKMLTKNIRLN 262 (307)
Q Consensus 232 ~l~~~c~~~~p~~RPs~~~v~~~L~~~~~~~ 262 (307)
+++..|++.+|++||+++.+.+.|+++++..
T Consensus 250 ~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 250 KYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 7778899999999999999999998887544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=311.44 Aligned_cols=237 Identities=22% Similarity=0.309 Sum_probs=175.5
Q ss_pred CCCEEEEEEccccC--hHhHHHHHHHHHHHhcC---CCCCccceeeEEEe-----CCeeEEEEeccCCCCHHHHhccCCC
Q 021774 6 NGRRIAVKPLSAES--KQGVREFITEIMTLSNV---RHPNLVELIGCCVQ-----GTRRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 6 ~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
+|+.||||+++... ......+.+|+.+|+.+ +||||+++++++.. ....+++||++.++++..... .
T Consensus 32 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~ 108 (305)
T d1blxa_ 32 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---V 108 (305)
T ss_dssp TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---S
T ss_pred CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh---c
Confidence 36679999986542 22223466777777665 89999999999863 346789999998877765542 3
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++...... .......||+.|+|
T Consensus 109 ~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~A 183 (305)
T d1blxa_ 109 PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRA 183 (305)
T ss_dssp CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcC
Confidence 456689999999999999999999999 9999999999999999999999999998865332 23456789999999
Q ss_pred cccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc----------ccc----CCCCCC
Q 021774 156 PEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL----------ELV----DPELGE 221 (307)
Q Consensus 156 PE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~----~~~~~~ 221 (307)
||++.+..++.++||||+||++|||+||+.||...... .....+.......... ... ......
T Consensus 184 PE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (305)
T d1blxa_ 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260 (305)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred cchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence 99999999999999999999999999999998654322 1111121111110000 000 000111
Q ss_pred CCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 YPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
........+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 12223345778899999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-44 Score=305.09 Aligned_cols=240 Identities=18% Similarity=0.245 Sum_probs=178.8
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL-VELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWE 83 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~ 83 (307)
.+|+.||||++...... ..+..|++++++++|+|+ +.+.+++.+.+..++||||+ +++|...+. .....+++.
T Consensus 30 ~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~---~~~~~~~~~ 103 (299)
T d1ckia_ 30 AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFN---FCSRKFSLK 103 (299)
T ss_dssp TTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHH---HTTTCCCHH
T ss_pred CCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhh---hccCCCcHH
Confidence 56899999988754322 357889999999976664 55556667888899999999 557766652 345579999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCceEEeeccCcccCCCCcc------cccccccCCCCcC
Q 021774 84 KRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQ---EFNPKIGDFGLAKLFPDNIT------HITTRIAGTTGYL 154 (307)
Q Consensus 84 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~ 154 (307)
.+..++.|++.||+|||++ ||+||||||+|||++. +..++|+|||+++.+..... .......||+.|+
T Consensus 104 ~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 180 (299)
T d1ckia_ 104 TVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSC
T ss_pred HHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCcccc
Confidence 9999999999999999999 9999999999999864 45699999999997754322 1234567999999
Q ss_pred CcccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHH
Q 021774 155 APEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVA 234 (307)
Q Consensus 155 aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
|||++.+..++.++|||||||++|||+||+.||........................ .. + .......+.+++
T Consensus 181 aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~---~~~~p~~~~~li 252 (299)
T d1ckia_ 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV----L---CKGYPSEFATYL 252 (299)
T ss_dssp CHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-HH----H---TTTSCHHHHHHH
T ss_pred CHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-hH----h---ccCCCHHHHHHH
Confidence 999999999999999999999999999999999765443222111111111111111 00 0 111223477888
Q ss_pred HhccccccCCCCCHHHHHHHHHhcccc
Q 021774 235 FFCTQAAASRRPQMNQVIKMLTKNIRL 261 (307)
Q Consensus 235 ~~c~~~~p~~RPs~~~v~~~L~~~~~~ 261 (307)
..||+.+|++||++.++.+.|+.+...
T Consensus 253 ~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 253 NFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 889999999999999999999887653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=303.79 Aligned_cols=239 Identities=22% Similarity=0.279 Sum_probs=175.6
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe--------CCeeEEEEeccCCCCHHHHhccCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ--------GTRRILVYEYVENNSLDRVLLGAT 74 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~ 74 (307)
.+|+.||||++... .......+.+|+.+|++++||||+++++++.. ....++|||++.++.+....
T Consensus 33 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~---- 108 (318)
T d3blha1 33 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---- 108 (318)
T ss_dssp TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT----
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh----
Confidence 57999999998654 23445678999999999999999999999865 34678999999887666554
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc---cccccccCCC
Q 021774 75 KANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT---HITTRIAGTT 151 (307)
Q Consensus 75 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~ 151 (307)
.....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++........ .......||+
T Consensus 109 ~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~ 185 (318)
T d3blha1 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185 (318)
T ss_dssp CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCG
T ss_pred hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCH
Confidence 3456789999999999999999999999 999999999999999999999999999987654321 1233456899
Q ss_pred CcCCcccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc--cccC----------CC
Q 021774 152 GYLAPEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL--ELVD----------PE 218 (307)
Q Consensus 152 ~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----------~~ 218 (307)
.|+|||++.+. .++.++|||||||++|||++|+.||....... ............... ...+ ..
T Consensus 186 ~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T d3blha1 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPEVWPNVDNYELYEKLELVK 262 (318)
T ss_dssp GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTCCCC-------CCS
T ss_pred HHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcCCCChhhccccchhhhhhhhcccc
Confidence 99999998765 68999999999999999999999986543322 112222221111000 0000 00
Q ss_pred CCCCCH-H------HHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 219 LGEYPP-N------EIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 219 ~~~~~~-~------~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...... . ....+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 263 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000011 1 1234567899999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=307.57 Aligned_cols=234 Identities=23% Similarity=0.306 Sum_probs=179.8
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEeccCCCCHHHHhccCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT------RRILVYEYVENNSLDRVLLGATK 75 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~ 75 (307)
..+|+.||||+++.. +....+.+.+|+++|++++||||++++++|...+ ..++||||+ +.+|..+..
T Consensus 40 ~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~---- 114 (346)
T d1cm8a_ 40 GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK---- 114 (346)
T ss_dssp TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH----
T ss_pred CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH----
Confidence 356999999999754 4455678899999999999999999999998655 469999999 668888773
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCC
Q 021774 76 ANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLA 155 (307)
Q Consensus 76 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~a 155 (307)
...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... .....||..|+|
T Consensus 115 -~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~a 186 (346)
T d1cm8a_ 115 -HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRA 186 (346)
T ss_dssp -HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCC
T ss_pred -hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCc----cccccccccccC
Confidence 34699999999999999999999999 9999999999999999999999999999876543 344678999999
Q ss_pred cccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCC------------------cccccC
Q 021774 156 PEYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEK------------------PLELVD 216 (307)
Q Consensus 156 PE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~ 216 (307)
||++.+. .++.++||||+||++|||++|+.||........ ............ ......
T Consensus 187 PE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (346)
T d1cm8a_ 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK 263 (346)
T ss_dssp THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCC
T ss_pred HHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH---HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccc
Confidence 9998764 568999999999999999999999865432111 111101000000 000000
Q ss_pred CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 217 PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 217 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
..+..........+.+++.+||..||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 264 KDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0111111222345778999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=306.74 Aligned_cols=239 Identities=23% Similarity=0.288 Sum_probs=177.8
Q ss_pred cCCCCEEEEEEcccc-ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE-SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGT----RRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 4 ~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
..+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.... ..+++++++.+|+|.+++. ..
T Consensus 30 ~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~-----~~ 104 (345)
T d1pmea_ 30 NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQ 104 (345)
T ss_dssp TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHH-----HC
T ss_pred CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhh-----cC
Confidence 357999999999754 3455678999999999999999999999997653 2345555666999999983 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcc--cccccccCCCCcCCc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNIT--HITTRIAGTTGYLAP 156 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aP 156 (307)
.+++..+..++.|++.||+|||++ ||+||||||+||||++++.+||+|||++........ .......||+.|+||
T Consensus 105 ~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aP 181 (345)
T d1pmea_ 105 HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181 (345)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechH
Confidence 699999999999999999999999 999999999999999999999999999987644322 123456789999999
Q ss_pred ccccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccc-------------ccCCCCCCC
Q 021774 157 EYVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLE-------------LVDPELGEY 222 (307)
Q Consensus 157 E~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~ 222 (307)
|++.. ..++.++||||+||++|||++|+.||......... .............. ...+.....
T Consensus 182 E~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (345)
T d1pmea_ 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 258 (345)
T ss_dssp GGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC
T ss_pred HHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhhhhhhhhhhhhcccccCCccCCC
Confidence 98854 56789999999999999999999998654322111 11111100000000 000000000
Q ss_pred -----CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 223 -----PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 223 -----~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.+....++.+++.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 259 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112235788999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=306.50 Aligned_cols=229 Identities=25% Similarity=0.301 Sum_probs=182.0
Q ss_pred CCCEEEEEEcccc----ChHhHHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCC
Q 021774 6 NGRRIAVKPLSAE----SKQGVREFITEIMTLSNVRH-PNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKL 80 (307)
Q Consensus 6 ~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 80 (307)
+|+.||||.++.. +....+.+.+|++++++++| |||+++++++.+....+++|||+.+|+|.+++. ....+
T Consensus 51 ~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~----~~~~~ 126 (322)
T d1vzoa_ 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERF 126 (322)
T ss_dssp TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH----HHSCC
T ss_pred CCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHH----hcccc
Confidence 5889999998753 12234568899999999965 899999999999999999999999999999983 44467
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 81 NWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 81 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+............|++.|+|||.+.
T Consensus 127 ~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~ 203 (322)
T d1vzoa_ 127 TEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203 (322)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred cHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhh
Confidence 8899999999999999999999 9999999999999999999999999999877665555556678999999999987
Q ss_pred CC--cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcccccCCCCCCCCHHHHHHHHHHHHhcc
Q 021774 161 GG--QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELVDPELGEYPPNEIIRYMKVAFFCT 238 (307)
Q Consensus 161 ~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~ 238 (307)
+. .++.++|||||||++|||+||+.||........... .......... ..+......+.+++.+||
T Consensus 204 ~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~~~~----------~~~~~~s~~~~~li~~~l 271 (322)
T d1vzoa_ 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSEP----------PYPQEMSALAKDLIQRLL 271 (322)
T ss_dssp TCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHHCCC----------CCCTTSCHHHHHHHHHHT
T ss_pred cCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcccCCC----------CCcccCCHHHHHHHHHHc
Confidence 64 467899999999999999999999876543322111 1111111111 112233446888899999
Q ss_pred ccccCCCCC-----HHHHHH
Q 021774 239 QAAASRRPQ-----MNQVIK 253 (307)
Q Consensus 239 ~~~p~~RPs-----~~~v~~ 253 (307)
+.||.+||| ++|+++
T Consensus 272 ~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 272 MKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CSSGGGSTTSSTTTHHHHHT
T ss_pred ccCHHHcCCCCcccHHHHHc
Confidence 999999994 788764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=294.50 Aligned_cols=240 Identities=19% Similarity=0.240 Sum_probs=184.8
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
..+|+.||||+++.. .......+.+|+.+|++++||||+++++++.+....++|++++.+++|..++ .....++
T Consensus 24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~----~~~~~~~ 99 (292)
T d1unla_ 24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD----SCNGDLD 99 (292)
T ss_dssp TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHH----HTTTCCC
T ss_pred CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccc----ccccccc
Confidence 357899999998654 3345678999999999999999999999999999999999999999988887 3456789
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCcccccC
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVLG 161 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 161 (307)
+..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.+........ ......++..|+|||.+.+
T Consensus 100 ~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 100 PEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTT
T ss_pred hhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-cceeeccccchhhhhHhcc
Confidence 999999999999999999999 999999999999999999999999999987654332 2333456788999998877
Q ss_pred Cc-ccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCcc------c----------ccCCCCCCCCH
Q 021774 162 GQ-LTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPL------E----------LVDPELGEYPP 224 (307)
Q Consensus 162 ~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~----------~~~~~~~~~~~ 224 (307)
.. ++.++|||||||++|||++|+.|+....... ................ . ...........
T Consensus 176 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (292)
T d1unla_ 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTST
T ss_pred CCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccc
Confidence 65 6899999999999999999999875433221 1122121111110000 0 00011122223
Q ss_pred HHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 225 NEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 225 ~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
.....+.+++.+||+.||.+|||++|+++
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 254 KLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33456788899999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=306.20 Aligned_cols=236 Identities=22% Similarity=0.232 Sum_probs=173.4
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEeccCCCCHHHHhccCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNLVELIGCCVQG------TRRILVYEYVENNSLDRVLLGATKANI 78 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~ 78 (307)
.+|+.||||+++.... .+.+|+++|++++||||+++++++... ...++||||++++.+..+. .......
T Consensus 43 ~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~-~~~~~~~ 117 (350)
T d1q5ka_ 43 DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR-HYSRAKQ 117 (350)
T ss_dssp TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHH-HHHHTTC
T ss_pred CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHH-hhhhccC
Confidence 5699999999975432 234799999999999999999998643 3568999999765444332 2234556
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCcc
Q 021774 79 KLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPE 157 (307)
Q Consensus 79 ~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 157 (307)
.+++..+..++.||+.||+|||++ ||+||||||+||||+.++ .+||+|||++........ .....|+..|+|||
T Consensus 118 ~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE 192 (350)
T d1q5ka_ 118 TLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPE 192 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc--cccccccccccChH
Confidence 799999999999999999999999 999999999999999775 899999999987654322 33457899999999
Q ss_pred cccC-CcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHH----------HHhhcCCcccccCCCC------C
Q 021774 158 YVLG-GQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAW----------QLHQEEKPLELVDPEL------G 220 (307)
Q Consensus 158 ~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~------~ 220 (307)
.+.+ ..++.++||||+||++|||++|+.||....... .+..... ...... .....-+.. .
T Consensus 193 ~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 269 (350)
T d1q5ka_ 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKAHPWTK 269 (350)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCC----CCCCCCCCCCCGGG
T ss_pred HhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhhhccc-hhhccccccccCchhh
Confidence 8765 578999999999999999999999986543221 1111110 000000 000000000 0
Q ss_pred CCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 221 EYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 221 ~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
...+.....+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 270 VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223445788999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=297.37 Aligned_cols=234 Identities=22% Similarity=0.277 Sum_probs=171.2
Q ss_pred CCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEe------CCeeEEEEeccCCCCHHHHhccCCCC
Q 021774 5 TNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQ------GTRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 5 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
.+|+.||||++... +.....++.+|+.++++++||||+++++++.. ....|+||||+.++.+. .+
T Consensus 40 ~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~------ 112 (355)
T d2b1pa1 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VI------ 112 (355)
T ss_dssp TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HH------
T ss_pred CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHH-hh------
Confidence 56999999999754 45556789999999999999999999999964 36889999999765544 44
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.++++|||+++..... .......||..|+||
T Consensus 113 ~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aP 187 (355)
T d2b1pa1 113 QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAP 187 (355)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCH
T ss_pred hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccc--cccccccccccccCh
Confidence 23589999999999999999999999 9999999999999999999999999998865443 233455789999999
Q ss_pred ccccCCcccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHH-------------------hhcCCcc-----
Q 021774 157 EYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQL-------------------HQEEKPL----- 212 (307)
Q Consensus 157 E~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~----- 212 (307)
|++.+..++.++||||+||+++||++|+.||........ ....... .......
T Consensus 188 E~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (355)
T d2b1pa1 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264 (355)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCH
T ss_pred hhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH---HHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccc
Confidence 999999999999999999999999999999865432111 1111000 0000000
Q ss_pred -ccc----CCCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 213 -ELV----DPELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 213 -~~~----~~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
... .+............+.+++.+|++.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00001112234566889999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-42 Score=296.53 Aligned_cols=234 Identities=23% Similarity=0.292 Sum_probs=173.4
Q ss_pred cCCCCEEEEEEcccc--ChHhHHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHhccCCCC
Q 021774 4 LTNGRRIAVKPLSAE--SKQGVREFITEIMTLSNVRHPNLVELIGCCVQG-----TRRILVYEYVENNSLDRVLLGATKA 76 (307)
Q Consensus 4 ~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~ 76 (307)
..+|+.||||+++.. +....+.+.+|+++|++++||||+++++++... ...+++++++.||+|.+++.
T Consensus 40 ~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~----- 114 (348)
T d2gfsa1 40 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----- 114 (348)
T ss_dssp TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-----
T ss_pred CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-----
Confidence 467999999999754 345556789999999999999999999998643 34466777788999999983
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccccccccCCCCcCCc
Q 021774 77 NIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHITTRIAGTTGYLAP 156 (307)
Q Consensus 77 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aP 156 (307)
...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++..... ......|+..|+||
T Consensus 115 ~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~ap 187 (348)
T d2gfsa1 115 CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAP 187 (348)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSCHHHHTSCH
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc----ccccccccccccCc
Confidence 34699999999999999999999999 999999999999999999999999999975432 23445688899999
Q ss_pred ccccCC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHHHHHHhhcCCccccc--------------CCCCCC
Q 021774 157 EYVLGG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEWAWQLHQEEKPLELV--------------DPELGE 221 (307)
Q Consensus 157 E~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~ 221 (307)
|...+. .++.++|||||||++|+|++|+.||........ ...+....... ..... ......
T Consensus 188 E~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (348)
T d2gfsa1 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTP-GAELLKKISSESARNYIQSLTQMPK 263 (348)
T ss_dssp HHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC-CHHHHTTCCCHHHHHHHTTSCCCCC
T ss_pred hhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCC-ChHHhhhccchhhhhhhhhcccCCC
Confidence 987765 468899999999999999999999865432211 11111111000 00000 000000
Q ss_pred C-----CHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 222 Y-----PPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 222 ~-----~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
. .......+.+++.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0112345778999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=292.66 Aligned_cols=234 Identities=18% Similarity=0.217 Sum_probs=174.9
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcC-CCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHhccCCCCCCCCC
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNV-RHPNLVELIGCCVQG--TRRILVYEYVENNSLDRVLLGATKANIKLN 81 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~ 81 (307)
.+|+.||||+++... .+++.+|+++|+++ .||||+++++++... ...++||||+.+++|..+. ..++
T Consensus 58 ~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~ 127 (328)
T d3bqca1 58 TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLT 127 (328)
T ss_dssp TTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCC
T ss_pred CCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCC
Confidence 578999999998543 35688999999999 499999999999844 5689999999999987653 3589
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-ceEEeeccCcccCCCCcccccccccCCCCcCCccccc
Q 021774 82 WEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEF-NPKIGDFGLAKLFPDNITHITTRIAGTTGYLAPEYVL 160 (307)
Q Consensus 82 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 160 (307)
+..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....... ......+|..|+|||.+.
T Consensus 128 e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~ 202 (328)
T d3bqca1 128 DYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLV 202 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC--cccccccCccccCccccc
Confidence 999999999999999999999 999999999999998655 69999999998765432 234456899999999987
Q ss_pred CC-cccccCceeehHHHHHHHHhCCCCCCccccchhHHHHHH----------HHHHhhcCCccc---ccCC--------C
Q 021774 161 GG-QLTMKADVYSFGVLVLEIISGRNSGKAMWGQMNKFLLEW----------AWQLHQEEKPLE---LVDP--------E 218 (307)
Q Consensus 161 ~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---~~~~--------~ 218 (307)
+. .++.++||||+||++|||++|+.||.............. ............ .... .
T Consensus 203 ~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (328)
T d3bqca1 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282 (328)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGG
T ss_pred CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhc
Confidence 75 579999999999999999999999865443221111000 000000000000 0000 0
Q ss_pred C-CCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 219 L-GEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 219 ~-~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
. ..........+.+++.+||+.||.+|||++|+++
T Consensus 283 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011122345788999999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-36 Score=262.86 Aligned_cols=239 Identities=19% Similarity=0.221 Sum_probs=170.1
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC-----------CCCccceeeEEEe--CCeeEEEEeccCCCCH-HHHh
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR-----------HPNLVELIGCCVQ--GTRRILVYEYVENNSL-DRVL 70 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL-~~~l 70 (307)
.+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++.. ....+++++++..+.. ....
T Consensus 36 ~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (362)
T d1q8ya_ 36 VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114 (362)
T ss_dssp TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHH
T ss_pred CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccc
Confidence 579999999998543 33456788999888774 5889999998764 3455666666654433 2222
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeeCCCCCCcEEECCCCc------eEEeeccCcccCCCCcccc
Q 021774 71 LGATKANIKLNWEKRSDICVGIAKGLAFLHE-ELVPHIVHRDIKASNILLDQEFN------PKIGDFGLAKLFPDNITHI 143 (307)
Q Consensus 71 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~------~kl~dfg~~~~~~~~~~~~ 143 (307)
. ......+++..+..++.||+.||+|||+ . ||+||||||+||||+.++. ++++|||.+......
T Consensus 115 ~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---- 185 (362)
T d1q8ya_ 115 K--KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185 (362)
T ss_dssp H--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----
T ss_pred c--cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeecccccccccc----
Confidence 1 2455678999999999999999999997 7 9999999999999986653 999999999865432
Q ss_pred cccccCCCCcCCcccccCCcccccCceeehHHHHHHHHhCCCCCCccccch----hHHHHHHHHHHh--------hcCC-
Q 021774 144 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLVLEIISGRNSGKAMWGQM----NKFLLEWAWQLH--------QEEK- 210 (307)
Q Consensus 144 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~----~~~~~~~~~~~~--------~~~~- 210 (307)
.....||+.|+|||++.+..++.++||||+||++++|++|+.||....... ...+........ ....
T Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~ 265 (362)
T d1q8ya_ 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT 265 (362)
T ss_dssp CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTH
T ss_pred cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccc
Confidence 345678999999999999999999999999999999999999986543221 111111111000 0000
Q ss_pred --------cccccC-----------CCCCCCCHHHHHHHHHHHHhccccccCCCCCHHHHHH
Q 021774 211 --------PLELVD-----------PELGEYPPNEIIRYMKVAFFCTQAAASRRPQMNQVIK 253 (307)
Q Consensus 211 --------~~~~~~-----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~RPs~~~v~~ 253 (307)
....+. +............+.+++.+|++.||.+|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 266 RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0012334567778999999999999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.1e-21 Score=153.10 Aligned_cols=153 Identities=15% Similarity=0.077 Sum_probs=105.5
Q ss_pred cccCCCCEEEEEEccccC------------------hHhHHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeccCC
Q 021774 2 GTLTNGRRIAVKPLSAES------------------KQGVREFITEIMTLSNVRHPNLVELIGCCVQGTRRILVYEYVEN 63 (307)
Q Consensus 2 g~~~~g~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 63 (307)
|+..+|+.||||+++... .........|+..+.++.|.+++..+++. ..+++||++++
T Consensus 19 a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~ 94 (191)
T d1zara2 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDA 94 (191)
T ss_dssp EEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCC
T ss_pred EECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeecc
Confidence 456789999999875321 01123345789999999999999887653 23799999988
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCceEEeeccCcccCCCCcccc
Q 021774 64 NSLDRVLLGATKANIKLNWEKRSDICVGIAKGLAFLHEELVPHIVHRDIKASNILLDQEFNPKIGDFGLAKLFPDNITHI 143 (307)
Q Consensus 64 ~sL~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 143 (307)
..+.. ++......++.|++.||+|||++ ||+||||||+|||++++ .++|+|||++..........
T Consensus 95 ~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~ 159 (191)
T d1zara2 95 KELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE 159 (191)
T ss_dssp EEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH
T ss_pred ccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHH
Confidence 65433 33344567899999999999999 99999999999999865 58999999998654332211
Q ss_pred cccccCCCCcCCcccccCCcccccCceeehHHHH
Q 021774 144 TTRIAGTTGYLAPEYVLGGQLTMKADVYSFGVLV 177 (307)
Q Consensus 144 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l 177 (307)
.-.. ... .-.+ +-...|..++|+||+.--+
T Consensus 160 ~l~r--d~~-~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 160 ILER--DVR-NIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HHHH--HHH-HHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred HHHH--HHH-HHHH-HHcCCCCCcccHHHHHHHH
Confidence 0000 000 0011 1135788899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.69 E-value=2.1e-08 Score=81.24 Aligned_cols=120 Identities=12% Similarity=0.058 Sum_probs=84.2
Q ss_pred CCCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCHHH
Q 021774 6 NGRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNWEK 84 (307)
Q Consensus 6 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~ 84 (307)
+++.++||+...........+.+|...+..+. +--+.+++.+..+++..++||++++|.++.+.... . ..
T Consensus 36 ~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~----~-----~~ 106 (263)
T d1j7la_ 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED----E-----QS 106 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----C-----SC
T ss_pred CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc----c-----cc
Confidence 46678888877554333445677888887763 44468888888889999999999999888765411 0 11
Q ss_pred HHHHHHHHHHHHHHHhcCCC--------------------------------------------------------CCee
Q 021774 85 RSDICVGIAKGLAFLHEELV--------------------------------------------------------PHIV 108 (307)
Q Consensus 85 ~~~i~~~i~~~l~~LH~~~~--------------------------------------------------------~~i~ 108 (307)
...++.+++..++.||+... ..++
T Consensus 107 ~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~ 186 (263)
T d1j7la_ 107 PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFS 186 (263)
T ss_dssp HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEE
T ss_pred HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEE
Confidence 22345555666666664321 2378
Q ss_pred eCCCCCCcEEECCCCceEEeeccCcc
Q 021774 109 HRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 109 H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
|+|+.|.||++++++.+-|+||+.+.
T Consensus 187 HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 187 HGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EeeccCcceeecCCceEEEeechhcc
Confidence 99999999999977666799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.33 E-value=6.5e-07 Score=71.85 Aligned_cols=115 Identities=17% Similarity=0.109 Sum_probs=74.2
Q ss_pred CCCCEEEEEEccccChHhHHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeccCCCCHHHHhccCCCCCCCCCH
Q 021774 5 TNGRRIAVKPLSAESKQGVREFITEIMTLSNVR--HPNLVELIGCCVQGTRRILVYEYVENNSLDRVLLGATKANIKLNW 82 (307)
Q Consensus 5 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 82 (307)
.+|..++||....... ..+..|+..++.+. .-.+.+++.+..+.+..++||++++|.++.... ...
T Consensus 33 ~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~---------~~~ 100 (255)
T d1nd4a_ 33 QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH---------LAP 100 (255)
T ss_dssp TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC---------CCH
T ss_pred CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc---------ccH
Confidence 4577789998765432 23566777777662 334678888888888899999999886543210 111
Q ss_pred HHHHHHHHHHHHHHHHHhc---------------------------------------------------CC----CCCe
Q 021774 83 EKRSDICVGIAKGLAFLHE---------------------------------------------------EL----VPHI 107 (307)
Q Consensus 83 ~~~~~i~~~i~~~l~~LH~---------------------------------------------------~~----~~~i 107 (307)
. ..+.+++..|+.||+ .. .+.+
T Consensus 101 ~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (255)
T d1nd4a_ 101 A---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVV 177 (255)
T ss_dssp H---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEE
T ss_pred H---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceE
Confidence 1 112223333333332 11 1247
Q ss_pred eeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 108 VHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 108 ~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
+|+|+.|.|||++++..+-|+||+.+.
T Consensus 178 iHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 178 THGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp ECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EeCCCCCcceEEeCCceEEEEEchhcc
Confidence 999999999999987667799999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.44 E-value=0.00014 Score=61.77 Aligned_cols=29 Identities=21% Similarity=0.314 Sum_probs=25.4
Q ss_pred CeeeCCCCCCcEEECCCCceEEeeccCccc
Q 021774 106 HIVHRDIKASNILLDQEFNPKIGDFGLAKL 135 (307)
Q Consensus 106 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 135 (307)
.++|||+.+.|||+++++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 689999999999998764 89999988763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00072 Score=55.65 Aligned_cols=128 Identities=14% Similarity=0.099 Sum_probs=70.4
Q ss_pred cCCCCEEEEEEccccChHhHHHHHHHHHHHhcCCCCCc--ccee-----eEEEeCCeeEEEEeccCCCCHH-----HH--
Q 021774 4 LTNGRRIAVKPLSAESKQGVREFITEIMTLSNVRHPNL--VELI-----GCCVQGTRRILVYEYVENNSLD-----RV-- 69 (307)
Q Consensus 4 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~lv~e~~~~~sL~-----~~-- 69 (307)
.++|+.+++|+..... ....++.+|+..+..|....+ +..+ ..+......+.++++++|..+. .+
T Consensus 43 ~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~ 121 (325)
T d1zyla1 43 DEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEA 121 (325)
T ss_dssp CTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHH
T ss_pred cCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHH
Confidence 5789999999987542 223556778888877632211 1111 1234456778899999764321 11
Q ss_pred -----------hccCCCC-CCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCCeeeCCCCC
Q 021774 70 -----------LLGATKA-NIKLNWE----------------------KRSDICVGIAKGLAFL-HEELVPHIVHRDIKA 114 (307)
Q Consensus 70 -----------l~~~~~~-~~~~~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp 114 (307)
....... ....++. .....+.++...+.-+ .+..+.+++|+|+.+
T Consensus 122 lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~ 201 (325)
T d1zyla1 122 VGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHA 201 (325)
T ss_dssp HHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSG
T ss_pred HHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCc
Confidence 1110000 0111111 1222333333333322 122345899999999
Q ss_pred CcEEECCCCceEEeeccCcc
Q 021774 115 SNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 115 ~Nill~~~~~~kl~dfg~~~ 134 (307)
.|||++++ ..++||+-+.
T Consensus 202 ~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 202 GNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp GGEEESSS--EEECCCTTCC
T ss_pred ccEEEeCC--ceEEechhcc
Confidence 99999743 4589999776
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.92 E-value=0.001 Score=56.32 Aligned_cols=54 Identities=11% Similarity=0.137 Sum_probs=34.5
Q ss_pred CCEEEEEEccccChHhHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeccCCCCH
Q 021774 7 GRRIAVKPLSAESKQGVREFITEIMTLSNVR-HPNLVELIGCCVQGTRRILVYEYVENNSL 66 (307)
Q Consensus 7 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 66 (307)
++.|++++... .. ...+..+|..+++.+. +.-..++++++.+ .+|+||++|.++
T Consensus 74 ~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 45677776652 22 2234567888988884 4444677777642 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.72 E-value=0.011 Score=47.83 Aligned_cols=31 Identities=19% Similarity=0.236 Sum_probs=27.5
Q ss_pred CCCeeeCCCCCCcEEECCCCceEEeeccCcc
Q 021774 104 VPHIVHRDIKASNILLDQEFNPKIGDFGLAK 134 (307)
Q Consensus 104 ~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~ 134 (307)
+.|+||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4589999999999999988777899999885
|